<SEC-DOCUMENT>0001493152-22-001056.txt : 20220112
<SEC-HEADER>0001493152-22-001056.hdr.sgml : 20220112
<ACCEPTANCE-DATETIME>20220112165604
ACCESSION NUMBER:		0001493152-22-001056
CONFORMED SUBMISSION TYPE:	S-4
PUBLIC DOCUMENT COUNT:		67
FILED AS OF DATE:		20220112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Globis NV Merger Corp.
		CENTRAL INDEX KEY:			0001903870
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-262126
		FILM NUMBER:		22527084

	BUSINESS ADDRESS:	
		STREET 1:		7100 W. CAMINO REAL, SUITE 302-48
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33433
		BUSINESS PHONE:		2128473248

	MAIL ADDRESS:	
		STREET 1:		7100 W. CAMINO REAL, SUITE 302-48
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33433

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Globis Acquisition Corp.
		CENTRAL INDEX KEY:			0001823383
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				852703418
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-262126-01
		FILM NUMBER:		22527085

	BUSINESS ADDRESS:	
		STREET 1:		7100 W. CAMINO REAL
		STREET 2:		SUITE 302-48
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33433
		BUSINESS PHONE:		2128473248

	MAIL ADDRESS:	
		STREET 1:		7100 W. CAMINO REAL
		STREET 2:		SUITE 302-48
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33433
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4
<SEQUENCE>1
<FILENAME>forms-4.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:GLAQ="http://globis.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_GLAQ_globis.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20210101_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001903870 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_079_XDX_forms%2D4.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Days_0_Days -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityCentralIndexKey">0001903870</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0057" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0064" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0111" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0114" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0125" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0149" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:ChangeInSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0323" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnderwritingIncomeLoss" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:InitialSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:AccretionForCommonStockToRedemptionAmount" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0350" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:PromissoryNoteRelatedParty" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0623" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0631" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0635" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0643" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0663" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0674" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0701" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0703" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0710" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0714" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0748" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0754" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0760" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0765" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0769" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0781" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:OfferingCostsIncludedInAccruedOfferingCosts" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0789" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0869" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0881" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0893" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0904" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0910" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0916" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember" id="xdx2ixbrl0919" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="glaq-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_PrivatePlacementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCAndUpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCAndUpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-13</xbrli:startDate>
        <xbrli:endDate>2021-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-13</xbrli:startDate>
        <xbrli:endDate>2021-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TrustAccountMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:TrustAccountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FranchiseMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:UnderwriterMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-12</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-30</xbrli:startDate>
        <xbrli:endDate>2020-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-05</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-052020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-05</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-052020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-05</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-13</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-30</xbrli:startDate>
        <xbrli:endDate>2020-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MinimumMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceBelowNinePointFiveZeroPerShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceAboveSixteenPointFiveZeroPerShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-11_srt_MaximumMember_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-11_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-02_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-19_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-13_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-21</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-062020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-062020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-11_custom_LenderMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:LenderMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_LenderMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:LenderMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-19_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-13_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PublicWarrantsMember_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceBelowNinePointFiveZeroPerShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceAboveSixteenPointFiveZeroPerShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903870</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Days">
      <xbrli:measure>GLAQ:Days</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on January 12, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20210101__20210930_zZzO9R7amqG9"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentType">S-4</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UNDER</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>THE
SECURITIES ACT OF 1933</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20210101__20210930_z7pwSiog4Wy3"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityRegistrantName">Globis
NV Merger Corp.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20210101__20210930_ztNuKH1BEzr5"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span>*</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityPrimarySicNumber_c20210101__20210930_z5iHKzjxw2H4"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityPrimarySicNumber">6770</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20210101__20210930_zXWtqVbmSw38"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">85-2703418</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
                                            or other jurisdiction of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation
    or organization)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Primary
    Standard Industrial Classification Code Number)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
                                            Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20210101__20210930_z7ojaQzYMMDc"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine1">7100
W. Camino Real</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20210101__20210930_z1Xgvv9AVfvg"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine2">Suite 302-48</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20210101__20210930_zXF08WQKavSe"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressCityOrTown">Boca
Raton</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20210101__20210930_z3PsD8uGfuql"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20210101__20210930_zZvzTsqnND8g"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressPostalZipCode">33433</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20210101__20210930_zkYIlk4JGoAh"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:CityAreaCode">212</ix:nonNumeric></span>-<span id="xdx_90E_edei--LocalPhoneNumber_c20210101__20210930_ziN7lVwwDXGh"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:LocalPhoneNumber">847-3248</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paul
Packer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zbvgKMF1vp72"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">7100
W. Camino Real</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zFX6pygaY2Jf"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">Suite 302-48</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zK3QJyNxb6pi"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Boca
Raton</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zfQ4xU78yz29"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zomCohaHB9J5"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">33433</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--CityAreaCode_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zXSGt1njz545"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:CityAreaCode">212</ix:nonNumeric></span>-<span id="xdx_90F_edei--LocalPhoneNumber_c20210101__20210930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zpXYxBdzVtA2"><ix:nonNumeric contextRef="From2021-01-012021-09-30_dei_BusinessContactMember" name="dei:LocalPhoneNumber">847-3248</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copies
of all communications, including communications sent to agent for service, should be sent to:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 51%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mark
                                            S. Selinger, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Daniel
    L. Woodard, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>McDermott
    Will &amp; Emery LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
    Vanderbilt Avenue</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, New York 10017</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel:
    (212) 547-5400</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fax:
    (212) 547-5444</b></span></p></td>
    <td style="text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 47%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Laurence
                                            S. Tauber</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cohen
    Tauber Spievack &amp;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wagner
    P.C.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>420
    Lexington Ave., Suite 2400</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York NY 10170-2499</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel:
    (212) 586-5800</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fax:
    (212) 586-5095</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public</b>: As soon as practicable after (i) this registration statement is declared effective
and (ii) upon completion of the applicable transactions described in the enclosed proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance
with General Instruction G, check the following box. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntitySmallBusiness_c20210101__20210930_zvXcKuCfUNDk"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityFilerCategory_c20210101__20210930_zIWMO4ii83nl" style="display: none"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20210101__20210930_zS64sK6H7my5"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span id="xdx_909_edei--EntityExTransitionPeriod_c20210101__20210930_zzWYNOqVF2Bg"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CALCULATION
OF REGISTRATION FEE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Title
    of Each Class of Securities to be Registered</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
    to be Registered<sup>(6)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Proposed
    Maximum Offering Price Per Share</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><sup>&#160;</sup></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Proposed
    Maximum Aggregate Offering Price</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
                                            Fee</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares, $0.001 nominal
    value<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,050,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(7)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">152,615,446.62</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,147.45</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares issuable upon exercise of warrants
    <sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,789,722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(8)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">181,581,803.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,832.63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase ordinary
    shares <sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,789,722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.72</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(9)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,368,599.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(10)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares, $0.001 nominal value<sup>(4)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,004,762</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(7)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,428,286.68</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,984.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares, $0.001 nominal value<sup>(5)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(7)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,280,000.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,879.96</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>&#160;</sup></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,844.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of ordinary shares of New Forafric (as defined below) being registered represents (i) 11,500,000 shares (the &#8220;Public
    Shares&#8221;) of common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;) of Globis Acquisition Corp., a Delaware
    corporation (&#8220;Globis&#8221;), that were registered pursuant to the Registration Statement on Form S-1 (SEC File No. 333-250939)
    (the &#8220;IPO registration statement&#8221;) and offered by Globis in its initial public offering and (ii) 3,550,833 shares of
    Common Stock. The Common Stock will automatically be converted by operation of law into Ordinary Shares of New Forafric as a result
    of the Redomiciliation (as defined below). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    ordinary shares of New Forafric to be issued upon the exercise of (i) 11,500,000 redeemable warrants (the &#8220;Public Warrants&#8221;)
    to purchase Common Stock of Globis that were registered pursuant to the IPO registration statement and offered by Globis in its initial
    public offering and (ii) 4,289,722 warrants to purchase Common Stock of Globis that were issued in private placements concurrently
    with the initial public offering (the &#8220;Private Placement Warrants&#8221; and, together with the Public Warrants, the &#8220;Warrants&#8221;).
    The Warrants will automatically be converted by operation of law into warrants to acquire Ordinary Shares of New Forafric as a result
    of the Redomiciliation. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of warrants to acquire ordinary shares of New Forafric being registered represents (i) 11,500,000 Public Warrants and (ii)
    4,289,722 Private Placement Warrants. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of ordinary shares of New Forafric being registered represents the maximum number of Ordinary Shares of New Forafric to be
    issued to Seller in connection with the Closing of the Business Combination described herein.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of ordinary shares of New Forafric being registered represents the maximum number of Ordinary Shares of New Forafric to be
    issued to Seller as Earnout Shares (as defined below).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), there are also being registered an indeterminable
    number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common
    Stock of Globis (the entity to which New Forafric will succeed following the Redomiciliation) on The Nasdaq Stock Market (&#8220;Nasdaq&#8221;)
    on January 7, 2022 ($10.14 per share of Common Stock). January 7, 2022 was a recent date for which the reported
    high and low prices of the shares of Common Stock of Globis were available prior to the initial filing of this registration statement
    (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange
    Commission (the &#8220;SEC&#8221;)). This calculation is in accordance with Rule 457(f)(1) of the Securities Act. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the exercise price of the Warrants. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Public Warrants
    of Globis (the entity to which New Forafric will succeed following the Redomiciliation) on Nasdaq on January 7, 2022 ($0.72
    per Public Warrant). January 7, 2022 was a recent date for which the reported high and low prices of the Public Warrants
    of Globis were available prior to the initial filing of this registration statement (such date being within five business days of
    the date that this registration statement was first filed with the SEC). This calculation is in accordance with Rule 457(f)(1) of
    the Securities Act. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    registration fee is required pursuant to Rule 457(g) under the Securities Act. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
    prior to the consummation of the Business Combination described in the proxy statement/prospectus, Globis NV Merger Corp. intends
    to effect a Redomiciliation in accordance with the applicable provisions of Nevada law and the Companies Act 2014 of the Laws of
    Gibraltar (the &#8220;Companies Act&#8221;) and the Companies (Re-domiciliation) Regulations 1996 of the Laws of Gibraltar (the &#8220;Re-domiciliation
    Regulations&#8221;), pursuant to which the jurisdiction of incorporation for Globis NV Merger Corp. will be changed from the State
    of Nevada to Gibraltar (the &#8220;Redomiciliation&#8221;). All securities being registered will be issued by the continuing entity
    following the Redomiciliation, which will be renamed &#8220;Forafric Global PLC&#8221; in connection with the Business Combination,
    as further described in the proxy statement/prospectus. As used in this proxy statement/prospectus, the term &#8220;registrant&#8221;
    refers to Globis Acquisition Corp. (a Delaware corporation) prior to the Merger and Redomiciliation and to New Forafric (a Gibraltar
    public company limited by shares) following the Merger and Redomiciliation. As used herein, &#8220;New Forafric&#8221; refers to
    Globis Acquisition Corp. as a Gibraltar public company limited by shares by way of continuation following the Merger and Redomiciliation
    and the Business Combination, which in connection with the Merger and Redomiciliation and simultaneously with the Business Combination,
    will change its corporate name to &#8220;Forafric Global PLC.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the
SEC, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #EB0029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. The prospectus is not an offer to sell these securities nor a solicitation
of an offer to buy these securities in any jurisdiction where the offer and sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #EB0029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #EB0029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROXY STATEMENT AND PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #EB0029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBJECT
TO COMPLETION, DATED JANUARY 12, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #EB0029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY
STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
FOR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>49,845,317
ORDINARY SHARES AND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15,789,722
WARRANTS OF <span style="text-transform: uppercase">Globis NV Merger Corp.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(AFTER
ITS REDOMICILIATION AS A PUBLIC COMPANY LIMITED BY SHARES INCORPORATED IN GIBRALTAR, WHICH WILL BE RENAMED &#8220;<span style="text-transform: uppercase">Forafric
Global PLC</span>&#8221; IN CONNECTION WITH THE BUSINESS COMBINATION DESCRIBED HEREIN)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of Globis Acquisition Corp., a Delaware corporation (&#8220;<b>Globis</b>&#8221;), has unanimously approved, and Globis
has entered into, a securities purchase agreement, dated December 19, 2021 (as it may be further amended or supplemented from time to
time, the &#8220;<b>Business Combination Agreement</b>&#8221;) which provides for the proposed Business Combination (as defined below)
between Globis and Forafric Agro Holdings Limited, a Gibraltar private company limited by shares (&#8220;<b>FAHL</b>&#8221;). As described
in this proxy statement/prospectus, Globis&#8217; stockholders are being asked to consider and vote upon (among other things) the Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement provides for the consummation of the following transactions (collectively, the &#8220;<b>Business Combination</b>&#8221;):
(i) Globis will merge with and into Globis NV Merger Corp., a Nevada corporation and a wholly-owned subsidiary of Globis (&#8220;<b>Globis
Nevada</b>&#8221;), with Globis Nevada surviving (the &#8220;<b>Merger</b>&#8221;); (ii) Globis Nevada will change its jurisdiction of
incorporation by transferring by way of a redomiciliation and domesticating as a Gibraltar public company limited by shares (the &#8220;<b>Redomiciliation</b>&#8221;)
and change its name to &#8220;Forafric Global PLC&#8221; (referred to herein as &#8220;<b>New Forafric</b>&#8221;); and (iii) immediately
following the effectiveness of the Redomiciliation, New Forafric will acquire 100% of the equity interests in FAHL from the Lighthouse
Capital Limited (&#8220;<b>Seller</b>&#8221;) and FAHL will become a direct subsidiary of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Merger and the Redomiciliation and prior to the consummation of the Business Combination, (i) the issued and outstanding
shares of Common Stock, par value $0.0001 per share (the &#8220; <b>Common Stock</b>&#8221;), of Globis will convert automatically by
operation of law, on a one-for-one basis, into ordinary shares, nominal value $0.001 per share, of New Forafric (the &#8220;<b>Ordinary
Shares</b>&#8221;); (ii) the issued and outstanding redeemable warrants that were registered pursuant to the Registration Statement on
Form S-1 (SEC File No. 333-250939) of Globis (the &#8220;<b>IPO registration statement</b>&#8221;) will automatically become redeemable
warrants to acquire Ordinary Shares at an exercise price of $11.50 per share on the terms and subject to the conditions set forth in
the applicable warrant agreement (no other changes will be made to the terms of any issued and outstanding public warrants as a result
of the Redomiciliation); (iii) each issued and outstanding warrant of Globis issued in a private placement will automatically become
warrants to acquire Ordinary Shares at an exercise price of $11.50 per share on the terms and subject to the conditions set forth in
the applicable warrant agreement (no other changes will be made to the terms of any issued and outstanding private placement warrants
as a result of the Redomiciliation); and (iv) each issued and outstanding unit of Globis that has not been previously separated into
the underlying Common Stock and underlying warrant upon the request of the holder thereof, will be cancelled and will entitle the holder
thereof to one Ordinary Share and one redeemable warrant to acquire one Ordinary Share at an exercise price of $11.50 per share on the
terms and subject to the conditions set forth in the applicable warrant agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Accordingly, this
prospectus covers 34,055,595 Ordinary Shares, 15,789,722 Ordinary Shares issuable upon exercise of warrants and 15,789,722 warrants
to acquire Ordinary Shares. It is anticipated that, upon completion of the Business Combination, (1) Globis&#8217; Public
Stockholders will own approximately 33.5% of the outstanding Ordinary Shares of New Forafric, (2) the Seller will own 44.0%
of the outstanding Ordinary Shares of New Forafric, (3) the Sponsors and Globis&#8217; independent directors (excluding Ordinary
Shares purchased by officers and directors of Globis participating in the FAHL Bonds) are expected to own approximately 9.2%
of the outstanding Ordinary Shares of New Forafric, (4) the PIPE Investors will own 5.0% of the Ordinary Shares of New
Forafric, which includes Ordinary Shares to be purchased by certain officers and directors of Globis, (5) the FAHL Bond Holders will own
2.9% of the Ordinary Shares of New Forafric and (6) FAHL Related Party Loan Holders will own 4.2% of the Ordinary Shares
of New Forafric. These percentages (i) assume no Public Stockholders exercise their Redemption Rights in connection with the
Business Combination and (ii) do not take into account Public Warrants or Private Placement Warrants to purchase Ordinary Shares of
New Forafric that will be outstanding immediately following the completion of the Business Combination. If the actual facts are
different than these assumptions, the percentage ownership retained by New Forafric&#8217;s existing stockholders in New Forafric
will be different.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes the pro forma ownership of Ordinary Shares of New Forafric following the Business Combination, including for the
Seller those Ordinary Shares issuable upon the exchange of the Seller&#8217;s FAHL Equity Securities for Ordinary Shares, under two scenarios:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            No</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            Maximum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Globis&#8217; Public Stockholders<sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">11,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">33.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsors and Independent
    Directors<sup>(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Underwriter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Seller<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,248,307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">PIPE Investors<sup>(5)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168,566</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Bond Holders<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Related Party Loan
    Holders<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.2</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that 11,500,000 Public Shares (the estimated maximum number of Public Shares that could be redeemed in connection with the
    Business Combination based on a per share redemption price of $10.20) are redeemed in connection with the Business Combination.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    3,148,333 Ordinary Shares issued upon conversion of the existing Common Stock in connection with the Redomiciliation. The Ordinary
    Shares are issued upon the automatic conversion of Common Stock concurrently with the consummation of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
    1,005,291 Ordinary Shares issuable upon the conversion of the FAHL Bonds (as defined in the accompanying proxy statement/prospectus)
    purchased by certain affiliates of the Sponsors. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
                                            an amount of Remaining Cash (as defined in the Business Combination Agreement) at the Closing
                                            based on Remaining Cash as of September 30, 2021.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to the terms of the PIPE Subscription Agreement, calculated as 4.99% of all issued and outstanding
                                            ordinary shares, after taking into account the completion of the Business Combination and
                                            related transactions.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Bonds. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Related Party Loans (as defined in the accompanying proxy
    statement/prospectus). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
units, Common Stock and warrants are currently listed on Nasdaq under the symbols &#8220;GLAQU,&#8221; &#8220;GLAQ&#8221; and &#8220;GLAQW,&#8221;
respectively. Globis will apply for listing, to be effective at the time of the Business Combination, of New Forafric&#8217;s Ordinary
Shares and warrants on Nasdaq under the proposed symbols &#8220;AFRI&#8221; and &#8220;AFRIW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
proxy statement/prospectus provides stockholders of Globis with detailed information about the Business Combination and other matters
to be considered at the special meeting of stockholders of Globis. We encourage you to read this entire document, including the Annexes
and other documents referred to herein, carefully and in their entirety. You should also carefully consider the risk factors described
in &#8220;<i>Risk Factors</i>&#8221; beginning on page 34 of this proxy statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED
IN THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION OR RELATED TRANSACTIONS
OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY
CONSTITUTES A CRIMINAL OFFENSE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
proxy statement/prospectus is dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 and</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>is
first being mailed to Globis&#8217; stockholders on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7100
W. Camino Real, Suite 302-48,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Boca
Raton, Florida 33433</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders of Globis:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the special meeting of stockholders (the &#8220;<b>Stockholders Meeting</b>&#8221;) of Globis Acquisition
Corp., a Delaware corporation (&#8220;Globis&#8221; and, after the Redomiciliation as described below, &#8220;<b>New Forafric</b>&#8221;),
at 9 a.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022, at the
offices of McDermott Will &amp; Emery LLP located at One Vanderbilt Avenue, 45<sup>th</sup> Floor, New York, New York 10017, or via a
virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be adjourned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
all stockholders will no doubt be aware, due to the current novel coronavirus (&#8220;<b>COVID-19</b>&#8221;) global pandemic, there
are restrictions in place in many jurisdictions relating to the ability to conduct in-person meetings. As part of our precautions regarding
COVID-19, we are planning for the possibility that the meeting may be held virtually over the Internet, but the physical location of
the meeting will remain at the location specified above. If we take this step, we will announce the decision to do so via a press release
and posting details on our website that will also be filed with the SEC as proxy material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Stockholders Meeting, stockholders of Globis will be asked to consider and vote upon a proposal, which is referred to herein as the
&#8220;<b>Business Combination Proposal</b>,&#8221; to approve and adopt the Business Combination Agreement, entered into as of December
19, 2021 (as may be further amended or supplemented from time to time, the &#8220;<b>Business Combination Agreement</b>&#8221;), by and
among Globis, Lighthouse Capital Limited (&#8220;<b>Seller</b>&#8221;) and Forafric Agro Holdings Limited (&#8220;<b>FAHL</b>&#8221;),
a copy of which is attached to the accompanying proxy statement/prospectus as <i>Annex A</i>, and the transactions contemplated
thereby. In accordance with the terms and subject to the conditions of the Business Combination Agreement, among other things, following
the Merger and the Redomiciliation of Globis Nevada (as defined below) to Gibraltar as described below, New Forafric (as defined below)
will acquire 100% of the equity interests of FAHL from Seller, its sole shareholder, with FAHL becoming a direct subsidiary of New Forafric
as a result thereof (the &#8220;<b>Business Combination</b>&#8221;). As a condition to closing the Business Combination, the board of
directors of Globis has unanimously approved, and stockholders of Globis are being asked to consider and vote upon (i) a proposal to
approve and adopt (the &#8220;<b>Merger Proposal</b>&#8221;) the merger of Globis with and into Globis NV Merger Corp., a Nevada corporation
and a wholly-owned subsidiary of Globis (&#8220;<b>Globis Nevada</b>&#8221;), with Globis Nevada surviving (the &#8220;<b>Merger</b>&#8221;),
and (ii) a proposal to approve and adopt (the &#8220;<b>Redomiciliation Proposal</b>&#8221;) a change of Globis Nevada&#8217;s jurisdiction
of incorporation by deregistering as a corporation in the State of Nevada and transferring by way of continuation and redomiciliation
as a public company limited by shares incorporated under the laws of Gibraltar (the &#8220;<b>Redomiciliation</b>&#8221;) and, in connection
with the Redomiciliation and simultaneously with the consummation of the Business Combination, a change of its corporate name  to
&#8220;Forafric Global PLC&#8221; (referred to herein as &#8220;<b>New Forafric</b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total consideration to be paid to the Seller in the Business Combination will be (i) 15,100,000 Ordinary Shares, subject to
reduction to the extent that the Closing Payment (as defined below) is less than $0, provided that the Seller may be issued up to
1,904,762 additional Ordinary Shares determined based on the amount of Remaining Cash (as defined in the Business Combination
Agreement) at the Closing; plus (ii) an amount (the &#8220;Closing Payment&#8221;) equal to $20,000,000 minus the outstanding amount
of all Funded Debt (as defined in the Business Combination Agreement) as of the Closing (other than Permitted Debt); provided that
Seller may receive up to an additional $20,000,000 determined based on the amount of Remaining Cash (as defined in the Business
Combination Agreement) at the Closing. The Closing Payment shall be funded by remaining funds in the Trust Account after giving
effect to any Buyer Share Redemptions (as defined in the Business Combination Agreement) and the proceeds of any potential private
placement financing.</span> In addition, the Seller is also entitled to receive up to 2,000,000 Ordinary Shares (the
&#8220;<b>Earnout Shares</b>&#8221;), subject to New Forafric achieving certain performance and share price thresholds prior to
certain future dates, in each case as described in the Business Combination Agreement. The Seller will also be entitled to receive,
as additional consideration, 20% of any cash proceeds received by New Forafric from the exercise of outstanding warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Merger and the Redomiciliation and prior to the consummation of the Business Combination, (i) the issued and outstanding
shares of Common Stock, par value $0.0001 per share (the &#8220; <b>Common Stock</b>&#8221;), of Globis will convert automatically by
operation of law, on a one-for-one basis, into ordinary shares, nominal value $0.001 per share, of New Forafric (the &#8220;<b>Ordinary
Shares</b>&#8221;); (ii) the issued and outstanding redeemable warrants that were registered pursuant to the Registration Statement on
Form S-1 (SEC File No. 333-250939) of Globis (the &#8220;<b>IPO registration statement</b>&#8221;) will automatically become redeemable
warrants to acquire Ordinary Shares at an exercise price of $11.50 per share on the terms and subject to the conditions set forth in
the applicable warrant agreement (no other changes will be made to the terms of any issued and outstanding public warrants as a result
of the Redomiciliation); (iii) each issued and outstanding warrant of Globis issued in a private placement will automatically become
warrants to acquire Ordinary Shares at an exercise price of $11.50 per share on the terms and subject to the conditions set forth in
the applicable warrant agreement (no other changes will be made to the terms of any issued and outstanding private placement warrants
as a result of the Redomiciliation); and (iv) each issued and outstanding unit of Globis that has not been previously separated into
the underlying Common Stock and underlying warrant upon the request of the holder thereof, will be cancelled and will entitle the holder
thereof to one Ordinary Share and one redeemable warrant to acquire one Ordinary Share at an exercise price of $11.50 per share on the
terms and subject to the conditions set forth in the applicable warrant agreement. For further details, see &#8220;<i>Proposal 1: The
Merger Proposal</i>&#8221; and &#8220;<i>Proposal 2: The Redomiciliation Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
conditions to closing the Business Combination and effecting the Merger and the Redomiciliation, you will also be asked to consider and
vote upon, assuming the Business Combination Proposal, the Merger Proposal and the Redomiciliation Proposal are approved and adopted,
(i) a proposal to approve and adopt the Forafric 2022 Long Term Employee Share Incentive Plan, or the Equity Incentive Plan, a copy of
which is attached to the accompanying proxy statement/prospectus as <i>Annex H</i> (the &#8220;<b>Equity Incentive Plan Proposal</b>&#8221;);
(ii) a proposal to elect six directors who, upon consummation of the Business Combination, will be the directors of New Forafric (the
&#8220;<b>Director Election Proposal</b>&#8221;); (iii) a proposal to approve and adopt the proposed Memorandum and Articles of Association
(as defined below) upon the Redomiciliation (the &#8220;<b>Charter Proposal</b>&#8221;); and (iv) a proposal to approve, for purposes
of complying with the applicable provisions of Nasdaq Stock Exchange Listing Rule 5635, the issuance of Ordinary Shares and securities
convertible into or exchangeable for Ordinary Shares in connection with the Business Combination, and the Ordinary Shares issued in connection
with the closing of the PIPE Investment, the conversion of the FAHL Bonds and the conversion of the FAHL Related Party Loans (the &#8220;<b>Nasdaq
Proposal</b>&#8221;). The Business Combination will be consummated only if the Business Combination Proposal, the Merger Proposal, the
Redomiciliation Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal and the Charter Proposal and the Nasdaq
Proposal (collectively, the &#8220;<b>Condition Precedent Proposals</b>&#8221;) are approved at the Stockholders Meeting, or otherwise
waived by the party for whose benefit such condition exists. Each of the Condition Precedent Proposals is cross-conditioned on the approval
of each other.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, you will be asked to consider and vote upon (i) on a non-binding advisory basis, certain material differences between Globis&#8217;
existing Amended and Restated Certificate of Incorporation (the &#8220;<b>Existing Organizational Documents</b>&#8221;) and the proposed
new Memorandum and Articles of Association (the &#8220;<b>Memorandum and Articles of Association</b>&#8221;) of New Forafric upon the
Redomiciliation (the &#8220;<b>Organizational Documents Proposals</b>&#8221;); and (ii) a proposal to approve the adjournment of the
Stockholders Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there
are insufficient votes for the approval of one or more proposals at the Stockholders Meeting, which is referred to herein as the &#8220;<b>Adjournment
Proposal</b>.&#8221; The Adjournment Proposal is not conditioned upon the approval of any other proposal. Each of these proposals is
more fully described in the accompanying proxy statement/prospectus, which each stockholder is encouraged to read carefully in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms and subject to the conditions of the Business Combination Agreement and assuming No Redemptions, at the Effective
Time, (i) the Seller will receive (a) up to 17,004,762 Ordinary Shares in New Forafric, and (b) the Closing Payment, (ii) existing stockholders
of Globis will retain 15,050,833 Ordinary Shares in New Forafric (iii) PIPE Investors will receive 1,712,245 Ordinary Shares sold
through the PIPE Investment, (iv) holders of the FAHL Bonds will receive 1,005,291 Ordinary Shares in New Forafric upon the conversion
of the FAHL Bonds, (v) holders of the FAHL Related Party Loans will receive 1,445,164 Ordinary Shares in New Forafric upon the
conversion of the FAHL Convertible Debt and (vi) New Forafric will hold 100% of FAHL&#8217;s equity securities. For further details,
see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination Agreement &#8212; Business Combination Consideration</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, on December 31, 2021, Globis entered into a subscription agreement (the &#8220;<b>PIPE Subscription
Agreement</b>&#8221;) with an &#8220;accredited investor&#8221; (as such term is defined in Rule 501 of Regulation D) (the &#8220;<b>PIPE
Investor</b>&#8221;), pursuant to, and on the terms and subject to the conditions of which, the PIPE Investor will purchase Ordinary
Shares of New Forafric in a private placement following the Redomiciliation and prior to the closing of the Business Combination. Pursuant
to the PIPE Subscription Agreement, the PIPE Investor will purchase, at a purchase price of $10.50 per share, a number of Ordinary
Shares (the &#8220;<b>PIPE Shares</b>&#8221;) that will be equal to the lesser of (i) 4.99% of all issued and outstanding ordinary
shares, after taking into account the completion of the Business Combination and all ordinary shares issued pursuant to the FAHL Bonds
(defined below) and other related subscription agreements, if any, and (ii) 1,904,761 ordinary shares (the &#8220;<b>PIPE Investment</b>&#8221;);
accordingly, the maximum aggregate amount to be paid by the PIPE Investor for the PIPE Shares is approximately $20 million. The purpose
of the sale of the PIPE Shares is to raise additional capital for use in connection with the Business Combination. The closing of the
PIPE Investment is contingent upon, among other things, the substantially concurrent consummation of the Business Combination. The PIPE
Subscription Agreement provide that Globis will grant the investors in the PIPE Investment certain customary registration rights and
indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the proposed Business Combination, between December 31, 2021 and January 3, 2022, affiliates (each a &#8220;Bond Investor&#8221;)
of Up and Up Capital, LLC and Globis SPAC LLC, the sponsors of Globis, subscribed for convertible bonds of FAHL, as issuer, in an aggregate
principal amount of $9.5 million (the &#8220;<b>FAHL Bonds</b>&#8221;) in a private placement, issued pursuant to a Bond Subscription
Deed (the &#8220;Bond Subscription Deed&#8221;), among FAHL, the Seller and the Bond Investors. The FAHL Bonds are unsecured obligations
of FAHL and are not transferable without the consent of FAHL (such consent not to be unreasonably withheld). Unless earlier converted
or redeemed in accordance with the terms of the FAHL Bonds, the FAHL Bonds will mature and be redeemed on June 15, 2026. Interest shall
accrue on the FAHL Bonds at a rate of 6% per annum and the Bond Investors are entitled to certain customary information rights. Pursuant
to the current terms of the FAHL Bonds, upon consummation of the Business Combination, the FAHL Bonds will automatically convert into
ordinary shares of New Forafric at  a price per share that is a 10% discount to the PIPE Investment, subject to certain adjustments.
The number of ordinary shares will be equal to the quotient that results from dividing the aggregate principal amount of the respective
FAHL Bond by $9.45, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt">In connection
with the proposed Business Combination, certain loans issued by parties <span style="background-color: white">affiliated with the Seller
(the </span>&#8220;<b>FAHL Related Party Loans</b>&#8221;) will be repaid at the Closing of the Business Combination; provided that up
to $20 million of the FAHL Related Party Loans may be converted into Ordinary Shares of FAHL at a price of $10.50 per share at the option
of the lender. As of September 30, 2021, the FAHL Related Party Loans had a balance of $15.2 million and thus were convertible into up
to 1,445,164 Ordinary Shares. For further details, see &#8220;<i>Certain Relationships and Related Person Transactions &#8212; FAHL Related
Person Transactions &#8212; Related Party Loans</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt">Concurrently
with the IPO, on December 15, 2020, Globis and the Sponsor Parties entered into the Letter Agreement (the &#8220;<b>Sponsor Letter Agreement</b>&#8221;),
pursuant to which, among other things, the Sponsor Parties agreed to (i) vote in favor of the Business Combination Agreement and the
transactions contemplated thereby, (ii) be bound by certain other covenants and agreements related to the Business Combination and (iii)
be bound by certain transfer restrictions with respect to his, her or its shares in Globis prior to the closing of the Business Combination
(the date on which such closing occurs, the &#8220;<b>Closing Date</b>&#8221;), or the earlier termination of the Business Combination
Agreement. For further details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination Agreement
&#8212; Business Combination Consideration</i>.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the consummation of the Business Combination, Seller and the Sponsors will execute and deliver to New Forafric the Lock-Up Agreement,
substantially in the forms attached to this proxy statement/prospectus as <i>Annexes D</i> and <i>E</i>, pursuant to which,
among other things, the Seller and Sponsors will agree not to, subject to certain exceptions set forth in the Lock-Up Agreement, during
the period commencing from the Closing and through the date that is 180 days from the date of the Closing (the &#8220;Lock-Up Period&#8221;):
(i) sell, offer to sell, contract, or agree to sell, hypothecate, pledge, grant any option to purchase, or otherwise transfer or dispose
of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease
a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to, any portion of New Forafric&#8217;s
Ordinary Shares, or (ii) enter into any swap or other contract that transfers to another, in whole or in part, any of the economic consequences
of ownership of any of the Ordinary Shares, whether any such transaction is to be settled by delivery of Ordinary Shares or such other
equity securities, in cash or otherwise, or (iii) publicly announce any intention to effect any transaction specified in clause (i) or
(ii). Any waiver by New Forafric of the provisions of the Lock-Up Agreement requires the approval of a committee consisting of (a) Paul
Packer and another individual designated by Paul Packer, and (b) two &#8220;independent&#8221; directors of Globis as of after the Closing,
who shall be agreed to by each of Globis and FAHL before the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, certain related agreements have been, or will be entered into on or prior to the closing of
the Business Combination (the date on which such closing occurs, the &#8220;<b>Closing Date</b>&#8221;), including the Memorandum and
Articles of Association (as defined in the accompanying proxy statement/prospectus). See &#8220;<i>Proposal 3: The Business Combination
Proposal &#8212; Certain Agreements Related to the Business Combination</i>&#8221; in the accompanying proxy statement/prospectus for
more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Organizational Documents, a holder of Public Shares (&#8220;<b>Public Stockholder</b>&#8221;) may request that Globis
redeem all or a portion of such stockholder&#8217;s Public Shares for cash if the Business Combination is consummated. Holders of units
must elect to separate the units into the underlying Public Shares and Public Warrants prior to exercising redemption rights with respect
to the Public Shares. If holders hold their units in an account at a brokerage firm or bank, holders must notify their broker or bank
that they elect to separate the units into the underlying Public Shares and Public Warrants, or if a holder holds units registered in
its own name, the holder must contact VStock Transfer, LLC (the &#8220;<b>Transfer Agent</b>&#8221;), Globis&#8217; transfer agent, directly
and instruct it to do so. The redemption rights include the requirement that a holder must identify itself in writing as a beneficial
holder and provide its legal name, phone number and address to the Transfer Agent in order to validly redeem its shares. <b>Public Stockholders
may elect to redeem their Public Shares even if they vote &#8220;FOR&#8221; the Business Combination Proposal</b>. If the Business Combination
is not consummated, the Public Shares will be returned to the respective holder, broker or bank. If the Business Combination is consummated,
and if a Public Stockholder properly exercises its right to redeem all or a portion of the Public Shares that it holds and timely delivers
its shares to the Transfer Agent, New Forafric will redeem such Public Shares for a per-share price, payable in cash, equal to the pro
rata portion of the Globis&#8217; trust account established at the consummation of its initial public offering (the &#8220;<b>Trust Account</b>&#8221;),
calculated as of two business days prior to the consummation of the Business Combination. For illustrative purposes, as of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, this would have amounted to approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
per issued and outstanding Public Share. If a Public Stockholder exercises its redemption rights in full, then it will be electing to
exchange its Public Shares for cash and will no longer own Public Shares. The redemption takes place following the Redomiciliation and
accordingly it is Ordinary Shares of New Forafric that will be redeemed immediately after consummation of the Business Combination. See
&#8220;<i>Stockholders Meeting &#8212; Redemption Rights</i>&#8221; in the accompanying proxy statement/prospectus for a detailed description
of the procedures to be followed if you wish to redeem your Public Shares for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a Public Stockholder, together with any affiliate of such Public Stockholder or any other person with whom such Public
Stockholder is acting in concert or as a &#8220;group&#8221; (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934,
as amended (&#8220;<b>Exchange Act</b>&#8221;)), will be restricted from redeeming its Public Shares with respect to more than an aggregate
of 20% of the Public Shares. Accordingly, if a Public Stockholder, alone or acting in concert or as a group, seeks to redeem more than
20% of the Public Shares, then any such shares in excess of that 20% limit would not be redeemed for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement is also subject to the satisfaction or waiver of certain other closing conditions as described in the
accompanying proxy statement/prospectus. There can be no assurance that the parties to the Business Combination Agreement would waive
any such provision of the Business Combination Agreement. In addition, the Business Combination Agreement provides that the obligations
of FAHL, the Seller and Globis to consummate the Business Combination are conditioned on, among other things, Globis having, after giving
effect to the Business Combination and the transactions contemplated thereby, net tangible assets (as determined in accordance with Rule
3a51-1(g)(1) of the Exchange Act) of at least $5,000,001.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is providing the accompanying proxy statement/prospectus and accompanying proxy card to Globis&#8217; stockholders in connection with
the solicitation of proxies to be voted at the Stockholders Meeting and at any adjournments of the special meeting. Information about
the Stockholders Meeting, the Business Combination and other related business to be considered by Globis&#8217; stockholders at the Stockholders
Meeting is included in the accompanying proxy statement/prospectus. <b>Whether or not you plan to attend the Stockholders Meeting, all
of Globis&#8217; stockholders are urged to read the accompanying proxy statement/prospectus, including the Annexes and other documents
referred to therein, carefully and in their entirety. You should also carefully consider the risk factors described in &#8220;<i>Risk
Factors</i></b>&#8221; beginning on page 34  of the accompanying proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
careful consideration, the board of directors of Globis has unanimously approved the Business Combination and unanimously recommends
that stockholders vote &#8220;FOR&#8221; the adoption of the Business Combination Agreement and approval of the transactions contemplated
thereby, including the Business Combination, and &#8220;FOR&#8221; all other proposals presented to Globis&#8217; stockholders in the
accompanying proxy statement/prospectus. When you consider the recommendation of these proposals by the board of directors of Globis,
you should keep in mind that Globis&#8217; directors and officers have interests in the Business Combination that may conflict with your
interests as a stockholder. See the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Interests of Globis&#8217;
Directors and Officers and Others in the Business Combination</i>&#8221; in the accompanying proxy statement/prospectus for a further
discussion of these considerations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Equity Incentive Plan Proposal, the Organizational Documents Proposals, the Nasdaq Proposal and the Adjournment Proposal
will require the affirmative vote of a majority of the votes cast by the stockholders present in person (which would include presence
at a virtual meeting) or represented by proxy at the Stockholders Meeting. The Organizational Documents Proposals are voted upon on a
non-binding advisory basis. Notwithstanding the foregoing, the Business Combination is conditioned upon the approval of the Condition
Precedent Proposals. The approval of the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal will require the affirmative
vote of the holders of a majority of the outstanding shares of Common Stock, voting together as a single class. Directors are elected
by a plurality of all of the votes cast by the stockholders present in person (which would include presence at a virtual meeting) or
represented by proxy at the Stockholder Meeting. This means that the six director nominees who receive the most affirmative votes will
be elected. If any of the Condition Precedent Proposals fail to receive the required approval by the stockholders of Globis at the Stockholders
Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Your
vote is very important. </i>Whether or not you plan to attend the Stockholders Meeting, please vote as soon as possible by following
the instructions in the accompanying proxy statement/prospectus to make sure that your shares are represented at the Stockholders Meeting.
If you hold your shares in &#8220;street name&#8221; through a bank, broker or other nominee, you will need to follow the instructions
provided to you by your bank, broker or other nominee to ensure that your shares are represented and voted at the Stockholders Meeting.
The transactions contemplated by the Business Combination Agreement will be consummated only if the Condition Precedent Proposals are
approved at the Stockholders Meeting. Each of the Condition Precedent Proposals is cross-conditioned on the approval of each other. The
Adjournment Proposal is not conditioned on the approval of any other proposal set forth in the accompanying proxy statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you sign, date and return your proxy card without indicating how you wish to vote, your proxy will be voted FOR each of the proposals
presented at the Stockholders Meeting. If you fail to return your proxy card or fail to instruct your bank, broker or other nominee how
to vote, and do not attend the Stockholders Meeting in person, the effect will be, among other things, that your shares will not be counted
for purposes of determining whether a quorum is present at the Stockholders Meeting. If you are a stockholder of record and you attend
the Stockholders Meeting and wish to vote in person, you may withdraw your proxy and vote in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
EXERCISE YOUR REDEMPTION RIGHT, YOU MUST DEMAND IN WRITING THAT YOUR PUBLIC SHARES ARE REDEEMED FOR A PRO RATA PORTION OF THE FUNDS HELD
IN THE TRUST ACCOUNT AND TENDER YOUR SHARES TO GLOBIS&#8217; TRANSFER AGENT AT LEAST TWO BUSINESS DAYS PRIOR TO THE VOTE AT THE STOCKHOLDERS
MEETING. IN ORDER TO EXERCISE YOUR REDEMPTION RIGHT, YOU NEED TO IDENTIFY YOURSELF AS A BENEFICIAL HOLDER AND PROVIDE YOUR LEGAL NAME,
PHONE NUMBER AND ADDRESS IN YOUR WRITTEN DEMAND. YOU MAY TENDER YOUR SHARES BY EITHER DELIVERING YOUR SHARE CERTIFICATES (IF ANY) AND
OTHER REDEMPTION FORMS TO THE TRANSFER AGENT OR BY DELIVERING YOUR SHARES ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANY&#8217;S DWAC
(DEPOSIT WITHDRAWAL AT CUSTODIAN) SYSTEM. IF THE BUSINESS COMBINATION IS NOT COMPLETED, THEN THESE SHARES WILL BE RETURNED TO YOU OR
YOUR ACCOUNT. IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANK OR BROKER TO WITHDRAW
THE SHARES FROM YOUR ACCOUNT IN ORDER TO EXERCISE YOUR REDEMPTION RIGHT.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of the board of directors of Globis, I would like to thank you for your support and look forward to the successful completion
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 336.6pt; text-align: justify; text-indent: -12.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED
IN THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION OR RELATED TRANSACTIONS
OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY
CONSTITUTES A CRIMINAL OFFENSE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying proxy statement/prospectus is dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022
and is first being mailed to stockholders on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ADDITIONAL
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
accompanying document is the proxy statement of Globis for the Stockholders Meeting and the prospectus for the securities of New Forafric,
the continuing Gibraltar public company limited by shares following the Redomiciliation. This registration statement and the accompanying
proxy statement/prospectus is available without charge to stockholders of Globis upon written or oral request. This document and other
filings by Globis with the Securities and Exchange Commission may be obtained by either written or oral request to Globis Acquisition
Corp., 7100 W. Camino Real, Suite 302-48, Boca Raton, FL 33433 or by telephone at (212) 847-3248.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities and Exchange Commission maintains an internet site that contains reports, proxy and information statements, and other information
regarding issuers that file electronically with the Securities and Exchange Commission. You may obtain copies of the materials described
above at the commission&#8217;s internet site at www.sec.gov.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">In addition, if you have questions
about the Proposals or the accompanying proxy statement/ prospectus, would like additional copies of the accompanying proxy statement/prospectus,
or need to obtain proxy cards or other information related to the proxy solicitation, please contact &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(&#8220;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8221;), our proxy solicitor, by calling (&#160;&#160;&#160;&#160;&#160;&#160;&#160;)
&#160;&#160;&#160;&#160;&#160;&#160;&#160;- &#160;&#160;&#160;&#160;&#160;&#160;&#160;, or banks and brokers can call collect at
(&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) &#160;&#160;&#160;&#160;&#160;&#160;&#160;- &#160;&#160;&#160;&#160;&#160;&#160;,
or by emailing &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. You will not be charged for
any of the documents that you request.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section entitled &#8220;<i>Where You Can Find More Information</i>&#8221; of the accompanying proxy statement/ prospectus for further
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
contained on the Globis website, or any other website, is expressly not incorporated by reference into the accompanying proxy statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
obtain timely delivery of the documents, you must request them no later than five business days before the date of the Stockholders Meeting,
or no later than &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7100
W. Camino Real, Suite 302-48</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Boca
Raton, FL 33433</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
OF <span style="text-transform: uppercase">special meeting of stockholders</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TO
BE HELD ON &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
THE STOCKHOLDERS OF GLOBIS ACQUISITION CORP.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN that a special meeting of stockholders (the &#8220;<b>Stockholders Meeting</b>&#8221;) of Globis Acquisition Corp., a
Delaware corporation (&#8220;<b>Globis</b>&#8221; and, after the Redomiciliation as described below, <b>&#8220;New Forafric&#8221;</b>),
will be held at 9 a.m., Eastern Time, on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2022, at the offices
of McDermott Will &amp; Emery located at One Vanderbilt Avenue, 45th Floor, New York, New York 10017, or via a virtual meeting, or at
such other time, on such other date and at such other place to which the meeting may be adjourned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
all stockholders will no doubt be aware, due to the current novel coronavirus (&#8220;<b>COVID-19</b>&#8221;) global pandemic, there
are restrictions in place in many jurisdictions relating to the ability to conduct in-person meetings. As part of our precautions regarding
COVID-19, we are planning for the possibility that the meeting may be held virtually over the Internet, but the physical location of
the meeting will remain at the location specified above for the purposes of our Amended and Restated Certificate of Incorporation. If
we take this step, we will announce the decision to do so via a press release and posting details on our website that will also be filed
with the SEC as proxy material. You are cordially invited to attend the Stockholders Meeting, which will be held for the following purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 1 &#8212; The Merger Proposal &#8212; </i>To consider and vote upon a proposal to approve and adopt the merger of Globis with
    and into Globis NV Merger Corp., a Nevada corporation and a wholly-owned subsidiary of Globis (&#8220;<b>Globis Nevada</b>&#8221;),
    with Globis Nevada surviving (the &#8220;<b>Merger</b>&#8221;). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 2 &#8212; The Redomiciliation Proposal &#8212; </i>To consider and vote upon a proposal to change the corporate structure and
    jurisdiction of incorporation of Globis Nevada by way of continuation from a corporation incorporated under the laws of the State
    of Nevada to a public company limited by shares incorporated under the laws of Gibraltar (the &#8220;<b>Redomiciliation</b>&#8221;).
    The Redomiciliation will be effected immediately prior to the consummation of the Business Combination (as defined below) by Globis
    Nevada filing an application for establishing domicile in Gibraltar, along with all applicable notices, undertakings and other documents
    required to be filed, and filing an application to de-register with the Nevada Secretary of State. As used herein, &#8220;<b>New
    Forafric</b>&#8221; refers to Globis as a Gibraltar public company limited by shares by way of continuation following the Redomiciliation,
    which, in connection with the Redomiciliation and simultaneously with the consummation of the Business Combination, will change its
    corporate name to &#8220;Forafric Global PLC.&#8221; We refer to this proposal as the &#8220;<b>Redomiciliation Proposal</b>.&#8221;
    The form of the proposed Memorandum and Articles of Association of New Forafric to become effective upon the Redomiciliation, is
    attached to the accompanying proxy statement/ prospectus as <i>Annex C</i>. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No.3 &#8212; The Business Combination Proposal &#8212; </i>To consider and vote upon a proposal to approve the Business Combination
    Agreement, entered into as of December 19, 2021 (as amended or supplemented from time to time, the &#8220;<b>Business Combination
    Agreement</b>&#8221;), by and among Globis, Lighthouse Capital Limited (&#8220;<b>Seller</b>&#8221;) and Forafric Agro Holdings Limited
    (&#8220;<b>FAHL</b>&#8221;), and the transactions contemplated by the Business Combination Agreement (collectively, the &#8220;<b>Business
    Combination</b>&#8221;). Pursuant to the Business Combination Agreement, among other things, Globis will acquire 100% of the equity
    interests of FAHL from Seller, its sole shareholder, with FAHL becoming a direct subsidiary of New Forafric as a result thereof,
    as described in more detail in the accompanying proxy statement/prospectus. We refer to this proposal as the &#8220;<b>Business Combination
    Proposal</b>.&#8221; A copy of the Business Combination Agreement is attached to the accompanying proxy statement/prospectus as <i>Annex
    A</i>. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 4 &#8212; The Equity Incentive Plan Proposal &#8212; </i>To consider and vote upon the approval of the Equity Incentive Plan.
    We refer to this as the &#8220;<b>Equity Incentive Plan Proposal</b>.&#8221; A copy of the Equity Incentive Plan is attached to the
    accompanying proxy statement/prospectus as <i>Annex H.</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 5 &#8212; The Director Election Proposal&#8201; &#8212;</i> To consider and vote upon a proposal to elect six directors to serve
    on the board of directors of New Forafric (the &#8220;<b>New Forafric Board</b>&#8221;) until the 2025 annual general meeting
    and until their respective successors are duly elected and qualified. We refer to this as the &#8220;<b>Director Election Proposal</b>.&#8221;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 6 &#8212; The Charter Proposal &#8212;</i> To consider and vote upon the approval of the amendment and restatement of the Existing
    Organizational Documents (as defined herein) in their entirety by the proposed new memorandum and articles of association (the &#8220;<b>Memorandum
    and Articles of Association</b>&#8221;) of New Forafric (a public company limited by shares domiciled in Gibraltar), assuming the
    Merger Proposal and the Redomiciliation Proposal is approved and adopted, and the filing with and acceptance by the Registrar of
    Companies in Gibraltar of the filing of the application for establishing domicile in Gibraltar in accordance with the Companies Act
    2014 of the Laws of Gibraltar (the &#8220;<b>Companies Act</b>&#8221;) and the Companies (Re-domiciliation) Regulations 1996 of the
    Laws of Gibraltar (the &#8220;<b>Re-domiciliation Regulations</b>&#8221;), including authorization of the change in authorized share
    capital as indicated therein and the change of name of Globis to &#8220;Forafric Global PLC&#8221; in connection with the Business
    Combination. We refer to this as the &#8220;<b>Charter Proposal</b>.&#8221; A copy of the Memorandum and Articles of Association
    is attached to the accompanying proxy statement/prospectus as <i>Annex C</i>. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 7 &#8212; The Organizational Documents Proposals</i> &#8212; To consider and vote upon, on a non-binding advisory basis, certain
    governance provisions in the Memorandum and Articles of Association (collectively, the &#8220;<b>Organizational Documents Proposals</b>&#8221;),
    to approve the following material differences between the current Amended and Restated Certificate of Incorporation of Globis (the
    &#8220;<b>Existing Organizational Documents</b>&#8221;) and the Memorandum and Articles of Association (the &#8220;<b>Proposed Organizational
    Documents</b>&#8221;) of New Forafric: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
    Documents Proposal 7A</i> &#8212; An amendment to change the authorized capital stock of Globis from (i) 100,000,000 shares of common
    stock, par value $0.0001 per share (the &#8220;<b>Common Stock</b>&#8221;), and 1,000,000 shares of preferred stock, par value $0.0001
    per share, to (ii) 100,000,000 ordinary shares, nominal value $0.001 per share, of New Forafric (the &#8220;<b>Ordinary Shares</b>&#8221;),
    and 1,000,000 preferred shares, nominal value $0.001 per share, of New Forafric (the &#8220;<b>Preferred Shares</b>&#8221;) (this
    proposal is referred to herein as &#8220;<b>Organizational Documents Proposal 7A</b>&#8221;); </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
    Documents Proposal 7B</i> &#8212; Certain other changes in connection with the replacement of Existing Organizational Documents with
    the Proposed Organizational Documents to be adopted as part of the Merger and the Redomiciliation, including (1) changing the post-Business
    Combination corporate name from &#8220;Globis Acquisition Corp.&#8221; to &#8220;Forafric Global PLC,&#8221; which is expected to
    occur after the Redomiciliation in connection with the Business Combination, (2) making New Forafric&#8217;s corporate existence
    perpetual and (3) removing certain provisions related to our status as a blank check company that will no longer be applicable upon
    consummation of the Business Combination, all of which the board of directors of Globis believes are necessary to adequately address
    the needs of New Forafric after the Business Combination (this proposal is referred to herein as &#8220;<b>Organizational Documents
    Proposal 7B</b>&#8221;).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 8 &#8212; The Nasdaq Proposal</i> &#8212; To consider and vote upon a proposal to approve, for the purposes of complying with
    the applicable provisions of Nasdaq Stock Exchange Listing Rule 5635, the issuance of Ordinary Shares and securities convertible
    into or exchangeable for Ordinary Shares in connection with the Business Combination and the Ordinary Shares issued in connection
    with the PIPE Investment, the conversion of the FAHL Bonds and the conversion of the FAHL Related Party Loans (this proposal is referred
    to herein as the &#8220;<b>Nasdaq Proposal</b>&#8221;). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    No. 9 &#8212; The Adjournment Proposal &#8212; </i>To consider and vote upon a proposal to approve the adjournment of the special
    meeting of stockholders to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that
    there are insufficient votes for the approval of one or more proposals at the special meeting of stockholders (this proposal is referred
    to herein as the &#8220;<b>Adjournment Proposal</b>&#8221;). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Proposals are described in the accompanying proxy statement/prospectus, which we encourage you to read in its entirety before voting.
Only holders of record of ordinary shares of Globis at the close of business on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 (the &#8220;<b>Record Date</b>&#8221;)
are entitled to notice of the Stockholders Meeting and to vote and have their votes counted at the Stockholders Meeting and any adjournments
of the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
careful consideration, the board of directors of Globis has determined that the Proposals are fair to and in the best interests of Globis
and its stockholders and unanimously recommends that the holders of Globis&#8217; common stock entitled to vote with respect to each
of the Proposals, vote or give instruction to vote &#8220;FOR&#8221; the Merger Proposal, &#8220;FOR&#8221; the Redomiciliation Proposal,
&#8220;FOR&#8221; the Business Combination Proposal, &#8220;FOR&#8221; the Equity Incentive Plan Proposal, &#8220;FOR&#8221; the Director
Election Proposal, &#8220;FOR&#8221; the Charter Proposal, &#8220;FOR&#8221; each of the Organizational Documents Proposals, &#8220;FOR&#8221;
the Nasdaq Proposal and &#8220;FOR&#8221; the Adjournment Proposal.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
existence of any financial and personal interests of one or more of Globis&#8217; directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Globis and its stockholders and what he,
she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for the Proposals.
See the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Interests of Globis&#8217; Directors and Officers
and Others in the Business Combination</i>&#8221; in the accompanying proxy statement/prospectus for a further discussion of these considerations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Organizational Documents, a holder of Globis common stock (&#8220;<b>Public Shares</b>&#8221;) that were registered pursuant
to the initial public offering registration statement of Globis (&#8220;<b>Public Stockholder</b>&#8221;) may request that Globis redeem
all or a portion of its Public Shares for cash if the Business Combination is consummated. As a holder of Public Shares, you will be
entitled to receive cash for any Public Shares to be redeemed only if you:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    hold Public Shares, or (b) hold Public Shares through units, you elect to separate your units into the underlying Public Shares and
    warrants prior to exercising your redemption rights with respect to the Public Shares; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submit
    a written request to VStock Transfer, LLC, Globis&#8217; transfer agent (the &#8220;<b>Transfer Agent</b>&#8221;), in which you (a)
    request that Globis redeem all or a portion of your Public Shares for cash, and (b) identify yourself as the beneficial holder of
    the Public Shares and provide your legal name, phone number and address; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
    your Public Shares to VStock Transfer, LLC, Globis&#8217; transfer agent, physically or electronically through The Depository Trust
    Company (&#8220;<b>DTC</b>&#8221;). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Stockholders may seek to have their Public Shares redeemed by Globis, regardless of whether they vote for or against the Business Combination
Proposal or any other Proposal and whether they held Globis common stock as of the Record Date or acquired them after the Record Date
(&#8220;<b>Redemption</b>&#8221;). Any Public Stockholder who holds common stock of Globis on or before&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 (two (2) business days before the Stockholders Meeting) will have the right to demand that his, her or its shares be redeemed
for a <i>pro rata</i> share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid. For
illustrative purposes, based on funds in the Trust Account of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
million on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2022 and including anticipated additional interest
through the closing of the Business Combination (assuming interest accrues at recent rates and no additional tax payments are made out
of the Trust Account), the estimated per share redemption price is expected to be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
.. A Public Stockholder who has properly tendered his, her or its Public Shares for Redemption will be entitled to receive his, her or
its pro rata portion of the aggregate amount then on deposit in the Trust Account in cash for such shares only if the Business Combination
is completed. If the Business Combination is not completed, the Redemptions will be canceled and the tendered shares will be returned
to the relevant Public Stockholders as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
stockholders who seek to redeem their Public Shares must demand Redemption no later than 5:00 p.m., Eastern Time, on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 (two (2) business days before the Stockholders Meeting) by (a) submitting a written request to the Transfer Agent that Globis
redeem such holder&#8217;s Public Shares for cash, (b) affirmatively certifying in such request to the Transfer Agent for Redemption
if such holder is acting in concert or as a &#8220;group&#8221; (as defined in Section 13 d-3 of the Exchange Act) with any other stockholder
with respect to common stock of Globis and (c) delivering their common stock, either physically or electronically using DTC&#8217;s deposit/withdrawal
at custodian system (&#8220;<b>DWAC</b>&#8221;), at the holder&#8217;s option, to the Transfer Agent prior to the Stockholders Meeting.
If you hold the shares in &#8220;street name&#8221;, you will have to coordinate with your broker to have your shares certificated or
delivered electronically. Certificates that have not been tendered to the Transfer Agent (either physically or electronically) in accordance
with these procedures will not be redeemed for cash. There is a nominal cost associated with this tendering process and the act of certificating
the shares or delivering them through the DWAC system. The Transfer Agent will typically charge the tendering broker a nominal fee and
it would be up to the broker whether or not to pass this cost on to the redeeming stockholder. In the event the Business Combination
is not completed, this may result in an additional cost to stockholders for the return of their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a Public Stockholder, together with any affiliate of his, her, its or any other person with whom he, she or it is acting
in concert or as a &#8220;group&#8221; (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking Redemption
Rights with respect to 20% or more of Globis&#8217; Public Shares. Accordingly, any shares held by a Public Stockholder or &#8220;group&#8221;
in excess of such 20% cap will not be redeemed by Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the initial public offering of Globis, on December 15, 2020, Globis entered into the Sponsor Letter Agreement, pursuant to
which , the Sponsor, officers and directors of Globis have waived all of their Redemption Rights and will not have Redemption Rights
with respect to any Globis common stock owned by them, directly or indirectly. Holders of the warrants will not have redemption rights
with respect to the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the Director
Election Proposal, the Charter Proposal and the Nasdaq Proposal is interdependent upon the others and must be approved in order for Globis
to complete the Business Combination contemplated by the Business Combination Agreement. If any of the Merger Proposal, the Redomiciliation
Proposal, Business Combination Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal, the Charter Proposal or
the Nasdaq Proposal fails to receive the required approval by the stockholders of Globis at the Stockholders Meeting, the Business Combination
will not be completed. The approval of the Equity Incentive Plan Proposal, the Organizational Documents Proposals, the Nasdaq Proposal
and the Adjournment Proposal will require the affirmative vote of a majority of the votes cast by the stockholders present in person
(which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. The Organizational Documents
Proposals are voted upon on a non-binding advisory basis. Notwithstanding the foregoing, the Business Combination is conditioned upon
the approval of the Business Combination Proposal, the Merger Proposal, the Redomiciliation Proposal, the Equity Incentive Plan Proposal,
the Director Election Proposal, the Charter Proposal and the Nasdaq Proposal (collectively, the &#8220;<b>Condition Precedent Proposals</b>&#8221;).
Each of the Condition Precedent Proposals is cross-conditioned on the approval of each other. The approval of the Merger Proposal, the
Redomiciliation Proposal, and the Charter Proposal will require the affirmative vote of the holders of a majority of the outstanding
shares of Common Stock, voting together as a single class. Directors are elected by a plurality of all of the votes cast by the stockholders
present in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholder Meeting. This means
that the six director nominees who receive the most affirmative votes will be elected. If any of the Condition Precedent Proposals fail
to receive the required approval by the stockholders of Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we are required to meet virtually to take necessary precautions due to COVID-19, all stockholders of Globis are cordially invited to
attend the Stockholders Meeting in person. To ensure your representation at the Stockholders Meeting, however, you are urged to mark,
sign and date the enclosed proxy card and return it as soon as possible in the pre-addressed postage paid envelope provided. If you are
a stockholder of record of Globis common stock, you may also cast your vote in person at the Stockholders Meeting. If your shares are
held in an account at a brokerage firm or bank, or by a nominee, you must instruct your broker, bank or nominee on how to vote your shares
or, if you wish to attend the Stockholders Meeting and vote in person, obtain a proxy from your broker, bank or nominee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not you plan to attend the Stockholders Meeting, we urge you to read the accompanying proxy statement/prospectus (and any documents
incorporated into the accompanying proxy statement/ prospectus by reference) carefully. Please pay particular attention to the section
entitled &#8220;<i>Risk Factors</i>&#8221; in the accompanying proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Your
vote is important regardless of the number of shares you own. </b>Whether you plan to attend the Stockholders Meeting or not, please
mark, sign and date the enclosed proxy card and return it as soon as possible in the envelope provided. If your shares are held in &#8220;street
name&#8221; or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially
own are properly counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for your participation. We look forward to your continued support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
Order of the Board of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Paul
    Packer, Chairman</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IF
YOU RETURN YOUR PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR SHARES WILL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS.
YOU MAY EXERCISE YOUR RIGHTS TO DEMAND THAT GLOBIS REDEEM YOUR SHARES FOR A PRO RATA PORTION OF THE FUNDS HELD IN THE TRUST ACCOUNT WHETHER
YOU VOTE FOR OR AGAINST THE PROPOSALS. TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST TENDER YOUR SHARES TO GLOBIS&#8217; TRANSFER AGENT
AT LEAST TWO (2) BUSINESS DAYS PRIOR TO THE STOCKHOLDERS MEETING. YOU MAY TENDER YOUR SHARES FOR REDEMPTION BY EITHER YOUR SHARE CERTIFICATES
(IF ANY) AND OTHER REDEMPTION FORMS TO THE TRANSFER AGENT OR BY DELIVERING YOUR SHARES ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANY&#8217;S
DEPOSIT/WITHDRAWAL AT CUSTODIAN (&#8220;DWAC&#8221;) SYSTEM. IF THE BUSINESS COMBINATION IS NOT COMPLETED, THEN THESE TENDERED SHARES
WILL NOT BE REDEEMED FOR CASH AND WILL BE RETURNED TO THE APPLICABLE <span style="text-transform: uppercase">stockholder</span>. IF YOU
HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BROKER OR BANK TO WITHDRAW THE SHARES FROM YOUR
ACCOUNT IN ORDER TO EXERCISE YOUR REDEMPTION RIGHTS. SEE THE SECTION ENTITLED <i>&#8220;STOCKHOLDERS MEETING &#8212; REDEMPTION RIGHTS&#8221;
</i>FOR MORE SPECIFIC INSTRUCTIONS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">TABLE
OF CONTENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Gk_001">FREQUENTLY
    USED TERMS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Gk_002">MARKET
    AND INDUSTRY DATA</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Gk_003">TRADEMARKS
    AND SERVICE MARKS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Gk_004">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Gk_005">SUMMARY
    OF THE PROXY STATEMENT/PROSPECTUS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_001">SELECTED
    HISTORICAL FINANCIAL INFORMATION OF GLOBIS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_002">SELECTED
    HISTORICAL COMBINED FINANCIAL AND OTHER DATA OF FAHL</a> </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_003">COMPARATIVE
    PER SHARE INFORMATION</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>33</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_004">QUESTIONS
    AND ANSWERS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>34</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_005">RISK
    FACTORS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>48</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_006">STOCKHOLDERS
    MEETING</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>56</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_007">PROPOSAL
    1: THE MERGER PROPOSAL</a> </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>61</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#Na_008">PROPOSAL
    2: THE REDOMICILIATION PROPOSAL</a> </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>62</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#mani_001"><span style="font-size: 10pt"><b>PROPOSAL
    3: THE BUSINESS COMBINATION PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>77</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#mani_002"><span style="font-size: 10pt"><b>PROPOSAL
    4: THE EQUITY INCENTIVE PLAN PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>110</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#mani_003"><span style="font-size: 10pt"><b>PROPOSAL
    5: THE DIRECTOR ELECTION PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>113</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#mani_004"><span style="font-size: 10pt"><b>PROPOSAL
    6: THE CHARTER PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>114</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#mani_005"><span style="font-size: 10pt"><b>PROPOSAL
    7: THE ORGANIZATIONAL DOCUMENTS PROPOSALS</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>115</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_001"><span style="font-size: 10pt"><b>PROPOSAL
    8: NASDAQ PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>120</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_002"><span style="font-size: 10pt"><b>PROPOSAL
    9: THE ADJOURNMENT PROPOSAL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>121</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_003"><span style="font-size: 10pt"><b>UNAUDITED
    PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>122</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_004"><span style="font-size: 10pt"><b>COMPARATIVE
    PER SHARE INFORMATION </b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>133</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_005"><span style="font-size: 10pt"><b>INFORMATION
    ABOUT GLOBIS</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>134</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_006"><span style="font-size: 10pt"><b>DIRECTORS,
    OFFICERS, EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE OF GLOBIS PRIOR TO THE BUSINESS COMBINATION</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>139</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_007"><span style="font-size: 10pt"><b>MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF GLOBIS</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>147</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_008"><span style="font-size: 10pt"><b>DESCRIPTION
    OF NEW FORAFRIC&#8217;S SECURITIES</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>152</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_009"><span style="font-size: 10pt"><b>BENEFICIAL
    OWNERSHIP OF SECURITIES</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>159</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ma_010"><span style="font-size: 10pt"><b>INFORMATION
    ABOUT FAHL</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>160</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_017">MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF FAHL</a> </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>171</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#kd_002"><span style="font-size: 10pt"><b>EXECUTIVE
    COMPENSATION OF FAHL </b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>179</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_003">MANAGEMENT
    OF NEW FORAFRIC FOLLOWING THE BUSINESS COMBINATION</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>183</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_004">CERTAIN
    RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>188</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_005">SECURITIES
    ACT RESTRICTIONS ON RESALE OF NEW FORAFRIC&#8217;S SECURITIES</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>191</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_006">SHAREHOLDER
    PROPOSALS AND NOMINATIONS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_007">APPRAISAL
    RIGHTS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#kd_008"><span style="font-size: 10pt; text-transform: uppercase"><b>stockholder
    </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMUNICATIONS</span></b></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_009">LEGAL
    MATTERS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_010">EXPERTS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_011">DELIVERY
    OF DOCUMENTS TO <span style="text-transform: uppercase">stockholder</span>S</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_012">TRANSFER
    AGENT</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_013">SUBMISSION
    OF PROPOSALS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>193</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#kd_014">ENFORCEABILITY
    OF CIVIL LIABILITY</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>193</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#kd_015"><span style="font-size: 10pt"><b>WHERE
    YOU CAN FIND MORE INFORMATION</b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>193</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#kd_016"><span style="font-size: 10pt"><b>INDEX
    TO FINANCIAL STATEMENTS </b></span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    A BUSINESS COMBINATION AGREEMENT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    B EXISTING ORGANIZATIONAL DOCUMENTS OF GLOBIS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    C FORM OF COMPANY&#8217;S MEMORANDUM AND ARTICLES OF ASSOCIATION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    D FORM OF SELLER LOCK-UP AGREEMENT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    E FORM OF SPONSOR LOCK-UP AGREEMENT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    F SPONSOR LETTER AGREEMENT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    G <span style="text-transform: uppercase">Registration Rights Agreement</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G-1</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
    H <span style="text-transform: uppercase">Forafric 2022 Long Term Employee Share Incentive Plan</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H-1</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br />&#160;</b></span></p>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Gk_001"></span>FREQUENTLY
USED TERMS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Definitions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and &#8220;Globis&#8221;
refer to Globis Acquisition Corp. (which prior to the Merger and the Redomiciliation is a corporation incorporated under the laws of
the Delaware and thereafter a public company limited by shares incorporated under the laws of Gibraltar).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this document:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Adjournment
Proposal</b>&#8221; means the proposal to be considered at the Stockholders Meeting to adjourn the Stockholders Meeting to a later date
or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval
of one or more proposals at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Aggregate
Transaction Proceeds</b>&#8221; means an amount equal to the aggregate proceeds from the PIPE Investment and the aggregate cash proceeds
available for release to Globis from the Trust Account in connection with the Business Combination, less the aggregate amount of fees
and expense payable by Globis in connection with the Business Combination which remain unpaid as of immediately prior to the Closing
and the aggregate accrued liabilities of Globis as of the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Amended
and Restated Certificate of Incorporation</b>&#8221; means Globis&#8217; Amended and Restated Certificate of Incorporation, dated December
10, 2020, as may hereafter be amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>ASC</b>&#8221;
means the Accounting Standards Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Business
Combination</b>&#8221; means the transactions contemplated by the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Business
Combination Agreement</b>&#8221; means the Business Combination Agreement, entered into as of December 19, 2021, by and among Globis,
FAHL and Seller, as it may be amended and supplemented from time to time. A copy of the Business Combination Agreement is attached to
this proxy statement/ prospectus as <i>Annex A</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Business
Combination Proposal</b>&#8221; means the proposal to be considered at the Stockholders Meeting to approve the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Charter
Proposal</b>&#8221; means Proposal No. 6 to approve the Memorandum and Articles of Association of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Closing</b>&#8221;
means the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Closing
Date</b>&#8221; means the date on which the closing of the Business Combination occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Code</b>&#8221;
means the Internal Revenue Code of 1986, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Combination
Period</b>&#8221; means the 12 months from the closing of the IPO, or such period as extended by a resolution of the Globis board of
directors, within which Globis is required to complete an initial business combination under its Amended and Restated Certificate of
Incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Common
Stock</b>&#8221; means the common stock of Globis, par value $0.0001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Companies
Act</b>&#8221; means the Companies Act 2014 of the Laws of Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Condition
Precedent Proposals</b>&#8221; means the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity
Incentive Plan Proposal, the Director Election Proposal, the Charter Proposal and the Nasdaq Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FAHL
Bonds</b>&#8221; means the convertible bonds in an amount of $9.5 million issued by FAHL to third-party holders, pursuant to which
the outstanding principal of the convertible bonds and accrued interest, concurrently with the consummation of the PIPE Investment and
the Business Combination, convert to Ordinary Shares of New Forafric at the rate of $9.45 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FAHL
Bond Holders</b>&#8221; means the holders who have been issued the FAHL Bonds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FAHL
Related Party Loans</b>&#8221; means the loans issued by certain parties <span style="background-color: white">affiliated with the
Seller</span> in an aggregate amount of approximately  $15.2 million which will be repaid at the Closing of the
Business Combination; provided that up to $20 million of such loans may be convertible into Ordinary Shares of FAHL at a price of
$10.50 per share at the option of the lender.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>DGCL</b>&#8221;
means the Delaware General Corporation Law, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Director
Election Proposal</b>&#8221; means Proposal No. 5 to elect six directors to serve on the board of directors of New Forafric until the 2025 annual general meeting and until their respective successors are duly elected and qualified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>DTC</b>&#8221;
means the Depository Trust Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>DWAC</b>&#8221;
means The Depository Trust Company&#8217;s deposit/withdrawal at custodian system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Equity
Incentive Plan</b>&#8221; means the Forafric 2022 Long Term Employee Share Incentive Plan, which will become effective on the Closing
Date. A copy of the Equity Incentive Plan is attached to this proxy statement/ prospectus as <i>Annex H</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Equity
Incentive Plan Proposal</b>&#8221; means the proposal to be considered at the Stockholders Meeting to approve the Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Exchange
Act</b>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Existing
Organizational Documents</b>&#8221; means the current Amended and Restated Certificate of Incorporation adopted as of December 10, 2020
of Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FAHL</b>&#8221;
means Forafric Agro Holdings Limited, a Gibraltar private company limited by shares with incorporation number 114436 and registered office
at 57/67 Line Wall Road, Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FAHL
2021 Plan</b>&#8221; means the Forafric 2021 Long Term Employee Share Incentive Plan adopted on June 22, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FATCA</b>&#8221;
means the Foreign Account Tax Compliance Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>foreign
action</b>&#8221; has the meaning provided in the Organizational Documents Proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>GAAP</b>&#8221;
means U.S. generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Globis</b>&#8221;
means Globis Acquisition Corp. (which, prior to the Merger and Redomiciliation, is a corporation incorporated under the laws of the State
of Delaware and after the Merger and Redomiciliation will be a public company limited by shares incorporated under the laws of Gibraltar
and will be referred to as &#8220;New Forafric&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Globis
Board</b>&#8221; means the board of directors of Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Globis
Shares</b>&#8221; means, shares of Globis Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Investment
Company Act</b>&#8221; means the Investment Company Act of 1940, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>IPO</b>&#8221;
means Globis&#8217; initial public offering of its Units, Public Shares and Public Warrants pursuant to the IPO registration statement
and completed on December 15, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>IPO
registration statement</b>&#8221; means the registration statement filed for Globis&#8217; IPO on Form S-1 declared effective by the
SEC on December 8, 2020 (SEC File Nos. 333-250939).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>JOBS
Act</b>&#8221; means the Jumpstart Our Business Startups Act of 2012, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Lock-up
Agreement</b>&#8221; means each of the Lock-Up Agreements to be entered into between New Forafric and certain equityholders of New Forafric
upon the consummation of the Business Combination. The forms of Seller Lock-Up Agreement and Sponsor Lock-Up Agreement are attached to
this proxy statement/ prospectus as <i>Annexes D and E</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Maximum
Redemptions</b>&#8221; means the maximum number of Globis Common Stock that may be redeemed in connection with the proposed Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Memorandum
and Articles of Association</b>&#8221; means the proposed Memorandum and Articles of Association of New Forafric to be in effect following
the Redomiciliation and the Business Combination, a form of which is attached to this proxy statement/prospectus as <i>Annex C</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Merger</b>&#8221;
means the merger of Globis with and into Globis Nevada, a wholly-owned subsidiary of Globis, with Globis Nevada surviving the merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Merger
Agreement</b>&#8221; means the Agreement and Plan of Merger, dated as of December 19, 2021, by and between Globis and Globis Nevada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Merger
Proposal</b>&#8221; means the proposal to be considered at the Stockholders Meeting to approve and adopt the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>New
Forafric</b>&#8221; means Globis Nevada as a Gibraltar public company by way of continuation following the Redomiciliation and the Business
Combination. Simultaneously with the Redomiciliation and in connection with the Business Combination, Globis Nevada will change its corporate
name to &#8220;Forafric Global PLC.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>New
Forafric Board</b>&#8221; means the board of directors of New Forafric subsequent to the completion of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Globis
Nevada</b>&#8221; means Globis NV Merger Corp., a Nevada corporation and a wholly-owned subsidiary of Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8221;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
means &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, as proxy solicitor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Nasdaq</b>&#8221;
means The Nasdaq Stock Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>No
Redemptions</b>&#8221; means no Common Stock of Globis being redeemed in connection with the proposed Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Ordinary
Shares</b>&#8221; means the Ordinary Shares of New Forafric, nominal value $0.001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Organizational
Documents Proposals</b>&#8221; means, collectively, Organizational Documents Proposal 7A and Organizational Documents Proposal 7B.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>PFIC</b>&#8221;
means passive foreign investment company under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>PIPE
Investment</b>&#8221; means the private placement pursuant to which PIPE Investors have committed to make a private investment in the
aggregate amount up to $20,000,000  in the form of Ordinary Shares on the terms and conditions set forth in
the Subscription Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>PIPE
Investors</b>&#8221; means the investors that have signed Subscription Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Preferred
Shares</b>&#8221; means the preferred shares of USD 0.001 (one thousandth United States Dollars) each, to be authorized for future issuance
by New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Preferred
Stock</b>&#8221; means the preferred stock of Globis, par value $0.0001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Private
Placement</b>&#8221; means the private placement by Globis of (i) 4,188,889 Private Placement Warrants to the Sponsors and (ii) 100,833
Private Placement Units to the Sponsors simultaneously with the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Private
Placement Warrants</b>&#8221; means Globis&#8217; 4,289,722 warrants, including 100,833 warrants included in the Private Placement Units,
sold to the Sponsors simultaneously with the closing of the IPO in Private Placements. Each Private Placement Warrant is exercisable
for one share of common stock of Globis at a price of $11.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Private
Placement Units</b>&#8221; means Globis&#8217; 100,833 Units sold to the Sponsors simultaneously with the closing of the IPO in a private
placement at a price of $10.00 per Unit. Each Private Placement Unit is identical to the Public Units sold in the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Proposals</b>&#8221;
means, collectively, (i) the Merger Proposal, (ii) the Redomiciliation Proposal, (iii) the Business Combination Proposal, (iv) the Equity
Incentive Plan Proposal, (v) Director Election Proposal, (vi) the Charter Proposal, (vii) the Organizational Documents Proposals, (viii)
the Nasdaq Proposal and (ix) the Adjournment Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Proposed
Organizational Documents</b>&#8221; means the proposed Memorandum and Articles of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>proxy
statement/prospectus</b>&#8221; means the proxy statement/prospectus forming a part of this registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Public
Shares</b>&#8221; means Globis&#8217; Common Stock sold in the IPO (whether they were purchased in the IPO or thereafter in the open
market).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Public
Stockholder</b>&#8221; means a holder of Public Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Public
Units</b>&#8221; means a unit sold in the IPO (including pursuant to the overallotment option) consisting of one Public Share and one
Public Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Public
Warrant Holder</b>&#8221; means a holder of Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Public
Warrants</b>&#8221; means Globis&#8217; warrants sold in the IPO (whether they were purchased in the IPO or thereafter in the open market).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Record
Date</b>&#8221; means &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Redemption</b>&#8221;
means the redemption of Public Shares for the Redemption Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Redemption
Price</b>&#8221; means an amount equal to a pro rata portion of the aggregate amount then on deposit in the Trust Account in accordance
with the Amended and Restated Certificate of Incorporation (as equitably adjusted for stock splits, stock dividends, combinations, recapitalizations
and the like after the Closing). The Redemption Price will be calculated two business days prior to the completion of the Business Combination
in accordance with Globis&#8217; Amended and Restated Certificate of Incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Redemption
Right</b>&#8221; means the right of each Public Stockholder (as determined in accordance with the Existing Organizational Documents and
the Trust Agreement) to redeem all or a portion of such holder&#8217;s Common Stock, at the Redemption Price in connection with the Stockholders
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Redomiciliation</b>&#8221;
means the continuation of Globis Nevada by way of Redomiciliation of Globis Nevada into a Gibraltar public company limited by shares,
with the common stock of Globis Nevada becoming ordinary shares of the Gibraltar public company limited by shares under the applicable
provisions of Nevada law, the Companies Act and the Re-domiciliation Regulations; the term includes all matters and necessary or ancillary
changes in order to effect such Redomiciliation, including the adoption of the Memorandum and Articles of Association consistent with
the Companies Act and the Re-domiciliation Regulations and changing the name and registered office of Globis Nevada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Redomiciliation
Proposal</b>&#8221; means the proposal to be considered at the Stockholders Meeting to approve the Redomiciliation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Re-domiciliation
Regulations</b>&#8221; means the Companies (Re-domiciliation) Regulations of 1996 of the Laws of Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Related
Agreements</b>&#8221; means certain additional agreements to be entered into in connection with the Business Combination Agreement as
further described in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Registration
Rights Agreement</b>&#8221; means the Registration Rights Agreement, dated as of December 10, 2020, by and between Globis and the Sponsors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Rule
144</b>&#8221; means Rule 144 under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Sarbanes-Oxley
Act</b>&#8221; means the Sarbanes-Oxley Act of 2002, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>SEC</b>&#8221;
means the U.S. Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Securities
Act</b>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Seller</b>&#8221;
means Lighthouse Capital Limited, a Gibraltar private company limited by shares, as the sole shareholder of FAHL immediately prior to
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Stockholders
Meeting</b>&#8221; means the special meeting of Globis&#8217; stockholders, to be held at 9 a.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, at the offices of McDermott Will &amp; Emery LLP located at One Vanderbilt Avenue, 45<sup>th</sup> Floor, New York, New York 10017,
or via a virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be adjourned. As
part of our precautions regarding the novel coronavirus or COVID-19, we are planning for the possibility that the meeting may be held
virtually over the Internet. If we take this step, we will announce the decision to do so via a press release and posting details on
our website that will also be filed with the SEC as proxy material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Sponsors</b>&#8221;
means, collectively, Globis SPAC LLC, a Delaware limited liability company, and Up and Up Capital, LLC, a Delaware limited liability
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Sponsor
Letter Agreement</b>&#8221; means the Letter Agreement, dated as of December 15, 2020, entered into by Globis and the Sponsor Parties
concurrently with the IPO. A copy of the Sponsor Letter Agreement is attached to this proxy statement/prospectus as <i>Annex E</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Sponsor
Parties</b>&#8221; means the Sponsor and Globis&#8217; independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Transfer
Agent</b>&#8221; means VStock Transfer, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Treasury
Regulations</b>&#8221; means the Code, its legislative history, and final, temporary and proposed treasury regulations promulgated thereunder
as then amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Trust
Account</b>&#8221; means the trust account of Globis, which holds the net proceeds from the IPO and certain of the proceeds from the
sale of the Private Placements, together with interest earned thereon, less amounts released to pay taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Unit</b>&#8221;
means either a Public Unit or a Private Placement Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Warrants</b>&#8221;
means the Public Warrants and the Private Placement Warrants of Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Working
Capital Loans</b>&#8221; means certain loans that may be made by the Sponsors or an affiliate of the Sponsors, or certain of Globis&#8217;
officers and directors in connection with the financing of a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
Calculations and Ownership Percentages</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified (including in the sections entitled <i>&#8220;Unaudited Pro Forma Condensed Combined Financial Information&#8221;
</i>and <i>&#8220;Beneficial Ownership of Securities&#8221;</i>), the share calculations and ownership percentages set forth in this
proxy statement/prospectus with respect to New Forafric&#8217;s shareholders following the Business Combination are for illustrative
purposes only and assume the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Public Stockholders exercise their Redemption Rights in connection with the Closing, and the balance of the Trust Account as of the
    Closing is the same as its balance on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022 of $ . Please see the section entitled &#8220;<i>Stockholders Meeting &#8212; Redemption Rights</i>&#8221;; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    FAHL equity securities are exchanged for Ordinary Shares. Please see the section entitled &#8220;<i>Proposal 3: The Business Combination
    Proposal</i>&#8221;;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share redemption price is $10.20;
    the actual per share redemption price will be equal to the <i>pro rata</i> portion of the Trust Account calculated as of two business
    days prior to the consummation of the Business Combination; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PIPE Investors acquire at the Closing, in accordance with the Subscription Agreements, (A) assuming No Redemptions, an aggregate
    of 1,712,245 Ordinary Shares and (B) assuming Maximum Redemptions, an aggregate of 1,168,566 Ordinary Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    FAHL Bond Holders acquire at the Closing, in accordance with the FAHL Bonds, 1,005,291 Ordinary Shares; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    FAHL Related Party Loan Holders acquire at the Closing, in accordance with the FAHL Related Party Loans, 1,445,164 Ordinary
    Shares; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
    of the Ordinary Shares reserved for issuance under the Equity Incentive Plan has been issued; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
    of the warrants to purchase Ordinary Shares have been exercised for Ordinary Shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Gk_002"></span>MARKET
AND INDUSTRY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
contained in this proxy statement/prospectus concerning the market and the industry in which FAHL competes, including its market position,
general expectations of market opportunity and market size, is based on information from various third-party sources, on assumptions
made by FAHL based on such sources and FAHL&#8217;s knowledge of the markets for its services and solutions. Any estimates provided herein
involve numerous assumptions and limitations, and you are cautioned not to give undue weight to such information. Third-party sources
generally state that the information contained in such source has been obtained from sources believed to be reliable but that there can
be no assurance as to the accuracy or completeness of such information. The industry in which FAHL operates is subject to a high degree
of uncertainty and risk. As a result, the estimates and market and industry information provided in this proxy statement/prospectus are
subject to change based on various factors, including those described in the section entitled &#8220;<i>Risk Factors &#8212; Risks Related
to FAHL&#8217;s Business and </i>New Forafric <i>Following the Business Combination</i>&#8221; and elsewhere in this proxy statement/
prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Gk_003"></span>TRADEMARKS
AND SERVICE MARKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
and its subsidiaries own or license numerous domestic and foreign trademarks and other proprietary rights that are important to
their businesses. FAHL and its subsidiaries own or have rights to use the trademarks, service marks and trade names that they use in
conjunction with the operation of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Gk_004"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus contains forward-looking statements. These forward-looking statements relate to expectations for future financial
performance, business strategies or expectations for our business, and the timing and ability for Globis and FAHL to complete the Business
Combination. Specifically, forward-looking statements may include statements relating to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    benefits of the Business Combination; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    future performance of, and anticipated financial impact on, New Forafric following the Business Combination; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expansion
    plans and opportunities; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    statements preceded by, followed by or that include the words &#8220;may,&#8221; &#8220;can,&#8221; &#8220;should,&#8221; &#8220;will,&#8221;
    &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221;
    &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;target&#8221; or similar expressions. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are based on information available as of the date of this proxy statement/prospectus and Globis and FAHL managements&#8217;
current expectations, forecasts and assumptions, and involve a number of judgments, known and unknown risks and uncertainties and other
factors, many of which are outside the control of Globis, FAHL and their respective directors, officers and affiliates. Accordingly,
forward-looking statements should not be relied upon as representing Globis&#8217; views as of any subsequent date. Globis does not undertake
any obligation to update, add or to otherwise correct any forward-looking statements contained herein to reflect events or circumstances
after the date they were made, whether as a result of new information, future events, inaccuracies that become apparent after the date
hereof or otherwise, except as may be required under applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not place undue reliance on these forward-looking statements in deciding how your vote should be cast or in voting your ordinary
shares on the Proposals. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may
be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results
to differ include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    occurrence of any event, change or other circumstances that could delay the Business Combination or give rise to the termination
    of the Business Combination Agreement; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    outcome of any legal proceedings that may be instituted against FAHL or Globis following announcement of the proposed Business Combination
    and transactions contemplated thereby; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to complete the Business Combination, including due to the failure to obtain approval of the Globis stockholders, the failure
    of Globis to retain sufficient cash in the Trust Account or find replacement cash to meet the requirements of the Business Combination
    Agreement or the failure to meet other conditions to closing in the Business Combination Agreement; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount of redemption requirements made by Public Stockholders; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to maintain the listing of the Ordinary Shares of New Forafric on Nasdaq following the Business Combination; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that the proposed Business Combination disrupts current plans and operations; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability to recognize the anticipated benefits of the Business Combination, which may be affected
                                            by, among other things, competition, and the ability of New Forafric to grow and manage growth
                                            profitably and retain its key employees;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    related to the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to develop and maintain effective internal controls; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric&#8217;s ability to enter into new markets and success of acquisitions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risks and uncertainties indicated in this proxy statement/prospectus, including those set forth under the section entitled &#8220;<i>Risk
    Factors</i>.&#8221; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Gk_005"></span>SUMMARY
OF THE PROXY STATEMENT/PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights selected information from this proxy statement/prospectus, but does not contain all of the information that may be
important to you. To better understand the Proposals to be considered at the Stockholders Meeting, including the Business Combination
Proposal, and whether or not you plan to attend such meeting, we urge you to read this proxy statement/prospectus (including the annexes)
carefully, including the section entitled &#8220;Risk Factors.&#8221; See also the section entitled &#8220;Where You Can Find More Information.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this section to &#8220;FAHL,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to FAHL and
its subsidiaries prior to the Business Combination and to </i>New Forafric <i>and its consolidated subsidiaries after giving effect to
the Business Combination.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
of FAHL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Forafric Agro Holdings Limited is a private company
limited by shares incorporated on May 16, 2016 under the laws of Gibraltar. We are registered with the Registrar of Companies
in Gibraltar under registration number 114436. We are a holding company, and substantially all of our operations are conducted through
our subsidiaries. Our corporate headquarters are located at Madison Building, Midtown, Queensway, Gibraltar GX11 1AA. Our registered
office is located at 57/63 Line Wall Road, Gibraltar GX11 1AA.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
is an integrated, global business involved in the purchase, storage, transport, processing and sale of agricultural commodities and commodity
products while managing risk across various product lines. The principal agricultural commodities that we handle are flour and semolina,
and secondary processing products such as pasta and couscous.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
subsidiary Forafric Maroc is the combination of two former family owned businesses, Forafric (Maymouna) and Tria Group. Forafric (Maymouna) was
acquired by FAHL in April 2015 and Tria Group was acquired by FAHL in January 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tria
Group was established in 1923 in Morocco under the name Minoterie Biscuiterie d&#8217;Anfa. The brand Tria was created in 1949. Tria
Group was purchased by Mr. Mohmmed Jamaleddine (father of Mustapha Jamaleddine, CEO of the group) in 1974. At that
time Tria Group had only one mill with a total capacity of 70T per day. In 1981, a first investment was made to increase the capacity
to 150T/day. The production of pasta and couscous was launched in 1989. In 1995, a second investment to increase the capacity was made.
In 2004, Tria formed the Ceraelis trading company, and in 2008, Finalog, a logistics company, with storage facilities in Casablanca.
Tria Group was managed by the Jamaleddine family until 2016 and its acquisition by Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
(Maymouna) was created in 1943. It initially specialized in the import-export of cereals and various products of the land (legumes, sugar,
tea, aromatic plants, etc.) which in 1997 evolved into an industrial flour milling company by buying and then building its own
mills. In 2003, Forafric decided to market its own brand, MayMouna.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today,
we</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> sell processed commodity products to customers
in approximately forty-five countries in Europe, Asia, Africa and the Middle East. The principal purchasers of our products are
wholesale foods manufacturers and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed an extensive global logistics network including storage facilities with direct access to ports by rail. We contract with
third parties for transport services. To better serve our customer base and develop our global distribution and logistics capabilities,
we have agreements with third parties in storage and in transportation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
has established itself as a leading wheat milling player in Morocco. It owns six milling plants across Morocco (four dedicated to common
wheat and two to durum wheat) with total processing capacity of 2,200 tons per day and a total milling capacity of 700,000 tons per year.
FAHL also has 1 secondary processing unit, 2 logistics platforms, and 250,000 tons of grain storage facilities in Morocco. It is also
the owner of PRODELA, an animal feed processing company in Morocco, which was established in 1991 to commercialize the bran created by
the mills.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are exported to 45 countries. Our primary activities include the production and sale of a variety of wheat flours, Semolina
and Pasta and Couscous in Morocco and in more than 45 countries. Our two main brands in Morocco are MAYMOUNA and TRIA (see Our Brands
and Products).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Strengths</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leader
in the Moroccan market</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a leader in the Moroccan market in respect of the wheat milling business, with a milling capacity of 2,200T per day. This position
enables FAHL to have better access to raw materials, to improve its productivity and to benefit from the power of its two main brands,
Maymouna and Tria (See Our Brands and Products).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw
material is the key to profitability in our industry. Raw material accounts for up to 80% of total revenues. With a total volume of 500,000T
per year, the group has great bargaining power, ahead of many international providers of wheat, and has, accordingly, had access to excellent
conditions of purchasing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with every industrial business, productivity is key to performance. With 7 milling units in Morocco, we improved our productivity over
the past 3 years and reduced our industrial cost. We are now among the most best performing industrial units in our industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maymouna
and Tria are our two main brands in the Moroccan market. Maymouna is our most popular brand for Moroccan households and Tria is our
most popular brand for industrial clients in Morocco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stable
Product Demand</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are basic food staples in Morocco and Africa. Accordingly, demand for our products has been stable in Morocco and fast-growing
in Sub-Saharan Africa and Angola, even in periods of economic uncertainty.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Our business did not suffer any crisis of decrease of demand during the economic disruptions that impacted Africa and Asia in
2020-2021. During the recent pandemic crisis of COVID-19, demand for our products continued to remain high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sourcing
and Processing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dedicated to providing our customers with high quality, nutritious and healthy products and our production process is designed to
achieve these goals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supply:
</i>In addition to the choice of excellent raw materials, at harvest time, we measure the quality and quantity of protein in the samples
and ensure the absence of heavy metals, pesticide residues, and other harmful chemicals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reception:
</i>On delivery of the wheat, a representative sample undergoes a battery of analyzes ensuring compliance. From the pit, the wheat then
undergoes a pre-cleaning to eliminate any large waste.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cleaning</i>:
At this stage, the wheat undergoes a second cleaning which consists in eliminating the impurities (foreign seeds, straw, dust, etc.).
The stone remover makes it possible to remove the stones by density difference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
wheat is then wet in order to facilitate its grinding and the damaged grains or those whose color does not conform are removed using
a machine equipped with a camera.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grinding</i>:
The wheat thus prepared goes to the milling. This operation dissociates the bran and the floury part thanks to a succession of grinding
and sieving. The various finished products are evaluated according to their grain size, protein level, humidity, color, etc. These analyzes
are supplemented by use tests in the bakery, in particular to test the breadmaking. A series of sanitary analyzes is added to ensure
the wholesomeness of each product in compliance with the required standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditioning</i>:
The various flours and semolina obtained are packaged in food packaging suitable for their good conservation. Each batch is strictly
controlled to ensure compliance with specifications and standards in force.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
and Storage</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORAFRIC
has a unique storage infrastructure in Morocco. The group has 2 units dedicated to storage and more than 250,000 tons of grain storage
capacity in Morocco. This organization allows it to optimize and best meet the needs of all of its mills and to effectively manage the
costs of its supply chain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
of our trading companies, Forafric and Cerelis aim to import and sell wheat. Cerelis is based in Morocco and dedicated to meeting
the needs of the group for raw materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the group&#8217;s main logistics infrastructure, our Finalog subsidiary, which is based in Casablanca, manages transport, handling and
storage activities, with a capacity of 79,000 metric tons. The first multimodal platform (Road / Rail) is devoted 100% to cereals and
is linked to the port of Casablanca by rail, Finalog has a daily reception capacity of 7,000 tons and 3,000 tons per day for delivery.
Though most of its revenues are generated by the group, Finalog also rents part of its facilities to other companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sustainable
Growth</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
considers sustainable growth to be the pillar of its business management strategy, through which it consolidates its position as a benchmark
business group in its areas of activity and as a sound, innovative, sustainable, responsible enterprise, committed to: (i) social well-being,
diversity, environmental balance and social and economic progress; and (ii) tax responsibility, respect of human rights and prevention
of corruption and other illegal conduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
entails developing a business model focusing on the generation of value, taking into consideration the interests of its human team, shareholders
and investors, customers, suppliers, the media, the communities in which FAHL operates and the environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this regard, FAHL looks beyond the exclusive goal of achieving financial yield and includes environmental, social and ethical criteria
alongside economic variables in its decision-making processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
thus undertakes, as an essential principle in its actions, the creation of a business model that is respectful of and sustainable for
the environment and society overall and, while ensuring value, profitability and competitiveness, it promotes diversity, respect for
human rights, tax responsibility and the prevention of corruption, thus contributing towards the progress of society and generating trust
among our stakeholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
markets for our products are highly price competitive. Competition is based on a number of factors, including delivered price, product
offering and quality, location, raw material procurement, production efficiency, brand recognition, nutritional profile, dietary trends,
logistics and distribution capabilities, and customer service, including, in some cases, customer financing terms. FAHL faces competition
in each of its businesses and has numerous competitors. Competition is based on a variety of factors, including price, raw material procurement,
brand recognition, nutritional profile, dietary trends and distribution capabilities. Our major competitors in Morocco include: Moulins
du Maghreb, Zine Cereales, Rica Maroc, Casagrains and Dari Couspate. In addition, other regional or international Agribusinesses may
expand into our marketplaces increasing competition. We also face competition from changing technologies and industrial practices. We
must continuously improve our production, storage and distribution efficiencies to remain competitive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we produce a staple food product, we did not suffer any severe negative impact on our sales due to COVID-19. The only change was on the
seasonality of our sales and on the access to foreign currency in 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Parties to the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Globis</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is a blank check company incorporated on August 21, 2020 (inception) as a Delaware corporation for the purpose of effecting a merger,
share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, Globis consummated the IPO of 11,500,000 Units, including the issuance of 1,500,000 Units as a result of the underwriters&#8217;
full exercise of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $115 million. Each Unit consists of one
share of Common Stock and one Warrant. Each Public Warrant entitles the holder to purchase one Public Share at an exercise price of $11.50
per share, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, Globis consummated the Private Placement of (i) 4,188,889 Private Placement Warrants at a price of $0.75
per Private Placement Warrant to the Sponsors and (ii) 100,833 Private Placement Units at a price of $10.00 per Unit to a Sponsor, generating
gross proceeds of $4,150,000. Each Private Placement Warrant is exercisable for one share of common stock at a price of $11.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
incurred $2,516,841 in transaction costs, including $2,300,000 of underwriting fees and $216,841 of other offering costs
in connection with the IPO and the sale of the Private Placements. The underwriters in the IPO also received 402,500 equity participation
shares. The underwriters agreed not to transfer, assign or sell any equity participation shares until the completion of Globis&#8217;
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the IPO and the Private Placements, $116,150,000 ($10.10 per Unit) of the net proceeds of the sale of the Units in the
IPO and certain of the proceeds from the sale of the Private Placements was placed in a trust account and was invested in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in
any open-ended investment company that holds itself out as a money market fund selected by Globis meeting the conditions of paragraphs
(c)(2), (c)(3) and (c)(4) of Rule 2a-7 of the Investment Company Act, as determined by Globis, until the earlier of: (i) the completion
of an initial business combination; and (ii) the distribution of the Trust Account. As of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, there was approximately $ million held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
Units, Public Shares and Public Warrants are listed on Nasdaq under the symbols &#8220;GLAQU,&#8221; &#8220;GLAQ&#8221; and &#8220;GLAQW,&#8221;
respectively. Globis&#8217; principal executive offices are located at Globis Acquisition Corp., 7100 W. Camino Real, Suite 302-48, Boca
Raton, FL 33433.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, Globis has issued promissory notes in the aggregate amount of $700,000 to Globis SPAC LLC and its
designees. In addition, $1,150,000 of indebtedness was incurred on December 10, 2021 in connection with the extension of
the time that Globis needs to complete its initial business combination to March 15, 2022. Such date may be further extended to June
15, 2022, if Globis&#8217; Board of Directors extends the period of time to consummate a business combination. The remainder of the indebtedness
was incurred in connection with Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effectiveness of the Redomiciliation, Globis will become a Gibraltar public company limited by shares and will change its corporate
name to &#8220;Forafric Global PLC&#8221; and all outstanding securities of Globis will convert to outstanding securities of New Forafric.
Globis will apply for listing, to be effective at the time of the Business Combination, of New Forafric&#8217;s Ordinary Shares and warrants
on Nasdaq under the proposed symbols &#8220;AFRI&#8221; and &#8220;AFRIW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>FAHL</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
Agro Holdings Limited, a Gibraltar private company limited by shares, is a fully integrated agricultural processing company located in
Morocco. See &#8220;&#8212; <i>Overview</i>.&#8221; FAHL is wholly-owned by the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Seller</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lighthouse
Capital Limited, a Gibraltar private company limited by shares, is the sole shareholder of FAHL. In addition to the equity securities
in FAHL and, the Seller owns Millcorp Geneve SA,, a commodities trading business based in Switzerland which does not form part of the
Business Combination. The Seller has its main office in Gibraltar, and much of its administrative functions are carried out in Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Seller has a wide range of activities in the food and agriculture and soft commodities industry all over the world and mainly in Africa.
The Seller is active in all stages from wheat import to finished product distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sole shareholder and ultimate beneficial owner of Lighthouse Capital Limited is Lighthouse Corporation PTC, as trustee of the Lighthouse
Settlement. The Lighthouse Settlement is a discretionary trust of which Yariv Elbaz and his family are the named potential beneficiaries.
The trustee, Lighthouse Corporation PTC Limited, controls the affairs of the trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Proposals to be Submitted at the Stockholders Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this section to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to Globis prior to the Redomiciliation
and to </i>New Forafric <i>and its consolidated subsidiaries after giving effect to the Redomiciliation.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the proposals to be submitted at the Stockholders Meeting of Globis. None of the Organization Documents Proposals,
which will be voted upon on a non-binding advisory basis only, or the Adjournment Proposal is conditioned upon the approval of any other
proposal set forth in this proxy statement/prospectus. The transactions contemplated by the Business Combination Agreement will be consummated
only if the Condition Precedent Proposals are approved at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
1: The Merger Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Globis will ask its stockholders to approve the Merger Proposal. As a condition to closing
the Business Combination pursuant to the terms of the Business Combination Agreement, the Globis Board has unanimously approved the Merger
Proposal. If approved and adopted, the Merger will become effective prior to the consummation of the Business Combination and will be
effected by the filing of a certificate of merger with the Delaware Secretary of State and articles of merger with the Nevada Secretary
of State. The Merger Proposal, if approved and adopted, will authorize Globis to merge with and into Globis Nevada, a wholly-owned subsidiary
of Globis, with Globis Nevada surviving.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effectiveness of the Merger, Globis will continue its existence in the form of a Nevada corporation. Please read the section entitled
&#8220;<i>Proposal 1: The Merger Proposal</i>&#8221; for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
2: The Redomiciliation Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Globis will ask its stockholders to approve the Redomiciliation Proposal. As a condition
to closing the Business Combination pursuant to the terms of the Business Combination Agreement, the Globis Board has unanimously approved
the Redomiciliation Proposal. If approved, the Redomiciliation will become effective prior to the consummation of the Business Combination
and will be effected by the filing of an application for establishing domicile in Gibraltar, along with all applicable notices, undertakings
and other documents required to be filed, and filing an application to de-register with the Nevada Secretary of State. The Redomiciliation
Proposal, if approved, will authorize a change of Globis Nevada&#8217;s jurisdiction of incorporation from the State of Nevada to Gibraltar.
Accordingly, while Globis Nevada is currently governed by Nevada law, upon Redomiciliation, New Forafric will be governed by the Companies
Act and the Re-domiciliation Regulations. There are differences between Nevada corporate law and Gibraltar corporate law as well as the
Existing Organizational Documents and the Proposed Organizational Documents. Accordingly, we encourage stockholders to carefully consult
the information set out below under the section entitled &#8220;<i>Proposal 2: The Redomiciliation Proposal &#8212; Comparison of Shareholder
Rights under the Applicable Corporate Law Before and After the Redomiciliation</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the effective date of the Redomiciliation and immediately prior to the consummation of the Business Combination, (i) the issued and outstanding
Common Stock will convert automatically by operation of law, on a one-for-one basis, into Ordinary Shares; (ii) the issued and outstanding
redeemable warrants that were registered pursuant to the IPO will automatically become redeemable warrants to acquire Ordinary Shares
at an exercise price of $11.50 per share on the terms and subject to the conditions of the applicable warrant agreement (no other changes
will be made to the terms of any issued and outstanding Public Warrants as a result of the Redomiciliation); (iii) each issued and outstanding
Unit of Globis not otherwise separated into the underlying Ordinary Shares of New Forafric and the corresponding Public Warrant will
be cancelled and will entitle the holder thereof to one share of New Forafric&#8217;s Ordinary Shares and one redeemable warrant to acquire
Ordinary Shares of New Forafric at an exercise price of $11.50 per share on the terms and subject to the conditions of the applicable
warrant agreement; and (iv) the issued and outstanding warrants of Globis issued in the Private Placement will automatically become
warrants to acquire Ordinary Shares of New Forafric at an exercise price of $11.50 per share on the terms and subject to the conditions
of the applicable warrant agreement (no other changes will be made to the terms of any issued and outstanding Private Placement Warrants
as a result of the Redomiciliation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effectiveness of the Redomiciliation, Globis will continue its existence in the form of a Gibraltar public company limited by shares,
herein referred as &#8220;New Forafric&#8221;, and will change its corporate name to &#8220;Forafric Global PLC&#8221; Please read the
section entitled &#8220;<i>Proposal 2: The Redomiciliation Proposal</i>&#8221; for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
3: The Business Combination Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Globis is asking its shareholders to approve the Business Combination Agreement,
pursuant to which, at the Effective Time (as defined in the Business Combination Agreement) after completion of the Redomiciliation,
New Forafric will acquire 100% of the equity interests of FAHL from Seller, its sole shareholder, with FAHL becoming a direct
subsidiary of New Forafric as a result thereof. After consideration of the factors identified and discussed in the section entitled
&#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Globis Board&#8217;s Reasons for the Approval of the Business
Combination</i>,&#8221; the Globis Board concluded that the Business Combination met all of the requirements disclosed in the
prospectus for Globis&#8217; IPO, including that the businesses of FAHL had a fair market value of at least 80% of the balance of
the funds in the trust account at the time of execution of the Business Combination Agreement. For more information about the
transactions contemplated by the Business Combination Agreement, see &#8220;<i>Proposal 3: The Business Combination
Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
Combination Consideration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms and subject to the conditions of the Business Combination Agreement, Globis will effect the Business Combination
with the Seller in exchange for the Seller receiving a combination of cash consideration and Ordinary Shares of New Forafric, which collectively,
constitute the consideration for the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Business Combination Consideration</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Closing
Conditions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Business Combination is subject to the satisfaction or waiver of certain customary closing conditions of the respective
parties, including, among others, the approval and adoption by Globis&#8217; stockholders of the Business Combination Agreement and transactions
contemplated thereby and the absence of a Company Material Adverse Effect (as defined in the Business Combination Agreement) that is
continuing as of the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal</i>&#8221; for a summary of the terms of the Business Combination
Agreement and additional information regarding the terms of the Business Combination Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
4: The Equity Incentive Plan Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that its stockholders approve the Equity Incentive Plan which will become effective upon the Closing and will be used by
New Forafric on a going-forward basis following the Closing. The Equity Incentive Plan Proposal is cross-conditioned on the approval
of the other Condition Precedent Proposals. A summary of the Equity Incentive Plan is set forth in the section entitled &#8220;<i>Proposal
3: The Equity Incentive Plan Proposal</i>&#8221; of this proxy statement/prospectus and a complete copy of the Equity Incentive Plan
is attached hereto as <i>Annex H</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
5: The Director Election Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that its stockholders elect six directors to serve on the New Forafric Board until the 2025 annual general meeting and until
their respective successors are duly elected and qualified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
6: The Charter Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that its stockholders approve the amendment and restatement of the Existing Organizational Documents in their entirety by
the Proposed Organizational Documents of New Forafric, including authorization of the change in authorized share capital as indicated
therein and the change of name of Globis to &#8220;Forafric Global PLC.&#8221; We encourage stockholders to carefully consult the information
set out below under the section entitled &#8220;<i>Proposal 6: The Charter Proposal</i>&#8221; of this proxy statement/prospectus and
a complete copy of the Memorandum and Articles of Association is attached hereto as <i>Annex C</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
7: The Organizational Documents Proposals</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that its stockholders approve, on a non-binding advisory basis, three separate proposals (collectively, the &#8220;<b>Organizational
Documents Proposals</b>&#8221;) in connection with the replacement of the Existing Organizational Documents, under Delaware law, with
the Proposed Organizational Documents, under the Companies Act and Re-domiciliation Regulations. The Globis Board has unanimously approved
each of the Organizational Documents Proposals and believes such proposals are necessary to adequately address the needs of New Forafric
after the Business Combination. A brief summary of each of the Organizational Documents Proposals is set forth below. These summaries
are qualified in their entirety by reference to the complete text of the Proposed Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
    Documents Proposal 7A</i> &#8212; An amendment to authorize the change in the authorized capital stock of Globis from (i) 100,000,000
    Common Stock, and 1,000,000 Preferred Stock, par value $0.0001 per share, to (ii) 100,000,000 Ordinary Shares and 1,000,000 Preferred
    Shares of New Forafric; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
    Documents Proposal 7B</i> &#8212; An amendment to authorize all other changes in connection with the replacement of Existing Organizational
    Documents with the Memorandum and Articles of Association to be adopted as part of the Redomiciliation (a copy of which is attached
    to this proxy statement/prospectus as <i>Annex C</i>), including (i) changing the post-Business Combination corporate
    name to &#8220;Forafric Global PLC&#8221; (which is expected to occur after the Redomiciliation in connection with the Business Combination),
    (ii) making New Forafric&#8217;s corporate existence perpetual and (iii) removing certain provisions related to our status as a blank
    check company that will no longer be applicable upon consummation of the Business Combination, all of which the Globis Board believes
    are necessary to adequately address the needs of New Forafric after the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Organizational Documents differ in certain material respects from the Existing Organizational Documents and we encourage stockholders
to carefully consult the information set forth in the section entitled &#8220;<i>Proposal 7: The Organizational Documents Proposals</i>&#8221;
and the full text of the Memorandum and Articles of Association of New Forafric, attached hereto as <i>Annex C</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
8: The Nasdaq Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that its stockholders approve, for the purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635(a),
the issuance of Ordinary Shares and securities convertible into or exchangeable for Ordinary Shares in connection with the Business Combination,
and the Ordinary Shares issued in connection with the PIPE Investment, the conversion of the FAHL Bonds or the conversion of the FAHL
Related Party Loans. For additional information, see &#8220;<i>Proposal 8: The Nasdaq Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
9: The Adjournment Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is proposing that if, based on the tabulated vote, there are not sufficient votes at the time of the Stockholders Meeting to authorize
Globis to consummate the Business Combination (because any of the Condition Precedent Proposals have not been approved), the Globis Board
may submit a proposal to adjourn the Stockholders Meeting to a later date or dates, if necessary, to permit further solicitation and
vote of proxies. For additional information, see &#8220;<i>Proposal 9: The Adjournment Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Condition Precedent Proposals is cross-conditioned on the approval of each other. Neither the Organizational Documents Proposals,
which will be voted upon a non-binding advisory basis only, nor the Adjournment Proposal is conditioned upon the approval of any other
proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Globis
Board&#8217;s Reasons for the Approval of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating the transaction with FAHL, the Globis Board consulted with our management and legal counsel as well as financial and other
advisors, and the Globis Board considered and evaluated several factors. In particular, the Globis Board considered, among other things,
the following factors, although not weighted or in any order of significance:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    leadership position in the production and sale of a variety of wheat flours in Morocco,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FAHL strong leadership team, which will remain in place after the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    attractive valuation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    strong financial performance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    multi-pronged growth strategy</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the Business Combination Agreement and the Related Agreements; and.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of the due diligence investigation conducted by Globis&#8217; Board:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Globis Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business
    Combination, including, but not limited to, the following:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that future financial performance of FAHL may not meet the Globis Board&#8217;s expectations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainties
    regarding the potential impacts of the COVID-19 pandemic and related economic disruptions on FAHL&#8217;s operations and demand for
    its services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
    in the food, agriculture and soft commodities industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that the potential benefits of the Business Combination may not be fully achieved, or may not be achieved within the expected
    timeframe.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risks and costs to Globis&#8217; business if the Business Combination is not completed;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to pursue other potential transactions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that Globis&#8217; stockholders may fail to provide the respective votes necessary to effect the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that completion of the Business Combination is conditioned on the satisfaction of certain closing conditions that are not within
    Globis&#8217; control.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">various
    other risks associated with the Business Combination, the business of Globis, and the business of FAHL described in the section entitled
    &#8220;<i>Risk Factors</i>.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to considering the factors described above, the Globis Board also considered that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a more complete description of the Globis Board&#8217;s reasons for approving the Business Combination and the factors and risks considered
by the Globis Board, see the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Globis Board&#8217;s Reasons
for the Approval of the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes certain additional agreements entered into or to be entered into pursuant to the Business Combination Agreement. For
additional information, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Certain Agreements Related to the Business
Combination.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organizational
Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagrams below depict simplified versions of the current organizational structures of Globis and FAHL, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Globis
(Current Structure)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="forms-4_001.jpg" alt="" style="height: 357px; width: 500px" /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">FAHL
(Current Structure)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img src="forms-4_02.jpg" alt="" style="height: 362px; width: 580px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagram below depicts a simplified version of our organizational structure immediately following the completion of the Redomiciliation
and the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-4_03.jpg" alt="" style="height: 362px; width: 580px" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of the Business Combination, New Forafric Board will consist of six members: Saad Bendidi, Julien Benitah, Franco Cassar,
James Lasry, Paul Packer, and Ira Greenstein. Please see the section entitled &#8220;Management of New Forafric Following the Business
Combination.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership
of Globis and New Forafric</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, Globis has an aggregate of 15,050,833 shares of Common Stock issued and outstanding,
and an aggregate of 15,789,722 Warrants issued and outstanding, which comprise the 4,289,722 Private Placement Warrants held by the Sponsors
and the 11,500,000 Public Warrants. Each whole Warrant entitles the holder thereof to purchase one share of common stock and, following
the Merger and the Redomiciliation, will entitle the holder thereof to purchase one Ordinary Share of New Forafric. Upon the consummation
of the Merger and the Redomiciliation, Globis&#8217; Common Stock will convert into Ordinary Shares of New Forafric, as further described
herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">It is anticipated that, upon
completion of the Business Combination, (1) Globis&#8217; Public Stockholders will own approximately 33.5% of the outstanding
Ordinary Shares of New Forafric, (2) the Sponsor and Globis&#8217; independent directors (excluding affiliates of the Sponsors and
officers and directors of Globis participating in the FAHL Bonds) are expected to own approximately 9.2% of the outstanding
Ordinary Shares of New Forafric, (4) the PIPE Investors will own 5.0% of the Ordinary Shares of New Forafric, (5) the FAHL Bond
Holders will own 2.9% of the Ordinary Shares of New Forafric and (6) FAHL Related Party Loan Holders will own 4.2% of the
Ordinary Shares of New Forafric. These percentages (i) assume no Public Stockholders exercise their Redemption Rights in connection with
the Business Combination and (ii) do not take into account Public Warrants or Warrants issued in Private Placements to purchase Ordinary
Shares of New Forafric that will be outstanding immediately following the Closing. If the actual facts are different than these assumptions,
the percentage ownership retained by Globis&#8217; existing stockholders in New Forafric will be different.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes the pro forma ownership of Ordinary Shares of New Forafric following the Business Combination, including for the
Seller those Ordinary Shares issuable upon the exchange of the Seller&#8217;s FAHL equity securities for Ordinary Shares of New Forafric,
under two scenarios:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            No</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            Maximum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Globis&#8217; Public Stockholders<sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">11,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">33.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsors and Independent
    Directors<sup>(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Underwriter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Seller<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,248,307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">PIPE Investors<sup>(5)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168,566</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Bond Holders<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Related Party Loan
    Holders<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.2</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that 11,500,000 Public Shares (the estimated maximum number of Public Shares that could be redeemed in connection with the
    Business Combination based on a per share redemption price of $10.20) are redeemed in connection with the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    3,148,333 Ordinary Shares issued upon conversion of the existing Common Stock in connection with the Redomiciliation. The Ordinary
    Shares are issued upon the automatic conversion of Common Stock concurrently with the consummation of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
    1,005,291 Ordinary Shares issuable upon the conversion of the FAHL Bonds purchased by certain affiliates of the Sponsors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
                                            an amount of Remaining Cash (as defined in the Business Combination Agreement) at the Closing
                                            based on Remaining Cash as of September 30, 2021.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to the terms of the PIPE Subscription Agreement, calculated as 4.99% of all issued and outstanding
                                            ordinary shares, after taking into account the completion of the Business Combination and
                                            related transactions.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Bonds. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Related Party Loans.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration paid to Seller in connection with the Business Combination is subject to adjustment to appropriately reflect the effect
of any stock dividend, share capitalization, subdivision, reclassification, recapitalization, split, combination, consolidation or exchange
of shares, or any similar event that shall have occurred (including any of the foregoing in connection with the Redomiciliation) prior
to the Closing. For further details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination Agreement
&#8212; Business Combination Consideration</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Stockholders Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Date,
Time and Place of Stockholders Meeting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stockholders Meeting will be held at 9 a.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, at the offices of McDermott Will &amp; Emery LLP located at One Vanderbilt Avenue, 45<sup>th</sup> Floor, New York, New York, 10017,
and via a virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be adjourned, to
consider and vote upon the Proposals, including, if necessary, the Adjournment Proposal to permit further solicitation and vote of proxies
if, based upon the tabulated vote at the time of the Stockholders Meeting, each of the Condition Precedent Proposals have not been approved.
As part of our precautions regarding COVID-19, we are planning for the possibility that the meeting may be held virtually over the Internet.
If we take this step, we will announce the decision to do so via a press release and posting details on our website that will also be
filed with the SEC as proxy material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Record
Date; Outstanding Shares; Stockholders Entitled to Vote</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
has fixed the close of business on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, as the Record Date for determining the Globis stockholders entitled to notice of and to attend and vote at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the close of business on such date, there were 15,050,833 shares of Common Stock outstanding and entitled to vote. The Sponsors and
Globis&#8217; independent directors own 3,148,333 shares of Common Stock of Globis. Pursuant to the Sponsor Letter Agreement among
Globis, the Sponsor and Globis&#8217; directors and officers, (i) all shares of common stock owned by the Sponsors and Globis&#8217;
independent directors and (ii) any other common stock of Globis owned by the Sponsor or Globis&#8217; officers and directors will be
voted in favor of the Business Combination Proposal at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proxy
Solicitation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies
with respect to the Stockholders Meeting may be solicited by telephone, by facsimile, by mail, on the Internet or in person. Globis has
engaged to assist in the solicitation of proxies. If a shareholder grants a proxy, it may still vote its shares in person if it revokes
its proxy before the Stockholders Meeting. A shareholder may also change its vote by submitting a later-dated proxy, as described in
the section entitled &#8220;<i>Stockholders Meeting &#8212; Revoking Your Proxy; Changing Your Vote</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Quorum
and Vote Required for Approval</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum of Globis stockholders is necessary to hold the Stockholders Meeting. The presence, in person or by proxy, at a Stockholders Meeting
of the holders of shares of outstanding capital stock of Globis representing a majority of the voting power of all outstanding shares
of capital stock of Globis entitled to vote at such meeting shall constitute a quorum for the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Condition Precedent Proposals must be approved in order for Globis to complete the Business Combination. Each of the Condition
Precedent Proposals is cross-conditioned on the approval of each other. None of the Organizational Documents Proposals, which
will be voted upon a non-binding advisory basis only, or the Adjournment Proposal is conditioned upon the approval of any other proposal.
The approval of the Business Combination Proposal, the Equity Incentive Plan Proposal, the Organizational Documents Proposals, the Nasdaq
Proposal and the Adjournment Proposal will require the affirmative vote of a majority of the votes cast by the stockholders present in
person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. The approval of the Merger
Proposal, the Redomiciliation Proposal and the Charter Proposal will require the affirmative vote of the holders of a majority of the
outstanding shares of Globis Common Stock, voting together as a single class. Directors are elected by a plurality of all of the votes
cast by the stockholders present in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholder
Meeting. This means that the six director nominees who receive the most affirmative votes will be elected. If any of Condition Precedent
Proposals fail to receive the required approval by the stockholders of Globis at the Stockholders Meeting, the Business Combination will
not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Organizational Documents, a Public Stockholder may request of Globis that Globis redeem all or a portion of its Public
Shares for cash if the Business Combination is consummated. As a holder of Public Shares, you will be entitled to receive cash for any
Public Shares to be redeemed only if you:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    hold Public Shares, or (b) if you hold Public Shares through Units, you elect to separate your Units into the underlying Public Shares
    and Public Warrants prior to exercising your Redemption Rights with respect to the Public Shares; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submit
    a written request to the Transfer Agent, in which you (a) request that Globis redeem all or a portion of your Public Shares for cash,
    and (b) identify yourself as the beneficial holder of the Public Shares and provide your legal name, phone number and address; and
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
    your Public Shares to the Transfer Agent, physically or electronically through DTC. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Stockholders may seek to have their Public Shares redeemed by Globis, regardless of whether they vote for or against the Business Combination
or any other Proposals and whether they held Public Shares as of the Record Date or acquired them after the Record Date. Any Public Stockholder
who holds Public Shares of Globis on or before&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ,
2022 (two (2) business days before the Stockholders Meeting) will have the right to demand that his or her Public Shares be redeemed
for a pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid. For illustrative
purposes, based on funds in the Trust Account of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
million on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 and including anticipated additional
interest through the Closing (assuming interest accrues at recent rates and no additional tax payments are made out of the Trust Account),
the estimated per share redemption price is expected to be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
.. A Public Stockholder that has properly tendered his, her or its Public Shares for Redemption will be entitled to receive his, her or
its pro rata portion of the aggregate amount then on deposit in the Trust Account in cash for such Public Shares only if the Business
Combination is completed. If the Business Combination is not completed, the Redemptions will be canceled and the tendered Public Shares
will be returned to the relevant Public Stockholders as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Public Stockholders who seek to redeem their Public Shares must demand Redemption no later than 5:00 p.m., Eastern Time, on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 (two (2) business days before the Stockholders Meeting) by (a) submitting a written request to the Transfer Agent that Globis
redeem such Public Stockholder&#8217;s Public Shares for cash, (b) affirmatively certifying in such request to the Transfer Agent for
Redemption if such Public Stockholder is acting in concert or as a &#8220;group&#8221; (as described in Section 13(d)(3) of the Exchange
Act) with any other shareholder with respect to Common Stock of Globis and (c) delivering their Public Shares, either physically or electronically
using DTC&#8217;s DWAC System, at the Public Stockholder&#8217;s option, to the Transfer Agent prior to the Stockholders Meeting. If
a Public Stockholder holds the Public Shares in &#8220;street name&#8221;, such Public Stockholder will have to coordinate with his,
her or its broker to have such Public Shares certificated or delivered electronically. Certificates that have not been tendered to the
Transfer Agent (either physically or electronically) in accordance with these procedures will not be redeemed for cash. There is a nominal
cost associated with this tendering process and the act of certificating the shares or delivering them through the DWAC system. The Transfer
Agent will typically charge the tendering broker a nominal fee and it would be up to the broker whether or not to pass this cost on to
the redeeming Public Stockholder. In the event the Business Combination is not completed, this may result in an additional cost to Public
Stockholders for the return of their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a Public Stockholder, together with any affiliate of his, her, its or any other person with whom he, she or it is acting
in concert or as a &#8220;group&#8221; (as described in Section 13(d)(3) of the Exchange Act) will be restricted from seeking Redemption
Rights with respect to 20% or more of Globis&#8217; Public Shares. Accordingly, any shares held by a Public Stockholder or &#8220;group&#8221;
in excess of such 20% cap will not be redeemed by Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Sponsor Letter Agreement, the Sponsor and officers and directors of Globis have waived all of their Redemption Rights and will
not have Redemption Rights with respect to any Globis Shares owned by them, directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Public Warrants will not have Redemption Rights with respect to the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, see &#8220;<i>Stockholders Meeting &#8212; Redemption Rights.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appraisal
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
holders of shares of Globis Common Stock nor holders of Globis&#8217; warrants are entitled to appraisal rights in connection with the
Merger, the Redomiciliation or the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Globis&#8217; Directors and Officers and Others in the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the Globis Board in favor of approval of the Business Combination Proposal, you should keep in mind
that Globis&#8217; directors and officers may have interests in such proposal that are different from, or in addition to, those of Globis
stockholders and warrant holders generally. These interests include, among other things, the interests listed below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    Globis does not complete an initial business combination transaction by March 15, 2022 (or June 15, 2022, if Globis&#8217; Board
    of Directors extends the period of time to consummate a business combination), Globis will cease all operations except for the purpose
    of winding up, redeeming all of the outstanding Public Shares for cash and, subject to the approval of the Globis Board and Globis&#8217;
    remaining shareholders, dissolving and liquidating, subject in each case to its obligations under Delaware law to provide for claims
    of creditors and the requirements of other applicable laws. In such event, the 3,047,500 shares of Common Stock owned by the Sponsors
    and Globis&#8217; independent directors would be worthless because, following the Redemption of the Public Shares, Globis would likely
    have few, if any, net assets and because the Sponsors and Globis&#8217; independent directors have agreed, in the Sponsor Letter
    Agreement, to waive their rights to liquidating distributions from the Trust Account with respect to the shares of common stock if
    Globis fails to complete a Business Combination within the required period. The Sponsors purchased the shares of Common Stock prior
    to Globis&#8217; IPO for an aggregate purchase price of $26,500, or approximately $0.001 per share. Such shares of Common Stock had
    an aggregate market value of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million based
    upon the closing price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share on Nasdaq
    on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022, the most recent closing price.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsors paid $3.14 million for its Private Placement of 4,188,889 Private Placement Warrants to purchase Common Stock and such Private
    Placement Warrants will expire worthless if an initial business combination is not consummated by March 15, 2022 (or June 15, 2022,
    if Globis Board extends the period of time to consummate a business combination).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    and Up Capital, LLC purchased an aggregate of 100,833 units (the &#8220;Placement Units&#8221;) at a purchase price of $10.00 per
    Private Placement Unit, or $1,008,333 in the aggregate, which each Private Placement Unit consists of one share of Common Stock and
    one redeemable warrant entitling the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment.
    The Common Stock will be worthless and the warrants will expire worthless if an initial business combination is not consummated by
    March 15, 2022 (or June 15, 2022, if Globis Board extends the period of time to consummate a business combination).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliates
    of the Sponsors, in aggregate, have purchased $9.5 million in FAHL Bonds and will acquire at the Closing, in accordance
    with the FAHL Bonds, 1,005,291 Ordinary Shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsors and Globis&#8217; officers, directors or their affiliates have made Working Capital Loans prior to the Closing of the Business
    Combination in the amount of $5 million as of December 30, 2021, which may not be repaid if the Business Combination is not completed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer, Chief Executive Officer, Chief Financial Officer and director of Globis, is expected to be a director of New Forafric after
    the consummation of the Business Combination. As such, in the future, he may receive cash fees, stock options, stock awards or other
    remuneration that New Forafric Board determines to pay to its directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    existing directors and officers will be eligible for continued indemnification and continued coverage under Globis&#8217; directors&#8217;
    and officers&#8217; liability insurance after the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    order to protect the amounts held in the Trust Account, the Sponsors have agreed to be liable to Globis if and to the extent any
    claims by a vendor for services rendered or products sold to Globis, or a prospective target business with which Globis has discussed
    entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per Public Share or (ii)
    such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions
    in the value of trust assets, in each case net of the interest which may be withdrawn to pay Globis&#8217; tax obligation and up
    to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek
    access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under Globis&#8217; indemnity
    of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    completion of the Business Combination, the Sponsors, Globis&#8217; officers and directors and their respective affiliates will be
    entitled to reimbursement for any reasonable out-of-pocket expenses related to identifying, investigating and completing an initial
    business combination (which will be the Business Combination should it occur), and repayment of any other loans, if any, and on such
    terms as to be determined by Globis from time to time, made by the Sponsor or certain of Globis&#8217; officers and directors to
    finance transaction costs in connection with an intended initial business combination (which will be the Business Combination should
    it occur). If Globis fails to complete a Business Combination within the required period, the Sponsor and Globis&#8217; officers
    and directors and their respective affiliates will not have any claim against the Trust Account for reimbursement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to the Registration Rights Agreement, the Sponsors will have customary registration rights, including demand and piggy-back rights,
    subject to cooperation and cut-back provisions with respect to the Ordinary Shares and warrants of New Forafric held by such parties.
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
directors and executive officers have agreed to vote all of their Common Stock in favor of the proposals being presented at the Stockholders
Meeting and waive their redemption rights with respect to such Common Stock in connection with the consummation of the Business Combination.
As of the date of this proxy statement/prospectus, Globis&#8217; directors and executive officers beneficially own approximately 20%
of the issued and outstanding Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3pt; text-align: justify; text-indent: 24.5pt">At any time at or
prior to the Business Combination, during a period when they are not then aware of any material nonpublic information regarding us or
our securities, the Sponsor Parties or their respective affiliates may purchase Public Shares from institutional and other investors
who vote, or indicate an intention to vote, against any of the Condition Precedent Proposals, or execute agreements to purchase such
shares from such investors in the future, or they may enter into transactions with such investors and others to provide them with incentives
to acquire Public Shares or vote their Public Shares in favor of the Condition Precedent Proposals. Such a purchase may include a contractual
acknowledgement that such shareholder, although still the record or beneficial holder of such Public Shares, is no longer the beneficial
owner thereof and therefore agrees not to exercise its Redemption Rights. In the event that the Sponsors or their respective affiliates
purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their Redemption Rights,
such selling shareholder would be required to revoke their prior elections to redeem their shares. The purpose of such share purchases
and other transactions would be to increase the likelihood of satisfaction of the requirements that (1) a majority of the votes cast
by the stockholders present in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders
Meeting, are voted in favor of the Business Combination Proposal, the Equity Incentive Plan Proposal, the Organizational Documents
Proposals, the Nasdaq Proposal and the Adjournment Proposal, (2) holders of a majority of the outstanding shares of Globis Common Stock
vote in favor of the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal, (3) the six directors named in the
Director Election Proposal are elected to serve on the Board of Directors of New Forafric, (4) otherwise limit the number of Public Shares
electing to redeem and (5) Globis&#8217; net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act)
being at least $5,000,001.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on the price of the ordinary shares. For example, as a result of these arrangements,
an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely
to sell the shares he or she owns, either at or prior to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
such transactions are effected, the consequence could be to cause the Business Combination to be consummated in circumstances where such
consummation could not otherwise occur. Purchases of shares by the persons described above would allow them to exert more influence over
the approval of the proposals to be presented at the Stockholders Meeting and would likely increase the chances that such proposals would
be approved. We will file or submit a Current Report on Form 8-K to disclose any material arrangements entered into or significant purchases
made by any of the aforementioned persons that would affect the vote on the proposals to be submitted at the Stockholders Meeting or
the redemption threshold. Any such report will include descriptions of any arrangements entered into or significant purchases by any
of the aforementioned persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Globis&#8217; directors may result in a conflict of interest on the part
of such director(s) between what he/she or they may believe is in the best interests of Globis and its stockholders and what he/she or
they may believe is best for himself/ herself or themselves in determining to recommend that stockholders vote for the proposals. In
addition, Globis&#8217; officers have interests in the Business Combination that may conflict with your interests as a stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
to Stockholders of Globis</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Globis Board has unanimously approved the Proposals.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Globis Board unanimously recommends that stockholders:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Merger Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Redomiciliation Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Business Combination Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Equity Incentive Plan Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Director Election Proposal;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Charter Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; each of the Organizational Documents Proposals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Nasdaq Proposal; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Adjournment Proposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify; text-indent: 35.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify; text-indent: 35.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of any financial and personal interests of one or more of Globis&#8217; directors may be argued to result in a conflict of
interest on the part of such director(s) between what he, she or they may believe is in the best interests of Globis and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the Proposals. See the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Interests of Globis&#8217; Directors
and Officers and Others in the Business Combination</i>&#8221; in this proxy statement/prospectus for a further discussion of such interests
and potential conflicts of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; text-indent: 35.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sources
and Uses of Funds for the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables summarize the estimated sources and uses for funding the Business Combination assuming (i) that none of Globis&#8217;
outstanding shares of Common Stock are redeemed in connection with the Business Combination (&#8220;<b>No Redemptions</b>&#8221;) and
(ii) that 11,500,000 of Globis&#8217; outstanding shares of Common Stock are redeemed in connection with the Business Combination
(representing the maximum amount of public shares that can be redeemed (&#8220;<b>Maximum Redemptions</b>&#8221;). The number of shares
of Common Stock redeemable assuming Maximum Redemptions assumes that the per share Redemption Price is $10.20; the actual per
share Redemption Price will be equal to the pro rata portion of the Trust Account calculated as of two business days prior to the consummation
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estimated
Sources and Uses (No Redemptions, in millions)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold">Sources</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold">Uses</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis Cash
    Held in Trust<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">117.3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 41%; text-align: left">Cash Consideration to Balance Sheet</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">126.9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PIPE Investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Cash Consideration to Seller</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">FAHL Bonds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9.5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Transaction
    Fees<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Sources</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">144.8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Total
    Uses</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">144.8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estimated
Sources and Uses (Maximum Redemptions, in millions)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold">Sources</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold">Uses</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis Cash
    Held in Trust<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">117.3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 41%; text-align: left">Cash Consideration to Balance Sheet</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">16.0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PIPE Investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;Cash Consideration to Seller</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">FAHL Bonds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9.5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Fees<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">5.8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder Redemptions<sup>(3) </sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">117.3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Total Sources</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">139.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Total Uses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">139.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the expected amount of the restricted investments and cash held in the Trust Account upon consummation of the Business Combination.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the total estimated transaction fees and expenses incurred by Globis and FAHL as part of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that the maximum number of shares of Common Stock that can be redeemed are redeemed. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Federal Income Tax Consequences</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of the tax consequences for Public Stockholders exercising Redemption Rights in connection with the Business Combination,
see the sections entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Material U.S. Federal Income Tax Consequences
of the Business Combination to Globis stockholders &#8212; U.S. Holders &#8212; Tax Consequences to U.S. Holders That Elect to Exercise
Redemption Rights</i>&#8221; and &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Material U.S. Federal Income Tax Consequences
of the Business Combination to Globis stockholders &#8212; Non-U.S. Holders &#8212; Tax Consequences to Non-U.S. Holders That Elect to
Exercise Redemption Rights</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
tax consequences of the Redomiciliation are complex and will depend on a holder&#8217;s particular circumstances. All holders are urged
to consult their tax advisors on the tax consequences to them of the Redomiciliation, including the applicability and effect of U.S.
federal, state, local and foreign income and other tax laws. For a more complete discussion of the U.S. federal income tax considerations
of the Redomiciliation, including with respect to Public Warrants, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212;
Material U.S. Federal Income Tax Consequences of the Business Combination to Globis stockholders.</i>&#8221;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<div style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Approvals</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger, the Redomiciliation, the Business Combination and the transactions contemplated by the Business Combination Agreement are not
subject to any additional regulatory requirement or approval, except for (i) filings with the Registrar of Companies of Gibraltar, Secretary
of State of the State of Delaware and Secretary of State of the State of Nevada necessary to effectuate the Merger and the Redomiciliation
and (ii) filings required with the SEC pursuant to the reporting requirements applicable to Globis, and the requirements of the Securities
Act and the Exchange Act, including the requirement to file the registration statement of which this proxy statement/prospectus forms
a part and to disseminate this proxy statement/prospectus to Globis&#8217; stockholders. Based on the anticipated pro-forma voting power
of New Forafric, no filings are required under the HSR Act in connection with the Business Combination; however, such a filing may be
required to the extent the anticipated pro forma ownership changes. Globis must comply with applicable U.S. federal and state securities
laws in connection with the Redomiciliation, including the filing with Nasdaq of a press release disclosing the Redomiciliation, among
other things.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in Globis&#8217; periodic reports and proxy
statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval
of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. Globis has elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, Globis, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the
new or revised standard. This may make comparison of Globis&#8217; financial statements with certain other public companies difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earlier of: (1) the last day of the fiscal year (a) following the fifth anniversary
of the closing of Globis&#8217; IPO, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are
deemed to be a large accelerated filer, which means the market value of our common equity that is held by non-affiliates exceeds $700
million as of the end of the prior fiscal year&#8217;s second fiscal quarter; and (2) the date on which we have issued more than $1.00
billion in non-convertible debt securities during the prior three-year period. References herein to &#8220;emerging growth company&#8221;
shall have the meaning associated with it in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Summary
of Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating the Proposals set forth in this proxy statement/prospectus, you should carefully read this proxy statement/prospectus, including
the annexes, and especially consider the factors discussed in the section entitled &#8220;<i>Risk Factors</i>.&#8221; The occurrence
of one or more of the events or circumstances described in the section titled </span><span style="font-family: Times New Roman, Times, Serif">&#8220;<i>Risk
Factors</i>,&#8221; alone or in combination with other events or circumstances, may materially adversely affect our business, financial
condition and operating results. Such risks include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Risks
Relating to FAHL&#8217;s Business and New Forafric Following the Business Combination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severe
    adverse weather conditions may also result in crop failures or significantly reduced harvests, and increase the cost of raw
    materials, extensive property damage, extended business interruption, personal injuries and other loss and damage to FAHL&#8217;s
    business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business may be adversely affected by fluctuations in agricultural commodity and other raw material prices, transportation costs,
    energy prices, interest rates and foreign currency exchange rates.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business may be adversely affected if it is unable to obtain sufficient quality raw materials.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
                                            business is currently dependent upon a single supplier, which is an affiliate of the Seller,
                                            to obtain substantially all of its raw materials.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    COVID-19 pandemic could have a material adverse impact on FAHL&#8217;s business, results of operations and financial condition.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business may be adversely affected by disruptions in its distribution and logistical systems.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is vulnerable to the effects of supply and demand imbalances in the flour milling industry.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to global and regional economic downturns and related risks.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to economic, political and other risks of doing business globally and in emerging markets. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to industry and other risks that could adversely affect our reputation and financial results, including, without
    limitation, spoilage, contamination, tampering or other adulteration of products, product liability claims and recalls and government
    regulation regarding matters such as food and feed safety, nutritional standards and genetically modified organism, and shifts in
    customer and consumer preferences.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
    may be subject to significant liability that is not covered by insurance.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    natural disaster, economic depression or other adverse events affecting Morocco where most of FAHL&#8217;s facilities and customers
    are located could adversely affect FAHL&#8217;s business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    claims, government investigations or other regulatory enforcement actions could subject FAHL to civil and criminal penalties.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation
    or legal proceedings could expose FAHL to significant liabilities and have a negative impact on FAHL&#8217;s reputation or business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to risks related to our ability to retain existing customers, attract new customers, expand product offerings,
    and increase processed volumes and revenue from both new and existing customers.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to risks related to growth, including, without limitation, its ability to achieve the efficiencies, savings and
    other benefits anticipated from our cost reduction, margin improvement and other business optimization initiatives.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to risks related government regulation, including, without limitation, taxes, tariffs, duties, subsidies, import
    and export restrictions on agricultural commodities and commodity products and energy policies (including biofuels mandates), and
    obtaining necessary government permits and certifications.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business face significant competition in each of FAHL&#8217;s businesses and FAHL has numerous competitors, some of which are larger
    and have greater financial resources than New Forafric will have after the Business Combination is effected.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business is subject to risks related to data security and its ability to protect its intellectual property.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL&#8217;s
    business requires significant amounts of capital to operate our business and fund capital expenditures and if New Forafric in unable
    to generate sufficient cash flows or raise sufficient external financing to fund these activities and working capital after the Business
    Combination, New Forafric&#8217;s operations and growth may be adversely affected.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric&#8217;s ability to be successful following the Business Combination will depend upon the efforts of the New Forafric Board
    and FAHL&#8217;s key personnel and the loss of such persons could negatively impact the operations and profitability of New Forafric&#8217;s
    business following the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
Relating to the Business Combination and Globis</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders will experience dilution due to the issuance to the Seller of securities entitling it to a significant voting stake
    in New Forafric. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near
    future. This could cause the market price of our Common Stock to drop significantly, even if New Forafric&#8217;s business is doing
    well. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ability of Globis&#8217; stockholders to exercise Redemption Rights with respect to Globis&#8217; Public Shares may prevent Globis
    from completing the Business Combination or optimizing its capital structure. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
    to the completion of the Business Combination, New Forafric may be required to take write-downs or write-offs, restructuring and
    impairment or other charges that could have a significant negative effect on its financial condition and its share price, which could
    cause you to lose some or all of your investment. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric&#8217;s ability to be successful following the Business Combination will depend upon the efforts of New Forafric Board and
    FAHL&#8217;s key personnel and the loss of such persons could negatively impact the operations and profitability of New Forafric&#8217;s
    business following the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric will be a holding company and its only material asset after completion of the Business Combination will be its interest
    in FAHL, and it is accordingly dependent upon distributions made by its subsidiaries to pay taxes and pay dividends. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">FAHL may become a &#8220;controlled company&#8221; within
    the meaning of the rules of Nasdaq and, as a result, may qualify for, and may rely on, exemptions from certain corporate governance
    requirements.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric may become a &#8220;foreign private issuer&#8221; and may choose to take advantage of the reduced reporting requirements
    applicable to foreign private issuers.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_001"></span>SELECTED
HISTORICAL FINANCIAL INFORMATION OF GLOBIS<sup>1</sup></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">Globis
is providing the following selected historical financial information to assist you in your analysis of the financial aspects of the Business
Combination. Globis&#8217; condensed balance sheet data as of December 31, 2020 and the statement of operations data for the period from
August 21, 2020 (inception) through December 31, 2020 are derived from Globis&#8217; audited financial statements included elsewhere
in this proxy statement/prospectus. Globis&#8217; condensed balance sheet data as of September 30, 2021 and the statement of operations
data for the nine months ended September 30, 2021 and for the period from August 21, 2020 (inception) through September 30, 2020 has
been derived from Globis&#8217; unaudited condensed financial statements, which is included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">The
information is only a summary and should be read in conjunction with Globis&#8217; financial statements and related notes and &#8220;<i>Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations of Globis</i>&#8221; contained elsewhere in this proxy statement/prospectus.
Globis&#8217; historical results are not necessarily indicative of future results, and the results for any interim period are not necessarily
indicative of the results that may be expected for a full fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Income Statement Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine Months Ended<br /> September
    30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the Period from </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
                                            21, 2020 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Inception)
                                            Through September 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the Period from </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
                                            21, 2020 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Inception)
                                            Through December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Loss from operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(1,607</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(1</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(90</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,602</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(90</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share, redeemable common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average shares outstanding, basic and diluted, <br />redeemable common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share, non-redeemable common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.00</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average shares outstanding &#8211; basic and diluted, non-redeemable common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,550,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,179,573</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Balance Sheet Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br />
 September 30, <br />
2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> December 31,<br /> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Total current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">159</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">485</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,156</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,150</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,635</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Value of common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,150</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholders&#8217; (deficit) equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,182</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_002"></span>SELECTED
HISTORICAL COMBINED FINANCIAL AND OTHER DATA OF FAHL </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following tables summarize
FAHL&#8217;s consolidated financial data. The summary consolidated statement of operations data for the years ended December 31, 2020
and 2019 and the summary consolidated balance sheet data as of December 31, 2020 and 2019  are derived from FAHL&#8217;s audited
consolidated financial statements that are included elsewhere in this proxy statement/prospectus. The data for the nine months ended
September 30, 2021 and 2020 has been derived from FAHL&#8217;s unaudited condensed consolidated financial statements, which
is included elsewhere in this proxy statement/prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The
                                            summary historical financial data below also includes references to EBITDA and Adjusted EBITDA,
                                            which are non-GAAP financial measures. A non-GAAP financial measure is a performance metric
                                            that departs from GAAP because it excludes earnings components that are required under GAAP.
                                            FAHL defines EBITDA as net income (loss) adjusted for (i) net interest expense, (ii) tax
                                            expense, and (iii) depreciation and amortization; and defines Adjusted EBITDA as EBITDA adjusted
                                            for (i) non-recurring income (expenses), including tax penalties, bad debt
                                            resulting from customers who ceased operations during the COVID-19 pandemic, and a
                                            decrease of governmental subsidies during 2021, and (ii) foreign currency
                                            exchange gains or losses. Other companies may define non-GAAP financial measures differently
                                            and, as a result, FAHL&#8217;s non-GAAP financial measures may not be directly comparable
                                            to those of other companies. Therefore, these measures should not be considered in isolation
                                            or as an alternative to net loss or other measures of financial performance or liquidity
                                            under GAAP. The presentation of non-GAAP financial measures provides additional information
                                            to investors regarding FAHL&#8217;s results of operations that management believes is useful
                                            for trending, analyzing and benchmarking the performance and value of FAHL&#8217;s business.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
historical results are not necessarily indicative of future results, and the results for any interim period are not necessarily indicative
of the results that may be expected for a full fiscal year. You should read the summary historical financial data below in conjunction
with the section titled &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of FAHL</i>&#8221;
and the financial statements and related notes included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br /></span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; padding-right: 0.1in; padding-left: 0.1in; margin-bottom: 0pt"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine
    months ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    </span><span style="font-family: Times New Roman, Times, Serif">ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September <span style="font-family: Times New Roman, Times, Serif">30,</span></p></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of USD</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif">Revenues</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">185,517</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">145,938</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">196,596</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,209</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Cost of sales</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">157,202</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">119,130</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,188</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,498</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    profit</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,315</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,808</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,408</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,711</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    expenses:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,415</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,735</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,517</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,733</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,415</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,735</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,517</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,733</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,900</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,073</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,891</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,978</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    expense (income):</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(282</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,387</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,399</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,847</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,432</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign
    Exchange loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,004</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,734</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,043</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">141</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    other expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,109</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,131</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,887</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,568</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(Loss)
    Income</span><span style="font-family: Times New Roman, Times, Serif"> before income taxes</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,209</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,590</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax (benefit) expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(831</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,407</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,509</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,378</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,465</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(139</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,099</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    income (loss) attributable to non-controlling interest</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">158</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to the Company</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,536</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,465</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(110</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,099</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    per common share - basic and diluted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.03</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(396.98</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.03</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,194.85</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Weighted average
    number of shares outstanding - basic and diluted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,690</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,620,017</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,690</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,378</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,465</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(139</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,099</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    comprehensive (loss) income, net of tax:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign
    currency translation adjustments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,373</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,660</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,774</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">535</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    other comprehensive (loss) income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,373</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,660</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,774</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">535</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    (loss)</span><span style="font-family: Times New Roman, Times, Serif"> income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,751</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,125</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,635</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,564</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">less: Comprehensive income (loss) attributable to</span> <span style="font-family: Times New Roman, Times, Serif">non-controlling interest</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    (loss) income attributable to the Company</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,806</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,125</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,664</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,564</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">EBITDA
    Calculation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,378</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,465</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(139</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,099</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    expense, net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,397</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,844</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,427</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax (benefit)</span><span style="font-family: Times New Roman, Times, Serif"> expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(831</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,407</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,509</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,633</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,632</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,971</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,045</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">EBITDA</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,529</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,971</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,819</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,882</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    non-recurring expense (income)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restructuring
    </span><span style="font-family: Times New Roman, Times, Serif">expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,940</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,071</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,772</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,784</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign
    exchange loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,004</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,734</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,043</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">141</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transactions
    fees</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,153</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,610</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">522</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,044</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,798</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjusted
    EBITDA</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,236</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,298</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,678</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,009</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">% revenues</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.1</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.4</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance
    sheet</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,763</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">268,104</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">234,578</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">212,577</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">247,769</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">346,312</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,584</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">286,660</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    (Deficit)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,994</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78,208</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,994</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(74,083</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
</div>
<p style="margin: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_003"></span>COMPARATIVE
PER SHARE INFORMATION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the historical comparative per share information of Globis, on a stand-alone basis and the unaudited pro forma
combined per share information after giving effect to the Business Combination, assuming no redemptions and maximum redemptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average shares outstanding and net earnings per share information reflect the Business Combination as if it had occurred on
January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in the following table should be read in conjunction with the selected historical financial information summary included
elsewhere in this proxy statement/prospectus, and the historical financial statements of Globis and FAHL and related notes that are included
elsewhere in this proxy statement/prospectus. The unaudited pro forma combined per share information is derived from, and should be read
in conjunction with, the unaudited pro forma combined financial statements and related notes included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma combined earnings per share information below does not purport to represent the earnings per share which would have
occurred had the companies been combined during the period presented, nor earnings per share for any future date or period. The unaudited
pro forma combined book value per share information below does not purport to represent what the value of Globis and FAHL would have
been had the companies been combined during the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.2pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited
    pro forma per share information of the combined company assuming two redemption scenarios as follows: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    No Redemptions scenario assumes that no Globis stockholders elect to redeem their shares of common stock for a pro rata portion of
    cash in the Trust Account in connection with the Business Combination, and thus the full amount held in the Trust Account as of the
    Closing is available for the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Maximum Redemptions scenario assumes that Globis&#8217; stockholders redeem 11.5 million shares at $10.20 per share, for an aggregate
    payment of approximately $117.3 million of their shares of common stock for a pro rata portion of cash in the Trust Account in connection
    with the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Globis</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">FAHL</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Redemptions</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maximum<br /> Redemptions</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Nine Months Ended September 30, 2021</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(1,602</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(3,378</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; (deficit) equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,182</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,994</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,050,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss per share &#8211; Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book value per share <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash dividends per share &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Year Ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(90</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(139</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,382</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,382</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,179,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss per share &#8211; Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash dividends per share &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book
    value per share = (Total shareholders&#8217; equity / shares outstanding) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_004"></span>QUESTIONS
AND ANSWERS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    am I receiving this proxy statement/prospectus? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    are receiving this proxy statement/prospectus in connection with the Stockholders Meeting of Globis&#8217; stockholders. Globis is
    holding the Stockholders Meeting to consider and vote upon the Proposals described below. Your vote is important. You are encouraged
    to vote as soon as possible after carefully reviewing this proxy statement/prospectus. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    is being voted on at the Stockholders Meeting? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
                                            stockholders are being asked to consider and vote upon the Merger Proposal to approve and
                                            adopt the Merger. If approved and adopted, the Merger will become effective prior to the
                                            consummation of the Business Combination and will be effected by the filing of a certificate
                                            of merger with the Delaware Secretary of State and articles of merger with the Nevada Secretary
                                            of State. The Merger Proposal, if approved and adopted, will authorize Globis to merge with
                                            and into Globis NV Merger Corp., a Nevada corporation and a wholly-owned subsidiary of Globis,
                                            with Globis NV Merger Corp. surviving. See the section entitled &#8220;<i>Proposal 1: The
                                            Merger Proposal</i>.&#8221;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are being asked to consider and vote upon the Merger Proposal and the Redomiciliation Proposal to change the corporate
    structure and domicile of Globis by way of a merger whereby the corporation will merge with and into a corporation incorporated under
    the laws of Nevada. Immediately after the Merger, Globis will seek to effect a continuation from such corporation to a public company
    limited by shares incorporated under the laws of Gibraltar. The Redomiciliation will be effected by Globis filing an application
    for establishing domicile in Gibraltar, along with all applicable notices, undertakings and other documents required to be filed,
    and filing an application to de-register with the Nevada Secretary of State and all outstanding securities of Globis will convert
    to outstanding securities of New Forafric, as described in more detail in this proxy statement/prospectus. In connection with the
    Redomiciliation, and simultaneously with the Business Combination, Globis Nevada will change its corporate name to &#8220;Forafric
    Global PLC.&#8221; The Redomiciliation will become effective immediately prior to the completion of the Business Combination. The
    form of the proposed Memorandum and Articles of Association of New Forafric is attached to this proxy statement/prospectus as <i>Annex
    C</i>. See the sections entitled &#8220;<i>Proposal 1: The Merger Proposal.</i>&#8221; and &#8220;<i>Proposal 2: The
    Redomiciliation Proposal.</i>&#8221;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon the Business Combination Proposal to approve the Business Combination
    Agreement and the Business Combination contemplated thereby. The Business Combination Agreement provides that, among other things,
    Globis will acquire 100% of the equity interests of FAHL from Seller, its sole shareholder, with FAHL becoming a direct subsidiary
    of New Forafric as a result thereof. Shareholder approval of the Business Combination Agreement and the transactions contemplated
    thereby is required by the Business Combination Agreement and the Amended and Restated Certificate of Incorporation. A copy of the
    Business Combination Agreement is attached to this proxy statement/ prospectus as <i>Annex A </i>and Globis encourages its
    shareholders to read it in its entirety. See the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal</i>.&#8221;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon the Equity Incentive Plan Proposal to adopt the Equity Incentive Plan.
    Among other things, the Equity Incentive Plan, which would become effective upon the completion of the Business Combination, is intended
    to maintain and strengthen New Forafric&#8217;s ability to attract and retain key employees, directors, consultants and certain other
    individuals providing services to New Forafric and to motivate them to remain focused on long-term shareholder value. See the section
    entitled &#8220;<i>Proposal 4: The Equity Incentive Plan Proposal.</i>&#8221; A copy of the Equity Incentive Plan is attached to
    this proxy statement/ prospectus as <i>Annex H</i>, and Globis encourages its shareholders to read the plan in its
    entirety.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon the amendment and restatement of the Existing Organizational Documents
    in their entirety by the new Memorandum and Articles of Association, assuming the Merger Proposal and the Redomiciliation Proposal
    are approved and adopted, and the filing with and acceptance by the Gibraltar Companies Registrar in accordance with the Companies
    Act and Re-domiciliation Regulations, including the authorization of the change in authorized share capital as indicated therein
    and the change of name of Globis to &#8220;Forafric Global PLC&#8221; in connection with the Business Combination. The new Memorandum
    and Articles of Association of New Forafric is attached hereto as <i>Annex C</i> and Globis encourages its shareholders to
    read it in its entirety. See the section entitled &#8220;<i>Proposal 6: The Charter Proposal</i>.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon a non-binding advisory basis] the Organizational Documents Proposals
    to approve certain material differences between the Existing Organizational Documents and the Proposed Organizational Documents of
    New Forafric (a public company limited by shares incorporated in Gibraltar), assuming the Charter Proposal is approved and adopted.
    See the section entitled &#8220;<i>Proposal 7: The Organizational Documents Proposals</i>.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon the Nasdaq Proposal. Our Units, Public Shares, and Public Warrants
    are listed on Nasdaq and, as such, we are seeking shareholder approval for the purposes of complying with the applicable provisions
    of the Nasdaq Listing Rule 5635 of the issuance of ordinary shares and securities convertible into or exchangeable for ordinary shares
    in connection with the Business Combination, and the ordinary shares issued in connection with the PIPE Investment, the conversion
    of the FAHL Bonds and the conversion of the FAHL Related Party Loans. See the section entitled &#8220;<i>Proposal 8: The Nasdaq Proposal.</i>&#8221;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    stockholders are also being asked to consider and vote upon the Adjournment Proposal to adjourn the Stockholders Meeting to a later
    date or dates, including, if necessary, to permit further solicitation and vote of proxies if it is determined by Globis that more
    time is necessary or appropriate to approve one or more Proposals at the Stockholders Meeting. See the section entitled &#8220;<i>Proposal
    9: The Adjournment Proposal</i>.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    presence, in person or by proxy, of Globis stockholders representing a majority of the issued and outstanding Common Stock on the
    Record Date and entitled to vote on the Proposals to be considered at the Stockholders Meeting will constitute a quorum for the Stockholders
    Meeting. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YOUR
VOTE IS IMPORTANT. YOU ARE ENCOURAGED TO VOTE AS SOON AS POSSIBLE AFTER CAREFULLY REVIEWING THIS PROXY STATEMENT/PROSPECTUS. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Are
    the Proposals conditioned on one another? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
    Director Election Proposal, the Charter Proposal and the Nasdaq Proposal is interdependent upon the others and must be approved in
    order for Globis to complete the Business Combination. None of the Organizational Documents Proposals, which will be voted upon a
    non-binding advisory basis only, or the Adjournment Proposal is conditioned upon the approval of any other proposal. The approval
    of the Business Combination Proposal, the Equity Incentive Plan Proposal, the Organizational Documents Proposals, the Nasdaq Proposal
    and the Adjournment Proposal will require the affirmative vote of a majority of the votes cast by the stockholders present in person
    (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. The Organizational Documents
    Proposals are voted upon on a non-binding advisory basis. Notwithstanding the foregoing, the Business Combination is conditioned
    upon the approval of the Condition Precedent Proposals The approval of the Merger Proposal, the Redomiciliation Proposal and the
    Charter Proposal will require the affirmative vote of the holders of a majority of the outstanding shares of Globis Common Stock,
    voting together as a single class. Directors are elected by a plurality of all of the votes cast by the stockholders present in person
    (which would include presence at a virtual meeting) or represented by proxy at the Stockholder Meeting. This means that the six director
    nominees who receive the most affirmative votes will be elected. If any of the Condition Precedent Proposals fail to receive the
    required approval by the stockholders of Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    is Globis proposing the Redomiciliation?</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board believes that there are significant advantages to New Forafric that will arise as a result of being domiciled in Gibraltar,
    including (i) being redomiciled in Gibraltar will create operational efficiencies for the combined company due to the fact that FAHL
    is a Gibraltar private company limited by shares and its subsidiaries are all located outside the United States and (ii) the elimination
    of our obligation to pay the annual Delaware franchise tax and the expected savings as a result of not having a franchise tax. FAHL
    required that Globis redomicile in the state of Gibraltar in order to enter into the Business Combination Agreement. See &#8220;<i>The
    Redomiciliation Proposal</i>&#8221; for a further discussion of these factors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    is involved with the Redomiciliation? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Redomiciliation will require Globis Nevada to file certain documents in both the State of Nevada and Gibraltar. At the effective
    time of the Redomiciliation, which will be the Closing Date, Globis Nevada will cease to be a corporation incorporated under the
    laws of the State of Nevada and in connection with the Business Combination, Globis Nevada will continue as a Gibraltar public company
    limited by shares and, simultaneously with the Business Combination, will change its corporate name to &#8220;Forafric Global PLC.&#8221;
    The Certificate of Incorporation will be replaced by the proposed Memorandum and Articles of Association and your rights as a shareholder
    will cease to be governed by Nevada law and will be governed by the laws of Gibraltar. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>When
    do you expect that the Redomiciliation will be effective? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Redomiciliation is expected to become effective immediately prior to the completion of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    will the Redomiciliation affect my securities of Globis? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to the Redomiciliation and the Business Combination and without further action on the part of Globis&#8217; stockholders, each outstanding
    share of Common Stock will convert to one outstanding Ordinary Share of New Forafric. Although it will not be necessary for you to
    exchange your certificates representing Common Stock after the Redomiciliation, New Forafric will, upon request, exchange your Globis
    share certificates for the applicable number of New Forafric&#8217;s Ordinary Shares, and all certificates for securities
    issued after the Redomiciliation will be certificates representing securities of New Forafric. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    are the material U.S. federal income tax consequences of the Business Combination to Holders of Globis Shares and Warrants? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            described more fully under the section entitled &#8220;<i>Certain Material U.S. Federal Income
                                            Tax Considerations &#8212; U.S. Holders &#8212; U.S. Federal Income Tax Considerations of
                                            the Business Combination</i>,&#8221; the parties have structured the Merger to meet the relevant
                                            requirements provided in U.S. tax law to qualify the Merger as a tax-free reorganization
                                            (a &#8220;reorganization&#8221;) within the meaning of Section 368(a) of the Internal Revenue
                                            Code of 1986, as amended (the &#8220;Code&#8221;) to U.S. Holders (as defined below) of Globis
                                            Shares and/or Warrants. However, since there is currently insufficient authority from the
                                            Internal Revenue Service that is factually on point with the Merger regarding satisfaction
                                            of all of the requirements under U.S. tax law allowing such tax-free treatment, the parties
                                            to the Merger can provide no assurance that treatment as a tax-free reorganization will result
                                            for the exchanging stockholders. Accordingly, there are significant factual and legal uncertainties
                                            as to whether the Merger will qualify as a reorganization within the meaning of Code Section
                                            368.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition, Section 367(a) of the Code and the Treasury regulations promulgated thereunder, in certain circumstances, may impose additional
    requirements for certain U.S. Holders to qualify for tax-deferred treatment with respect to the exchange of Globis Common Stock and/or
    Globis Warrants in the Merger.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    tax consequences of the Merger are complex and will depend on your particular circumstances. For a more detailed discussion of the
    U.S. federal income tax considerations of the Merger for U.S. Holders of Globis Shares and/or Warrants, including the application
    of Section 367(a) of the Code, see the section entitled &#8220;<i>Certain Material U.S. Federal Income Tax Considerations &#8212;
    U.S. Holders &#8212; U.S. Federal Income Tax Considerations of the Business Combination</i>.&#8221; If you are a U.S. Holder whose
    Globis Shares and/or Warrants are exchanged in the Merger, you are urged to consult your tax advisor to determine the tax consequences
    thereof.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    summary above is qualified in its entirety by the more detailed discussion provided in the section entitled &#8220;<i>Certain Material
    U.S. Federal Income Tax Considerations</i>.&#8221;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    are the material U.S. federal income tax consequences to Holders of Globis Shares that exercise their Redemption Rights? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
    the redemption is subject to U.S. federal income tax depends on the particular facts and circumstances. Please see the section entitled
    &#8220;<i>Certain Material U.S. Federal Income Tax Considerations &#8212; U.S. Holders &#8212; U.S. Holders Exercising Redemption
    Rights with Respect to Globis Common Stock</i>&#8221; or &#8220;<i>Certain Material U.S. Federal Income Tax Considerations &#8212;
    Non-U.S. Holders &#8212; Non-U.S. Holders Exercising Redemption Rights with Respect to Globis Common Stock</i>&#8221; for additional
    information. You are urged to consult your tax advisors regarding the tax consequences of exercising your redemption rights.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    is Globis proposing the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    was organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar
    business combination with one or more businesses or entities. Since Globis&#8217; organization, the Globis Board has sought to identify
    suitable candidates in order to effect such a transaction. In its review of FAHL, the Globis Board considered a variety of factors
    weighing positively and negatively in connection with the Business Combination. After careful consideration, the Globis Board has
    determined that the Business Combination presents a highly-attractive business combination opportunity and is in the best interests
    of Globis stockholders. The Globis Board believes that, based on its review and consideration, the Business Combination with FAHL
    presents an opportunity to increase shareholder value. However, there can be no assurance that the anticipated benefits of the Business
    Combination will be achieved. Shareholder approval of the Business Combination is required by the Business Combination Agreement
    and the Amended and Restated Certificate of Incorporation, as well as to comply with Nasdaq Listing Rule 5635.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    will happen in the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Business Combination consists of a series of transactions pursuant to which (i) Globis will complete the Redomiciliation and (ii)
    Globis will acquire 100% of the equity interests of FAHL from Seller, with Globis continuing to operate as New Forafric. Upon the
    completion of the Redomiciliation and the Business Combination, each issued and outstanding share of Common Stock of Globis will
    become an Ordinary Share, and each issued and outstanding Warrant to purchase shares of Common Stock of Globis will become a warrant
    to purchase an equal number of Ordinary Share of New Forafric. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    consideration will the Seller receive in connection with the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with the terms and subject to the conditions of the Business Combination Agreement, Globis will effect the Business Combination
    with the Seller in exchange for a combination of cash consideration and newly-issued Ordinary Shares of New Forafric. For further
    details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination Agreement &#8212; Consideration
    to be Received in the Business Combination</i>.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    equity stake will current Globis stockholders and the Seller hold in New Forafric immediately after the completion of the Business
    Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the completion of the Business Combination (assuming, among other things, that no Globis stockholders exercise Redemption Rights
    with respect to their ordinary shares upon completion of the Business Combination and the other assumptions described under the section
    entitled &#8220;<i>Frequently Used Terms &#8212; Share Calculations and Ownership Percentages</i>&#8221;), the current holders of
    Globis Common Stock are expected to own Ordinary Shares of New Forafric representing approximately &#160;&#160;&#160;&#160;% of the
    voting power of New Forafric. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    any of Globis&#8217; stockholders exercise their Redemption Rights, the percentage of New Forafric&#8217;s outstanding voting stock
    held by the current holders of Globis Common Stock will decrease and the percentage of New Forafric&#8217;s outstanding voting stock
    held by the Seller will increase, in each case relative to the percentage held if none of the Globis Common Stock are redeemed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    relative percentage above is for illustrative purposes only and is based upon certain assumptions as described in the section entitled
    &#8220;<i>Frequently Used Terms &#8212; Share Calculations and Ownership Percentages</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
    one or more of the assumptions prove incorrect, actual beneficial ownership percentages may vary materially from those described
    in this proxy statement/prospectus as anticipated, believed, estimated, expected or intended.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Did
    the Globis Board obtain a third-party valuation or fairness opinion in determining whether or not to proceed with the Business Combination?
    </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
    The Globis Board did not obtain a third-party valuation or fairness opinion in connection with its determination to approve the Business
    Combination. Globis&#8217; officers and directors have substantial experience in evaluating the operating and financial merits of
    companies from a wide range of industries and concluded that their experience and backgrounds, together with the experience and sector
    expertise of Globis&#8217; advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination.
    Accordingly, investors will be relying solely on the judgment of the Globis Board in valuing FAHL&#8217;s business and assuming the
    risk that the Globis Board may not have properly valued such business. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    will the Seller and Globis receive in connection with the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with the terms and subject to the conditions of the Business Combination Agreement, at the Effective Time, (i) the Seller
    will receive (a) up to 17,004,762 Ordinary Shares in New Forafric, and (b) the Closing Payment,, and (ii) New Forafric will receive
    equity interests in FAHL For further details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination
    Agreement &#8212; Business Combination Consideration.</i>&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    happens to the funds deposited in the Trust Account after consummation of the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    the closing of our IPO, an amount equal to $116,150,000 ($10.10 per unit) of the net proceeds from our IPO and certain of the proceeds
    from the sale of the Private Placements was placed in the Trust Account. At&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;was held in the Trust Account
    for the purposes of consummating an initial business combination (which will be the Business Combination should it occur). These
    funds will remain in the Trust Account, except for the withdrawal of interest to pay taxes, if any, until the earliest of (1) the
    completion of a business combination (including the closing of the Business Combination) or (2) the redemption of all of the public
    shares if we are unable to complete a business combination by March 15, 2022 (or June 15, 2022 if such date is extended), subject
    to applicable law. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our initial business combination (which will be the Business Combination should it occur) is paid for using equity or debt securities
    or not all of the funds released from the Trust Account are used for payment of the consideration in connection with our initial
    business combination (which will be the Business Combination should it occur) or used for redemptions or purchases of the public
    shares, we may apply the balance of the cash released to us from the Trust Account for general corporate purposes, including for
    maintenance or expansion of operations of New Forafric, the payment of principal or interest due on indebtedness incurred in completing
    our Business Combination, to fund the purchase of other companies or for working capital. See &#8220;<i>Summary of the Proxy Statement/Prospectus
    &#8212; Sources and Uses of Funds for the Business Combination</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    happens if a substantial number of the Public Stockholders vote in favor of the Business Combination Proposal and exercise their
    Redemption Rights? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Public Stockholders are not required to vote &#8220;AGAINST&#8221; the Business Combination in order to exercise their Redemption
    Rights, although redemption is only available if the Business Combination is consummated. Accordingly, the Business Combination may
    be consummated even though the funds available from the Trust Account and the number of Public Stockholders are reduced as a result
    of redemptions by Public Stockholders. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Business Combination Agreement is also subject to the satisfaction or waiver of certain other closing conditions as described in
    the accompanying proxy statement/prospectus. There can be no assurance that the parties to the Business Combination Agreement would
    waive any such provision of the Business Combination Agreement. In addition, the Business Combination Agreement provides that the
    obligations of FAHL, the Seller and Globis to consummate the Business Combination are conditioned on, among other things, Globis
    having, after giving effect to the Business Combination and the transactions contemplated thereby, net tangible assets (as determined
    in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of at least $5,000,001.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
    as a result of redemptions, the trading market for the Ordinary Shares of New Forafric may be less liquid than the market for the
    Public Shares was prior to consummation of the Business Combination and we may not be able to meet the listing standards for Nasdaq
    or another national securities exchange.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    conditions must be satisfied to complete the Business Combination? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of the Business Combination is subject to the satisfaction or waiver of certain customary closing conditions of the
    respective parties, including, among others: (a) the approval of each of the Condition Precedent Proposals by Globis stockholders;
    (b) there shall not be any applicable law in effect that makes the consummation of the transactions contemplated by the Business
    Combination Agreement illegal or any order in effect preventing the consummation of the transactions contemplated thereby; (c) this
    Form S-4 shall have become effective in accordance with the provisions of the Securities Act, no stop order shall have been issued
    by the SEC and no proceeding seeking such stop order has been threatened or initiated by the SEC that remains pending; (d) after
    giving effect to the transactions contemplated by the Business Combination Agreement, New Forafric has at least $5,000,001 of net
    tangible assets immediately after the Effective Time; and (e) no Company Material Adverse Effect (as defined in the Business Combination
    Agreement) has occurred that is then continuing. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    a summary of the conditions that must be satisfied or waived prior to completion of the Business Combination, see the section entitled,
    &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business Combination Agreement &#8212; Closing Conditions</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>When
    do you expect the Business Combination to be completed? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is currently expected that the Business Combination will be completed in the first quarter of 2022. This timing depends, among other
    things, on the approval of the Proposals to be presented at the Stockholders Meeting. However, the Stockholders Meeting could be
    adjourned if the Adjournment Proposal is adopted at the Stockholders Meeting and Globis elects to adjourn the Stockholders Meeting
    to a later date or dates to permit further solicitation and vote of proxies if reasonably determined to be necessary or desirable
    by Globis. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    happens if the Business Combination is not completed? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    a Public Stockholder has tendered shares to be redeemed but the Business Combination is not completed, the Redemptions will be canceled
    and the tendered shares will be returned to the relevant Public Stockholders as appropriate. The current deadline set forth in the
    Amended and Restated Certificate of Incorporation for Globis to complete its initial business combination (which will be the Business
    Combination should it occur) is March 15, 2022, subject to Globis Board&#8217;s election to extend the period of time for completing
    an initial business combination to June 15, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    is Globis proposing the Equity Incentive Plan Proposal? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purpose of the Equity Incentive Plan is to enable New Forafric to offer eligible employees, directors and consultants cash and other
    stock-based and other performance-based incentive awards in order to attract, retain and reward these individuals and strengthen
    the mutuality of interests between them and New Forafric&#8217;s shareholders. For more information, see the section entitled &#8220;<i>Proposal
    4: The Equity Incentive Plan Proposal.</i>&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    amendments will be made to the current constitutional documents of Globis? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of the Business Combination is conditioned, among other things, on the Redomiciliation. Accordingly, in addition to
    voting on the Business Combination, Globis&#8217; stockholders also are being asked to consider and vote upon a proposal to approve
    the Redomiciliation, and replace our Existing Organizational Documents, in each case, under Nevada law with the Proposed
    Organizational Documents, in each case, under Gibraltar law, which differ materially from the Existing Organizational Documents in
    the following respects: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
    Organizational Documents</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
    Organizational Documents</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
                                            Shares</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7A)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents authorize 101,000,000 shares, consisting of 100,000,000 shares of Common Stock and 1,000,000 shares
    of Preferred Stock.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents authorize 101,000,000 shares, consisting of 100,000,000 Ordinary Shares and 1,000,000 Preferred
    Shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 5 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Memorandum of Association of </i>Forafric Global <i>PLC</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Require
                                            New Forafric to Seek Shareholder Consent Prior to Issuances of Preferred Shares</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents authorize the issuance of 1,000,000 shares of Preferred Stock with such designations, rights and
    preferences as may be determined from time to time by our board of directors. Accordingly, Globis Board is empowered under the Existing
    Organizational Documents, without shareholder approval, to issue shares of preferred stock with dividend, liquidation, redemption,
    voting or other rights which could adversely affect the voting power or other rights of the holders of ordinary shares.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Proposed Organizational Documents provide that New Forafric may issue shares with such rights
                                            or restrictions as may be determined by ordinary resolution of the shareholders of New Forafric.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric may issue shares which are to be redeemed, or are liable to be redeemed at the option of New Forafric or the holder, and
    the directors may determine the terms, conditions and manner of redemption of any such shares.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 5 of our Existing Organizational Documents</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    article 160 of the Articles of Association.</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusive
                                            Forum</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents do not contain a provision adopting an exclusive forum for certain shareholder litigation.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not contain a provision adopting an exclusive forum for shareholder litigation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
    Organizational Documents</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
    Organizational Documents</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
                                            Name</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents provide the name of New Forafric is &#8220;Globis Acquisition Corp.&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents will provide that the name of the company will be &#8220;Forafric Global PLC&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    paragraph 1 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Perpetual
                                            Existence</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents provide that if we do not consummate a business combination (as defined in the Existing Organizational
    Documents) by March 15, 2022 (or June 15, 2022 if such date is extended), Globis shall cease all operations except for the purposes
    of winding up and shall redeem the shares issued in our IPO and liquidate the Trust Account.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not contain a provision for the mandatory winding up of New Forafric in any circumstances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 6.F of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Takeovers
                                            by Interested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents do not provide restrictions on takeovers of Globis by a related shareholder following a business
    combination.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
    Proposed Organizational Documents do not provide restrictions on takeovers of New Forafric by a related shareholder following a business
    combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provisions
                                            Related to Status as</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Blank
    Check Company</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents set forth various provisions related to our status as a blank check company prior to the consummation
    of a business combination.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not include such provisions related to our status as a blank check company, which no longer
    will apply upon consummation of the Business Combination, as we will cease to be a blank check company at such time.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 6 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, see the section entitled &#8220;<i>Proposal 7: The Organizational Documents Proposals</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    is Globis proposing the Adjournment Proposal? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    is proposing the Adjournment Proposal to allow the adjournment of the Stockholders Meeting to a later date or dates, including if
    necessary to permit further solicitation and vote of proxies if it is determined by Globis that more time is necessary or appropriate
    to approve one or more Proposals at the Stockholders Meeting. Please see the section entitled &#8220;<i>Proposal 9: The Adjournment
    Proposal</i>&#8221; for additional information. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>When
    and where will the Stockholders Meeting be held? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Stockholders Meeting will be held at 9 a.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022, at the offices of McDermott Will &amp; Emery LLP located at One Vanderbilt Avenue, 45<sup>th</sup> Floor, New York, New York
    10017, and via a virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be adjourned.
    As part of our precautions regarding COVID-19, we are planning for the possibility that the meeting may be held virtually over the
    Internet. If we take this step, we will announce the decision to do so via a press release and posting details on our website that
    will also be filed with the SEC as proxy material. Only shareholders who held common stock of Globis at the close of business on
    the Record Date will be entitled to vote at the Stockholders Meeting. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Who
    is entitled to vote at the Stockholders Meeting? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    has fixed &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022 as the Record Date. If you were a shareholder of Globis at the close of business on the Record Date, you are entitled to vote
    on matters that come before the Stockholders Meeting. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    do I vote? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are a record owner of your shares, there are two ways to vote your Globis Shares at the Stockholders Meeting: </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">You
    Can Vote By Signing and Returning the Enclosed Proxy Card</span>. If you vote by proxy card, your &#8220;proxy,&#8221; whose name is
    listed on the proxy card, will vote your shares as you instruct on the proxy card. If you sign and return the proxy card but do not
    give instructions on how to vote your shares, your shares will be voted as recommended by the Globis Board &#8220;FOR&#8221; the
    Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the Nasdaq
    Proposal, the Charter Proposal, each of the Organizational Documents Proposals and the Adjournment Proposal (if presented). Votes
    received after a matter has been voted upon at the Stockholders Meeting will not be counted.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">You
    Can Attend the Stockholders Meeting and Vote in Person</span>. When you arrive, you will receive a ballot that you may use to cast your
    vote.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker to ensure
    that votes related to the shares you beneficially own are properly counted. If you wish to attend the Stockholders Meeting and vote
    in person and your shares are held in &#8220;street name,&#8221; you must obtain a legal proxy from your broker, bank or nominee.
    That is the only way Globis can be sure that the broker, bank or nominee has not already voted your shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
    my shares are held in &#8220;street name&#8221; in a stock brokerage account or by a broker, bank or other nominee, will my broker,
    bank or other nominee vote my shares for me? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            your shares are held in &#8220;street name&#8221; in a stock brokerage account or by a broker,
                                            bank or other nominee, you must provide the record holder of your shares with instructions
                                            on how to vote your shares. Please follow the voting instructions provided by your broker,
                                            bank or other nominee. Please note that you may not vote shares held in &#8220;street name&#8221;
                                            by returning a proxy card directly to Globis or by voting in person (which would include
                                            presence at a virtual meeting) at the Stockholder Meeting unless you provide a &#8220;legal
                                            proxy,&#8221; which you must obtain from your broker, bank or other nominee.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the rules of the Nasdaq, brokers who hold shares in &#8220;street name&#8221; for a beneficial owner of those shares typically have
    the authority to vote in their discretion on &#8220;routine&#8221; proposals when they have not received instructions from beneficial
    owners. However, brokers are not permitted to exercise their voting discretion with respect to the approval of matters that the Nasdaq
    determines to be &#8220;non-routine&#8221; without specific instructions from the beneficial owner. It is expected that all proposals
    to be voted on at the Stockholder Meeting are &#8220;non-routine&#8221; matters. Broker non-votes occur when a broker or nominee
    is not instructed by the beneficial owner of shares to vote on a particular proposal for which the broker does not have discretionary
    voting power.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are a Globis stockholder holding your shares in &#8220;street name&#8221; and you do not instruct your broker, bank or other
    nominee on how to vote your shares, your broker, bank or other nominee will not vote your shares on the Merger Proposal, the Redomiciliation
    Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal, the Charter Proposal,
    the Organizational Documents Proposals, the Nasdaq Proposal or the Adjournment Proposal. Such broker non-votes will be the equivalent
    of a vote &#8220;AGAINST&#8221; the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal, but will have no effect
    on the vote count for such other proposals.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    if I attend the Stockholder Meeting but I do not vote my Globis Shares or if I abstain from voting? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of the Business Combination Proposal, the Equity Incentive Plan Proposal, the Organizational
                                            Documents Proposals, the Nasdaq Proposal and the Adjournment Proposal will require the affirmative
                                            vote of a majority of the votes cast by the stockholders present in person (which would include
                                            presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. The Organizational
                                            Documents Proposals are voted upon on a non-binding advisory basis. Notwithstanding the foregoing,
                                            the Business Combination is conditioned upon the approval of the Condition Precedent Proposals.
                                            The approval of the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal
                                            will require the affirmative vote of the holders of a majority of the outstanding shares
                                            of Globis Common Stock, voting together as a single class. Directors are elected by a plurality
                                            of all of the votes cast by the stockholders present in person (which would include presence
                                            at a virtual meeting) or represented by proxy at the Stockholder Meeting. This means that
                                            the six director nominees who receive the most affirmative votes will be elected.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
    will be considered present for the purposes of establishing a quorum. With respect to the Business Combination Proposal, the Equity
    Incentive Plan Proposal, the Director Election Proposal, the Organizational Documents Proposals, the Nasdaq Proposal and the Adjournment
    Proposal, abstentions will not count as votes cast at the Stockholders Meeting and, therefore, will have no effect on the outcome
    of such proposals. With respect to the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal, abstentions will
    count as a vote &#8220;AGAINST&#8221; those proposals.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
    Proposals must be passed in order for the Business Combination to be completed? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Business Combination will not be completed unless the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal,
    the Charter Proposal, the Equity Incentive Proposal and the Nasdaq Proposal are approved. If Globis does not complete an initial
    business combination (which will be the Business Combination should it occur) by May 18, 2022, Globis will be required to dissolve
    and liquidate itself and return the monies held within its Trust Account to its Public Stockholders unless Globis submits and its
    stockholders approve an extension. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    does the Globis Board recommend that I vote on the Proposals? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Globis Board unanimously recommends that the holders of Globis&#8217; Common Stock entitled to vote on the Proposals, vote as follows:
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Merger Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Redomiciliation Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Business Combination Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Equity Incentive Plan Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Director Election Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Charter Proposal;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of each of the Organizational Documents Proposals;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
</b>approval of the Nasdaq Proposal; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>FOR</b>&#8221;
approval of the Adjournment Proposal, if presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    many votes do I have? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    stockholders have one vote per each ordinary share of Globis held by them on the Record Date for each of the Proposals to be voted
    upon. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Why
    is Globis proposing the Organizational Documents Proposals? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    is requesting that its shareholders vote upon, on a non-binding advisory basis, proposals to approve certain governance provisions
    contained in the Certificate of Incorporation that materially affect shareholder rights. This separate vote is not required by Delaware
    law separate and apart from the Charter Proposal, but pursuant to SEC guidance, Globis is required to submit these provisions to
    its shareholders separately for approval. However, the shareholder vote regarding this proposal is an advisory vote, and is not binding
    on Globis and the Globis Board (separate and apart from the approval of the Charter Proposal). Furthermore, the Business Combination
    is not conditioned on the separate approval of the Organizational Documents Proposals (separate and apart from approval of the Charter
    Proposal). Please see the section entitled &#8220;<i>Proposal No. 7 &#8212; The Organizational Documents Proposals</i>&#8221; for
    additional information. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    will the Sponsor and Globis&#8217; officers and directors vote in connection with the Proposals? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of the Record Date, the Sponsors and Globis&#8217; independent directors owned of record an aggregate of 3,148,333 shares
    of Common Stock, representing approximately 21% of the issued and outstanding Globis Shares. Pursuant to the Sponsor Letter
    Agreement, the Sponsor and Globis&#8217; directors and officers have agreed to vote the Common Stock owned by them in favor of the
    Proposals. The Sponsor and Globis&#8217; officers and directors, as of the Record Date, have not acquired any Common Stock during
    or after our IPO in the open market. However, any subsequent purchases of Common Stock prior to the Record Date by the Sponsors or
    Globis&#8217; officers and directors in the aftermarket will make it more likely that the Proposals will be approved as such shares
    would be voted in favor of the Proposals. As of the Record Date, there were 15,050,833 shares of common stock of Globis outstanding.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Do
    I have Redemption Rights with respect to my Globis Shares? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    Section 6.A of the Amended and Restated Certificate of Incorporation, prior to the completion of the Business Combination, Globis
    will provide all of the Public Stockholders with the opportunity to have their shares redeemed upon the completion of the Business
    Combination, subject to certain limitations, for cash equal to the applicable Redemption Price; provided, however, that Globis may
    not redeem such shares to the extent that such Redemption would result in Globis having net tangible assets (as determined in accordance
    with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 upon the completion of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Stockholders may seek to have their shares redeemed regardless of whether they vote for or against the Business Combination, whether
    or not they were holders of Globis common stock as of the Record Date or acquired their shares after the Record Date. The Redemptions
    will be effectuated in accordance with the Amended and Restated Certificate of Incorporation, DGCL, and other applicable laws and
    regulations. Any Public Stockholder who holds common stock of Globis on or before &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022 (two business days before the Stockholders Meeting) will have the right to demand that his, her or its shares be redeemed for
    a pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid, at the completion
    of the Business Combination; provided that such Public Stockholders follow the procedures provided for exercising such Redemption
    as set forth in the Amended and Restated Certificate of Incorporation, as described below, by such date. However, the proceeds held
    in the Trust Account could be subject to claims that could take priority over those of Public Stockholders exercising Redemption
    Rights, regardless of whether such holders vote for or against the Business Combination Proposal and whether such holders are holders
    of Common Stock as of the Record Date. Therefore, the per-share distribution from the Trust Account in such a situation may be less
    than originally anticipated due to such claims. A Public Stockholder will be entitled to receive cash for these shares only if the
    Business Combination is completed. For more information, see &#8220;<i>Stockholders Meeting &#8212; Redemption Rights.</i>&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>May
    the Sponsors, Globis&#8217; directors, officers, advisors or their affiliates purchase shares in connection with the Business Combination?
    </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsors and Globis&#8217; directors, officers, advisors or their affiliates may purchase Globis Shares in privately negotiated transactions
    or in the open market either prior to or after the Closing, including from Globis stockholders who would have otherwise exercised
    their Redemption Rights. However, the Sponsor, directors, officers and their affiliates have no current commitments or plans to engage
    in such transactions and have not formulated any terms or conditions for any such transactions at the date of this proxy statement/prospectus,
    other than certain affiliates of the Sponsors, directors and officers of Globis in connection with the FAHL Bonds.
    If Globis engages in such transactions, any such purchases will be subject to limitations regarding possession of any material nonpublic
    information not disclosed to the seller of such shares and they will not make any such purchases if such purchases are prohibited
    by Regulation M under the Exchange Act. Any such purchase after the Record Date would include a contractual acknowledgement that
    the selling shareholder, although still the record holder of Globis Shares, is no longer the beneficial owner thereof and therefore
    agrees not to exercise its Redemption Rights. In the event the Sponsor or Globis&#8217; directors, officers or advisors or their
    affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their
    Redemption Rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. Any such privately
    negotiated purchases may be effected at purchase prices that are in excess of the per-share pro rata portion of the aggregate amount
    then on deposit in the Trust Account. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Is
    there a limit on the number of shares I may redeem? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Public Stockholder, together with any affiliate or any other person with whom such Public Stockholder is acting in concert or as
    a &#8220;group&#8221; (as defined in Section 13(d)(3) of the Exchange Act), will be restricted from seeking Redemption Rights with
    respect to 20% or more of the Public Shares. Accordingly, any shares held by a Public Stockholder or &#8220;group&#8221; in excess
    of such 20% cap will not be redeemed by Globis. Any Public Stockholder who holds less than 20% of the Public Shares may have
    all of the Public Shares held by him or her redeemed for cash. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>How
    do I exercise my Redemption Rights? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    Public Stockholders who seek to redeem their Public Shares must demand Redemption no later than 5:00 p.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022 (two (2) business days before the Stockholders Meeting) by (a) submitting a written request to the Transfer Agent that Globis
    redeem such Public Stockholder&#8217;s Public Shares for cash, (b) affirmatively certifying in such request to the Transfer Agent
    for Redemption if such Public Stockholder is acting in concert or as a &#8220;group&#8221; (as described in Section 13(d)(3) of the
    Exchange Act) with any other shareholder with respect to common stock of Globis and (c) delivering their Public Shares, either physically
    or electronically using DTC&#8217;s DWAC System, at the Public Stockholder&#8217;s option, to the Transfer Agent prior to the Stockholders
    Meeting. &#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    request for Redemption, once made by a Public Stockholder, may not be withdrawn once submitted to Globis unless the Globis Board
    determines (in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole or in part).
    In addition, if you deliver your share certificates (if any) and other redemption forms for Redemption to the Transfer Agent
    and later decide prior to the Stockholders Meeting not to elect Redemption, you may request that the Transfer Agent return the shares
    (physically or electronically). You may make such request by contacting the&#160;&#160;Transfer Agent at the phone number or address
    listed at the end of this section.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    corrected or changed written demand of Redemption Rights must be received by Globis&#8217; secretary two business days prior to the
    vote taken on the Business Combination Proposal at the Stockholders Meeting. No demand for Redemption will be honored unless the
    holder&#8217;s share certificates (if any) and other redemption forms have been delivered (either physically or electronically) to
    the Transfer Agent at least two business days prior to the vote at the Stockholders Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Stockholders seeking to exercise their Redemption Rights and opting to deliver share certificates (if any) and other redemption forms
    should allot sufficient time to obtain physical certificates from the Transfer Agent and time to effect delivery. It is Globis&#8217;
    understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the Transfer Agent.
    However, Globis does not have any control over this process and it may take longer than two weeks. Shareholders who hold their shares
    in &#8220;street name&#8221; will have to coordinate with their banks, brokers or other nominees to have the shares certificated
    or delivered electronically. There is a cost associated with this tendering process and the act of certificating the shares or delivering
    them through the DWAC system. The Transfer Agent will typically charge a nominal fee to the tendering broker and it would be up to
    the broker whether or not to pass this cost on to the redeeming stockholder. In the event the Business Combination is not completed,
    this may result in an additional cost to shareholders for the return of their shares. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    a Public Stockholder properly demands Redemption as described above, then, if the Business Combination is completed, Globis will
    redeem the shares subject to the Redemptions for cash. Such amount will be paid promptly after completion of the Business Combination.
    If you exercise your Redemption Rights, then you will be exchanging your Globis Shares for cash and will no longer own these shares
    following the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are a Public Stockholder and you exercise your Redemption Rights, it will not result in either the exercise or loss of any Warrants
    that you may hold. Your Warrants will continue to be outstanding following a Redemption of your Globis Shares and will become exercisable
    in connection with the completion of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you intend to seek Redemption of your Public Shares, you will need to deliver your share certificates (if any) and other redemption
    forms (either physically or electronically) to the Transfer Agent prior to the meeting, as described in this proxy statement/prospectus.
    If you have questions regarding the certification of your position or delivery of your share certificates (if any) and other redemption
    forms, please contact: </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
    Transfer, LLC </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
    State Street, 30th Floor </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10004 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    __</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
__</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
    I am a holder of Units, can I exercise Redemption Rights with respect to my Units? </i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
    Holders of issued and outstanding Units must elect to separate the Units into the underlying Public Shares and Public Warrants prior
    to exercising Redemption Rights with respect to the Public Shares. If you hold your Units in an account at a brokerage firm or bank,
    you must notify your broker or bank that you elect to separate the Units into the underlying Public Shares and Public Warrants, or
    if you hold Units registered in your own name, you must contact the Transfer Agent directly and instruct them to do so. The Redemption
    Rights include the requirement that a holder must identify itself in writing as a beneficial holder and provide its legal name, phone
    number and address to the Transfer Agent in order to validly redeem its shares. You are requested to cause your Public Shares to
    be separated and delivered to the Transfer Agent by 5:00 p.m., Eastern Time, on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2022 (two business days before the Stockholders Meeting) in order to exercise your Redemption Rights with respect to your Public
    Shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_005"></span>RISK
FACTORS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider all the following risk factors, together with all of the other information in this proxy statement/prospectus,
including the financial information, before deciding how to vote or instruct your vote to be cast to approve the Proposals described
in this proxy statement/prospectus. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
value of your investment following the completion of the Business Combination will be subject to significant risks affecting, among other
things, New Forafric&#8217;s business, financial condition and results of operations. If any of the events described below occur, New
Forafric&#8217;s post-Business Combination business and financial results could be adversely affected in material respects. This could
result in a decline, which may be significant, in the trading price of New Forafric&#8217;s securities and you therefore may lose all
or part of your investment. The risk factors described below are not necessarily exhaustive and you are encouraged to perform your own
investigation with respect to the businesses of Globis and FAHL. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to FAHL&#8217;s Business and New Forafric Following the Business Combination. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Throughout
this section, unless otherwise indicated or the context otherwise requires, references in this section to &#8220;FAHL,&#8221; &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to FAHL and its subsidiaries prior to the Business Combination and
to New Forafric and its consolidated subsidiaries after giving effect to the Business Combination. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Our business, financial condition
or results of operations could be materially adversely affected by any of the risks and uncertainties described below. Additional risks
not presently known to us, or that we currently deem immaterial, may also impair our financial condition and business operations. Thus,
New Forafric will be faced with a market environment that cannot be predicted and that involves significant risks, many of which
will be beyond its control.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Severe
adverse weather conditions, such as hurricanes or severe storms, or the effects of global warming, may also result in extensive property
damage, extended business interruption, personal injuries and other loss and damage to us. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The international price of
wheat is the main risk in our operations. Fluctuation of wheat cost depends on weather and strategies of the main producers of wheat
based in North America, Central Europe and around the Black Sea. Adverse weather conditions have historically caused volatility in the
agricultural commodity industry by causing crop failures or significantly reduced harvests, which may affect the supply and pricing of
the agricultural commodities that we sell and use in our business, negatively affect the creditworthiness of agricultural producers who
do business with us or impact our ability to obtain sufficient unprocessed grains to meet demand. The variation in the acquisition price
of the wheat cannot be directly impacted on our average selling price of flour, semolina, pasta and couscous.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severe
adverse weather conditions, such as hurricanes or severe storms, may also result in extensive property damage, extended business interruption,
personal injuries and other loss and damage to us. Our operations also rely on dependable and efficient transportation services. A disruption
in transportation services, as a result of weather conditions or otherwise, may also significantly adversely impact our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the potential physical impacts of climate change are uncertain and may vary by region. These potential effects could include changes
in rainfall patterns, water shortages, changing sea levels, changing storm patterns and intensities, and changing temperature levels
that could adversely impact our costs and business operations, the location and costs of global agricultural commodity production and
the supply and demand for agricultural commodities. Climate change could also lead to stronger production variability than today which
could result in price volatility. Climate change could cause temperature increases and rainfall changes that could lead to lower yields
in Morocco and other semi-arid Mediterranean countries in the future, which could impact raw material costs, availability and quality.
These effects could be material to our results of operations, liquidity or capital resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is subject to fluctuations in agricultural commodity and other raw material prices, transportation costs, energy prices, interest
rates and foreign currency exchange rates, in each case caused by factors outside of our control that could adversely affect our operating
results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we cannot control the average selling price of our finished products, any increase in the cost of raw materials has a direct impact
on our margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to fluctuations in agricultural commodity and other raw material prices caused by other factors outside of our control
such as currency exchange rate fluctuations, local and international changes in supply and demand caused by factors outside of our control,
including farmer planting and selling decisions, government agriculture programs and policies, global inventory levels, demand for biofuels,
weather and crop conditions and demand for and supply of, competing commodities and substitutes, that could adversely affect our
operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is dependent upon our ability to obtain quality raw materials.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The quality of our products
depends upon the quality of raw materials. If we do not have access to high quality of wheat, we have to use enhancers such
as enzymes, ascorbic acid and gluten, to reach a higher level of quality. Such additional costs will negatively impact our
results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on a related party supplier from which we obtain substantially all of our raw material.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2018, we entered into
a five-year supply agreement with Millcorp Geneve SA (&#8220;Millcorp&#8221;) a wholly owned subsidiary of the Seller, pursuant to which
we are obligated to obtain at least 80% of our annual requirements of common wheat, durum wheat, or any other cereal, from Millcorp
until March 31, 2023. Millcorp is currently providing 100% of FAHL&#8217;s imported grain needs. Any disruption of Millcorp&#8217;s
operations or its inability to perform its supply obligations could adversely affect our operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe our transactions
with Millcorp, contain fair market value terms, such transactions with an entity in which related parties hold ownership
interests present potential for conflicts of interest, as the interests of Millcorp and its shareholders may not align
with the interests of New Forafric and its shareholders. Since after the consummation of the Business Combination, Seller
will still be a shareholder of New Forafric, conflicts of interest may also arise in connection with the exercise of contractual
remedies under these transactions, such as the treatment of events of default.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Business may be adversely affected by disruptions in its distribution and logistical systems. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The cost of wheat is affected
not only by the wheat market but also upon freight cost. Supply and distribution disruptions have occurred since the
onset of the COVID-19 pandemic. Such disruptions may continue and may significantly impact shipping and freight costs. Significant
increases in shipping and freight cost could adversely affect our operating costs and results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Business is vulnerable to the effects of supply and demand imbalances in our industries.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the market of flour mills in Morocco is imbalanced, with periods of high demand and period of low demand and with a supply capacity exceeding
the demand. To maintain our market shares, we must compete on price and reduce margin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to global and regional economic downturns and related risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level of demand for our products is affected by global and regional demographic and macroeconomic conditions, including population growth
rates and changes in standards of living. A significant downturn in global economic growth, or recessionary conditions in major geographic
regions, may lead to reduced demand for agricultural commodities, which could adversely affect our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
COVID-19 pandemic could have a material adverse impact on our business, results of operations and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify">As a result of the COVID-19
pandemic, governments have implemented significant measures, including closures, quarantines, travel restrictions and other social distancing
directives, intended to control the spread of the virus. Companies have also taken precautions, such as requiring employees to work remotely,
imposing travel restrictions and temporarily closing businesses. To the extent that these restrictions remain in place, additional prevention
and mitigation measures are implemented in the future, or there is uncertainty about the effectiveness of these or any other measures
to contain or treat COVID-19, there is likely to be an adverse impact on global economic conditions and consumer confidence and spending,
which could materially and adversely affect our supply chain as well as our ability to operate efficiently. While we have not to date
experienced severe disruptions to our supply chain, we have experienced increases in both raw material and logistics costs and some of
our customers have ceased operations. Continued uncertainty regarding the COVID-19 pandemic, further sustained measures to reduce
the spread of the virus and an increase in the severity, length or contagiousness of the Covid-19, including, the discovery of new variants,
and any resulting negative impact on our primary supplier and its sources, co-manufacturers, distributors or transportation
or logistics providers, could further negatively affect the price of raw materials, their availability and our ability to process our
products and deliver them to our customers to meet their demands, all of which could have a material adverse impact on our business,
results of operations and financial condition.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our products are staple foods generally not subject to volatility of consumer demand, consumer demand for our products could be affected
by travel restrictions or social distancing directives, as well as the temporary inability of consumers to purchase our products due
to illness, quarantine or financial hardship, decreased consumer confidence and spending or pantry-loading activity, any of which may
negatively impact our results</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to currency exchange rate fluctuations which may have an adverse effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the international nature of our business, we are exposed to currency exchange rate fluctuations. Changes in exchange rates between
the U.S. dollar and other currencies, particularly the Angolan Kwanza and the Euro affect our revenues and expenses that are denominated
in local currencies and may also have a negative impact on the value of our assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engage in hedging transactions to manage or reduce the risks to our business caused by fluctuations in agricultural commodity prices,
transportation costs, energy prices, interest rates and foreign currency exchange rates. However, our exposures may not always be fully
hedged and our hedging strategies may not be successful in minimizing our exposure to these fluctuations. While we have implemented a
broad range of control procedures and policies to mitigate potential losses, they may not in all cases successfully protect us from losses
that have the potential to impair our financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to economic, political and other risks of doing business globally and in emerging markets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a global business with all of our assets and operations located outside the United States. In addition, part of our strategy involves
expanding our business in several emerging market regions, including Eastern Europe, Asia-Pacific, the Middle East and Africa. Volatile
international economic, political and market conditions may have a negative impact on our operating results and our ability to achieve
our business strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also exposed to other risks of international operations, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.26in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in laws and regulations or their interpretation or enforcement in the countries where we operate, such as tax laws, </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sovereign
    risk;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exchange
    controls or other currency restrictions and limitations on the movement of funds, such as on the remittance of dividends by subsidiaries;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in maintaining an effective internal control environment with operations in multiple international locations, including language
    differences, varying levels of U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) expertise in international
    locations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">labor
    disruptions, civil unrest, significant political instability, wars or other armed conflict or acts of terrorism.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    trade policies or trade barriers on agricultural commodities and commodity products</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inflation
    and hyperinflationary economic conditions and adverse economic effects resulting from governmental attempts to control inflation,
    such as imposition of wage and price controls and higher interest rates; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in enforcing agreements or judgments and collecting receivables in foreign jurisdictions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">government
    intervention, including through expropriation, or regulation of the economy or natural resources, including restrictions on foreign
    ownership of land or other assets;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks could adversely affect our operations, business strategies and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
natural disaster, economic depression or other adverse events affecting Morocco where most our facilities and customers are located facilities
could adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
we have been expanding our reach in recent years into new markets, FAHL&#8217;s operations and most of its sales are in Morocco. A natural
disaster, economic downturn or depression, civil unrest, significant political instability, wars or other armed conflict or acts of terrorism
affecting the country could have a negative adverse impact on our operations and business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent upon a small group of key executives and employees - If we fail to retain and motivate members of our management team and
other key employees or fail to attract, train and retain additional employees to support our operations, our business and future growth
prospects would be harmed. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success and future growth depend largely upon the continued services of our executive officers as well as our other key employees. These
executives and certain key employees members have been primarily responsible for the success and growth of our Company and development
of our brands, reputation and relationships with our customers. None of such persons is subject to long term written employment arrangements.
The loss of any such persons could adversely affect our business and ability to grow. In addition, our success depends in part upon our
ability to attract, train and retain a sufficient number of employees and managers who understand and appreciate our culture and can
represent our brand effectively and establish credibility with our business partners and consumers. An inability to either replace
departing personnel or attract and retain new qualified personnel could adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to industry and other risks that could adversely affect our reputation and financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to food and feed industry risks which include, but are not limited to, crop disease, spoilage, contamination, tampering or
other adulteration of products, product liability claims and recalls and government regulation regarding matters such as food and feed
safety, nutritional standards and genetically modified organisms. We are also subject to shifts in customer and consumer preferences.
These risks could not only adversely affect our business and operating results but also our corporate reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company whose products comprise staple food and feed products sold globally, maintaining a good corporate reputation is critical to
our continued success. Reputational value is based in large part on perceptions, which can shift rapidly in response to negative incidents.
The failure or alleged failure to maintain high standards for quality, safety, integrity, environmental sustainability and social responsibility,
including with respect to raw materials, even if untrue, may result in adverse tangible effects, such as reduced demand for our
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to significant liability that is not covered by insurance.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that FAHL&#8217;s insurance coverage is consistent with industry practice, and is sufficient for its needs. However, claims under
our insurance policies may be subject to certain exceptions, may not be honored fully, in a timely manner, or at all, or we may incur
severe, unexpected losses that are not fully covered by our insurance. If we were to incur substantial liabilities or if our business
operations were interrupted for a substantial period of time, our business and operating results could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Ability To Retain Existing Customers, Attract New Customers, Expand Product Offerings, and Increase Processed Volumes
and Revenue from Both New and Existing Customers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
future growth of our business depends on our ability to retain existing customers, attract new customers as well as getting existing
customers and new customers to increase the volumes of purchases and therefore grow revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer&#8217;s purchase of our products may decrease for a variety of reasons, including the customer&#8217;s level of satisfaction
with our products and services, the expansion of business to offer new products and services, the effectiveness of our support services,
the pricing of our products and services, the pricing, range and quality of competing products or services, the effects of global economic
conditions, regulatory or financial institution limitations, trust, and our ability to deliver quality products at competitive prices
in a timely fashion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure by us to retain existing customers, attract new customers, and increase revenue from both new and existing customers could materially
and adversely affect our business, financial condition, results of operations and prospects. These efforts may require substantial financial
expenditures, commitments of resources, developments of our processes, and other investments and innovations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Growth </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
risk management strategies may not be effective.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to achieve the efficiencies, savings and other benefits anticipated from our cost reduction, margin improvement and other
business optimization initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are continually implementing programs to reduce
costs, increase efficiencies and enhance our business. Initiatives implemented in the past years have included the outsourcing
of certain activities in several regions and the rationalization of manufacturing operations globally, including the implementation
of an operational improvement program. Unexpected delays, increased costs, adverse effects on our internal control environment,
inability to retain and motivate employees or other challenges arising from these initiatives could adversely affect our ability to realize
the anticipated savings or other intended benefits of these activities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not realize the anticipated benefits of acquisitions or joint ventures.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an active acquirer of other companies, and we have joint ventures partners. Part of our strategy involves acquisitions, alliances
and joint ventures designed to expand and enhance our business. Our ability to benefit from acquisitions, joint ventures and alliances
depends on many factors, including our ability to identify suitable prospects, negotiate favorable transaction terms and successfully
consummate and integrate any businesses we acquire.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
acquisition activities may involve unanticipated delays, costs and other problems. If we encounter unexpected problems with one of our
acquisitions, our senior management may be required to divert attention away from other aspects of our businesses to address these
problems. Additionally, we may fail to consummate proposed acquisitions, after incurring expenses and devoting substantial resources,
including management time, to such transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions
also pose the risk that we may be exposed to successor liability relating to actions by an acquired company and its management before
the acquisition. The due diligence we conduct in connection with an acquisition, and any contractual guarantees or indemnities that we
receive from the sellers of acquired companies, may not be sufficient to protect us from, or compensate us for, actual liabilities. A
material liability associated with an acquisition could adversely affect our reputation and results of operations and reduce the benefits
of the acquisition. Additionally, acquisitions involve other risks, such as differing levels of management and internal control effectiveness
at the acquired entities, systems integration risks, the risk of impairment charges relating to goodwill and intangible assets recorded
in connection with acquisitions, the risk of significant accounting charges resulting from the completion and integration of a sizeable
acquisition, the need to fund increased capital expenditures and working capital requirements, our ability to retain and motivate employees
of acquired entities and other unanticipated problems and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Government Regulation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agricultural
commodity production and trade flows are significantly affected by government policies and regulations. Governmental policies affecting
the agricultural industry, such as taxes, tariffs, duties, subsidies, import and export restrictions on agricultural commodities and
commodity products and energy policies (including biofuels mandates), can influence industry profitability, the planting of certain crops
versus other uses of agricultural resources, the location and size of crop production, whether unprocessed or processed commodity products
are traded and the volume and types of imports and exports. In addition, international trade disputes can adversely affect agricultural
commodity trade flows by limiting or disrupting trade between countries or regions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Moroccan market where the bulk of our business originates and where we operate four flour mills, is highly regulated by the Moroccan
government. In particular:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soft
    wheat cannot be freely imported during the calendar year. All our soft wheat must be imported before end of April and from beginning
    of September or October depending on the harvests of local wheat in Morocco. This is designed to protect local Moroccan producers
    of wheat by enabling them to sell their production on the local market. For an industrial producer such as FAHL, the quality
    of local wheat is not high enough to ensure a good quality of finished products.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
    of the flour on the Moroccan market is subsidized by the government. This mechanism is to disappear in the next few
    months which may change the competition on the market.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    soft wheat imported to Morocco must be certificated for import by the National Office for Food Safety in Morocco (Office National
    de Securit&#233; Sanitaire des Produits Alimentaires or &#8220;ONSSA&#8221;).&#160;&#160;Our subsidiaries have generally been successful
    in obtaining ONSSA certification of the export of wheat to Morocco. Any failure or delay in our ability to obtain ONSSA certification
    in the future cold have a material adverse effect on our business. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we operate in a highly regulated environment with constantly evolving legal and regulatory frameworks, we are subject to the risk of
legal claims, government investigations or other regulatory enforcement actions. Although we have implemented policies and procedures
designed to ensure compliance with existing laws and regulations, there can be no assurance that FAHL, or its suppliers, and distributors
will not violate our policies and procedures. Moreover, a failure to maintain effective control processes could lead to violations, unintentional
or otherwise, of laws and regulations. Legal claims, government investigations or regulatory enforcement actions arising out of our failure
or alleged failure to comply with applicable laws and regulations could subject us to civil and criminal penalties that could materially
and adversely affect our product sales, reputation, financial condition and operating results. In addition, the costs and other effects
of defending potential and pending litigation and administrative actions against us may be difficult to determine and could adversely
affect our financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation
or legal proceedings could expose us to significant liabilities and have a negative impact on our reputation or business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may be party to various claims and litigation proceedings. We evaluate these claims and litigation proceedings to assess
the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates,
we may establish reserves, as appropriate. These assessments and estimates are based on the information available to management at the
time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from our assessments and
estimates. Although we carry insurance for certain potential liabilities, such coverage may be insufficient or may not cover the potential
liabilities with which we may be faced. We are not currently party to any material litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face significant competition in each of our businesses and we have numerous competitors, some of which are larger and have greater financial
resources than we have. As many of the products we sell are global commodities, the markets for our products are highly price competitive
and in many cases sensitive to product substitution. In addition, to compete effectively, we must continuously focus on improving efficiency
in our production and distribution operations, as well as developing and maintaining appropriate market share and customer relationships.
Competition could cause us to lose market share or reduce pricing, which could have an adverse effect on our business and profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Data Security and Intellectual Property </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
information technology systems and processes may suffer a significant breach or disruption that may adversely affect our ability to conduct
our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
information technology systems, some of which are dependent on services provided by third parties, provide critical data and services
for internal and external users, including procurement and inventory management, transaction processing, financial, commercial and operational
data, human resources management, and other information and processes necessary to operate and manage our business. Our information technology
and infrastructure may experience attacks by hackers, breaches or other failures or disruptions that could compromise our systems and
the information stored there. While we have implemented security measures and disaster recovery plans designed to protect the security
and continuity of our networks and critical systems, these measures may not adequately prevent adverse events such as breaches or failures
from occurring or mitigate their severity if they do occur. If our information technology systems are breached, damaged or fail to function
properly due to any number of based attacks, systems implementation difficulties, catastrophic events or power outages, and our security,
contingency or disaster recovery plans do not effectively mitigate these occurrences on a timely basis, we may experience a material
disruption in our ability to manage our business operations. We may also be subject to legal claims or proceedings, liability under laws
that protect the privacy of personal information, potential regulatory penalties and damage to our reputation. Such events may
adversely impact our business, results of operations and financial condition, as well as our competitive position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Capital Requirements </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a capital intensive business and depend on cash provided by our operations as well as access to external financing to operate and
expand our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
require significant amounts of capital to operate our business and fund capital expenditures. In addition, our working capital needs
are directly affected by the prices of agricultural commodities, with increases in commodity prices generally causing increases in our
borrowing levels. Furthermore, the expansion of our business and pursuit of acquisitions or other business opportunities may require
us to have access to significant amounts of capital and working capital. If we are unable to generate sufficient cash flows or raise
sufficient external financing to fund these activities and their working capital, we may be forced to limit our operations and growth
plans, which may adversely impact our competitiveness and, therefore, our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Ordinary Shares and Being a Private Company </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric will be the sole shareholder of FAHL, and it will therefore be accordingly dependent upon distributions made by FAHL (and in
turn from its subsidiaries) to pay taxes and pay dividends. The directors of FAHL will make any such decisions, although it should be
noted that New Forafric, in its capacity as sole shareholder, will have the power to remove and appoint directors of FAHL and
its subsidiaries. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Business Combination and Globis </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric&#8217;s ability to be successful following the Business Combination will depend upon the efforts of New Forafric&#8217;s Board
and FAHL&#8217;s key personnel and the loss of any of such persons could negatively impact the operations and profitability of
New Forafric&#8217;s business following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may become a &#8220;controlled company&#8221; within the meaning of the rules of Nasdaq and, as a result, may qualify for, and may rely
on, exemptions from certain corporate governance requirements. To the extent that we elect to rely on these exemptions, shareholders will not
have the same protections afforded to stockholders of companies that are subject to such requirements. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon
completion of the Business Combination, Seller may control a majority of the voting power of the outstanding Ordinary Shares of New Forafric.
As a result, we may be a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of  Nasdaq. Under
these rules, a listed company of which more than 50% of the voting power is held by an individual, group or another company is a &#8220;controlled
company&#8221; and may elect not to comply with certain corporate governance requirements, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the
    requirement that a majority of the board of directors consist of independent directors; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the
    requirement that our nominating and corporate governance committee be composed entirely of independent directors with a written charter
    addressing the committee&#8217;s purpose and responsibilities; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the
    requirement that our compensation committee be composed entirely of independent directors with a written charter addressing the committee&#8217;s
    purpose and responsibilities; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">To
the extent that Seller controls a majority of the voting power of New Forafric&#8217;s outstanding Ordinary Shares, we may rely on these
exemptions and, to the extent that we choose to do so, New Forafric may not have a majority of independent directors on its board of
directors or corporate governance and compensation committees consisting entirely of independent directors, and we will not have written
charters addressing these committees&#8217; purposes and responsibilities. Accordingly, you may not have the same protections afforded
to stockholders of companies that are subject to all of the corporate governance requirements of  Nasdaq.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Incorporation in Gibraltar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may become a &#8220;foreign private issuer&#8221; and we cannot be certain if the reduced reporting requirements applicable to foreign
private issuers will make owning our Ordinary Shares less attractive to investors.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a Delaware corporation, Globis is currently required to file periodic reports and registration statements on U.S. domestic reporting
company forms with the SEC. After the Redomicliation, we will continue as a Gibraltar public company limited by shares. We may qualify
as a foreign private issuer if less than fifty percent of our outstanding voting securities are directly or indirectly owned of record
by residents of the United States or none of the following three circumstances applies: (i) the majority of our executive officers or
directors are U.S. citizens or residents; (ii) more than 50% of our assets are located in the U.S.; or (iii) our business is administered
principally in the U.S. Under FAHL&#8217;s current business structure, we expect to qualify as a foreign private issuer within a year
after the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we would not be subject to the same requirements that are imposed upon U.S. domestic issuers by the SEC. Under
the Exchange Act, we would be subject to reporting obligations that, in certain respects, are
less detailed and less frequent than those of U.S. domestic reporting companies. For example, we would not be required to issue proxy
statements that comply with the requirements applicable to U.S. domestic reporting companies. We would also have four months after the
end of each fiscal year to file our annual reports with the SEC and will not be required to file current reports as frequently or promptly
as U.S. domestic reporting companies. Furthermore, our officers, directors, and principal shareholders would be exempt from the requirements
to report transactions in our equity securities and from the short-swing profit liability provisions contained in Section 16 of the Exchange
Act. These exemptions and leniencies, along with other corporate governance exemptions resulting from our ability to rely on home country
rules, will reduce the frequency and scope of information and protections to which you may otherwise have been eligible in relation to
a U.S. domestic reporting companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_006"></span>STOCKHOLDERS
MEETING </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date,
Time and Place of Stockholders Meeting </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
Stockholders Meeting is to be held at 9 a.m., Eastern Time, on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022, at the offices of McDermott Will &amp; Emery LLP located at One Vanderbilt Avenue, 45<sup>th</sup> Floor, New York, New York
10017, and via a virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be adjourned.
As part of our precautions regarding COVID-19, we are planning for the possibility that the meeting may be held virtually over the Internet.
If we take this step, we will announce the decision to do so via a press release and posting details on our website that will also be
filed with the SEC as proxy material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose
of the Stockholders Meeting </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Stockholders Meeting, Globis is asking holders of its ordinary shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.34in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the Merger Proposal;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the Redomiciliation
    Proposal. The form of the proposed Memorandum and Articles of Association of New Forafric to become effective upon the Redomiciliation
    is attached to this proxy statement/prospectus as <i>Annex C</i>;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon a proposal to
    adopt and approve the Business Combination. A copy of the Business Combination Agreement is attached to this proxy statement/prospectus
    as <i>Annex A</i>;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the approval of
    the Equity Incentive Plan. A copy of the Equity Incentive Plan is attached to this proxy statement/prospectus as <i>Annex H</i>;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the approval of
    the Director Election Proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the approval of
    the Charter Proposal. A copy of the Memorandum and Articles of Association is attached to this proxy statement/prospectus as <i>Annex
    C</i>;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon, on a non-binding
    advisory basis, each of the Organizational Documents Proposals and thereby (i) authorize change to authorized capital stock, and
    (ii) approve other changes to be made in connection with the adoption of organizational documents;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the Nasdaq Proposal
    regarding the issuance of Ordinary Shares in connection with the Business Combination, the PIPE Investment and the conversion of
    the Convertible Bonds, to the extent such issuance would require a shareholder vote under Nasdaq Listing Rule 5635(a); and</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">to consider and vote upon the Adjournment
    Proposal, if presented.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Proposals </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board unanimously recommends that stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Merger Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Redomiciliation Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Business Combination Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Equity Incentive Plan Proposal; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Director Election Proposal;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Charter Proposal; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; each of the Organizational Documents Proposals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Nasdaq Proposal; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    &#8220;FOR&#8221; the Adjournment Proposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Record
Date; Outstanding Shares; Stockholders Entitled to Vote </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
has fixed the close of business on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022, as the Record Date for determining the Globis stockholders entitled to notice of and to attend and vote at the Stockholders Meeting.
As of the close of business on such date, there were 15,050,833 shares Common Stock outstanding and entitled to vote. The shares Common
Stock vote together as a single class and each share is entitled to one vote per share at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Sponsors and Globis&#8217;
independent directors own 3,148,333 shares Common Stock. Pursuant to the Sponsor Letter Agreement among Globis, the Sponsors
and Globis&#8217; directors and officers, (i) the 3,148,333 shares Common Stock owned by the Sponsor and (ii) any other common stock
of Globis owned by the Sponsor or Globis&#8217; officers and directors will be voted in favor of the Business Combination Proposal at
the Stockholders Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Quorum
and Vote Required for Approval </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
Your Shares </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Globis Share that you own in your name entitles you to one vote. If you are a record owner of your shares and/or warrants, there are
two ways to vote your Globis Shares at the Stockholders Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">You
Can Vote By Signing and Returning the Enclosed Proxy Card</span>. If you vote by proxy card, your &#8220;proxy,&#8221; whose name is listed
on the proxy card, will vote your shares as you instruct on the proxy card. If you sign and return the proxy card but do not give instructions
on how to vote your shares, your shares will be voted as recommended by the Globis Board &#8220;FOR&#8221; the Merger Proposal, the Redomiciliation
Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal, the Charter Proposal,
each of the Organizational Documents Proposals, the Nasdaq Proposal and the Adjournment Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">You
Can Attend the Stockholders Meeting and Vote in Person</span>. When you arrive, you will receive a ballot that you may use to cast your
vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker to ensure that
votes related to the shares you beneficially own are properly counted. If you wish to attend the Stockholders Meeting and vote in person
and your shares are held in &#8220;street name,&#8221; you must obtain a legal proxy from your broker, bank or nominee. That is the only
way Globis can be sure that the broker, bank or nominee has not already voted your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstentions
and Broker Non-Votes </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
and broker non-votes will be considered present for the purposes of establishing a quorum. With respect to the Business Combination Proposal,
the Equity Incentive Plan Proposal, the Director Election Proposal, the Organizational Documents Proposals, the Nasdaq Proposal and the
Adjournment Proposal, abstentions and broker non-votes will not count as votes cast at the Stockholders Meeting and, therefore, will
have no effect on the outcome of such proposals. With respect to the Merger Proposal, the Redomiciliation Proposal, and the Charter Proposal,
abstentions and broker non-votes will count as a vote &#8220;AGAINST&#8221; those proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revoking
Your Proxy; Changing Your Vote </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a record owner of your shares and you give a proxy, you may change or revoke it at any time before it is exercised by doing any
one of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
    may send another proxy card with a later date; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
    may notify Globis&#8217; secretary in writing before the Stockholders Meeting that you have revoked your proxy; or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may attend the Stockholders Meeting, revoke your proxy and vote in person as described above. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker for information
on how to change or revoke your voting instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Rights </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Organizational Documents, a Public Stockholder may request of Globis that New Forafric redeem all or a portion of its
Public Shares for cash if the Business Combination is consummated. As a holder of Public Shares, you will be entitled to receive cash
for any Public Shares to be redeemed only if you:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    hold Public Shares, or (b) if you hold Public Shares through Units, you elect to separate your Units into the underlying Public Shares
    and Public Warrants prior to exercising your Redemption Rights with respect to the Public Shares; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submit
    a written request to the Transfer Agent, in which you (a) request that New Forafric redeem all or a portion of your Public Shares
    for cash, and (b) identify yourself as the beneficial holder of the Public Shares and provide your legal name, phone number and address;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
    your Public Shares to the Transfer Agent, physically or electronically through DTC. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Stockholders may seek to have their Public Shares redeemed by Globis, regardless of whether they vote for or against the Business Combination
Proposal or any other Proposals and whether they held Public Shares as of the Record Date or acquired them after the Record Date. Any
Public Stockholder who holds Public Shares of Globis on or before , 2022 (two (2) business days before the Stockholders Meeting) will
have the right to demand that his or her Public Shares be redeemed for a pro rata share of the aggregate amount then on deposit in the
Trust Account, less any taxes then due but not yet paid. For illustrative purposes, based on funds in the Trust Account of approximately
$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 and including anticipated additional interest through the closing of the Business Combination (assuming interest accrues at recent
rates and no additional tax payments are made out of the Trust Account), the estimated per share redemption price is expected to be approximately
$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . A Public Stockholder that has properly tendered his
or her Public Shares for Redemption will be entitled to receive his or her pro rata portion of the aggregate amount then on deposit in
the Trust Account in cash for such Public Shares only if the Business Combination is completed. If the Business Combination is not completed,
the Redemptions will be canceled and the tendered Public Shares will be returned to the relevant Public Stockholders as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Public Stockholders who seek to redeem their Public Shares must demand Redemption no later than&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, Eastern Time, on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 (two (2) business days before the Stockholders Meeting) by (i) submitting a written request to the Transfer Agent that Globis
redeem such Public Stockholder&#8217;s Public Shares for cash, (ii) affirmatively certifying in such request to the Transfer Agent for
Redemption if such Public Stockholder is acting in concert or as a &#8220;group&#8221; (as described in Section 13(d)(3) of the Exchange
Act) with any other stockholder with respect to Public Shares of Globis and (iii) delivering their ordinary shares, either physically
or electronically using DTC&#8217;s DWAC System, at the Public Stockholder&#8217;s option, to the Transfer Agent prior to the Stockholders
Meeting. If a Public Stockholder holds the Public Shares in &#8220;street name&#8221;, such Public Stockholder will have to coordinate
with his or her broker to have such Public Shares certificated or delivered electronically. Certificates that have not been tendered
to the Transfer Agent (either physically or electronically) in accordance with these procedures will not be redeemed for cash. There
is a nominal cost associated with this tendering process and the act of certificating the shares or delivering them through the DWAC
system. The Transfer Agent will typically charge the tendering broker a nominal fee and it would be up to the broker whether or not to
pass this cost on to the redeeming Public Stockholder. In the event the Business Combination is not completed, this may result in an
additional cost to Public Stockholders for the return of their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request for redemption, once made by a holder of public ordinary shares, may not be withdrawn once submitted to New Forafric unless the
Board of Directors of New Forafric determine (in their sole discretion) to permit the withdrawal of such redemption request (which they
may do in whole or in part). Furthermore, if a Public Stockholder demands Redemption of such shares and subsequently decides prior to
the applicable date not to elect to exercise such rights, he or she may simply request that the Transfer Agent return the shares (physically
or electronically).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
corrected or changed written demand of Redemption Rights must be received by Globis&#8217; secretary two business days prior to the vote
taken on the Business Combination Proposal at the Stockholders Meeting. No demand for Redemption will be honored unless the Public Stockholder&#8217;s
Share certificates (if any) and other redemption forms have been delivered (either physically or electronically) to the Transfer Agent
at least two business days prior to the vote at the Stockholders Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Stockholders seeking to exercise their Redemption Rights and opting to deliver share certificates (if any) and other redemption forms
should allow sufficient time to obtain physical certificates from the Transfer Agent and time to effect delivery. It is Globis&#8217;
understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the Transfer Agent. However,
Globis does not have any control over this process and it may take longer than two weeks. Shareholders who hold their shares in &#8220;street
name&#8221; will have to coordinate with their banks, brokers or other nominees to have the shares certificated or delivered electronically.
There is a cost associated with this tendering process and the act of certificating the shares or delivering them through the DWAC system.
The Transfer Agent will typically charge a nominal fee to the tendering broker and it would be up to the broker whether or not to pass
this cost on to the redeeming stockholder. In the event the Business Combination is not completed, this may result in an additional cost
to shareholders for the return of their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Public Stockholder will be entitled to receive cash for these shares only if the shareholder properly demands Redemption as described
above and the Business Combination is completed. If a Public Stockholder properly seeks Redemption and the Business Combination is completed,
Globis will redeem these shares for cash and the holder will no longer own these shares following the Business Combination. If the Business
Combination is not completed for any reason, then the Public Stockholders who exercised their Redemption Rights will not be entitled
to receive cash for their shares. In such case, Globis will promptly return any shares delivered by the Public Stockholders. Globis and
FAHL will not complete the Business Combination if, immediately prior to the Closing and after payment of all transaction and other expenses
payable by Globis and payments for Redemptions, Globis does not have net tangible assets (as determined in accordance with Rule 3a51-1(g)(1)
of the Exchange Act) of at least $5,000,001 . For more information, see the section entitled &#8220;<i>Proposal 3: The Business Combination
Proposal &#8212; The Business Combination Agreement &#8212; Closing Conditions.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a Public Stockholder, together with any affiliate of his, her, its or any other person with whom he, she or it is acting
in concert or as a &#8220;group&#8221; (as described in Section 13(d)(3) of the Exchange Act) will be restricted from seeking Redemption
Rights with respect to 20% or more of Globis&#8217; Public Shares. Accordingly, any shares held by a Public Stockholder or &#8220;group&#8221;
in excess of such 20% cap will not be redeemed by Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Sponsor Letter Agreement, the Sponsor, officers and directors of Globis have waived all of their Redemption Rights and will not
have Redemption Rights with respect to any Globis Shares owned by them, directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the warrants will not have redemption rights with respect to the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing price of Globis Common Stock on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 was $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . The cash held in the Trust Account
as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2022 was approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per Public Share. Prior to exercising
Redemption Rights, shareholders should verify the market price of Globis Shares as they may receive higher proceeds from the sale of
their shares in the public market than from exercising their Redemption Rights if the market price per share is higher than the Redemption
price. Globis cannot assure its shareholders that they will be able to sell their Globis Shares in the open market, even if the market
price per share is higher than the Redemption price stated above, as there may not be sufficient liquidity in its securities when its
shareholders wish to sell their shares. A Public Stockholder who properly exercises its Redemption Rights pursuant to the procedures
set forth herein will be entitled to receive a pro rata portion of the aggregate amount then on deposit in the Trust Account, less amount
required to pay Globis&#8217; income and franchise taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appraisal
Rights </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
holders of shares of Globis Common Stock nor holders of Globis&#8217; warrants are entitled to appraisal rights in connection with the
Merger, the Redomiciliation or the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Solicitation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is soliciting proxies on behalf of the Globis Board. This solicitation is being made by mail but also may be made by telephone or in
person. Globis and its directors, officers and employees may also solicit proxies in person, by telephone or by other electronic means.
Globis will bear all of the costs of the solicitation, which Globis estimates will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
in the aggregate. Globis has engaged  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;as proxy solicitor to assist in the solicitation of proxies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
will ask banks, brokers and other institutions, nominees and fiduciaries to forward the proxy materials to their principals and to obtain
their authority to execute proxies and voting instructions. Globis will reimburse them for their reasonable expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a shareholder grants a proxy, it may still vote its shares in person if it revokes its proxy before the Stockholders Meeting. A shareholder
may also change its vote by submitting a later-dated proxy as described in the section entitled &#8220;&#8212; <i>Revoking Your Proxy</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Householding
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted a rule concerning the delivery of annual reports and proxy statements. It permits Globis, with your permission, to send
a single notice of meeting and, to the extent requested, a single copy of this proxy statement/prospectus to any household at which two
or more Globis stockholders reside if they appear to be members of the same family. This rule is called &#8220;householding,&#8221; and
its purpose is to help reduce printing and mailing costs of proxy materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of brokerage firms have instituted householding for shares held in &#8220;street name.&#8221; If you and members of your household
have multiple accounts holding common stock of Globis, you may have received a householding notification from your broker. Please contact
your broker directly if you have questions, require additional copies of this proxy statement/prospectus or wish to revoke your decision
to household. These options are available to you at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
Can Answer Your Questions About Voting Your Shares? </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">If you are a holder of Globis&#8217;
Common Stock and have any questions about how to vote or direct a vote in respect of your securities, you may call &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
our proxy solicitor, by calling (&#160;&#160;&#160;) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, or banks and brokers can call collect at (&#160;&#160;)&#160;&#160;&#160;&#160;&#160;&#160; - &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or by emailing &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_007"></span>PROPOSAL
1: THE MERGER PROPOSAL </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Globis is asking its stockholders to approve the Merger Proposal. Under the Business Combination
Agreement, the approval of the Merger Proposal is also a condition to the Closing. If the Merger Proposal is approved, but the Redomiciliation
Proposal, Business Combination Proposal or the Charter Proposal are not approved, then none of the Merger, the Redomiciliation or the
Business Combination will be consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a condition to the Closing under the terms of the Business Combination Agreement, Globis has agreed to change its jurisdiction of incorporation
from Delaware to Nevada to effect the reincorporation, pursuant to the terms of the Merger Agreement. Globis will merge with and into
Globis Nevada, with Globis Nevada surviving the merger. Immediately upon effectiveness of the reincorporation, the currently issued and
outstanding shares of Globis Common Stock will be exchanged, on a one-for-one basis, for shares of Globis Nevada common stock. Similarly,
the outstanding Warrants will become warrants to acquire the corresponding number of shares of Globis Nevada common stock on the same
terms as the current outstanding Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Proposal, if approved, will approve of the merger of Globis with and into Globis Nevada, with Globis Nevada surviving the merger.
As a result, Globis&#8217; jurisdiction of incorporation will change from Delaware to Nevada. Accordingly, while Globis is currently
governed by the DGCL, upon reincorporation, Globis Nevada will be governed by Nevada law. We urge stockholders to carefully consult the
information set out below under &#8220;<i>Comparison of Stockholder&#8217;s Rights</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Merger Agreement is attached as Annex I hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the Merger Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Merger Proposal will require the affirmative vote of the holders of a majority of the outstanding shares of Globis Common
Stock, voting together as a single class. Thus, with respect to the Merger Proposal, abstentions and broker non-votes will count as a
vote &#8220;AGAINST&#8221; this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the Merger Agreement in the form attached as <i>Annex I</i> to the proxy statement/prospectus in respect of the Stockholders Meeting
of New Forafric to be approved and adopted in all respects&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE MERGER PROPOSAL. </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Na_008"></span>PROPOSAL
2: THE REDOMICILIATION PROPOSAL </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
effecting the Pre-Globis is proposing to change its corporate structure and domicile from a corporation incorporated under the laws of
the State of Delaware to a public company limited by shares incorporated under the laws of Gibraltar. This change will be implemented
as a legal continuation of Globis under the applicable laws of the State of Delaware and Gibraltar as described under the section entitled
<i>&#8220;&#8212; Manner of Effecting the Merger and the Redomiciliation and the Legal Effect of the Merger and the Redomiciliation</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Redomiciliation will be
effected by filing an application for re-domiciliation to the Registrar of Companies at Companies House Gibraltar accompanied
by all required documentation and filing an application to de-register Globis Nevada with Nevada Secretary of State. In connection
with the Redomiciliation, all outstanding securities of Globis Nevada will convert to outstanding securities of the continuing Gibraltar
public company limited by shares. The Redomiciliation will become effective immediately prior to the completion of the Business Combination.
The proposed Memorandum and Articles of Association, which will become effective upon the Redomiciliation, is attached to this proxy
statement/prospectus as <i>Annex C</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the effective time of the Redomiciliation, which will be the Closing Date, the separate existence of Globis Nevada will cease as a Nevada
corporation and will become and continue as a Gibraltar public company limited by shares, which is herein referred as &#8220;New Forafric&#8221;.
The Certificate of Incorporation will be replaced by the Memorandum and Articles of Association and your rights as a shareholder will
cease to be governed by the laws of the State of Nevada and you will become a stockholder of New Forafric with all rights as such governed
by Gibraltar law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Redomiciliation and simultaneously with the Business Combination, the corporate name of Globis will change to &#8220;Forafric
Global PLC&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Redomiciliation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board believes that there are significant advantages to New Forafric that will arise as a result of being domiciled in Gibraltar, including
(i) being redomiciled in Gibraltar will create operational efficiencies for the combined company due to the fact that FAHL is a Gibraltar
private company limited by shares and its subsidiaries are all located outside the United States and (ii) the elimination of our obligation
to pay the annual Delaware franchise tax and the expected savings as a result of not having a franchise tax. FAHL required that Globis
redomicile in the state of Gibraltar in order to enter into the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Name Change </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board believes that it would be in the best interests of Globis Nevada to, in connection with the Redomiciliation and simultaneously
with the Business Combination, change its corporate name to &#8220;Forafric Global PLC&#8221; in order to more accurately reflect its
business purpose and activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Approvals; Third Party Consents </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is not required to make any filings or to obtain any approvals or clearances from any antitrust regulatory authorities in the United
States or other countries in order to complete the Redomiciliation; however, because the Redomiciliation must occur immediately prior
to the Business Combination, it will not occur unless the Business Combination can be completed, which will require the approvals as
described below under the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal</i>.&#8221; Globis must comply with
applicable United States federal and state securities laws in connection with the Redomiciliation, including the filing with Nasdaq of
a press release disclosing the Redomiciliation, among other things.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomiciliation will not breach any covenants or agreements binding upon Globis and will not be subject to any additional federal or
state regulatory requirements, except compliance with the laws of Nevada and Gibraltar necessary to effect the Redomiciliation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
and Articles of Association</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
with the effective time of the Redomiciliation, which will be the Closing Date, the Memorandum and Articles of Association will govern
the rights of stockholders in New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
chart comparing your rights as a holder of shares of Common Stock of Globis as a Delaware corporation with your rights as a holder of
New Forafric&#8217;s ordinary shares as a Gibraltar public company limited by shares can be found below in &#8220;&#8212; <i>Comparison
of Shareholder Rights under the Applicable Corporate Law Before and After the Redomiciliation</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparison
of Shareholder Rights under Applicable Corporate Law Before and After the Redomiciliation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Redomiciliation is completed, the rights of stockholders will be governed by Gibraltar law, rather than by the laws of the State
of Delaware. Certain differences exist between the Gibraltar Companies Act and DGCL that will alter certain of the rights of shareholders
and affect the powers of New Forafric Board and management following the Redomiciliation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
should consider the following summary comparison of the laws of the DGCL, on the one hand, and Gibraltar laws, on the other. This comparison
is not intended to be complete and is qualified in its entirety by reference to the DGCL and the Gibraltar Companies Act and Companies
Regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
owners of a Delaware corporation&#8217;s shares are referred to as &#8220;stockholders.&#8221; For purposes of language consistency,
in certain sections of this proxy statement/prospectus, we may continue to refer to the share owners of New Forafric as &#8220;stockholders.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provision</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Applicable
    legislation</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Corporation Law of the State of Delaware.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Companies Act (As Revised).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
    Vote Required for Combinations with Interested Stockholders/Shareholders</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally
    a corporation may not engage in a business combination with an interested stockholder for a period of three years after the time
    of the transaction in which the person became an interested stockholder, unless the corporation opts out of the statutory provision.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Similar Provision.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Appraisal
    Rights</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally
    a stockholder of a publicly traded corporation does not have appraisal rights in connection with a merger. Stockholders of a publicly
    traded corporation do, however, generally have appraisal rights in connection with a merger if they are required by the terms of
    a Business Combination Agreement to accept for their shares anything except: (a) shares or depository receipts of the corporation
    surviving or resulting from such merger; (b) shares of stock or depository receipts that will be either listed on a national securities
    exchange or held of record by more than 2,000 holders; (c) cash in lieu of fractional shares or fractional depository receipts described
    in (a) and (b) above; or (d) any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or
    fractional depository receipts described in (a), (b) and (c) above.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Similar Provision.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Requirements
    for Stockholder/Shareholder Approval</i></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the certificate of incorporation, stockholder approval of mergers, a sale of all or substantially all the assets of the corporation,
    dissolution and amendments of constitutional documents require a majority of outstanding shares; most other stockholder approvals
    require a majority of those present and voting, provided a quorum is present.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 35%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            instances require the shareholders to pass a special resolution (75% majority). The following
                                            resolutions will therefore only be passed if, on a show of hands, at least 75% of the shareholders
                                            present vote in its favor or, on a poll vote, if more than 75% of the votes cast are in favor:</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    </tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">alteration
    of the Articles of New Forafric (s25);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
    of name of New Forafric (s29)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">re-registration
    of New Forafric from a public company to a private company (s45);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whitewash
    procedure to ensure that any financial assistance provided by New Forafric in connection with the purchase of its own shares is permissible
    </span><span style="font: 10pt Times New Roman, Times, Serif">(s. 103)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
    of the contract in respect of redemption or buy back of shares of New Forafric (s109);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduction
    of share capital of New Forafric (s136);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redenomination
    of share capital of New Forafric (s139);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric making the liability of the directors unlimited (s225);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduction
    of share capital below the authorized minimum (s. 142)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reserving
    the liability of New Forafric i.e. determine that any portion of its share capital which has not been already called up shall not
    be capable of being called up, except in the event and for the purposes of New Forafric being wound up (s129);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorising
    New Forafric to pay interest out of capital in certain cases (s134);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
    an inspector to investigate New Forafric&#8217;s affairs (s213);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorising
    the assignment by a director of his office to another person (s230);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    the voluntary winding up of New Forafric (s364);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorising
    a liquidator to accept shares as consideration for sale of the property of New Forafric (s384). ); and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">removal
    of director from office (article 74A of the articles of association).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    shareholder approvals require an ordinary resolution, being a simple majority.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provision</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar</b></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Requirement
    for Quorum</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum
    is a majority of shares entitled to vote at the meeting unless otherwise set in the constitutional documents, but cannot be less
    than one-third of shares entitled to vote at the meeting.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Similar Provision, however note that under the Articles of Association the holders of 33
                                            1/3% of New Forafric&#8217;s issued and outstanding share capital present in person or by
                                            proxy and entitled to vote on the business to be transacted shall be a quorum.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder/Shareholder
    Consent to Action Without Meeting</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise provided in the certificate of incorporation, stockholders may act by written consent.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
    may not act by written consent. </span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inspection
    of Books and Records</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    stockholder may inspect the corporation&#8217;s books and records for a proper purpose during the usual hours for business.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Companies Act affords certain rights of inspection to shareholders, and contains provisions which entitle a shareholder to be furnished
    with particular information in respect of New Forafric. A shareholder is entitled during normal business hours to inspect the following
    at the registered office of New Forafric, free of charge:</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Directors (section 222)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Secretaries (section 223)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Charges (section 176)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minutes
    of Shareholders Meetings (copies must be provided for the prescribed sum) (section 210)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Members (copies must be provided within 10 days, for the prescribed sum) (section 183)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of debenture holders (copies must be provided for the prescribed sum) (section 164)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents
    relating to a merger (section 312)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents
    relating to a division (section 333)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement
    as to pending liquidation (section 406)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    for the purchase of own shares (section 114)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
    a shareholder is required to be furnished with the following on payment of the prescribed sum:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    up-to-date copy of New Forafric&#8217;s memorandum and articles;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    copy of any resolution or agreement relating to New Forafric to which Chapter 1 of Part III applies (resolutions and agreements affecting
    a company&#8217;s constitution) and that is for the time being in force;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    copy of any document required to be sent to the Registrar under section 36 (alterations in the articles);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    copy of any court order under either or both of sections 299 and 300 (order sanctioning compromise or arrangement, reconstruction
    or amalgamation);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    copy of New Forafric&#8217;s current certificate of incorporation, and of any past certificates of incorporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of a company with a share capital, a current statement of capital</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder/Shareholder
    Lawsuits</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    stockholder may bring a derivative suit subject to procedural requirements.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    shareholder may bring a derivative action subject to procedural requirements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Removal
    of Directors</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    director or the entire board may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote
    at an election of directors, except as follows: (1) unless the charter otherwise provides, in the case of a corporation with a classified
    board, stockholders may effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Similar Provision, however note that under the Articles of Association New Forafric may, by ordinary resolution of which special
    notice has been given, or by special resolution, remove any director from office</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provision</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
    removal only for cause; or (2) in the case of a corporation having cumulative voting, if less than the entire board is to be removed,
    no director may be removed without cause if the votes cast against such director&#8217;s removal would be sufficient to elect such
    director if then cumulatively voted at an election of the entire board. Because the corporation board will be classified after the
    closing of the Business Combination, a director may be removed from office only for cause and only by the affirmative vote of at
    least a majority of the total voting power of the outstanding shares of capital stock of the corporation entitled to vote in any
    annual election of directors or class of directors, voting together as a single class.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Number
    of Directors</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of directors is fixed by the Bylaws, unless the certificate of incorporation fixes the number of directors, in which case
    a change in the number of directors shall be made only by amendment of the certificate of incorporation. The Bylaws may provide that
    the board may increase the size of the board and fill any vacancies.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
    public limited company shall have at least two directors (s215)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Classified
    or Staggered Boards</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classified
    boards are permitted.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Similar Provision</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiduciary
    Duties of Directors</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    must exercise a duty of care and duty of loyalty and good faith to New Forafric and its stockholders.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiduciary
                                            duties are common law duties and are not codified in the Companies Act:</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director is required to act and exercise his or her powers in good faith in what he or she considers (not what a court may consider)
    is in the best interests of the company as a whole (i.e., the company itself and all of its shareholders as a group), and not for
    an unrelated purpose, even if there is no question of personal gain</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director is required to exercise the degree of skill and care that may reasonably be expected from someone in their position as director,
    but a higher standard may be imposed depending on their own ability and experience.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director must not put himself or herself in a position where personal interests conflict with those of New Forafric</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director has an obligation to protect and use the property of New Forafric as if he or she were a trustee of it.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provision</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnification
    of Directors and Officers</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have the power to indemnify any person who was or is a party to any proceeding because such person is or was a
    director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer,
    employee or agent of another entity against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred
    if the person acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation,
    and, with respect to any criminal proceeding, had no reasonable cause to believe their conduct was unlawful. If the action was brought
    by or on behalf of the corporation, no indemnification is made when a person is adjudged liable to the corporation unless a court
    determines such person is fairly and reasonably entitled to indemnity for expenses the court deems proper.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            section 231 of the Companies Act, any provision (whether in the articles or in a contract
                                            with a company) exempting or indemnifying any officer of New Forafric for negligence, default
                                            or breach of duty is void. However, New Forafric may, if permitted by its articles or a contract:</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    indemnify a director as to the costs of successful court proceedings; and/or</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    purchase and maintain for any director insurance for any liability referred to in section 231.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    person not being New Forafric may indemnify a director against any liability referred to in section 231.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limited
    Liability of Directors</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permits
    the limiting or eliminating of the monetary liability of a director to a corporation or its stockholders, except with regard to breaches
    of duty of loyalty, intentional misconduct, unlawful stock repurchases or dividends, or improper personal benefit.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    a limited company the liability of the directors, if so provided by the memorandum, may be unlimited.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparison
of Shareholder Rights under the Applicable Organizational Documents Before and After the Redomiciliation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Redomiciliation is completed, the rights of shareholders will be governed by the Memorandum and Articles of Association, rather than
the Amended and Restated Certificate of Incorporation and Bylaws (which will cease to be effective) and the rights of shareholders and
the scope of the powers of New Forafric&#8217;s Board and management will be altered as a result.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
should consider the following summary comparison of the Amended and Restated Certificate of Incorporation and Bylaws, on the one hand,
and the Memorandum and Articles of Association, on the other hand. This comparison assumes that the changes to be made to the proposed
Certificate of Incorporation and proposed Bylaws in connection with the Organizational Documents Proposals are approved. This comparison
is not intended to be complete and is qualified in its entirety by reference to the Amended and Restated Certificate of Incorporation
and the proposed Memorandum and Articles of Association of New Forafric. You should read the form of Memorandum and Articles of Association
attached to this proxy statement/prospectus as <i>Annex C</i>, carefully in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
                                            Amended and Restated Certificate of Incorporation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Bylaws</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
                                            </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
    and Articles of Association</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
    Purpose</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purpose shall be to engage in any lawful act or activity for which corporations may be organized under the DGCL.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric&#8217;s Memorandum and Articles of Association do not specifically restrict the objects of New Forafric, and as such its
    objects are unrestricted</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
    Stock</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total number of shares of all classes of capital stock which New Forafric shall have authority to issue is 101,000,000 of which 100,000,000
    shares shall be common stock, par value $0.0001 per share and 1,000,000 shares shall be preferred stock, par value $0.0001 per share.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    authorised share capital of New Forafric is USD 101,000 (one hundred and one thousand United States Dollars) divided into: (i) 100,000,000
    ordinary shares, nominal value $0.001 per share, and (ii) 1,000,000 preferred shares, nominal value $0.001 per share, each conferring
    those rights, entitlements, obligations and restrictions as more particularly set out in the articles of association of New Forafric.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            Stock</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Board of Directors is expressly granted authority to issue shares of Preferred Stock, in one or more series, and to fix for each
    such series the number of shares constituting such series and the designation, the voting powers (if any), and the powers, preferences
    and relative, participating, optional, or other special rights and such qualifications, limitations or restrictions thereof as shall
    be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issue of such series
    (a &#8220;Preferred Stock Designation&#8221;) and as may be permitted by the DGCL. The number of authorized shares of Preferred Stock
    may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders
    of a majority of the voting power of all of the then outstanding shares of the capital stock of New Forafric entitled to vote thereon,
    without a separate vote of the holders of the common stock or Preferred Stock, unless a vote of any such holders is required pursuant
    to the Certificate of Incorporation or any Preferred Stock Designation.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            Shares</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric may issue shares with such rights and/or restrictions as may be determined by ordinary resolution.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    holder of common stock is entitled to one vote for each share of common stock held of record by such holder on all matters on which
    stockholders generally are entitled to vote.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
                                            Shares</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    a show of hands every shareholder present in person shall have one vote.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    a poll every shareholder shall have one vote for each share of which he is the holder</span></p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
                                            Amended and Restated Certificate of Incorporation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Bylaws</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
                                            </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
    and Articles of Association</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors;
    Classes</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the Certificate of Incorporation, the Board of Directors will determine the number of directors who will serve on the board. The
    exact number of directors will be fixed from time to time by a majority of the Board of Directors. The Board of Directors will be
    divided into three classes designated as Class I, Class II and Class III. Class I directors will initially serve for a term expiring
    at the first annual meeting of stockholders following the closing of the Business Combination. Class II and Class III directors shall
    initially serve for a term expiring at the second and third annual meeting of stockholders following the closing of the Business
    Combination, respectively. At each succeeding annual meeting, successors to the class of directors whose term expires at that annual
    meeting will be elected for a term expiring at the third succeeding annual meeting of stockholders. There will be no limit on the
    number of terms a director may serve on the Board of Directors.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            board of directors of New Forafric shall be fixed for a period of (i) three years from the
                                            date of the adoption of the Articles, and (ii) for subsequent periods of three years.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
    Vacancies; Removal</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    vacancy on the Board of Directors, including a vacancy that results from an increase in the number of directors or a vacancy that
    results from the removal of a director with cause, may be filled only by a majority of the directors then in office.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
                                            Forafric may by ordinary resolution appoint a person who is willing to act to be a director
                                            to fill a vacancy.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
                                            Amended and Restated Certificate of Incorporation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Bylaws</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
                                            </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
    and Articles of Association</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder/Shareholder
    Voting</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
                                            of directors need not be by ballot unless the Bylaws so provide.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the rights of holders of any series of Preferred Stock, special meetings of the stockholders of the company may be called only
    by or at the direction of the board, the chairman of the board or the chief executive officer of the company.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
    must comply with certain advance notice procedures to nominate candidates to the company Board or to propose matters to be acted
    upon at a stockholders&#8217; meeting.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
    pursuant to a certificate of designation by the holders of one or more series of Preferred Stock, voting separately as a series or
    separately as a class with one or more other such series, any action required or permitted to be taken by the holders of stock of
    the company must be effected at a duly called annual or special meeting of such holders and may not be effected by any consent in
    writing by such holders.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            person who is willing to act as a director, and is permitted by law to do so, may be appointed
                                            to be a director&#8211;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    by ordinary resolution, or</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    by a decision of the directors.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric may, by ordinary resolution of which special notice has been given, or by special resolution, remove any director from office</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendments
    to the Governing Documents</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board of Directors shall have the power, without the assent or vote of the stockholders,
                                            to make, alter, amend, change, add to, or repeal the Bylaws.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    affirmative vote of the holders of at least 66<sup>2</sup>&#8260;<sub>3</sub>% of the total voting power of all the then outstanding
    shares of stock of the company entitled to vote generally in the election of directors, voting together as a single class, shall
    be required to alter, amend, repeat or rescind, in whole or in part, any provision of Article I, Article II or Article IV of the
    Bylaws of the company, or to adopt any provision inconsistent therewith and, with respect to any other provision of the Bylaws, the
    affirmative vote of the holders of at least a majority of the total voting power of all the then outstanding shares of stock of the
    company entitled to vote generally in the election of directors, voting together as a single class, shall be required in order for
    the stockholders of the company to alter, amend, repeal or rescind, in whole or in part, any provision of the Bylaws of the company,
    or to adopt any provision inconsistent therewith.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    provisions of the Certificate of Incorporation may only be amended, altered, repealed, or rescinded by the affirmative vote of the
    holders of at least 66-2/3% of the total voting power of all the then outstanding shares of stock of the company entitled to vote
    generally in the election of directors, voting together as a single class.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            provision in the Articles of Association.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Companies Act requires that an alteration to New Forafric&#8217;s articles is made by special resolution (75% majority)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
    Amended and Restated Certificate of Incorporation and Bylaws</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
    Memorandum and Articles of Association</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Authority
    of the Directors</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    directors are empowered to exercise all such powers and do all such acts and things as may be exercised or done by the company; subject,
    nevertheless, to the provisions of the statutes of Delaware, of the Certificate of Incorporation, and to any Bylaws from time to
    time made by the stockholders; provided, however, that no Bylaw so made shall invalidate any prior act of the directors which would
    have been valid if such Bylaw had not been made.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    directors are responsible for the management of the company&#8217;s business subject to and in accordance with the provisions of
    the memorandum and articles of association of New Forafric and also subject to the laws of Gibraltar, for which purpose they may
    exercise all the powers of the company</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liability
    of Directors</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director of the company shall not be personally liable to the company or its stockholders for monetary damages for any breach of
    fiduciary duty as a director, except for liability (i) for any breach of the director&#8217;s duty of loyalty to the company or its
    stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
    (iii) under Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. If
    the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
    of a director of the company shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. Any repeal
    or modification of this provision by the stockholders of the company shall not adversely affect any right or protection of a director
    of the company with respect to events occurring prior to the time of such repeal or modification.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to article 297 of the articles of association of New Forafric, a relevant director of the
                                            company or an associated company may be indemnified out of New Forafric&#8217;s assets against
                                            any liability which by virtue of any rule of law would otherwise attach to him in respect
                                            of any negligence, default, breach of duty or breach of trust of which he may be guilty in
                                            relation to the company. New Forafric is able to procure and pay insurance premiums for Directors
                                            &amp; Officers insurance in favor of the directors of New Forafric.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    297 provides that the above does not authorise any indemnity which would be prohibited or rendered void by any provision of the Act
    or by any other provision of law.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    section 231 of the Companies Act, any provision (whether in the articles or in a contract with a company) exempting or indemnifying
    any officer of New Forafric for negligence, default or breach of duty is void. However, New Forafric may, if permitted by its articles
    or a contract:</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    indemnify a director as to the costs of successful court proceedings; and/or</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    purchase and maintain for any director insurance for any liability referred to in section 231.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    person not being New Forafric may indemnify a director against any liability referred to in section 231.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnification
    of Directors, Officers, Employees and Others</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
    whether civil, criminal, administrative or investigative or any other type whatsoever, by reason of the fact that he or she is or
    was a director or an officer of New Forafric or, while a director or officer of New Forafric, is or was serving at the request of
    the company as a director, officer, employee, agent or trustee of another corporation or of a partnership, joint venture, trust or
    other enterprise, shall be indemnified and held harmless by the company to the fullest extent permitted by Delaware law against all</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &#8220;Liability of Directors&#8221; above</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
                                            Amended and Restated Certificate of Incorporation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Bylaws</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
                                            </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
    and Articles of Association</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expense,
    liability and loss reasonably incurred or suffered by such indemnitee in connection therewith, provided, however, that, except in
    certain circumstances, the company shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated
    by such indemnitee only if such proceeding (or part thereof) was authorized by the company&#8217;s board of directors. An indemnitee
    shall also have the right to be paid by the company the expenses(including attorney&#8217;s fees) incurred in appearing at, participating
    in or defending any such proceeding in advance of its final disposition or in connection with a proceeding brought to establish or
    enforce a right to indemnification or advancement of expenses under the Bylaws.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exclusive
    Forum</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    Unless the company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or,
    if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the
    State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District
    of Delaware) shall be the sole and exclusive forum for the following types of actions or proceedings: (A) any derivative action or
    proceeding brought on behalf of New Forafric; (B) any action asserting a claim of breach of or based on a fiduciary duty owed by
    any current or former director, officer or other employee of New Forafric to New Forafric or New Forafric&#8217;s shareholders; (C)
    any action asserting a claim against the company or any current or former director or officer or other employee of the company arising
    pursuant to any provision of the DGCL, the Certificate of Incorporation or the Bylaws (including any right, obligation or remedy
    thereunder); (D) any action to interpret, apply, enforce or determine the validity of the Certificate of Incorporation or the Bylaws;
    (E) any action or proceeding as to which the DGCL confers jurisdiction to the Court of Chancery of the State of Delaware; or (F)
    any action asserting a claim that is governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law
    and subject to the court&#8217;s having personal jurisdiction over any indispensable parties named as defendants. The foregoing shall
    not apply to any claims arising under the Exchange Act or the Securities Act; and (b) unless the company consents in writing to the
    selection of an alternative forum, the federal district courts of the United States of America shall be the sole and exclusive</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Articles of Association do not contain a provision adopting an exclusive forum for shareholder litigation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
    Amended and Restated Certificate of Incorporation and Bylaws</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
    Memorandum and Articles of Association</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
    Opportunities</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">forum
    for the resolution of any complaint asserting a cause of action arising under the Securities Act. If any action that is the subject
    matter of which is within the scope of the foregoing is filed in a court other than a court located within the State of Delaware
    (a &#8220;Foreign Action&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal
    jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such
    court to enforce the foregoing (an &#8220;Enforcement Action&#8221;) and (ii) having service of process made upon such stockholder
    in any such Enforcement Action by service upon such stockholder&#8217;s counsel in the Foreign Action as agent for such stockholder.
    If any provision of the Bylaws becomes or is declared on any ground by a court of competent jurisdiction to be illegal, unenforceable
    or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from the Bylaws,
    and the court will replace such illegal, void or unenforceable provision of the Bylaws with a valid and enforceable provision that
    most accurately reflects the company&#8217;s intent, in order to achieve, to the maximum extent possible, the same economic, business
    and other purposes of the illegal, void or unenforceable provision. The balance of the Bylaws shall be enforceable in accordance
    with its terms. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the corporation
    shall be deemed to have notice of and consented to the provisions of the foregoing.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company renounces any interest or expectancy that it has in, or right to be offered an opportunity to participate in, any business
    opportunities that may be a corporate opportunity for its directors or their respective affiliates, other than those officers, directors,
    stockholders or affiliates who are our employees. Non-employee directors or his or her affiliates have no duty to refrain from (i)
    engaging in a corporate opportunity in the same or similar lines of business in which the company or its affiliates now engage or
    propose to engage or (ii) otherwise competing with the company or its affiliates. In the event that any non-employee director or
    any of his or her affiliates acquires knowledge of a potential transaction or other business opportunity which may be a corporate
    opportunity for itself or himself or herself or its or his or her affiliates or for the company or its affiliates, such</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    similar provision</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
    Amended and Restated Certificate of Incorporation and Bylaws</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gibraltar
                                            Memorandum and Articles of Association</b></span></p>

</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">person
    will have no duty to communicate or offer such transaction or business opportunity to New Forafric or any of its affiliates and they
    may take any such opportunity for themselves or offer it to another person or entity. The company does not renounce its interest
    in any business opportunity that is expressly offered to a non-employee director solely in his or her capacity as a director or officer
    of the company. A business opportunity will not be deemed to be a potential corporate opportunity for the company if it is a business
    opportunity that (i) the company is neither financially or legally, nor contractually permitted to undertake, (ii) from its nature,
    is not in the line of the company&#8217;s business or is of no practical advantage to New Forafric, (iii) is one in which the company
    has no interest or expectancy or (iv) is presented to any account for the benefit of a member of the Board or such member&#8217;s
    affiliate over which such member of the Board has no direct or indirect influence or control, including, but not limited to, a blind
    trust.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
    with Certain Stockholders/Shareholders</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company has elected not to be subject to provisions Section 203 of the DGCL, which generally prohibits &#8220;interested stockholders&#8221;
    (stockholders holding 15% or more of the outstanding stock) from engaging in business combinations with the company for a period
    of time unless certain conditions are met.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    similar provision</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
Treatment of the Redomiciliation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomiciliation is being proposed solely for the purpose of changing the legal domicile of Globis. There will be no accounting effect
or change in the carrying amount of the assets and liabilities of Globis as a result of the Redomiciliation. The business, capitalization,
assets and liabilities and financial statements of Globis immediately following the Redomiciliation will be the same as those immediately
prior to the Redomiciliation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
                                            that the application by Globis Nevada to the Office of the Secretary of State in the State
                                            of Nevada and in Gibraltar&#160; for the de-registration of Globis Nevada as a company registered
                                            in the State of Nevada and for registration of Globis Nevada in Gibraltar and the continuance
                                            as a public company limited by shares established under the laws of Gibraltar be and is hereby
                                            approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to effect the desired registration of Globis Nevada in Gibraltar and for the continuance of Globis Nevada under the laws of Gibraltar
in accordance with the Companies (Re-domiciliation) Regulations 1996 of Gibraltar as amended, the directors of Globis (or any of them)
and/or Hassans International Law Firm Limited, the legal and the other professional advisers of Globis in the name of and on behalf of
Globis Nevada, be and are hereby authorized to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;
apply for the consent of the Registrar of Companies in Gibraltar for registration in Gibraltar and for the continuance of Globis Nevada
under the laws of Gibraltar;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;
file with the Registrar of Companies in Gibraltar the appropriate Form 442A;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
file with the Gibraltar authorities any and all documents required to be filed pursuant to the Companies (Re-domiciliation) Regulations
1996 and pursuant to the Companies Act 2014 (as amended from time to time);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;
obtain from the Registrar of Companies in Gibraltar a certificate of continuance for Globis Nevada;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
forward a copy of such certificate of continuance to the Secretary of State of Nevada and to obtain from the Secretary of State of Nevada
a certificate of continuance of a company overseas and thereafter a certificate (or other evidence) of discontinuance as a company registered
in the State of Nevada; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
do all other acts as may be necessary or desirable in connection with the foregoing and the Re-domiciliation generally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99.25pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the receipt by Globis Nevada of the certificate of continuance of Globis Nevada evidencing the registration of Globis Nevada in Gibraltar
and the continuance of Globis Nevada in Gibraltar under the laws of Gibraltar, the registered office of Globis Nevada shall be Madison
Building, Midtown, Queensway, Gibraltar GX11 1AA, Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
the name of Globis Nevada upon and following the Re-domiciliation of Globis Nevada to Gibraltar will be &#8220;Forafric Global PLC.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
the shareholders upon and following the re-domiciliation of Globis Nevada to Gibraltar will remain shareholders at the time of the Re-domiciliation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">That the company secretary
of Globis Nevada upon and following its Re-domiciliation to Gibraltar, will be Line Secretaries Limited of 57/63 Line Wall Road, Gibraltar
GX11 1AA and that the existing registered agent shall therefore be removed as registered agent upon and following the conclusion of the
Re-domiciliation.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
the Memorandum and Articles of Association be adopted upon the registration of Globis Nevada in Gibraltar and the continuance of Globis
Nevada in Gibraltar under the laws of Gibraltar as Memorandum and Articles of Association of Globis Nevada in substitution for and to
the entire exclusion of the existing Articles of Incorporation, bylaws and/or all other constitutional documents of Globis Nevada.&#8221;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval with Respect to the Redomiciliation Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Redomiciliation Proposal will require the affirmative vote of the holders of a majority of the outstanding shares of
Globis Common Stock, voting together as a single class. Thus, with respect to the Redomiciliation Proposal, abstentions and broker non-votes
will count as a vote &#8220;AGAINST&#8221; this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Redomiciliation Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT <span style="text-transform: uppercase">stockholder</span>S VOTE &#8220;FOR&#8221; THE REDOMICILIATION
PROPOSAL. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="mani_001"></span>PROPOSAL
3: THE BUSINESS COMBINATION PROPOSAL </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is asking its stockholders to adopt and approve the Business Combination Agreement, certain related agreements and the transactions contemplated
thereby (including the Business Combination). Globis stockholders should read carefully this proxy statement/prospectus in its entirety
for more detailed information concerning the Business Combination Agreement, which is attached as <i>Annex A</i> to this proxy
statement/prospectus, and the transactions contemplated thereby. Please see &#8220; <i>&#8212; The Business Combination Agreement</i>&#8221;
below for additional information and a summary of certain terms of the Business Combination Agreement. You are urged to read carefully
the Business Combination Agreement in its entirety before voting on this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may complete the Business Combination only if it is approved by holders of a majority, as of the Record Date, of the Globis Shares that
are present and vote at the Stockholders Meeting. If any of the Redomiciliation Proposal, the Business Combination Proposal, the Equity
Incentive Plan Proposal, the Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval
by the stockholders of Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Business Combination Agreement </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes the material provisions of the Business Combination Agreement, but does not purport to describe all of the terms of
the Business Combination Agreement. The following summary is qualified in its entirety by reference to the complete text of the Business
Combination Agreement, which is attached as <i>Annex A</i> to this proxy statement/prospectus. You are urged to read the Business
Combination Agreement in its entirety because it is the primary legal document that governs the Business Combination. Unless otherwise
defined herein, the capitalized terms used in this section &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; The Business
Combination Agreement</i>&#8221; not defined herein are defined in the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations, warranties and covenants that the respective parties made to each other as of
the date of the Business Combination Agreement or other dates specified therein. The assertions embodied in or by those representations,
warranties and covenants were made for purposes of the contract among the respective parties thereto and are subject to important qualifications
and limitations agreed to by the parties in connection with negotiating, and as set forth in, the Business Combination Agreement. The
representations, warranties and covenants in the Business Combination Agreement are also modified in part by the underlying disclosure
schedules, which are not filed publicly and which are subject to a contractual standard of materiality different from the standard generally
applicable to stockholders and were used for the purpose of allocating risk among the parties to the Business Combination Agreement rather
than establishing matters as facts. Additionally, the representations and warranties of the parties to the Business Combination Agreement
may or may not have been accurate as of any specific date and do not purport to be accurate as of the date of this proxy statement/prospectus.
Accordingly, no person should rely on the representations and warranties in the Business Combination Agreement or the summaries thereof
in this proxy statement/prospectus as characterizations of the actual state of facts about Globis, the Sponsor, the Seller, FAHL, any
of their respective affiliates or subsidiaries or any other matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 19, 2021, Globis, the Seller and FAHL entered into the Business Combination Agreement, which provides for, among other things,
the following transactions: (a) Globis will form under the laws of the State of Nevada a wholly-owned subsidiary of Globis, or Globis
Nevada, change its jurisdiction of incorporation to Nevada by merging with and into Globis Nevada such that Globis Nevada will survive
the merger, and Globis Nevada will change its jurisdiction of incorporation by transferring by way of a redomiciliation and domesticating
as a Gibraltar public company limited by shares, referred to herein as the &#8220;Redomiciliation&#8221; and change its name to &#8220;Forafric
Global PLC,&#8221; referred to herein as New Forafric; and (b) immediately following the effectiveness of the Redomiciliation, New Forafric
will acquire 100% of the equity interests in FAHL from the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, certain related agreements have been, or will be entered into on or prior to the closing of
the Business Combination, including the Subscription Agreements, the Lock-Up Agreements and the Sponsor Letter Agreement (each as defined
in the accompanying proxy statement/prospectus). See &#8220;<i>&#8212; Related Agreements</i>&#8221; for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Existing
Organizational Structure </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagrams below depict simplified versions of the current organizational structures of Globis and FAHL, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-4_001.jpg" alt="" style="height: 357px; width: 500px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-4_02.jpg" alt="" style="height: 362px; width: 580px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
Structure Following the Business Combination </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagram below depicts a simplified version of our organizational structure immediately following the completion of the Redomiciliation
and the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_03.jpg" alt="" style="height: 362px; width: 580px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effect
of the Redomiciliation on Existing Globis Equity in the Business Combination </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomiciliation will result in, among other things, the following, each of which will occur prior to the Effective Time on the Closing
Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    share of Common Stock of Globis that is issued and outstanding immediately prior to the Redomiciliation shall become one ordinary
    share of New Forafric; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    Warrant that is outstanding immediately prior to the Redomiciliation will, from and after the Redomiciliation, represent the right
    to purchase one Ordinary Share of New Forafric, at the exercise price of $11.50 per share, on the terms and subject to the conditions
    set forth in the Warrant Agreement; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    existing governing documents of Globis will be amended and restated and become the Memorandum and Articles of Association as described
    in this proxy statement/prospectus and Globis&#8217; name will change to &#8220;Forafric Global PLC&#8221; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Consideration </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total consideration to be paid to the Seller in the Business Combination will be (i) 15,100,000 Ordinary Shares, subject to reduction
to the extent that the Closing Payment (as defined below) is less than $0, provided that the Seller may be issued up to 1,904,762
additional Ordinary Shares determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the
Closing; plus (ii) an amount (the &#8220;Closing Payment&#8221;) equal to $20,000,000 minus the outstanding amount of all Funded Debt
(as defined in the Business Combination Agreement) as of the Closing (other than Permitted Debt); provided that Seller may receive up
to an additional $20,000,000 determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the
Closing. The Closing Payment shall be funded by remaining funds in the Trust Account after giving effect to any Buyer Share Redemptions
(as defined in the Business Combination Agreement) and the proceeds of any potential private placement financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">In addition to the foregoing
consideration, the Seller shall be entitled to receive, as additional consideration, and without any action on behalf of Globis or Globis&#8217;
Stockholders, additional Ordinary Shares (the &#8220;Earnout Shares&#8221;), to be issued as follows during the period from and after
the Closing until the end of calendar year 2024 (A) 500,000 Earnout Shares, if, during calendar year 2022, Adjusted EBITDA (as defined
in the Business Combination Agreement) of New Forafric is equal to or greater than $27 million, (B) 500,000 Earnout Shares, if,
during calendar year 2023, Adjusted EBITDA of New Forafric is equal to or greater than $33 million, and (C) 1,000,000 Earnout
Shares, if, during calendar year 2024, the Buyer Trading Price (as defined in the Business Combination Agreement) during the standard
market trading hours of a trading day is greater than or equal to $16.50 for any 20 trading days within any period of 30 consecutive
trading days. The Seller will also be entitled to receive, as additional consideration, and without any action on behalf of New Forafric
or New Forafric&#8217;s stockholders, 20% of any cash proceeds received by New Forafric from the exercise of New Forafric&#8217;s outstanding
warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Aggregate
Transaction Proceeds </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Aggregate Transaction Proceeds will be used to pay off existing debt of FAHL and its subsidiaries as of the Effective Time, and for general
corporate purposes after the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Closing
and Effective Time of the Business Combination </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Closing of the transactions contemplated by the Business Combination Agreement is required to take place electronically by exchange of
the closing deliverables on the third (3rd) business day following the satisfaction (or, to the extent permitted by applicable law, waiver)
of the conditions described below under the section entitled &#8220;<i>&#8212; Conditions to Closing of the Business Combination</i>&#8221;
(other than those conditions that by their nature are to be satisfied at the Closing, but subject to satisfaction or waiver of such conditions)
or at such other place, date and/or time as Globis and FAHL may agree in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conditions
to Closing of the Business Combination </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions
to Each Party&#8217;s Obligations </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
respective obligations of each party to the Business Combination Agreement to consummate the transactions contemplated by the Business
Combination Agreement are subject to the satisfaction or, if permitted by applicable law, waiver by the party for whose benefit such
condition exists of the following conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    order or law issued by any court of competent jurisdiction or other governmental entity or other legal restraint or prohibition preventing
    the consummation of the transactions contemplated by the Business Combination Agreement being in effect; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
    registration statement of which this proxy statement/prospectus forms a part becoming effective in accordance with the provisions
    of the Securities Act, no stop order being issued by the SEC and remaining in effect with respect to this registration statement
    of which this proxy statement/prospectus forms a part, and no proceeding seeking such a stop order being threatened or initiated
    by the SEC and remaining pending; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    approval of each Condition Precedent Proposal by the affirmative vote of the holders of the requisite number of common stock of Globis
    entitled to vote thereon being obtained in accordance with Globis&#8217; governing documents and applicable law; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    giving effect to the transactions contemplated by the Business Combination Agreement (including the PIPE Investment), Globis having
    at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) immediately after
    the Effective Time of the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Conditions to the Obligations of Globis </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Globis to consummate the transactions contemplated by the Business Combination Agreement are subject to the satisfaction
or, if permitted by applicable law, waiver by Globis of the following further conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Conditions to the Obligations of FAHL and Seller </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of FAHL and Seller to consummate the transactions contemplated by the Business Combination Agreement are subject to the satisfaction
or, if permitted by applicable law, waiver by Seller of the following further conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Representations
and Warranties </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Business Combination Agreement, each of FAHL and Seller made customary representations and warranties to Globis relating to, among
other things: organization and qualification; capitalization; authorization; financial statements and absence of undisclosed liabilities,
consents and approvals; permits; material contracts; absence of certain changes; litigation; compliance with law; employee plans; environmental
matters; intellectual property; labor matters; insurance; tax matters; brokers; real and personal property; transactions with affiliates;
data privacy and security; compliance with international trade and anti-corruption laws; information supplied; regulatory compliance;
affiliated provider practices; and investigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Business Combination Agreement, Globis made customary representations and warranties to FAHL relating to, among other things: organization
and qualification; authorization; consent and approvals; brokers; information supplied; capitalization; SEC filings; the Trust Account;
transactions with affiliates; litigation; compliance with law; business activities; internal controls, listing and financial statements;
absence of undisclosed liabilities; compliance with international trade and anti-corruption laws; and investigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Material
Adverse Effect </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Business Combination Agreement, certain representations and warranties of FAHL, Seller and Globis are qualified in whole or in part
by materiality thresholds. In addition, certain representations and warranties of FAHL, Seller and Globis are qualified in whole or in
part by a material adverse effect standard for purposes of determining whether a breach of such representations and warranties has occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, a &#8220; <b>Material Adverse Effect</b>&#8221; means any change, effect, event, occurrence, state
of facts or development that was, is, or would reasonably be expected to be materially adverse to the results of operations, condition
(financial or otherwise), Business, or assets or liabilities of the Acquired Companies (as defined therein), taken as a whole; provided
that any adverse change, effect, event, occurrence, state of facts or development attributable to the following will not constitute,
and will not be taken into account in determining whether there has been or will be, a Material Adverse Effect: (a) changes in conditions
generally affecting the economy as a whole or the capital, credit or financial markets in general or the markets in which the Acquired
Companies operate, including changes in interest rates; (b) any change in accounting requirements or principles or any change in applicable
Laws (including IFRS or GAAP) or the interpretation thereof by a Governmental Authority; (c) actions required to be taken under applicable
Laws; (d) any acts of war (whether or not declared), armed hostilities, sabotage or terrorism or the continuation, escalation or worsening
of any such acts of war, armed hostilities, sabotage or terrorism; (e) changes in political or social conditions, including, any natural
disaster, earthquake, hurricane, tsunami, tornado, flood, mudslide, wild fire or other natural disaster or act of God, political instability,
epidemic or pandemic (including, before the Signing Date, the COVID-19 pandemic), or any worsening of any of the foregoing, whether or
not occurring or commenced before or after the Signing Date; (f) changes in the markets in which the Acquired Companies operate, including
changes in the cost of raw materials or other inputs or in the generally available selling prices for products produced by them; or (g)
the failure by the Acquired Companies to meet any projections, estimates or budgets (but not the underlying cause or event of such failure
to meet any internal projection or forecast if the same would otherwise constitute a Material Adverse Effect); provided, further, that
any change, effect, event, occurrence, state of facts or development described in clauses (a) through (f) above will not be precluded
from being or having, or taken into account in determining whether there has been or will be, a &#8220;Material Adverse Effect&#8221;
if it disproportionately adversely impacts the Acquired Companies when compared to other similarly situated businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Business Combination Agreement, certain representations and warranties of Globis are qualified in whole or in part by a material
adverse effect standard for purposes of determining whether a breach of such representations and warranties has occurred. Pursuant to
the Business Combination Agreement, a &#8220;<b>Buyer Material Adverse Effect</b>&#8221; means a material adverse effect on the ability
of Globis to consummate the transactions contemplated by this Agreement and perform all of its obligations hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Covenants
of the Parties </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covenants
of Seller </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
made certain covenants under the Business Combination Agreement, including, among others, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covenants
of Globis </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
made certain covenants under the Business Combination Agreement, including, among others, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mutual
Covenants of the Parties </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties to the Business Combination Agreement made certain covenants under the Business Combination Agreement, including, among others,
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the parties agreed that Globis and FAHL will prepare and mutually agree upon and Globis will file with the SEC, this registration
statement of which this proxy statement/prospectus forms a part on Form S-4 relating to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board
of Directors </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the parties agreed, upon Closing, that the New Forafric Board (and committees of the New Forafric
Board) and officers shall consist of two persons to be appointed by the Sponsors and the remaining members nominated by the Seller.
All directors will have a three-year term on the New Forafric Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Survival
of Representations, Warranties and Covenants </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations and warranties of the parties pursuant to the Business Combination Agreement will survive the Closing until 11:59 p.m.
Eastern Time on the date that is 12 months after the Closing Date, except that Buyer Fundamental Representations and the Seller Fundamental
Representations (as defined therein) will survive the Closing until 11:59 p.m. Eastern Time on the date that is 48 months after the Closing
Date. The covenants, obligations, and agreements to be performed under the Business Combination Agreement (a) at or before the Closing
will survive the Closing until 11:59 p.m. Eastern Time on the date that is 12 months after the Closing Date and (b) in whole or in part
after the Closing Date will survive the Closing until the end of the period of applicable performance or until otherwise fully performed
or waived by the Party with the authority to make such waiver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement may be terminated at any time prior to the Closing under certain circumstances, including, among others,
(i) by mutual written consent of Globis and the Seller, or (ii) by either Globis or the Seller if the Closing has not occurred on or
before March 15, 2022 (or until June 15, 2022, if Globis&#8217; Board of Directors (in its sole discretion) has extended the period
of time to consummate a business combination in accordance with its organizational documents, or such later date as Globis and the Seller
may mutually agree), provided that such right to terminate is not available to Globis or the Seller if such party&#8217;s breach of the
Business Combination Agreement has directly caused the failure of, or has prevented, the consummation of the transactions contemplated
by the Business Combination Agreement to occur by such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expenses
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fees and expenses incurred in connection with the Business Combination Agreement and the applicable ancillary documents, and, in each
case, the transactions contemplated thereby, including the fees and disbursements of counsel, financial advisors and accountants, will
be paid by the party incurring such fees or expenses; provided that, (i) if the Business Combination Agreement is terminated in accordance
with its terms, Seller or FAHL shall pay, or cause to be paid, all unpaid fees and expenses incurred by or on behalf of Seller and any
Group Company in connection with the transactions contemplated by the Business Combination Agreement (the &#8220;<b>Company Expenses</b>&#8221;)
and Globis shall pay, or cause to be paid, all unpaid fees and expenses incurred by or on behalf of Globis in connection with the transactions
contemplated by the Business Combination Agreement (the &#8220;<b>Globis Expenses</b>&#8221;) and (ii) if the Closing occurs, then New
Forafric shall pay, or cause to be paid, all Company Expenses and all Globis Expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governing
Law </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
matters relating to the interpretation, construction, validity and enforcement of the Business Combination Agreement will be governed
by and construed in accordance with the domestic Laws of the State of New York without giving effect to any choice or conflict of Law
provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of Laws of any jurisdiction
other than the State of New York (except that the Laws of Gibraltar and the Laws of the State of Nevada shall also apply to the Redomiciliation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendments
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement not be modified, amended, supplemented, canceled, or discharged, except by written instrument executed
by each of the Seller and Globis. No failure to exercise, and no delay in exercising, any right, power, or privilege under the Business
Combination Agreement will operate as a waiver, nor will any single or partial exercise of any right, power, or privilege hereunder
preclude the exercise of any other right, power, or privilege. No waiver of any breach of any provision will be deemed to be a waiver
of any preceding or succeeding breach of the same or any other provision, nor will any waiver be implied from any course of dealing between
the parties to the Business Combination Agreement. No extension of time for performance of any obligations or other acts hereunder or
under any other agreement will be deemed to be an extension of the time for performance of any other obligations or any other acts. No
waiver by any of the parties of any of the provisions hereof shall be effective unless explicitly set forth in writing and executed by
the party sought to be charged with such waiver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ownership
of New Forafric </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">As of the date of this proxy
statement/prospectus, there are 15,050,833 shares of common stock issued and outstanding. As of the date of this proxy statement/prospectus,
there is outstanding an aggregate of 15,789,722 warrants, comprised of 4,289,722 private placement warrants held by Sponsors and 11,500,000
public warrants. Each whole warrant entitles the holder thereof to purchase one share of Common Stock and, following the Merger and
Redomiciliation, will entitle the holder thereof to purchase one ordinary share of New Forafric. Therefore, as of the date of this
proxy statement/prospectus (without giving effect to the Business Combination and assuming that none of Globis&#8217; outstanding Common
Stock are redeemed in connection with the Business Combination), Globis&#8217; fully-diluted share capital would be 30,900,555 shares
of Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates varying ownership levels in New Forafric&#8217; Ordinary Shares immediately following the consummation
of the Business Combination, assuming varying levels of redemptions by the Public Stockholders and that the Business Combination and
the transactions contemplated by the Business Combination Agreement are consummated in accordance with the terms of the Business Combination
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            No</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            Maximum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Globis&#8217; Public Stockholders<sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">11,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">33.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsors and Independent
    Directors<sup>(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Underwriter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Seller<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,248,307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">PIPE Investors<sup>(5)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168,566</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Bond Holders<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL Related Party Loan
    Holders<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.2</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that 11,500,000 Public Shares (the estimated maximum number of Public Shares that could be redeemed in connection with the Business
    Combination based on a per share redemption price of $10.20) are redeemed in connection with the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    3,148,333 Ordinary Shares issued upon conversion of the existing Common Stock in connection with the Redomiciliation. The Ordinary
    Shares are issued upon the automatic conversion of Common Stock concurrently with the consummation of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
    1,005,291 Ordinary Shares issuable upon the conversion of the FAHL Bonds (as defined in the accompanying proxy statement/prospectus)
    purchased by certain affiliates of the Sponsors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(4)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
                                            an amount of Remaining Cash (as defined in the Business Combination Agreement) at the Closing
                                            based on Remaining Cash as of September 30, 2021.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(5)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to the terms of the PIPE Subscription Agreement, calculated as 4.99% of all issued and outstanding ordinary shares, after taking
    into account the completion of the Business Combination and related transactions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Bonds.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of Ordinary Shares issuable upon the conversion of the FAHL Related Party Loans (as defined in the accompanying proxy
    statement/prospectus).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Agreements Related to the Business Combination </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
section describes the material provisions of certain additional agreements entered into or to be entered into pursuant to the Business
Combination Agreement (the &#8220;Related Agreements&#8221;) but does not purport to describe all of the terms thereof or include all
of the additional agreements entered into or to be entered into pursuant to the Business Combination Agreement. The following summary
is qualified in its entirety by reference to the complete text of each of the Related Agreements. Stockholders and other interested parties
are urged to read such Related Agreements in their entirety. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
and certain equityholders of Globis (Sponsor and each of the directors and executive officers of Globis) have entered into the Registration
Rights Agreement, a copy of which is attached as <i>Annex G </i>to this proxy statement/prospectus, pursuant to which, among other
things, the Sponsors hold certain registration rights and certain preemptive rights with respect to its respective shares of Globis&#8217;
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, the Registration Rights Agreement provides for the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Demand
    registration rights</span>. At any time after the period commencing from the Closing and through the date that is thirty (30) days from
    the date of the Closing (the &#8220;Registration Rights Agreement Lock-Up Period&#8221;), Globis will be required, upon the written
    request of the requisite number of holders of such rights, to file a registration statement and use reasonable best efforts to effect
    the registration of all or part of their registrable securities, including, under certain circumstances, the offering of such registrable
    securities in the form of an underwritten offering. Globis is not obligated to effect (i) more than one demand registration during
    any six-month period or (ii) any demand registration if an effective registration statement on Form S-3 or its successor form, or,
    if Globis is ineligible to use Form S-3, a registration statement on Form S-1, for an offering to be made on a continuous basis pursuant
    to Rule 415 of the Securities Act registering the resale from time to time of all of the registrable securities then held by participating
    Stockholders that are not covered by an effective resale registration statement (a &#8220;Resale Shelf Registration Statement&#8221;)
    already on file with the SEC. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Piggy-back
    registration rights</span>. At any time after the Closing Date, if Globis proposes to file a registration statement to register any
    of its equity securities under the Securities Act or to conduct a public offering, either for its own account or for the account
    of any other person, subject to certain exceptions, the holders of registrable securities are entitled to include their registrable
    securities in such registration statement. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Expenses
    and indemnification</span>. All fees, costs and expenses of underwritten registrations will be borne by Globis and underwriting discounts
    and selling commissions will be borne by the holders of the shares being registered. The Registration Rights Agreement contains customary
    cross-indemnification provisions, under which Globis is obligated to indemnify holders of registrable securities in the event of
    material misstatements or omissions in the applicable registration statement attributable to Globis, and holders of registrable securities
    are obligated to indemnify Globis for material misstatements or omissions attributable to them. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Registrable
    securities</span>. Securities of Globis shall cease to be registrable securities when (i) a registration statement with respect to the
    sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of in accordance
    with such registration statement, (ii) such securities shall have been otherwise transferred, new certificates or book-entry positions
    for them not bearing a legend restricting further transfer shall have been delivered by Globis and subsequent public distribution
    of them shall not require registration under the Securities Act or (iii) such securities shall have ceased to be outstanding. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lock-Up
Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Closing, Seller and the Sponsors will execute and deliver to New Forafric the Lock-Up Agreement, substantially in the forms attached
to this proxy statement/prospectus as <i>Annexes D</i> and <i>E</i>, pursuant to which, among other things, the Seller
and Sponsors will agree not to, subject to certain exceptions set forth in the Lock-Up Agreement, during the period commencing from the
Closing and through the date that is 180 days from the date of the Closing (the &#8220;Lock-Up Period&#8221;): (i) sell, offer to sell,
contract, or agree to sell, hypothecate, pledge, grant any option to purchase, or otherwise transfer or dispose of or agree to transfer
or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent
position within the meaning of Section 16 of the Exchange Act with respect to, any portion of New Forafric&#8217;s Ordinary Shares, or
(ii) enter into any swap or other contract that transfers to another, in whole or in part, any of the economic consequences of ownership
of any of the Ordinary Shares, whether any such transaction is to be settled by delivery of Ordinary Shares or such other equity securities,
in cash or otherwise, or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii). Any waiver
by New Forafric of the provisions of the Lock-Up Agreement requires the approval of a committee consisting of (a) Paul Packer and another
individual designated by Paul Packer, and (b) two &#8220;independent&#8221; directors of Globis as of after the Closing, who shall be
agreed to by each of Globis and FAHL before the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Letter Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the IPO, the Sponsors, certain other holders of Common Stock and Globis entered into the Sponsor Letter Agreement. Under
the Sponsor Letter Agreement, the Sponsors agreed to (i) vote in favor of the Business Combination Agreement and the transactions contemplated
thereby (including the Business Combination), (ii) be bound by certain other covenants and agreements related to the Business Combination
and (iii) be bound by certain transfer restrictions with respect to his, her or its shares in Globis prior to the Closing Date, or the
earlier termination of the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor Letter Agreement is attached to this proxy statement/prospectus as <i>Annex F </i>and is incorporated by reference as
an exhibit to the registration statement of which this proxy statement/ prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Globis&#8217; Directors and Officers and Others in the Business Combination </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the Globis Board in favor of approval of the Business Combination Proposal, you should keep in mind
that Globis&#8217; directors and officers may have interests in such proposal that are different from, or in addition to, those of Globis
stockholders and warrant holders generally. These interests include, among other things, the interests listed below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    Globis does not complete an initial business combination transaction by March 15, 2022 (or June 15, 2022, if Globis Board extends
    the period of time to consummate a business combination), Globis will cease all operations except for the purpose of winding up,
    redeeming all of the outstanding Public Shares for cash and, subject to the approval of the Globis Board and Globis&#8217; remaining
    shareholders, dissolving and liquidating, subject in each case to its obligations under Delaware law to provide for claims of creditors
    and the requirements of other applicable laws. In such event, the 3,047,500 shares of Common Stock (Founder Shares) owned by the
    Sponsors and Globis&#8217; independent directors would be worthless because, following the Redemption of the Public Shares, Globis
    would likely have few, if any, net assets and because the Sponsors and Globis&#8217; independent directors have agreed, in the Sponsor
    Letter Agreement, to waive their rights to liquidating distributions from the Trust Account with respect to the shares of common
    stock if Globis fails to complete a Business Combination within the required period. The Sponsors purchased the shares of Common
    Stock prior to Globis&#8217; IPO for an aggregate purchase price of $26,500, or approximately $0.001 per share. Such shares of Common
    Stock had an aggregate market value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;million based upon the closing price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;per
    share on Nasdaq on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022, the most recent closing price.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsors paid $3.14 million for its Private Placement of 4,188,889 Private Placement Warrants to purchase Common Stock and such Private
    Placement Warrants will expire worthless if an initial business combination is not consummated by March 15, 2022 (or June 15, 2022,
    if Globis Board extends the period of time to consummate a business combination).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.34in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    and Up Capital, LLC purchased an aggregate of 100,833 Private Placement Units at a purchase price of $10.00 per Private Placement
    Unit, or $1,008,333 in the aggregate, which each Private Placement Unit consists of one share of Common Stock and one redeemable
    warrant entitling the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Common
    Stock will be worthless and the warrants will expire worthless if an initial business combination is not consummated by March 15,
    2022 (or June 15, 2022, if Globis&#8217; Board of Directors extends the period of time to consummate a business combination).</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliates
    of the Sponsors, in aggregate, have purchased $9.5 million in FAHL Bonds and will acquire at the Closing, in accordance with
    the FAHL Bonds, 1,005,291 Ordinary Shares.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer, Chief Executive Officer, Chief Financial Officer and director of Globis, is expected to be a director of New Forafric after
    the consummation of the Business Combination. As such, in the future, he may receive cash fees, stock options, stock awards or other
    remuneration that New Forafric Board determines to pay to its directors.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsors and Globis&#8217; officers, directors or their affiliates have made Working Capital Loans prior to the Closing of the Business
    Combination, which may not be repaid if the Business Combination is not completed. As of September 30, 2021, Globis has issued
    promissory notes in the aggregate amount of $700,000 to Globis SPAC LLC and its designees. In addition, $1,150,000 of indebtedness
    was incurred on December 10, 2021 in connection with the extension of the time that Globis needs to complete its initial business
    combination to March 15, 2022.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    existing directors and officers will be eligible for continued indemnification and continued coverage under Globis&#8217; directors&#8217;
    and officers&#8217; liability insurance after the Business Combination.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    order to protect the amounts held in the Trust Account, the Sponsors have agreed to be liable to Globis if and to the extent any
    claims by a vendor for services rendered or products sold to Globis, or a prospective target business with which Globis has discussed
    entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per Public Share or (ii)
    such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions
    in the value of trust assets, in each case net of the interest which may be withdrawn to pay Globis&#8217; tax obligation and up
    to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek
    access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under Globis&#8217; indemnity
    of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    completion of the Business Combination, the Sponsor, Globis&#8217; officers and directors and their respective affiliates will be
    entitled to reimbursement for any reasonable out-of-pocket expenses related to identifying, investigating and completing an initial
    business combination (which will be the Business Combination should it occur), and repayment of any other loans, if any, and on such
    terms as to be determined by Globis from time to time, made by the Sponsor or certain of Globis&#8217; officers and directors to
    finance transaction costs in connection with an intended initial business combination (which will be the Business Combination should
    it occur). If Globis fails to complete a Business Combination within the required period, the Sponsors and Globis&#8217; officers
    and directors and their respective affiliates will not have any claim against the Trust Account for reimbursement.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to the Registration Rights Agreement, the Sponsors and certain of Globis&#8217; directors and officers will have customary registration
    rights, including demand and piggy-back rights, subject to cooperation and cut-back provisions with respect to the Ordinary Shares
    and warrants of New Forafric held by such parties. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
directors and executive officers have agreed to vote all of their Common Stock in favor of the proposals being presented at the Stockholders
Meeting and waive their redemption rights with respect to such ordinary shares in connection with the consummation of the Business Combination.
As of the date of this proxy statement/prospectus, Globis&#8217; directors and executive officers beneficially own approximately 20%
of the issued and outstanding Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">At any time at or prior to the
Business Combination, during a period when they are not then aware of any material nonpublic information regarding us or our securities,
the Sponsors or their respective affiliates may purchase Public Shares from institutional and other investors who vote, or indicate an
intention to vote, against any of the Condition Precedent Proposals, or execute agreements to purchase such shares from such investors
in the future, or they may enter into transactions with such investors and others to provide them with incentives to acquire Public Shares
or vote their Public Shares in favor of the Condition Precedent Proposals. Such a purchase may include a contractual acknowledgement
that such shareholder, although still the record or beneficial holder of such Public Shares, is no longer the beneficial owner thereof
and therefore agrees not to exercise its Redemption Rights. In the event that the Sponsors or their respective affiliates purchase shares
in privately negotiated transactions from Public Stockholders who have already elected to exercise their Redemption Rights, such selling
shareholder would be required to revoke their prior elections to redeem their shares. The purpose of such share purchases and other transactions
would be to increase the likelihood of satisfaction of the requirements that (1) a majority of the votes cast by the stockholders present
in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting, are voted in favor
of the Business Combination Proposal, the Equity Incentive Plan Proposal, the Organizational Documents Proposals, the Nasdaq Proposal
and the Adjournment Proposal, (2) holders of a majority of the outstanding shares of Globis Common Stock vote in favor of the Merger
Proposal, the Redomiciliation Proposal and the Charter Proposal, (3) the six directors named in the Director Election Proposal
are elected to serve on the Board of Directors of New Forafric, (4) otherwise limit the number of Public Shares electing to redeem and
(5) Globis&#8217; net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) being at least $5,000,001.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on the price of the Common Stock. For example, as a result of these arrangements,
an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely
to sell the shares he or she owns, either at or prior to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
such transactions are effected, the consequence could be to cause the Business Combination to be consummated in circumstances where such
consummation could not otherwise occur. Purchases of shares by the persons described above would allow them to exert more influence over
the approval of the proposals to be presented at the Stockholders Meeting and would likely increase the chances that such proposals would
be approved. We will file a Current Report on Form 8-K to disclose any material arrangements entered into or significant purchases made
by any of the aforementioned persons that would affect the vote on the Proposals or the redemption threshold. Any such report will include
descriptions of any arrangements entered into or significant purchases by any of the aforementioned persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Globis&#8217; directors may result in a conflict of interest on the part
of such director(s) between what he/she or they may believe is in the best interests of Globis and its stockholders and what he/she or
they may believe is best for himself/ herself or themselves in determining to recommend that stockholders vote for the proposals. In
addition, Globis&#8217; officers have interests in the Business Combination that may conflict with your interests as a stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
Listing </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
Units (each consisting of one share of Common Stock and one redeemable warrant), Common Stock and Warrants (each to purchase one share
of Common Stock) are currently traded on Nasdaq under the symbols &#8220;GLAQU&#8221; &#8220;GLAQ&#8221; and &#8220;GLAQW.&#8221; At
the closing of the Business Combination, Globis&#8217; Units will separate into their component Ordinary Shares of New Forafric and warrants
so that the units will no longer trade separately under &#8220;GLAQU.&#8221; Globis has applied for the continued listing of New Forafric&#8217;s
Ordinary Shares and warrants on Nasdaq under the ticker symbols &#8220;AFRI&#8221; and &#8220;AFRIW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background
of the Business Combination </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is a blank check company incorporated under the laws of the State of Delaware on August 21, 2020 for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The terms
of the Business Combination Agreement are the result of extensive arm&#8217;s-length negotiations between Globis and the Seller and their
respective representatives. The following is a brief description of the background of these negotiations and summarizes the key meetings
and events that led to the signing of the Business Combination Agreement. The following chronology does not purport to catalogue every
conversation among the parties to the Business Combination Agreement or their representatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, Globis consummated its IPO of 11,500,000 Units, including 1,500,000 Units as a result of the full exercise of the
underwriters&#8217; over-allotment option. Each Unit consists of one share of common stock of Globis, $0.0001 par value per share, and
one Public Warrant, with each Public Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price
of $11.50 per share, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $115,000,000 (before underwriting discounts and
commissions and offering expenses). Simultaneously with the consummation of the IPO and the sale of the Units, Globis consummated a private
placement of 4,188,889 Private Placement Warrants at a price of $0.75 per Private Placement Warrant, issued to the Sponsors, generating
gross proceeds of $3,141,667. In addition, Up and Up Capital, LLC purchased an aggregate of 100,833 Placement Units at a purchase price
of $10.00 per Placement Unit, or $1,008,333 in the aggregate. Each Placement Unit consists of one share of Common Stock and one Private
Placement Warrant. Each Private Placement Warrant entitles the holders to purchase one share of Common Stock at a price of $11.50 per
share, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$116,150,000
of the net proceeds from the IPO and certain of the proceeds from the private placements with the Sponsors was deposited in the Trust
Account established for the benefit of Globis&#8217; public stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the consummation of its IPO, neither Globis, nor anyone on its behalf, contacted any prospective target business or had any substantive
discussions, formal or otherwise, with respect to a potential business combination with Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the IPO, Globis engaged Valyans Consulting (&#8220;<b>Valyans</b>&#8221;) to identify companies in the North African region that would
be potential targets of a business combination. Valyans prepared a presentation on 10 companies. Of the potential targets, Globis expressed
interest in 5 of the companies, one of which was FAHL, and asked Valyans to prepare additional information on them and continued further
due diligence on them. Following receipt and review of this additional information, Globis determined that FAHL was the best candidate
for a potential business combination. Valyans subsequently made introductions between Globis and FAHL management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 12, 2021, Globis and FAHL executed a confidentiality agreement and subsequently FAHL provided representatives of Globis with
access to a data room and began to share confidential information regarding its business with Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter,
and on various occasions through May 2021, the management teams of FAHL and Globis met, during which FAHL shared presentation materials
with Globis, and provided Globis with detailed company information regarding FAHL that included financial information and metrics about
FAHL and an overview of FAHL&#8217;s business and the markets in which it operates. Between February 15, 2021 and May 2021, Mr. Packer
engaged in discussions with representatives of FAHL regarding a potential business combination. During this time, Globis conducted further
financial and business due diligence on FAHL while at the same time reviewing other potential targets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2021, Globis&#8217; legal advisor, McDermott Will &amp; Emery LLP (&#8220;<b>MWE</b>&#8221;) sent FAHL&#8217;s legal advisor,
Hassans International Law Firm Limited (&#8220;<b>FAHL Counsel</b>&#8221;) a draft letter of intent regarding a potential business combination
between Globis and FAHL. The May 20, 2021 proposal included consideration to the Seller of 15,000,000 shares of Globis&#8217; common
stock, $20,000,000 in cash, additional cash or stock consideration of $20,000,000 based on the amount of cash retained at closing of
the proposed business combination, as well as contingent consideration based on the exercise of Globis&#8217; warrants and certain to-be-determined
financial and per-share targets after closing of the business combination. The proposal also contained provisions regarding governance,
lock-up periods, indemnification obligations (including an escrow of shares), and exclusivity, among other terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2021, following discussions between representatives of Globis and FAHL, FAHL&#8217;s legal counsel sent a revised letter of intent
to Globis&#8217; legal counsel, including an increase in the share consideration to be paid to the Seller at closing of the proposed
business combination to 15,100,000 shares of Globis&#8217; common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the submission of a revised proposal, Mr. Packer updated the members of the Globis Board on the discussions with FAHL regarding a
potential business combination, including the status of Globis&#8217; due diligence and the terms of the potential transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 6, 2021, following further discussions and negotiations between the parties, Globis&#8217; legal counsel sent a revised letter of
intent to FAHL&#8217;s legal counsel. Globis&#8217; June 6, 2021 proposal agreed to FAHL&#8217;s prior proposal as to the consideration
framework.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
June 7, 2021 and June 16, 2021, the parties further negotiated the letter of intent, and FAHL Counsel and MWE, exchanged drafts reflecting
the progressing discussions of the parties, including with respect to the indemnification construct and related matters. The parties
also continued due diligence activities and ongoing discussions regarding future value creation as well as began preparation of certain
investor materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 16, 2021, the parties executed the letter of intent (the &#8220;<b>Letter of Intent</b>&#8221;), which included the financial terms
of the transaction. The Letter of Intent also set out the parties&#8217; agreed framework with respect to post-closing governance of
the combined public company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the entry into the Letter of Intent, the Seller and FAHL agreed not to continue or engage in any discussions or negotiations,
or enter into any agreements, with respect to a competing transaction (including other M&amp;A transactions), subject to certain exceptions,
including for preexisting competing buyers, until 45 days after the execution of the Letter of Intent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the execution of the Letter of Intent, Globis and its advisors continued their due diligence review of FAHL, including business, legal,
accounting, and tax due diligence, as well as due diligence calls with FAHL management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2021, MWE delivered an initial draft of the Business Combination Agreement to FAHL Counsel and FAHL&#8217;s US legal advisor
Cohen Tauber Spievack &amp; Wagner P.C. (&#8220;<b>CTSW</b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
July and December 2021, Globis and the Seller exchanged drafts of the Business Combination Agreement and drafts and/or summaries of the
ancillary documents, including New Forafric&#8217;s Memorandum and Articles of Association. The various drafts exchanged reflected the
parties&#8217; negotiations on, among other things, the consideration structure, interim operating covenants, allocation of tax risk
and responsibility, treatment of tax benefits, post-closing governance matters, scope of registration rights and other matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2021, Sponsor extended the time available to Globis to complete the Business Combination to March 15, 2022 by depositing
$1,150,000 into our trust account. In conjunction with the extension, Globis drew down $1,150,000 under an unsecured promissory note
that was previously issued to Globis SPAC LLC in exchange for depositing such amount into the trust account. The note is non-interest
bearing and due upon the consummation of a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 16, the Globis Board met to review the terms of the proposed Business Combination with FAHL and the proposed final
definitive documentation. The Globis Board also reviewed proposed resolutions which would be adopted by the Globis Board in order to
approve the entry into the Business Combination Agreement and related transactions. During the meeting, Globis&#8217; management
provided the Globis Board reiterated its prior overview of FAHL&#8217;s business, strategy, and future operating plans and
prospects, the results and findings of Globis&#8217; due diligence process and financial analyses, The Globis Board unanimously
determined that it was in the best interests of Globis to proceed with executing a transaction on the terms discussed and based on
the documents reviewed, and authorized Globis&#8217; officers to finalize the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 19, 2021, the parties executed the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 20, 2021, a press release was issued announcing the Business Combination. Shortly thereafter, Globis filed a current report
on Form 8-K attaching the press release and the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Globis
Board&#8217;s Reasons for the Approval of the Business Combination </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating the transaction with FAHL, the Globis Board consulted with Globis&#8217; management and its legal counsel as well as other
advisors. The Globis Board considered and evaluated several factors, including, but not limited to, the factors discussed below. In light
of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the Globis Board
did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that
it considered in reaching its determination and supporting its decision. The Globis Board viewed its decision as being based on all the
information available and the factors presented to and considered by it. In addition, individual directors may have given different weight
to different factors. This explanation of reasons for the Business Combination and all other information presented in this section is
forward-looking in nature and, therefore, should be read in light of the factors discussed under &#8220;Cautionary Note Regarding Forward-Looking
Statements.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
reaching its decision, the Globis Board discussed the material results of its management&#8217;s due diligence activities, which included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
</span> <span style="font-family: Times New Roman, Times, Serif">extensive meetings and calls with FAHL&#8217;s management team regarding
FAHL&#8217;s operations and projections, including interviews of top executives;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">research on the food, agriculture and soft commodities industry, including historical and projected growth
trends;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">financial and valuation analyses prepared by Globis management;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
the financial projections provided by FAHL discussed below;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
research on the public trading values of comparable peer companies as well as private transaction precedents;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">multiple site visits and tours of various FAHL facilities;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
financial, accounting, tax, IT and public-market readiness due diligence;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
 engagement of MWE for legal due diligence; and</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board considered a number of factors pertaining to the Business Combination as generally supporting its decision to enter into
the Business Combination Agreement, and the transactions contemplated thereby, including but not limited to, the following material factors
and viewpoints:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Leader in Wheat Milling. FAHL is a leader in the production and sale of a variety of wheat flours in Morocco, Semolina in Morocco and
Africa and Pasta &amp; Couscous in Morocco and in several countries in Africa, Europe and the US. FAHL owns six milling plants across
Morocco (four dedicated to common wheat and two to durum wheat) with total processing capacity of 2,200 tons per day and a total milling
capacity of 700,000 tons per year.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Management. FAHL&#8217;s Chairman is Saad Bendidi who has turned around the profitability of FAHL over the last few years. The Globis
Board believes that he has assembled a strong leadership team to lead FAHL toward future growth and expansion.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Attractive valuation. The Globis Board reviewed the market capitalization, implied enterprise value and
revenue and Adjusted EBITDA multiples and other metrics of certain companies which Globis&#8217; management believed had operational,
business and/or financial characteristics that, for purposes of its analyses, were similar to FAHL, based on its professional judgment
and expertise, and compared the same to the implied enterprise value and other metrics of FAHL determined in accordance with the internal
valuation analysis of Globis&#8217; management.</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Globis considered a basket of (i) agribusiness companies including Archer-Daniels Midland Co., The Mosaic Company, Bunge Ltd., Darling
Ingredients Inc., Adecoagro SA, The Andersons Inc., and S&amp;W Seed Co. (together, &#8220;the Agri Comps&#8221;), (ii) diversified
food companies including General Mills Inc., Herc Holdings Inc., McCormick &amp; Co.. Inc., Kellogg Co., Conagra Brands Inc., Campbell
Soup Co., The JM Smucker Co., Post Holdings Inc., Lancaster Colony Corp., TreeHouse Foods Inc., and B&amp;G Foods Inc. (together &#8220;the
Diversified Food Comps&#8221;), and (iii) snacks/confectionary companies including Mondelez International Inc., Hershey Co., Flowers
Foods Inc., Simply Good Foods Co., J&amp;J Snack Foods Corp., Utz Brands Inc., Hostess Brands Inc., and John B Sanfilippo &amp; Son Inc.
(together &#8220;the Snack Comps&#8221;).</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Globis reviewed FAHL against these companies using a number of metrics, including estimated compounded
annual growth rates, enterprise value, , estimated revenue and estimated Adjusted EBITDA.</span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Globis&#8217; management estimated that FAHL&#8217;s implied post-transaction enterprise value of $300 million equaled 0.9 x estimated
2022 revenue. In comparison, the median of Agri Comps, the Diversified Food Comps and the Snack Comps was 1.2x, 2.3x and 2.7x respectively
or a total median of 2.1x. In addition, the implied post-transaction enterprise value of $300 million equaled 9.1x estimated 2022
adjusted EBITDA. In comparison, the median of the Agri Comps, the Diversified Food Comps and the Snack Comps was 7.1x, 11.9x, 16.7x
respectively or a total median of 12.3x. The estimated revenue compound annual growth rate (&#8220;CAGR&#8221;) from 2020-2024
for FAHL is 30.9% versus 6.9%, 1.7% and 5.0% for the Agri Comps, the Diversified Food Comps and the Snack Comps, respectively or a total
median of 4.3%. The estimated adjusted EBITDA CAGR from 2020-2024 for FAHL is 41.0% versus 19.2%, 1.8% and 7.9% for the
Agri Comps, the Diversified Food Comps and the Snack Comps, respectively or a total median of 6.4%. Based on the foregoing, Globis
believed that the valuation of FAHL was attractive relative to its peers.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Strong financial performance. The Globis Board considered FAHL&#8217;s strong financial position, including historical financial results,
outlook and financial plan, as well as valuations of future growth initiatives and acquisitions.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Multi-pronged growth strategy. The Globis Board noted FAHL&#8217;s growth strategy through developing new markets, cultivating organic
growth and acquisitions.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Terms of transaction. The Globis Board reviewed and considered the terms of the Business Combination Agreement
and related agreements, including the parties&#8217; conditions to their respective obligations to complete the transactions contemplated
therein and their ability to terminate the agreement. See <i>&#8220;&#8212;The Business Combination Agreement</i>&#8221; and &#8220;<i>&#8212;Certain
Agreements Related to the Business Combination&#8221; </i>for detailed discussions of the terms and conditions of these agreements.</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Results of due diligence process. The Globis Board considered the scope of the due diligence investigation conducted by Globis&#8217;
management and outside advisors and evaluated the results thereof and information available to it related to FAHL, including:</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
multiple meetings and calls with the FAHL management team regarding its operations, financial metrics, historical performance and financial
projections and the proposed transaction;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
review of materials related to FAHL made available by FAHL, including strategic plans, key metrics and performance indicators, benefit
plans, insurance policies, litigation information, financial statements, compliance plans, risk mitigation materials and other financial
and legal diligence;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">review of the due diligence reports of all third-party advisors;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
interviews with FAHL&#8217;s management as well as interviews of industry experts;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
analysis of industry competitors and publicly traded comparable companies; and</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
research regarding the food, agriculture and soft commodities markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination,
including, but not limited to, the following:</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Future financial performance. The risk that future financial performance of FAHL may not meet the Globis
Board&#8217;s expectations due to factors in New Forafric&#8217;s control or out of its control, including due to economic cycles or
other macroeconomic factors.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
COVID-19. Uncertainties regarding the potential impacts of the COVID-19 pandemic and related economic disruptions on FAHL&#8217;s operations
and demand for its services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Competition for acquisitions. Food, agriculture and soft commodities companies that compete with FAHL may pursue acquisitions that FAHL
may otherwise have an interest in pursuing. Major competitors include Moulins du Maghreb, Zine Cereales, Rica Maroc, Casagrains and Dari
Couspate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Potential benefits may not be achieved. The risk that the potential benefits of the Business Combination,
including </span>FAHL&#8217;s future value-creation strategies and identified cost savings or revenue opportunities, may not be fully
<span style="font-size: 10pt">achieved, or may not be achieved within the expected timeframe.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Liquidation of Globis. The risks and costs to Globis&#8217; business if the Business Combination is not
completed, including the risk of diverting management focus and resources from other businesses combination opportunities, which could
result in our inability to effect a business combination by March 15, 2022 (or June 15, 2022 if the Globis Board decides to extend the
period of time to consummate a business combination) and force Globis to liquidate and the warrants to expire worthless.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Exclusivity. The fact that the Business Combination Agreement includes an exclusivity provision that prohibits Globis from soliciting
other business combination proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Stockholder vote. The risk that Globis&#8217; stockholders may fail to provide the respective votes necessary
to effect the Business Combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Closing conditions. The fact that completion of the Business Combination is conditioned on the satisfaction of certain closing conditions
that are not within Globis&#8217; control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Litigation. The possibility of litigation challenging the Business Combination or that an adverse judgment granting permanent injunctive
relief could indefinitely enjoin consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;
<span style="font-size: 10pt">Fees and expenses. The fees and expenses associated with completing the Business Combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Other risks. Various other risks associated with the Business Combination, the business of Globis, and the business of FAHL described
in the section entitled &#8220;<i>Risk Factors</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to considering the factors described above, the Globis Board also considered that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Interests of Certain Persons. Some officers and directors of Globis may have interests in the Business Combination that are in addition
to, and that may be different from, the interests of New Forafric&#8217;s stockholders (see &#8212; &#8220;<i>Interests of Globis&#8217;
Directors and Officers and Others in the Business Combination</i>&#8221;). Globis&#8217; independent directors reviewed and considered
these interests during the negotiation of the Business Combination and in evaluating and unanimously approving, as members of the Globis
Board, the Business Combination Agreement and the transactions contemplated therein, including the Business Combination.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board concluded that the potential benefits that it expects New Forafric and its stockholders to achieve as a result of the Business
Combination outweigh the risks associated with the Business Combination. Accordingly, the Globis Board unanimously determined that the
Business Combination Agreement, and the transactions contemplated thereby, including the Business Combination, are advisable, fair to,
and in the best interests of, Globis and its shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Note Regarding Unaudited Prospective Financial Information of FAHL </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
does not as a matter of course make public projections as to future sales, earnings or other results. However, management prepared and
provided to members of the FAHL board of directors, FAHL financial advisors, members of the Globis board of directors and Globis&#8217;
financial advisors certain internal, unaudited prospective financial information in connection with the evaluation of the Business Combination.
FAHL management prepared such financial information based on their judgment and assumptions regarding the future financial performance
of FAHL. The inclusion of such information in this proxy statement/prospectus should not be regarded as an indication that FAHL or any
other recipient of this information considered, or now considers, it to be necessarily predictive of actual future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited prospective financial information is subjective in many respects. As a result, there can be no assurance that the prospective
results will be realized or that actual results will not be significantly higher or lower than estimated. Since the unaudited prospective
financial information covers multiple years, that information by its nature becomes less predictive with each successive year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
presented in this proxy statement/prospectus with numeric specificity, the information was based on numerous variables and assumptions
that are inherently uncertain and may be beyond the control of FAHL management, including, among other things, the matters described
in the sections entitled &#8220;Cautionary Note Regarding Forward-Looking Statements; &#8220;Market and Industry Data&#8221; and &#8220;Risk
Factors.&#8221; FAHL believes the assumptions in the prospective financial information were reasonable at the time the financial information
was prepared, given the information FAHL had at the time. However, important factors that may affect actual results and cause the results
reflected in the prospective financial information not to be achieved include, among other things, risks and uncertainties relating to
FAHL business, industry performance, the regulatory environment, and general business and economic conditions. The prospective financial
information also reflects assumptions as to certain business decisions that are subject to change. The unaudited prospective financial
information was not prepared with a view toward public disclosure or with a view toward complying with the guidelines of the SEC, or
the guidelines established by the American Institute of Certified Public Accountants with respect to prospective financial information.
However, in the view of FAHL management, such unaudited prospective financial information was prepared on a reasonable basis, reflects
the best available estimates and judgments at the time given, and presents, to the best of management&#8217;s knowledge and belief, the
expected course of action and the expected future financial performance of FAHL. However, this information is not fact and should not
be relied upon as being necessarily indicative of future results, and readers of this proxy statement/consent solicitation statement/prospectus
are cautioned not to place undue reliance on the prospective financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
FAHL independent auditors, nor any other independent accountants, have compiled, examined or performed any procedures with respect to
the prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance on such information
or its achievability, and assume no responsibility for, and disclaim any association with, the prospective financial information. The
audit reports included in this proxy statement/consent solicitation statement/prospectus relate to historical financial information.
They do not extend to the prospective financial information and should not be read to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXCEPT
AS REQUIRED BY APPLICABLE SECURITIES LAWS, FAHL DOES NOT INTEND TO MAKE PUBLICLY AVAILABLE ANY UPDATE OR OTHER REVISION TO THE PROSPECTIVE
FINANCIAL INFORMATION. THE PROSPECTIVE FINANCIAL INFORMATION DOES NOT TAKE INTO ACCOUNT ANY CIRCUMSTANCES OR EVENTS OCCURRING AFTER THE
DATE THAT INFORMATION WAS PREPARED. READERS OF THIS PROXY STATEMENT/CONSENT SOLICITATION STATEMENT/PROSPECTUS ARE CAUTIONED NOT TO PLACE
UNDUE RELIANCE ON THE UNAUDITED PROSPECTIVE FINANCIAL INFORMATION SET FORTH BELOW. NONE OF GLOBIS, FAHL NOR ANY OF THEIR RESPECTIVE AFFILIATES,
OFFICERS, DIRECTORS, ADVISORS OR OTHER REPRESENTATIVES HAS MADE OR MAKES ANY REPRESENTATION TO ANY FAHL STOCKHOLDER, GLOBIS STOCKHOLDER
OR ANY OTHER PERSON REGARDING ULTIMATE PERFORMANCE COMPARED TO THE INFORMATION CONTAINED IN THE PROSPECTIVE FINANCIAL INFORMATION OR
THAT FINANCIAL AND OPERATING RESULTS WILL BE ACHIEVED.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the measures included in the prospective financial information may be considered non-GAAP financial measures. Non-GAAP financial measures
should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and non-GAAP
financial measures as used by FAHL may not be comparable to similarly titled amounts used by other companies. Financial measures provided
to a financial advisor in connection with a business combination transaction are excluded from the definition of non-GAAP financial measures
and therefore are not subject to SEC rules regarding disclosures of non-GAAP financial measures, which would otherwise require a reconciliation
of a non-GAAP financial measure to a GAAP financial measure. Accordingly, we have not provided a reconciliation of such financial measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Satisfaction
of 80% Test </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is a requirement under the Existing Organizational Documents that any business acquired by Globis have a fair market value equal to at
least 80% of the balance of the funds in the trust account at the time of the execution of a definitive agreement for an initial business
combination. Based on the financial analysis of FAHL generally used to approve the transaction, the Globis Board determined that this
requirement was met. The Globis Board determined that the consideration being paid in the Business Combination, which amount was negotiated
at arms-length, was fair to and in the best interests of Globis and its stockholders and appropriately reflected FAHL&#8217;s value.
In reaching this determination, the Globis Board concluded that it was appropriate to base such valuation in part on qualitative factors
such as management strength and depth, competitive positioning, customer relationships, and technical skills, as well as quantitative
factors such as FAHL&#8217;s historical growth rate and its potential for future growth in revenue and profits. The Globis Board believes
that the financial skills and background of its members qualify it to conclude that the acquisition of FAHL met this requirement and
make the other determinations regarding the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Federal Income Tax Consequences of the Redomiciliation to Globis Stockholders. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of the material U.S. federal income tax considerations of the Business Combination to U.S. Holders
(as defined below) of Globis Common Stock and Globis Warrants (collectively &#8220;<b>Globis securities</b>&#8221;). The following discussion
also summarizes the material U.S. federal income tax consequences to U.S. Holders and Non-U.S. Holders (as defined below) of Globis Common
Stock that elect to have their Common Stock redeemed for cash and the material U.S. federal income tax consequences of the ownership
and disposition of New Forafric Ordinary Shares and New Forafric Warrants following the Business Combination. This discussion applies
only to Globis securities, New Forafric Ordinary Shares, and New Forafric Warrants, as the case may be, that are held as &#8220;capital
assets&#8221; within the meaning of Section 1221 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (generally,
property held for investment).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following does not purport to be a complete analysis of all potential tax effects arising in connection with the closing of the Business
Combination, the redemption of Globis Common Stock, or the ownership and disposition of New Forafric Ordinary Shares and New Forafric
Warrants. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S.
tax laws are not discussed. This discussion is based on the Code, Treasury regulations promulgated thereunder, judicial decisions, and
published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;<b>IRS</b>&#8221;), in each case
in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing
interpretation may be applied retroactively in a manner that could adversely affect the tax consequences discussed below. Globis and
FAHL have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the
IRS will not take, or a court will not sustain, a contrary position regarding the tax consequences discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussion does not address all U.S. federal income
tax consequences relevant to a holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on net
investment income and the alternative minimum tax. In addition, it does not address consequences relevant to holders subject to special
rules, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks, insurance companies,
  and certain other financial institutions;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated investment companies
  and real estate investment trusts;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers, dealers, or traders
  in securities;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders in securities that
  elect to mark to market;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt organizations
  or governmental organizations;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. expatriates and former
  citizens or long-term residents of the U.S.;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify">persons holding Globis securities or New Forafric
  Ordinary Shares and/or New Forafric Warrants, as the case may be, as part of a hedge, straddle, constructive
  sale, or other risk reduction strategy or as part of a conversion transaction or other integrated or similar transaction;</td></tr>
  <tr style="vertical-align: top"><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons subject to special
  tax accounting rules as a result of any item of gross income with respect to Globis securities or New Forafric Ordinary Shares and/or
  New Forafric Warrants, as the case may be, being taken into account in an applicable financial statement;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons that actually or
  constructively own 5% or more (by vote or value) of the outstanding Globis Common Stock or, after the Business Combination, the issued
  New Forafric Ordinary Shares;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">founders, sponsors, officers
  or directors of Globis or holders of private placement warrants;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;controlled foreign
  corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal
  income tax (and their shareholders);</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S corporations, partnerships,
  or other entities or arrangements treated as partnerships or other flow-through entities for U.S. federal income tax purposes (and
  investors therein);</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. Holders having a functional
  currency other than the U.S. dollar;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who hold or received
  Globis securities or New Forafric Ordinary Shares and/or New Forafric Warrants, as the case may be, pursuant to the exercise of any
  employee stock option or otherwise as compensation; and</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-qualified retirement
  plans.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, this summary does not address any tax consequences to investors that directly or indirectly hold equity interests in Forafric
Agro prior to the Business Combination, including holders of Globis securities that also hold, directly or indirectly, equity interests
in Forafric Agro. With respect to the consequences of holding New Forafric Ordinary Shares, this discussion is limited to holders who
acquire such New Forafric Ordinary Shares in connection with the Business Combination or as a result of the exercise of an Forafric Global
Warrant. With respect to the consequences of holding New Forafric Warrants, this discussion is limited to holders who held Globis Warrants
prior to and through the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Globis securities, New Forafric Ordinary
Shares and/or New Forafric Warrants, the tax treatment of an owner of such entity will depend on the status of the owner or participant
in the arrangement, the activities of the entity or arrangement, and certain determinations made at the owner or participant level. Accordingly,
entities or arrangements treated as partnerships for U.S. federal income tax purposes and the partners in such partnerships should consult
their tax advisors regarding the U.S. federal income tax consequences to them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, because any Globis Unit consisting of one share of Globis Common Stock and one Globis Warrant is separable
at the option of the holder, Globis is treating any share of Globis Common Stock and Globis Warrant held by a holder in the form of a
single Globis Unit as separate instruments and is assuming that the Globis Unit itself will not be treated as an integrated instrument.
Under this treatment the separation of an Globis Unit prior to or in connection with the consummation of the Business Combination generally
would not be a taxable event for U.S. federal income tax purposes. This position is not free from doubt, and no assurance can be given
that the IRS would not assert, or that a court would not sustain, a contrary position. Holders of Globis Units and Globis securities
are urged to consult their tax advisors concerning the U.S. federal, state, local, and foreign tax consequences of the transactions contemplated
by the Business Combination (including any redemption of Globis Common Stock for cash) with respect to any Globis securities held through
an Globis Unit (including alternative characterizations of an Globis Unit).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;<b>U.S. Holder</b>&#8221; is any beneficial owner of shares of Globis securities, New Forafric
Ordinary Shares and/or New Forafric Warrants, as the case may be, that is for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an individual who is a citizen
  or resident of the U.S.;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a corporation (or other entity
  taxable as a corporation) created or organized in, or under the laws of, the U.S., any state thereof, or the District of Columbia;</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an estate, the income of
  which is subject to U.S. federal income tax regardless of its source; or</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a trust that (1) is subject
  to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; (within the meaning of
  Section 7701(a)(30) of the Code) or (2) has a valid election in effect to be treated as a United States person for U.S. federal income
  tax purposes.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
U.S. FEDERAL INCOME TAX TREATMENT OF THE BUSINESS COMBINATION AND THE U.S. FEDERAL INCOME TAX TREATMENT TO HOLDERS OF <span style="text-transform: uppercase">Globis
</span>UNITS OR <span style="text-transform: uppercase">Globis</span> SECURITIES DEPEND IN SOME INSTANCES ON DETERMINATIONS OF FACT AND
INTERPRETATIONS OF COMPLEX PROVISIONS OF U.S. FEDERAL INCOME TAX LAW FOR WHICH NO CLEAR PRECEDENT OR AUTHORITY MAY BE AVAILABLE. IN ADDITION,
THE U.S. FEDERAL INCOME TAX TREATMENT OF THE BUSINESS COMBINATION, THE EXERCISE OF REDEMPTION RIGHTS WITH RESPECT TO <span style="text-transform: uppercase">Globis
</span>COMMON STOCK, AND THE OWNERSHIP AND DISPOSITION OF NEW FORAFRIC ORDINARY SHARES AND/OR NEW FORAFRIC WARRANTS TO ANY PARTICULAR
HOLDER WILL DEPEND ON THE HOLDER&#8217;S PARTICULAR TAX CIRCUMSTANCES. YOU ARE URGED TO CONSULT YOUR TAX ADVISOR REGARDING THE U.S. FEDERAL,
STATE, LOCAL, AND NON-U.S. INCOME AND OTHER TAX CONSEQUENCES TO YOU, IN LIGHT OF YOUR PARTICULAR INVESTMENT OR TAX CIRCUMSTANCES, OF
THE BUSINESS COMBINATION, THE EXERCISE OF YOUR REDEMPTION RIGHTS WITH RESPECT TO <span style="text-transform: uppercase">Globis</span>
COMMON STOCK, AND THE OWNERSHIP AND DISPOSITION OF NEW FORAFRIC ORDINARY SHARES AND/OR NEW FORAFRIC WARRANTS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Federal Income Tax Treatment of Forafric Global</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Residence of Forafric Global for U.S. Federal Income Tax Purposes.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Forafric Global is incorporated and tax resident in Gibraltar, following the closing of the Business Combination the IRS may assert that
it should be treated as a U.S. corporation for U.S. federal income tax purposes pursuant to Section 7874 of the Code. For U.S. federal
income tax purposes, a corporation is generally considered a U.S. &#8220;domestic&#8221; corporation if it is created or organized in
or under the laws of the U.S., any state thereof, or the District of Columbia. Because Forafric Global is not so created or organized
(but is instead incorporated only in Gibraltar), it would generally be classified as a foreign corporation (that is, a corporation other
than a U.S. &#8220;domestic&#8221; corporation) under these rules. Section 7874 of the Code provides an exception under which a corporation
created or organized only under foreign law may, in certain circumstances, be treated as a U.S. corporation for U.S. federal income tax
purposes. The Section 7874 rules are complex and require analysis of all relevant facts, and there is limited guidance and significant
uncertainties as to their application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Code Section 7874, a corporation created or organized outside the U.S. (i.e., a foreign corporation) will nevertheless be treated as
a U.S. corporation for U.S. federal income tax purposes when (i) the foreign corporation directly or indirectly acquires substantially
all of the assets held directly or indirectly by a U.S. corporation (including the indirect acquisition of assets of the U.S. corporation
by acquiring the outstanding shares of the U.S. corporation), (ii) the shareholders of the acquired U.S. corporation hold, by vote or
value, at least 80% of the shares of the foreign acquiring corporation after the acquisition by reason of holding shares in the U.S.
acquired corporation (the &#8220;Section 7874 Percentage&#8221;), and (iii) the foreign corporation&#8217;s &#8220;expanded affiliated
group&#8221; does not have substantial business activities in the foreign corporation&#8217;s country of creation or organization relative
to such expanded affiliated group&#8217;s worldwide activities (the &#8220;Substantial Business Activities Exception&#8221;). In order
to satisfy the Substantial Business Activities Exception, at least 25% of the employees (by headcount and compensation), real and tangible
assets, and gross income of the foreign acquiring corporation&#8217;s &#8220;expanded affiliated group&#8221; must be based, incurred,
located, and derived, respectively, in the country in which the foreign acquiring corporation is created or organized. The Section 7874
Regulations further provide for a number of special rules that aggregate multiple acquisitions of U.S. corporations for purposes of Code
Section 7874 that are made as part of a plan or made over a 36-month period, making it more likely that Code Section 7874 will apply
to a foreign acquiring corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
Global will acquire substantially all of the assets of Globis through the Business Combination. As a result, Section 7874 of the Code
may apply to cause Forafric Global to be treated as a U.S. corporation for U.S. federal income tax purposes following the Business Combination
depending on whether the Section 7874 Percentage equals or exceeds 80%, subject to the applicability of the Substantial Business Activities
Exception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the terms of the Business Combination, the rules for determining share ownership under Code Section 7874 and the Section 7874 Regulations,
and certain factual assumptions, Globis and Forafric Global currently expect that the Section 7874 Percentage of Globis stockholders
in Forafric Global should be less than 80% after the Business Combination. Accordingly, Forafric Global is not expected to be treated
as a U.S. corporation for U.S. federal income tax purposes under Section 7874 of the Code. The calculation of the Section 7874 Percentage
is complex, is subject to detailed regulations (the application of which is uncertain in various respects and could be impacted by changes
in U.S. tax laws and regulations with possible retroactive effect), and is subject to certain factual uncertainties. Whether the Section
7874 Percentage is less than 80% must be finally determined after completion of the Business Combination, by which time there could be
adverse changes to the relevant facts and circumstances. Moreover, former holders of Globis Common Stock may be deemed to own an amount
of New Forafric Ordinary Shares in respect to certain redemptions by former holders of Globis Common Stock prior to the Business Combination
for purposes of determining the ownership percentage of former holders of Globis Common Stock under Section 7874 of the Code. Accordingly,
there can be no assurance that the IRS will not challenge the status of Forafric Global as a foreign corporation under Code Section 7874
or that such challenge would not be sustained by a court.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the IRS were to successfully challenge under Code Section 7874 Forafric Global&#8217;s status as a foreign corporation for U.S. federal
income tax purposes, Forafric Global and certain Forafric Global shareholders could be subject to significant adverse tax consequences,
including a higher effective corporate income tax rate on Forafric Global and future withholding taxes on certain Forafric Global shareholders.
In particular, holders of New Forafric Ordinary Shares and/or New Forafric Warrants would be treated as holders of stock and warrants
of a U.S. corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
even if the Section 7874 Percentage was such that Forafric Global were still respected as a foreign corporation under Code Section 7874,
Forafric Global may be limited in using its equity to engage in future acquisitions of U.S. corporations over a 36-month period following
the Business Combination. If Forafric Global were to be treated as acquiring substantially all of the assets of a U.S. corporation within
a 36-month period after the Business Combination, the Section 7874 Regulations would exclude certain shares of Forafric Global attributable
to the Business Combination for purposes of determining the Section 7874 Percentage of that subsequent acquisition, making it more likely
that Code Section 7874 would apply to such subsequent acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remainder of this discussion assumes that Forafric Global will not be treated as a U.S. corporation for U.S. federal income tax purposes
under Section 7874 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Utilization
of Globis&#8217; Tax Attributes and Certain Other Adverse Tax Consequences to Forafric Global and Forafric Global&#8217;s Shareholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the acquisition of a U.S. corporation by a foreign corporation, Code Section 7874 can limit the ability of the acquired U.S. corporation
and its U.S. affiliates to use U.S. tax attributes (including net operating losses and certain tax credits) to offset U.S. taxable income
resulting from certain transactions, as well as result in certain other adverse tax consequences, even if the acquiring foreign corporation
is respected as a foreign corporation for purposes of Code Section 7874. Specifically, Code Section 7874 can apply in this manner if
(i) the foreign corporation acquires, directly or indirectly, substantially all of the properties held directly or indirectly by a U.S.
corporation, (ii) after the acquisition, the former shareholders of the acquired U.S. corporation hold at least 60% (by either vote or
value) but less than 80% (by vote and value) of the shares of the foreign acquiring corporation by reason of holding shares in the acquired
U.S. corporation, and (iii) the foreign corporation&#8217;s &#8220;expanded affiliated group&#8221; does not meet the Substantial Business
Activities Exception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the terms of the Business Combination, the rules for determining share ownership under Section 7874 of the Code and the Section
7874 Regulations, and certain factual assumptions, Globis and Forafric Global currently expect that the Section 7874 Percentage should
be less than 60% after the Business Combination. Accordingly, the limitations and other rules described above are not expected to apply
to Forafric Global or Globis after the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Section 7874 Percentage applicable to the Business Combination is at least 60% but less than 80%, Forafric</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
and certain of Forafric Global&#8217;s shareholders may be subject to adverse tax consequences including, but not limited to, restrictions
on the use of tax attributes with respect to &#8220;inversion gain&#8221; recognized over a 10-year period following the transaction,
disqualification of dividends paid from preferential &#8220;qualified dividend income&#8221; rates, and the requirement that any U.S.
corporation owned by Forafric Global include as &#8220;base erosion payments&#8221; that may be subject to a minimum U.S. federal income
tax any amounts treated as reductions in gross income paid to certain related foreign persons. Furthermore, certain &#8220;disqualified
individuals&#8221; (including officers and directors of a U.S. corporation) may be subject to an excise tax on certain stock-based compensation
at a rate of 20%. However, as a blank check company whose assets are primarily comprised of cash and cash equivalents, it is not expected
that Globis will have a significant amount of inversion gain as a result of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
determination that the Section 7874 Percentage should be less than 60% after the Business Combination is subject to detailed regulations
(the application of which is uncertain in various respects and would be impacted by future changes in tax laws and regulations, with
possible retroactive effect) and is subject to certain factual uncertainties. Whether the Section 7874 Percentage is less than 60% must
be finally determined after completion of the Business Combination, by which time there could be adverse changes to the relevant facts
and circumstances. There can be no assurance that the IRS will not challenge whether Forafric Global is subject to the above rules or
that such a challenge would not be sustained by a court. If the IRS successfully applied these rules to Forafric Global, significant
adverse tax consequences could result for Forafric Global and for certain Forafric Global shareholders, including a higher effective
corporate tax rate on Forafric Global U.S. Holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>U.S.
Federal Income Tax Considerations of the Business Combination.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Consequences of the Business Combination Under Section 368(a) of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties to the Business Combination intend that the Business Combination qualifies as a reorganization within the meaning of Section
368(a) of the Code (a &#8220;reorganization&#8221;), and subject to the balance of this discussion, the parties expect the Business Combination
to so qualify. If the Business Combination qualifies as a reorganization, then the Business Combination will have the material tax consequences
described in the remainder of this paragraph. The Business Combination is not expected to result in gain being recognized by U.S. Holders
of Globis Common Stock and/or Globis Warrants immediately prior to the Effective Time (other than possibly with respect to any such holder
that would own, actually or constructively, 5% or more (by vote or value) of the outstanding Ordinary Shares of New Forafric immediately
after the Business Combination) (together, the &#8220;Intended Tax Treatment&#8221;), as discussed below under &#8220;Tax Consequences
of the Business Combination Under Section 367(a) of the Code&#8221;. Subject to the discussion of Code Section 367, below, a U.S. Holder&#8217;s
initial tax basis in New Forafric Ordinary Shares and/or New Forafric Warrants received in the Business Combination will equal the tax
basis of the Globis securities exchanged therefor. Subject to the discussion of Code Section 367, below, a U.S. Holder&#8217;s holding
period in New Forafric Ordinary Shares and/or New Forafric Warrants received in the Business Combination will include the holding period
for the Globis securities surrendered in exchange therefor. The parties intend to report the Business Combination in a manner consistent
with the Intended Tax Treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
qualify as a reorganization, a transaction must satisfy certain requirements, including, among others, that the acquiring corporation
(or, in the case of certain reorganizations structured similarly to the Business Combination, its corporate parent) continue, either
directly or indirectly through certain controlled corporations, either a significant line of the acquired corporation&#8217;s historic
business or use a significant portion of the acquired corporation&#8217;s historic business assets in a business, in each case, within
the meaning of Treasury regulations Section 1.368-1(d). However, due to the absence of guidance bearing directly on how the above rules
apply in the case of an acquisition of a corporation with investment-type assets, such as Globis, the qualification of the Business Combination
as a reorganization is not free from doubt, since the Department of Treasury and Internal Revenue Service have never issue guidance or
other authority that is factually on point with the present transaction. As a result, neither Globis&#8217; nor Forafric Global&#8217;s
counsel is able to opine as to whether the Business Combination will qualify as a reorganization. Moreover, the closing of the Business
Combination is not conditioned upon the receipt of an opinion of counsel that the Business Combination will qualify as a reorganization,
and neither Globis nor Forafric Global intends to request a ruling from the IRS regarding the U.S. federal income tax treatment of the
Business Combination. Accordingly, no assurance can be given that the IRS will not challenge the Business Combination&#8217;s qualification
as a reorganization or that a court will not sustain such a challenge by the IRS. U.S. Holders of Globis securities are urged to consult
their tax advisors regarding the proper U.S. federal income tax treatment of the Business Combination, including with respect to its
qualification as a &#8220;reorganization.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the Effective Time, any requirement for the application of Code Section 368(a) is not met, a U.S. Holder of Globis securities generally
would recognize gain or loss in an amount equal to the difference, if any, between the fair market value as of the closing date of the
Business Combination of New Forafric Ordinary Shares and/or New Forafric Warrants received by such holder in the Business Combination
over such holder&#8217;s adjusted tax basis in the Globis securities surrendered by such holder in the Business Combination. Any gain
or loss so recognized would generally be long-term capital gain or loss if the U.S. Holder had held the Globis securities for more than
one year (or short-term capital gain otherwise). Long-term capital gains of non-corporate U.S. Holders (including individuals) currently
are eligible for preferential U.S. federal income tax rates. However, the deductibility of capital losses is subject to limitations.
A U.S. Holder&#8217;s initial tax basis in New Forafric Ordinary Shares and/or New Forafric Warrants received in the Business Combination
will equal the fair market value of such stock or warrants upon receipt. A U.S. Holder&#8217;s holding period in New Forafric Ordinary
Shares and/or New Forafric Warrants received in the Business Combination, if any, will begin on the day following the closing date of
the Business Combination and would not include the holding period for the Globis securities surrendered in exchange therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Consequences of the Business Combination Under Section 367(a) of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
367(a) of the Code and the Treasury regulations promulgated thereunder provide that, where a U.S. person exchanges stock or securities
in a U.S. corporation for stock or securities in a foreign corporation in a transaction that qualifies as a reorganization, the U.S.
person is required to recognize any gain (but not loss) realized on such exchange unless certain additional requirements are satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, for the Business Combination to meet these additional requirements, certain reporting requirements must be satisfied and (i)
no more than 50% of both the total voting power and the total value of the stock of the transferee foreign corporation is received, in
the aggregate, by the &#8220;U.S. transferors&#8221; (as defined in the Treasury regulations and computed taking into account direct,
indirect and constructive ownership) in the transaction; (ii) no more than 50% of each of the total voting power and the total value
of the stock of the transferee foreign corporation is owned, in the aggregate, immediately after the transaction by &#8220;U.S. persons&#8221;
(as defined in the Treasury regulations) that are either officers or directors or &#8220;five-percent target shareholders&#8221; (as
defined in the Treasury regulations and computed taking into account direct, indirect and constructive ownership) of the transferred
U.S. corporation; and (iii) the &#8220;active trade or business test&#8221; as defined in Treasury regulations Section 1.367(a)-3(c)(3)
must be satisfied. Conditions (i), (ii), and (iii) are expected to be met, and, as a result, the Business Combination is expected to
satisfy the applicable requirements under Section 367(a) of the Code on account of such conditions. Accordingly, it is intended that
the Business Combination does not result in gain recognition by a U.S. Holder exchanging Globis Common Stock for New Forafric Ordinary
Shares so long as either (A) the U.S. Holder is not a &#8220;five-percent transferee shareholder&#8221; (as defined in the Treasury regulations
and computed taking into account direct, indirect and constructive ownership) of the transferee foreign corporation (by total voting
power or by total value) or (B) the U.S. Holder is a &#8220;five-percent transferee shareholder&#8221; of the transferee foreign corporation
and enters into an agreement with the IRS to recognize gain under certain circumstances. All U.S. Holders of Globis Securities that will
own 5% or more of either the total voting power or the total value of the outstanding shares of Forafric Global after the Business Combination
(taking into account, for this purpose, ownership of New Forafric Ordinary Shares acquired in connection with the Business Combination
and any New Forafric Ordinary Shares not acquired in connection with the Business Combination) may want to enter into a valid &#8220;gain
recognition agreement&#8221; under applicable Treasury regulations and are strongly urged to consult their own tax advisors to determine
the particular consequences to them of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
the requirements described above are met will depend on facts existing at the Effective Time, and the closing of the Business Combination
is not conditioned upon the receipt of an opinion of counsel or ruling from the IRS that the Business Combination will not result in
gain being recognized by U.S. Holders of Globis securities under Section 367(a) of the Code. In addition, no assurance can be given that
the IRS will not challenge the satisfaction of the relevant requirements under Section 367(a) of the Code and the Treasury regulations
promulgated thereunder with respect to the Business Combination or that a court would not sustain such a challenge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination does meet the requirements of Section 368(a) of the Code but, at the Effective Time, </span><span style="font-family: Times New Roman, Times, Serif">any
requirement for Section 367(a) of the Code not to impose gain on a U.S. Holder is not satisfied, then a U.S. Holder of Globis securities
generally would recognize gain (but not loss) in an amount equal to the excess, if any, of the fair market value as of the closing date
of the Business Combination of New Forafric Ordinary Shares and/or New Forafric Warrants received by such holder in the Business Combination
over such U.S. Holder&#8217;s tax basis in the Globis securities surrendered by such U.S. Holder in the Business Combination. Any gain
so recognized would generally be long-term capital gain if the U.S. Holder had held the Globis securities for more than one year at the
Effective Time (or short-term capital gain otherwise). Long-term capital gain of non-corporate U.S. Holders (including individuals) currently
is eligible for preferential U.S. federal income tax rates. A U.S. Holder&#8217;s initial tax basis in New Forafric Ordinary Shares and/or
New Forafric Warrants received in the Business Combination will equal the fair market value of such stock or warrants upon receipt. A
U.S. Holder&#8217;s holding period in New Forafric Ordinary Shares and/or New Forafric Warrants received in the Business Combination
may not include the holding period for the Globis securities surrendered in exchange therefor. In such case, the holding period will
begin on the day following the closing date of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules dealing with Section 367(a) of the Code discussed above are very complex and are affected by various factors in addition to those
described above. Accordingly, you are strongly urged to consult your tax advisor concerning the application of these rules to your exchange
of Globis securities under your particular circumstances, including whether you will be a five-percent transferee shareholder and the
possibility of entering into a &#8220;gain recognition agreement&#8221; under applicable Treasury regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Holders exchanging Globis Securities for New Forafric Ordinary Shares and/or New Forafric Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination qualifies as a reorganization under Section 368(a) of the Code and is not taxable under Section 367(a) of the
Code, as is intended by the parties, a U.S. Holder generally would not recognize gain or loss if, pursuant to the Business Combination,
the U.S. Holder either (i) exchanges only Globis Common Stock (but not Globis Warrants) for New Forafric Ordinary Shares, (ii) exchanges
Globis Warrants for New Forafric Warrants, or (iii) both exchanges Globis Common Stock for New Forafric Ordinary Shares and exchanges
its Globis Warrants for New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such a case, the aggregate tax basis of New Forafric Ordinary Shares received by a U.S. Holder in the Business Combination should be
equal to the aggregate adjusted tax basis of Globis Common Stock surrendered in exchange therefor. The tax basis in an Forafric Global
Warrant received by a U.S. Holder in the Business Combination should be equal to the adjusted tax basis of the Globis Warrant exchanged
therefor. The holding period of New Forafric Ordinary Shares and/or New Forafric Warrants received by a U.S. Holder in the Business Combination
should include the period during which the Globis Common Stock and/or Globis Warrants exchanged therefor were held by such U.S. Holder.
It is unclear whether the redemption rights with respect to the Globis Common Stock may suspend the running of the applicable holding
period for this purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>U.S.
Holders Exercising Redemption Rights with Respect to Globis Common Stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a U.S. Holder&#8217;s shares of Globis Common Stock are redeemed for cash pursuant to the redemption provisions described
herein, the treatment of such redemption for U.S. federal income tax purposes will depend on whether the redemption qualifies as a sale
of stock under Section 302 of the Code. Whether a redemption qualifies for sale treatment will depend largely on the total number of
shares of Globis Common Stock treated as held by the U.S. Holder relative to all of the shares of Globis Common Stock outstanding both
before and after the redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption of Globis Common Stock generally will be treated as a sale of stock (rather than as a corporate distribution) if the redemption
(i) results in a &#8220;complete termination&#8221; of the U.S. Holder&#8217;s interest in Globis, (ii) is &#8220;substantially disproportionate&#8221;
with respect to the U.S. Holder or (iii) is &#8220;not essentially equivalent to a dividend&#8221; with respect to the U.S. Holder. These
tests are explained more fully below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining whether any of the foregoing tests are satisfied, a U.S. Holder generally should take into account not only Globis Common
Stock actually owned by such U.S. Holder but also Globis Common Stock constructively owned by such holder. A U.S. Holder may constructively
own, in addition to shares owned directly, shares owned by certain related individuals and entities in which the U.S. Holder has an interest
or that have an interest in such U.S. Holder, as well as any shares the U.S. Holder has a right to acquire by exercise of an option,
which would generally include Globis Common Stock or New Forafric Ordinary Shares which could be directly or constructively acquired
pursuant to the exercise of Globis Warrants or New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
will be a complete termination of a U.S. Holder&#8217;s interest if either (i) all of Globis Common Stock actually and constructively
owned by the U.S. Holder is redeemed or (ii) all of Globis Common Stock actually owned by the U.S. Holder is redeemed and the U.S. Holder
is eligible to waive, and effectively waives in accordance with specific rules, the attribution of shares owned by certain family members
and the U.S. Holder does not constructively own any other shares. In order to meet the &#8220;substantially disproportionate&#8221; test,
the percentage of outstanding voting stock actually or constructively owned by a U.S. Holder immediately following the redemption generally
must be less than (a) 80% of the percentage of outstanding voting stock actually or constructively owned by such U.S. Holder immediately
prior to the redemption and (b) 50% of the total combined voting power of Globis Common Stock. The redemption of Globis Common Stock
will not be essentially equivalent to a dividend if a U.S. Holder&#8217;s redemption results in a &#8220;meaningful reduction&#8221;
of the U.S. Holder&#8217;s proportionate interest in Globis. Whether the redemption will result in a meaningful reduction in a U.S. Holder&#8217;s
proportionate interest in Globis will depend on the particular facts and circumstances. However, the IRS has indicated in a published
ruling that even a small reduction in the proportionate interest of a small minority shareholder in a publicly held corporation who exercises
no control over corporate affairs may constitute such a &#8220;meaningful reduction.&#8221; U.S. Holders should consult with their tax
advisors as to the tax consequences of a redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the redemption qualifies as a sale of stock by the U.S. Holder under Section 302 of the Code, the U.S. Holder would generally be required
to recognize gain or loss in an amount equal to the difference, if any, between the amount of cash received and the tax basis of the
shares of Globis Common Stock redeemed. Such gain or loss generally would be treated as capital gain or loss if such shares were held
as a capital asset on the date of the redemption. A U.S. Holder&#8217;s tax basis in such holder&#8217;s Globis Common Stock generally
will equal the cost of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the redemption does not qualify as a sale of stock under Section 302 of the Code, then the U.S. Holder will be treated as receiving a
corporate distribution. Such distribution generally will constitute a dividend for U.S. federal income tax purposes to the extent paid
from current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of
current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below
zero) the U.S. Holder&#8217;s adjusted tax basis in such U.S. Holder&#8217;s Globis Common Stock. Any remaining excess will be treated
as gain realized on the sale or other disposition of Globis Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
treated as dividends that Globis pays to a U.S. Holder that is treated a taxable corporation generally will qualify for the dividends
received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated
as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are
met, amounts treated as dividends that Globis pays to a non-corporate U.S. Holder may be taxed as &#8220;qualified dividend income&#8221;
at the preferential tax rate accorded to long-term capital gains. It is unclear whether the redemption rights described herein with respect
to the Globis Common Stock may have suspended the running of the applicable holding period for these purposes. If the holding period
requirements are not satisfied, then a corporation may not be able to qualify for the dividends received deduction and would have taxable
income equal to the entire dividend amount and non-corporate U.S. Holders may be subject to tax on such dividend at regular ordinary
income tax rates instead of the preferential rate that applies to &#8220;qualified dividend income.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the application of those rules, any remaining tax basis of the U.S. Holder in the redeemed Globis Common Stock will be added to the U.S.
Holder&#8217;s adjusted tax basis in its remaining Globis Common Stock, or, if it has none, to the U.S. Holder&#8217;s adjusted tax basis
in its Globis Warrants or possibly in other shares of Globis Common Stock constructively owned by it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>U.S.
Federal Income Tax Consequences of the Ownership and Disposition of New Forafric Ordinary Shares and New Forafric Warrants to U.S. Holders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions
on New Forafric Ordinary Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below under &#8220;&#8212; <i>Passive Foreign Investment Company Rules</i>,&#8221; if Forafric Global makes distributions
of cash or property on New Forafric Ordinary Shares, such distributions will be treated first as a dividend to the extent of Forafric
Global&#8217;s current and accumulated earnings and profits (as determined for U.S. federal income tax purposes), and then as a tax-free
return of capital to the extent of the U.S. Holder&#8217;s tax basis, with any excess treated as gain from the sale or exchange of the
shares. The amount of any such distribution will include any amounts withheld by Forafric Global (or another applicable withholding agent).
If Forafric Global does not provide calculations of its earnings and profits under U.S. federal income tax principles, a U.S. Holder
should expect all cash distributions to be reported as dividends for U.S. federal income tax purposes. Any dividend will not be eligible
for the dividends received deduction allowed to corporations in respect of dividends received from U.S. corporations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussions above under &#8220;&#8212; <i>Utilization of Globis&#8217; Tax Attributes and Certain Other Adverse Tax Consequences
to Forafric Global and Forafric Global&#8217;s Shareholders</i>&#8221; and below under &#8220;&#8212; <i>Passive Foreign Investment Company
Rules</i>,&#8221; dividends received by certain non-corporate U.S. Holders (including individuals) may be &#8220;qualified dividend income,&#8221;
which is taxed at the lower applicable capital gains rate, provided that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
    (a) the shares are readily tradable on an established securities market in the U.S. or (b) Forafric Global is eligible for the benefits
    of a qualifying income tax treaty with the U.S. that includes an exchange of information program;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
    Global is neither a PFIC (as discussed below under below under &#8220;&#8212; <i>Passive Foreign Investment Company Rules</i>&#8221;)
    nor treated as such with respect to the U.S. Holder for Forafric Global&#8217;s taxable year in which the dividend is paid or the
    preceding taxable year;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    U.S. Holder satisfies certain holding period requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    U.S. Holder is not under an obligation to make related payments with respect to positions in substantially similar or related property;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    taxpayer does not take the dividends into account as investment income under Code Section 163(d)(4)(B).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no comprehensive income tax treaty between the U.S. and Gibraltar, thus Forafric Global will not be eligible for benefits of an applicable
comprehensive income tax treaty. In addition, there can be no assurance that New Forafric Ordinary Shares will be considered &#8220;readily
tradable&#8221; on an established securities market in accordance with applicable legal authorities. Furthermore, Forafric Global will
not constitute a qualified foreign corporation for purposes of these rules if it is a PFIC for the taxable year in which it pays a dividend
or for the preceding taxable year. See &#8220;&#8212; <i>Passive Foreign Investment Company Rules.</i>&#8221; U.S. Holders should consult
their tax advisors regarding the availability of the lower rate for dividends paid with respect to New Forafric Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of any dividend distribution paid in foreign currency will be the U.S. dollar amount calculated by reference to the applicable
exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S.
dollars at that time. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date
of receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain exceptions, dividends on New Forafric Ordinary Shares will constitute foreign source income for foreign tax credit limitation
purposes. If the dividends are qualified dividend income (as discussed above), the amount of the dividend taken into account for purposes
of calculating the foreign tax credit limitation will be limited to the gross amount of the dividend, multiplied by a fraction, the numerator
of which is the reduced rate applicable to qualified dividend income and the denominator of which is the highest rate of tax normally
applicable to dividends. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes
of income. For this purpose, dividends distributed by Forafric Global with respect to New Forafric Ordinary Shares generally will constitute
&#8220;passive category income&#8221; but could, in the case of certain U.S. Holders, constitute &#8220;general category income.&#8221;
The rules governing foreign tax credits are complex and U.S. Holders are urged to consult their tax advisors regarding the creditability
of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, a U.S. Holder may, in certain circumstances,
deduct foreign taxes in computing the holder&#8217;s taxable income, subject to generally applicable limitations under U.S. law. Generally,
an election to deduct foreign taxes instead of claiming foreign tax credits applies to all foreign taxes paid or accrued in the taxable
year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale,
Exchange, Redemption or Other Taxable Disposition of New Forafric Ordinary Shares and New Forafric Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below under &#8220;&#8212; <i>Passive Foreign Investment Company Rules</i>,&#8221; a U.S. Holder generally will recognize
gain or loss on any sale, exchange, redemption or other taxable disposition of New Forafric Ordinary Shares or New Forafric Warrants
in an amount equal to the difference between (i) the amount realized on the disposition and (ii) such U.S. Holder&#8217;s adjusted tax
basis in such shares and/or warrants. Any gain or loss recognized by a U.S. Holder on a taxable disposition of New Forafric Ordinary
Shares or New Forafric Warrants generally will be capital gain or loss. A non-corporate U.S. Holder, including an individual, who has
held New Forafric Ordinary Shares and/or New Forafric Warrants for more than one year generally will be eligible for reduced tax rates
for such long-term capital gains. The deductibility of capital losses is subject to limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such gain or loss recognized generally will be treated as U.S. source income or loss. Accordingly, in the event any Gibraltar tax (including
withholding tax) is imposed upon such sale or other disposition, a U.S. Holder may not be able to utilize foreign tax credits unless
such holder has foreign source income or gain in the same category from other sources. U.S. Holders are urged to consult their tax advisor
regarding the ability to claim a foreign tax credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise,
Lapse, or Redemption of an Forafric Global Warrant</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the PFIC rules discussed below, a U.S. Holder generally will not recognize gain or loss upon the acquisition of an Forafric Global
ordinary share on the exercise of an Forafric Global Warrant for cash. A U.S. Holder&#8217;s tax basis in an New Forafric Ordinary Shares
received upon exercise of the Forafric Global Warrant generally should be an amount equal to the sum of the U.S. Holder&#8217;s tax basis
in the Globis Warrant exchanged therefor (assuming the Business Combination is not a taxable transaction, as discussed above) and the
exercise price. The U.S. Holder&#8217;s holding period for an Forafric Global Ordinary Share received upon exercise of the Forafric Global
Warrant will begin on the date following the date of exercise (or possibly the date of exercise) of the Forafric Global Warrant and will
not include the period during which the U.S. Holder held the Forafric Global Warrant. If an Forafric Global Warrant is allowed to lapse
unexercised, a U.S. Holder generally will recognize a capital loss equal to such holder&#8217;s tax basis in the Forafric Global Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax consequences of a cashless exercise of an Forafric Global Warrant are not clear under current tax law. Subject to the PFIC rules
discussed below, a cashless exercise may be tax-deferred, either because the exercise is not a gain realization event or because the
exercise is treated as a recapitalization for U.S. federal income tax purposes. In either tax-deferred situation, a U.S. Holder&#8217;s
basis in New Forafric Ordinary Shares received generally would equal the U.S. Holder&#8217;s basis in New Forafric Warrants exercised
therefor. If the cashless exercise is not treated as a gain realization event, a U.S. Holder&#8217;s holding period in New Forafric Ordinary
Shares would be treated as commencing on the date following the date of exercise (or possibly the date of exercise) of New Forafric Warrants
and will not include the period during which the U.S. Holder held New Forafric Warrants. If the cashless exercise were treated as a recapitalization,
the holding period of New Forafric Ordinary Shares would include the holding period of New Forafric Warrants exercised therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also possible that a cashless exercise of an Forafric Global Warrant could be treated in part as a taxable exchange in which gain
or loss would be recognized in the manner set forth above under &#8220;&#8212; <i>Sale, Exchange, Redemption or Other Taxable Disposition
of New Forafric Ordinary Shares and New Forafric Warrants</i>.&#8221; In such event, a U.S. Holder could be deemed to have surrendered
warrants equal to the number of New Forafric Ordinary Shares having an aggregate fair market value equal to the exercise price for the
total number of warrants to be exercised. Subject to the PFIC rules discussed below, the U.S. Holder would recognize capital gain or
loss with respect to New Forafric Warrants deemed surrendered in an amount generally equal to the difference between (i) the fair market
value of New Forafric Ordinary Shares that would have been received in a regular exercise of New Forafric Warrants deemed surrendered,
net of the aggregate exercise price of such New Forafric Warrants and (ii) the U.S. Holder&#8217;s tax basis in such New Forafric Warrants.
In this case, a U.S. Holder&#8217;s aggregate tax basis in New Forafric Ordinary Shares received would equal the sum of (i) U.S. Holder&#8217;s
tax basis in New Forafric Warrants deemed exercised and (ii) the aggregate exercise price of such New Forafric Warrants. A U.S. Holder&#8217;s
holding period for New Forafric Ordinary Shares received in such case generally would commence on the date following the date of exercise
(or possibly the date of exercise) of New Forafric Warrants and will not include the period during which the U.S. Holder held New Forafric
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the absence of authority on the U.S. federal income tax treatment of a cashless exercise of warrants, including when a U.S. Holder&#8217;s
holding period would commence with respect to the Forafric Global Ordinary Share received, there can be no assurance regarding which,
if any, of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly,
U.S. Holders should consult their tax advisors regarding the tax consequences of a cashless exercise of New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the PFIC rules described below, if Forafric Global redeems New Forafric Warrants for cash pursuant to the redemption provisions described
in the section of this registration statement entitled &#8220;<i>&#8212; Description of New Forafric Warrants </i>&#8220; or if Forafric
Global purchases New Forafric Warrants in an open market transaction, such redemption or purchase generally will be treated as a taxable
disposition to the U.S. Holder, taxed as described above under &#8220;&#8212; <i>Sale, Exchange, Redemption or Other Taxable Disposition
of New Forafric Ordinary Shares and New Forafric Warrants</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Possible
Constructive Distributions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of each Forafric Global Warrant provide for an adjustment to the number of New Forafric Ordinary Shares for which the Forafric
Global Warrant may be exercised or to the exercise price of the Forafric Global Warrant in certain events, as discussed in the section
of this registration statement captioned &#8220;<i>Description of New Forafric Warrants</i>.&#8221; An adjustment which has the effect
of preventing dilution generally is not taxable. A U.S. Holder of an Forafric Global Warrant would, however, be treated as receiving
a constructive distribution from Forafric Global if, for example, the adjustment increases the holder&#8217;s proportionate interest
in Forafric Global&#8217;s assets or earnings and profits (for instance, through an increase in the number of New Forafric Ordinary Shares
that would be obtained upon exercise of such warrant) as a result of a distribution of cash or other property such as other securities
to the holders of New Forafric Ordinary Shares which is taxable to the U.S. Holders of such shares as described under &#8220;&#8212;
<i>Distributions on New Forafric Ordinary Shares</i>&#8221; above. Such constructive distribution would be subject to tax as described
under that section in the same manner as if the U.S. Holder of such Forafric Global Warrant received a cash distribution from Forafric
Global equal to the fair market value of such increase in interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Passive
Foreign Investment Company Rules</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
treatment of U.S. Holders of New Forafric Ordinary Shares and New Forafric Warrants could be materially different from that described
above, if Forafric Global is treated as a &#8220;passive foreign investment company,&#8221; or PFIC, for U.S. federal income tax purposes.
An entity treated as a foreign corporation for U.S. federal income tax purposes generally will be a PFIC for U.S. federal income tax
purposes for any taxable year if either:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least 75% of its gross income for such year is passive income (such as interest, dividends, rents and royalties (other than rents
    or royalties derived from the active conduct of a trade or business) and gains from the disposition of assets giving rise to passive
    income); or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is attributable
    to assets that produce passive income or are held for the production of passive income.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
this purpose, Forafric Global will be treated as owning its proportionate share of the assets and earning its proportionate share of
the income of any other entity treated as a corporation for U.S. federal income tax purposes in which Forafric Global own, directly or
indirectly, 25% or more (by value) of the stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the current and anticipated composition of the income, assets and operations of Forafric Global and its subsidiaries, Forafric Global
does not believe it will be treated as a PFIC for U.S. federal income tax purposes for its current taxable year, which includes the Business
Combination, and does not expect to become one for U.S. federal income tax purposes in the near future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevertheless,
whether Forafric Global is treated as a PFIC is determined on an annual basis. The determination of whether a non-U.S. corporation is
a PFIC is a factual determination that depends on, among other things, the composition of Forafric Global&#8217;s income and assets,
and the market value of its shares and assets, including the composition of income and assets and the market value of shares and assets
of its subsidiaries, from time to time, and thus the determination can only be made annually after the close of each taxable year. Thus,
no assurance can be given as to whether Forafric Global will be a PFIC in 2021 or for any future taxable year. In addition, neither Globis&#8217;
nor Forafric Global&#8217;s respective U.S. counsel expresses any opinion with respect to Forafric Global&#8217;s PFIC status for 2021
or future taxable years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PFIC rules, if Forafric Global were considered a PFIC at any time that a U.S. Holder owns New Forafric Ordinary Shares or New Forafric
Warrants, Forafric Global would generally continue to be treated as a PFIC with respect to such holder in a particular year unless (i)
Forafric Global has ceased to be a PFIC and (ii) (a) the U.S. Holder has made a valid &#8220;QEF election&#8221; (as described below)
for the first taxable year in which the holder owned such holder&#8217;s New Forafric Ordinary Shares in which Forafric Global was a
PFIC, (b) a valid mark-to-market election (as described below) is in effect for the particular year, or (c) the U.S. Holder has made
a &#8220;deemed sale&#8221; election under the PFIC rules. If such a &#8220;deemed sale&#8221; election is made, a U.S. Holder will be
deemed to have sold its New Forafric Ordinary Shares at their fair market value on the last day of the last taxable year in which Forafric
Global is classified as a PFIC, and any gain from such deemed sale would be subject to the consequences described below. After the &#8220;deemed
sale&#8221; election, New Forafric Ordinary Shares with respect to which the &#8220;deemed sale&#8221; election was made will not be
treated as shares in a PFIC unless Forafric Global subsequently becomes a PFIC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each taxable year that Forafric Global is treated as a PFIC with respect to a U.S. Holder&#8217;s New Forafric Ordinary Shares or New
Forafric Warrants, the U.S. Holder will be subject to special tax rules with respect to any &#8220;excess distribution&#8221; (as defined
below) received and any gain realized from a sale or disposition (including a pledge of New Forafric Ordinary Shares and under proposed
regulations transfers of New Forafric Warrants and certain transfers of New Forafric Ordinary Shares that would otherwise qualify as
nonrecognition transactions for U.S. federal income tax purposes) of its New Forafric Ordinary Shares or New Forafric Warrants (collectively
the &#8220;<i>excess distribution rules</i>&#8221;), unless, with respect to New Forafric Ordinary Shares, the U.S. Holder makes a valid
QEF or mark-to-market election as discussed below. Generally, distributions received by a U.S. Holder in a taxable year that are greater
than 125% of the average annual distributions received by such U.S. Holder during the shorter of the three preceding taxable years or
the portion of such U.S. Holder&#8217;s holding period for New Forafric Ordinary Shares or New Forafric Warrants that preceded the taxable
year of the distribution will be treated as excess distributions. Under these special tax rules:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    excess distribution or gain will be allocated ratably over the U.S. Holder&#8217;s holding period for New Forafric Ordinary Shares
    or New Forafric Warrants;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to the U.S. Holder&#8217;s taxable year in which the U.S. Holder recognized the gain or received the excess distribution
    or to the period in the U.S. Holder&#8217;s holding period before the first day of Forafric Global&#8217;s first taxable year in
    which Forafric Global is a PFIC, will be treated as ordinary income; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to each other taxable year (or portions thereof) of the U.S. Holder and included in such holder&#8217;s holding
    period will be subject to the highest tax rate in effect for individuals or corporations, as applicable, for each such year without
    regard to the U.S. Holder&#8217;s other items of income and loss for such year; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    interest charge generally applicable to underpayments of tax will be imposed on the U.S. Holder with respect to the resulting tax
    attributable to each such year.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the excess distribution rules, the tax liability for amounts allocated to taxable years prior to the year of disposition or excess distribution
cannot be offset by any net operating losses, and gains (but not losses) realized on the sale of New Forafric Ordinary Shares or New
Forafric Warrants cannot be treated as capital gains, even though the U.S. Holder holds New Forafric Ordinary Shares or New Forafric
Warrants as capital assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the PFIC rules may impact U.S. Holders with respect to equity interests in subsidiaries and other entities which Forafric Global may
hold, directly or indirectly, that are PFICs (collectively, &#8220;<i>Lower-Tier PFICs</i>&#8221;). There can be no assurance, however,
that Forafric Global does not own, or will not in the future acquire, an interest in a subsidiary or other entity that is or would be
treated as a Lower-Tier PFIC. U.S. Holders should consult their tax advisors regarding the application of the PFIC rules to any of Forafric
Global&#8217;s subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Forafric Global is a PFIC, a U.S. Holder of shares in Forafric Global may avoid taxation under the excess distribution rules described
above in respect to New Forafric Ordinary Shares by making a timely and valid &#8220;qualified electing fund&#8221; (&#8220;<i>QEF</i>&#8221;)
election (if eligible to do so). However, a U.S. Holder may make a QEF election with respect to its New Forafric Ordinary Shares only
if Forafric Global provides U.S. Holders on an annual basis with certain financial information specified under applicable U.S. Treasury
regulations, including the information provided in a PFIC Annual Information Statement. There can be no assurance, however, that Forafric
Global will have timely knowledge of its status as a PFIC in the future or that Forafric Global will timely provide such information
for such years. The failure to provide such information on an annual basis could prevent a U.S. Holder from making a QEF election or
result in the invalidation or termination of a U.S. Holder&#8217;s prior QEF election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder that makes a QEF election with respect to its New Forafric Ordinary Shares would generally be required to include in income
for each year that Forafric Global is treated as a PFIC the U.S. Holder&#8217;s pro rata share of Forafric Global&#8217;s ordinary earnings
for the year (which would be subject to tax as ordinary income) and net capital gains for the year (which would be subject to tax at
the rates applicable to long-term capital gains), without regard to the amount of any distributions made in respect of New Forafric Ordinary
Shares. Any net deficits or net capital losses of Forafric Global for a taxable year, however, would not be passed through and included
on the tax return of the U.S. Holder. A U.S. Holder&#8217;s basis in New Forafric Ordinary Shares would be increased by the amount of
income inclusions under the QEF rules. Dividends actually paid on New Forafric Ordinary Shares generally would not be subject to U.S.
federal income tax to the extent of prior income inclusions and would reduce the U.S. Holder&#8217;s basis in New Forafric Ordinary Shares
by a corresponding amount. If Forafric Global owns any interests in a Lower-Tier PFIC, a U.S. Holder generally must make a separate QEF
election for each Lower-Tier PFIC, subject to Forafric Global&#8217;s providing the relevant tax information for each Lower-Tier PFIC
on an annual basis. There can be no assurance that Forafric Global will have timely knowledge of the status of any such Lower-Tier PFIC.
In addition, Forafric Global may not hold a controlling interest in any such Lower-Tier PFIC and thus there can be no assurance Forafric
Global will be able to cause the Lower-Tier PFIC to provide such required information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a U.S. Holder does not make a QEF election effective from the first taxable year of a U.S. Holder&#8217;s holding period for New Forafric
Ordinary Shares in which Forafric Global is a PFIC (or a mark-to-market election, as discussed below), then the U.S. Holder generally
will remain subject to the excess distribution rules. A U.S. Holder that first makes a QEF election in a later year may avoid the continued
application of the excess distribution rules to its New Forafric Ordinary Shares by making a &#8220;deemed sale&#8221; election. In that
case, the U.S. Holder will be deemed to have sold New Forafric Ordinary Shares at their fair market value on the first day of the taxable
year in which the QEF election becomes effective, and any gain from such deemed sale would be subject to the excess distribution rules
described above. As a result of the &#8220;deemed sale&#8221; election, the U.S. Holder will have additional basis (to the extent of
any gain recognized on the deemed sale) and, solely for purposes of the PFIC rules, a new holding period in New Forafric Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not entirely clear how various aspects of the PFIC rules apply to New Forafric Warrants. However, a U.S. Holder may not be eligible
to make a QEF election with respect to its New Forafric Warrants. As a result, if a U.S. Holder sells or otherwise disposes of such warrants
(other than upon exercise of such warrants) and Forafric Global was a PFIC at any time during the U.S. Holder&#8217;s holding period
of such warrants, any gain recognized generally will be treated as an excess distribution, taxed as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a U.S. Holder that exercises such warrants properly makes and maintains a QEF election with respect to the newly acquired New Forafric
Ordinary Shares (or has previously made a QEF election with respect to New Forafric Ordinary Shares), the QEF election will apply to
the newly acquired New Forafric Ordinary Shares. Notwithstanding such QEF election, the rules relating to &#8220;excess distributions&#8221;
discussed above, adjusted to take into account the current income inclusions resulting from the QEF election, will continue to apply
with respect to such newly acquired New Forafric Ordinary Shares (which under proposed regulations will be deemed to have a holding period
for purposes of the PFIC rules that includes the period the U.S. Holder held New Forafric Warrants), unless the U.S. Holder makes a &#8220;deemed
sale&#8221; election under the PFIC rules. U.S. Holders are urged to consult their tax advisors as to the application of the rules governing
&#8220;deemed sale&#8221; elections to their particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
QEF election is made on a shareholder-by-shareholder basis and, once made, can be revoked only with the consent of the IRS. A U.S. Holder
that is eligible to make a QEF election with respect to its New Forafric Ordinary Shares generally may do so by providing the appropriate
information to the IRS in the U.S. Holder&#8217;s timely filed tax return for the year in which the election becomes effective. Retroactive
QEF elections generally may be made only by filing a protective statement with such return and if certain other conditions are met or
with the consent of the IRS. U.S. Holders should consult their tax advisors regarding the availability and tax consequences of a retroactive
QEF election under their particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
if Forafric Global is a PFIC and New Forafric Ordinary Shares constitute &#8220;marketable stock&#8221; (as defined below), a U.S. Holder
may make a mark-to-market election for such holder&#8217;s New Forafric Ordinary Shares with respect to such shares for the first taxable
year in which it holds (or is deemed to hold) New Forafric Ordinary Shares and each subsequent taxable year to elect out of the excess
distribution rules discussed above. If a U.S. Holder makes a mark-to-market election with respect to its New Forafric Ordinary Shares,
such U.S. Holder generally will include in income for each year that Forafric Global is treated as a PFIC with respect to such New Forafric
Ordinary Shares an amount equal to the excess, if any, of the fair market value of New Forafric Ordinary Shares as of the close of the
U.S. Holder&#8217;s taxable year over the adjusted basis in New Forafric Ordinary Shares as of the beginning of such taxable year. A
U.S. Holder will be allowed a deduction for the excess, if any, of the adjusted basis of New Forafric Ordinary Shares over their fair
market value as of the close of the taxable year. However, deductions will be allowed only to the extent of any net mark-to-market gains
on New Forafric Ordinary Shares included in the U.S. Holder&#8217;s income for prior taxable years. Amounts included in income under
a mark-to-market election, as well as gain on the actual sale or other disposition of New Forafric Ordinary Shares, will be treated as
ordinary income. Ordinary loss treatment will also apply to the deductible portion of any mark-to-market loss on New Forafric Ordinary
Shares, as well as to any loss realized on the actual sale or disposition of New Forafric Ordinary Shares, to the extent the amount of
such loss does not exceed the net mark-to-market gains for such New Forafric Ordinary Shares previously included in income. A U.S. Holder&#8217;s
basis in New Forafric Ordinary Shares will be adjusted to reflect any mark-to-market gain or loss. If a U.S. Holder makes a mark-to-market
election, any distributions Forafric Global makes would generally be subject to the rules discussed above under &#8220;<i>&#8212; Distributions
on New Forafric Ordinary Shares</i>,&#8221; except the lower rates applicable to qualified dividend income would not apply. Currently,
U.S. Holders of New Forafric Warrants may not be able to make a mark-to-market election with respect to their New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mark-to-market election is available only for &#8220;marketable stock,&#8221; which is stock that is regularly traded on a qualified
exchange or other market, as defined in applicable U.S. Treasury regulations. New Forafric Ordinary Shares, which are expected to be
listed on Nasdaq, are expected to qualify as marketable stock for purposes of the PFIC rules, but there can be no assurance that New
Forafric Ordinary Shares will be &#8220;regularly traded&#8221; for purposes of these rules. If made, a mark-to-market election would
be effective for the taxable year for which the election was made and for all subsequent taxable years unless New Forafric Ordinary Shares
cease to qualify as &#8220;marketable stock&#8221; for purposes of the PFIC rules or the IRS consents to the revocation of the election.
Because a mark-to-market election cannot be made for equity interests in any Lower-Tier PFICs, a U.S. Holder that does not make the applicable
QEF elections generally will continue to be subject to the excess distribution rules with respect to its indirect interest in any Lower-Tier
PFICs as described above, even if a mark-to-market election is made for New Forafric Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a U.S. Holder does not make a mark-to-market election (or a QEF election, as discussed above) effective from the first taxable year of
a U.S. Holder&#8217;s holding period for New Forafric Ordinary Shares in which Forafric Global is a PFIC, then the U.S. Holder generally
will remain subject to the excess distribution rules. A U.S. Holder that first makes a mark-to-market election with respect to New Forafric
Ordinary Shares in a later year will continue to be subject to the excess distribution rules during the taxable year for which the mark-to-market
election becomes effective, including with respect to any mark-to-market gain recognized at the end of that year. In subsequent years
for which a valid mark-to-mark election remains in effect, the excess distribution rules generally will not apply. A U.S. Holder that
is eligible to make a mark-to-market with respect to such holder&#8217;s New Forafric Ordinary Shares may do so by providing the appropriate
information on IRS Form 8621 and timely filing that form with the U.S. Holder&#8217;s tax return for the year in which the election becomes
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders should consult their tax advisors as to the availability and desirability of a mark-to-market election, as well as the impact
of such election on interests in any Lower-Tier PFICs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder of a PFIC may be required to file an IRS Form 8621 on an annual basis and to provide such other information as may be required
by the U.S. Treasury Department. Failure to do so, if required, will extend the statute of limitations applicable to such U.S. Holder
until such required information is furnished to the IRS. U.S. Holders should consult their tax advisors regarding any reporting requirements
that may apply to them if Forafric Global is a PFIC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules dealing with PFICs and with the QEF, &#8220;deemed sale,&#8221; and mark-to-market elections are very complex and are affected
by various factors in addition to those described above. U.S. Holders are strongly encouraged to consult their tax advisors regarding
the application of the PFIC rules to their particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-U.S.
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
section applies to Non-U.S. Holders of New Forafric Ordinary Shares and New Forafric Warrants. For purposes of this discussion, a Non-U.S.
Holder means a beneficial owner (other than a partnership or an entity or arrangement so characterized for U.S. federal income tax purposes)
of New Forafric Ordinary Shares or New Forafric Warrants that is for U.S. federal income tax purposes not a U.S. Holder, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    nonresident alien individual, other than certain former citizens and residents of the U.S. subject to U.S. tax as expatriates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    foreign corporation; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    foreign estate or trust;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">but
generally does not include a beneficial owner who has been or is engaged in the conduct of a trade or business within the U.S. or an
individual who is present in the U.S. for 183 days or more in the taxable year of the disposition of New Forafric Ordinary Shares or
New Forafric Warrants (except to the extent discussed below). If you are such an individual, you should consult your tax advisor regarding
the U.S. federal income tax consequences of exercising redemption rights with respect to Globis Common Stock or the ownership and disposition
of New Forafric Ordinary Shares or New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-U.S.
Holders Exercising Redemption Rights with Respect to Globis Common Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
characterization for U.S. federal income tax purposes of the redemption of a Non-U.S. Holder&#8217;s Globis Common Stock generally will
correspond to the U.S. federal income tax characterization of such a redemption of a U.S. Holder&#8217;s Globis Common Stock, as described
above under <i>&#8220;&#8212; U.S. Holders Exercising Redemption Rights with Respect to Globis Common Stock</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below concerning backup withholding, if such a redemption qualifies as a sale of the Globis Common Stock, any redeeming
Non-U.S. Holder will generally not be subject to U.S. federal income tax or withholding tax on any gain recognized as a result of the
redemption or be able to utilize a loss in computing U.S. federal income tax liability unless one of the exceptions described below under
&#8220;&#8212; <i>U.S. Federal Income Tax Consequences of the Ownership and Disposition of New Forafric Ordinary Shares and New Forafric
Warrants to Non-U.S. Holders</i>&#8221; applies in respect of gain from the disposition of Globis Common Stock. Moreover, redeeming Non-U.S.
Holders may be subject to U.S. federal income tax on any gain recognized as a result of the redemption if Globis Common Stock constitutes
a U.S. real property interest by reason of Globis&#8217; status as a U.S. real property holding corporation for U.S. federal income tax
purposes. Globis believes that it is not and has not been at any time since its formation a U.S. real property holding corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Non-U.S. Holder receives cash for Globis Common Stock, and the redemption is treated as a corporate distribution (rather than a sale
of stock under Section 302 of the Code), the Non-U.S. Holder will be subject to a 30% withholding tax (unless otherwise reduced by an
applicable income tax treaty and the Non-U.S. Holder provides a proper certificate of its eligibility for such reduced rate (usually
on an IRS Form W-8BEN or W-8BEN-E, as applicable)) on the gross amount of the distribution to the extent the distribution is paid from
current or accumulated earnings and profits, as determined under U.S. federal income tax principles, and treated as dividends, provided
such dividends are not effectively connected with such Non-U.S. Holder&#8217;s conduct of a trade or business within the U.S. Any distribution
not constituting a dividend will be treated first as reducing (but not below zero) the Non-U.S. Holder&#8217;s adjusted tax basis in
its Globis Common Stock and then, to the extent such distribution exceeds the Non-U.S. Holder&#8217;s adjusted tax basis, as gain realized
from the sale or other disposition of such Globis Common Stock, which will be treated as described in the paragraph immediately above.
A redemption treated as a dividend by Globis to a Non-U.S. Holder that is effectively connected with such Non-U.S. Holder&#8217;s conduct
of a trade or business within the United States (and if an income tax treaty applies, are attributable to a U.S. permanent establishment
or fixed base maintained by the Non-U.S. Holder in the U.S.) will generally not be subject to U.S. withholding tax, provided such Non-U.S.
Holder complies with certain certification and disclosure requirements (usually by providing an IRS Form W-8ECI). Instead, such dividends
will generally be subject to U.S. federal income tax, net of certain deductions, at the same corporate or graduated individual rates
applicable to U.S. Holders (together with branch profits tax, at a 30% rate, or such lower rate specified by an applicable tax treaty,
as adjusted for certain items, if such Non-U.S. Holder is a corporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IF
YOU ARE A NON-U.S. HOLDER OF <span style="text-transform: uppercase">Globis</span> COMMON STOCK CONTEMPLATING EXERCISE OF YOUR REDEMPTION
RIGHTS, WE URGE YOU TO CONSULT YOUR TAX ADVISOR CONCERNING THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES
THEREOF.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Federal Income Tax Consequences of the Ownership and Disposition of New Forafric Ordinary Shares and New Forafric Warrants to Non-U.S.
Holders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below concerning backup withholding, any (i) dividends of cash or property (including constructive distributions treated
as dividends as further described under the heading &#8220;<i>U.S. Holders &#8212; U.S. Federal Income Tax Consequences of the Ownership
and Disposition of New Forafric Ordinary Shares and New Forafric Warrants to U.S. Holders &#8212; Possible Constructive Distributions</i>&#8221;)
paid or deemed paid to a Non-U.S. Holder in respect of New Forafric Ordinary Shares or (ii) gain realized upon the sale or other taxable
disposition of New Forafric Ordinary Shares and/or New Forafric Warrants by a Non-U.S. Holder generally will not be subject to U.S. federal
income taxation or withholding tax unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    gain or dividend is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States
    (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment or a &#8220;fixed base&#8221;
    in the United States to which such gain is attributable); or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of any gain, the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or more during
    the taxable year of the disposition and certain other requirements are met.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
or distributions described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis
at the regular rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower
rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified
by an applicable income tax treaty), which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual
is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with
respect to such losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax treatment of a Non-U.S. Holder&#8217;s exercise of an Forafric Global Warrant, or the lapse of an Forafric Global
Warrant held by a Non-U.S. Holder, generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of an
Forafric Global Warrant by a U.S. Holder, as described under &#8220;<i>U.S. Holders &#8212; U.S. Federal Income Tax Consequences of the
Ownership and Disposition of New Forafric Ordinary Shares and New Forafric Warrants to U.S. Holders &#8212; Exercise, Lapse or Redemption
of an Forafric Global Warrant</i>&#8221; above, although to the extent a cashless exercise or lapse results in a taxable exchange, the
consequences would be similar to those described in the preceding paragraphs above for a Non-U.S. Holder&#8217;s gain on the sale or
other disposition of New Forafric Ordinary Shares and New Forafric Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
characterization for U.S. federal income tax purposes of the redemption of the Non-U.S. Holder&#8217;s New Forafric Warrants generally
will correspond to the U.S. federal income tax treatment of such a redemption of a U.S. Holder&#8217;s warrants, as described under &#8220;<i>U.S.
Holders &#8212; U.S. Federal Income Tax Consequences of the Ownership and Disposition of New Forafric Ordinary Shares and New Forafric
Warrants to U.S. Holders &#8212; Exercise, Lapse or Redemption of an Forafric Global Warrant</i>&#8221; above, and the consequences of
the redemption to the Non-U.S. Holder will be as described in the first paragraph above under the heading &#8220;&#8212; <i>U.S. Federal
Income Tax Consequences of the Ownership and Disposition of New Forafric Ordinary Shares and New Forafric Warrants to Non-U.S. Holders</i>&#8221;
based on such characterization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
Reporting and Backup Withholding</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
reporting requirements may apply to cash received in redemption of Globis Common Stock, dividends received by U.S. Holders of New Forafric
Ordinary Shares, and the proceeds received on the disposition of New Forafric Ordinary Shares effected within the U.S. (and, in certain
cases, outside the U.S.), in each case other than U.S. Holders that are exempt recipients (such as corporations). Backup withholding
(currently at a rate of 24%) may apply to such amounts if the U.S. Holder fails to provide an accurate taxpayer identification number
(generally on an IRS Form W-9 provided to the paying agent of the U.S. Holder&#8217;s broker) or is otherwise subject to backup withholding.
Any redemptions treated as dividend payments with respect to Globis Common Stock or New Forafric Ordinary Shares and proceeds from the
sale, exchange, redemption or other disposition of New Forafric Ordinary Shares may be subject to information reporting to the IRS and
possible U.S. backup withholding. U.S. Holders should consult their tax advisors regarding the application of the U.S. information reporting
and backup withholding rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
returns may be required to be filed with the IRS in connection with, and Non-U.S. Holders may be subject to backup withholding on amounts
received in respect of, a Non-U.S. Holder&#8217;s disposition of Globis securities or their New Forafric Ordinary Shares, unless the
Non-U.S. Holder furnishes to the applicable withholding agent the required certification as to its non-U.S. status, such as by providing
a valid IRS Form W-8BEN, IRS Form W-8BEN-E or IRS Form W-8ECI, as applicable, or the Non-U.S. Holder otherwise establishes an exemption.
Dividends paid with respect to New Forafric Ordinary Shares and proceeds from the sale of other disposition of New Forafric Ordinary
Shares received in the U.S. by a Non-U.S. Holder through certain U.S.-related financial intermediaries may be subject to information
reporting and backup withholding unless such Non-U.S. Holder provides proof of an applicable exemption or complies with certain certification
procedures described above, and otherwise complies with the applicable requirements of the backup withholding rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Amounts withheld as backup withholding may be credited against the taxpayer&#8217;s U.S. federal
income tax liability, and a taxpayer may obtain a refund of any excess amounts withheld under the backup withholding rules by timely
filing the appropriate claim for a refund with the IRS and furnishing any required information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
U.S. FEDERAL INCOME TAX DISCUSSION SET FORTH ABOVE IS INCLUDED FOR GENERAL </b></span><b><span style="font-family: Times New Roman, Times, Serif">INFORMATION
ONLY AND MAY NOT BE APPLICABLE TO YOU DEPENDING UPON YOUR PARTICULAR SITUATION. YOU ARE URGED TO CONSULT YOUR OWN TAX ADVISOR WITH RESPECT
TO THE TAX CONSEQUENCES TO YOU OF THE BUSINESS COMBINATION, THE EXERCISE OF YOUR REDEMPTION RIGHTS WITH RESPECT TO <span style="text-transform: uppercase">Globis
</span>COMMON STOCK, AND OF THE OWNERSHIP AND DISPOSITION OF NEW FORAFRIC ORDINARY SHARES AND NEW FORAFRIC WARRANTS, AS APPLICABLE, INCLUDING
THE TAX CONSEQUENCES UNDER STATE, LOCAL, FOREIGN AND OTHER TAX LAWS AND TAX TREATIES AND THE POSSIBLE EFFECTS OF CHANGES IN U.S. OR OTHER
TAX LAWS.</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Matters </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination and the transactions contemplated by the Business Combination Agreement are not subject to any additional federal
or state regulatory requirement or approval, (i) except for filings with the Gibraltar and Delaware necessary to effectuate the Redomiciliation
and (ii) the Business Combination and filings required of solicitation materials pursuant to Rule 14a-12 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the entry of Globis into the Business Combination Agreement, entered into as of December 19, 2021 (as amended, restated, supplemented
and/or otherwise modified from time to time, the &#8220;<b>Business Combination Agreement</b>&#8221;), by and among Globis, FAHL and
the Seller, the consummation of the transactions contemplated by the Business Combination Agreement, including the issuance of the acquisition
consideration thereunder, and the performance by Globis of its obligations thereunder thereby be ratified, approved, adopted and confirmed
in all respects.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval with Respect to the Business Combination Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Business Combination Proposal will require the affirmative vote of a majority of the votes cast by the stockholders present
in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. Accordingly, a Globis
stockholder&#8217;s failure to vote by proxy or to vote in person, as well as an abstention from voting and a broker non-vote with regard
to the Business Combination Proposal will have no effect on the Business Combination Proposal. Abstentions will be counted in connection
with the determination of whether a valid quorum is established but will have no effect on the Business Combination Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Business Combination Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT THE GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE BUSINESS COMBINATION PROPOSAL.
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="mani_002"></span><span style="font-size: 10pt"><b>PROPOSAL
4: THE EQUITY INCENTIVE PLAN PROPOSAL </b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is asking its shareholders to approve the Forafric 2022 Long Term Employee Share Incentive Plan, referred to herein as the &#8220;<b>Equity
Incentive Plan</b>.&#8221; The Globis Board intends to adopt the Equity Incentive Plan, subject to the approval from the holders of Globis
Shares. If approved, the Equity Incentive Plan will become effective upon the Closing and will be used by New Forafric following the
Closing. Where the interests of FAHL (before the Closing) and the interests of New Forafric (following the Closing) are the same with
respect to the Equity Incentive Plan, the term &#8220;New Forafric&#8221; will be used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board believes that New Forafric must offer a competitive equity incentive program if it is to successfully attract and retain
the best possible candidates for positions of substantial responsibility within New Forafric. The Globis Board expects that the Equity
Incentive Plan will be an important factor in attracting, retaining and rewarding high caliber employees who are essential to New Forafric&#8217;s
success and providing incentives to these individuals to promote the success of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary description of the Equity Incentive Plan, or the Equity Incentive Plan, as proposed to be adopted by Globis in
connection with the Business Combination. This summary is not a complete statement of the Equity Incentive Plan and is qualified in its
entirety by reference to the complete text of the Equity Incentive Plan, a copy of which is attached hereto as <i>Annex H </i>
to the proxy statement/prospectus. Globis stockholders should refer to the Equity Incentive Plan for more complete and detailed information
about the terms and conditions of the Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Equity Incentive Plan is to provide a means whereby New Forafric can align the long-term financial interests of its employees,
consultants, and directors with the financial interests of its stockholders. In addition, the Globis Board believes that the ability
to grant options and other equity-based awards will help New Forafric to attract, retain and motivate employees, consultants, and directors
and encourages them to devote their best efforts to New Forafric&#8217;s business and financial success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Equity Incentive Plan by Globis stockholders is required, among other things, in order to: (i) comply with Nasdaq rules requiring
stockholder approval of equity compensation plans and (ii) allow the grant of incentive stock options to participants in the Equity Incentive
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Equity Incentive Plan Proposal is approved by Globis stockholders, the Equity Incentive Plan will become effective as of the date
immediately preceding the date of the Closing. Approval of the Equity Incentive Plan by Globis stockholders will allow New Forafric to
grant nominal cost options or phantom options at levels determined appropriate by its board of directors or Compensation Committee of
New Forafric following the closing of the Business Combination. The Equity Incentive Plan will also allow New Forafric to utilize a broad
array of equity incentives and performance-based cash incentives in order to secure and retain the services of its employees, directors
and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests
of its stockholders following the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric&#8217;s employee equity compensation program, as implemented under the Equity Incentive Plan, will allow New Forafric to remain
competitive with comparable companies in its industry by giving it the resources to attract and retain talented individuals to achieve
its business objectives and build stockholder value. Approval of the Equity Incentive Plan will provide New Forafric with the flexibility
it needs to use equity compensation and other incentive awards to attract, retain and motivate talented employees, directors and consultants
who are important to New Forafric&#8217;s long-term growth and success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board has approved the award of restricted stock units and stock options to&#160;&#160;&#160;&#160;&#160;&#160;executive officers
and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;members of senior management under the Equity Incentive
Plan, subject to stockholder approval of the Equity Incentive Plan. These awards are shown in the table entitled &#8220;New Plan Benefits&#8221;
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Material Features of the Equity Incentive Plan </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Equity Incentive Plan allows for the grant of awards, consisting of nominal cost options or phantom options to employees, directors and
consultants of New Forafric or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Forafric Board is responsible for the administration of the Equity Incentive Plan and may, from time to time, make or amend regulations
for the administration of the Equity Incentive Plan. The decision of the New Forafric Board on all matters relating to the administration
of the Equity Incentive Plan, including the resolution of any ambiguity of the rules in the Equity Incentive Plan, is final and binding.
The New Forafric Board may also terminate or, from time to time, suspend the grant of awards. The New Forafric Board may also make, subject
to certain restrictions, amendments to the rules of the Equity Incentive Plan or any subplans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
an award is granted by the execution by New Forafric of an award certificate, which provides information regarding the award&#8217;s
date of grant, the number of Ordinary Shares in respect of which an option is granted pursuant to the award, vesting schedule, and exercisability.
The exercise price for nominal cost options is 50% of the nominal value of the shares, and in the case of phantom options is the market
value of the shares less 50% of their nominal value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the exception of an individual&#8217;s death or in the event of a corporate transaction, awards are not capable of being transferred,
charged or otherwise alienated. Any time an award holder purports to make one of these transfers, the award shall lapse immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of Shares which may be the subject of awards under the Equity Incentive Plan may not exceed 10% of the issued share capital
of New Forafric from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain provisions of the Equity Incentive Plan, no award can be exercised after the tenth anniversary of the date of grant. With
the exception of certain special circumstances, an award can only be exercised while the award holder is employed or engaged by New Forafric
or any of its subsidiaries. Subject to certain provisions, a vested award may be exercised in whole or in part at any time after its
date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
there are certain corporate transactions related to New Forafric, such as a compulsory acquisition, a general offer, a reconstruction,
a merger or division of New Forafric, the winding up of New Forafric, or the sale of New Forafric&#8217;s business or subsidiary, the
New Forafric Board has discretion (subject to certain requirements) to allow all awards (vested or unvested) to be exercised in whole
or in part. In certain circumstances, if the New Forafric Board exercises such discretion and the awards are not exercised, they will
instead lapse. If New Forafric is acquired, all award holders are required to release their awards in consideration of the grant of a
new award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
award can lapse when it has not been exercised after the tenth anniversary of the date of grant. It can also lapse when the award holder
ceases to be a director, an employee, or a consultant with New Forafric or any of its subsidiaries. An award will lapse when an order
is made by a court (or when a resolution is passed) for the compulsory winding up of New Forafric. Finally, an award lapses when the
award holder becomes bankrupt, enters into a compromise with their creditors generally except as permitted under certain circumstances.
Prior to the exercise of an award, an award holder has no rights in respect of any shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a reorganization, vesting conditions may be adjusted by the New Forafric Board, subject to an auditors&#8217; confirmation
that the adjustment is fair and reasonable and notice to the award holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
award may not vest or be exercised until the New Forafric Board is satisfied that the award holder will be able to pay for any tax or
social security liability that is owed by the holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination the FAHL 2021 Plan shall be replaced by the Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Plan Benefits </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
of awards under the Equity Incentive Plan are subject to the discretion of the plan administrator. Therefore, it is not possible to determine
the future benefits that will be received by participants under the Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
S-8 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, when permitted by SEC rules, we intend to file with the SEC a registration statement on
Form S-8 covering the Ordinary Shares issuable under the Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#8220;RESOLVED, that the Forafric
2022 Long Term Employee Share Incentive Plan in the form attached as <i>Annex H</i> to the proxy statement/prospectus in
respect of the Stockholders Meeting of New Forafric to be approved and adopted in all respects with effect from the closing of the Business
Combination and transactions contemplated by the Business Combination Agreement.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the Equity Incentive Plan Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Equity Incentive Plan Proposal will require the affirmative vote of a majority of the votes cast by the stockholders
present in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. Accordingly,
a Globis stockholder&#8217;s failure to vote by proxy or to vote in person, as well as an abstention from voting and a broker non-vote
with regard to the Equity Incentive Plan Proposal will have no effect on the Equity Incentive Plan Proposal. Abstentions will be counted
in connection with the determination of whether a valid quorum is established but will have no effect on the Equity Incentive Plan Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Equity Incentive Plan Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT THE GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE EQUITY INCENTIVE PLAN PROPOSAL. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="mani_003"></span><span style="font-size: 10pt"><b>PROPOSAL
5: DIRECTOR ELECTION PROPOSAL </b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
stockholders are also being asked to elect six directors to serve on the Board of Directors of New Forafric (the &#8220;Board&#8221;)
until the 2025  annual general meeting and, in each case until their respective successors are duly elected and qualified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 1.11 of the Business Combination Agreement, as a condition to the closing of the Business Combination, the board of directors
of New Forafric will consist of six directors, four of whom will be designated by Seller and two of whom will be designated by Global
SPAC LLC. Our Board has nominated Saad Bendidi, Julien Benitah, Franco Cassar, James Lasry, Paul Packer, and Ira Greenstein to
serve on New Forafric&#8217;s board of directors effective as of the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Stockholders Meeting, Globis&#8217; stockholders are being asked to appoint Saad Bendidi, Julien Benitah, Franco Cassar, James Lasry,
Paul Packer, and Ira Greenstein until the 2025 annual general meeting and, in each case until their respective successors are
duly elected and qualified, or until their earlier resignation, removal or death. See &#8220;Management of New Forafric Following the
Business Combination&#8221; of this proxy statement/prospectus for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that Saad Bendidi, Julien Benitah, Franco Cassar, James Lasry, Paul Packer and Ira Greenstein be appointed as directors serving until
New Forafric&#8217;s 2025 annual general meeting; and in each case, effective as of the closing of the Business Combination in accordance
with the Business Combination Agreement.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the Director Election Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected by a plurality of all of the votes cast by the stockholders present in person (which would include presence at a virtual
meeting) or represented by proxy at the Stockholder Meeting. This means that the six director nominees who receive the most affirmative
votes will be elected. With respect to the Director Election Proposal, abstentions and broker non-votes will not count as votes cast
at the Stockholders Meeting and, therefore, will have no effect on the outcome of this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Equity Incentive Plan Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT THE GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE DIRECTOR ELECTION PROPOSAL. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="mani_004"></span><span style="font-size: 10pt"><b>PROPOSAL
6: THE CHARTER PROPOSAL </b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
stockholders are also being asked to adopt the new Memorandum and Articles of Association in the form attached hereto as <i>Annex C</i>,
which, in the judgment of the Globis Board, is necessary to adequately address the needs of Globis following the Redomiciliation
and the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a summary of the key differences between the Amended and Restated Certificate of Incorporation of Globis under the DGCL and the new Memorandum
and Articles of Association of New Forafric under Gibraltar law, please see <i>&#8220;Proposal 7: The Organizational Documents Proposals.&#8221;
</i>The summary is qualified in its entirety by reference to the full text of the Memorandum and Articles of Association, a copy of which
is included as <i>Annex C </i> to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the Amended and Restated Certificate of Incorporation of Globis Acquisition Corp. currently in effect be amended and restated by
the deletion in their entirety and the substitution in their place of the proposed Memorandum and Articles of Association (copy of which
is attached to the proxy statement/prospectus in respect of the Stockholders Meeting as <i>Annex C</i>) including the authorization
of the change in authorized share capital as indicated therein and the change of name to &#8220;Forafric Global PLC&#8217;&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the Charter Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Charter Proposal will require the affirmative vote of the holders of a majority of the outstanding shares of Common Stock,
voting together as a single class. Thus, with respect to the Charter Proposal, abstentions and broker non-votes will count as a vote
&#8220;AGAINST&#8221; this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Charter Proposal </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT THE GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE CHARTER PROPOSAL. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="mani_005"></span>PROPOSAL
7: THE ORGANIZATIONAL DOCUMENTS PROPOSALS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
stockholders are asked to consider and vote upon, on a non-binding advisory basis, three separate proposals (collectively, the &#8220;<b>Organizational
Documents Proposals</b>&#8221;) in connection with the replacement of the Existing Organizational Documents with the Proposed Organizational
Documents. The Organizational Documents Proposals are not conditioned on the approval of any other proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the judgment of the Globis Board, these provisions are necessary to adequately address the needs of Globis and its stockholders following
the consummation of the Business Combination and the Redomiciliation. Accordingly, regardless of the outcome of the non-binding advisory
vote on these proposals, Globis intends that the Memorandum and Articles of Association in the form set forth on <i>Annex C will
take effect at consummation of the Business Combination and Redomiciliation, assuming adoption of the Charter Proposal.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Organizational Documents differ materially from the Existing Organizational Documents. The following table sets forth a summary
of the principal changes proposed to be made between our Amended and Restated Certificate of Incorporation and the proposed Memorandum
and Articles of Association for New Forafric. This summary is qualified by reference to the complete text of the Existing Organizational
Documents of Globis, attached to this proxy statement/prospectus as <i>Annex B</i>, the complete text of the proposed Memorandum
and Articles of Association, a copy of which is attached to this proxy statement/prospectus as <i>Annex C</i>. All shareholders
are encouraged to read each of the Proposed Organizational Documents in its entirety for a more complete description of its terms. Additionally,
as the Existing Organizational Documents are governed by the DGCL and the Proposed Organizational Documents will be governed by the laws
of Gibraltar , we encourage stockholders to carefully consult the information set out under the section entitled &#8220;<i>Proposal 2:
The Redomiciliation Proposal &#8212; Comparison of Shareholder Rights under the Applicable Organizational Documents Before and After
the Redomiciliation,</i>&#8221; &#8220;<i>Proposal 2: The Redomiciliation Proposal &#8212; Comparison of Shareholder Rights under Applicable
Corporate Law Before and After the Redomiciliation</i>&#8221; and &#8220;<i>Proposal 6: The Charter Proposal.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
    Organizational <br />
    Documents</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
    Organizational <br />
    Documents</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
                                            Shares</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7A)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents authorize 101,000,000 shares, consisting of 100,000,000 shares of Common Stock and 1,000,000 shares
    of Preferred Stock.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents authorize 101,000,000 shares, consisting of 100,000,000 Ordinary Shares and 1,000,000 Preferred
    Shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 5 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Memorandum of Association of </i>Forafric Global <i>PLC</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Require
    New Forafric to Seek Shareholder Consent Prior to Issuances of Preferred Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents authorize the issuance of 1,000,000 shares of Preferred Stock with such designations, rights and
    preferences as may be determined from time to time by our board of directors. Accordingly, Globis Board is empowered under the Existing
    Organizational Documents, without shareholder approval, to issue shares of preferred stock with dividend, liquidation, redemption,
    voting or other rights which could adversely affect the voting power or other rights of the holders of ordinary shares.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 29%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Proposed Organizational Documents provide that New Forafric may issue shares with such rights
                                            or restrictions as may be determined by ordinary resolution of the shareholders of New Forafric.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Forafric may issue shares which are to be redeemed, or are liable to be redeemed at the option of New Forafric or the holder, and
    the directors may determine the terms, conditions and manner of redemption of any such shares.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 5 of our Existing Organizational Documents</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    article 160 of the Articles of Association.</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusive
    Forum</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents do not contain a provision adopting an exclusive forum for certain shareholder litigation.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not contain a provision adopting an exclusive forum for shareholder litigation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
    Organizational <br />
    Documents</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
    Organizational <br />
    Documents</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
                                            Name</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents provide the name of New Forafric is &#8220;Globis Acquisition Corp.&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents will provide that the name of the company will be &#8220;Forafric Global PLC&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    paragraph 1 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Perpetual
                                            Existence</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents provide that if we do not consummate a business combination (as defined in the Existing Organizational
    Documents) by March 15, 2022 (or June 15, 2022 if such date is extended), Globis shall cease all operations except for the purposes
    of winding up and shall redeem the shares issued in our IPO and liquidate the Trust Account.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not contain a provision for the mandatory winding up of New Forafric in any circumstances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 6.F of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 37%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Takeovers
                                            by Interested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents do not provide restrictions on takeovers of Globis by a related shareholder following a business
    combination.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
    Proposed Organizational Documents do not provide restrictions on takeovers of New Forafric by a related shareholder following a business
    combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provisions
                                            Related to Status as</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Blank
    Check Company</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Organizational
    Documents</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proposal
    7B)</i></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Existing Organizational Documents set forth various provisions related to our status as a blank check company prior to the consummation
    of a business combination.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Proposed Organizational Documents do not include such provisions related to our status as a blank check company, which no longer
    will apply upon consummation of the Business Combination, as we will cease to be a blank check company at such time.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
    Article 6 of our Existing Organizational Documents.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed in connection with the replacement of the Existing Organizational Documents with the Proposed
Organizational Documents is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as a non-binding advisory resolution, that the proposed Memorandum and Articles of Association (a copy of which is attached to the proxy
statement/prospectus in respect of the Stockholders Meeting as <i>Annex C</i>), will be approved and adopted with such
principal changes as described in Organizational Documents Proposals 7C.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the Organizational Documents Proposals </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Organizational Documents proposals will require the affirmative vote of a majority of the votes cast by the stockholders
present in person (which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. Accordingly,
a Globis stockholder&#8217;s failure to vote by proxy or to vote in person, as well as an abstention from voting and a broker non-vote
with regard to the Organizational Documents Proposals will have no effect on the Organizational Documents Proposal. Abstentions will
be counted in connection with the determination of whether a valid quorum is established but will have no effect on the Organizational
Documents Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, a vote to approve the Organizational Documents Proposals is an advisory vote, and therefore, is not binding on Globis
or its Board. Accordingly, regardless of the outcome of the non-binding advisory vote, Globis intends that each of the proposed Memorandum
and Articles of Association of New Forafric, in the form set forth on <i>Annex C  </i>of the proxy statement
and prospectus, and containing the provisions noted above, will take effect at consummation of the Business Combination and Redomiciliation,
assuming adoption of the Charter Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board with Respect to the Organizational Documents Proposals </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT THE GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE ORGANIZATIONAL DOCUMENTS
PROPOSALS. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ORGANIZATIONAL
DOCUMENTS PROPOSAL 7A &#8212; APPROVAL OF AUTHORIZATION OF CHANGE TO AUTHORIZED CAPITAL STOCK, AS SET FORTH IN THE PROPOSED ORGANIZATIONAL
DOCUMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organizational
Documents Proposal 7A &#8212; </b>An amendment to change the authorized capital stock of Globis from (i) 100,000,000 shares of Common
Stock and 1,000,000 shares of preference stock of Globis to (ii) 100,000,000 ordinary shares and 1,000,000 preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there are 15,050,833 shares of Common Stock issued and outstanding, which includes
an aggregate of 3,148,333 shares of Common Stock held by the Sponsors and Globis&#8217; independent directors. In addition, as
of the date of this proxy statement/prospectus, there is outstanding an aggregate of 15,789,722 Warrants to acquire ordinary shares,
which comprise the 4,289,722 Private Placement Warrants held by Sponsor and the 11,500,000 Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, at the Closing, New Forafric will issue up to 17,004,762 Ordinary Shares to the Seller
for all FAHL Equity Securities held by the Seller. For further details, see &#8220;<i>Proposal 3: The Business Combination Proposal &#8212;
The Business Combination Agreement &#8212; Business Combination Consideration</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to ensure that New Forafric has sufficient authorized capital for future issuances our board of directors has approved, subject
to stockholder approval, that the Proposed Organizational Documents of New Forafric change the authorized capital stock of Globis from
(i) 100,000,000 shares of Common Stock and 1,000,000 shares of preferred stock of Globis to (ii) 100,000,000 Ordinary shares of New Forafric
and 1,000,000 preferred shares of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is qualified by reference to the complete text of the proposed Memorandum and Articles of Association of New Forafric, copies
of which is attached to this proxy statement/prospectus as <i>Annex C</i>. All stockholders are encouraged to read the
proposed Memorandum and Articles of Association in its entirety for a more complete description of their terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Amendments </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of this proposal is to provide for an authorized capital structure of New Forafric that will enable it to continue
as an operating company governed by the laws of Gibraltar. Our board of directors believes that it is important for us to have available
for issuance a number of authorized ordinary shares and preferred shares sufficient to support our growth and to provide flexibility
for future corporate needs (including, if needed, as part of financing for future growth acquisitions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT GLOBIS STOCKHOLDERS VOTE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;FOR&#8221;
THE APPROVAL OF ORGANIZATIONAL DOCUMENTS PROPOSAL 7A. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ORGANIZATIONAL
DOCUMENTS PROPOSAL 7B &#8212; APPROVAL OF OTHER CHANGES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IN
CONNECTION WITH ADOPTION OF THE PROPOSED ORGANIZATIONAL DOCUMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organizational
Documents Proposal 7B &#8212; </b>An amendment to authorize all other changes in connection with the replacement of the Existing Organizational
Documents with the Memorandum and Articles of Association as part of the Redomiciliation (a copy of which is attached to this proxy statement/prospectus
as <i>Annex C</i>), including (1) changing the corporate name from &#8220;Globis Acquisition Corp.&#8221; to &#8220;Forafric
Global PLC&#8221; (which will occur as part of the Redomiciliation in connection with the Business Combination), (2) making New Forafric&#8217;s
corporate existence perpetual, and (3) removing certain provisions related to our status as a blank check company that will no longer
be applicable upon consummation of the Business Combination, all of which the Globis Board believes are necessary to adequately address
the needs of New Forafric after the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders are also being asked to approve, on a non-binding advisory basis, Organizational Documents Proposal 7B which is, in the
judgment of the Globis Board, necessary to adequately address the needs of New Forafric after the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Organizational Documents will provide that the name of the corporation will be &#8220;Forafric Global PLC&#8221; However, this
name change will occur in connection with the Business Combination and as part of the Redomiciliation and associated adoption of the
Proposed Organizational Documents. In addition, the Proposed Organizational Documents will make New Forafric&#8217;s corporate existence
perpetual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Organizational Documents will not contain provisions related to a blank check company (including those related to operation
of the Trust Account, winding up of our operations should we not complete a business combination by a specified date, and other such
blank check-specific provisions as are present in the Existing Organizational Documents) because following the consummation of the Business
Combination, New Forafric will not be a blank check company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adoption
of each of the Organizational Documents Proposals, assuming approval of each of the Condition Precedent Proposals, will result, upon
the Redomiciliation, in the wholesale replacement of Globis&#8217; Existing Organizational Documents with New Forafric&#8217;s Proposed
Organizational Documents. While certain material changes between the Existing Organizational Documents and the Proposed Organizational
Documents have been unbundled into distinct Organizational Documents Proposals or otherwise identified in this Organizational Documents
Proposal 7B there are other differences between the Existing and Proposed Organizational Documents (arising from, among other things,
differences between the DGCL and the laws of Gibraltar and the typical form of organizational documents under each such body of law)
that will be approved (subject to the approval of the aforementioned related proposals and consummation of the Business Combination)
if we adopt this Organizational Documents Proposal 7B Accordingly, we encourage stockholders to carefully review the terms of the proposed
Memorandum and Articles of Association of New Forafric, attached hereto as <i>Annex C</i>, as well as the information set
under the section entitled &#8220;<i>Proposal 2: The Redomiciliation Proposal &#8212; Comparison of Shareholder Rights under the Applicable
Organizational Documents Before and After the Redomiciliation.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Amendments </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Name </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board believes that changing the post-business combination corporate name from &#8220;Globis Acquisition Corp.&#8221; to &#8220;Forafric
Global PLC&#8221; is desirable to reflect the Business Combination with FAHL and to clearly identify Forafric Global PLC as the publicly
traded entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Perpetual
Existence </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board believes that making New Forafric&#8217;s corporate existence perpetual is desirable to reflect the Business Combination.
Additionally, perpetual existence is the usual period of existence for public corporations, and the Globis Board believes that it is
the most appropriate period for New Forafric following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Provisions
Related to Status as Blank Check Company </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
elimination of certain provisions related to our status as a blank check company is desirable because these provisions will serve no
purpose following the Business Combination. For example, the Proposed Organizational Documents do not include the requirement to dissolve
New Forafric and allow it to continue as a corporate entity with perpetual existence following consummation of the Business Combination.
Perpetual existence is the usual period of existence for public corporations, and the Globis Board believes it is the most appropriate
period for New Forafric following the Business Combination. In addition, certain other provisions in our current certificate require
that proceeds from the Globis&#8217; initial public offering be held in the Trust Account until a business combination or liquidation
of Globis has occurred. These provisions cease to apply once the Business Combination is consummated and are therefore not included in
the Proposed Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF ORGANIZATIONAL DOCUMENTS PROPOSAL
7B</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ma_001"></span><b>PROPOSAL
8: THE NASDAQ PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq Proposal &#8212; to consider and vote upon a proposal to approve, for the purposes of complying with the applicable provisions
of the Nasdaq Listing Rule 5635(a), the issuance of Ordinary Shares and securities convertible into or exchangeable for Ordinary Shares
in connection with the Business Combination, and the Ordinary Shares issued in connection with the PIPE Investment, the conversion of
the FAHL Bonds and the conversion of the FAHL Related Party Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Approval for Purposes of NASDAQ Listing Rule 5635(a)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5635(a), a company is required to obtain stockholder approval prior to the issuance of common stock, or of securities
convertible into or exercisable for common stock, if the number of shares of common stock to be issued is, or will be upon issuance,
equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or of securities
convertible into or exercisable for common stock. In the Business Combination, the PIPE Investment, the conversion of the FAHL Bonds
and the conversion of the FAHL Related Party Loans, Globis currently expects to issue an estimated 1,445,164 Ordinary Shares (including
Ordinary Shares to be issued upon the exchange or conversion of securities to be outstanding upon consummation of the Business Combination).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
pursuant to Nasdaq Listing Rule 5635(a), when a Nasdaq-listed company proposes to issue securities in connection with the Business Combination
of the stock or assets of another company, stockholder approval is required if a substantial stockholder of such company has a 5% or
greater interest, directly or indirectly, in such company or the assets to be acquired or in the consideration to be paid in the transaction
or series of related transactions and the present or potential issuance of common stock could result in an increase in outstanding shares
of common stock or voting power of 5% or more. Nasdaq Listing Rule 5635(e)(3) defines a substantial stockholder as the holder of an interest
of 5% or more of either the number of shares of common stock or the voting power outstanding of a Nasdaq -listed company. Because the
Sponsors currently own greater than 5% of Globis&#8217; Common Stock, the Sponsor is considered a substantial shareholder of Globis under
Nasdaq Listing Rule 5635(a)(2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that this proposal is not approved by Globis stockholders, the Business Combination cannot be consummated. In the event that
this proposal is approved by Globis stockholders, but the Business Combination Agreement is not consummated, New Forafric will not issue
such Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval With Respect to the NASDAQ Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;The
approval of the NASDAQ Proposal will require the affirmative vote of a majority of the votes cast by the stockholders present in person
(which would include presence at a virtual meeting) or represented by proxy at the Stockholders Meeting. Accordingly, a Globis stockholder&#8217;s
failure to vote by proxy or to vote in person, as well as an abstention from voting and a broker non-vote with regard to the NASDAQ Proposal
will have no effect on the NASDAQ Proposal. Abstentions will be counted in connection with the determination of whether a valid quorum
is established but will have no effect on the NASDAQ Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Merger Proposal, the Redomiciliation Proposal, the Business Combination Proposal, the Equity Incentive Plan Proposal, the
Director Election Proposal, the Charter Proposal or the Nasdaq Proposal fail to receive the required approval by the stockholders of
Globis at the Stockholders Meeting, the Business Combination will not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>RESOLVED</b>,
that for the purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635(a), the issuance of Ordinary Shares and
securities convertible into or exchangeable for Ordinary Shares in connection with the Business Combination, and the Ordinary Shares
issued with the PIPE Investment be approved.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE NASDAQ PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_002"></span><span style="font-size: 10pt"><b>PROPOSAL
9: THE ADJOURNMENT PROPOSAL</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adjournment Proposal allows the Globis Board to submit a proposal to approve the adjournment of the Stockholders Meeting to a later date
or dates, if necessary, to permit further solicitation and vote of proxies in the event, based on the tabulated votes, there are not
sufficient votes at the time of the Stockholders Meeting to approve the Condition Precedent Proposals. The purpose of the Adjournment
Proposal is to permit further solicitation of proxies and votes and to provide additional time for Sponsor and Globis and the Globis
stockholders to make purchases of ordinary shares or other arrangements that would increase the likelihood of obtaining a favorable vote
on the proposals to be submitted at the Stockholders Meeting. See &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Interests
of Globis&#8217; Directors and Officers and Others in the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consequences
if the Adjournment Proposal is Not Approved</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Adjournment Proposal is presented to the Stockholders Meeting and is not approved by the shareholders, the Globis Board may not be
able to adjourn the Stockholders Meeting to a later date in the event that, based on the tabulated votes, there are not sufficient votes
at the time of the Stockholders Meeting to approve the Condition Precedent Proposals. In such event, the Business Combination would not
be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED<b>,
</b>that the adjournment of the Stockholders Meeting to a later date or dates, if necessary, to permit further solicitation and vote
of proxies in the event that there are insufficient votes for the approval of one or more proposals at the Stockholders Meeting be approved.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Globis Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
GLOBIS BOARD UNANIMOUSLY RECOMMENDS THAT GLOBIS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE ADJOURNMENT PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Globis&#8217; directors may result in a conflict of interest on the part
of such director(s) between what he or they may believe is in the best interests of Globis and its stockholders and what he or they may
believe is best for himself or themselves in determining to recommend that stockholders vote for the proposals. In addition, Globis&#8217;
officers have interests in the Business Combination that may conflict with your interests as a shareholder. See the section entitled
See &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Interests of Globis&#8217; Directors and Officers and Others in the
Business Combination&#8221; </i>for a further discussion of these considerations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ma_003"></span>UNAUDITED
PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
December 19, 2021, Globis entered into the Business Combination Agreement, which provides for a business combination between Globis and
FAHL (the &#8220;Business Combination&#8221;). The Business Combination Agreement provides for the consummation of the following transactions:
(a) Globis will form under the laws of the State of Nevada a wholly-owned subsidiary of Globis, or Globis Nevada, change its jurisdiction
of incorporation to Nevada by merging with and into Globis Nevada such that Globis Nevada will survive the merger, and Globis Nevada
will change its jurisdiction of incorporation by transferring by way of a redomiciliation and domesticating as a Gibraltar public company
limited by shares, referred to herein as the &#8220;Redomiciliation&#8221; and change its name to &#8220;Forafric Global PLC,&#8221;
referred to herein as &#8220;New Forafric&#8221;; and (b) immediately following the effectiveness of the Redomiciliation, New Forafric
will acquire 100% of the equity interests in FAHL from the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation
S-X, as amended by the final rule, Release No. 33-10786, &#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses,&#8221;
and presents the combination of the historical financial information of Globis and FAHL adjusted to give effect to the Business Combination,
the PIPE Investment and the purchase of the Convertible Bonds. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined balance sheet as of September 30, 2021 combines the unaudited historical balance sheet of Globis
as of September 30, 2021 with the unaudited historical condensed balance sheet of FAHL as of September 30, 2021, giving effect to the
Business Combination, the PIPE Investment and the purchase of the Convertible Bonds, as if each had been consummated as of that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2021 and for the year ended December
31, 2020 combines the unaudited historical condensed statement of operations of Globis for the nine months ended September 30, 2021 and
the audited historical statement of operations of Globis for the period from August 21, 2020 (inception) through December 31, 2020 with
the unaudited historical condensed consolidated statement of operations of FAHL for the nine months ended September 30, 2021 and the
audited historical consolidated statement of operations of FAHL for the year ended December 31, 2020, respectively, giving effect
to the Business Combination, the PIPE Investment and the purchase of the Convertible Bonds, as if each had been consummated as of January
1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
historical financial information has been adjusted to give pro forma effect to events that relate to material financing transactions
consummated after September 30, 2021 and pro forma adjustments that are directly attributable to the Business Combination, the PIPE Investment
and the purchase of the Convertible Bonds, are factually supportable and, with respect to the unaudited pro forma condensed combined
statements of operations, are expected to have a continuing impact on the results of the combined company. The adjustments presented
on the unaudited pro forma condensed combined financial statements have been identified and presented to provide relevant information
necessary for an accurate understanding of the combined company upon consummation of the Business Combination, the PIPE Investment and
the purchase of the Convertible Bonds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined financial information is for illustrative purposes only. The financial results may have been different
had the companies always been combined. You should not rely on the unaudited pro forma condensed combined financial information as being
indicative of the historical results that would have been achieved had the companies always been combined or the future results that
the combined company will experience. Globis and FAHL have not had any historical relationship prior to the Business Combination. Accordingly,
no pro forma adjustments were required to eliminate activities between the companies. This information should be read together with the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    (a) historical audited financial statements of Globis as of December 31, 2020 and for the period August 21, 2020 (inception) through
    December 31, 2020 and (b) historical unaudited condensed financial statements of Globis as of and for the nine months ended September
    30, 2021;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    (a) historical audited consolidated financial statements of FAHL as of and for the years ended December 31, 2020 and December 31,
    2019 and (b) historical unaudited condensed consolidated financial statements of FAHL as of and for the nine months ended September
    30, 2021; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    sections titled &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Globis</i>,&#8221;
    and &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of FAHL</i>&#8221; and
    other financial information included elsewhere in this proxy statement/prospectus; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">other
    information relating to Globis and FAHL included in this proxy statement/prospectus, including the Business Combination Agreement
    and the description of certain terms thereof set forth under the section entitled &#8220;The Business Combination.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description
of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total consideration to be paid to the Seller in the Business Combination will be (i) 15,100,000 Ordinary Shares, subject to reduction
to the extent that the Closing Payment (as defined below) is less than $0, provided that the Seller may be issued up to 1,904,762
additional Ordinary Shares determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the
Closing; plus (ii) an amount (the &#8220;Closing Payment&#8221;) equal to $20,000,000 minus the outstanding amount of all Funded Debt
(as defined in the Business Combination Agreement) as of the Closing (other than Permitted Debt); provided that Seller may receive up
to an additional $20,000,000 determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the
Closing. The Closing Payment shall be funded by remaining funds in the Trust Account after giving effect to any Buyer Share Redemptions
(as defined in the Business Combination Agreement) and the proceeds of any potential private placement financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify">In addition to the foregoing consideration, the Seller
shall be entitled to receive, as additional consideration, and without any action on behalf of the Company or the Company&#8217;s stockholders,
additional Ordinary Shares (the &#8220;Earnout Shares&#8221;), to be issued as follows during the period from and after the Closing until
the end of calendar year 2024 (A) 500,000 Earnout Shares, if, during calendar year 2022, Adjusted EBITDA (as defined in the Business
Combination Agreement) of the Company is equal to or greater than $27 million, (B) 500,000 Earnout Shares, if, during calendar
year 2023, Adjusted EBITDA of New Forafric is equal to or greater than $33 million, and (C) 1,000,000 Earnout Shares, if, during
calendar year 2024, the Buyer Trading Price (as defined in the Business Combination Agreement) during the standard market trading hours
of a trading day is greater than or equal to $16.50 for any 20 trading days within any period of 30 consecutive trading days.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
also entered into a subscription agreement (the &#8220;PIPE Subscription Agreement&#8221;) with an accredited investor (the &#8220;PIPE
Investor&#8221;), pursuant to which the PIPE Investor will purchase Ordinary Shares of New Forafric in a private placement following
the Redomiciliation and prior to the closing of the Business Combination. Pursuant to the PIPE Subscription Agreement, the PIPE Investor
will purchase, at a purchase price of $10.50 per share, a number of ordinary shares of New Forafric (the &#8220;PIPE Shares&#8221;) that
will be equal to the lesser of (i) 4.99% of all issued and outstanding ordinary shares, after taking into account the completion of the
Business Combination and all ordinary shares issued pursuant to the FAHL Bonds (defined below) and other related subscription agreements,
if any, and (ii) 1,904,761 ordinary shares (the &#8220;PIPE Investment&#8221;); accordingly, the maximum aggregate amount to be paid
by the PIPE Investor for the PIPE Shares is approximately $20 million. The closing of the PIPE Investment is contingent upon, among other
things, the substantially concurrent consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the proposed Business Combination, between December 31, 2021 and January 3, 2022, affiliates (each a &#8220;Bond Investor&#8221;)
of Up and Up Capital, LLC and Globis SPAC LLC, the sponsors of Globis, subscribed for convertible bonds of FAHL, as issuer, in an aggregate
principal amount of $9.5 million (the &#8220;FAHL Bonds&#8221;) in a private placement, issued pursuant to a Bond Subscription Deed (the
&#8220;Bond Subscription Deed&#8221;), among FAHL, the Seller and the Bond Investors. Unless earlier converted or redeemed in accordance
with the terms of the FAHL Bonds, the FAHL Bonds will mature and be redeemed on June 15, 2026. Interest shall accrue on the FAHL Bonds
at a rate of 6% per annum and the Bond Investors are entitled to certain customary information rights. Pursuant to the current terms
of the FAHL Bonds, upon consummation of the Business Combination, the FAHL Bonds will automatically convert into ordinary shares of New
Forafric at a price per share that is a 10% discount to the PIPE Investment, subject to certain adjustments. The number of ordinary shares
will be equal to the quotient that results from dividing the aggregate principal amount of the respective FAHL Bond by $9.45, subject
to certain adjustments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Anticipated
Accounting Treatment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify">The Business Combination
will be accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Globis, who is
the legal acquirer, will be treated as the &#8220;acquired&#8221; company for accounting purposes and FAHL will be treated as the accounting
acquirer. Accordingly, the Business Combination will be treated as the equivalent of FAHL issuing shares at the closing of the Business
Combination for the net assets of Globis as of the closing date, accompanied by a recapitalization. The net assets of Globis will be
stated at historical cost, with no goodwill or other intangible assets recorded.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL
has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL&#8217;s
    stockholders will have the largest voting interest in New Forafric under both the no redemption and maximum redemption scenarios;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
    board of directors of the post-combination company has six members, and FAHL stockholders have the ability to nominate at least the
    majority of the members of the board of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL&#8217;s
    senior management is the senior management of the post-combination company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
    business of FAHL will comprise the ongoing operations of New Forafric; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL
    is the larger entity, in terms of substantive operations and employee base.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Basis
of Pro Forma Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined financial information has been prepared assuming two redemption scenarios as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Assuming
    No Redemptions</i>: This scenario assumes that no shares of Globis Common Stock are redeemed; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Assuming
    Maximum Redemptions</i>: This scenario assumes that 11,500,000 shares of Globis Common Stock, the maximum redemption of the outstanding
    Globis Common Stock, are redeemed for their pro rata share of the cash in the Trust Account. This presentation assumes that Globis
    stockholders exercise their redemption rights with respect to a maximum of 11,500,000 shares of common stock upon consummation of
    the Business Combination at a redemption price of approximately $10.20 per share. The maximum redemption amount reflects the maximum
    number of Globis public shares that can be redeemed without violating the conditions of the Business Combination Agreement or the
    requirement of Globis&#8217; current Amended and Restated Certificate of Incorporation that Globis cannot redeem public shares if
    it would result in Globis having a minimum net tangible asset value of less than $5,000,001, after giving effect to the payments
    to redeeming stockholders. Scenario 2 includes all adjustments contained in Scenario 1 and presents additional adjustments to reflect
    the effect of the maximum redemptions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the shares outstanding and weighted average shares outstanding as presented in the pro forma combined financial statements are the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assuming
    No Redemptions:</i> an aggregate of 15,100,000 combined company shares to be issued to the Seller; the PIPE Investment of
    $18.0 million in proceeds for the sale of 1,712,245 PIPE Shares to PIPE Investor and 1,005,291 shares issued upon the conversion
    of the FAHL Bonds upon the consummation of the Business Combination. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Assuming
    Maximum Redemptions: </i>an aggregate of 16,248,307 combined company shares to be issued to FAHL stockholders; the PIPE Investment
    of $12.3 million in proceeds for the sale of 1,168,566 PIPE Shares to PIPE Investor and 1,005,291 shares issued upon the conversion
    of the FAHL Bonds upon the consummation of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
    Earnout Shares have not been included, as these have been deemed financial instruments to be issued upon the occurrence of contingent
    earn out provisions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Business Combination, assuming no redemptions of Globis shares for cash, Globis current stockholders will own approximately 42.7%
of the outstanding combined company shares, the former stockholders of FAHL will own approximately 44.0% of the outstanding combined
company shares, the underwriters will own approximately 1.2% of the outstanding combined company shares, the PIPE Investor will own approximately
5.0% of the outstanding combined company shares, certain related parties of FAHL will own approximately 4.2% of the outstanding company
shares&#8221; and the Bond Investors will own approximately 2.9% of the outstanding combined company shares. Assuming redemption by holders
of 11,500,000 Globis shares, Globis stockholders will own approximately 13.4% of the outstanding combined company shares, the former
stockholders of FAHL will own approximately 69.4% of the outstanding combined company shares, the underwriters will approximately
1.7% of the outstanding combined company shares, the PIPE investors will own approximately 5.0% of the outstanding combined company shares,
certain related parties of FAHL will own approximately 6.2% of the outstanding company shares and the Bond Investors will
own approximately 4.3% of the outstanding combined company shares (in each case, not giving effect to any shares issuable upon the exercise
or conversion of warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
foregoing scenarios are for illustrative purposes only as the actual number of redemptions by Globis&#8217; public stockholders is unknowable
prior to the Globis shareholder vote with respect to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following presents the calculation of basic and diluted weighted average shares outstanding. The computation of diluted loss per share
excludes the effect of warrants to purchase 15,789,722 shares to be issued because the inclusion of any of these securities would be
anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 1<br /> Combined<br /> (Assuming No<br /> Redemptions<br /> Into Cash)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 2<br /> Combined<br /> (Assuming<br /> Maximum<br /> Redemptions<br /> Into Cash)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average shares calculation, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%">Globis public shares</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">11,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Globis Sponsor and director shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Globis underwriter shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">PIPE Investor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168,566</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bond Investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Related Party Loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Combined company shares issued in Business Combination</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,100,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,248,307</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,313,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,418,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Percent of shares owned by FAHL holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Percent of shares owned by Globis public holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Percent of shares owned by Globis Sponsor and directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Percent of shares owned by underwriters</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Percent of shares owned by PIPE Investor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Percent of shares owned by Bond Investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Percent of shares issued for Related Party Loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.2</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED BALANCE SHEET </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
of September 30, 2021 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in
thousands) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(A)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">FAHL (Historical)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(B)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Globis (Historical)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Transaction Accounting Adjustments (Assuming No Redemptions)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming No Redemptions)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Additional Transaction Accounting Adjustments (Assuming Maximum Redemptions)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming Maximum Redemptions)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 28%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">20,040</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">117,306</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">(2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">117,640</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(117,306</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">(3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">6,682</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,979</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,709</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,500</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,057</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,800</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,543</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,850</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,030</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amounts due from related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,565</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,603</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,298</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">151</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-align: left">Total Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,702</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,592</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(110,958</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,495</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,885</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,190</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,946</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other assets, noncurrent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,691</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,156</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,150</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(117,306</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(2)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">300,763</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116,315</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(18,564</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">398,514</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(110,958</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">287,556</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities and Stockholders&#8217; Equity</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,591</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(647</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(6)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,591</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,591</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lines of credit - working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lines of credit - wheat inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,497</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,658</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Promissory note - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,150</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,850</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,005</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185,761</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,603</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholder loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(225</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,174</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,500</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,500</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">247,769</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(44,007</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,109</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,109</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(116,150</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120,000</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116,149</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(117,305</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,604</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,979</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,709</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,250</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,057</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,500</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,174</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,039</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(77,933</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,691</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,153</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(83,086</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(83,086</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,691</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,888</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,888</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,888</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Stockholders&#8217; Equity (Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">52,994</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,182</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">141,593</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">193,405</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(110,958</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">82,447</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Liabilities and Stockholders&#8217;
    Equity (Deficit)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">300,763</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116,315</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(18,564</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">398,514</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(110,958</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">287,556</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nine
Months Ended September 30, 2021 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in
thousands, except share and per share data) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(A)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">FAHL (Historical)</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(B)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Globis (Historical)</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Transaction Accounting Adjustments (Assuming No Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming No Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Additional Transaction Accounting Adjustments (Assuming Maximum Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming Maximum Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold">Revenue</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">185,517</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">185,517</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">185,517</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Gross profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">28,315</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">28,315</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">28,315</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,415</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,607</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(1)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,022</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,022</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,415</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,607</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,022</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,022</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Operating income (loss)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,900</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,607</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,293</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,293</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,387</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,387</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,387</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,004</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,004</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,004</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest earned on marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(2)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,209</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(1,602</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,816</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,816</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">831</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(3)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">831</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">831</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(3,378</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,602</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(4,985</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(4,985</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Weighted average shares outstanding, basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,050,833</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,262,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">(4)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,313,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,895,372</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">(4)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,418,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.11</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.15</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.21</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Year
Ended December 31, 2020 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in
thousands, except share and per share data) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(C)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">FAHL (Historical)</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(D)</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Globis (Historical)</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Transaction Accounting Adjustments (Assuming No Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming No Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Additional Transaction Accounting Adjustments (Assuming Maximum Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined (Assuming Maximum Redemptions)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold">Revenue</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">196,596</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">196,596</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">196,596</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">156,188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">156,188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">156,188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Gross profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">40,408</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">40,408</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">40,408</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">90</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,153</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(1)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,760</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,760</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">90</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,153</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,760</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,760</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Operating income (loss)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">9,891</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(90</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(5,153</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,648</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,648</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,847</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,847</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,847</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Foreign exchange loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,043</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,043</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,043</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Income (loss) before taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(90</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,153</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,239</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,239</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">(3)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(139</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(90</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5,153</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5,382</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5,382</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Weighted average shares outstanding, basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,179,573</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,133,960</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">(4)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,313,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,895,372</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">(4)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,418,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.16</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.23</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Basis
    of Presentation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined financial information has been adjusted to give effect to transaction accounting adjustments related
to the Business Combination linking the effects of the Business Combination to the historical financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Business Combination will be accounted for as a reverse recapitalization in accordance with the Financial Accounting Standards Board&#8217;s
Accounting Standards Codification Topic 805, Business Combinations. Globis has been determined to be the accounting acquirer under both
the no redemption and the maximum redemption scenarios. Under the reverse recapitalization model, the Business Combination will be treated
as FAHL issuing equity for the net assets of Globis, with no goodwill or intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
pro forma adjustments have been prepared as if the Business Combination had been consummated on September 30, 2021, in the case of the
unaudited pro forma condensed combined balance sheet, and on January 1, 2020, the beginning of the earliest period presented, in the
case of the unaudited pro forma condensed combined statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
pro forma combined balance sheet as of September 30, 2021 has been prepared using the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL&#8217;s
    historical condensed consolidated balance sheet as of September 30, 2021, as included elsewhere in this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Globis&#8217;
    historical condensed balance sheet as of September 30, 2021, as included elsewhere in this prospectus.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 49.5pt; text-align: justify; text-indent: -23.4pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma combined statement of operations for the nine months ended September 30, 2021 has been prepared using the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL&#8217;s
    historical condensed consolidated statement of operations for the nine months ended September 30, 2021, as included elsewhere in
    this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Globis&#8217;
    condensed statement of operations for the nine months ended September 30, 2021, as included elsewhere in this prospectus.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 49.5pt; text-align: justify; text-indent: -23.4pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
pro forma combined statement of operations for the year ended December 31, 2020 has been prepared using the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">FAHL&#8217;s
    historical consolidated statement of operations for the year ended December 31, 2020, as included elsewhere in this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Globis&#8217;
    condensed statements of operations for the period from August 21, 2020 (inception) through December 31, 2020.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
adjustments presented in the unaudited pro forma condensed combined financial information have been identified and presented to provide
relevant information necessary for an accurate understanding of New Forafric after giving effect to the Business Combination. Management
has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed
combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially
from the information presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
pro forma adjustments reflecting the consummation of the Business Combination are based on certain currently available information and
certain assumptions and methodologies that management believes are reasonable under the circumstances. The unaudited condensed pro forma
adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated.
Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may
be material. Management believes that its assumptions and methodologies provide a reasonable basis for presenting all of the significant
effects of the Business Combination based on information available to management at this time and that the pro forma adjustments give
appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and
financial position would have been had the Business Combination taken place on the dates indicated, nor are they indicative of the future
consolidated results of operations or financial position of the post-combination company. They should be read in conjunction with the
historical financial statements and notes thereto of FAHL and Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Adjustments
    to Unaudited Pro Forma Condensed Combined Balance Sheet as of September 30, 2021</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation
S-X.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Transaction Accounting Adjustments included in the unaudited pro forma condensed combined balance sheet as of September 30, 2021 are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(A)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the unaudited condensed consolidated balance sheet of FAHL as of September 30, 2021.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(B)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the unaudited condensed balance sheet of Globis as of September 30, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            reflect the additional contribution of $1.15 million to the Trust Account by related
                                            parties to extend the date by which Globis has to consummate a Business Combination
                                            to March 15, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            reflect the release of cash from marketable securities held in the Trust Account.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
                                            Scenario 1, which assumes no Globis shareholders exercise their redemption rights, the common
                                            stock subject to redemption for cash amounting to $116.1 million would be transferred to
                                            permanent equity. In Scenario 2, which assumes the same facts as described in Item 1 and
                                            2 above, but also assumes the maximum number of shares are redeemed for cash by the Globis
                                            shareholders, $117.3 million would be paid out in cash. The $117.3 million, or 11,500,000
                                            shares, represents the maximum redemption amount, after giving effect to payments to redeeming
                                            stockholders based on a consummation of the Business Combination on September 30, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            Scenario 1, reflects proceeds received of $18.0 million from the PIPE Investor in exchange
                                            for the issuance of 1,712,245 PIPE Shares at a price of $10.50 per share. In Scenario
                                            2, reflects proceeds received of $12.3 million from the PIPE Investor in exchange for the
                                            issuance of 1,168,566 PIPE Shares at a price of $10.50 per share. Under both scenarios, the
                                            PIPE Shares represent 5% of all issued and outstanding ordinary shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            proceeds received of $9.5 million from the Bond Investors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            reflect the payment of an aggregate of $5.8 million of estimated legal, financial
                                            advisory and other professional fees related to the Business Combination and the payment
                                            of $0.6 million of accounts payable and accrued expenses. The direct, incremental
                                            costs of the Business Combination related to the legal, financial advisory, accounting and
                                            other professional fees of approximately $5.2 million is reflected as an adjustment to accumulated
                                            deficit.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            reflect the recapitalization of FAHL through (a) the contribution of all the share capital
                                            in FAHL to New Forafric ordinary shares (b) the issuance of 15,100,000 New Forafric shares
                                            in Scenario 1 and 16,248,307 New Forafric shares in Scenario 2, (c) the elimination
                                            of the historical accumulated deficit of Globis of $1.7 million, the legal acquiree, (d)
                                            the repayment of FAHL&#8217;s debt and stockholder loan in the aggregate amount of $27.5
                                            million, and (e) in Scenario 1, the cash payment of $12.1 million to the Seller, at the consummation
                                            of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reflects
                                            the conversion of the $9.5 million in FAHL Bonds into 1,005,291 ordinary shares of New Forafric
                                            at $9.45 per share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(9)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reflects
                                            the conversion of the $15.2 million in FAHL stockholder loans into 1,445,164 ordinary shares
                                            of New Forafric at $10.50 per share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(10)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reflects
                                            the repayment of the promissory note due to related parties.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unaudited
Condensed Combined Pro Forma Adjustments to the Statements of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments
    to Unaudited Pro Forma Condensed Combined Statements of Operations for the Nine Months Ended September 30, 2021 and the Year
    Ended December 31, 2020</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
transaction accounting adjustments included in the unaudited pro forma condensed combined statements of operations for the nine and twelve
months ended September 30, 2021 and December 30, 2020 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(A)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the unaudited condensed consolidated statement of operations of FAHL for the nine months
                                            ended September 30, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(B)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the unaudited condensed statement of operations of Globis for the nine months ended
                                            September 30, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(C)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the consolidated statement of operations of FAHL for the year ended December 31, 2020.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(D)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derived
                                            from the statement of operations of Globis for the period from August 21, 2020 (inception)
                                            through December 31, 2020.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            an adjustment to eliminate the effect of the pro forma balance sheet adjustment presented
                                            in Entry #2(6) above in the aggregate amount of $5.2 million for the direct, incremental
                                            costs of the Business Combination, assuming those adjustments were made as of the beginning
                                            of the fiscal year presented.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Represents
                                            an adjustment to eliminate interest income on marketable securities held in the trust account
                                            as of the beginning of the period.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            the blended statutory rate for the redomesticated entity post business combination would
                                            be 21%, the consolidated combined pro forma information under both scenarios results
                                            in a net loss for tax purposes. As such, a full valuation allowance has been applied resulting
                                            in no adjustment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify; text-indent: -19.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
                                            calculation of weighted average shares outstanding for basic and diluted net loss per share
                                            assumes that Globis&#8217; initial public offering occurred as of the beginning of the earliest
                                            period presented. In addition, as the Business Combination is being reflected as if it had
                                            occurred at the beginning of the periods presented, the calculation of weighted average shares
                                            outstanding for basic and diluted net loss per share assumes that the shares have been outstanding
                                            for the entire periods presented. This calculation is retroactively adjusted to eliminate
                                            the number of shares redeemed for the entire period.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 125.8pt 0pt 24pt; text-indent: -24pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b>4.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Net
    Loss per Share</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Represents
the net loss per share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in
connection with the Business Combination and related transactions, assuming the shares were outstanding since January 1, 2020. As the
Business Combination and related transactions are being reflected as if they had occurred at the beginning of the period presented, the
calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issued in connection
with the Business Combination have been outstanding for the entire period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed combined financial information has been prepared assuming two alternative levels of redemption of Globis&#8217;
public shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 125.8pt 0pt 24pt; text-indent: -24pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming No Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming Maximum Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Nine Months Ended September 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares calculations,
    basic and diluted</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Pro
    Forma Combined Assuming No Redemptions into Cash</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Pro
    Forma Combined Assuming Maximum Redemptions into Cash</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Globis public shares</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Globis initial stockholders&#8217;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,148,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,148,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Globis underwriters</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">402,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">402,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">PIPE Investor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,712,245</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,168,566</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Bond Investors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,005,291</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,005,291</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion of Related Party Loans</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,445,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,445,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">FAHL stockholders</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,100,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,248,307</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding &#8211;
    basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,313,533</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,418,161</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 125.8pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming No Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming Maximum Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Year Ended December 31, 2020 (FAHL) and for the period from August 21, 2020 (inception) through December 31,2020 (Globis)</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(5,382</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(5,382</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Weighted average shares calculations, basic and diluted</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming No Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined Assuming Maximum Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Globis public shares</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">11,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Globis initial stockholders&#8217;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Globis underwriters</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PIPE Investor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168,566</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Bond Investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,005,291</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of Related Party Loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,445,164</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">FAHL stockholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,100,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,248,307</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Weighted average shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,313,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,418,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ma_004"></span>COMPARATIVE
PER SHARE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the historical comparative per share information of Globis, on a stand-alone basis and the unaudited pro forma
combined per share information after giving effect to the Business Combination, assuming no redemptions and maximum redemptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average shares outstanding and net earnings per share information reflect the Business Combination as if it had occurred on
January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in the following table should be read in conjunction with the selected historical financial information summary included
elsewhere in this proxy statement/prospectus, and the historical financial statements of Globis and FAHL and related notes that are included
elsewhere in this proxy statement/prospectus. The unaudited pro forma combined per share information is derived from, and should be read
in conjunction with, the unaudited pro forma combined financial statements and related notes included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma combined earnings per share information below does not purport to represent the earnings per share which would have
occurred had the companies been combined during the period presented, nor earnings per share for any future date or period. The unaudited
pro forma combined book value per share information below does not purport to represent what the value of Globis and FAHL would have
been had the companies been combined during the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.1pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited
    pro forma per share information of the combined company assuming two redemption scenarios as follows: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    No Redemptions scenario assumes that no Globis stockholders elect to redeem their shares of common stock for a pro rata portion of
    cash in the Trust Account in connection with the Business Combination, and thus the full amount held in the Trust Account as of the
    Closing is available for the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Maximum Redemptions scenario assumes that Globis&#8217; stockholders redeem 11.5 million shares at $10.20 per share, for an aggregate
    payment of approximately $117.3 million of their shares of common stock for a pro rata portion of cash in the Trust Account in connection
    with the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Combined</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Globis</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">FAHL</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Redemptions</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maximum<br /> Redemptions</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Nine Months Ended September 30, 2021</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(1,602</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(3,378</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(4,985</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; (deficit) equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,182</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,994</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,050,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss per share &#8211; Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book value per share <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash dividends per share &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">For the Period from August 21, 2020 Inception) Through December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(90</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(139</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,382</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,382</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,179,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,313,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,418,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss per share &#8211; Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash dividends per share &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book
    value per share = (Total shareholders&#8217; equity / shares outstanding)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_005"></span><span style="font-size: 10pt"><b>INFORMATION
ABOUT GLOBIS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is a blank check company incorporated on August 21, 2020 (inception) as a Delaware corporation for the purpose of effecting a merger,
share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is an early stage and emerging growth company and, as such, Globis is subject to all of the risks associated with early stage and emerging
growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Significant
Activities Since Inception</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, Globis consummated the IPO of 11,500,000 Units, including the issuance of 1,500,000 Units as a result of the underwriters&#8217;
full exercise of their over-allotment option, at $10.00 per unit, generating gross proceeds of $115 million. Each Unit consists of one
share of Common Stock and one Warrant. Each whole Public Warrant entitles the holder to purchase one Public Share at an exercise price
of $11.50 per share, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, Globis consummated the Private Placements of (i) 4,188,889 Private Placement Warrants at a price of $0.75
per Private Placement Warrant and (ii) 100,833 Private Placement Units at a price of $10.00 per Private Placement Unit to the Sponsors,
generating gross proceeds of $4,150,000. Each Private Placement Warrant is exercisable for one share of common stock at a price of $11.50
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Globis incurred $2,516,841
in transaction costs, including $2,300,000 of underwriting fees and $216,841 of other offering costs in connection with the
IPO and the sale of the Private Placements. The underwriters in the IPO also received 402,500 equity participation shares. The underwriters
agreed not to transfer, assign or sell any equity participation shares until the completion of our initial business combination. Each
Private Placement Unit is identical to the Unit, except as described in the IPO registration statement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO, an amount of $116,150,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO and certain
of the proceeds from the sale of the Private Placements was placed in a Trust Account which will be invested in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by Globis meeting the conditions of Rule 2a-7 of the Investment
Company Act, as determined by Globis, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of
the funds held in the Trust Account, as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placements,
although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. So long
as Globis&#8217; securities are then listed on the Nasdaq, Globis&#8217; initial business combination must be with one or more target
businesses that together have a fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of
deferred underwriting discounts and taxes payable on the income earned) at the time of the signing of the agreement to enter into a business
combination. Globis will only complete a business combination if the post business combination company owns or acquires 50% or more of
the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be
required to register as an investment company under the Investment Company Act. There is no assurance that Globis will be able to complete
the Business Combination successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
will provide the holders of its issued and outstanding Public Shares with the opportunity to redeem all or a portion of their Public
Shares upon the completion of the Business Combination either (i) in connection with a stockholder meeting called to approve the Business
Combination or (ii) by means of a tender offer. The decision as to whether Globis will seek shareholder approval of a Business Combination
or conduct a tender offer will be made by Globis, solely in its discretion. The Public Stockholders will be entitled to redeem their
Public Shares for a pro rata portion of the amount then in the Trust Account ($10.10 per Public Share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to Globis to pay income taxes). The per-share amount to be
distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions Globis
will pay to the underwriters. There will be no redemption rights upon the completion of the Business Combination with respect to Globis&#8217;
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
units began trading on December 11, 2020 on the Nasdaq under the symbol &#8220;GLAQU.&#8221; Commencing on February 5, 2021, the
securities comprising the units began separate trading. The ordinary shares and warrants are trading on the Nasdaq under the symbols
&#8220;GLAQ&#8221; and &#8220;GLAQU,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, Globis has issued promissory notes in the aggregate amount of $700,000  to Globis SPAC LLC and
its designees. In addition, $1,150,000 of indebtedness was incurred on December 10, 2021 in connection with the extension
of the time that Globis needs to complete its initial business combination to March 15, 2022. Such date may be further extended to June
15, 2022, if Globis Board extends the period of time to consummate a business combination. The remainder of the indebtedness was incurred
in connection with Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effecting
a Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is not presently engaged in and Globis will not engage in, any substantive commercial business until it completes the Business Combination
with FAHL or another target business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Market Value of Target Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Nasdaq listing rules, the target business or businesses that Globis acquires must collectively have a fair market value equal to at
least 80% of the balance of the funds in the Trust Account (less any deferred underwriting commissions and taxes payable on interest
earned) at the time of the execution of a definitive agreement for Globis&#8217; initial business combination. The fair market value
of the target or targets will be determined by the Globis Board based upon one or more standards generally accepted by the financial
community, such as discounted cash flow valuation or value of comparable businesses. Our shareholders will be relying on the business
judgment of the Globis Board, which will have significant discretion in choosing the standard used to establish the fair market value
of the target or targets, and different methods of valuation may vary greatly in outcome from one another. As discussed in the Section
entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Satisfaction of 80% Test</i>,&#8221; the Globis Board determined
that this test was met in connection with the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
Approval of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is seeking shareholder approval of the Business Combination at the Stockholders Meeting to which this proxy statement/prospectus relates
and, in connection with such meeting, holders of Public Shares may redeem their shares for cash in accordance with the procedures described
in this proxy statement/prospectus. Such Redemption Rights will be effected under the Amended and Restated Certificate of Incorporation
and the DGCL. Unlike other blank check companies in which the initial shareholders agree to vote their common stock in accordance with
the majority of the votes cast by the Public Stockholders in connection with an initial business combination, the Sponsor and Globis&#8217;
directors and officers have agreed in the Sponsor Letter Agreement (i) to vote the all of the Common Stock held by the Sponsors and Globis&#8217;
independent directors and (b) any other Common Stock owned by the Sponsor or Globis&#8217; directors and officers, in favor of the Business
Combination; and (ii) to not redeem any Globis Shares in connection with a shareholder vote to approve a proposed initial business combination,
including the Business Combination, or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating
to shareholders&#8217; rights or pre-business combination activity. If the Business Combination is not completed, then Public Stockholders
electing to exercise their Redemption Rights will not receive such payments and their shares will not be redeemed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
will proceed with a business combination if Globis has net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the
Exchange Act) of at least $5,000,001 upon such consummation of a business combination and, only if a majority of the Common Stock, represented
in person or by proxy and entitled to vote thereon and who vote at a stockholder meeting, are voted in favor of the business combination.
If a shareholder vote is not required by law and Globis does not decide to hold a shareholder vote for business or other reasons, Globis
will, pursuant to its Amended and Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC
and file tender offer documents with the SEC prior to completing a business combination. If, however, shareholder approval of the transactions
is required by law, or Globis decides to obtain shareholder approval for business or reasons, Globis will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder
may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If
Globis seeks shareholder approval in connection with a business combination, the Sponsor, executive officers and directors (the &#8220;<b>initial
shareholders</b>&#8221;) have agreed to vote their shares of Common Stock and any Public Shares purchased during or after the IPO in
favor of approving a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, if Globis seeks shareholder approval of a business combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of
such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section
13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares,
without the prior consent of Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the net tangible asset condition, Globis may be able to complete the Business Combination even if a majority of Globis&#8217; Public
Stockholders do not agree with the Business Combination and have redeemed their shares or if Globis has entered into privately negotiated
agreements for investors to sell their shares to Globis&#8217; Sponsor, directors and officers, advisors or their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial shareholders have agreed to waive their redemption rights with respect to any shares of Common Stock , including Public Shares
held by them, in connection with (i) the completion of New Forafric&#8217;s initial Business Combination and (ii) a shareholder vote
to approve an amendment to New Forafric&#8217;s Amended and Restated Certificate of Incorporation (A) that would modify the substance
or timing of New Forafric&#8217;s obligation to provide holders of the Public Shares the right to have their shares redeemed in connection
with New Forafric&#8217;s initial Business Combination or to redeem 100% of the Public Shares if New Forafric does not complete its initial
Business Combination within the Combination Period (defined below) or (B) with respect to any other provision relating to the rights
of holders of the Public Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section entitled &#8220;<i>Risk Factors &#8212; Risks Related to the Business Combination and Globis</i>&#8221; for more
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation
if No Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
will have until March 15, 2022 (or June 15, 2022, if Globis&#8217; Board of Directors extends the period of time to consummate a business
combination) to complete a business combination. If Globis has not completed a business combination within the Combination Period, Globis
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business
days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account including interest earned on the funds held in the Trust Account and not previously released to Globis to pay income taxes
(less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which
redemption will completely extinguish Public Stockholders&#8217; rights as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of Globis&#8217;
remaining shareholders and Globis&#8217; board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to
Globis&#8217; obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will
be no redemption rights or liquidating distributions with respect to Globis&#8217; warrants, which will expire worthless if Globis fails
to complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount in the Trust Account under the DGCL will be treated as share premium which is distributable under the DGCL provided that immediately
following the date on which the proposed distribution is proposed to be made, Globis is able to pay its debts as they fall due in the
ordinary course of business. If Globis is forced to liquidate the Trust Account, Globis anticipates that it would distribute to its Public
Stockholders the amount in the Trust Account calculated as of the date that is two days prior to the distribution date (including any
accrued interest). Prior to such distribution, Globis would be required to assess all claims that may be potentially brought against
it by its creditors for amounts they are actually owed and make provision for such amounts, as creditors take priority over the Public
Stockholders with respect to amounts that are owed to them. Globis cannot assure you that it will properly assess all claims that may
be potentially brought against it. As such, shareholders could potentially be liable for any claims of creditors to the extent of distributions
received by them as an unlawful payment in the event Globis enters an insolvent liquidation. Furthermore, while Globis will seek to have
vendors, service providers (other than its independent auditors), prospective target businesses or other entities with which it does
business execute agreements with Globis waiving any right, title, interest or claim of any kind they may have in or to any monies held
in the Trust Account, there is no guarantee that they will execute such agreements. Nor is there any guarantee that, even if such entities
execute such agreements with Globis, they will not seek recourse against the Trust Account or that a court would conclude that such agreements
are legally enforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial shareholders have agreed to waive their liquidation rights with respect to the Common Stock if Globis fails to complete a Business
Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public
Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if Globis fails to complete a Business
Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission
held in the Trust Account in the event Globis does not complete a Business Combination within the Combination Period and, in such event,
such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public
Shares. In the event of such distribution, it is possible that the per-share value of the assets remaining available for distribution
will be less than the IPO price per unit ($10.10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, FAHL has agreed that it and its affiliates will not have any right, title, interest or claim of
any kind in or to any monies in Globis&#8217; Trust Account held for its Public Stockholders, and agreed not to, and waived any right
to, make any claim against the Trust Account (including any certain distributions therefrom) except, in each case with respect to claims
that FAHL or its affiliates may have in the future against Globis&#8217; assets or funds that are not held in the Trust Account (other
than distributions to Public Stockholders) and claims against any other person (or any affiliate thereof) that is party to an alternative
business combination consummated by Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Globis is unable to complete the Business Combination and expends all of the net proceeds of Globis&#8217; IPO, other than the proceeds
deposited in the Trust Account and without taking into account interest, if any, earned on the Trust Account, the per-share distribution
from the Trust Account would be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;based on the value of the
Trust Account as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds deposited in the Trust Account could, however, become subject to the claims of Globis&#8217; creditors which would be prior
to the claims of the Public Stockholders. Although Globis has obtained and will continue to seek to have all vendors, including lenders
for money borrowed, prospective target businesses or other entities Globis engages execute agreements with Globis waiving any right,
title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Stockholders, there
is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing
claims against the Trust Account, including but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with a claim against
Globis&#8217; assets, including the funds held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">In order to protect the amounts
held in the Trust Account, the Sponsors have agreed to be liable to Globis if and to the extent any claims by a third party for services
rendered or products sold to Globis, or a prospective target business with which Globis has discussed entering into a transaction agreement,
reduce the amounts in the Trust Account to below the lesser of (i) $10.10 per Public Share and (ii) the actual amount per Public
Share held in the Trust Account if less than $10.10 per Public Share due to reductions in the value of the trust assets. This
liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the
Trust Account nor to any claims under Globis&#8217; indemnity of the underwriters of the IPO against certain liabilities, including liabilities
under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor
will not be responsible to the extent of any liability for such third-party claims. Globis will seek to reduce the possibility that the
Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except
for Globis&#8217; independent registered public auditors), prospective target businesses or other entities with which Globis does business,
execute agreements with Globis waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 24.5pt">We
have one executive officer, Paul Packer, who serves as our chief executive officer and chief financial officer. Mr. Packer is not obligated
to devote any specific number of hours to our matters and intends to devote only as much time as he deems necessary to our affairs. We
do not intend to have any full time employees prior to the consummation of a business combination.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Facilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
maintains its executive offices at Globis Acquisition Corp., 7100 W. Camino Real, Suite 302-48, Boca Raton, FL 33433. The cost for use
of this space is included in the $10,000 per month fee Globis pays to an affiliate of the Sponsor for office space, administrative and
support services which will be paid through the earlier of the consummation of a business combination or Globis&#8217; liquidation. Globis
considers its current office space adequate for its current operations. Upon completion of the Business Combination, the principal executive
offices of New Forafric will be located at Casablanca, Morocco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Proceedings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no material litigation, arbitration or governmental proceeding currently pending against Globis or any members of its management team
in their capacity as such.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_006"></span><span style="font-size: 10pt"><b>DIRECTORS,
OFFICERS, EXECUTIVE</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMPENSATION
AND CORPORATE GOVERNANCE OF GLOBIS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRIOR
TO THE BUSINESS COMBINATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
current directors and executive officers are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chief Financial Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claude
    Benitah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    A. Ferguson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    M. Horne</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paul
Packer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Packer, age 50, has been Globis&#8217; Chief Executive Officer, Chief Financial Officer and a Director since inception. Mr. Packer has
served as the Managing Member of Globis Capital Advisors LLC, an investment advisory firm, since founding the firm in 2001. Since October
2017, Mr. Packer has served as Chairman of The United States Commission for the Preservation of America&#8217;s Heritage Abroad, when
he was first appointed by President Donald J. Trump. He has served on the board of directors of Zedge, Inc. (NYSE AMERICAN: ZDGE), a
provider of content distribution platforms, since April 2020. Mr. Packer also serves as a director on the board of Elementor Ltd., a
privately held company that offers an intuitive, front-end site builder for WordPress. Previously, he served on the boards of directors
of Wakingapp Ltd., an augmented reality technology company, from October 2014 until its sale to Scope AR in October 2019 and Penguin
Digital, Inc., a mobile application developer, before it was acquired by Shutterfly Inc. in 2012. Mr. Packer received a B.A. from Yeshiva
University. We believe Mr. Packer&#8217;s extensive knowledge of the capital markets, corporate finance, and public company governance
practices as a result of his investment experience, together with his significant board experience at companies in the technology sector,
makes him well-qualified to serve on the Globis board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Claude
Benitah</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Benitah, age 72, has been a Director since the completion of Globis&#8217; initial public offering. Mr. Benitah has more than 35 years&#8217;
duty free and travel retail experience, including extensive experience in African markets. He currently serves as a consultant to public
and private companies advising on, among other things, optimization of production, procurement, budgeting, and strategy formation. He
has served as a Senior Advisor to Africa Projects Corporation since January 2017, a Management Advisor to TAXFRY AFRICA since 2012 and
Manager at Duty Free Africa since 2010. Previously, he served as a Manager of Worldwide Development at Flemingo Duty Free, an operator
of duty free stores across the world in airports and seaports of various sizes. Prior to that, from 2001 to 2009, Mr. Benitah served
as the Chief Executive Officer of Saresco Afrique, an owner and operator of Duty Free shops in Western and Central Africa. He also previously
held several senior positions at SAGA Group, a provider of global transportation and logistics services. We believe Mr. Benitah&#8217;s
more than three decades of experience in international duty free and travel retail, including his extensive experience developing multimodal
transportation logistic strategies and overseeing and advising on supply chain organization and management makes him well-qualified to
serve on the Globis board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Honorable Michael A. Ferguson</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ferguson, age 51, has been a Director since the completion of Globis&#8217; initial public offering. He is currently a senior advisor
at BakerHostetler, where he serves as the leader of their Federal Policy team since joining the firm in June 2016. Prior to this, Mr.
Ferguson founded and served as the chief executive officer and chairman of Ferguson Strategies, LLC, a government affairs and strategic
business consulting firm, from January 2009 until June 2016. From 2001 to January 2009, he served in the U.S. House of Representatives,
representing New Jersey&#8217;s 7th congressional district. While in Congress, he was a member of the House Energy and Commerce Committee,
which has wide jurisdiction over the healthcare, telecommunications and energy industries. He served as vice chairman of the panel&#8217;s
Health Subcommittee, where he became a key member on health care issues and helped to ensure passage of the Medicare Part D prescription
drug benefit in 2003. In addition, he served as a member of the Telecommunications and Internet Subcommittee as well as the Oversight
and Investigations Subcommittee. Mr. Ferguson was also a member of the House Financial Services Committee, where he cosponsored the Sarbanes-Oxley
Act of 2002 and helped enact the initial terrorism risk insurance law. Mr. Ferguson was the former chairman of the Board of Commissioners
of the New Jersey Sports and Exhibition Authority and also serves as a senior fellow of the Center for Medicine in the Public Interest&#8217;s
Odyssey Initiative for Biomedical Innovation and Human Health. Since April 2015, he has served on the Board of Directors of NanoVibronix,
Inc. (Nasdaq: NAOV Previously, he served as the Chairman of the Board of Ohr Pharmaceutical Inc. (n/k/a Neubase Therapeutics Inc.
(Nasdaq: NBSE)) from May 2017 until its merger with Neubase Therapeutics Inc. in July 2019. He has also served on various corporate
advisory boards and committees, including for Pfizer, Inc., the National Italian American Foundation and the United States Golf Association.
Mr. Ferguson received a B.A. in government from the University of Notre Dame and a Master of Public Policy degree with a specialization
in education policy from Georgetown University. We believe Mr. Ferguson&#8217;s extensive experience in government affairs, including
regulatory and policymaking initiatives across a wide range of sectors and industries, acquired through his service as a U.S. Congressman,
together with his expertise in business strategy and development, makes him well-qualified to serve on the Globis board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>John
M. Horne</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Horne, age 54, has been a Director since the completion of Globis&#8217; initial public offering. He is an entrepreneur and venture capitalist.
Over the past twenty-five years, Mr. Horne has had a diverse career in both the private and public sectors, including recently serving
as both Deputy Assistant to President Donald J. Trump and Deputy Chief of Staff to Vice President Michael R. Pence from May 2018 to October
2019. In addition, in September 2019, President Trump nominated Mr. Horne to become a member of The United States Commission for the
Preservation of America&#8217;s Heritage Aboard, where he continues to serve. Mr. Horne is also the founder and President of multiple
successful private companies, and has served as President of Zurmos, Inc., a consulting company which focuses on providing U.S. and International
companies with strategic international market sector analyzes, strategic expansion plans, risk and political stability assessments and
international government affairs plans, since founding New Forafric in December 2006. Mr. Horne has significant political experience,
including serving as a Member of the Executive Roundtable of the Republican Governors Association since its inception in 2009, serving
as a Senior Advisor to Governor Mike Huckabee during the 2008 Presidential campaign and working with the Trump Presidential Finance and
Transition and Inaugural Committees. He has also served as a Senior Advisor to Secretary of Commerce Don Evans and was appointed by President
George W. Bush to serve as the Executive Director of Export Assistance and Business Outreach for the International Trade Administration.
Mr. Horne holds an MBA degree from the University of Arkansas, a Finance degree from the University of Tulsa, and studied International
Business at the University of Salzburg, Austria. We believe Mr. Horne&#8217;s experience as a successful entrepreneur and his expertise
in international strategic market analysis and risk assessment, coupled with his significant experience in public service, including
serving in senior advisory capacities to elected officials, makes him well-qualified to serve on the Globis board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
and Terms of Office of Officers and Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board has four members, three of whom are deemed &#8220;independent&#8221; under SEC and Nasdaq rules. We may not hold an annual
meeting of stockholders until after we consummate our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers are appointed by the Globis Board and serve at the discretion of the board of directors, rather than for specific terms of office.
The Globis Board is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide
that our directors may consist of a chairman of the board, and that our officers may consist of chief executive officer, president, chief
financial officer, executive vice president(s), vice president(s), secretary, treasurer and such other officers as may be determined
by the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
executive officer has received any cash compensation for services rendered to us. No compensation of any kind, including finders, consulting
or other similar fees, will be paid to any of our existing stockholders, including our directors, or any of their respective affiliates,
prior to, or for any services they render in order to effectuate, the consummation of a business combination. However, such individuals
will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential
target businesses and performing due diligence on suitable business combinations. There is no limit on the amount of these out-of-pocket
expenses and there will be no review of the reasonableness of the expenses by anyone other than the Globis board of directors and audit
committee, which includes persons who may seek reimbursement, or a court of competent jurisdiction if such reimbursement is challenged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting,
management or other fees from the combined company. Any compensation to be paid to our executive officers will be determined by a compensation
committee constituted solely of independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation
of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment
or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or
consulting arrangements to retain their positions with us may influence our management&#8217;s motivation in identifying or selecting
a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business
combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any
agreements with our executive officers and directors that provide for benefits upon termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
requires that a majority of the Globis Board must be composed of &#8220;independent directors.&#8221; Currently, Messrs. Benitah, Ferguson
and Horne are each considered an &#8220;independent director&#8221; under the Nasdaq listing rules, which is defined generally as a person
other than an officer or employee of New Forafric or its subsidiaries or any other individual having a relationship, which, in the opinion
of New Forafric&#8217;s board of directors would interfere with the director&#8217;s exercise of independent judgment in carrying out
the responsibilities of a director. Our independent directors have regularly scheduled meetings at which only independent directors are
present.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will only enter into a business combination if it is approved by a majority of our independent directors. Additionally, we will only
enter into transactions with our officers and directors and their respective affiliates that are on terms no less favorable to us than
could be obtained from independent parties. Any related-party transactions must also be approved by our audit committee and a majority
of disinterested independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis board of directors has two standing committees: an audit committee and a compensation committee. Subject to phase-in rules and
a limited exception, the rules of Nasdaq and Rule 10A of the Exchange Act require that the audit committee of a listed company be comprised
solely of independent directors. Subject to phase-in rules and a limited exception, the rules of Nasdaq require that the compensation
committee of a listed company be comprised solely of independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of
whom must be independent. We have established an audit committee of the board of directors consisting of Messrs. Benitah, Ferguson and
Horne, each of whom is an independent director under Nasdaq&#8217;s listing standards. Mr. Ferguson is the Chairperson of the audit committee.
Each member of the audit committee is financially literate and the Globis board of directors has determined that Mr. Ferguson qualifies
as an &#8220;audit committee financial expert&#8221; as defined in applicable SEC rules. The audit committee&#8217;s duties, which are
specified in the Globis Audit Committee Charter, include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with management and the independent auditor the annual audited financial statements, and recommending to the board
    whether the audited financial statements should be included in Globis&#8217; Form 10-K;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
    with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation
    of Globis&#8217; financial statements;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
    with management major risk assessment and risk management policies;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    the independence of the independent auditor;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">verifying
    the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible
    for reviewing the audit as required by law;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving all related-party transactions;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inquiring
    and discussing with management Globis&#8217; compliance with applicable laws and regulations;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
    all audit services and permitted non-audit services to be performed by Globis&#8217; independent auditor, including the fees and
    terms of the services to be performed;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
    or replacing the independent auditor;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and
    the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls
    or reports which raise material issues regarding Globis&#8217; financial statements or accounting policies; and</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    reimbursement of expenses incurred by Globis&#8217; management team in identifying potential target businesses.</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
    with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation
    of Globis&#8217; financial statements;</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee is governed by a charter that complies with the rules of the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board has established a compensation committee. The members of Globis&#8217; compensation committee consist of Messrs. Benitah,
Ferguson and Horne, each of whom is an independent director under Nasdaq&#8217;s listing standards. Mr. Benitah is the Chairperson of
the compensation committee. The compensation committee&#8217;s duties, which are specified in Globis&#8217; Compensation Committee Charter,
include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving the compensation (if any) of all of Globis&#8217; executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    Globis&#8217; executive compensation policies and plans;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
    and administering Globis&#8217; incentive compensation equity-based remuneration plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
    management in complying with Globis&#8217; proxy statement and annual report disclosure requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    all special perquisites, special cash payments and other special compensation and benefit arrangements for Globis&#8217; executive
    officers and employees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">producing
    a report on executive compensation to be included in Globis&#8217; annual proxy statement; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    evaluating and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and be directly responsible for the appointment, compensation and oversight of the work of any such adviser.
However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation
committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Nominations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a standing nominating committee, though we intend to form a corporate governance and nominating committee as and when required
to do so by law or Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may recommend
a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily
carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee.
The directors who will participate in the consideration and recommendation of director nominees are Messrs. Benitah, Ferguson and Horne.
In accordance with Rule 5605 of the Nasdaq rules, all such directors are independent. As there is no standing nominating committee, we
do not have a nominating committee charter in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors will also consider director candidates recommended for nomination by Globis&#8217; stockholders during such times
as they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special
meeting of stockholders). Globis&#8217; stockholders that wish to nominate a director for election to the Globis board of directors should
follow the procedures set forth in Globis&#8217; bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of
professional experience, knowledge of Globis&#8217; business, integrity, professional reputation, independence, wisdom, and the ability
to represent the best interests of Globis&#8217; stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
has adopted a Code of Ethics applicable to all of Globis&#8217; executive officers, directors and employees. The code of ethics codifies
the business and ethical principles that govern all aspects of Globis&#8217; business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
to Obtain the Code of Ethics and Committee Charters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
has filed a copy of Globis&#8217; Code of Ethics as an exhibit to the registration statement relating to Globis&#8217; IPO. Globis&#8217;
Code of Ethics and the charters of the committees of the Globis Board may be reviewed by accessing Globis&#8217; public filings at the
SEC&#8217;s web site at <i><span style="text-decoration: underline">www.sec.gov</span>. </i>In addition, a copy of the Code of Ethics will be provided without charge upon request
from Globis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conflicts
of Interest</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
should be aware of the following potential conflicts of interest:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
    of Globis&#8217; officers and directors is required to commit their full time to Globis&#8217; affairs and, accordingly, they may
    have conflicts of interest in allocating their time among various business activities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the course of their other business activities, Globis&#8217; officers and directors may become aware of investment and business opportunities
    which may be appropriate for presentation to Globis as well as the other entities with which they are affiliated. Globis&#8217; officers
    and directors may have conflicts of interest in determining to which entity a particular business opportunity should be presented.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
    officers and directors may in the future become affiliated with entities, including other blank check companies, engaged in business
    activities similar to those intended to be conducted by Globis.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    Globis consummates its initial business combination, Globis&#8217; officers, directors and insiders will not receive reimbursement
    for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited
    in the trust account and the amount of interest income from the trust account that may be released to us as working capital.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    founder shares beneficially owned by Globis&#8217; officers and directors will be released from escrow only if Globis&#8217; initial
    business combination is successfully completed. Additionally, if we are unable to complete an initial business combination within
    the required time frame, Globis&#8217; officers and directors will not be entitled to receive any amounts held in the trust account
    with respect to any of their founder shares or shares issued in connection with Private Placement. For the foregoing reasons, Globis&#8217;
    board may have a conflict of interest in determining whether a particular target business is an appropriate business with which to
    effect Globis&#8217; initial business combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, officers and directors of a corporation incorporated under the laws of the State of Delaware are required to present business
opportunities to a corporation if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    corporation could financially undertake the opportunity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    opportunity is within the corporation&#8217;s line of business; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    would not be fair to the corporation and its stockholders for the opportunity not to be brought to the attention of the corporation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
as a result of multiple business affiliations, Globis&#8217; officers and directors may have similar legal obligations relating to presenting
business opportunities meeting the above-listed criteria to multiple entities. Furthermore, Globis&#8217; Amended and Restated Certificate
of Incorporation will provide that the doctrine of corporate opportunity will not apply with respect to any of Globis&#8217; officers
or directors in circumstances where the application of the doctrine would conflict with any fiduciary duties or contractual obligations
they may have. In order to minimize potential conflicts of interest which may arise from multiple affiliations, Globis&#8217; officers
and directors (other than Globis&#8217; independent directors) have agreed to present to us for Globis&#8217; consideration, prior to
presentation to any other person or entity, any suitable opportunity to acquire a target business, until the earlier of: (1) Globis&#8217;
consummation of an initial business combination and (2) 24 months from the date of its IPO. This agreement is, however, subject to any
pre-existing fiduciary and contractual obligations such officer or director may from time to time have to another entity. Accordingly,
if any of them becomes aware of a business combination opportunity which is suitable for an entity to which he or she has pre-existing
fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination
opportunity to such entity, and only present it to us if such entity rejects the opportunity. We do not believe, however, that the pre-existing
fiduciary duties or contractual obligations of Globis&#8217; officers and directors will materially undermine Globis&#8217; ability to
complete Globis&#8217; business combination because in most cases the affiliated companies are closely held entities controlled by the
officer or director or the nature of the affiliated company&#8217;s business is such that it is unlikely that a conflict will arise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the current pre-existing fiduciary or contractual obligations of Globis&#8217; officers and directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Individual</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Affiliated Company</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity&#8217;s
    Business</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Affiliation</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
    Capital Advisors LLC (and affiliated entities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    advisory firm</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder
    and Managing Member</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elementor,
    Ltd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zedge,
    Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operates
    as a content distribution platform</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claude
    Benitah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    A. Ferguson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BakerHostetler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
    firm</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Advisor</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix,
    Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    medical device company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    M. Horne</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zurmos,
    Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provides
    strategic international market sector analysis, strategic expansion plans, risk and political stability assessments and international
    government affairs plans</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder
    and President</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
insiders have agreed, pursuant to a letter agreement, to offer all suitable business combination opportunities to us before any other
person or company until the consummation by us of a business combination, subject to any pre-existing contractual or fiduciary obligations
they may have; provided, that Globis&#8217; insiders shall not be limited with respect to their individual activity as a sponsor or independent
director of a separate special purpose acquisition vehicle that does not conflict or compete with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
insiders have agreed to vote any shares of common stock held by them in favor of Globis&#8217; initial business combination. In addition,
they have agreed to waive their respective rights to receive any amounts held in the Trust Account with respect to their founder shares
and shares issued in connection with the Private Placement if we are unable to complete Globis&#8217; initial business combination within
the required time frame. If they purchase shares of common stock in this offering or in the open market, however, they would be entitled
to receive their pro rata share of the amounts held in the trust account if we are unable to complete Globis&#8217; initial business
combination within the required time frame, but have agreed not to convert such shares in connection with the consummation of Globis&#8217;
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
ongoing and future transactions between us and any of Globis&#8217; officers and directors or their respective affiliates will be on
terms believed by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions will require
prior approval by Globis&#8217; audit committee and a majority of Globis&#8217; uninterested &#8220;independent&#8221; directors, or
the members of Globis&#8217; board who do not have an interest in the transaction, in either case who had access, at Globis&#8217; expense,
to Globis&#8217; attorneys or independent legal counsel. We will not enter into any such transaction unless Globis&#8217; audit committee
and a majority of Globis&#8217; disinterested &#8220;independent&#8221; directors determine that the terms of such transaction are no
less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further minimize conflicts of interest, we have agreed not to consummate Globis&#8217; initial business combination with an entity that
is affiliated with any of Globis&#8217; officers, directors or insiders, unless we have obtained (i) an opinion from an independent investment
banking firm that the business combination is fair to Globis&#8217; unaffiliated stockholders from a financial point of view and (ii)
the approval of a majority of Globis&#8217; disinterested and independent directors (if we have any at that time). Furthermore, in no
event will Globis&#8217; insiders or any of the members of Globis&#8217; management team be paid any finder&#8217;s fee, consulting fee
or other similar compensation prior to, or for any services they render in order to effectuate, the consummation of Globis&#8217; initial
business combination (regardless of the type of transaction that it is).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
on Liability and Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
certificate of incorporation provides that Globis&#8217; directors and officers will be indemnified by us to the fullest extent authorized
by Delaware law as it now exists or may in the future be amended. In addition, Globis&#8217; certificate of incorporation provides that
Globis&#8217; directors will not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, unless
they violated their duty of loyalty to us or Globis&#8217; stockholders, acted in bad faith, knowingly or intentionally violated the
law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived an improper personal benefit
from their actions as directors. Notwithstanding the foregoing, as set forth in Globis&#8217; certificate of incorporation, such indemnification
will not extend to any claims Globis&#8217; insiders may make to us to cover any loss that they may sustain as a result of their agreement
to pay debts and obligations to target businesses or third parties or other entities that are owed money by us for services rendered
or contracted for or products sold to us as described elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis&#8217;
bylaws also permit us to secure insurance on behalf of any officer, director or employee for any liability arising out of his or her
actions, regardless of whether Delaware law would permit indemnification. We will purchase a policy of directors&#8217; and officers&#8217;
liability insurance that insures Globis&#8217; directors and officers against the cost of defense, settlement or payment of a judgment
in some circumstances and insures us against Globis&#8217; obligations to indemnify the directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may discourage stockholders from bringing a lawsuit against Globis&#8217; directors for breach of their fiduciary duty. These
provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such
an action, if successful, might otherwise benefit us and Globis&#8217; stockholders. Furthermore, a stockholder&#8217;s investment may
be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these
provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented
and experienced directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to Globis&#8217; directors, officers and controlling
persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification
is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 161; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_007"></span><span style="font-size: 10pt"><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND
RESULTS OF OPERATIONS OF GLOBIS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, all references in this section to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;
refer to Globis prior to the consummation of the Business Combination. The following discussion and analysis of Globis&#8217; financial
condition and results of operations should be read in conjunction with Globis&#8217; consolidated financial statements and notes to those
statements included in this proxy statement/ prospectus. Certain information contained in the discussion and analysis set forth below
includes forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated
in these forward-looking statements as a result of many factors. Please see &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;
and &#8220;Risk Factors&#8221; in this proxy statement/prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company formed under the laws of the State of Delaware on August 21, 2020, for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (a
&#8220;Business Combination&#8221;). We intend to effectuate our Business Combination using cash from the proceeds of our initial public
offering (the &#8220;Initial Public Offering&#8221;) of 11,500,000 units (the &#8220;Units,&#8221; which included the full exercise by
the underwriter of its over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit) and the sale of 4,188,889 warrants
(the &#8220;Private Warrants&#8221;) at a price of $0.75 per Private Warrant and 100,833 units (the &#8220;Placement Units&#8221; and,
together with the Private Warrants, the &#8220;Private Securities&#8221;), our capital stock, debt or a combination of cash, stock and
debt. Each Unit consists of one share of Common Stock and one Public Warrant. Each whole Public Warrant and each whole Private Warrant
entitles the holder to purchase one share of Common Stock at an exercise price of $11.50 per share, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
incurred $2,516,841 in transaction costs, including $2,300,000 of underwriting fees and $216,841 of other offering costs
in connection with the Initial Public Offering and the sale of the Private Placements. The underwriters in the Initial Public Offering
also received 402,500 equity participation shares. The underwriters agreed not to transfer, assign or sell any equity participation shares
until the completion of our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the Initial Public Offering and the Private Placement, $116,150,000 ($10.10 per Unit) of the net proceeds of the sale
of the Units in the Initial Public Offering and certain of the proceeds from the sale of the Private Placement Warrants in the Private
Placement was placed in a trust account and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a
money market fund selected by Globis meeting the conditions of paragraphs (c)(2), (c)(3) and (c)(4) of Rule 2a-7 of the Investment Company
Act, as determined by Globis, until the earlier of: (i) the completion of an initial business combination; and (ii) the distribution
of the Trust Account. As of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022, there was approximately $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
million held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 19, 2021 (the &#8220;Effective Date&#8221;), Globis, entered in the Business Combination Agreement, by and among Globis, FAHL,
and Seller. The Business Combination Agreement provides for the consummation of the following transactions for completion of the Business
Combination: (a) Globis will form under the laws of the State of Nevada a wholly-owned subsidiary of Globis, change its jurisdiction
of incorporation to Nevada by merging with and into the new subsidiary such that the new subsidiary will survive the merger, and change
its jurisdiction of incorporation again by transferring by way of a redomiciliation and domesticating as a Gibraltar public company limited
by shares, with the resulting entity referred herein as &#8220;New Forafric&#8221;; and (b) immediately following the effectiveness
of the redomiciliation, New Forafric will acquire 100% of the equity interests in FAHL from the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 162; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through September 30, 2021
were organizational activities and those necessary to prepare for the Initial Public Offering, described below, and search for a Business
Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect
to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We expect
that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing
compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.31in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2021, we had a net loss of $890,359, which consisted of general and administrative expenses of $892,144
offset by interest earned on marketable securities held in the Trust Account of $1,785.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.31in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2021, we had a net loss of $1,601,809, which consisted of general and administrative expenses of
$1,607,436 offset by interest earned on marketable securities held in the Trust Account of $5,627.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.31in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period from August 21, 2020 (inception) through September 30, 2020, we had a net loss of $1,000, which consisted of formation and
operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, we consummated the Initial Public Offering of 11,500,000 Units, which included the full exercise by the underwriters
of their over-allotment option in the amount of 1,500,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $115,000,000.
Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 4,188,889 Private Warrants to the Sponsors
at a price of $0.75 per Private Warrant and 100,833 Placement Units to the Sponsors at a price of $10.00 per Placement Units, generating
gross proceeds of $4,150,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Securities, a total of $116,150,000
was placed in a trust account (the &#8220;Trust Account&#8221;), and we had $209,439 of cash held outside of the Trust Account, after
payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred $6,541,841 in transaction
costs, including $2,300,000 of underwriting fees, $4,025,000 representing 402,500 shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#8220;equity participation shares&#8221;) and $216,841
of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2021, cash used in operating activities was $893,655. Net loss of $1,601,809 was impacted by interest
earned on marketable securities held in the Trust Account of $5,627. Changes in operating assets and liabilities provided $713,781 of
cash from operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 163; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, we had marketable securities held in the Trust Account of $116,155,627. We intend to use substantially all of
the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be
net of taxes payable, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes and up to $150,000
of dissolution expenses, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete
a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of
the target business or businesses, make other acquisitions and pursue our growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, we had cash of $8,413. We intend to use the funds held outside the Trust Account primarily to identify and evaluate
target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of
prospective target businesses, structure, negotiate and complete a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsors or an
affiliate of our Sponsors or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (&#8220;Working
Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may
repay the notes out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we
may use a portion of the working capital held outside the Trust Account to repay the notes, but no proceeds from our Trust Account would
be used for such repayment. On January 11, 2021, we issued an unsecured promissory note (the &#8220;Note&#8221;) to Globis SPAC LLC that
permits us to borrow from time to time up to $1,000,000 from Globis SPAC LLC or its assignees or successors. The Note is non-interest
bearing and payable upon the consummation of a Business Combination. On various dates during the nine months ended September 30, 2021,
Globis drew a total of $700,000 under the Note in accordance with the Working Capital Loans. On April 28, 2021, the Note was amended
to terminate the option for a holder to convert the amount outstanding under the Note into Private Warrants. On July 19, 2021, the Note
was amended to increase the principal amount of the Note from $1,000,000 to $2,000,000. On October 13, 2021, the Note was amended to
increase the principal amount of the Note from $2,000,000 to $3,000,000. On December 29, 2021, 2021, the Note was amended to increase
the principal amount of the Note from $3,000,000 to $5,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business following
our issuance of the Note. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence
and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to
operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete
our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business
Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, Globis consummated (i) the private placement of 4,188,889 Private Placement Warrants
at a price of $0.75 per Private Placement Warrant to the Sponsors and (ii) the private placement of 100,833 Private Placement Units at
a price of $10.00 per Private Placement Unit , generating gross proceeds of $4.15 million. Each Private Placement Warrant is exercisable
for one share of common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the private placement warrants
were added to the proceeds from the Initial Public Offering to be held in the trust account. If we do not complete a business combination
within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable
and exercisable on a cashless basis so long as they are held by the Sponsors or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 164; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controls
and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently required to maintain an effective system of internal controls as defined by Section 404 of the Sarbanes-Oxley Act.
We will be required to comply with the internal control requirements of the Sarbanes- Oxley Act for the fiscal year ending December 31,
2021. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging
growth company would we be required to comply with the independent registered public accounting firm attestation requirement on internal
control over financial reporting. Further, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend
to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not
&#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the independent registered public
accounting firm attestation requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to assess the internal controls of our target business or businesses prior to the completion of the Business Combination and,
if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective
system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy
of internal controls. Many small and mid-sized target businesses we may consider for our initial business combination may have internal
controls that need improvement in areas such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">staffing
    for financial, accounting and external reporting areas, including segregation of duties; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reconciliation
    of accounts; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">proper
    recording of expenses and liabilities in the period to which they relate; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidence
    of internal review and approval of accounting transactions; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">documentation
    of processes, assumptions and conclusions underlying significant estimates; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">documentation
    of accounting policies and procedures. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
it will take time, management involvement and perhaps outside resources to determine what internal control</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">improvements
are necessary for us to meet regulatory requirements and market expectations for our operation of a target business, we may incur significant
expenses in meeting our public reporting responsibilities, particularly in the areas of designing, enhancing, or remediating internal
and disclosure controls. Doing so effectively may also take longer than we expect, thus increasing our exposure to financial fraud or
erroneous financing reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
our management&#8217;s report on internal controls is complete, we will retain our independent auditors to audit and render an opinion
on such report when required by Section 404 of the Sarbanes-Oxley Act. The independent auditors may identify additional issues concerning
a target business&#8217;s internal controls while performing their audit of internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures about Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering,
the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in certain U.S. government
obligations with a maturity of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term
nature of these investments, we believe there will be no associated material exposure to interest rate risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-balance
Financing Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2021. We do
not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as
variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have
not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments
of other entities, or purchased any non-financial assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 165; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in
the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the
periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Subject to Possible Redemption</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;)
Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified as a liability
instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our
control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. Our common
stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future
events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the
stockholders&#8217; equity section of our balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Income (Loss) Per Common Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share of common stock is computed by dividing net loss by the weighted average number of ordinary shares outstanding during
the period. We apply the two-class method in calculating earnings per share of common stock. Accretion associated with the redeemable
shares of common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent
Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted,
would have a material effect on Globis&#8217; condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JOBS
Act</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will
qualify as an &#8220;emerging growth company&#8221; and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject
to certain conditions set forth in the JOBS Act, if, as an &#8220;emerging growth company,&#8221; we choose to rely on such exemptions
we may not be required to, among other things, (i) provide an auditor&#8217;s attestation report on our system of internal controls over
financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required
of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement
that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional
information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation
related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer&#8217;s
compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our
initial public offering or until we are no longer an &#8220;emerging growth company,&#8221; whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 166; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_008"></span><span style="font-size: 10pt"><b>DESCRIPTION
OF NEW FORAFRIC&#8217;S SECURITIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain provisions of New Forafric&#8217;s securities does not purport to be complete and is subject to the proposed
Memorandum and Articles of Association and the provisions of applicable law. Copies of the proposed Memorandum and Articles of Association
are attached to this proxy statement/prospectus as <i>Annexes C</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
and Outstanding Share Capital</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorized share capital of New Forafric is USD 101,000 (one hundred and one thousand United States Dollars) divided into: (i)
100,000,000 ordinary shares of USD 0.001 (one thousandth United States Dollars) each; and (ii) 1,000,000 preferred shares of USD 0.001
(one thousandth United States Dollars) each, each conferring those rights, entitlements, obligations and restrictions as more particularly
set out in the Memorandum and Articles of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of the Business Combination, we expect that there will be Ordinary Shares of New Forafric outstanding, assuming that no Public
Shares are redeemed in connection with the Business Combination. All Ordinary Shares are fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
rights</i>. Each holder of Ordinary Shares is entitled to one vote for each Ordinary Share held of record by such holder on all matters
on which shareholders generally are entitled to vote. Holders of Ordinary Shares will vote together as a single class on all matters
presented to New Forafric&#8217;s shareholders for their vote or approval. Generally, all matters to be voted on by shareholders must
be approved by a majority (or, in the case of election of directors, by a plurality) of the votes entitled to be cast by all shareholders
present in person or represented by proxy, voting together as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Rights</i>. New Forafric may declare an interim or final dividend to be paid to the holders of its ordinary shares in proportion to their
respective shareholdings. Under the Companies Act and the Memorandum and Articles of Association, final dividend distributions are recommended
by the Board and approved by an ordinary resolution of the shareholders. The amount of such final dividend may not exceed the amount
recommended by the directors. Dividends may not be paid otherwise than out of New Forafric&#8217;s distributable reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
upon liquidation</i>. In the event of the liquidation of New Forafric, after satisfaction of liabilities to creditors, the assets of
New Forafric will be distributed to the holders of the Ordinary Shares in New Forafric in proportion to their respective shareholdings.
This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to
the holders of a class of Preferred Shares with preferential rights that may be authorized by ordinary resolution in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
rights</i>. The holders of Ordinary Shares have no preemptive or conversion rights or other subscription rights. There are no redemption
or sinking fund provisions applicable to the Ordinary Shares. The rights, preferences and privileges of holders of the Ordinary Shares
may be subject to those of the holders of any Preferred Shares New Forafric may issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Preferred Shares will be issued or outstanding immediately after the completion of the Business Combination. The Memorandum and Articles
of Association of New Forafric allow the board of directors of New Forafric (the &#8220;Board&#8221;) to issue Preferred Shares following
the passing of an ordinary resolution. Unless required by law or any stock exchange, the authorized Preferred Shares will be available
for issuance by the Board upon the passing of an ordinary resolution of the holders of the Ordinary Shares. The ordinary resolutions
of the shareholders of New Forafric would stipulate the powers, preferences and relative, participating, optional and other rights or
special rights, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, as well
as any restrictions, of the class of Preferred Shares as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 167; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of Preferred Shares may have the effect of delaying, deferring or preventing a change in control of New Forafric without further
action by the shareholders. Additionally, the issuance of Preferred Shares may adversely affect the holders of Ordinary Shares by restricting
dividends on the Ordinary Shares, diluting the voting power of the Ordinary Shares or subordinating the liquidation rights of the Ordinary
Shares. As a result of these or other factors, the issuance of Preferred Shares could have an adverse impact on the market price of the
Ordinary Shares. At present, Globis has no plans to issue any Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
redeemable warrant entitles the registered holder to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment
as discussed below, at any time commencing on the later of the completion of an initial business combination and 12 months from the closing
of this offering. Except as set forth below, no warrants will be exercisable for cash unless we have an effective and current registration
statement covering the Ordinary Shares issuable upon exercise of the warrants and a current prospectus relating to such Ordinary Share.
Notwithstanding the foregoing, if a registration statement covering the Ordinary Share issuable upon exercise of the warrants is not
effective within 90 days from the consummation of our initial business combination, warrant holders may, until such time as there is
an effective registration statement and during any period when we shall have failed to maintain an effective registration statement,
exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided
that such exemption is available. In such event, each holder would pay the exercise price by surrendering the warrants for that number
of Ordinary Share equal to the quotient obtained by dividing (x) the product of the number of Ordinary Share underlying the warrants,
multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)
the fair market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the Ordinary Share for
the 10 trading days ending on the third trading day prior to the date of exercise. For example, if a holder held 150 warrants to purchase
150 shares and the fair market value on the date prior to exercise was $15.00, that holder would receive 35 shares without the payment
of any additional cash consideration. If an exemption from registration is not available, holders will not be able to exercise their
warrants on a cashless basis. The warrants will expire five years from the consummation of a business combination at 5:00 p.m., Eastern
Standard Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may call the outstanding warrants for redemption (excluding the private warrants and warrants underlying the units that may be issued
upon conversion of working capital loans), in whole and not in part, at a price of $0.01 per warrant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time while the warrants are exercisable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than 30 days&#8217; prior written notice of redemption to each warrant holder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the Ordinary Share equals or exceeds $16.50 per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-day trading period ending on the third
    business day prior to the notice of redemption to warrant holders (the &#8220;Force-Call Provision&#8221;), and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the Ordinary Share underlying such warrants at the
    time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of
    redemption.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and
after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder&#8217;s
warrant upon surrender of such warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 168; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium
to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the warrant exercise
price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below
the exercise price of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we call the warrants for redemption as described above, our management will have the option to require all holders that wish to exercise
warrants to do so on a &#8220;cashless basis.&#8221; In such event, each holder would pay the exercise price by surrendering the warrants
for that number of Ordinary Share equal to the quotient obtained by dividing (x) the product of the number of Ordinary Share underlying
the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined
below) by (y) the fair market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of our Ordinary
Share for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders
of warrants. Whether we will exercise our option to require all holders to exercise their warrants on a &#8220;cashless basis&#8221;
will depend on a variety of factors including the price of our common shares at the time the warrants are called for redemption, our
cash needs at such time and concerns regarding dilutive share issuances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) we issue additional Ordinary Shares or equity-linked securities for capital raising purposes in connection with the
closing of our initial business combination at an issue price or effective issue price of less than $9.50 per Ordinary Share (with such
issue price or effective issue price to be determined in good faith by our board of directors), (y) the aggregate gross proceeds from
such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business
combination (net of redemptions), and (z) the Market Value is below $9.50 per share, the exercise price of the warrants will be adjusted
(to the nearest cent) to be equal to 115% of the Market Value, and the $16.50 per share redemption trigger price described above will
be adjusted (to the nearest cent) to be equal to 165% of the Market Value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants will be issued in registered form under a warrant agreement between VStock Transfer, LLC, as warrant agent, and us. The warrant
agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any
defective provision, but requires the approval, by written consent or vote, of the holders of a majority of the then outstanding warrants
in order to make any change that adversely affects the interests of the registered holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of Ordinary Share issuable on exercise of the warrants may be adjusted in certain circumstances including in
the event of a share dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the
warrants will not be adjusted for issuances of Ordinary Share at a price below their respective exercise prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full
payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised. The warrant
holders do not have the rights or privileges of holders of Ordinary Share and any voting rights until they exercise their warrants and
receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise of the warrants, each holder will be entitled to one vote
for each share held of record on all matters to be voted on by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described above, no public warrants will be exercisable for cash and we will not be obligated to issue Ordinary Share unless at the
time a holder seeks to exercise such warrant, a prospectus relating to the Ordinary Share issuable upon exercise of the warrants is current
and the Ordinary Share have been registered or qualified or deemed to be exempt under the securities laws of the state of residence of
the holder of the warrants. Under the terms of the warrant agreement, we have agreed to use our best efforts to meet these conditions
and to maintain a current prospectus relating to the Ordinary Share issuable upon exercise of the warrants until the expiration of the
warrants. However, we cannot assure you that we will be able to do so and, if we do not maintain a current prospectus relating to the
Ordinary Share issuable upon exercise of the warrants, holders will be unable to exercise their warrants and we will not be required
to settle any such warrant exercise. If the prospectus relating to the Ordinary Share issuable upon the exercise of the warrants is not
current or if the Ordinary Share is not qualified or exempt from qualification in the jurisdictions in which the holders of the warrants
reside, we will not be required to net cash settle or cash settle the warrant exercise, the warrants may have no value, the market for
the warrants may be limited and the warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 169; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be
able to exercise their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess
of 9.9% of the Ordinary Share outstanding. Notwithstanding the foregoing, any person who acquires a warrant with the purpose or effect
of changing or influencing the control of our company, or in connection with or as a participant in any transaction having such purpose
or effect, immediately upon such acquisition will be deemed to be the beneficial owner of the underlying Ordinary Share and not be able
to take advantage of this provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive
a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Ordinary Share to be issued
to the warrant holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
exchange offer made to both the publicly traded warrants and the warrants held by our sponsors on the same terms will not constitute
an amendment requiring consent of any warrant holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants and Placement Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed that we will not redeem the private warrants or placement warrants and we will allow the holders to exercise such warrants
on a cashless basis (even if a registration statement covering the shares of common stock issuable upon exercise of such warrants is
not effective). Additionally, the representative of the underwriters has agreed that it will not be permitted to exercise any private
warrants to be issued to it and/or its designees upon consummation of this offering after the five year anniversary of the effective
date of the registration statement of which this prospectus forms a part. Furthermore, because the private warrants and placement warrants
will be issued in private transactions, the holders and their transferees will be allowed to exercise the private warrants and placement
warrants on a cashless basis or for cash even if a registration statement covering the shares of common stock issuable upon exercise
of such warrants is not effective and receive unregistered shares of common stock. In the event that a holder of private warrants or
placement warrants elects to exercise such warrants on a cashless basis, each holder would pay the exercise price by surrendering the
warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares
of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair
market value&#8221; (defined below) by (y) the fair market value. With respect to the private warrants or placement warrants, the &#8220;fair
market value&#8221; shall mean, at the discretion of the holder, either (x) the last reported sale price of the shares of common stock
for the trading day prior to the date of exercise or (y) the average reported last sale price of the shares of common stock for the 10
trading days ending on the third trading day prior to the date of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
did not declare any dividend in the past and the Board will consider whether or not to institute a divided policy in the future. The
payment of future dividends on the Ordinary Shares will depend on the financial condition of New Forafric after the completion of the
Business Combination subject to the discretion of the New Forafric Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
Controls</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no currency control restrictions on remittances of dividends on Ordinary Shares, proceeds from the sale of the shares or
interest or other payments to non-residents of Gibraltar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 170; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Meetings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric will call annual general meetings pursuant to the provisions of the Memorandum and Articles of Association in accordance
with the Companies Act. The New Forafric Board may call extraordinary general meetings whenever they see fit in accordance with the
provisions of the Companies Act and the Memorandum and Articles of Association. A general meeting of New Forafric, other than a
meeting for the passing of a special resolution, may be called by 7 days&#8217; prior written notice. A general meeting of New
Forafric for the passing of a special resolution may be called by giving at least 21 days&#8217; prior written notice and specifying
in the notice the resolution that will be proposed as a special resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the Companies Act and the regulations promulgated thereunder, shareholders entitled to participate and vote at general
meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and forty days prior
to the date of the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Appointment
of Directors, Election of Directors and Vacancies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
person who is willing to act as a director, is permitted by law to do so may be appointed to be a director of New Forafric by ordinary
resolution, or by a decision of the New Forafric Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
of New Forafric are generally appointed for periods of three calendar years, save as provided below. At every annual general meeting
of New Forafric, any director who has at the start of the annual general meeting been in office for three calendar years or more since
his last appointment or re-appointment shall retire at that annual general meeting but he may offer himself for reappointment by the
shareholders. If New Forafric does not fill the vacancy in the New Forafric Board at the meeting at which a director retires by rotation
or otherwise, the retiring director shall, if willing to act, be deemed to have been re-appointed unless at the meeting it is resolved
not to fill the vacancy or unless a resolution for the re-appointment of the director is put to the meeting and lost. The appointment
of any person proposed as a director shall be effected by a separate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
person other than a director retiring by rotation shall be appointed a director at any general meeting unless he is recommended by the
New Forafric Board or, not less than three nor more than forty-two days before the date appointed for the general meeting, a notice executed
by any shareholder qualified to vote at the meeting (not being the person to be proposed) has been received by New Forafric of the intention
to propose that person for appointment stating the particulars of that nominee, together with confirmation in writing executed by that
person of his willingness to be appointed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
as provided above, New Forafric may by ordinary resolution appoint a person who is willing to act to be a director either to fill a vacancy
or as an additional director and may also determine the rotation in which any additional directors are to retire. The appointment of
a person to fill a vacancy or as an additional director shall take effect from the end of the meeting. The New Forafric Board may also
appoint a person who is willing to act to be a director, either to fill a vacancy or as an additional director and in either case whether
or not for a fixed term. Irrespective of the terms of his appointment, a director appointed by the New Forafric Board shall hold office
only until the next annual general meeting and shall be taken into account in determining the directors who are to retire by rotation
at the meeting. If not re-appointed at such annual general meeting, he shall vacate office at its conclusion. A director who retires
at an annual general meeting may, if willing to act, be re-appointed. If he is not re-appointed, he shall retain office until the meeting
appoints someone in his place, or if it does not do so, until the end of the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
of New Forafric are not required to hold any shares in the capital of New Forafric by way of qualification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the following paragraph, New Forafric may by ordinary resolution of which special notice has been given, or by special resolution,
remove from office a director appointed by ordinary resolution or by a decision of the directors, notwithstanding any provisions of the articles of association or of any agreement between New Forafric and such director, but without prejudice to any claim the director
may make for damages for breach of such agreement. New Forafric may, by ordinary resolution, appoint another person to be a director
in the place of a director so removed from office. In default of such appointment the vacancy so arising may be filled by the New Forafric
Board as a casual vacancy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 171; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the first three calendar years commencing from the date of adoption of the articles of association of New Forafric, the company may only
by special resolution or extraordinary resolution, remove from office a director appointed by ordinary resolution or by a decision of
the directors, notwithstanding any provisions of the articles of association or of any agreement between New Forafric and such director,
but without prejudice to any claim such director may make for damages for breach of such agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quorum</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Memorandum and Articles of Association provide that the holders of 33 1/3% of the issued and outstanding share capital of New Forafric
present in person or by proxy and entitled to vote on the business to be transacted, shall be a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vote
Requirements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
ordinary resolution of the shareholders (or of a class of shareholders) of New Forafric means a resolution that is passed by members
representing a simple majority (more than 50%) of the total voting rights of the shareholders or, as the case may be, of the class of
shareholders. An extraordinary resolution of the shareholders means a resolution that is passed by shareholders representing a majority
of not less than 75% of those shareholders at a general meeting of which notice specifying the terms of the resolution and the intention
to propose the resolution as an extraordinary resolution has been given.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Measures; Regulation of Takeovers of Gibraltar Companies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Companies
(Cross-Border Mergers) Regulations 2010</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric will be incorporated in Gibraltar and it is governed by Gibraltar legislation which regulates the takeover of Gibraltar registered
companies. The Companies (Cross-Border Mergers) Regulations 2010, or the Regulations, transpose Directive 2005/56/EC of the European
Parliament and of the Council of 26 October 2005 on cross border mergers of limited liability companies into the law of Gibraltar. This
EC Directive has been incorporated into the laws of other EC member states, including in the United Kingdom by the Companies (Cross-Border
Mergers) Regulations 2007. The Regulations in force in Gibraltar, or the Regulations, in effect, are broadly similar but not identical
to those in place in the United Kingdom. These Regulations are designed to facilitate cross-border mergers of limited liability companies
registered in European Member States and to thereby allow for cross-border merger of a national limited liability company of one Member
State with a limited liability company of another Member State. Under the Regulations, a Gibraltar merging company has to make an application
to the court to obtain a pre-merger certificate prior to any merger taking place (&#8220;Pre-Merger Certificate&#8221;). In order to
obtain such a certificate, the Gibraltar company must provide the court, inter alia, with the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">draft
    terms of the proposed merger (indicating, inter alia, details for the companies involved, share exchange ratios, effects of the merger
    on employees, rights or restrictions on shares, articles of association, employee participation rights, assets and liabilities transferred
    and account dates) (the &#8220;Draft Terms&#8221;). The Draft Terms must be approved by 75% of the members of the company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    directors&#8217; report (indicating, inter alia, the effects of a cross-border merger for members, creditors and employees, legal
    and economic grounds for the Draft Terms and any material interests of the directors). The report must be delivered to the employees
    of the company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    independent expert&#8217;s report (indicating, inter alia, details of share exchange ratios and valuation difficulties). Employees
    of the Gibraltar company must be able to inspect and make copies of these documents.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 172; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
courts of Gibraltar may make an order approving the completion of a cross-border merger on the joint application of all the merging companies
if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    order for a Pre-Merger Certificate (either granted by the courts in Gibraltar or another competent authority in another member state)
    has been made within 6 months;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Draft Terms presented for acquiring the Pre-Merger Certificate have not been amended; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
    are appropriate arrangements for employee participation in the transferee company in accordance with part 4 of the Regulations. Such
    an order will specify the date on which the consequences of the cross-border merger are to have effect. A copy of this order must
    be provided to the Registrar of Companies of Gibraltar within 7 days of the order if this has been made in Gibraltar or within 14
    days if this has been made in another Member State.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies (Cross-Border Mergers) Regulations 2010 only apply to mergers between companies in different European Member States. More commonly,
takeovers of a Gibraltar registered company can also take place via a scheme of arrangement pursuant to the Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Gibraltar Companies Act 2014</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
takeover of a Gibraltar registered company can take place via a scheme of arrangement under the Companies Act. The relevant sections
of the Companies Act provide, inter alia, that an application must be made to court in order to convene a meeting of members of such
company where such an arrangement can be proposed between a company and its members. Draft terms of the merger as well as other reports
and accounting statements would need to be prepared, filed with the Companies Registrar and published prior to such a meeting being convened.
At such meeting, at least 75% of the members present in person or by proxy must approve the arrangement in order for a court to thereafter
be able to sanction the same. If sanctioned, the court may also order the transfer of undertaking, property and/or liabilities of the
transferor company in accordance with the terms of the scheme.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above, another mechanism exists under s.208 of the Gibraltar Companies Act 1930 and s.352(A) of the Companies Act (commonly
referred to as the &#8220;Squeeze Out provisions&#8221;) which provides for the situation where a bidder proposes a scheme or contract
to take over the shares of a Gibraltar registered company and certain shareholders do not consent to the proposal. If within four months
from making such a proposal more than 90% of shareholders of a target company agree to the terms of such a scheme or contract, then the
bidding company may within two months after the expiration of said four months give notice to the dissenting members of the target company
that it will acquire the shares and certain shareholders do not consent to the proposal on the same terms of the scheme or contract.
A Gibraltar scheme of arrangement, therefore, eliminates the risk that a minority of less than 10% of the target company&#8217;s shareholders
may resist the transfer of their shares to the bidder. It should be noted, however, that such a scheme can be subject to the sanction
of the court as any dissenting members may apply to court for an order seeking relief from such a scheme or contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
Services Act 2019 &#8211; Part 20 Acquisitions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
20 of the Financial Services Act 2019 applies to takeover bids for the securities of companies governed by the law of Gibraltar, where
all or some of those securities are admitted to trading on a regulated market in Gibraltar. However, Gibraltar does not, as yet, have
a regulated market. The Gibraltar Financial Services Commission is designated as the competent authority for the purposes of Part 20.
Part 20 contains provisions on the conduct of bids, squeeze outs and sell outs, and applicable offences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
New Forafric shareholders will have registration rights with respect to their Ordinary Shares following the consummation
of the Business Combination. See &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Certain Agreements Related to the Business
Combination</i>&#8221; for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for New Forafric capital stock will be VStock Transfer, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing
of Ordinary Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
has applied for the continued listing of New Forafric&#8217;s Ordinary Shares and warrants on Nasdaq under the ticker symbols &#8220;AFRI&#8221;
and &#8220;AFRIW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 173; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_009"></span><span style="font-size: 10pt"><b>BENEFICIAL
OWNERSHIP OF SECURITIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following table sets forth
information regarding the beneficial ownership of (i) Globis as of January 12, 2022 (pre-Business Combination) and (ii) New Forafric
immediately following the completion of the Business Combination (post-Business Combination), assuming no Redemptions, and alternatively
that 11,500,000 shares of Common Stock of Globis are redeemed, by:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person known by Globis to be the beneficial owner of more than 5% of the shares of Globis Shares or the beneficial owner of more
    than 5% of the shares of Globis&#8217; common stock upon completion of the Business Combination; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of Globis&#8217; officers and directors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person who will become an officer or is nominated to become a director of New Forafric upon completion of the Business Combination;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    officers and directors of New Forafric as a group prior to the completion of the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security
if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently
exercisable or exercisable within 60 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt">The expected
beneficial ownership of shares of New Forafric&#8217;s ordinary shares immediately following completion of the Business Combination has
been determined based on the following assumptions: (i) there will be an aggregate of 15,050,833 common stock of Globis issued and outstanding
immediately prior to the completion of the Business Combination, which shares will have been converted into ordinary shares of New Forafric
upon completion of the Business Combination, (ii) the PIPE Investors will have been issued (A) assuming No Redemptions, an aggregate
of 1,712,245 ordinary shares and (B) assuming Maximum Redemptions, an aggregate of 1,208,296 ordinary shares, (ii) an aggregate of 1,005,291
ordinary shares will have been issued to the FAHL Bond Holders, (iv) an aggregate of 1,445,164 ordinary shares will have been issued
to the FAHL Related Party Loan Holders, (v) the Seller receiving, immediately following the completion of the Business Combination, (A)
assuming No Redemptions, an aggregate of 15,100,000 ordinary shares and (B) assuming Maximum Redemptions, an aggregate of 17,004,762
ordinary shares; and (iv) each of the other assumptions set forth under the section entitled &#8220;Frequently Used Terms &#8212; Share
Calculations and Ownership Percentages.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares
beneficially owned by them. Unless otherwise noted, the business address of each of the following entities or individuals is Globis Acquisition
Corp., 7100 W. Camino Real, Suite 302-48, Boca Raton, FL 33433.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in the table below for Pre-Business Combination Globis Shares does not include shares underlying the Private Placement Warrants
held or to be held by Globis&#8217; officers or the Sponsor because these securities are not exercisable within 60 days of this proxy
statement/prospectus and are contingent upon the occurrence of the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pre-Business Combination</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Post-Business Combination</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming No Redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming Maximum Redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Globis Shares<br /> Beneficially Owned<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">New Forafric Ordinary Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"><sup>&#160;</sup></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">New Forafric Ordinary Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Packer<sup>(2)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">2,830,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">18.8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,570,741</td><td style="width: 1%; text-align: left"><sup>(3)&#160;</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">10.2</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,570,741</td><td style="width: 1%; text-align: left"><sup>(3)</sup>&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">14.7</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claude Benitah</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael A. Ferguson</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John M. Horne<sup></sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -12pt; padding-left: 12pt">All pre-Business Combination Globis officers
    and directors as a group (four individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,875,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,675,741</td><td style="text-align: left"><sup>(3)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,675,741</td><td style="text-align: left"><sup>(3)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Named Executive Officers and Director Nominees of New Forafric
    Post-Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Saad Bendidi</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Mustapha Jamaleddine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Julien Benitah</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Packer<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,830,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,570,741</td><td style="text-align: left"><sup>(3)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,570,741</td><td style="text-align: left"><sup>(3)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Franco Cassar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">James Lasry</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ira Greenstein</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; text-indent: -12pt; padding-left: 12pt">All post-Business Combination New Forafric
    officers and directors as a group (nine individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,830,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,570,741</td><td style="text-align: left"><sup>(3)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,570,741</td><td style="text-align: left"><sup>(3)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Five Percent Holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lighthouse Capital Limited<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,731,614</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,636,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.8</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than one percent. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Business
    Combination amounts consist entirely of founder shares, which will be exchanged for New Forafric Ordinary Shares in connection with
    the Merger and Redomiciliation, and excludes 3,628,889 shares of Globis Common Stock underlying private placement warrants held by
    Globis SPAC LLC and 60,000 shares of Globis Common Stock (20,000 shares each) underlying private placement warrants held by Globis'
    independent directors that will only become exercisable after completion of an initial business combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 2,830,000 shares of Globis Common Stock owned by Globis SPAC LLC, one of our sponsors and 740,741 Ordinary Shares of New Forafric
    that will have been issued to an affiliate of Globis. Mr. Packer may be deemed to control and have voting and investment power over
    these securities. upon conversion of the FAHL Bonds. Mr. Packer disclaims beneficial ownership over these securities except to the
    extent of his pecuniary interest therein.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">(3)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
    3,628,889 shares of Globis Common Stock underlying private placement warrants held by Globis SPAC LLC that are subject to a 9.9%
    beneficial ownership limitation pursuant to the terms of such warrants. Such warrants may not be exercised to the extent that the
    holder or any of its affiliates would beneficially own in excess of 9.9% of the number of shares of Common Stock issuable upon exercise
    of such warrants (as calculated in accordance with Section 13(d) of the Exchange Act).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    631,614 Ordinary Shares of New Forafric that will have been issued to Lighthouse Settlement upon conversion of the FAHL Related Party
    Loans. Lighthouse Settlement is the sole shareholder of Lighthouse Capital Limited. Lighthouse Corporation PTC, as trustee of Lighthouse
    Settlement, may be deemed to be the beneficial owner of the securities held by Lighthouse Settlement as trustee. Lighthouse Corporation
    PTC Limited disclaims beneficial ownership over these securities except to the extent of its pecuniary interest therein.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 174; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="ma_010"></span><span style="font-size: 10pt"><b>INFORMATION
ABOUT FAHL</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated or the context otherwise requires, references in this section to &#8220;FAHL,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; the &#8220;group&#8221; and other similar terms refer to FAHL and its subsidiaries prior to the Business Combination
and to New Forafric and its consolidated subsidiaries after giving effect to the Business Combination as the context may require.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
Agro Holdings Limited is a private company limited by shares incorporated in Gibraltar under the laws of Gibraltar. We are registered
with the Registrar of Companies in Gibraltar under registration number 114436. We are a holding company, and substantially all of our
operations are conducted through our subsidiaries. Our corporate headquarters is located at Madison Building, Midtown, Queensway,
Gibraltar GX11 1AA. Our registered office is located at 57/63 Line Wall Road, Gibraltar GX11 1AA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
is an integrated, global business involved in the purchase, storage, transport, processing and sale of agricultural commodities and commodity
products while managing risk across various product lines. The principal agricultural commodities that we handle are flour and semolina,
and secondary processing products such as pasta and couscous.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
subsidiary Forafric Maroc is the combination of two former family owned businesses, Forafric (Maymouna) and Tria Group. Forafric (Maymouna) was
acquired by FAHL in April 2015 and the Tria Group was acquired by FAHL in January 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tria
Group was established in 1923 in Morocco under the name Minoterie Biscuiterie d&#8217;Anfa. The brand Tria was created in 1949. Tria
Group was purchased by Mr. Mohammed Jamaleddine (father of Mustapha Jamaleddine, CEO of the group) in 1974. At this time the group
had only one mill with a total capacity of 70T per day. In 1981, a first investment was made to increase the capacity to 150T/day. The
production of pasta and couscous was launched in 1989. In 1995, a second investment to increase the capacity was made. In 2004, Tria
formed the Ceraelis trading company, and in 2008, Finalog, a logistics company, with storage facilities in Casablanca. Tria
Group was managed by the Jamaleddine family until 2016 and its acquisition by Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
(Maymouna) was created in 1943. It initially specialized in the import-export of cereals and various products of the land (legumes, sugar,
tea, aromatic plants, etc.) which in 1997 evolved into industrial flour milling by buying and then building its own mills. In 2003,
Forafric decided to market its own brand, MayMouna.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today,
we</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> sell processed commodity products to customers
in approximately forty-five countries in Europe, Asia, Africa and the Middle East. The principal purchasers of our products are
wholesale foods manufacturers and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed an extensive global logistics network including storage facilities with direct access to ports by rail. We contract with
third parties for transport services. To better serve our customer base and develop our global distribution and logistics capabilities,
we have agreements with third parties in storage and in transportation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate primarily in the large and growing African food  market, providing base products such as flour, semolina pasta and couscous,
which are staple products for most consumers in this and other developing markets. We foresee continued market growth with the projected
demographical increase and urbanization in the region. The African population was approximately 1.3 billion in 2020 and according to
the Organisation for Economic Co-operation and Development will reach approximately 2.5 billion by 2050. Urbanization in Africa is projected
to reach 1.5 billion by 2050, adding 950 million people since 2015. 36% of the world&#8217;s undernourished population is in Africa.
Such increase in urbanization is expected to lead to increased demand for more processed products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 175; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wheat
is unique as a source of the gluten proteins that alone have the dough-forming properties needed to make the variety of foods that rely
on the rheology of dough, namely, leavened breads, pasta, noodles, flat/pocket breads, steamed breads, biscuits, cakes, pastries and
various food ingredients. Therefore wheat, an essential part of the diet of most of the world&#8217;s population, is prominent in world
trade. Its quality traits are the most critical of all the grains.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
has shown that fiber may play a large role in maintaining bowel health, lowering cholesterol, stabilizing blood glucose levels and controlling
weight gain. In recent years, the awareness of the health benefits of high fiber diets has increased. Wheat flour is known for its high
fiber, as well as a source of thiamin, riboflavin, niacin, and vitamin E. It is also considered to be a good source of several minerals
such as iron, calcium, selenium, manganese, copper, phosphorous, and folate. It offers a number of health benefits, which has led to
increased demand for wheat flour among end users. Skin protection, nourishment, and energy are some of the basic health benefits offered
by the consumption of wheat flour.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
high fiber content in wheat is known to promote gut health and reduce the risk of colon cancer. Consumption of wheat flour has also showed
positive effects on blood sugar levels and cholesterol levels, which are some of the reasons that are contributing to change in dietary
preferences of individuals. We do not believe that concerns regarding gluten intolerance and celiac disease, which impact only small
percentages of the population, will have any appreciable impact on projected sales growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of our assets are based in Morocco. The total consumption in Morocco is 5 metric tons (MT) of wheat and 0.8MT of durum per year for
a total production of 4MT of flour and 600 kilotons (KT) of semolina. The total consumption of wheat-based product per person in Morocco
is the second highest in the world with 200kg per person per year. This is 3 times the average consumption per person per year of the
rest of the world as bread remains a staple of both the Moroccan diet and of Moroccan culture. The population of Morocco is projected
to grow from approximately 36 million to 46 million by 2050.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Strengths</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leader
in the Moroccan market</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a leader in the Moroccan market in respect of the wheat milling business, with a milling capacity of 2,200T per day. This position
enables FAHL to have better access to raw materials, to improve its productivity and to benefit from the power of its two main brands,
Maymouna and Tria <i>(See Our Brands and Products).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Raw materials
are the key to profitability in our industry. Raw material accounts for up to 80% of total cost. With a total volume of 500,000T
per year, the group has great bargaining power, ahead of many international providers of wheat, and has, accordingly, had access to excellent
conditions of purchasing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with every industrial business, productivity is key to performance. With 7 milling units in Morocco, we improved our productivity over
the past 3 years and reduced our industrial cost. We are now among the most best performing industrial units in our industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maymouna
and Tria are our two main brands in the Moroccan market. Maymouna is the most popular brand for Moroccan households and Tria is our
most popular brand for industrial clients in Morocco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Stable Product Demand</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are basic food staples in Morocco and Africa. Accordingly, demand for our products has been stable in Morocco and fast-growing
in Sub-Saharan Africa and Angola, even in periods of economic uncertainty.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Our business did not suffer any crisis of decrease of demand during the economic disruptions that impacted Africa and Asia in
2020-2021. During the recent pandemic crisis of COVID-19, demand for our products continued to remain high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 176; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Near-term
and long-term Opportunities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Near-term
opportunities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Moroccan flour sector is
changing. Though in the 1960s Morocco was largely self-sufficient, producing more than 80% of the wheat for domestic consumption, only
60% of the total domestic demand for wheat was met by the end the 20th century. Despite the introduction of improved wheat varieties
and significant increases in yields, yield levels remain below both the global average of over 3 metric tons per Hectare (t/ha) and the
African average of 2.3 t/ha. Consequently, Morocco continued to import large volumes, making wheat the most important (in both volume
and value terms) of all agricultural imports. Governmental efforts to support yield growth are expected to continue, including the use
of new technologies for better seed-delivery and to increase crop yield. The transformation of the sector will create immediate
opportunities to grow and gain market share. As the leader on this market, we expect to benefit from this transformation.
Due to abundant rains, wheat production in Morocco is expected to triple to 7.54 million tons, according to a recent Global Agricultural
Information Network report from the US Department of Agriculture and New Forafric is expected to benefit from this increase.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 47.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the International Grains Council, the global forecast for world stocks at the end of 2021-22 has been lowered to 274 million tons
(down 4 million tons from the previous year), representing the first global drawdown in three seasons, due to sharp reduction in output
in Iran as a result of drought, as well as downgrades in Kazakhstan, Algeria and the European Union. At the same time, world wheat consumption
is currently at record levels, creating both potential sales opportunities for New Forafric as well as increases in raw material costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Supply chain shortages did not
have a material adverse effect on the our operations in 2021, and though there have been predictions that such disruptions will
ease in 2022, the risk remains that transportation costs could still increase if supply chain disruptions continue.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Long-term
opportunities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the market in which we operate is sustainable and growing. We expect future growth in our market will be led by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    demographical growth in the African continent from approximately 1.3 billion in 2020 to approximately 2.5 billion by 2050;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasing
    urbanization in Africa, projected to reach 1.5 billion by 2050, adding 950 million people since 2015; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    continued growth in the consumption of our products in the region, which are and are excepted to not only remain staple products,
    but to gain further traction with increasing urbanization.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Business Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
considers sustainable growth to be the pillar of its business management strategy, through which it consolidates its position as a benchmark
business group in its areas of activity and as a sound, innovative, sustainable, responsible enterprise, committed to: (i) social well-being,
diversity, environmental balance and social and economic progress; and (ii) tax responsibility, respect of human rights and prevention
of corruption and other illegal conduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
entails developing a business model focusing on the generation of value, taking into consideration the interests of its human team, shareholders
and investors, customers, suppliers, the media, the communities in which FAHL operates and the environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this regard, FAHL looks beyond the exclusive goal of achieving financial yield and includes environmental, social and ethical criteria
alongside economic variables in its decision-making processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
thus undertakes, as an essential principle in its actions, the creation of a business model that is respectful of and sustainable for
the environment and society overall and, while ensuring value, profitability and competitiveness, it promotes diversity, respect for
human rights, tax responsibility and the prevention of corruption, thus contributing towards the progress of society and generating trust
among our stakeholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 177; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Fundamental Values</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nutrition:
We ensure the supply of products essential for human nutrition by contributing to the health and well-being of consumers. Our brands
are symbols of quality and good nutrition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proximity:
We maintain lasting relationships with consumers, our customers and suppliers, by constantly listening to them. We build relationships
of trust based on mutual respect. We support the social and economic well-being of our growers, suppliers and local communities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrity:
We are responsible for our actions and performance. We expect similar behavior from our partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excellence:
We aim for the best quality for our products, and process for the contribution of our teams. We are aware of our responsibility to provide
high quality product and product our customers from damaging additives and chemical residues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sustainability:
We always act with respect for our environment, and incorporate sustainability in all areas of our business, from operation of our facilities,
to engagement with customers, suppliers and communities. Long term sustainability and environmental responsibility are fundamental to
the future of our business. We are dedicated to reducing our carbon footprint by reduction of power consumption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Business Model</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
has established itself as a leading wheat milling player in Morocco. It owns six milling plants across Morocco (four dedicated to common
wheat and two to durum wheat) with total processing capacity of 2,200 tons per day and a total milling capacity of 700,000 tons per year.
FAHL also has 1 secondary processing unit, 2 logistics platforms, and 250,000 tons of grain storage facilities in Morocco. It is also
the owner of PRODELA, an animal feed processing company in Morocco, which was established in 1991 to commercialize the bran created by
the mills.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are exported to 45 countries. Our primary activities include the production and sale of a variety of wheat flours, Semolina
and Pasta and Couscous in Morocco and in more than 45 countries. Our two main brands in Morocco are MAYMOUNA and TRIA (see Our Brands
and Products).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Brands and Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
owns two leading brands: Tria and MayMouna.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="forms-4_008.jpg" alt="" style="height: 56px; width: 170px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tria</i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><img src="forms-4_005.jpg" alt="" /></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 178; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Tria
brand was born more than 60 years ago from a family that had a passion for the transmission of Moroccan culinary traditions,
associated with a high level of quality.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-bottom: 0pt">As
a result, Tria brand quickly established itself as a key player in the flour milling sector and in the transformation of wheat
grains into pasta and couscous. Its growing success with Moroccans was the result of strong commitments from the brand, which
since 1958 has perpetuated the tradition by offering products of constant quality with good ancestral taste.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-bottom: 0pt">For
several generations, Tria has strived to keep intact the fundamentals that have made its reputation, from the selection of an high
quality raw materials, to constantly reinventing its products in order to support changing consumer needs, or even
anticipating them.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-bottom: 0pt">Tria
continues to be a highly respected brand for packaged flour, precooked couscous and packaged pasta on the Moroccan market.
Today, Tria perfectly combines modernity and tradition, which makes it one of the favorite brands of Moroccans, representing a precious
heritage that is passed from mother to daughter and from generation to generation. Tria has approximately 15% of the overall market in
Morocco of couscous and approximately 28% in the market of packaged couscous. Tria also has approximately 9% of the overall market of
pasta in Morocco.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tria
branded products include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRIA
    DAKIK MINE NAWH MOUMTAZ for Flour, Pasta and Couscous</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRIA
    COUSCOUS DE QUALITE SUPERIEURE for Couscous</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRIA
    PATES DE QUALITE SUPERIEURE for Pasta</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRIA
    FARINE DE QUALITE SUPERIEURE for Flour</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><img src="forms-4_006.jpg" alt="" /></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>MayMouna</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="forms-4_007.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Maymouna, whose Arabic name
derives from &#8220;Youmn&#8221; which intimates values of kindness and blessing, has been a success story since its
initial launch.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Recognized for being a brand
that innovates to make life easier for every housewife. The Maymouna brand has redefined the rules on the Moroccan
market, by adopting a daring strategy which is reflected in its unique packaging, and establishing a color code allowing the clear
identification of each of its products. The brand also integrates this time into its packaging culinary presentations allowing
each housewife to easily recognize the right product capable of meeting each of their needs.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 179; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Maymouna is appreciated for
its quality but also for the richness of its range. The brand has, on a regular basis, introduced new products to attract
the average housewife, its primary consumer (e.g., under the registered trademark Finette) and meet the needs of professionals
(e.g., Farine Boulang&#232;re). This has enabled Maymouna to maintain its popularity and reputation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In 2014, Maymouna was nominated
at the Morocco&#8217;s National Agricultural Fair (SIAM) for an award in the Innovation Brand category, and was awarded
the prize of best price and quality at the SIAM 2014 and 2016 editions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MayMouna
offers a diversified range of products segmented into two categories: soft wheat products and durum wheat products. In order to meet market demands, the products are sold in polypropylene packaging for the traditional circuit (wholesalers, groceries), in kraft paper
for mass distribution. The industry, on the other hand, is delivered in bulk by tanker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soft
wheat products: Soft wheat is the most widely used and cultivated variety of wheat in the world. It is used to produce flour, particularly
for making bread and pastries. All our soft wheat flours are enriched with iron and vitamins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pastry
    flour - Flower flour comes from the heart of the grain (the almond), the extraction of which produces the noblest and whitest flour.
    Thanks to its milling know-how, MayMouna has developed a flour that is 100% flower and guaranteed without lumps, with a mineralization
    rate not exceeding 0.38%. Ideal for the daily needs of the housewife, this flour is perfect for fine culinary preparations: pastries,
    b&#233;chamel, sauces, harira. MayMouna Pastry flour is available in 1kg, 2kg, 5kg and 10kg kraft packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extra
    white - Used mainly by pastry and bakery professionals, MayMouna Extra white flour is very fluid. Guaranteed lump-free, it offers
    excellent hold for all kinds of preparation. It is distinguished by its purity and by its whiteness with a mineralization rate not
    exceeding 0.42%. MayMouna Extra white is available in 5kg, 10kg and 25kg polypropylene packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Baker - This flour suitable for breadmaking is intended exclusively for the baking industry. MayMouna La Boulang&#232;re is available
    in 25kg and 50kg polypropylene packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    also sell products in Morocco under the AMBRE and BRIO brands, which include LA AMBRA, AL DENTE Flour, AMBRA Flour, AMBRE Flour,
    ASSALA, BRIO and BRIO, MLAOUI, BAGHRIR for pasta and couscous. BRIO is also used for export to Europe.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Durum
wheat products: As in most Mediterranean countries and the Maghreb, durum wheat is part of the traditional meal in Morocco. Naturally
rich in fiber, it benefits from recognized digestive virtues. Durum wheat can be transformed into semolina for the production of pasta
and couscous, but also into flour for making bread. In Morocco, the main use of durum wheat is in breadmaking and couscous.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whole
    meal Flour - Naturally rich in fiber, MayMouna Whole meal flour has the particularity of giving a whole hard wheat bread with recognized
    digestive and dietary virtues. MayMouna Whole meal Flour is available in 2kg, 5kg and 10kg kraft, 5kg, 10kg and 25kg polypropylene
    packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finot
    - A flagship product of the entire range, this very fine semolina is ideal for delicate preparations, for golden and well-leavened
    homemade bread. MayMouna Finot also makes it possible to achieve flaky and crispy <i>msemens</i>, a traditional Moroccan type of
    pancake. MayMouna Finot is available in kraft 5kg and 10kg, polypropylene 5kg, 10kg and 20kg packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fine
    semolina - This semolina is used mainly by industrial manufacturers of couscous and pasta. It is also used by housewives and bakers
    for light and golden <i>baghrirs</i>, which is a traditional Moroccan type of pancake or crepe, various semolina cakes, and <i>harcha,
    </i>a Moroccan pan-fried bread.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MayMouna
    Fine Semolina is available in 1kg and 5kg kraft packaging, 5kg, 10kg and 25kg polypropylene.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Course
    semolina - MayMouna Semoule Grosse is mainly intended for the preparation of artisan couscous. With a regular grain size, this semolina
    is ideal to be worked by hand, in the pure respect of tradition. MayMouna Semoule Grosse is available in 5kg kraft, 5kg, 10kg and
    25kg polypropylene packaging.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finette
    - It is an exclusive product of MayMouna, specially created to offer the consumer a flour suitable for the preparation of homemade
    bread. Recognized for its baking qualities, Finette is very fluid. Finette by MayMouna is available in 5kg, 10kg and 25kg polypropylene
    packaging.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 180; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
Tria and Maymouna are our most popular and well-known brands, our products are sold under a number of other brand names, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LES
GRANDES SEMOULERIES DU MAROC : Semolina</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAMSAMDA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TARGA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTRA
BLANCHE: Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOUYAM:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AL
FADANE: Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EL
GHALA: Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FARINOR:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANABIL:
Semolina</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LMLIH,
EL FEN: Semolina</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIAMANDA
: Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SABA:
Pasta and Couscous</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">JAWDA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BADIA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LA
BELLA, ZERDA: Pasta and Couscous</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANABIL:
Semolina</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CH&#8217;RIFA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AL
BACHA: Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYLA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F&#8217;DILA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CH&#8217;MICHA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOUIRA:
Flour</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sourcing
and Processing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dedicated to providing our customers with high quality, nutritious and healthy products and our production process is designed to
achieve these goals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Supply: </i>In addition to the choice of excellent
raw materials, at harvest time, samples are tested for the quality and quantity of protein and for the presence
of heavy metals, pesticide residues, and other harmful chemicals.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Reception: </i>On delivery of the wheat, a representative
sample undergoes a battery of analyzes ensuring compliance with FAHL&#8217;s quality stnadards. From the pit, the wheat then undergoes
a pre-cleaning to eliminate any large waste.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cleaning</i>:
At this stage, the wheat undergoes a second cleaning which consists of eliminating the impurities (foreign seeds, straw, dust,
etc.). The stone remover makes it possible to remove the stones by density difference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
wheat is then wet in order to facilitate its grinding and damaged grains or those whose color does not conform are removed using
a machine equipped with a camera.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 181; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grinding</i>:
The wheat then goes to milling. This operation dissociates the bran and the floury part thanks to a succession of grinding
and sieving. The various finished products are evaluated according to their grain size, protein level, humidity, color, etc. These analyzes
are supplemented by use tests in the bakery, in particular to test the breadmaking. A series of sanitary analyzes is added to ensure
the wholesomeness of each product in compliance with the required standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditioning</i>:
The various flours and semolina obtained are packaged in food packaging suitable for their good conservation. Each batch is strictly
controlled to ensure compliance with specifications and standards in force.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
and Storage</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORAFRIC
has a unique storage infrastructure in Morocco. The group has 2 units dedicated to storage and more than 250,000 tons of grain storage
capacity in Morocco. This organization allows it to optimize and best meet the needs of all of its mills and to effectively manage the
costs of its supply chain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
of our trading companies, Forafric and Cerelis aim to import and sell wheat. Cerelis is based in Morocco and dedicated to meet
the needs of the group in raw materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Our Finalog
subsidiary, with a capacity of 79,000 metric tons, which is based in Casablanca, manages transport, handling and storage activities.
The Finalog&#8217;s multimodal platform (Road / Rail) is devoted 100% to cereals and is linked to the port of Casablanca by rail.
Finalog has a daily reception capacity of 7,000 tons and 3,000 tons per day for delivery. Though most of its revenues are generated by
FAHL, Finalog also rents part of its facilities to other companies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
Events and Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">FAHL has emerged
as the leading wheat milling player in Morocco through the acquisition and consolidation of well-known businesses Forafric (Maymouna)
and the Tria Group. Forafric (Maymouna) was created in 1943 with focus on imports, repositioning its core activity on milling
in the 2000s and recently developing its branding strategy to becoming a leading wheat flour brand in Morocco. Forafric (Maymouna)
was acquired by FAHL in April 2015. The Tria group was created in 1949 under the name Minoterie Biscuiterie d&#8217;Anfa,
with focus on milling activity, and was acquired by FAHL in January 2016.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Effective on November
5, 2020, pursuant to an investment and shareholders agreement (&#8220;Trigola Agreement&#8221;) dated November 5, 2020, FAHL entered
into an agreement with Trigola, SU, LDA (&#8220;Trigola&#8221;), an entity incorporated in the Republic of Angola and owned by the Parent
for a majority share in Trigola&#8217;s equity of 75%. Pursuant to the terms of the agreement, FAHL would provide financial investments
in Trigola for the construction, commissioning and operation of a new industrial facility for the processing of wheat and the
production of wheat flour, management services and other services on an exclusive basis in relation to Trigola&#8217;s business. FAHL
agreed to fund Trigola for operational cash flow needs and bear the risk of Trigola&#8217;s losses from operations and Trigola agreed
that FAHL would be entitled to 75% of Trigola&#8217;s net profits, if any.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Effective on April
30, 2021, FAHL completed a share purchase acquisition of Moulins du Sahel Mali S.A. (&#8220;MDS Mali&#8221;). By way of the acquisition,
FAHL acquired a 70.35% stake in a wheat milling business in Mali. The investment in MDS Mali enables FAHL to obtain a strategic
footprint in west Africa. Details of the acquisition are included in the footnotes to the financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Effective
                                            on July 30, 2021, FAHL completed a share purchase acquisition of Moulin du Sahel Burkina
                                            (&#8220;MDS Burkina&#8221;). By way of the acquisition, the Company acquired a 78.21%
                                            stake in a wheat milling business in Burkina. Details of the acquisition are included in
                                            the footnotes to the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2021, FAHL acquired 37.10% of the capital stock of GMT Niger headquartered in Niger, which is a non-operational wheat milling
facility. FAHL has accounted for this investment as an equity method investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 182; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, FAHL acquired a majority stake in Moulin Sanabil based in Meknes Morocco. The strategy of the group in Morocco is to expand
its capacity to reach 20% of market share and to expand geographically to reach all important customers in Morocco. Meknes is based in
the center region of Morocco where Forafric did not have mills. This opportunity enables the group to enter into this region with a huge
capacity to expand. This region is also the main producer of wheat in Morocco so thanks to this new acquisition, the whole group will
benefit from good conditions on the acquisition of local wheat produced in this region.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021, the price of raw materials went up dramatically as reflected in the increase in the group&#8217;s
cost of goods. See <i>Management&#8217;s Discussion And Analysis Of Financial Condition And Results Of Operations Of FAHL - Results of
Operations</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of COVID-19 on the Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
World Health Organization declared the global outbreak of COVID-19, a disease caused by the novel coronavirus, a pandemic in March 2020.
This pandemic has resulted in worldwide government authorities and businesses issuing public health guidelines and enacting emergency
measures intended to limit the spread of the virus. These measures include shelter-in-place orders, social distancing, mask requirements,
travel restrictions, border closures, and unnecessary business shutdown. In response to the pandemic, we have implemented measures to
ensure the health and safety of our employees and customers, including allowing our entire workforce to work remotely, restricting physical
contact between our employees, and establishing safety protocols for the offices. As we produce a staple food product, we have to date
not experienced any material negative impact on our sales due to Covid 19. The only change was on the seasonality of our sales and on
the access to foreign currency in 2020. There can be no assurance that if the pandemic worsens, or new variants emerge, that our business
will not be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Factors Affecting Operating Results</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to a variety of laws in each of the countries in which we operate which govern various aspects of our business, including
the processing, handling, storage, transport and sale of our products; risk management activities; land-use and ownership of land, including
laws regulating the acquisition or leasing of rural properties by certain entities and individuals; and environmental, health and safety
matters. To operate our facilities, we must obtain and maintain numerous permits, licenses and approvals from governmental agencies and
our facilities are subject to periodic inspection by governmental agencies. In addition, we are subject to other laws and government
policies affecting the food and agriculture industries, including food and feed safety, nutritional and labeling requirements and food
security policies. In particular, the National Office for Food Safety in Morocco (Office National de Securit&#233; Sanitaire des Produits
Alimentaires, &#8220;ONSSA&#8221;) requires various certifications for the export of products to Morocco. ONSSA certifications have been
obtained for the following subsidiaries of FAHL: Forafric SA; Finalog; Maymouna GrainLes Grands Moulins de Tensift; Les Grandes Semouleries
de Casablanca; Les Grandes Semouleries de Safi; Tria Group; and Arzak.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, agricultural production shortfalls in certain regions and growing demand for agricultural commodities for feed, food and
fuel use have caused prices for relevant agricultural commodities to rise. High commodity prices and regional crop shortfalls have led,
and in the future may lead, governments to impose price controls, tariffs, export restrictions and other measures designed to assure
adequate domestic supplies and/or mitigate price increases in their domestic markets, as well as increase the scrutiny of competitive
conditions in their markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 183; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->168<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Environmental
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to various environmental protection and occupational health and safety laws and regulations in the countries in which we
operate. Our operations may emit or release certain substances, which may be regulated or limited by applicable laws and regulations.
In addition, we handle and dispose of materials and wastes classified as hazardous or toxic by one or more regulatory agencies. Our operations
are also subject to laws relating to environmental licensing of facilities, restrictions on land use in certain protected areas and water
use. We incur costs to comply with health, safety and environmental regulations applicable to our activities and have made and expect
to make substantial capital expenditures on an ongoing basis to continue to ensure our compliance with environmental laws and regulations.
However, due to our extensive operations across multiple industries and jurisdictions globally, we are exposed to the risk of claims
and liabilities under environmental regulations. Violation of these laws and regulations can result in substantial fines, administrative
sanctions, criminal penalties, revocations of operating permits and/or shutdowns of our facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
our business could be affected in the future by regulation or taxation of greenhouse gas emissions, or policies related to national emission
reduction plans. It is difficult to assess the potential impact of any resulting regulation of greenhouse gas emissions. Potential consequences
could include increased energy, transportation and raw material costs, and we may be required to make additional investments to modify
our facilities, equipment and processes. Climate change could also lead to stronger production variability than today which could result
in price volatility. Climate change could cause temperature increases and rainfall changes that could lead to lower yields in Morocco
and other semi-arid Mediterranean countries in the future. In response to such concerns, the effects of additional climate change regulatory
initiatives could have adverse impacts on our business and results of operations. Compliance with environmental laws and regulations
did not materially affect our earnings or competitive position in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
markets for our products are highly price competitive. Competition is based on a number of factors, including delivered price, product
offering and quality, location, raw material procurement, production efficiency, brand recognition, nutritional profile, dietary trends,
logistics and distribution capabilities, and customer service, including, in some cases, customer financing terms. FAHL faces competition
in each of its businesses and has numerous competitors. Competition is based on a variety of factors, including price, raw material procurement,
brand recognition, nutritional profile, dietary trends and distribution capabilities. Our major competitors in Morocco include: Moulins
du Maghreb, Zine Cereales, Rica Maroc, Casagrains and Dari Couspate. These competitors would be at an advantage if they are able to obtain
superior financing capabilities. In addition, other regional or international Agribusinesses may expand into our marketplaces increasing
competition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
compete effectively, we must continuously focus on improving efficiency in our production and distribution operations, as well as developing
and maintaining appropriate market share and customer relationships, and brand reputations for quality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, FAHL and its subsidiaries may become subject to various legal proceedings. There are currently three separate actions pending
against FAHL for unfair dismissal by former employees; however, none of such proceedings, individually, or in the aggregate, would have
a material adverse effect on the FAHL or its operations if decided adversely against FAHL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insurance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
each country where FAHL conducts business, our operations and assets are subject to varying degrees of risk and uncertainty. We insure
our businesses and assets in each country in a manner that it deems appropriate for a company of our size and activities, based on an
analysis of the relative risks and costs. If we were to incur a significant loss or liability for which we were not fully insured, it
could have a materially adverse effect on our business, financial condition and results of operations. FAHL believes that it maintains
adequate policies of insurance to insure its operations against such risks as can be reasonably anticipated in the markets in which it
operates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 184; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->169<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonality</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-align: justify; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a degree of seasonality in the growing season and procurement of our principal raw materials. Further, in the Moroccan market where
the bulk of our business originates and where we operate four flour mills, soft wheat cannot be freely imported during the calendar year.
All our soft wheat must be imported before end of April and from beginning of September or October depending on the harvests of local
wheat in Morocco. This is designed to protect local Moroccan producers of wheat by enabling them to sell their production on the local
market. Accordingly, the third fiscal quarters of the year has generally been our weakest in terms of financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
and Human Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had approximately 750 employees, located in 4 countries. None of our employees are represented by labor unions.
In general, we consider our employee relations to be good.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
international workforce naturally results in a diversity of cultural, national and religious representation. We care about our people,
and seek to promote their welfare, development and personal growth. New Forafric is dedicated to creating incentive programs to encourage
and reward innovation and dedication.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, FAHL owns and leases 10 refining, packing and milling facilities throughout the world with an aggregate production
capacity of 2.800 metric tons per day, including 7 facilities in Morocco with an aggregate capacity of 2.200 metric tons per day. We
also have 2 storage facilities in Morocco with an aggregate storage capacity of 250,000 metric tons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters in Gibraltar, occupies approximately 1200 square feet of space under a lease that expires in June 2025. We also
own or lease other office space for our operations worldwide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 185; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->170<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_017"></span><span id="kd_001"></span>RESULTS
OF OPERATIONS OF FAHL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated or the context otherwise requires, references in this section to &#8220;FAHL,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our&#8221; and other similar terms refer to FAHL and its subsidiaries prior to the Business Combination and to New Forafric and
its consolidated subsidiaries after giving effect to the Business Combination. The following discussion and analysis summarizes the significant
factors affecting the consolidated operating results, financial condition, liquidity and cash flows of our company as of and for the
periods presented below. The following discussion and analysis should be read in conjunction with our consolidated financial statements
and the related notes thereto included elsewhere in this proxy statement/prospectus and our unaudited consolidated financial statements
and related notes and other information included elsewhere in this proxy statement/prospectus. The discussion contains forward-looking
statements that are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management.
Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors,
including those discussed below and elsewhere in this proxy statement/prospectus, particularly in the sections entitled &#8220;Risk Factors&#8221;
and &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; Additionally, FAHL&#8217;s historical results are not necessarily
indicative of the results that may be expected for any period in the future.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Factors Affecting Our Performance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key factors affecting the performance of our business are described below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of Raw material. The cost of wheat is almost 90% of total cost in our business. Fluctuation on the price of the wheat has
a direct impact on our performance. The cost of wheat depends on weather, supply and demand and strategies of main international producers.
The cost of raw material depends also on freight cost and currency exchange rate fluctuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
cost. The crushing cost is the second main factor affecting our performance. This cost includes equipment, labor and interest over financing.
To perform on our business, we have to maintain this cost below 30 USD per ton produced. To achieve this performance, we have to monitor
energy, equipment usage, logistics, human resources and financial cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
selling price. The average selling price is based on the two components:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
    of flour/Semolina</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
    of Bran</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bran
is between 20% to 25% of the production of finished products. We have no impact on the price of the bran.<br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the price of finished product, we can have a limited impact due to high concurrency on the market.<br />
<b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Performance Metrics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Key Performance Metrics are the crushing cost and the average selling price of finished products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
crushing cost includes all industrial costs of units (equipment, labor, financial cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 186; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->171<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we produce a staple food product, we did not have any negative impact on our sales due to COVID-19. The only change was on the seasonality
of our sales and on the access to foreign currency in 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Components of Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales, cost of goods sold and gross profit figures are calculated with the following method:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales: Total consolidated sales + subsidies;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of goods sold: includes cost of raw materials, cost of freight, cost of foreign exchange and cost of improvements used in the production;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit: the difference between net sales and cost of goods sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key components of our results of operation are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
of raw materials, which is affected by many factors, including global and regional supply, which in turn is impacted by factors such
as weather conditions, local planting decisions, crop failure, reduced harvests, governmental policies (including both tariffs
and subsidies), and other agricultural conditions, as well as local, regional, and international demand. Raw material increased in 2021
over 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of freight, which is impacted by shipping availability, international demand, labor shortages, strikes, regional conflicts, inadequate
or obsolete port infrastructure and other factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
exchange rates, which are continually fluctuating due to the relative economic strengths or governmental policies of different countries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
resources productivity, which may be impacted by the training and skills of the available workforce, the nature of tools and facilities
in place, financial incentives and other factors over which we do not have any control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
consumption and costs, which may be affected by governmental policies, including green energy initiatives and the age and efficiency
of existing and newly acquired facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Results of Operations depends primarily on the cost of raw materials and on our industrial cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our business, most raw materials are imported from Europe, South America, Black Sea and Canada (for durum). In Morocco, there is production
of wheat but the quality is generally not high enough for industrial usage. The variation of the cost of raw materials has a huge impact
on our business and can explain the changes in the result of operation form period to period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
cost is the second main component of our result of operation. The industrial cost includes human resources, cost of equipment, maintenance,
power consumption and financial cost as main components. We launched a huge restructuring plan in 2018 to reduce our industrial cost
with success. We successfully reduced the industrial cost by 40% over the last three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Net sales of grain products increased
7.3% to $196.6 million in 2020 compared to $183.2 million in 2019, due to increased sales primarily in our
market share in Morocco. For the nine month period ended September 30, 2021, net sales totaled $185.5 million, increasing 27.1%
from $145.9 million during the comparable period in 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 187; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->172<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Cost of goods sold increased
5.9% to $156.1 million in 2020 compared to $147.5 million in 2019 as a result of higher volume of commodity acquired.
The average global price of wheat declined 3%, in 2020 compared to 2019. For the nine month period ended September 30, 2021, cost
of sales totaled $157.2 million, increasing 31.9% from $119.1 million during the same nine month period in 2020, reflecting increases
in raw material and shipping costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Gross profit increased 13.1%
to $40.4 million in 2020 from $35.7 million in 2019, primarily driven by an increase of the average selling price and
efficiencies in wheat acquisition by taking advantage of price and freight changes, and changes in the foreign currency markets.
Gross profits for the nine month period ended September 30, 2021, totaled $28.3 million, increasing 5.6% from $26.8 million during
the nine month period ended September 30, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in">SG&amp;A expenses were $30.5
million in 2020 compared to $31.7 million in 2019, a decrease of 3.8%. SG&amp;A benefitted in 2020 from decreases of
fixed cost, due to a significant restructuring. SG&amp;A expenses for the nine-month period ended September 30, 2021, totaled
$24.4 million, as compared to $19.7 million for the nine month period ended September 30, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in">Other income (expenses) &#8211;
Other expenses increased to $9.9 million for the year ended December 31, 2020, compared to other expenses of $9.6 million for
the year ended December 31, 2019, with the increase expenses attributable to an increase in foreign exchange losses to $3.0 million for the year ended December 31, 2020, from $10.1 million for the year ended December 31, 2019,
offsetting reductions in net interest expenses to $6.8 million for the year ended December 31, 2020 from $9.4 million for the year ended
December 31, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34.9pt">For the nine
month period ended September 30, 2021, other expenses totaled $8.1 million, increasing 13.7% from $7.1 million during the same nine month
period in 2020, reflecting increases in interest expense to $7.4 million for the nine month period ended September 30, 2021, from $5.4
million for the nine month period ended September 30, 2020, a 37% increase offsetting a 41% reduction in foreign currency exchange losses
to $1.0 million for the period ended September 30, 2021, from $1.7 million for the period ended September 20, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><i>Working
Capital and Working Capital Facilities. </i>Working capital deficits were $66.5 million at December 31, 2020, an increase of $5.6 million,
or 9%, from a working capital deficit of $60.9 million at December 31, 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
has available to it revolving working capital credit lines in the amount of $74.0 million. As of December 31, 2020, FAHL
had borrowed $65.2 million and had unused availability of $8.8 million under such credit lines. As of September 30,
2021, FAHL had borrowed $58.8 million and had unused availability of $14.2 million under such credit lines. FAHL has also entered into
credit agreements for asset-based credit facilities in order to fund wheat raw material purchases (&#8220;Wheat Credit Facilities&#8221;). </span>The Wheat Credit Facilities provide the ability
to borrow funds under consolidated lines of credit of up to approximately $90.0 million as of December 31, 2020 and $130.0 million as
of September 30, 2021. The Wheat Credit Facilities are secured by the Company&#8217;s inventory. The Wheat Credit Facilities must be
renewed on a semi-annual basis. As of December 31, 2020, FAHL had borrowed $48.0 million under the Wheat Credit Facilities, with unused
availability of approximately $42.0 million. As of September 30, 2021, FAHL had borrowed $90.5 million under the Wheat Credit Facilities,
with unused availability of approximately $39.5 million.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.95pt; text-align: justify; text-indent: 34.05pt">Pursuant to the
Business Combination Agreement, all FAHL Related Party Loans will be converted into Ordinary Shares upon consummation of the Business
Combination. Pursuant to the Business Combination Agreement, all FAHL Related Party Loans will be converted into Ordinary Shares upon
consummation of the Business Combination. As of September 30, 2021, FAHL has, in addition to its obligations under the working capital
credit lines and the Wheat Credit Facilities, $7.54 million in lease obligations and obligations to invest an additional $3.7 million
and $3.6 million in MDS Mali and MDS Burkina, respectively.&#160; FAHL believes it has sufficient capital available to it to fulfill
such obligations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
and Cash Equivalents - </i>Cash and cash equivalents were $12.7 million at December 31, 2020, an increase of $3.7 million from $9.0
million at December 31, 2019. Cash balances are managed in accordance with our investment policy, the objectives of which are to
preserve the principal value of our cash assets, maintain a high degree of liquidity and deliver competitive returns subject to prevailing
market conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trade
accounts receivable, net</i> - Trade accounts receivable, net were $27.5 million at December 31, 2020, a decrease of $0.48 million from
$27.9 million at December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>lnventories
-</i> Inventories were $26.5 million at December 31, 2020, an increase of $11.6 million from $14.9 million at December 31, 2019.
The increase is primarily related to higher volume and cost of raw materials at end of December 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 188; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->173<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMITMENTS
AND CONTINGENCIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
has commitments with banks to finance its operating activities. FAHL has provided collateral and mortgages to banks of $25,464 and $119,474,
respectively, as of December 31, 2020 and 2019. From time to time FAHL is involved in litigation incidental to the conduct of its business.
These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with
contract provisions and claims related to alleged violations of laws and regulations. When applicable, FAHL records accruals for contingencies
when it is probable that a liability will be incurred, and the amount of loss can be reasonably estimated. Defense costs are expensed
as incurred and are included in professional fees. While the outcome of lawsuits and other proceedings against FAHL cannot be predicted
with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits and other proceedings had or are expected
to have a material effect on the consolidated financial statements in 2020 and 2019. As of the nine month period ended September 30, 2021, there were no lawsuits or other proceedings commenced against FAHL, that in the opinion
of management, individually or in the aggregate, had or are expected to have a material effect on the consolidated financial statements
of FAHL as of such date, and, no such lawsuits and other proceedings had or are expected to have a material effect on the consolidated
financial statements for calendar year 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
accounting policies are more fully described in Note 2- Summary of Significant Accounting Policies to our consolidated financial statements
included as part of this S-4 Registration Statement. As disclosed in Note 2, the preparation of financial statements in conformity with
U.S. GAAP requires management to make substantial judgment or estimation in their application that may significantly affect reported
amounts in the financial statements and accompanying notes. Actual results could differ significantly from those estimates. We believe
the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of
our financial condition and results of operations and require management&#8217;s most difficult, subjective and complex judgments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
Recognition &#8211; FAHL follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation
by transferring control over a product or service to a customer. The majority of FAHL&#8217;s contracts with customers have one performance
obligation and a contract duration of one year or less. FAHL applies the practical expedient in Accounting Standards Codification (&#8220;ASC&#8221;)
paragraph 10-50-14 of ASC Topic 606, Revenue from Contracts with Customers and does not disclose information about remaining performance
obligations that have original expected durations of one year or less. Trade discounts or volume rebates are recognized as a deduction
in revenue. No payment terms beyond one year are granted at contract inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 189; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->174<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
related to the sale of goods and equipment is recognized when there is a formal agreement with the customer, delivery is arranged, revenue
amount can be measured in a reliable way, and when it is likely that the economic benefits associated with the transaction return to
FAHL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
received from customers prior to revenue recognition on a contract are recorded as contract liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and Handling Costs &#8211; Shipping and handling costs related to contracts with customers for the sale of goods are accounted for as
a fulfillment activity and are included in cost of sales. Accordingly, amounts billed to customers for such costs are included as a component
of revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
Collected from Customers and Remitted to Governmental Authorities &#8211; FAHL does not include taxes assessed by governmental authorities
that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in the measurement
of transactions prices or as a component of revenues and cost of sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
Receivable and Allowances for Credit Losses &#8211; We provide credit terms to customers in-line with industry standards, perform ongoing
credit evaluations of our customers, and maintain allowances for potential credit losses based on historical experience recorded. We
analyze the aging of customer accounts, customer concentrations, customer creditworthiness, current economic trends and changes in our
customer payment patterns when evaluating the adequacy of the allowance for credit losses. Customer balances are written off after all
collection efforts are exhausted. Estimated product returns, which have not been material, are deducted from sales at the time of shipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Receivables &#8211; Other receivables include government subsidies for the production and sale of flour. The Moroccan government provides
a fixed subsidy based on production and customer. Subsidies are paid by the Moroccan government twice a year based on sales of flour
for the previous six months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
Taxes &#8211; The provision for income taxes includes income taxes currently payable in Morocco and local jurisdictions, and those deferred
because of temporary differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities
are computed based on the difference between the financial statement and income tax bases of assets and liabilities using enacted tax
rates. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be
realized. Deferred income tax expenses or credits are based on the changes in the asset or liability from period to period. We account
for uncertain tax positions using a &#8220;more-likely-than-not&#8221; threshold. A tax benefit from an uncertain tax position is recognized
if it is more-likely-than-not that the tax position will be sustained on examination by the taxing authorities, based on the technical
merits of the position, or the statute of limitations concerning such issues lapses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
Currency Translation and Transactions FAHL&#8217;s functional currency is the Moroccan dirham, and its presentation currency is the United
States Dollar (&#8220;USD&#8221;). The functional currency is translated into U.S. dollars for balance sheet accounts using currency
exchange rates in effect as of the balance sheet date, and for revenue and expense accounts using a weighted-average exchange rate during
the fiscal year. The transactions in foreign currency (that is a different currency than the functional currency of the entity) are converted
at the exchange rate prevailing to the date of the transaction. The assets and liabilities denominated in foreign currencies are evaluated
in the current period on the date of the closing or at the opening rate, when applicable. The translation adjustments are deferred as
a separate component of equity in Accumulated other comprehensive income. Gains or losses resulting from transactions denominated in
foreign currencies and intercompany debt that is not of a long-term investment nature are included in (Gain) loss on foreign currency
exchange in the consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
- Inventories are stated at the lower of cost or net realizable value. FAHL &#8216;s inventory is valued using the weighted average cost
method. The costs of finished goods inventories include raw materials, labor, and overhead costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 190; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->175<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
Plant, and Equipment - Property, plant, and equipment are stated at acquisition cost, plus capitalized interest on borrowings during
the actual construction period of major capital projects. Depreciation and amortization are calculated using the straight-line method
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Lives</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment (technical installations)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-50
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-30
    years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building
improvements are depreciated over the shorter of the estimated useful life of the assets or the remaining useful life. Leasehold improvements
are amortized over the shorter of their useful life or remaining lease term. Expenditures for repairs and maintenance, which do not improve
or extend the life of the assets, are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
perform impairment tests when circumstances indicate that the carrying value of an asset may not be recoverable. Indicators of impairment
include deteriorations in operating cash flows, the anticipated sale or disposal of an asset group, and other significant changes in
business conditions. Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that
the carrying amount of an asset may not be recoverable. FAHL&#8217;s assessment of recoverability of property, plant and equipment is
performed on a reporting unit level. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of such asset to its estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of such asset
exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of
the asset exceeds the fair value of the asset. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair
value, less estimated costs to sell.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
and Other Intangible Assets - Identifiable intangible assets with finite lives are amortized over their estimated useful lives as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Lives</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents,
    trademarks, and licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    intangible assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-10
    years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized
intangible assets, exclusive of goodwill, are amortized over the useful lives of the assets unless that life is determined to be indefinite.
All of our intangible assets, exclusive of goodwill, are finite lived. All amortization expense related to intangible assets is recorded
in selling, general, and administrative expense in the consolidated statements of operations. Intangible assets with finite lives are
evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If an
evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is generally
based on discounted future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
is evaluated annually in the fourth quarter or more frequently, if events or changes in circumstances require an interim assessment.
We assess goodwill for impairment (as of December 31) at the reporting unit level using income and market approaches, employing significant
assumptions regarding growth, discount rates, and profitability at each reporting unit. Our estimates under the income approach are determined
based on a discounted cash flow model. The market approach uses a market multiple methodologies employing earnings before interest, taxes,
depreciation, and amortization (&#8220;EBITDA&#8221;) and applies a range of multiples to those amounts in determining the indicated
fair value. In determining the multiples used in this approach, we obtain the multiples for selected peer companies using the most recent
publicly available information. In determining the indicated fair value of each reporting unit, FAHL concludes based on the income approach,
and uses the market approach to corroborate, as FAHL believes the income approach is the most reliable indicator of the fair value of
the reporting units. The resulting value is then compared to the carrying value of each reporting unit to determine if impairment is
necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 191; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->176<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Accounting Pronouncements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adopted</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2019-12 - Income Taxes (Topic 740): Simplifying
the Accounting for Income Taxes, which removes certain exceptions to the general principles in Topic 740 and improves consistent application
of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This guidance is effective for fiscal
years and interim periods within those years beginning after December 15, 2020, with early adoption permitted. Amendments are to be applied
prospectively, except for certain amendments that are to be applied either retrospectively or with a modified retrospective approach
through a cumulative effect adjustment recorded to retained earnings. FAHL adopted this guidance effective January 1, 2019. Adoption
of the guidance had no impact on our results of operations, balance sheet, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued guidance ASU No. 2016-13 Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments which changes the accounting for credit losses for certain instruments, including accounts receivable, from
an incurred loss method to a current expected loss method. The measurement of expected credit losses is based on relevant information
about past events, including historical experience, current conditions, and reasonable and supportable forecasts. FAHL adopted this guidance
effective January 1, 2019. Adoption of the guidance had no impact on our results of operations, balance sheet, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Not
Yet Adopted</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial
Reporting, which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance
provides optional expedients and exceptions for applying GAAP to transactions affected by reference rate reform if certain criteria are
met. These transactions include contract modifications, hedging relationships, and the sale or transfer of debt securities classified
as held-to-maturity. Entities may apply the ASU from March 12, 2020 through December 31, 2022. FAHL is currently evaluating the impact
of this new ASU on its consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures About Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of our global activities, we are exposed to changes in, among other things, agricultural commodity prices, transportation costs,
foreign currency exchange rates, which may affect our results of operations and financial position. We actively monitor and manage these
various market risks associated with our business activities. Our risk management decisions take place in various locations, but exposure
limits are centrally set and monitored, operating under a global governance framework.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use derivative instruments for the purpose of managing the exposures associated with commodity prices, foreign currency exchange rates,
and for positioning our overall portfolio relative to expected market movements in accordance with established policies and procedures.
We enter into derivative instruments primarily with commodity exchanges in the case of commodity futures and options, major financial
institutions, or approved exchange clearing shipping companies in the case of ocean freight. While these derivative instruments are subject
to fluctuations in value, for hedged exposures those fluctuations are generally offset by the changes in the fair value of the underlying
exposures. The derivative instruments that we use for hedging purposes are intended to reduce the volatility of our results of operations.
However, they can occasionally result in earnings volatility, which may be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 192; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->177<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commodities
Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in many areas of the food industry, from agricultural raw materials to the production and sale of branded food products. As a
result, we purchase and produce various materials, many of which are agricultural commodities, including: Flour, Semolina, Pasta and
Couscous</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agricultural
commodities are subject to price fluctuations due to a number of unpredictable factors that may create price risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter into various derivative contracts with the primary objective of managing our exposure to adverse price movements in the agricultural
commodities used and produced in our business operations. We have established policies that limit the amount of unhedged fixed price
agricultural commodity positions permissible for our operating companies, which are generally a combination of volumetric, drawdown,
and value-at-risk (&#8220;VaR&#8221;) limits. We measure and review our commodity positions on a daily basis. We also employ stress-testing
techniques in order to quantify our exposures to price and liquidity risks under non-normal or event driven market conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Currency
Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
global operations require participation in foreign exchange markets. Our primary foreign currency exposures are the US <i>dollar</i>
and the <i>Euro.</i> To reduce the risk arising from foreign exchange rate fluctuations, we enter into derivative instruments, such as
foreign currency forward contracts, swaps and options. The changes in market value of such contracts have a high correlation to the price
changes in the related currency exposures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
potential loss in fair value for such net currency positions resulting from a hypothetical 10% adverse change in foreign currency exchange
rates as of December 31, 2020 was not material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1in; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivative
Instruments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1in; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 34pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Exchange Derivatives</i>-We use a combination of foreign exchange forward, swap, futures and option contracts in certain of our operations
to mitigate the risk of exchange rate fluctuations in connection with certain commercial and balance sheet exposures. The foreign exchange
forward swap and option contracts may be designated as cash flow or fair value hedges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1in; text-align: justify; text-indent: 34pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 193; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->178<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_018"></span><span id="kd_002"></span>EXECUTIVE
COMPENSATION OF FAHL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an emerging growth company, we have opted to comply with the executive compensation disclosure rules applicable to &#8220;smaller reporting
companies&#8221; as such term is defined in the rules promulgated under the Securities Act, which require compensation disclosure for
its principal executive officer and its two other most highly compensated executive officers. References in this section to &#8220;we&#8221;,
&#8220;our&#8221;, &#8220;us&#8221;, the &#8220;Company&#8221; and &#8220;FAHL&#8221;, generally refer FAHL prior to the Business Combination
and to New Forafric following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section discusses the material components of the executive compensation program offered to the executive officers of FAHL who would have
been &#8220;named executive officers&#8221; for 2021 and who will serve as executive officers of New Forafric following the consummation
of the Business Combination. Such executive officers consist of the following persons, referred to herein as our named executive officers
(the &#8220;NEOs&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saad
    Bendidi, our Chairman; </span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mustapha
    Jamaleddine, our Chief Executive Officer of Forafric Maroc; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julien
    Benitah, our Chief Financial Officer. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our NEOs will serve New Forafric in the same capacities after the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion may contain forward-looking statements that are based on our current plans, considerations, expectations and determinations
regarding future compensation programs. Actual compensation programs that New Forafric adopts following the closing of the Business Combination
could vary significantly from our historical practices and currently planned programs summarized in this discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021
Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information regarding the compensation earned or received by our NEOs for services rendered during the fiscal
year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    and Principal Position</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary
    ($)</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus
    ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other Compensation ($)<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    ($)</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Saad Bendidi,</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">212,709</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,702</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,411</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Chairman</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mustapha Jamaleddine,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">433,673</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">527,209</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Executive Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Julien Benitah,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,245</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,774</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,219</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Financial Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">No determination in respect of these bonuses for the
    fiscal year 2021 has yet been made but the New Forafric Board will do so in 2022.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    compensation includes employer contributions and social security paid by FAHL, a car allowance, and the value of other perquisites.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 194; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->179<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Base
Salaries</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the NEOs is paid a base salary commensurate with the executive&#8217;s skill set, experience, role and responsibilities. For Fiscal
Year 2021, the annual base salaries Messers Bendidi, Jaamleddine and Benitah were $212,709, $433,673 and $149,245, respectively. The
base salaries for Messers. Bendidi, Jaamleddine and Benitah will remain $212,709, $433,673 and $149,245 respectively for Fiscal Year
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Annual
Cash Bonuses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In Fiscal year 2020, Mr.
Benitah was awarded a cash bonus of $47,200. Mr. Benitah was eligible to earn his bonus based on the attainment of pre-determined
company and individual performance metrics, which were comprised of company key performance indicators and individual goals. In fiscal
year 2021, Mr. Benitah, Mr. Bendidi and Mr. Jamaleddine were each eligible to earn a cash bonus equal upon the attainment
of pre-determined Company and individual performance metrics, which were comprised of Company key performance indicators and individual
goals established by the FAHL board of directors. No determination in respect of these bonuses has yet been made, but the New Forafric
Board will do so in 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Agreements with Our Named Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAHL
does not have written employment agreements with any of its officers. The employment arrangements with our NEOs are all oral and on an
at-will basis. FAHL has no written, or unwritten understandings with any NEO regarding severance or other post-employment obligations
in the event of termination by FAHL</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2021 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">FAHL did not have any outstanding
equity awards as of December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.5pt"></p>


<!-- Field: Page; Sequence: 195; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->180<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee
Benefit and Equity Compensation Plans and Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Forafric 2021 Long Term Employee Share Incentive Plan (the &#8220;FAHL 2021 Plan&#8221;) was adopted on June 22, 2021. The FAHL 2021
Plan allows for the grant of awards, consisting of nominal cost options or phantom options to employees, directors and consultants of
FAHL or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of FAHL (the &#8220;FAHL Board&#8221;) is responsible for the administration of the FAHL 2021 Plan and may, from time
to time, make or amend regulations for the administration of the FAHL 2021 Plan. The decision of the FAHL Board on all matters relating
to the administration of the FAHL 2021 Plan, including the resolution of any ambiguity of the rules in the FAHL 2021 Plan, is final and
binding. The FAHL Board may also terminate or, from time to time, suspend the grant of awards. The FAHL Board may also make, subject
to certain restrictions, amendments to the rules of the FAHL 2021 Plan or any subplans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
an award is granted by the execution by FAHL of an award certificate, which provides information regarding the award&#8217;s date of
grant, the number of shares in respect of which an option is granted pursuant to the award, vesting schedule, and exercisability. The
exercise price for nominal cost options is 50% of the nominal value of the shares, and in the case of phantom options is the market value
of the shares less 50% of their nominal value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the exception of an individual&#8217;s death or in the event of a corporate transaction, awards are not capable of being transferred,
charged or otherwise alienated. Any time an award holder purports to make one of these transfers, the award shall lapse immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares which may be the subject of awards under the FAHL 2021 Plan may not exceed 10% of the issued share capital
of FAHL from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain provisions of the FAHL 2021 Plan, no award can be exercised after the tenth anniversary of the date of grant. With the exception
of certain special circumstances, an award can only be exercised while the award holder is employed or engaged by FAHL or any of its
subsidiaries. Subject to certain provisions, a vested award may be exercised in whole or in part at any time after its date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
there are certain corporate transactions related to FAHL, such as a compulsory acquisition, a general offer, a reconstruction, a merger
or division of FAHL, the winding up of FAHL, or the sale of FAHL&#8217;s business or subsidiary, the FAHL Board has discretion (subject
to certain requirements) to allow all awards (vested or unvested) to be exercised in whole or in part. In certain circumstances, if the
FAHL Board exercises such discretion and the awards are not exercised, they will instead lapse. If FAHL is acquired, all award holders
are required to release their awards in consideration of the grant of a new award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
award can lapse when it has not been exercised after the tenth anniversary of the date of grant. It can also lapse when the award holder
ceases to be a director, an employee, or a consultant with FAHL or any of its subsidiaries. An award will lapse when an order is made
by a court (or when a resolution is passed) for the compulsory winding up of FAHL. Finally, an award lapses when the award holder becomes
bankrupt, enters into a compromise with their creditors generally except as permitted under certain circumstances. Prior to the exercise
of an award, an award holder has no rights in respect of any shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 196; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->181<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a reorganization, vesting conditions may be adjusted by the FAHL Board, subject to an auditors&#8217; confirmation that
the adjustment is fair and reasonable and notice to the award holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
award may not vest or be exercised until the FAHL Board is satisfied that the award holder will be able to pay for any tax or social
security liability that is owed by the holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">As of December
31, 2021, no awards had been made under the FAHL 2021 Plan. Following the consummation of the Business Combination the FAHL 2021 Plan
shall be replaced by the Equity Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination the FAHL 2021 Plan shall be terminated, and outstanding awards, if any, shall be
surrendered, cancelled, and exchanged in substitution for awards on substantially the same terms in the Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
<i>Certain Relationships and Related Person Transactions &#8211; FAHL Related Person Transactions.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Compensation of FAHL</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the total compensation for each person who served as a non-employee director of the Board during fiscal year
2021. Both Saad Bendidi, an NEO who served on the Board, and Michael Elbaz, a consultant engaged by FAHL, who also serves on the Board,
did not receive any additional compensation from FAHL for services on its board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fees
    earned or paid in cash ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    ($)</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ariel Belilo</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,059</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,059</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Franco Cassar</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will reimburse all reasonable out-of-pocket expenses incurred by directors for their attendance at meetings of the FAHL Board or any
committee thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
directors or those engaged as consultants will receive no additional compensation for their service as a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 197; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->182<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_003"></span>MANAGEMENT
OF NEW FORAFRIC FOLLOWING THE BUSINESS COMBINATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt">The following table
sets forth certain information, as of the date of this proxy statement/prospectus, concerning the persons who are expected to serve as
executive officers of New Forafric following the completion of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saad
    Bendidi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mustapha
    Jamaleddine</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julien
    Benitah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mustapha
    Ghazali</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">50</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oury
    Marciano</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">37</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP
    Business Development</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric Board following the Business Combination is expected to be comprised of six directors. Each director will hold office until
his or her term expires at the next annual meeting of stockholders for such director&#8217;s class or until his or her death, resignation,
removal or the earlier termination of his or her term of office. The following table sets forth certain information, as of the date of
this proxy statement/prospectus, concerning the persons who are expected to serve as directors following the completion of the Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saad
    Bendidi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julien
    Benitah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franco
    Cassar</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Lasry</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ira
    Greenstein</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Officers and Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Saad Bendidi, 63 &#8211; Mr. Bendidi has served
as the Chairman of FAHL since March 2018. He is the chairman and a partner of Mediterrania Capital Partners, private equity fund since
October 2013. Mr. Bendidi was the CEO of Saham Group, from December 2013 to October 2017. Prior to Saham, Mr. Bendidi served as the chairman
and CEO of ONA (now Al Mada) from January 2005 to April 2008. Mr. Bendidi holds a master&#8217;s degree in engineering from Ecole centrale
de Paris, a master&#8217;s degree in political science from Innovation &amp; Economic Prosperity Universities (IEP), and a master&#8217;s
degree of Business Administration from Hautes &#201;tudes Commerciales (HEC).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Mustapha Jamaleddine, 60 &#8211; Mr. Jamaleddine
has served as the CEO of Forafric Maroc since March 2018. Mr. Jamaleddine was the Vice president of Forafric Maroc from March 2016 to
March 2018 and the CEO of Tria Group, from March 2011 to February 2020. Mr. Jamaleddine holds a master&#8217;s degree in Engineering
from the Ecole Nationale Des Travaux Publics De L&#8217;Etat (ENTPE).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Julien Benitah, 39 &#8211; Mr. Benitah has served
as Chief Financial Officer of FAHL since March 2018. Mr. Benitah was the COO of Ycap Asset Management (now Homa Capital), from January
2016 to October 2017. Prior to Homa Capital, Mr. Benitah served as Partner and COO of Smart Equity from January 2011 to September 2015.
Mr. Benitah holds a master&#8217;s degree in Management from the EM Lyon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Mustapha Ghazali, 50 &#8211; Mr. Ghazali has served
as the CTO of Forafric Maroc since June 2018. Mr Ghazali was a plant manager at TRIA Group from January 2013 to May 2018, later, Mr Ghazali
served as the Technical Director from March 1996 to December 2012. Mr Ghazali was educated at University of Economics of Casablanca,
and he holds a degree from the National School of Milling and Cereal Industries in Casablanca and Paris.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Oury Marciano, 37 &#8211; Mr. Marciano has served
as VP Business Development of FAHL since July 2016. Mr. Marciano was an analyst from June 2009 to December 2011 at Societe Generale Corporate
and Investment Banking both in New York and Paris. He managed his own real estate acquisitions business in New York from January 2012
to June 2016. Mr. Marciano holds a master&#8217;s degree in Banking Finance and Insurance from Dauphine University in Paris, and he received
an M.A. in International Economics and Finance from Brandeis University in Massachusetts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 198; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->183<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franco
Cassar, 61 &#8211; Mr. Cassar has served as a member of the board of directors of FAHL since 2016. Mr. Cassar has held senior management
positions at Abacus Financial Services Ltd, SG Hambros Private Bank, Barclays Gibraltar and NatWest Gibraltar. Mr. Cassar was educated
at Uxbridge, Harrow and West London Colleges, UK.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
Lasry, 54 &#8211; Mr. Lasry will be appointed to the board of directors of New Forafric following the Business Combination. Mr. Lasry
is a Partner and Head of the Funds Team at Hassans International Law Firm, Gibraltar, and is President of Gibraltar-US Chamber of Commerce
(AmCham Gibraltar). Mr. Lasry was educated at Bar-Ilan University and Johns Hopkins University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
Packer, 50 &#8211; Mr. Packer has been Globis&#8217; Chief Executive Officer, Chief Financial Officer and a Director since inception.
Mr. Packer has served as the Managing Member of Globis Capital Advisors LLC, an investment advisory firm, since founding the firm in
2001. Since October 2017, Mr. Packer has served as Chairman of The United States Commission for the Preservation of America&#8217;s Heritage
Abroad, when he was first appointed by President Donald J. Trump. He has served on the board of directors of Zedge, Inc. (NYSE AMERICAN:
ZDGE), a provider of content distribution platforms, since April 2020. Mr. Packer also serves as a director on the board of Elementor
Ltd., a privately held company that offers an intuitive, front-end site builder for WordPress. Previously, he served on the boards of
directors of Wakingapp Ltd., an augmented reality technology company, from October 2014 until its sale to Scope AR in October 2019 and
Penguin Digital, Inc., a mobile application developer, before it was acquired by Shutterfly Inc. in 2012. Mr. Packer received a B.A.
from Yeshiva University. We believe Mr. Packer&#8217;s extensive knowledge of the capital markets, corporate finance, and public company
governance practices as a result of his investment experience, together with his significant board experience at companies in the technology
sector, makes him well-qualified to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ira Greenstein, 61 &#8211; Mr. Greenstein will be
appointed to the board of directors of New Forafric following the Business Combination. Mr. Greenstein served as Senior Advisor to Qrypt,
Inc., a quantum cryptography company from 2019-2021. He served as Deputy Assistant and Strategist to President Trump from 2017-2018.
Prior to serving in the Trump Administration, Mr. Greenstein was President of Genie Energy, Ltd., a retail energy and oil and gas exploration
company that was spun off from IDT Corp., an international telecommunications carrier, from 2011-2017. Mr. Greenstein served as President
and Counsel to the Chairman of IDT, from 2000-2011, and counsel and advisor to various companies, including Net2Phone, Inc., a pioneer
in voice over the internet protocol. Prior to joining IDT, Mr. Greenstein was a partner in Morrison &amp; Foerster LLP, where he served
as the Chairman of that firm&#8217;s New York office&#8217;s Business Department. Mr. Greenstein was an associate in the New York and
Toronto offices of Skadden, Arps, Slate, Meagher &amp; Flom LLP and served on the Securities Advisory Committee and as secondment counsel
to the Ontario Securities Commission. At the OSC, Mr. Greenstein advised on the implementation of the US-Canada Multijurisdictional Disclosure
System and on the securities law aspects of NAFTA. Mr. Greenstein served on the Boards of Directors of NanoVibronixInc. and Regal Bank
of New Jersey. Mr. Greenstein served on the Boards of Trustees of Young Israel of Scarsdale, Ramaz, SAR Academy and Friends of Jerusalem
College of Technology. Mr. Greenstein received a B.S. from Cornell University School of Industrial and Labor Relations (1981)
and a J.D. from Columbia University Law School (1985) where he currently serves as a member of the Dean&#8217;s Council.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
Governance Guidelines and Code of Business Conduct</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board
Composition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed more fully under the section entitled &#8220;Shareholder Proposal 5: Director Election Proposal&#8221;, as a condition to the
closing of the Business Combination, the board of directors of New Forafric will initially consist of six directors, four of whom
will be designated by Seller and two of whom will be designated by Global SPAC LLC. Our Board has nominated Saad Bendidi, Julien Benitah,
Franco Cassar, James Lasry, Paul Packer, Ira Greenstein to serve on New Forafric&#8217;s board of directors effective as of the closing
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 199; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->184<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Independence</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, New Forafric&#8217;s Ordinary Share will be listed on the Nasdaq. Under the rules of the Nasdaq,
independent directors must comprise a majority of a listed company&#8217;s board of directors. In addition, the rules of the Nasdaq require
that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating committees be independent.
Audit committee members must also satisfy the additional independence criteria set forth in Rule 10A-3 under the Exchange Act and the
rules of the Nasdaq. Compensation committee members must also satisfy the additional independence criteria set forth in Rule 10C-1 under
the Exchange Act and the rules of the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to be considered independent for purposes of Rule 10A-3 under the Exchange Act and under the rules of the Nasdaq, a member of an
audit committee of a listed company may not, other than in his or her capacity as a member of the committee, the board of directors,
or any other board committee: (1) accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed
company or any of its subsidiaries; or (2) be an affiliated person of the listed company or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be considered independent for purposes of Rule 10C-1 under the Exchange Act and under the rules of Nasdaq, the board of directors must
affirmatively determine that the member of the compensation committee is independent, including a consideration of all factors specifically
relevant to determining whether the director has a relationship to the company which is material to that director&#8217;s ability to
be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (i) the
source of compensation of such director, including any consulting, advisory or other compensatory fee paid by the company to such director;
and (ii) whether such director is affiliated with the company, a subsidiary of the company or an affiliate of a subsidiary of the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Forafric Board has undertaken a review of the independence of each director and considered whether each director of New Forafric
has a material relationship with New Forafric that could compromise his or her ability to exercise independent judgment in carrying out
his or her responsibilities. As a result of this review, New Forafric anticipates that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
will be considered &#8220;independent directors&#8221; as defined under the listing requirements and rules of the Nasdaq and the applicable
rules of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i>Controlled Company Exception</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Upon completion of the Business Combination,
we may meet the definition of a &#8220;controlled company&#8221; under the Nasdaq listing standards, and thus we may qualify for the
&#8220;controlled company&#8221; exemption to the board of directors and committee composition requirements under the Nasdaq listing
standards. If we were to rely on this exemption, we would be exempt from the requirements that (1) our board of directors be comprised
of a majority of independent directors, (2) we have a nominating and corporate governance committee composed entirely of independent
directors, and (3) our compensation committee be comprised solely of independent directors. The &#8220;controlled company&#8221; exception
does not modify the independence requirements for the audit committee, and we intend to comply with the requirements of the Sarbanes-Oxley
Act and the Nasdaq listing standards, which require that our audit committee be composed of at least three members and entirely of independent
directors within one year from the date of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">We have taken all actions necessary
to comply with the Nasdaq listing standards without reliance on the &#8220;controlled company&#8221; exemption, including appointing
a majority of independent directors to the board and establishing certain committees composed entirely of independent directors within
the time frames set forth under the Nasdaq listing standards. However, to the extent that New Forafric qualifies, and as long as it remains,
a &#8220;controlled company,&#8221; these requirements will not apply to New Forafric and New Forafric may, in the future, seek to utilize
some or all of these exemptions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board
Leadership Structure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric believes that the structure of New Forafric Board and its committees will provide strong overall management of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Committees
of New Forafric Board</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric Board will have an audit committee, compensation committee and nominating and corporate governance committee. The composition
and responsibilities of each of the committees of New Forafric Board is described below. Members will serve on these committees until
their resignation or until as otherwise determined by New Forafric Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and &#160;&#160;&#160;&#160;&#160;&#160;&#160;will serve as members of our Audit Committee. Under the Nasdaq rules and applicable SEC rules, all the directors on the Audit Committee
must be independent; our board of directors has determined that each of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are independent under the Nasdaq rules and applicable SEC
rules. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will serve as the Chairman of the Audit Committee. Each member of the Audit Committee is financially literate and our board of
directors has determined that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; qualifies as an &#8220;audit committee financial expert&#8221;
as defined in applicable SEC rules. New Forafric&#8217;s Audit Committee will be responsible for, among other things:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">selecting
    a qualified firm to serve as the independent registered public accounting firm to audit New Forafric&#8217;s financial statements;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 200; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->185<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">helping
    to ensure the independence and performance of the independent registered public accounting firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
    the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and the
    independent registered public accounting firm, New Forafric&#8217;s interim and year-end financial statements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    procedures for employees to submit concerns anonymously about questionable accounting or audit matters;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and overseeing New Forafric&#8217;s policies on risk assessment and risk management, including enterprise risk management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the adequacy and effectiveness of internal control policies and procedures and New Forafric&#8217;s disclosure controls and procedures;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    or, as required, pre-approving, all audit and all permissible non-audit services, other than de minimis non-audit services, to be
    performed by the independent registered public accounting firm.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric Board will adopt a written charter for the Audit Committee which will be available on New Forafric&#8217;s website upon the
completion of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will serve as members of our Compensation Committee. Under the Nasdaq rules, we are required to have a Compensation Committee composed
entirely of independent directors; our Board of Directors has determined that each of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are independent. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will serve as Chairman of
the Compensation Committee. New Forafric&#8217;s Compensation Committee will be responsible for, among other things:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    approving and determining the compensation of New Forafric&#8217;s officers and key employees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    approving and determining compensation and benefits, including equity awards, to directors for service on New Forafric Board or any
    committee thereof;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">administering
    New Forafric&#8217;s equity compensation plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    approving and making recommendations to New Forafric Board regarding incentive compensation and equity compensation plans; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    and reviewing general policies relating to compensation and benefits of New Forafric&#8217;s employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric Board will adopt a written charter for the Compensation Committee, which will be available on its website upon the completion
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
and Corporate Governance Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nominating and corporate governance committee will be responsible for making recommendations to New Forafric&#8217;s board of directors
regarding candidates for directorships and the size and composition of New Forafric&#8217;s board of directors. In addition, the nominating
and corporate governance committee will be responsible for overseeing New Forafric&#8217;s corporate governance policies and reporting
and making recommendations to New Forafric&#8217;s board of directors concerning governance matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The initial members of New
Forafric&#8217;s nominating and corporate governance committee will be &#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;and
&#160;&#160;&#160;&#160;&#160;&#160;&#160;, with &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;serving as the chair of the committee. Each of the members of New Forafric nominating
and corporate governance committee will be an independent director as defined in the listings standards. Our board of directors plans
to adopt a written charter for the nominating and corporate governance committee, which will be available on our corporate website upon
the completion of the Business Combination. The information on our website is not part of this proxy statement/prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 201; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->186<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, New Forafric intends to post its Code of Conduct and Ethics and to post any amendments to or any waivers from
a provision of its Code of Conduct and Ethics on its website, and also intends to disclose any amendments to or waivers of certain provisions
of its Code of Conduct and Ethics in a manner required by applicable rules or regulations of the SEC or securities exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee Interlocks and Insider Participation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of New Forafric&#8217;s officers currently serves, and in the past year has not served, (i) as a member of the compensation committee
or the board of directors of another entity, one of whose officers served on New Forafric&#8217;s compensation committee, or (ii) as
a member of the compensation committee of another entity, one of whose officers served on New Forafric Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Person Policy of New Forafric</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric will adopt a formal written policy that will be effective upon the Business Combination that sets forth the following policies
and procedures for the review and approval or ratification of related person transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;Related Person Transaction&#8221; is a transaction, arrangement or relationship in which New Forafric or any of its subsidiaries
was, is or will be a participant, the amount of which involved exceeds $120,000, and in which any related person had, has or will have
a direct or indirect material interest. A &#8220;Related Person&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    person who is, or at any time during the applicable period was, one of New Forafric&#8217;s officers or one of New Forafric&#8217;s
    directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    person who is known by New Forafric to be the beneficial owner of more than five percent (5%) of its voting stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law,
    father-in-law, daughter-in-law, brother-in-law or sister-in-law of a director, officer or a beneficial owner of more than five percent
    (5%) of its voting stock, and any person (other than a tenant or employee) sharing the household of such director, officer or beneficial
    owner of more than five percent (5%) of its voting stock; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    firm, corporation or other entity in which any of the foregoing persons is a partner or principal or in a similar position or in
    which such person has a ten percent (10%) or greater beneficial ownership interest.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also anticipated that New Forafric will enact policies and procedures designed to minimize potential conflicts of interest arising
from any dealings it may have with its affiliates and to provide appropriate procedures for the disclosure of any real or potential conflicts
of interest that may exist from time to time. Specifically, pursuant to its charter, the Audit Committee will have the responsibility
to review related person transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 202; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->187<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_004"></span>CERTAIN
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Globis
Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, Globis consummated the Private Placement of (i) 4,188,889 Private Placement Warrants at a price of $0.75
per Private Placement Warrant to the Sponsors and (ii) 100,833 Private Placement Units at a price of $10.00 per Unit to a Sponsor, generating
gross proceeds of $4,150,000. Each Private Placement Warrant is exercisable for one share of Common Stock at a price of $11.50 per share.
A portion of the proceeds from the sale of the Private Placement Warrants were added to the proceeds from the IPO to be held in the Trust
Account. If Globis does not complete a business combination within the Combination Period, the Private Placement Warrants will expire
worthless. The Private Placement Warrants are non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor
or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>FAHL
Bonds</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the proposed Business Combination, between December 31, 2021 and January 3, 2022, affiliates (each a &#8220;Bond Investor&#8221;)
of Up and Up Capital, LLC and Globis SPAC LLC, the sponsors of Globis, subscribed for convertible bonds of FAHL, as issuer, in an aggregate
principal amount of $9.5 million (the &#8220;<b>FAHL Bonds</b>&#8221;) in a private placement, issued pursuant to a Bond Subscription
Deed (the &#8220;Bond Subscription Deed&#8221;), among FAHL, the Seller and the Bond Investors. The FAHL Bonds are unsecured obligations
of FAHL and are not transferable without the consent of FAHL (such consent not to be unreasonably withheld). Unless earlier converted
or redeemed in accordance with the terms of the FAHL Bonds, the FAHL Bonds will mature and be redeemed on June 15, 2026. Interest shall
accrue on the FAHL Bonds at a rate of 6% per annum and the Bond Investors are entitled to certain customary information rights. Pursuant
to the current terms of the FAHL Bonds, upon consummation of the Business Combination, the FAHL Bonds will automatically convert into
ordinary shares of New Forafric at a price per share that is a 10% discount to the PIPE Investment, subject to certain adjustments. The
number of ordinary shares will be equal to the quotient that results from dividing the aggregate principal amount of the respective FAHL
Bond by $9.45, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December 10, 2020 (the &#8220;<b>Registration Rights Agreement</b>&#8221;), the holders
of the Common Stock, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Common
Stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital
Loans) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short
form demands, that New Forafric register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration
rights with respect to registration statements filed subsequent to the completion of the Business Combination. However, the Registration
Rights Agreement provides that New Forafric will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable lock-up period. New Forafric will bear the expenses incurred in connection with the filing of any
such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Globis
Related Parties Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an unsecured promissory note issued to Globis SPAC LLC on January 11, 2021 (the &#8220;<b>Note</b>&#8221;), Globis may borrow from
time to time up to $1,000,000 from Globis SPAC LLC or its assignees or successors. The Note is non-interest bearing and payable upon
the consummation of a Business Combination. On various dates during the nine months ended September 30, 2021, Globis drew a total of
$700,000 under the Note in accordance with the Working Capital Loans. On April 28, 2021, the Note was amended to terminate the
option for a holder to convert the amount outstanding under the Note into Private Warrants. On July 19, 2021, the Note was amended to
increase the principal amount of the Note from $1,000,000 to $2,000,000. On October 13, 2021, the Note was amended to increase the principal
amount of the Note from $2,000,000 to $3,000,000. On December 29, 2021, 2021, the Note was amended to increase the principal amount of
the Note from $3,000,000 to $5,000,000. <span style="background-color: white">Globis has drawn down $5,000,000 under the Note.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 203; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->188<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Post-Business
Combination Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, certain agreements were entered into or will be entered into pursuant to the Business Combination
Agreement. The agreements described in this section, or forms of such agreements as they will be in effect substantially concurrently
with the completion of the Business Combination, are filed as exhibits to the registration statement of which this prospectus forms a
part, and the following descriptions are qualified by reference thereto. These agreements include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor
    Letter Agreement (see the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Certain Agreements Related
    to the Business Combination &#8212; Sponsor Letter Agreement</i>&#8221;); </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Rights Agreement (see the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Certain Agreements Related
    to the Business Combination &#8212; Registration Rights Agreement</i>&#8221;); and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Incentive Plan (see the section entitled &#8220;<i>Proposal 3: The Business Combination Proposal &#8212; Certain Agreements Related
    to the Business Combination &#8212; Equity Incentive Plan</i>&#8221;). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FAHL
Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lease
agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, FAHL entered into a building lease agreement for the headquarters of Forafric Maroc, a wholly owned subsidiary, with a lease term
through 2024. The Seller owns 100% of the company that owns the building. Total rent is approximately $420,000 per year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exclusive
Supply Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Framework Contract for Delegation of Purchases and Terms of Application, between Forafric Maroc and Millcorp Geneve SA (&#8220;Millcorp&#8221;),
a wholly owned subsidiary of the Seller, FAHL is obligated to obtain at least 80% of its annual requirements of common wheat, durham
wheat, or any other cereal, for the five year period which began on April 1, 2018 and ends on March 31, 2023, will commissions payable
to Millcorp. As agreed upon by the parties. Millcorp is currently providing 100% of the imported grain to FAHL. The purchases incurred
were $94,015,000 and $101,208,000, as of September 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the beginning of 2021, FAHL received management fees of $500,000 from Millcorp Geneve SA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
parties <span style="background-color: white">affiliated with FAHL hold outstanding loans issued to FAHL (the &#8220;<b>FAHL Related
Party Loans</b>&#8221;), which, in the aggregate, equaled </span>$10,852,000 and $387,000 as of September 30, 2021 and December 31, 2020,
respectively. The FAHL Related Party Loans are interest-free loans with no maturity date: As of December 31, 2021, the outstanding amounts
held under the FAHL Related Party Loans were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Seller in the amount of $673,124;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sole shareholder of the Seller in the amount of $6,631,951;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Elbaz, a director FAHL and the Seller, in the amount of $4,926,915; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 204; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->189<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    beneficiary of the discretionary trust which is the sole shareholder of the Seller, in the amount of $2,942,233.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, FAHL may incur additional FAHL Related Party Loans up to an aggregate of $20 million. Upon
consummation of the Business Combination, all FAHL Related Party Loans will be converted into Ordinary Shares of New Forafric at
a price of $10.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
of Policy Regarding Transactions with Related Persons Following the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric will adopt a formal written policy that will be effective upon the completion of the Business Combination providing that New
Forafric&#8217;s officers, directors, nominees for election as directors, beneficial owners of more than 5% of any class of New Forafric&#8217;s
capital stock, any member of the immediate family of any of the foregoing persons and any firm, corporation or other entity in which
any of the foregoing persons is employed or is a general partner or principal or in a similar position or in which such person has a
5% or greater beneficial ownership interest, are not permitted to enter into a related party transaction with New Forafric without the
approval of New Forafric&#8217;s audit committee, subject to certain exceptions. For more information, see the section entitled &#8220;<i>Management
of New Forafric Following the Business Combination &#8212; Related Person Policy of New Forafric.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to article 297 of New Forafric&#8217;s Memorandum and Articles of Association, a relevant director of New Forafric or an associated company
may be indemnified out of New Forafric&#8217;s assets against any liability which by virtue of any rule of law would otherwise attach
to him in respect of any negligence, default, breach of duty or breach of trust of which he may be guilty in relation to New Forafric.
Article 297 provides that the above does not authorize any indemnity which would be prohibited or rendered void by any provision
of the Act or by any other provision of law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
section 231 of the Companies Act, any provision (whether in the articles or in a contract with a company) exempting or indemnifying any
officer of New Forafric for negligence, default or breach of duty is void. However, New Forafric may, if permitted by its articles or
a contract:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">indemnify
    a director as to the costs of successful court proceedings; and/or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase
    and maintain for any director insurance for any liability referred to in section 231.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
person not being New Forafric may indemnify a director against any liability referred to in section 231.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 205; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->190<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_005"></span>SECURITIES
ACT RESTRICTIONS ON RESALE OF NEW FORAFRIC&#8217;S SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 144 under the Securities Act (&#8220;<b>Rule 144</b>&#8221;), a person who has beneficially owned restricted ordinary shares
or warrants of New Forafric for at least six months would be entitled to sell their securities provided that (i) such person is not deemed
to have been an affiliate of New Forafric at the time of, or at any time during the three months preceding, a sale and (ii) New Forafric
is subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required
reports under Section 13 or 15(d) of the Exchange Act during the twelve months (or such shorter period as New Forafric was required to
file reports) preceding the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
who have beneficially owned restricted ordinary shares or warrants of New Forafric for at least six months but who are affiliates
of New Forafric at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions,
by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater
of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
    of the total number of ordinary shares of New Forafric then outstanding (as of the date of this proxy statement/prospectus, Globis
    has 15,050,833 shares of common stock outstanding); or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    average weekly reported trading volume of New Forafric ordinary shares during the four calendar weeks preceding the filing of a notice
    on Form 144 with respect to the sale. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by affiliates of New Forafric under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability
of current public information about New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions
on the Use of Rule 144 by Shell Companies or Former Shell Companies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell
companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to
this prohibition if the following conditions are met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities that was formerly a shell company has ceased to be a shell company; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding
    twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status
    as an entity that is not a shell company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, the Sponsors will be able to sell their ordinary shares and private placement warrants, as applicable, pursuant to Rule
144 without registration one year after Globis has completed its initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
anticipates that following the completion of the Business Combination, New Forafric will no longer be a shell company, and so, once the
conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of the above noted restricted
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section entitled &#8220;<i>Description of New Forafric Securities &#8212; Registration Rights</i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 206; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->191<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_006"></span>SHAREHOLDER
PROPOSALS AND NOMINATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Proposals</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric&#8217;s proposed Memorandum and Articles of Association establish an advance notice procedure for shareholders who wish to present
a proposal (as described in, and in compliance with, Rule 14a-8 of the Exchange Act; such shareholder proposal hereinafter being referred
to as a &#8220;proposal&#8221;) before an annual general meeting which is to be included by the New Forafric Board in a notice and any
proxies relating to an annual general meeting (or any adjournment thereof). New Forafric&#8217;s proposed Memorandum and Articles of
Association provide that the only business that may be conducted at an annual general meeting is business that is (i) specified in the
notice of such meeting (or any supplement or amendment thereto, as well as any notice of an adjourned meeting) given by or at the direction
of the New Forafric Board, (ii) otherwise brought at such meeting by or at the direction of the New Forafric Board, or (iii) to the extent
that New Forafric is subject to section 14 of the Exchange Act, otherwise brought at such meeting following a proposal made by a shareholder
who is a shareholder of record on the date of giving of the notice and on the record date for determination of shareholders entitled
to vote at such meeting who has complied with the procedures specified in New Forafric&#8217;s proposed Memorandum and Articles of Association
for the submission of a proposal. In order to comply with the procedures specified in New Forafric&#8217;s proposed Memorandum and Articles
of Association for the submission of a shareholder proposal so that these may be included in a notice and any proxies relating to an
annual general meeting, New Forafric&#8217;s secretary must receive the written notice containing the shareholder proposal at New Forafric&#8217;s
registered office address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
  <td style="text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify">not earlier than the 120th day; and</td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not later than the 90th
  day</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
the one-year anniversary of the preceding year&#8217;s annual general meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that no general meeting was held in the previous year or New Forafric holds its annual general meeting more than 30 days before
or more than 70 days following after the one-year anniversary of a preceding year&#8217;s annual general meeting, notice of a shareholder
proposal must be received no later than the 10<sup>th</sup> day following the day on which the public announcement (including an announcement
on the website of New Forafric) of such date was first made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
for New Forafric&#8217;s 2022 General Meeting, assuming the meeting is held on
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, notice of a nomination or proposal
must be delivered to New Forafric no later than
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and no earlier than
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Nominations and proposals also
must satisfy other &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; requirements set
forth in the Memorandum and Articles of Association. The Chairperson of the New Forafric Board may refuse to acknowledge the
introduction of any shareholder proposal not made in compliance with the foregoing procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Rule 14a-8 of the Exchange Act, a shareholder proposal to be included in the proxy statement and proxy card for the 2022 annual
general meeting pursuant to Rule 14a-8 must be received at our principal office on or before
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and must comply with Rule
14a-8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Director Nominees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Forafric&#8217;s proposed Memorandum and Articles of Association permit shareholders to nominate directors for election at an annual
general meeting of shareholders. No person other than a director retiring by rotation shall be appointed a director at any general meeting
unless: (i) that person is recommended by the New Forafric Board; or (ii) not less than three nor more than forty-two days before the
date of the annual general meeting, a notice executed by any shareholder qualified to vote at the meeting (not being the person to be
proposed) has been received by New Forafric of the intention to propose that person for appointment stating the particulars (i.e., full
name, residential address, date of birth, nationality and profession) which would, if he were so appointed, be required to be included
in the register of directors of New Forafric, together with confirmation in writing executed by that person of their willingness to be
so appointed as a director of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
Private Issuer Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is completed prior to June 30, 2022, we anticipate that as of June 30, 2022 New Forafric will qualify as a &#8220;foreign
private issuer&#8221; as defined in the Exchange Act and, beginning January 1, 2023, will be exempt from certain rules under the Exchange
Act that impose certain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, to the extent that New Forafric is not subject to such rules under the Exchange Act, shareholders of New Forafric may be
limited in their ability to present a proposal before an annual general meeting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_007"></span>APPRAISAL
RIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenters&#8217;
rights or appraisal rights are statutory rights that enable stockholders who object to certain extraordinary transactions to demand that
the corporation pay such stockholders the fair value of their shares instead of receiving the consideration offered to stockholders in
connection with the extraordinary transaction. However, appraisal rights are not available in all circumstances. Appraisal rights are
not available to Globis Stockholders or warrant holders in connection with the Merger, the Redomiciliation or the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b><br /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_008"></span>STOCKHOLDER
COMMUNICATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
and interested parties may communicate with the Globis Board, any committee chairperson or the non-management directors as a group by
writing to the Globis Board or committee chairperson at Globis Acquisition Corp., 7100 W. Camino Real, Suite 302-48, Boca Raton, FL 33433
(if sent before the Business Combination) or with New Forafric Board or any committee chairperson or the non-management directors as
a group, to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(if sent after the Business Combination). Each communication
will be forwarded, depending on the subject matter, to the applicable board, the appropriate committee chairperson or all non-management
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_009"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legality of the Ordinary Shares offered by this proxy statement/prospectus and certain other Gibraltar legal matters will be passed upon
for New Forafric by Hassans International Law Firm Limited. Certain other legal matters relating to U.S. law will be passed upon by McDermott
Will &amp; Emery LLP, New York, New York.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_010"></span>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Globis Acquisition Corp. as of December 31, 2020 and for the period from August 21, 2020 (inception) through
December 31, 2020, appearing in this prospectus have been audited by Marcum LLP, independent registered public accounting firm, as set
forth in their report thereon, appearing elsewhere in this proxy statement/prospectus, and are included in reliance upon such report
given on the authority of such firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of Forafric Agro Holdings Limited and Subsidiaries at December 31, 2019 and 2020, and for each of the
two years in the period ended December 31, 2020, included in the Proxy Statement of Globis Acquisition Corp., which is referred to and
made a part of this Prospectus and Registration Statement, have been audited by UHY LLP, independent registered public accounting firm,
as set forth in their report appearing elsewhere herein, and are included in reliance upon such report given on the authority of such
firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_011"></span>DELIVERY
OF DOCUMENTS TO SHAREHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the rules of the SEC, Globis and the services that it employs to deliver communications to its shareholders are permitted to deliver
to two or more shareholders sharing the same address a single copy of each of Globis&#8217; annual report to shareholders and Globis&#8217;
proxy statement/prospectus. Upon written or oral request, Globis will deliver a separate copy of the annual report to shareholder and/or
proxy statement/prospectus to any shareholder at a shared address to which a single copy of each document was delivered and who wishes
to receive separate copies of such documents. Shareholders receiving multiple copies of such documents may likewise request that Globis
deliver single copies of such documents in the future. Shareholders receiving multiple copies of such documents may request that Globis
deliver single copies of such documents in the future. Shareholders may notify Globis of their requests by calling or writing Globis
at 7100 W. Camino Real, Suite 302-48, Boca Raton, Florida 33433 (if before the Business Combination) or &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(if
after the Business Combination).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_012"></span>TRANSFER
AGENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for Globis&#8217; securities is VStock Transfer, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 207; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->192<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_013"></span>SUBMISSION
OF PROPOSALS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Globis Board is aware of no other matter that may be brought before the Stockholders Meeting. If any matter other than the Proposals
or related matters should properly come before such meetings, however, the persons named in the enclosed proxies will vote proxies in
accordance with their judgment on those matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the laws of Delaware, only business stated in the notice of a special meeting of stockholders may be transacted at such meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_014"></span>ENFORCEABILITY
OF CIVIL LIABILITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
is a Delaware corporation. If Globis changes its jurisdiction of incorporation from Delaware to Gibraltar effecting the Redomiciliation,
you may have difficulty serving legal process within the United States upon Globis. You may also have difficulty enforcing, both in
and outside the United States, judgment you may obtain in U.S. courts against Globis in any action, including actions based upon the
civil liability provisions of U.S. federal or state securities laws. Furthermore, there is doubt that the courts of the Gibraltar would
enter judgments in original actions brought in those courts predicated on U.S. federal or state securities laws. However, Globis may
be served with process in the United States with respect to actions against Globis arising out of or in connection with violation of
U.S. federal securities laws relating to offers and sales of Globis&#8217; securities by serving Globis&#8217; U.S. agent irrevocably
appointed for that purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_015"></span>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Nevada has filed a registration statement on Form S-4 to register the issuance of securities described elsewhere in this proxy statement/prospectus.
This proxy statement/prospectus is a part of that registration statement. This proxy statement/prospectus does not contain all of the
information included in the registration statement. For further information pertaining to Globis Nevada and its securities, you should
refer to the registration statement and to its exhibits. Whenever reference is made in this proxy statement/prospectus to any of Globis
Nevada or Globis&#8217; contracts, agreements or other documents, the references are not necessarily complete, and you should refer to
the annexes to the proxy statement/prospectus and the exhibits attached to the registration statement for copies of the actual contract,
agreement or other document.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effectiveness of the registration statement of which this proxy statement/prospectus forms a part, Globis Nevada will be subject
to the information and periodic reporting requirements of the Exchange Act and will file annual, quarterly and current reports, proxy
statements and other information with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
files reports, proxy statements and other information with the SEC as required by the Exchange Act. You may access information on Globis
at the SEC web site containing reports, the registration statement and other information at: http://www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus is available without charge to stockholders of Globis upon written or oral request. If you would like additional
copies of this proxy statement/prospectus or if you have questions about the Business Combination or the Proposals to be presented at
the Stockholders Meeting, you should contact Globis in writing at Globis Acquisition Corp., 7100 W. Camino Real, Suite 302-48, Boca Raton, FL 33433 or by telephone at (212) 847-3248.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">If you have questions about the
Proposals or this proxy statement/prospectus, would like additional copies of this proxy statement/prospectus, or need to obtain proxy
cards or other information related to the proxy solicitation, please contact &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, our proxy solicitor, by calling &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or banks and brokers
can call collect &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or by emailing &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. You will not be charged for any of the documents that you request.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain timely delivery of the documents, you must request them no later than five business days before the date of the meetings, or no
later than &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
and statements contained in this proxy statement/prospectus or any annex to this proxy statement/prospectus are qualified in all respects
by reference to the copy of the relevant contract or other annex filed as an exhibit to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information contained in this document relating to Globis has been supplied by Globis and all such information relating to FAHL has been
supplied by the Seller. Information provided by Globis or FAHL does not constitute any representation, estimate or projection of the
other.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 208; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->193<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="kd_016"></span>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Globis
    Acquisition Corp.</b> &#160;</span></td>
    <td style="vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements as of December 31, 2020</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_001">Report
    of Independent Registered Public Accounting Firm</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-2</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_002">Balance
    Sheets as of December 31, 2020 (as restated)</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-3</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_003">Statement
    of Operations for the period from August 21, 2020 (inception) through December 31, 2020 (as Restated)</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-4</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_004">Statement
    of Changes in Shareholders&#8217; Equity for the period from August 21, 2020 (inception) through December 31, 2020 (as Restated)</a>
    </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-5</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_005">Statement
    of Cash Flows for the period from August 21, 2020 (inception) through December 31, 2020 (as Restated)</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-6</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_006">Notes
    to Financial Statements</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-7</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited
    Condensed Financial Statements as of September 30, 2021</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_007">Condensed
    Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020 (as Restated)</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-17</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_008">Condensed
    Statements of Operations for the Three and Nine Months Ended September 30, 2021 and for the period from August 21, 2020 (inception)
    through September 30, 2020 (Unaudited)</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-18</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_009">Condensed
    Statement of Changes in Stockholders&#8217; Equity (Deficit) for the Three and Nine Months Ended September 30, 2021 and for the period
    from August 21, 2020 (inception) through September 30, 2020 (Unaudited)</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-19</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_010">Condensed
    Statement of Cash Flows for the Nine Months Ended September 30, 2021 and for the period from August 21, 2020 (inception) through
    September 30, 2020 (Unaudited)</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-20</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fi_011">Notes
    to Unaudited Condensed Financial Statements</a> </span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-21</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Forafric
    Agro Holdings Limited</b> &#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
    Financial Statements for the years ended December 31, 2020 and 2019</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">Report
    of Independent Registered Public Accounting Firm</a> </span></td>
    <td style="vertical-align: bottom; text-align: center">F-33</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Consolidated
    Balance Sheets as of December 31, 2020 and December 31, 2019</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-34</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Consolidated
    Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2020 and December 31, 2019</a> </span></td>
    <td style="vertical-align: bottom; text-align: center">F-35</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Consolidated
    Statement of Changes in Stockholder&#8217;s Equity (Deficit) for the years ended December 31, 2020 and December 31, 2019</a> </span></td>
    <td style="vertical-align: bottom; text-align: center">F-36</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Consolidated
    Statements of Cash Flows for the years ended December 31, 2020 and December 31, 2019</a> </span></td>
    <td style="vertical-align: bottom; text-align: center">F-37</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Notes
    to Consolidated Financial Statements</a> </span></td>
    <td style="vertical-align: bottom; text-align: center">F-38</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Financial Statements as of September 30, 2021 and December 31, 2020 and for the Nine Months Ended September 30, 2021 and
2020</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Condensed
    Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-54</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">Condensed
    Consolidated Statements of Operations and Comprehensive Loss for the Nine Months Ended September 30, 2021 and September 30, 2020
    (Unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-55</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Condensed
    Consolidated Statements of Changes in Stockholders&#8217; Equity (Deficit) for the Nine Months Ended September 30, 2021 and September
    30, 2020 (Unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-56</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Condensed
    Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2021 and September 30, 2020 (Unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-57</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Notes
    to Condensed Consolidated Financial Statements</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-58</td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 209; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">To
the Shareholders and Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Globis
Acquisition Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have audited the accompanying balance sheet of Globis Acquisition Corp. (the &#8220;Company&#8221;) as of December 31, 2020, the related
statements of operations, changes in stockholders&#8217; equity and cash flows for the period from August 21, 2020 (inception) through
December 31, 2020, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of
its operations and its cash flows for the period from August 21, 2020 (inception) through December 31, 2020, in conformity with accounting
principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>Restatement
of 2020 Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">As discussed
in Note 2 to the financial statements, the accompanying financial statements as of December 31, 2020 and for the period from August 21,
2020 (inception) through December 31, 2020 have been restated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>/s/ Marcum
<span style="font-variant: small-caps">llp</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Marcum <span style="font-variant: small-caps">llp</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">We have served
as the Company&#8217;s auditor since 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Melville, NY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">March
31, 2021, except for the effects of the restatement discussed in Notes 2, 3 and 8 as to which the date is December 7, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 210; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_119_hus-gaap--BusinessAcquisitionAxis__custom--GlobisAcquisitionCorpMember_znjZOSKj696j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_002"></span>BALANCE
SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(As
Restated)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zHiyQmMgxXe1" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20201231_zjNQLUPBbggd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pp0p0_maACz7eh_zz402k3XIqgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,068</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--PrepaidExpenseCurrent_i02I_pp0p0_maACz7eh_z74RcBsxlwsd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">283,333</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_pp0p0_mtACz7eh_maAzYjT_z2htum5AmVJ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Current Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">485,401</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_i01I_pp0p0_maAzYjT_zmwGzAn0wY5i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities
    held in Trust Account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--Assets_i01TI_pp0p0_mtAzYjT_zX19SKILNGf3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,635,401</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND STOCKHOLDERS&#8217;
    EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i01I_pp0p0_maLzynf_zOcqnDsxZhBl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities - accrued expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,628</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--PromissoryNoteRelatedParty_i01I_pp0p0_maLzynf_zToxyRcwlHq1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Promissory
    note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--Liabilities_i01TI_mtLzynf_maLASEzZl8_zTYrOjRtVHa5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">TOTAL LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0_maLASEzZl8_zCQHJCsknZWj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0057">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_pp0p0_maLASEzZl8_zkZ0lhHWJ499" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption
    <span id="xdx_90E_eus-gaap--TemporaryEquitySharesIssued_iI_c20201231_zGlTeUC4IEZ2"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    at redemption value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--StockholdersEquityAbstract_i01B_zF5d2fMQWU9b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzWUq_zLsp3TS5Ws74" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Preferred stock, $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">par value; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_ztnSrBhrkqki"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares authorized; <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20201231_zZqyRnffdI76"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no
    </ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif">shares issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0064">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzWUq_zi8WRj9KXyKe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_c20201231_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">par value; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20201231_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares authorized; <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares issued and outstanding (excluding <span id="xdx_90A_ecustom--CommonStockRedemptionShare_iI_c20201231_z2bXoojgjK2j"><ix:nonFraction name="GLAQ:CommonStockRedemptionShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares subject to possible redemption)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_pp0p0_maSEzWUq_zmRR2CwSsxvk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_maSEzWUq_zpYUELwOZJfa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_402_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEzWUq_maLASEzZl8_zfIqBHBoOkXk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Stockholders&#8217; Equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">419,773</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzZl8_zZKbN1clnMPj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,635,401</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 211; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_003"></span>STATEMENT
OF OPERATIONS</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(As
Restated)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE PERIOD FROM AUGUST 21, 2020 (INCEPTION) THROUGH DECEMBER 31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zUbRUIVUPqV6" summary="xdx: Statement - Condensed Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20200821__20201231_zmJ30uTxYy13" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_msOILzF0n_zeUVvwEOcUFk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">General
    and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_mtOILzF0n_zTV170bjs844" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Loss
    from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zLpdBbA6hGp5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Other
    income:</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentIncomeInterest_i01_maNIEzsgU_zUp9yNd4Rke" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Interest
    earned on marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzsgU_zMTc1GGG8lW7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Total
    other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maNILz31t_zwMg15e1EL44" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Loss
    before income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_msNILz31t_zpClh3ovLVv8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Benefit
    from (provision for) income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--FormationAndOperatingCosts_msNILz31t_zcgxSIDj28G1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Formation
    and operational costs</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:FormationAndOperatingCosts" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_iT_pp0p0_mtNILz31t_ziA6leQtcJH" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding, Common stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,520,661</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_uUSDPShares_zIq5ljA7zvij" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic
    and diluted net loss per share, Common stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding, Non-redeemable common stock</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,658,912</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_pid_uUSDPShares_zv5bW7NRtlFh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic
    and diluted net loss per share, Non-redeemable common stock</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 212; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_004"></span>STATEMENT
OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(As
Restated)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE PERIOD FROM AUGUST 21, 2020 (INCEPTION) THROUGH DECEMBER 31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_zZDucPzbTJz4" summary="xdx: Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zjZ0e8BShfw2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zzIVsyFfSL7k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zVi2mqTfhKpg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_custom--TotalStockholdersEquityMember_ziShma0ZCZO9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid-in</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total
    Stockholders&#8217;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_439_c20200821__20201231_eus-gaap--StockholdersEquity_iS_zcig22lPUWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; August 21, 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbylfglBo6ed" title="Balance, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0109">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0110">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0111">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0112">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of common stock to Sponsors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Issuance of common stock to Sponsors, shares" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,047,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">305</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,195</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueSaleOfPlacementUnits_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_PrivatePlacementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">Placement Units</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesSaleOfPlacementUnits_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Sale of 100,833 Placement Units, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:StockIssuedDuringPeriodSharesSaleOfPlacementUnits" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,008,320</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,008,330</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,188,889</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">Private Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0131">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,141,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0133">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,141,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueOther_zPhLXWH2YMf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Equity participation shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesOther_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Equity participation shares, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">402,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0139">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0140">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_di_zidkbXrRKqme" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Redemption adjustment for Common Stock to redemption
    amount</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0146">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0149">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0150">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_430_c20200821__20201231_eus-gaap--StockholdersEquity_iE_z1fc8Bzcps65" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; December
    31, 2020</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20200821__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zw6Iatw84gOa" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">419,773</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 213; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_005"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STATEMENT
OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(As
Restated)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE PERIOD FROM AUGUST 21, 2020 (INCEPTION) THROUGH DECEMBER 31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_112_z2OwkzKbz3m7" summary="xdx: Statement - Condensed Statement of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20200821__20201231_zlgu6UHsjXEb" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash Flows from Operating
    Activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_i01_pp0p0_maNCPBUztzg_zfRsXRBM2lYf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adjustments to reconcile
    net loss to net cash used in operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--InvestmentIncomeInterest_i02N_di_msNCPBUztzg_z0RpKrgsoxqi" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Interest
    earned on investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Changes in operating
    assets and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_pp0p0_di_msNCPBUztzg_zJCZD0CIxqYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">283,333</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_pp0p0_maNCPBUztzg_z9R52WlHFSP4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accrued
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,628</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUztzg_zmAwg9wGBfF9" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1.5pt; text-align: justify">Accounts
    payable and accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUztzg_maCCERCzrc9_zxwJBJD0ZObk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">307,591</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash Flows from Investing
    Activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--PaymentsToAcquireTrustPreferredInvestments_i01N_pp0p0_di_msNCPBUzXCC_zQXMMjTUuyob" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investment of cash
    in Trust Account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireTrustPreferredInvestments" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUzXCC_maCCERCzrc9_zJYyc9JGFbYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash Flows from Financing
    Activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_pp0p0_maNCPBUzx6v_zQAFVLMID929" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds from issuance of common stock to
    Sponsors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_i01_pp0p0_maNCPBUzx6v_z25J9KhLKZD5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds from sale of Units, net of underwriting
    discounts paid</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,700,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_pp0p0_maNCPBUzx6v_z2VCBo2nNp44" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds from sale of Placement Units</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,008,330</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfWarrants_i01_pp0p0_maNCPBUzx6v_z5uNeSOpcFe8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds from sale of Private Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,141,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ProceedsFromRelatedPartyDebt_i01_pp0p0_maNCPBUzx6v_zq0L4eDMhoed" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Advances from related party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_pp0p0_di_msNCPBUzx6v_zich8YpmXDdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Repayment of advances from related party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--PaymentsOfFinancingCosts_i01N_pp0p0_di_msNCPBUzx6v_zaBP6SiWGigk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Payment of offering
    costs</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">216,841</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzx6v_maCCERCzrc9_zsbvjshd8Eve" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,659,659</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_pp0p0_mtCCERCzrc9_z0YifGlFuxF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net Change in Cash</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,068</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zSfTCtm8gG6h" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash &#8211; Beginning
    of period</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zBPQqyE6O0Ne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
    &#8211; End of period</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,068</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and
    financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--OfferingCostsIncludedInAccruedOfferingCosts_i01_zg1lPPFLn7X5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Offering
    costs included in accrued offering costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Initial classification
    of common stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 214; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_006"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p id="xdx_04D_c20200821__20201231_zCER0uhN45Kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zug8xCBl6Um8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_82C_z32o1Osg5AD7">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
December 31, 2020 relates to the Company&#8217;s formation and the initial public offering (&#8220;Initial Public Offering&#8221;), which
is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public
Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Units&#8221; and, with respect
to the shares of common stock included in the Units sold, the &#8220;Public Shares,&#8221; which included the full exercise by the underwriter
of its over-allotment option in the amount of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z1rkB3eYjKzj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit), generating gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,188,889</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants (the &#8220;Private Warrants&#8221;)
at a price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Placement Units&#8221; and,
together with the Private Warrants, the &#8220;Private Securities&#8221;) at a price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z04xPkbrn9c8"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#8220;Up
and Up&#8221; and, collectively with Globis SPAC LLC, the &#8220;Sponsors&#8221;), which is described in Note 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20201213__20201215_pp0p0"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,541,841</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consisting of $<span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20201213__20201215_zbKXbSz3nxff"><ix:nonFraction name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,300,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of underwriting fees, $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20201213__20201215_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,025,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">402,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#8220;equity participation shares&#8221;), and $<span id="xdx_901_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20201213__20201215_zTEeBnAvfDmi"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">216,841</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_c20201215_pdd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#8220;Trust Account&#8221;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company
must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding
taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The
Company intends to only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its holders of the outstanding Public Shares (the &#8220;public stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated
to be $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201215_zfvQcOdG03Sh"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to
pay its tax or dissolution obligations). There will be no redemption rights upon the completion of a Business Combination with respect
to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 215; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentNet_c20201231__srt--RangeAxis__srt--MinimumMember_pp0p0"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated
Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares
irrespective of whether they vote for or against the proposed transaction or do not vote at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and the Company&#8217;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#8217;s obligation
to allow redemption in connection with the Company&#8217;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#8220;Combination Period&#8221;). The Company&#8217;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. <span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zD3SKOqznv57"><ix:nonNumeric contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">Pursuant
to the terms of the Company&#8217;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#8217;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) <span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHUQrr1GFJZ"><ix:nonNumeric contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember" name="us-gaap:LiquidationBasisOfAccountingCostsAndIncomes">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law,</ix:nonNumeric> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#8217;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 216; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $<span id="xdx_901_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_uUSDPShares_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TrustAccountMember_zFgnDrJK8KS4"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2020-12-31_custom_TrustAccountMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#8217;s tax obligation and up to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20201231_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#8217;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of December 31, 2020, the Company had cash of $<span id="xdx_905_ecustom--CashHeldOutsideTrust_c20201215_pp0p0"><ix:nonFraction name="GLAQ:CashHeldOutsideTrust" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,068</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held outside of the Trust Account, $<span id="xdx_909_eus-gaap--MarketableSecuritiesNoncurrent_iI_pp0p0_c20201231_zhIV7Sux7OQg"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held in the Trust Account to be used for a Business
Combination, and adjusted working capital of $<span id="xdx_904_ecustom--WorkingCapital_c20201215_pp0p0"><ix:nonFraction name="GLAQ:WorkingCapital" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">432,087</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which excludes $<span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_c20201231__srt--ProductOrServiceAxis__us-gaap--FranchiseMember_pp0p0"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2020-12-31_us-gaap_FranchiseMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,314</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of franchise taxes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#8217;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#8217;s working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#8220;Note&#8221;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#8220;Lender&#8221;), providing for borrowings from time to time of up to an aggregate of $1,000,000.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential transaction. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient financing
or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if the Company
extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There is no assurance
that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period of time to consummate
a Business Combination up to two times, each by an additional three months).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ErrorCorrectionTextBlock"><p id="xdx_804_eus-gaap--ErrorCorrectionTextBlock_zCf6KFDBqi2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_825_z69zMpFSac9c">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of the Company&#8217;s financial statements, management identified errors made in its historical financial
statements where, at the closing of the Company&#8217;s Initial Public Offering, the Company improperly valued its common stock subject
to possible redemption. The Company previously determined the common stock subject to possible redemption to be equal to the redemption
value, while also taking into consideration a redemption cannot result in net tangible assets being less than $<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231__srt--RangeAxis__srt--MinimumMember_z9ZeBuY4NwId"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become
redeemable subject to the occurrence of future events considered outside the Company&#8217;s control. Therefore, management concluded
that temporary equity should include all shares of common stock subject to possible redemption, resulting in the common stock subject
to possible redemption being equal to their redemption value. As a result, management has noted a classification error related to temporary
equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption
with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the change in presentation for the common stock subject to possible redemption, the Company also restated its income
(loss) per common share calculation to allocate net income (loss) evenly to all common stock. This presentation contemplates a Business
Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"></p>

<ix:exclude><!-- Field: Page; Sequence: 217; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been no change in the Company&#8217;s total assets, liabilities or operating results.&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zdSJWd6i1zQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B7_zkIKDrkP2O16" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br /> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 15, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td title="Common stock subject to possible redemption" id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zr1tDu8D9RW8" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,652,086</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zFV3u6dZ6BWf" title="Common stock subject to possible redemption" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,497,914</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215_zJLo6pZ96RJ5" title="Common stock subject to possible redemption" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--CommonStockValue_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1u8FSmwjWM2" title="Common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">401</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJOqUaBUI63k" title="Common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201215_zuIWn2qiL2Vk" title="Common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">356</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxDCFwdezsa4" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,007,172</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYOyO3xsgATd" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,497,869</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215_zGOkQMf6ARyf" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,303</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zv3zt32REHO2" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,571</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pdp0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGVNovl30gug" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215_zV4cW22ADfQ6" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,571</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPWGodXf84Xh" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,002</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdBCTW7la5M9" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,497,914</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215_zMOh0PQL3tRl" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">502,088</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeHAy5RxokO1" title="Weighted average shares outstanding - redeemable" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-12-132020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,054,662</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zc9V3ongOX33" title="Weighted average shares outstanding - redeemable" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-12-132020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">445,338</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockRedemptionShares_c20201213__20201215_zpItKGo9Qibc" title="Common stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3hCgC3NyId6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,569,772</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIdULU9bX9C" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,580,228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231_z5vCs9Oi8ct1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zI9bzOwDKgQ7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZFQN4mV307j" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--CommonStockValue_iI_pp0p0_c20201231_zhsKRPsyW40b" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,089,487</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,580,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231_pp0p0" title="Additional paid-in capital" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdp0" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0297">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231_pp0p0" title="Accumulated deficit" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsCMFzqndTr2" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJ0EEjklCdEk" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,580,228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231_zDthzg4HYMgb" title="Total Stockholders&apos; (Deficit) Equity" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">419,773</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVAnRbarvAWa" title="Common stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,046,512</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOFlAOLeikU9" title="Common stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--CommonStockRedemptionShares_c20200821__20201231_zT5AFZISJ2g" title="Common stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockRedemptionShares" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Cash Flows
    for the Period from August 21, 2020 (Inception) through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial classification of common stock subject
    to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJqUiheK12oc" title="Initial classification of common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,652,086</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zV6CbUeMo0Ug" title="Initial classification of common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,497,914</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231_zuctQ6H3xln2" title="Initial classification of common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of Common Stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBrsLUkQHPDl" title="Change in value of Common Stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:ChangeInSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">82,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zrWKWotoa70a" title="Change in value of Common Stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:ChangeInSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231_zSHAD2BlVR9l" title="Change in value of Common Stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0323">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity for the Period Ended December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVSUk9SIENPUlJFQ1RJT05TIEFORCBQUklPUiBQRVJJT0QgQURKVVNUTUVOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200812__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zmnvanOuGuLi"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">Units, net of underwriter discounts and offering expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuagBQBjeCIb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnderwritingIncomeLoss" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">112,483,159</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQt2KkRywt22" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UnderwritingIncomeLoss" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,483,159</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231_zkrIjxg6sjyj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0327">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial value of Common Stock subject to redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zi7rWRC82HM" title="Initial value of Common Stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:InitialSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">111,569,772</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsAXSHlgE9vi" title="Initial value of Common Stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:InitialSharesSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,569,772</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231_zlXdo4sdqXRi" title="Initial value of Common Stock subject to redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Redemption adjustment for Common Stock to redemption
    amount</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkefGMzoB9rj" title="Redemption adjustment for Common Stock to redemption amount" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0335">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGXkCxbnnht7" title="Redemption adjustment for Common Stock to redemption amount" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:AccretionForCommonStockToRedemptionAmount" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231_zgiqOcjTOiyg" title="Redemption adjustment for Common Stock to redemption amount" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:AccretionForCommonStockToRedemptionAmount" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Shareholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA0KxRLCfqN1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwPbyZLu3rj9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,580,228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20201231_zxtHWY01aUU7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">419,773</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations
    for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlTYmScAaj0c" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,054,662</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAv4YhHVd6x3" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,534,001</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231_z6k8fmmfMKHi" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,520,661</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share, common
    stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8oW5nThcxSc" title="Basic and diluted net income per share, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSfWobUqQ03e" title="Basic and diluted net income per share, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231_zP5Tgjnyfxs2" title="Basic and diluted net income per share, common stock subject to possible redemption" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK5MhbdHWop" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,717,799</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAwuKtSYp0i9" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231_zEnwjDGUhTsi" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,658,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss (income) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWSzpoOfsvd" title="Basic and diluted net loss (income) per share, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.03</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpyFsn5E87f" title="Basic and diluted net loss (income) per share, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231_z8ZL2LXcelB9" title="Basic and diluted net loss (income) per share, Non-redeemable common stock" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_8A8_zr9nkrRJjDU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zXIkZKYA2QZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_821_z5m8VbrtIb96">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zCnvjBgUYuWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zrEQ3p7X0co5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_849_ecustom--EmergingGrowthCompanyPolicyTextBlock_zl590eHjqXjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zKcn2m1iBIv4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 218; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_847_eus-gaap--UseOfEstimates_zCq2olwPhwA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B6_zFMc5EVybYAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzS17IVvVYh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z3TbZ5bZehce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20201231_zJm8zmHz7X91"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t
have any cash equivalents as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zSejwylhHry8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zGosV4OqdYid" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock"><p id="xdx_847_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_zqq9Q259rzT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zK2T3MJVoGgk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated,
see Note 2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Gross
    Proceeds</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,516,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Add:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion of carrying
    value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A3_zMuBfS88iyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zLIGKREPJ3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zKyLgmOsCDZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized
tax benefits as income tax expense. There were <span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pp0p0_do_c20201231_zU8VFDXPC6s7"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no
</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing
authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 219; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zGbK81JcrmC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_869_zlRrQYOdgkui" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss per Common Stock</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated, see Note
2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200821__20201231_pdd"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,789,722</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of December
31 2020, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    from August 21,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020 (Inception)
    Through</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss, as adjusted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">32,703</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">57,183</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,520,661</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,658,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zmTqGAuFrHCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zqzJccsZiRT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_86E_zVRw6LOq6qhe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_903_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20200821__20201231_pp0p0"><ix:nonFraction name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8vNJCJOEvJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86D_zc0ARhiAXMea" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuWxNENHOFB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zoZqII0npHK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:InitialPublicOfferingTextBlock"><p id="xdx_806_ecustom--InitialPublicOfferingTextBlock_zAnwuB3UewHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_ztA3hnsND2o9">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS4VWs9VmN3c"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zd5CcWhxcfI6"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at a price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_zEwntago3pRh"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_uUSDPShares_c20211231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z18GGFdmLym2"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:PrivatePlacementTextBlock"><p id="xdx_808_ecustom--PrivatePlacementTextBlock_z2JcZqPdqxt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_829_zfKTJn7HzvJ5">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq4KPmnGmE01"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,688,889</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxqFmu2YXw9h"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pip0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq0WPEPlObcg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,766,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Up and Up purchased <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zTQT3cXqJZUi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_z4wa6vKUpMLj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z9LbNaoaqoij"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z6bcPzZkIyp7"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zP6srB2f3Bgi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Units at a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit, or $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkQKH0e6Bk5i"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,008,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the aggregate. Each Placement Unit consists
of one share of common stock (&#8220;Placement Share&#8221;) and one redeemable warrant (&#8220;Placement Warrant&#8221;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zKoSSrRtAzI"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 220; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdnoTEf4Keqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_827_z5JncVu0RfU4">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2020, Globis SPAC LLC purchased <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock for
an aggregate price of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On December 7, 2020, the Company sold an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">172,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stocks to
Up and Up for an aggregate price of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
resulting in a total of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-052020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,047,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock being sold to the Sponsors
(the &#8220;Founder Shares&#8221;) and being issued and outstanding, of which an aggregate of up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201205__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zEFRyV7eMuJb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2020-12-052020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
<span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6PDN21JrOMl"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction>%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Company&#8217;s issued and outstanding
shares after the Initial Public Offering. As a result of the underwriters&#8217; election to fully exercise their over-allotment option
on December 15, 2020, no Founder Shares are currently subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $<span id="xdx_903_eus-gaap--PaymentsForRent_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#8217;s liquidation, the Company will cease paying these monthly
fees. For the period from August 21, 2020 (inception) through December 31, 2020, the Company incurred $<span id="xdx_903_eus-gaap--PrepaidExpenseCurrent_c20211231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_pp0p0"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in fees for these services, of which amount is
included in accrued expenses in the accompanying balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances
from Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 2, 2020, the Sponsor advanced the Company $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_zPmo2npWYsqd"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund certain offering cost in connection with
the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#8217;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#8217;s discretion, the notes may be converted upon completion of a Business Combination
into warrants at a price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20201231__us-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zOYaFl3WPJah"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant. Such warrants would be identical
to the Private Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside
the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital
Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:CommitmentsDisclosureTextBlock"><p id="xdx_807_eus-gaap--CommitmentsDisclosureTextBlock_zqvGhN1nlKqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_825_zOfHRYHF19Ol">COMMITMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 221; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are entitled to receive the <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_uShares_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zHVwbETODlRk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">402,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholders&#8217;
equity. The fair value of the equity participation shares is estimated to be $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zwW7orhs03Yk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,025,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
based upon the offering price of the Units of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zODzMPk7Ykub"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7l4fZBCsbHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span>STOCKHOLDERS&#8217; EQUITY</span></b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated,
see Note 2)</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_827_zUGePfJpVAq5" style="display: none">STOCKHOLDER&#8217;S EQUITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20201231_zKqx3BCiUSf5"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of preferred stock with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zSCVB2wRhf28"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share with such designations, voting and
other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At December 31, 2020,
there were no shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20201231_zEKbKFbbmawi"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zFPBjZ7rjNz2"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. At December 31, 2020, there were <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20201231_zLFM9aATovLh"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued and outstanding,
excluding <span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_c20201231_pdd"><ix:nonFraction name="GLAQ:CommonStockSharesSubjectToRedemption" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,500,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock subject to possible redemption which are presented as temporary equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i>&#8212;</b> The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of our initial business combination, warrant holders may, until such time as there is an effective
registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise
warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that
such exemption is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrants become exercisable, the Company may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $0.01 per warrant;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time while the warrants are exercisable;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than 30 days&#8217; prior written notice of redemption to each warrant holder;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201231__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zudK1PDt8loj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-31_srt_MinimumMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.50</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a <span id="xdx_90C_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20200821__20201231_zOqJobQ64Pgj"><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:durday" name="GLAQ:NoticePeriodForRedemptionOfWarrants">30</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-day
    trading period ending on the third business day prior to the notice of redemption to warrant holders; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless
basis,&#8221; as described in the warrant agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_90F_ecustom--PercentageOfProceedsFromBusinessCombination_iI_pid_dp_c20201231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVzTZhjYZYDd"><ix:nonFraction name="GLAQ:PercentageOfProceedsFromBusinessCombination" contextRef="AsOf2020-12-31_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the total equity proceeds, and interest thereon,
available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and
(z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior
the day on which the Company consummates a Business Combination (such price, the &#8220;Market Value&#8221;) is below $<span id="xdx_90D_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z9MppzZfHH9b"><ix:nonFraction name="GLAQ:MarketValueOfCommonStock" contextRef="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_900_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0gJtvSBZKha"><ix:nonFraction name="GLAQ:PercentageOfExercisePriceOfWarrants" contextRef="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115</ix:nonFraction>%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the higher of the Market Value and the Newly
Issued Price, and the $<span id="xdx_90A_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zGIOVlfbhMt9"><ix:nonFraction name="GLAQ:MarketValueOfCommonStock" contextRef="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to <span id="xdx_90C_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk5yhe4pjsU5"><ix:nonFraction name="GLAQ:PercentageOfExercisePriceOfWarrants" contextRef="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">165</ix:nonFraction>%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the higher of the Market Value and the Newly
Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 222; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zpgHjNlbXsQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. <span id="xdx_825_zYlZ9b0Uoy4b">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zAOCj6NRkip8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B7_zG4jNxgfhux7" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF DEFERRED TAX ASSETS</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zGiXYoajXVib" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzMY0_zitPGfSa5tFf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carryforward</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,586</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzMY0_zcSzChQ3J4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Startup and organizational costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,290</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzMY0_maDTANz7zZ_zB3FbCQTQVc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,876</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz7zZ_z4TMDZa1MPoc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,876</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz7zZ_zMUzXXTuRmi1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets, net valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zjuaNoTzJ9qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCrupi9qzu9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BF_zo0LW4fK0Ihj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF INCOME TAX PROVISION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200821__20201231_z8oSl5bK2Sr6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Federal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,876</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">State and Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Change in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,876</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zW8Wbftk193" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,886</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
U.S. federal net operating loss carryovers available to offset future taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
period from August 21, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $<span id="xdx_90A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20200821__20201231_zo9YPivOYeF3"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,876</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zej2VLh51Uu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</span></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B3_zErat1bBduCa" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200821__20201231_zsWxVwPsUMvg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_z06zX7JoNHol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory federal income tax rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zNZLSViTun7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">State taxes, net of federal tax benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_zlr9o2nUi9B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zAVdZMRWRol1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_z6XqdUDoJac8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 223; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The
Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York to be
a significant state tax jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_zpY0RgT1MLxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10. <span id="xdx_82F_zIjtWBjhsxxl">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zUmwt2pocHu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December
31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B4_ztrBuFYRINVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvMOUe6wZYTd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br /> 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Marketable securities held in
    Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zMgQCKWkPMp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zgugRdOjtUM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11.&#8201;<span id="xdx_822_zJSpmhaBOXw9">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have
required adjustment or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20210111__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-01-11_srt_MaximumMember_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. At
the election of the Lender, all or a portion of the unpaid principal amount of the Note may be converted upon the consummation of the
Company&#8217;s initial Business Combination into a number of warrants of the Company, with each warrant being exercisable for one share
of common stock of the Company (the &#8220;Conversion Warrants&#8221;), equal to: (x) the portion of the principal amount of the Note
being converted, divided by (y) $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20210111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zQ0hqdQZ8mJb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-11_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
rounded up to the nearest whole number of warrants. The Conversion Warrants are identical to the Private Warrants issued. On February
2, 2021, the Company borrowed <span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210202__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zmCqwADl3Kec">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-02-02_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in accordance with the Note.</span></p>

</ix:nonNumeric><p id="xdx_81D_zPPY6EjCZbtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 224; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_007"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_111_zxcOtOSfSv8" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930_zSuumn6BEODg" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20201231_zYtOzWwxQ7Fe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center">(Restated)</td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsAbstract_iB_zxGj6g5A5UIb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AssetsCurrentAbstract_i01B_zU1gU8Vj0Lpl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zSTddUvchQll" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; width: 64%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,413</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,068</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseCurrent_i02I_zHhnuGMOelL9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,653</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrent_i02TI_zw23SFqHlBxe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Current Assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,066</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">485,401</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--MarketableSecuritiesNoncurrent_i01I_zyF5Rss4Ool8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Marketable
    securities held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,155,627</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Assets_iTI_z4wLLlXdu4l8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,314,693</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,635,401</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zqK8LBagcaTe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES
    AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i01I_zycRGNKLrOg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    liabilities - Accounts payable and accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">646,729</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,628</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNoteRelatedParty_i01I_pp0p0_zghBcxWE0Pd5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Promissory
    note &#8211; related party</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:PromissoryNoteRelatedParty" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_zkVYTzdZBSNj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,346,729</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,628</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_iI_zdwYVjWKqvah" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments
    and Contingencies</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0552">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0553">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_z0AHA0vo4g3b" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock subject to possible redemption <span id="xdx_900_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20210930_zoqtYKybIfBc"><span id="xdx_901_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20201231_zL30vxiXUF9i"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares at redemption value at September 30, 2021 and December
    31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stockholders&#8217;
    (Deficit) Equity</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PreferredStockValue_i01I_zpS8rrmmRGB3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Preferred
    stock, $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zhYaKS6fPp3b"><span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zrhCj7XxNSmc"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">par
    value; <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210930_z0YurrqFWGac"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20201231_zOtdeUqypm0k"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    authorized; <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_do_c20210930_z7HcLtKV3RPf"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20210930_zjgzA0CPfF8e"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20201231_zRAu4OmfKQQ1"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20201231_zBxjOcXvYovj"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    issued and outstanding</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0564">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CommonStockValue_i01I_z1aqABshYKQh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zbTcvoCqocZ9"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201231_zp6IrBsMkdve"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">par
    value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210930_zzGrgdlWFrx3"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201231_zXafj5p5Rxv3"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    authorized; <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20210930_zL6UFDKVF62a"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20210930_zt38MBb7mysf"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,050,833</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    issued and outstanding (excluding <span id="xdx_90D_ecustom--CommonStockRedemptionShare_iI_pid_c20210930_zXpBO6VwmMK1"><span id="xdx_90C_ecustom--CommonStockRedemptionShare_iI_pid_c20201231_zKdDWFycMfUk"><ix:nonFraction name="GLAQ:CommonStockRedemptionShare" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="GLAQ:CommonStockRedemptionShare" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares subject to possible redemption) at September 30, 2021
    and December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AdditionalPaidInCapitalCommonStock_i01I_z7UvwGJAgdL9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional
    paid-in capital</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_z5OvKdir1ibg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,691,695</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,886</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockholdersEquity_i01TI_pp0p0_ztqJoCGqHFx5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Stockholders&#8217; (Deficit) Equity</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,182,036</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">419,773</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_zTVXGBSuuVwa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,314,693</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,635,401</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 225; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_008"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_z0RgYnjpJR74" summary="xdx: Statement - Condensed Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210701__20210930_z0Asq6w4eV41" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    The Three Months Ended September 30,</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210101__20210930_zst3BDaue4Ij" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                            months</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20200821__20200930_zraexyJQ3PLf" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the Period</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>from
                                            August 21,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Inception)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_zeMX1hD1mKQf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">General
    and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">892,144</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,607,436</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_zujHAYgA3fMe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    from operations</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">892,144</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,607,436</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zkk5pDRYmZe3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    income:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--InvestmentIncomeInterest_i01_zXbz5JBvfjrk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    earned on marketable securities held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,785</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,627</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0611">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_zsL3YzSQO9Ac" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    other income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,785</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,627</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zFo1Ju0eg2l6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income taxes</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">890,359</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,601,809</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_zh7X4eCBdK5f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Benefit
    from (provision for) income taxes</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0621">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0623">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_iT_zhYl7tiUTmG6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">890,359</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,601,809</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_zFyCsaVSClI7" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and
    diluted weighted average shares outstanding, Redeemable common stock</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0631">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_ztbylzrzZu09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic
    and diluted earnings (loss) per share, Redeemable common stock</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.06</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.11</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0635">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zoM3JkTiWwTc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic
    and diluted weighted average shares outstanding, Non-redeemable common stock</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareBasicAndDiluted_zBQYctixRpuc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic
    and diluted earnings (loss) per share, Non-redeemable common stock</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.06</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.11</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 226; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_009"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENT OF CHANGES IN STOCKHOLDERS&#8217; (DEFICIT) EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_114_zR7IIg3kszD2" summary="xdx: Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zNl6PnH0ETdb" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zN7WMPRtq4x" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z74c2G1V99u5" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--TotalStockholdersEquityMember_zzfyRcdCHo4j" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deficit</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    (Deficit)</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20210101__20210331_eus-gaap--StockholdersEquity_iS_zWKDNA2VWZxf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>Balance &#8212;
    January 1, 2021 (see Note 2 &#8211; as restated)</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRmJHio53K6h" title="Balance, shares" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,886</ix:nonFraction></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">419,773</ix:nonFraction></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zHB2PT0UV3d8" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issuance of Founder
    Shares to Sponsor</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_zHQ9zNd1WK9b" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issuance of Founder
    Shares to Sponsor, Shares</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zlUUTAhyontd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 34%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0662">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0663">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">363,959</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">363,959</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_439_c20210401__20210630_eus-gaap--StockholdersEquity_iS_zxHzT9pCEaU6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance
    &#8211; March 31, 2021 (see Note 2 &#8211; as restated)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEHzUqIQbrrk" title="Balance, shares" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">453,845</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,814</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_zhOGdpu9lca7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0675">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">347,491</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">347,491</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_438_c20210701__20210930_eus-gaap--StockholdersEquity_iS_zKPwPseegHG" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance
    &#8211; June 30, 2021 (see Note 2 &#8211; as restated)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziNHy2KfBoQ" title="Balance, shares" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">801,336</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">291,677</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_zbtyveRtkUz7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0687">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">890,359</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">890,359</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_43C_c20210701__20210930_eus-gaap--StockholdersEquity_iE_zXqqnL2tWVh4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance
    &#8211; September 30, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpdB5q47R20b" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,691,695</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,182,036</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE PERIOD FROM AUGUST 21, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deficit</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    (Deficit)</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43E_c20200821__20200930_eus-gaap--StockholdersEquity_iS_zcnqxfcniTzc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance
    &#8212; August 21, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20200821__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGBLvtMrvgX5" title="Balance, shares" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0698">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0699">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0700">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43B_c20200821__20200930_eus-gaap--StockholdersEquity_iS_ztNKXyLqn15j" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20200821__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyVuFCOQN612" title="Balance, shares" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0710">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0705">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0706">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0707">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zn47S3iOqdZk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 34%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance
    of Founder Shares to Sponsor</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200821__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWJ8Ecjx1Cu6" title="Issuance of Founder Shares to Sponsor, Shares" style="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">288</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,712</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0714">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zCgzSLKj6Rr3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0719">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0720">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_439_c20200821__20200930_eus-gaap--StockholdersEquity_iE_zbSPGXgGtim8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance
    &#8211; September 30, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20200821__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmPAedwMtajb" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">288</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,712</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_430_c20200821__20200930_eus-gaap--StockholdersEquity_iE_zLIs9gkkPxP6" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20200821__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHPAyMgLLzfd" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">288</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,712</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 227; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_010"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENT OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_112_zC7AzsZ1MwCb" summary="xdx: Statement - Condensed Statement of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20210101__20210930_zoFimVYHl1vg" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                            months</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20200821__20200930_zpmLdhyeKkOg" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Period
                                            from</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
                                            21,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
                                            (Inception)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zmc3euzcgLCe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    Flows from Operating Activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_zHYVY9qHWAwc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,601,809</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_ziBdoOp1JAM" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash used in operating activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InvestmentIncomeInterest_i02N_di_zfLoA8w41d3i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    earned on investments held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,627</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0748">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zoA7yzxwXCO8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_zCrYFmgNilja" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">132,680</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0754">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_zb7RC6yqI89g" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,101</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_zc6EtfiPmPz" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">893,655</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0760">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zGFghiaz4Rm6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    Flows from Financing Activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_zT9ZvT1XHkh6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of common stock to Sponsor</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0765">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromRelatedPartyDebt_i01_pp0p0_zdvY8tPIHt21" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from promissory note &#8211; related party</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0769">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsOfFinancingCosts_i01N_di_z6kPrgIIZVc2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payment
    of offering costs</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0771">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,035</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_z1ETVV98GHB3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,965</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_zWKM6vqLbCa2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Change in Cash</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">193,655</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,965</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zeqU0WUBMXyb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    &#8211; Beginning of period</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,068</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0781">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zKGDE1raMulk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    &#8211; End of period</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,413</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,965</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zWpjagpRCQH2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash
    investing and financing activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--OfferingCostsIncludedInAccruedOfferingCosts_i01_zCbrvS74FRDg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Offering
    costs included in accrued offering costs</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0789">&#8212;</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:OfferingCostsIncludedInAccruedOfferingCosts" contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 228; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<!-- Field: Split-Segment; Name: Split%2D001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fi_011"></span>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p id="xdx_047_c20210101__20210930_zuy3ixwnXVoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_803_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zse8mEBwkXD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_826_zoXiMxnmmlk2">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
September 30, 2021 relates to the Company&#8217;s formation, initial public offering (&#8220;Initial Public Offering&#8221;), which is
described below, and search for a Business Combination. The Company will not generate any operating revenues until after the completion
of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRu0RtU0UvDh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Units&#8221; and, with respect
to the shares of common stock included in the Units sold, the &#8220;Public Shares,&#8221; which included the full exercise by the underwriter
of its over-allotment option in the amount of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znXXZJHbPxzj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPoJm1SakIhj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit), generating gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGMatMH8AuP2"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDhkhYNgn2zc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,188,889</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants (the &#8220;Private Warrants&#8221;)
at a price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkuvIYEi4ljk"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z6GkzvESGua3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Placement Units&#8221; and,
together with the Private Warrants, the &#8220;Private Securities&#8221;) at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z4HgLKqDTDZk"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#8220;Up
and Up&#8221; and, collectively with Globis SPAC LLC, the &#8220;Sponsors&#8221;), which is described in Note 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20201213__20201215_zCo6hms5r5R5"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,541,841</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consisting of $<span id="xdx_90C_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20201213__20201215_pp0p0"><ix:nonFraction name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,300,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of underwriting fees, $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20201213__20201215_zM1gUI1fGg58"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,025,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_z7RUJocVOEd4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">402,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#8220;equity participation shares&#8221;), and $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20201213__20201215_pp0p0"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">216,841</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215_za1q969izmpk"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201215_zeFs74mXsoj1"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#8220;Trust Account&#8221;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward completing
a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201215_zDy1rS3YUZ9"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post-Business Combination
company owns or acquires <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20201215__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z40snssKk4a1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2020-12-15_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for
it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment
Company Act&#8221;). There is no assurance that the Company will be able to complete a Business Combination successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_903_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z7HVgMPEHHsl"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax or dissolution obligations).
There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 229; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentNet_c20210930__srt--RangeAxis__srt--MinimumMember_pp0p0"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated
Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares,
without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and the Company&#8217;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#8217;s obligation
to allow redemption in connection with the Company&#8217;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#8220;Combination Period&#8221;). The Company&#8217;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. <span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zISDycSwuO3"><ix:nonNumeric contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">Pursuant
to the terms of the Company&#8217;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#8217;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) <span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z8RLYhJmHKf4"><ix:nonNumeric contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" name="us-gaap:LiquidationBasisOfAccountingCostsAndIncomes">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#8217;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($<span id="xdx_90F_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z2wtKFROcli3"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 230; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $<span id="xdx_90C_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z5E8ME6jUsl7"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#8217;s tax obligation and up to $<span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__srt--RangeAxis__srt--MaximumMember_zETfveNxxHxl"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_srt_MaximumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#8217;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of September 30, 2021, the Company had cash of $<span id="xdx_90E_ecustom--CashHeldOutsideTrust_iI_uUSD_c20210930_z0Hp3Y7lDGkl"><ix:nonFraction name="GLAQ:CashHeldOutsideTrust" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,413</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held outside of the Trust Account, $<span id="xdx_906_eus-gaap--MarketableSecurities_iI_pp0p0_c20210930_zUvcjSiCa9L1"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,155,627</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held in the Trust Account to be used for a Business
Combination, and adjusted working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapital_iI_pp0p0_c20210930_zGLBc8sb0AV"><ix:nonFraction name="GLAQ:WorkingCapital" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,037,663</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which excludes $<span id="xdx_902_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930_zcUDT8fBxSX3"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
franchise taxes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#8217;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#8217;s working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#8220;Note&#8221;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#8220;Lender&#8221;), providing for borrowings from time to time of up to an aggregate of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930_zANvfeb5EIF5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On July 19, 2021 the Note was amended to increase the principal amount of the Note to $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719_z5pCEFgCBZTa"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-19_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and on October 13, 2021, the Note was further
amended to increase the principal amount of the Note to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9n92k8GRDm5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-13_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential Business Combination. The Company cannot provide any
assurance that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient
financing or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if
the Company extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There
is no assurance that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period
of time to consummate a Business Combination up to two times, each by an additional three months).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position and/or search for a target company, the specific impact is not readily
determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from
the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ErrorCorrectionTextBlock"><p id="xdx_80E_eus-gaap--ErrorCorrectionTextBlock_zkGsWlC47ESe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. <span id="xdx_829_zM90Ne9C0Y81">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of the Company&#8217;s financial statements as of September&#160;30, 2021, management determined it should
restate the Company&#8217;s previously reported financial statements. During the quarter ended September 30, 2021, the Company determined
that at the closing of the Company&#8217;s Initial Public Offering (including the sale of the shares issued pursuant to the exercise
of the underwriters&#8217; overallotment) it had improperly valued its common stock subject to possible redemption at the closing of
the Company&#8217;s Initial Public Offering and at the closing of the sale of shares pursuant to the exercise of the underwriters&#8217;
overallotment, it had improperly classified certain of its common stock subject to possible redemption. The Company previously determined
the common stock subject to possible redemption to be equal to the redemption value of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDG9Jn5jRej6"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-09-30_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock while also taking into
consideration that in accordance with the Company&#8217;s Charter, a redemption cannot result in net tangible assets being less than
$<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210930__srt--RangeAxis__srt--MinimumMember_zoUEsSdNwwe2"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Management determined that the common stock issued in the Initial Public Offering and pursuant to the exercise of the underwriters&#8217;
overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company&#8217;s
control. Therefore, management concluded that temporary equity should include all common stock subject to possible redemption, resulting
in the common stock subject to possible redemption being equal to its redemption value. As a result, management has noted a classification
adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common
stock subject to possible redemption with the offset recorded to additional paid-in capital and common stock&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the change in presentation for the common stock subject to redemption, the Company also restated its income (loss) per
share of common stock calculation to allocate net income (loss) evenly to the total shares of common stock. This presentation contemplates
a Business Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the
Company.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ztL7HMMfxEtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the restatement on the Company&#8217;s historical financial statements is reflected in the following tables:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z66gJO8ihi5k" style="display: none">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br /> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of March 31, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,205,807</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,944,193</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">404</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">49</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,453,448</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,944,144</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">453,845</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">453,845</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z7ZMviKeQx41" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,007</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaucjXCM2nf6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,944,193</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zlPWpAOopgn5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,814</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,010,476</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_iI_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdAuiM6EF805" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">489,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 231; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of June 30, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,858,319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,291,681</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">407</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">52</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--CommonStockIssuedValue_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:CommonStockIssuedValue" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,800,933</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,291,629</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">801,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">801,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXSrn6VFAUla" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,004</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2V50EAetD4i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,291,681</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zAzJ1HCZt7Cc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">291,677</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,976,071</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">523,929</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Operations for the
    Three Months Ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,046,512</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0869">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9HOzaPkD5ch" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,004,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMUOI7B614Ja" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331_zbyHglaM1fLd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Three Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,010,476</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">489,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,040,357</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z15QRe16Jyl1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">489,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Six Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,028,394</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">471,606</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0893">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.05</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.05</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,022,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z81HmPth73Mi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">471,606</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.18</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.05</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed
    Statement of Changes in Stockholders&#8217; Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Previously<br /> Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNrNrVN931W3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">363,065</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">363,065</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0904">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPEEhjpw1dhg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,007</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMSKAiQ3SETe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,944,193</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zNweztXwqS4c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,814</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">347,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">347,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0910">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoWdwOwYvAv8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,004</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgwNwPg2HhJa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,291,681</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zwyMLKaWmlB7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">291,677</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash Flows for the
    three months ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z53O2SOLHaqc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">363,965</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPc3ZV1v4fgk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">363,965</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331_zyORfDhwfJrh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0916">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash
    Flows for the six months ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zonMlT5P5895" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">711,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z569YmicyXO6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">711,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630_zi9WICxPqBGg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0919">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zBNrbSO2R59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. <span id="xdx_82C_z23TcnWnswHi">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTnS6kZ5mtK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 232; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_84E_ecustom--EmergingGrowthCompanyPolicyTextBlock_znhzZULg3Oz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_846_eus-gaap--UseOfEstimates_zlOEoyvaeqL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zI5qRXATKyPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zWfDyVHltKs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company&#8217;s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock"><p id="xdx_846_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_z2Q5FTxthpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock
resulted in charges against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock"><p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zv9YHgHVfzl" style="display: none">SCHEDULE
OF CONDENSED BALANCE SHEET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    proceeds</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock issuance costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" title="Common Stock issuance costs" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,516,841</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion
    of carrying value to redemption value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,666,841</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock subject to possible redemption</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z53XnCl72Jv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zYRX9qwmfYO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 233; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were <span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210930_zfEuY5fs1hac"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized
tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company has been subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_z3iVPmfMrpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210930_pdd"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,789,722</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of September
30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period
    from</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months
    Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine&#160;Months&#160;Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August 21,
    2020<br />
    (Inception)<br />
    Through</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,&#160;2020</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic and diluted net loss per common share</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of
    net loss, as adjusted</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">680,303</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">210,056</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,223,906</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">377,903</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted
    average shares outstanding</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss
    per common share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.06</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.06</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.11</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.11</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

</ix:nonNumeric><p id="xdx_8A7_zO33tm4aT123" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 234; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2h0h0Gfvm44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20210930_pp0p0"><ix:nonFraction name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zudSSrgYVNSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zsziBPSVIyL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify; text-indent: 19.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zakXvEAARJl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:InitialPublicOfferingTextBlock"><p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zyupDZFdjnQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_z5bqmd0WpVB">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ElRHWzflSe"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyhwMiWPkZSl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at a price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zBZpoKsR5CDc"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAD5ROBE7XYg"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 235; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="GLAQ:PrivatePlacementTextBlock"><p id="xdx_805_ecustom--PrivatePlacementTextBlock_zOrwb9fBUqLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_820_zrFVgzJqNy1">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zBjr1TsGV9R3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,688,889</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zt0zUUETBvb6"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_znIq3ufEpmOe"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,766,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Up and Up purchased <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkebEe4foRvg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxbmBKvbgqY"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zJHl0sBU8Nhd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zbuq7tqIKoTj"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_znukqKkhVaTc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Units at a purchase price of $10.00
per Placement Unit, or $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zEjyHTbNpZuk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,008,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the aggregate. Each Placement Unit consists
of one share of common stock (&#8220;Placement Share&#8221;) and one redeemable warrant (&#8220;Placement Warrant&#8221;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z1IpqYTHD3f1"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z8kNKU3obTt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_829_zLp2kv6zgzm8">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2020, Globis SPAC LLC purchased <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zYx5fPRCoFU6"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock for
an aggregate price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zXPA4pFb7rJ7"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On December 7, 2020, the Company sold an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zq2UxGoEly6d"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">172,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stocks to
Up and Up for an aggregate price of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zmQcTpOT3Xea"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
resulting in a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKlTFQkeV3Fa"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-062020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,047,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock being sold to the Sponsors
(the &#8220;Founder Shares&#8221;) and being issued and outstanding, of which an aggregate of up to <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201206__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0tmZpKt9Ql"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2020-12-062020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
<span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zNUMU23jNe2d"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters&#8217; election
to fully exercise their over-allotment option on December 15, 2020, no Founder Shares are currently subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $<span id="xdx_90F_eus-gaap--PaymentsForRent_pp0p0_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zX14Yq7WKyJ9"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#8217;s liquidation, the Company will cease paying these monthly
fees. For the three and nine months ended September 30, 2021, the Company incurred $<span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zKHU6ydsd23a"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-07-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--ProfessionalFees_pp0p0_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zsivcrxwtTxl"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in fees for these services. At September 30, 2021, $<span id="xdx_901_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zV7CvlL7pfpe"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is reflected in accrued expenses related to this
agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances
from Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 2, 2020, the Sponsor advanced the Company $<span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund certain offering costs in connection
with the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#8217;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#8217;s discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20210111__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2021-01-11_custom_LenderMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. On
various dates during the nine months ended September 30, 2021, the Company drew a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20210930__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-01-012021-09-30_custom_LenderMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under the Note in accordance with the Working
Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2021, the Note was amended to terminate the option for the Lender to convert the amount outstanding under the Note into Private
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2021, the Note was amended to increase the principal amount of the Note to $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719__srt--RangeAxis__srt--MaximumMember_zhkfLUitk6n5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-19_srt_MaximumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2021, the Note was amended to increase the principal amount of the Note to $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_zlc5VAe4knx2"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-13_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:CommitmentsDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsDisclosureTextBlock_zIhtXf3dEINb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_829_zZ3CkGSvowYj">COMMITMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 236; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are entitled to receive the <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">402,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholder&#8217;s
equity. The fair value of the equity participation shares is estimated to be $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,025,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
based upon the offering price of the Units of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8YfPPEiyugg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span id="xdx_825_zkwPe3u6haF9">STOCKHOLDER&#8217;S EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_c20201210_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of preferred stock with a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201210_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share with such designations, voting and other rights and
preferences as may be determined from time to time by the Company&#8217;s board of directors. At September 30, 2021 and December 31,
2020, there were no shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20210930_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock with a par value of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20210930_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. At September 30, 2021 and December
31, 2020, there were <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkI6IXZVVWr3"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,550,833</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued and outstanding,
excluding <span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_iI_c20201231_z1hydEqWImza"><ix:nonFraction name="GLAQ:CommonStockSharesSubjectToRedemption" contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,500,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock subject to possible redemption which are presented as temporary equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i>&#8212;</b> The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of the Company&#8217;s initial business combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration
statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrants become exercisable, the Company may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_iI_c20210930_zvQC2mQJgeH1"><ix:nonFraction name="GLAQ:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
    warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time while the warrants are exercisable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than <span id="xdx_904_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zOmPxPoGp2Oc"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt-sec:durday" name="GLAQ:NoticePeriodForRedemptionOfWarrants">30</ix:nonNumeric>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">days&#8217; prior written notice of redemption
    to each warrant holder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MinimumMember_pdd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_srt_MinimumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.50</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-day trading period ending on the third
    business day prior to the notice of redemption to warrant holders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless
basis,&#8221; as described in the warrant agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_909_ecustom--PercentageOfProceedsFromBusinessCombination_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTRY2qkOVXt5"><ix:nonFraction name="GLAQ:PercentageOfProceedsFromBusinessCombination" contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation
of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading
day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the &#8220;Market
Value&#8221;) is below $<span id="xdx_90A_ecustom--MarketValueOfCommonStock_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_pdd"><ix:nonFraction name="GLAQ:MarketValueOfCommonStock" contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_90A_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_zNSxZ3XCQRu1"><ix:nonFraction name="GLAQ:PercentageOfExercisePriceOfWarrants" contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the higher of the Market Value and the Newly Issued Price, and the $<span id="xdx_908_ecustom--MarketValueOfCommonStock_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd"><ix:nonFraction name="GLAQ:MarketValueOfCommonStock" contextRef="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to <span id="xdx_902_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0NPV7RbQBu"><ix:nonFraction name="GLAQ:PercentageOfExercisePriceOfWarrants" contextRef="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">165</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 237; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zlyRJqI9p1Kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9.&#8201; <span id="xdx_82E_zCUvpl57yn52">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zX0f0TdQIdF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zadfUy38R0i4" style="display: none">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable
    securities held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Marketable securities held in Trust Account" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,155,627</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Marketable securities held in Trust Account" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,150,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zqogmnYf5pE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zTHHcqlcWHhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10.&#8201;<span id="xdx_823_zDbllZquseQ1">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than described below and the restatement discussed in Note 2, the Company did not identify
any subsequent events that would have required adjustment or disclosure in the condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the Company increased the principal amount available under the Note (as defined in Note 1 under Liquidity) to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z48IjUkTsqGf"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

</ix:nonNumeric><p id="xdx_812_zut81TSBoJu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 238; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2020 AND 2019</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 239; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page(s)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#b_001">Report
    of Independent Auditors</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
    Financial Statements</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Consolidated
    Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Consolidated
    Statements of Operations and Comprehensive Income (Loss)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Consolidated
    Statements of Changes in Stockholder&#8217;s Equity (Deficit)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Consolidated
    Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Notes
    to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-38
    - F-52</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 240; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_001"></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><img src="forms-4_05.jpg" alt="" style="height: 69px; width: 660px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholder and the Board of Directors of Forafric Agro Holdings Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
on the Consolidated Financial Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying Consolidated Balance Sheets of Forafric Agro Holdings Limited (the &#8220;Company&#8221;), as of December
31, 2020 and 2019, the related Consolidated Statement of Operations and Comprehensive Income (Loss), Stockholder&#8217;s Equity (Deficit)
and Cash Flows for the years ended December 31, 2020 and 2019 and the related notes (collectively referred to as the &#8220;Consolidated
Financial Statements&#8221;). In our opinion, the Consolidated Financial Statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2020 and 2019, and the Consolidated results of its operations and its cash flows for the years
ended December 31, 2020 and 2019, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
for Opinion</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Consolidated Financial Statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s Consolidated Financial Statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the
United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
Consolidated Financial Statements are free of material misstatement, whether due to error or fraud. The Company is not required to have,
nor were we engaged to perform, an audit of its internal controls over financial reporting. As part of our audits, we are required to
obtain an understanding of internal controls over financial reporting, but not for the purpose of expressing an opinion on the effectiveness
of the Company&#8217;s internal controls over financial reporting. Accordingly, we express no such opinion. Our audits included performing
procedures to assess the risks of material misstatement of the Consolidated Financial Statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts
and disclosures in the Consolidated Financial Statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the Consolidated Financial Statements. We believe that
our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><img src="forms-4_04.jpg" alt="" style="height: 61px; width: 180px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melville, New York</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
17, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 241; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_002"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 68%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,683</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">8,994</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net of allowance for credit losses of $13,532 and $9,439,
    respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,949</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amount due from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">387</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,209</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,249</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Inventories, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,545</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,864</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other assets, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79,404</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,289</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant, and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86,445</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,299</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,669</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">448</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other assets, noncurrent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">484</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,578</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">212,577</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDER&#8217;S EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lines of credit &#8211; working capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">65,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">67,726</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lines of credit &#8211; wheat inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,375</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,410</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,801</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,351</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,336</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">659</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">828</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,894</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125,145</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,201</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholder loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128,255</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,864</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,059</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">286,660</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commitments and contingencies (Note 16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholder&#8217;s equity (deficit):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Common stock, $1 par value; 120,000,000 shares authorized, issued, and outstanding
    at December 31, 2020 and 3,690 shares authorized, issued, and outstanding at December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(74,397</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(74,622</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">535</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">82</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total stockholder&#8217;s equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51,994</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(74,083</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholder&#8217;s equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,578</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">212,577</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 242; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_003"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">Years ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">196,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">183,209</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">156,188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">147,498</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,408</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,711</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,733</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,733</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,978</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other expense (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,432</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign Exchange loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,043</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">141</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,887</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,568</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,590</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">143</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(139</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,099</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss attributable to non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(110</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(8,099</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss per common share - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.03</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,194.85</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average number of shares outstanding - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,620,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,690</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(139</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,099</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other comprehensive income, net of tax:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,774</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">535</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other comprehensive income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,774</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">535</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Comprehensive income (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,564</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">less: Comprehensive loss attributable to non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive income (loss) attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,664</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,564</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 243; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_004"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDER&#8217;S EQUITY (DEFICIT)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Other</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Comprehensive</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Controlling</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Interest</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; font-weight: bold">Balance, January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,690</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">4</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">(66,523</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(66,519</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,099</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,099</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign exchange gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">535</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">535</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2019</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(74,622</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">535</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(74,083</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consolidation of variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(139</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,774</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Conversion of stockholder loan to common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,996,310</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,996</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,996</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,000,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(74,397</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">82</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">51,994</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 244; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_005"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data) </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(139</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(8,099</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,740</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">149</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,183</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,168</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Bad debt expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,010</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,876</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,289</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,982</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,034</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,681</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,904</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,045</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(58,956</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other payables and liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(122</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(466</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,337</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases of property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(657</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,387</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales of property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,659</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions to intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(278</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(100</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Additions to right-of-use assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(353</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(242</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,052</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Borrowings on long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,301</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92,180</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Repayments on long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,535</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(130,112</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Net cash provided by (used in) financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,766</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,932</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net increase (decrease) in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,773</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents, beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,994</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">48,767</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,683</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,994</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Conversion of stockholder loan to common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">119,996</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Consolidation of variable interest entity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">446</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental cash flow disclosures:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Interest paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,847</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,432</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,904</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,122</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 245; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_006"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the years ended December 31, 2020 and 2019</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NATURE
                                            OF OPERATIONS AND BASIS OF PRESENTATION</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature
of Operations</i> - Forafric Agro Holdings Limited and Subsidiaries (the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or
&#8220;our&#8221;) through its subsidiaries is a market leader in the milling industry in Morocco, with a complete offering of flours
and semolina, secondary processing products including pasta and couscous, rice, and starches (&#8220;Milling Business&#8221;). The Company
is wholly owned by Lighthouse Capital Limited (the &#8220;Parent&#8221; or &#8220;Parent Company&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on November 5, 2020, pursuant to an investment and shareholders agreement (&#8220;Trigola Agreement&#8221;) dated November 5, 2020, the
Company entered into an agreement with Trigola, SU, LDA (&#8220;Trigola&#8221; or &#8220;VIE&#8221;), an entity incorporated in the Republic
of Angola and owned by the Parent for a majority share in Trigola&#8217;s equity of 75%. Pursuant to the terms of the agreement, the
Company will provide financial investments for the construction, commissioning and operation of a new industrial facility for the processing
of wheat and the production of wheat flour, management services and other services on an exclusive basis in relation to Trigola&#8217;s
business. The Company agreed to fund Trigola for operational cash flow needs and bear the risk of Trigola&#8217;s losses from operations
and Trigola agrees that the Company has rights to 75% of Trigola&#8217;s net profits, if any. Trigola is determined to be a variable
interest entity (&#8220;VIE&#8221;). Refer to Note 2 &#8211; Summary of Significant Accounting Policies and Note 14 &#8211; Variable
Interest Entities for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company owned common stock representing 100% ownership in Millcorp Geneva SA (&#8220;Millcorp&#8221;). Millcorp
is a trading company that trades grains and oils for use as animal feed (&#8220;Grain Trading Business&#8221;). On June 1, 2021 (&#8220;Separation
Date&#8221;), the Company distributed its 100% ownership in Millcorp to the Parent Company which resulted in the spin-off of its Grain
Trading business (&#8220;Restructuring&#8221;). The Company did not receive any consideration from the Parent Company for distributing
the 100% ownership in Millcorp. The assets, liabilities, and results of operations of Millcorp have been excluded from these consolidated
financial statements. Refer below to <i>Basis of Presentation</i> for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis
of Presentation </i>- These consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States (&#8220;GAAP&#8221;) and pursuant to the regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).
Based on an evaluation of the guidance under Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5.Z.7, <i>Accounting for the spin-off
of a subsidiary</i>, it was determined that the Restructuring should be reflected as a change in reporting entity. As such, the accompanying
consolidated financial statements of the Company retroactively reflect the Restructuring, including all distributions and transactions
in conjunction therewith, and exclude Millcorp for all periods presented. These consolidated financial statements are the consolidated
financial statements of the Company and its subsidiaries, each of which is controlled, and is based on the financial position and results
of operations of the Company as a standalone company. Intercompany balances and transactions between consolidated entities have been
eliminated. Refer to Note 18 &#8212; Related Parties for further information regarding the Company&#8217;s related party transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
                                            OF SIGNIFICANT ACCOUNTING POLICIES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use
of Estimates </i>- The preparation of our consolidated financial statements in conformity with GAAP requires management to use judgment
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the consolidated financial statements, and the reported amounts of net sales and expenses during the reporting
period. Significant accounting policy elections, estimates and assumptions include, among others, allowance for credit losses, valuation
assumptions of goodwill and intangible assets, useful lives of long-lived assets, and measurement of income tax assets. Given the uncertainty
of the global economic environment and the impact of COVID-19, our estimates could be significantly different than future performance.
Actual results could differ from these estimates. Historically, the aggregate differences, if any, between our estimates and actual amounts
in any year have not had a material effect on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 246; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principles
of Consolidation </i>&#8211; The accompanying consolidated financial statements include all entities controlled by the Company after
reflecting the Restructuring previously described.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control
exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity that most
significantly impact the entity&#8217;s economic performance and the obligation to absorb losses or the right to receive the benefits
from its activities that could potentially be significant to the entity. In assessing control, potential voting rights that are currently
exercisable or convertible are taken into account. The accounts of subsidiaries are included in the consolidated financial statements
from the date that control commences until the date that control ceases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Equivalents </i>- We consider temporary cash investments with an original maturity of three months or less to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventories
</i>- Inventories are stated at the lower of cost or net realizable value. The Company&#8217;s inventory is valued using the weighted
average cost method. The costs of finished goods inventories include raw materials, labor, and overhead costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property,
Plant, and Equipment </i>- Property, plant, and equipment are stated at acquisition cost, plus capitalized interest on borrowings during
the actual construction period of major capital projects. Depreciation and amortization are calculated using the straight-line method
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Lives</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment (technical installations)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-50
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-30
    years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building
improvements are depreciated over the shorter of the estimated useful life of the assets or the remaining useful life. Leasehold improvements
are amortized over the shorter of their useful life or remaining lease term. Expenditures for repairs and maintenance, which do not improve
or extend the life of the assets, are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
perform impairment tests when circumstances indicate that the carrying value of an asset may not be recoverable. Indicators of impairment
include deteriorations in operating cash flows, the anticipated sale or disposal of an asset group, and other significant changes in
business conditions. Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that
the carrying amount of an asset may not be recoverable. The Company&#8217;s assessment of recoverability of property, plant and equipment
is performed on a reporting unit level. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of such asset to its estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of such asset
exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of
the asset exceeds the fair value of the asset. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair
value, less estimated costs to sell.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Goodwill
and Other Intangible Assets </i>- Identifiable intangible assets with finite lives are amortized over their estimated useful lives as
follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Lives</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents,
    trademarks, and licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    intangible assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-10
    years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized
intangible assets, exclusive of goodwill, are amortized over the useful lives of the assets unless that life is determined to be indefinite.
All of our intangible assets, exclusive of goodwill, are finite lived. All amortization expense related to intangible assets is recorded
in Selling, general, and administrative expense in the consolidated statements of operations. Intangible assets with finite lives are
evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If an
evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is generally
based on discounted future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 247; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
is evaluated annually in the fourth quarter or more frequently, if events or changes in circumstances require an interim assessment.
We assess goodwill for impairment (as of December 31) at the reporting unit level using income and market approaches, employing significant
assumptions regarding growth, discount rates, and profitability at each reporting unit. Our estimates under the income approach are determined
based on a discounted cash flow model. The market approach uses a market multiple methodologies employing earnings before interest, taxes,
depreciation, and amortization (&#8220;EBITDA&#8221;) and applies a range of multiples to those amounts in determining the indicated
fair value. In determining the multiples used in this approach, we obtain the multiples for selected peer companies using the most recent
publicly available information. In determining the indicated fair value of each reporting unit, the Company concludes based on the income
approach, and uses the market approach to corroborate, as the Company believes the income approach is the most reliable indicator of
the fair value of the reporting units. The resulting value is then compared to the carrying value of each reporting unit to determine
if impairment is necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
Recognition &#8211; </i>The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance
obligation by transferring control over a product or service to a customer. The majority of the Company&#8217;s contracts with customers
have one performance obligation and a contract duration of one year or less. The Company applies the practical expedient in Accounting
Standards Codification (&#8220;ASC&#8221;) paragraph 10-50-14 of ASC Topic 606, <i>Revenue from Contracts with Customers</i> and does
not disclose information about remaining performance obligations that have original expected durations of one year or less. Trade discounts
or volume rebates are recognized as a deduction in revenue. No payment terms beyond one year are granted at contract inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
related to the sale of goods and equipment is recognized when there is a formal agreement with the customer, delivery is arranged, revenue
amount can be measured in a reliable way, and when it is likely that the economic benefits associated with the transaction return to
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
received from customers prior to revenue recognition on a contract are recorded as contract liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping
and Handling Costs</i> &#8211; Shipping and handling costs related to contracts with customers for the sale of goods are accounted for
as a fulfillment activity and are included in cost of sales. Accordingly, amounts billed to customers for such costs are included as
a component of revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxes
Collected from Customers and Remitted to Governmental Authorities</i> &#8211; The Company does not include taxes assessed by governmental
authorities that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in
the measurement of transactions prices or as a component of revenues and cost of sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts
Receivable and Allowances for Credit Losses</i> &#8211; We provide credit terms to customers in-line with industry standards, perform
ongoing credit evaluations of our customers, and maintain allowances for potential credit losses based on historical experience recorded.
We analyze the aging of customer accounts, customer concentrations, customer creditworthiness, current economic trends and changes in
our customer payment patterns when evaluating the adequacy of the allowance for credit losses. Customer balances are written off after
all collection efforts are exhausted. Estimated product returns, which have not been material, are deducted from sales at the time of
shipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Receivables</i> &#8211; Other receivables include government subsidies for the production and sale of flour. The Moroccan government
provides a fixed subsidy based on production and customer. Subsidies are paid by the Moroccan government twice a year based on sales
of flour for the previous six months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income
Taxes</i> &#8211; The provision for income taxes includes income taxes currently payable in Morocco and local jurisdictions, and those
deferred because of temporary differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets
or liabilities are computed based on the difference between the financial statement and income tax bases of assets and liabilities using
enacted tax rates. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit
will not be realized. Deferred income tax expenses or credits are based on the changes in the asset or liability from period to period.
We account for uncertain tax positions using a &#8220;more-likely-than-not&#8221; threshold. A tax benefit from an uncertain tax position
is recognized if it is more-likely-than-not that the tax position will be sustained on examination by the taxing authorities, based on
the technical merits of the position, or the statute of limitations concerning such issues lapses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 248; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Currency Translation and Transactions </i>- The Company&#8217;s functional currency is the Moroccan dirham, and its presentation currency
is the United States Dollar (&#8220;USD&#8221;). The functional currency is translated into U.S. dollars for balance sheet accounts using
currency exchange rates in effect as of the balance sheet date, and for revenue and expense accounts using a weighted-average exchange
rate during the fiscal year. The transactions in foreign currency (that is a different currency than the functional currency of the entity)
are converted at the exchange rate prevailing to the date of the transaction. The assets and liabilities denominated in foreign currencies
are evaluated in the current period on the date of the closing or at the opening rate, when applicable. The translation adjustments are
deferred as a separate component of equity in Accumulated other comprehensive income. Gains or losses resulting from transactions denominated
in foreign currencies and intercompany debt that is not of a long-term investment nature are included in (Gain) loss on foreign currency
exchange in the consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value</i> &#8211; Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. Certain assets and liabilities may be presented in the financial statements
at fair value. Assets and liabilities measured at fair value on a non-recurring basis may include property and equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair
value are observable in the market:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &#8211; inputs include quoted prices for identical instruments and are the most observable.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &#8211; inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and
    yield curves.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &#8211; inputs are not observable in the market and include management&#8217;s judgments about the assumptions market participants
    would use in pricing the asset or liability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
Risk</i> &#8211; Financial instruments potentially subject to concentration of credit risk consist primarily of cash and cash equivalents
and trade accounts receivable. At times during the periods presented, the Company had funds in excess of Deposit Insurance programs in
Morocco, on deposit at various financial institutions. Management believes the Company is not exposed to significant credit risk due
to the financial position of the depository institutions in which those deposits are held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s trade accounts receivable are unsecured and geographically dispersed. No single client&#8217;s trade accounts receivable
balance as of December 31, 2020 and 2019 exceeded 10% of the Company&#8217;s consolidated accounts receivable, net.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Variable
Interest Entities </i>&#8211; The Company entered into an agreement with Trigola, an entity incorporated in the Republic of Angola. The
Company has a direct majority ownership in Trigola and has been actively involved in their operations and has the power to direct the
activities and significantly impact Trigola&#8217;s economic performance. The Company also bears the risk of losses and has the right
to receive 75% of the benefits from Trigola. As such, in accordance with ASC 810-10-25-38A through 25-38J, Trigola is considered a VIE
of the Company and the financial statements of Trigola were consolidated from the date that the control existed, November 5, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Controlling
Interests</i> &#8211; Non-controlling interests on the consolidated statements of operations and comprehensive income (loss) represent
the portion of a majority-owned subsidiary&#8217;s net income or loss that is attributed by non-controlling stockholders. Non-controlling
interests on the consolidated balance sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECENTLY
                                            ISSUED ACCOUNTING PRONOUNCEMENTS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued <i>ASU No. 2019-12 - Income Taxes (Topic 740): Simplifying
the Accounting for Income Taxes</i>, which removes certain exceptions to the general principles in Topic 740 and improves consistent
application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This guidance is effective
for fiscal years and interim periods within those years beginning after December 15, 2020, with early adoption permitted. Amendments
are to be applied prospectively, except for certain amendments that are to be applied either retrospectively or with a modified retrospective
approach through a cumulative effect adjustment recorded to retained earnings. The Company adopted this guidance effective January 1,
2019. Adoption of the guidance had no impact on our results of operations, balance sheet, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 249; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued guidance <i>ASU No. 2016-13 Financial Instruments&#8212;Credit Losses (Topic 326)</i>: <i>Measurement of Credit
Losses on Financial Instruments </i>which changes the accounting for credit losses for certain instruments, including accounts receivable,
from an incurred loss method to a current expected loss method. The measurement of expected credit losses is based on relevant information
about past events, including historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted
this guidance effective January 1, 2019. Adoption of the guidance had no impact on our results of operations, balance sheet, or cash
flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Not
yet adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the FASB issued <i>ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on
Financial Reporting</i>, which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform.
The new guidance provides optional expedients and exceptions for applying GAAP to transactions affected by reference rate reform if certain
criteria are met. These transactions include contract modifications, hedging relationships, and the sale or transfer of debt securities
classified as held-to-maturity. Entities may apply the ASU from March 12, 2020 through December 31, 2022. The Company is currently evaluating
the impact of this new ASU on its consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operating leases for real estate and vehicles. The Company has finance leases for equipment and construction land space.
Leases are classified as finance leases because ownership of the underlying assets transfers at the end the lease term. Remaining lease
terms for these leases range from less than one year to four years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not record leases with a term of 12 months or less on the balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
balance sheet information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">Balance Sheet</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Classification</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 42%; text-align: left">Operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: left">Right-of-use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,818</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,982</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Right-of-use assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,816</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,634</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,299</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">667</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Current portion of long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,719</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,386</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Noncurrent liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,383</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,566</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,245</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total noncurrent liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,782</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,628</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,260</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,014</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets and their corresponding lease liabilities are measured and recognized based on the present value of the future minimum lease payments
over the lease term at the commencement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Discount
Rates</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the majority of its leases, the Company uses the rate implicit in the lease. For leases without an implicit rate, the Company uses its
incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments
for those leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 250; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average discount rates for the Company&#8217;s leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finance leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.1</td><td style="text-align: left">%</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Payments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company includes lease payments under options to extend or terminate the lease in the measurement of the right-of-use asset and lease
liability when it is reasonably certain that it will exercise such options. Fixed lease costs represent the explicitly quantified lease
payments prescribed by the lease agreement and are included in the measurement of the right-of-use asset and corresponding lease liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term of the Company&#8217;s leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
                                            years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
                                            years</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finance leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
                                            years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
                                            years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of lease expense were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Operating lease cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">674</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">590</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finance lease cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">578</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest on lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">655</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">604</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,772</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, future maturities of lease liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating Leases</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Finance Leases</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">729</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,749</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,400</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,097</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,350</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,035</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,945</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,315</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 251; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
information related to leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid for amounts included in the measurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>of lease liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 68%; text-align: left">Operating cash flows used for operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">674</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">590</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating cash flows used for finance leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">578</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Financing cash flows used for finance leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">655</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">604</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCOUNTS
                                            RECEIVABLE</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross and realizable value of accounts receivable are detailed in the chart below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">41,014</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">37,388</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Allowance for credit losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,532</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,439</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,482</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,949</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in allowances for credit losses consisted of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Allowance for</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
                                            thousands)</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold">Balance at January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(7,248</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current period provision for expected credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,516</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,439</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current period provision for expected credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(549</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,544</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(13,532</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
                                            CURRENT RECEIVABLES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
current receivables consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Government subsidies</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,222</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,537</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Value-added tax receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,479</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,531</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">702</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,283</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,249</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 252; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
INVENTORIES, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net, are detailed as follows: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Merchandise</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,424</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,814</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Raw materials and consumable supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,197</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finished products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,916</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventory reserves</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,145</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,063</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,545</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,864</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTY
                                            PLANT AND EQUIPMENT</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.25pt; text-indent: -8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,133</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,133</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,364</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,678</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,363</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,558</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">117,965</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Less accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34,934</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,295</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign exchange difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,344</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(225</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">89,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">86,445</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $3,639 and $3,740 for the years ended December 31, 2020 and 2019, respectively, included in cost of sales in the consolidated
statements of operations and comprehensive income (loss). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOODWILL
                                            AND OTHER INTANGIBLE ASSETS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the establishment of reporting segments for each reporting period, the Company allocated goodwill between reporting units
using a relative fair value allocation approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
on the balance sheet resulted from the acquisition of wholly owned subsidiaries, the Tria Group and Maymouna Food Group, in 2015. The
Company performed the annual impairment assessment as of December 31, 2020 and December 31, 2019, which did not result in impairment
losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the carrying amount of goodwill allocated to its reporting units for the years ended December 31, 2020 and 2019 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soft</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Durum</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Couscous</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wheat</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wheat</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    Pasta</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="18" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at January 1, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,787</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,598</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,982</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency exchange adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(122</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(121</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(313</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,384</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,760</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,048</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,477</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,669</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency exchange adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,324</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">461</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,331</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,403</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,708</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,047</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,509</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,808</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,072</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br /></span></p>


<!-- Field: Page; Sequence: 253; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the carrying amount of intangible assets for the years ended December 31, 2020 and 2019 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intangible</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
                                            thousands)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold">Balance at January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">558</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">448</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">278</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(262</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(149</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">48</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">363</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the weighted-average remaining amortization period for intangibles other than goodwill is 9.1 years and future
intangible amortization is expected to total the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;41</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">165</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">363</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCRUED
                                            EXPENSES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Accrued government subsidies and taxes</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">8,143</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,367</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,693</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">866</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accruals to social agencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">539</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,158</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,410</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,801</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br />
11. LINES OF CREDIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lines
of Credit &#8211; working capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into unsecured revolving credit agreements with several financial institutions to fund working capital requirements
(&#8220;WC Lines of Credit&#8221;). The WC Lines of Credit provide the Company with the ability to borrow funds under consolidated lines
of credit of up to approximately $74,000. Interest rates range from 5.6% to 6.4%. The WC Lines of Credit renew automatically on an annual
basis. The Company and certain of its subsidiaries are borrowers under the WC Lines of Credit, and their obligations are cross guaranteed
by certain other subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 254; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lines
of Credit &#8211; wheat inventories</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into credit agreements with several financial institutions for asset-based credit facilities in order to fund wheat
raw material purchases (&#8220;Wheat Credit Facilities&#8221;). The Wheat Credit Facilities provide the ability to borrow funds under
consolidated lines of credit of up to approximately $90,000, subject to certain borrowing base criteria. The Wheat Credit Facilities
are secured by the Company&#8217;s inventory. Interest rates range from 1.4% to 6.4% per annum. The Wheat Credit Facilities must be renewed
on a semi-annual basis. The Company and certain of its subsidiaries are borrowers under the Wheat Credit Facilities, and their obligations
are cross guaranteed by certain other subsidiaries. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LONG-TERM
                                            DEBT</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
long-term debt is presented as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Loans</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,523</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,260</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,014</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total outstanding debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,514</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,537</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,371</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,336</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,201</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term loans and other financial liabilities are evaluated according to the amortized cost method using the effective interest rate of
the loan. The loan issuance costs and premiums are determined at inception and are amortized over the useful life of the loan via the
effective interest rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term
Loans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains term loans with several financial institutions (the &#8220;Term Loans&#8221;). The Term Loans are unsecured and have
fixed monthly payments ranging from approximately $18 to $95. Interest on the Term Loans range from 5.8%-6.1% per annum. The Term Loans
mature and will be fully repaid throughout 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owes $9,260 and $11,014 related to its leases as of December 31, 2020 and 2019, respectively. Lease obligations are payable in
monthly installments of principal and interest and are collateralized by the related assets financed. Refer to Note 4 for additional
information regarding the Company&#8217;s leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scheduled maturities of outstanding debt as of December 31, 2020 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,371</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,764</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,829</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">550</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total outstanding debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,514</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 255; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME
                                            TAXES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the components of the December 31, 2020 and December 31, 2019 provision for income taxes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,904</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,122</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Deferred</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,761</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">387</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,509</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current tax expense corresponds to the amounts paid or pending of payment in short-term to the tax authorities for the period, according
to the applicable regulations and of the special agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a reconciliation of income tax expense computed at the Moroccan statutory tax rate to the income tax expense reported in
the consolidated statements of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(139</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(8,099</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">143</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Income (loss) before tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,590</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effective tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3575</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-45</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent differences not deductible for tax purposes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,192</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,083</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,124</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other differences</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(202</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recalculated tax expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,733</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Statutory tax rate in Morocco</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">31</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">31</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects of temporary differences giving rise to deferred income tax assets (liabilities) were:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Goodwill adjustment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">120</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">159</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fixed assets and intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22,445</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,036</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,660</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,124</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Receivables depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">381</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,184</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,564</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,198</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,660</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,124</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,864</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(22,059</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company has $5,660 and $2,124, respectively, as net operating losses that begin to expire
within four years. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 256; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realizability of these deferred tax assets, management considers whether it is more-likely-than-not that some portion or
all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income in those periods in which temporary differences become deductible and/or net operating loss carryforwards can be
utilized. The Company considers the level of historical taxable income, scheduled reversal of temporary differences, tax planning strategies,
and projected future taxable income in determining whether a valuation allowance is warranted. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintained a valuation allowance of $5,660 in 2020 and $2,124 in 2019 against its net operating losses. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VARIABLE
                                            INTEREST ENTITIES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-indent: -13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on November 5, 2020, pursuant to an investment and shareholders agreement dated November 5, 2020, the Company entered into an agreement
with Trigola, an entity incorporated in the Republic of Angola and owned by the Parent for a majority for a share in Trigola&#8217;s
equity of 75%. Pursuant to the terms of the agreement, the Company will provide financial investments for the construction, commissioning
and operation of a new industrial facility for the processing of wheat and the production of wheat flour, management services and other
services on an exclusive basis in relation to Trigola&#8217;s business. The Company agrees to fund Trigola for operational cash flow
needs and bear the risk of Trigola&#8217;s losses from operations and Trigola agrees that the Company has rights to 75% of Trigola&#8217;s
net profits, if any. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of Key Terms of the Trigola Agreement (&#8220;VIE&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;Forafric is the exclusive manager of
  the VIE.</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The VIE shall not directly or indirectly accept
  the same or similar services from other parties.</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Forafric agrees to fund the VIE&#8217;s operational
  needs and bear the risk of VIE&#8217;s losses from operations and the VIE agrees that the Company has rights to 75% of the VIE&#8217;s
  net profits, if any.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not provide financial or other support to the VIE for the period presented that the Company was not previously contractually
required to provide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, there were no pledges or collateralization of the VIE&#8217;s assets that can only be used to settle obligations
of the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the VIE&#8217;s assets and liabilities included in the consolidated financial statements are as follows at December
31, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,475</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Property, plant, and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">44</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,232</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">58</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,290</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
$2,700 in accounts payable included above are payables due to the Company and were eliminated in consolidation at December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 257; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operating results of the VIE included in the consolidated financial statements are as follows for the period from November 5, 2020 through
December 31, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>(in thousands)</b></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; padding-bottom: 2.5pt">Revenues</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">384</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(115</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EARNINGS
                                            PER SHARE</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share is computed by dividing net income by the number of weighted average common shares outstanding during the reporting
period. The Company&#8217;s weighted average number of shares outstanding used in calculating earnings per share are 3,620,017 and 3,690
for the years ended December 31, 2020 and 2019, respectively. Because there was no activity to cause dilution in the weighted average
common shares, basic and diluted earnings per share are disclosed together in each of the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMITMENTS
                                            AND CONTINGENCIES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has commitments with banks to finance its operating activities. The Company has provided collateral and mortgages to banks of
$25,464 and $119,474, respectively, as of December 31, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time the Company is involved in litigation incidental to the conduct of its business. These matters may relate to employment
and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related
to alleged violations of laws and regulations. When applicable, the Company records accruals for contingencies when it is probable that
a liability will be incurred, and the amount of loss can be reasonably estimated. Defense costs are expensed as incurred and are included
in professional fees. While the outcome of lawsuits and other proceedings against the Company cannot be predicted with certainty, in
the opinion of management, individually or in the aggregate, no such lawsuits and other proceedings had or are expected to have a material
effect on the consolidated financial statements in 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEGMENT
                                            INFORMATION</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company manages operations on a company-wide basis, thereby making determinations as to the allocation of resources in total rather than
on a segment-level basis. The Company has designated reportable segments based on how management views its business. The Company does
not segregate assets between segments for internal reporting. Therefore, asset-related information has not been presented. The reportable
segments, as presented below, are consistent with the manner in which the Company reports its results to the Chief Operating Decision
Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal products that comprise each segment are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Soft
Wheat</i> &#8211; The Soft Wheat segment includes the production and sale of soft wheat yielding flour that is used to make desserts
and sauces.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Durum
Wheat</i> - The Durum Wheat segment includes the production and sale of hard wheat yielding flour that is used to make pasta.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Couscous
and Pasta</i> &#8211; The Couscous and Pasta segment includes the secondary processing of products including couscous and pasta sold
to end customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
</i>&#8211; The Other segment includes distribution, trading and logistics, animal nutrition, and other operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the performance of its segments based on sales and operating income. Operating income is defined as gross profit less
sales &amp; marketing costs, direct selling, general, and administrative expenses, and other operating expenses. The amounts in the following
tables are obtained from reports used by senior management and do not include income taxes. Other expenses not allocated include unallocated
corporate expenses (other operating expenses). The accounting policies of the Company&#8217;s segments are the same as those described
in the summary of significant accounting policies set forth in Note 2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 258; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information relating to the Company&#8217;s reportable segments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td></td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Sales to external customers:</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 68%; text-align: left">Soft Wheat</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">115,273</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">112,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Durum Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,086</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Couscous &amp; Pasta</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,977</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,050</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,183</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">196,596</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">183,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Direct operating income (loss):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Soft Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">670</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Durum Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(482</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Couscous &amp; Pasta</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(416</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,868</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Operating income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,891</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,978</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED
                                            PARTIES </b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion summarizes activity between the Company and related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the Company entered into a building lease agreement for the headquarters of Forafric Maroc, a wholly owned subsidiary, with a lease
term through 2024. The Company&#8217;s Parent owns 100% of the company that owns the building. Total rent is approximately $420 per year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Millcorp
provides 100% of the imported grain to the Company. The purchases incurred were $112,538 and $74,035 as of December 31, 2020 and 2019,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s amounts due from related parties were $387 and $3,209 as of December 31, 2020 and 2019, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains an interest-free loan with no maturity date to the Parent Company in the amount of $8,683 and $128,255 as of December
31, 2020 and 2019, respectively. During 2020, a portion of the loan was converted into common shares of the Company in the amount of
$119,996.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not entered into any significant transactions with other related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBSEQUENT
                                            EVENTS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparing the consolidated financial statements through the December 31, 2020, the Company has evaluated subsequent events for recognition
and disclosure through December 17, 2021, the date that these consolidated financial statements and accompanying notes were available
for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2021, the Company completed a share purchase acquisition of Moulins du Sahel Mali S.A. (&#8220;MDS Mali&#8221;). By way of
the acquisition, the Company acquired a 70.35% stake in a wheat milling business in Mali. Pursuant to the terms of the agreement, the
Company will provide financial investments to MDS Mali in the form of a capital increase for a total amount of $9,579, $5,912 of which
have already been completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 259; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2021, the Company signed a letter of intent to be acquired by Globis Acquisition Corp (&#8220;Globis&#8221;). Globis is a special
purpose acquisition company (&#8220;SPAC&#8221;) listed on the NASDAQ exchange in the United States. This transaction is expected to
close in 2022, subject to approval by the SEC and the shareholders of the SPAC.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2021, pursuant to a Share Sale and Asset Acquisition Agreement, the Company acquired a controlling interest of 78.21% in certain
assets of Moulin du Sahel Burkina (&#8220;MDS Burkina&#8221;). The net assets acquired included a non-operational wheat mill, milling
equipment and other current liabilities. The total consideration paid for the aforementioned assets upon closing was $2,622 in cash,
$3,531 in assumed liabilities and $1,714 in non-controlling interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2021, the Company acquired 37.10% of the capital stock of Grands Moulins du Tenere Niger (&#8220;GMT Niger&#8221;) headquartered
in Niger, which is a non-operational wheat milling facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the Company acquired a controlling interest in Moulins Sanabil SA&#8217;s (&#8220;Sanabil SA&#8221;) capital stock, for
cash consideration of approximately $3,000. The company is privately-held and headquartered in Meknes, Morocco and is a soft wheat flour
manufacturer. The company offers a complete line of soft wheat and baking flour products. The Company has not yet completed a valuation
of the fair values of assets acquired and liabilities assumed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 260; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS
OF SEPTEMBER 30, 2021 AND DECEMBER 31, 2020 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 261; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">UNAUDITED</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">AUDITED</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(AS RESTATED)</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">20,040</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,683</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net of allowance for credit losses of $13,827 and $13,532,
    respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,482</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amount due from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">387</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,283</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,545</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">&#160;Other assets, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,702</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79,404</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant, and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,621</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,634</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,072</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other assets, noncurrent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,691</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">484</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,763</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,578</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDER&#8217;S EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lines of credit &#8211; working capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">65,176</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lines of credit &#8211; wheat inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,975</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,683</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,646</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,410</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,620</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,371</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">659</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,894</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholder loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,683</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,864</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247,769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,584</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commitments and contingencies (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Stockholder&#8217;s equity (deficit):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Common stock, $1 par value; 120,000,000 shares authorized; issued, and outstanding at September
    30, 2021 and December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(77,933</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(74,397</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,309</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,888</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">82</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total stockholder&#8217;s equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,994</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51,994</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholder&#8217;s equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,763</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,578</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 262; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(AS RESTATED)</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">185,517</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">145,938</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,130</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,315</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,808</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td style="color: white">&#160;</td>
    <td style="color: white; text-align: left">&#160;</td><td style="color: white; text-align: right">15.3</td><td style="color: white; text-align: left">%</td><td style="color: white">&#160;</td>
    <td style="color: white; text-align: left">&#160;</td><td style="color: white; text-align: right">18.4</td><td style="color: white; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,415</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,735</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,415</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,735</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,073</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other expense (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(282</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,387</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,399</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign Exchange loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,004</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,734</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,109</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,131</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,209</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(58</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax (benefit) expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,407</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,378</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,465</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net income attributable to noncontrolling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">158</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,536</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,465</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss per common share - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.03</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(396.98</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average number of shares outstanding - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,690</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,378</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,465</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other comprehensive loss, net of tax:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,373</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,660</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,373</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,660</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,751</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">less: Comprehensive income attributable to non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,806</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,125</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 214.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 263; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDER&#8217;S EQUITY (DEFICIT)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Other</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Total</b></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Comprehensive</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Controlling</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income (Loss)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance, December 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,690</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">4</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(74,622</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">535</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(74,083</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,465</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,465</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign exchange loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,660</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,660</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, September 30, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,690</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(76,087</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,125</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(78,208</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(74,397</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">51,994</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,536</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,378</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,270</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(103</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,373</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Consolidation of variable interest entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,751</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,751</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, September 30, 2021, as restated</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,000,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(77,933</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,039</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,888</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">52,994</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 264; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(In
thousands, except share and per share data) </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">(AS RESTATED)</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(3,378</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,465</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,670</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">861</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Bad debt expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">523</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">249</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,193</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,602</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,377</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,940</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,179</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,214</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,059</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,852</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,883</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other payables and liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,941</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(142</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 70pt; text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,378</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,522</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Acquisition of businesses, net of cash acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,503</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchase of equity method investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,098</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advances to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,287</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases of property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(352</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(519</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales of property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Additions to intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 70pt; text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22,240</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(465</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Borrowings on long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,901</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Repayments on long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,188</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,736</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 70pt; text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,165</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(612</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">837</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,015</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents, beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,683</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,994</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">22,009</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Consolidation of variable interest entities related to business acquisitions</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Fair value of assets acquired in business acquisitions</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,043</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Fair value of liabilities assumed in business acquisitions</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,216</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental cash flow disclosures:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Interest paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,651</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,471</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,877</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; color: Red"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><span style="font-family: Times New Roman, Times, Serif; color: Black"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; color: Red"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; color: Red"></p>


<!-- Field: Page; Sequence: 265; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span><b> (UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the period ended September 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
NATURE OF OPERATIONS AND BASIS OF PRESENTATION</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature
of Operations</i> - Forafric Agro Holdings Limited and Subsidiaries (the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or
&#8220;our&#8221;) through its subsidiaries is a market leader in the milling industry in Morocco, with a complete offering of flours
and semolina, secondary processing products including pasta and couscous, rice, and starches (&#8220;Milling Business&#8221;). The Company
is wholly owned by Lighthouse Capital Limited (the &#8220;Parent&#8221; or &#8220;Parent Company&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Effective on July 30, 2021, the Company
completed a share purchase acquisition of Moulin du Sahel Burkina (&#8220;MDS Burkina&#8221;). By way of the acquisition, we acquired
a 78.21% stake in a wheat milling business in Burkina Faso. The investment in MDS Burkina enables the Company to continue to expand its
strategic footprint in west Africa. The total consideration paid upon closing was $6,153 million in cash, $3,531 million in assumed liabilities
and $1,714 million in non-controlling interests. MDS Burkina is determined to be a variable interest entity (&#8220;VIE&#8221;). Refer
to Note 2 &#8211; Summary of Significant Accounting Policies and Note 15 &#8211; Variable Interest Entities and Acquisitions for further
information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on April 30, 2021, the Company completed a share purchase acquisition of Moulins du Sahel Mali S.A. (&#8220;MDS Mali&#8221;). By way
of the acquisition, the Company acquired a 70.35% stake in a wheat milling business in Mali. The investment in MDS Mali enables Forafric
to obtain a strategic footprint in west Africa. MDS Mali added incremental net revenues of $8,919 and incremental net income of $334
for the period from April 30, 2021 to September 30, 2021. As of the balance sheet date, the total investment for this transaction is
approximately $9,579, including an additional $3,667 due to be paid. MDS Mali is determined to be a VIE. Refer to Note
2 &#8211; Summary of Significant Accounting Policies and Note 15 &#8211; Variable Interest Entities and Acquisitions for
further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on November 5, 2020, pursuant to an investment and shareholders agreement (&#8220;Trigola Agreement&#8221;) dated November 5, 2020, the
Company entered into an agreement with Trigola, SU, LDA (&#8220;Trigola&#8221;), an entity incorporated in the Republic of Angola and
owned by the Parent for a majority share in Trigola&#8217;s equity of 75%. Pursuant to the terms of the agreement, the Company will provide
financial investments for the construction, commissioning and operation of a new industrial facility for the processing of wheat and
the production of wheat flour, management services and other services on an exclusive basis in relation to Trigola&#8217;s business.
The Company agreed to fund Trigola for operational cash flow needs and bear the risk of Trigola&#8217;s losses from operations and Trigola
agrees that the Business has rights to 75% of Trigola&#8217;s net profits, if any. Trigola is determined to be a VIE. Refer
to Note 2 &#8211; Summary of Significant Accounting Policies and Note 15 &#8211; Variable Interest Entities for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company owned common stock representing 100% ownership in Millcorp Geneva SA (&#8220;Millcorp&#8221;). Millcorp
is a trading company that trades grains and oils for use as animal feed (&#8220;Grain Trading Business&#8221;). On June 1, 2021 (&#8220;Separation
Date&#8221;), the Company distributed its 100% ownership in Millcorp to the Parent Company which resulted in the spin-off of its Grain
Trading business (&#8220;Restructuring&#8221;). The Company did not receive any consideration from the Parent Company for distributing
the 100% ownership in Millcorp. The assets, liabilities, and results of operations of Millcorp have been excluded from these condensed
consolidated financial statements. Refer below to <i>Basis of Presentation</i> for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on an evaluation of the guidance under Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5.Z.7, <i>Accounting for the spin-off of a
subsidiary</i>, it was determined that the Restructuring should be reflected as a change in reporting entity. As such, the accompanying
condensed consolidated financial statements of the Company retroactively reflect the Restructuring, including all distributions and transactions
in conjunction therewith, and exclude Millcorp for all periods presented. These condensed consolidated financial statements are the consolidated
financial statements of the Company and its subsidiaries, each of which is controlled, and is based on the financial position and results
of operations of the Company as a standalone company. Intercompany balances and transactions between consolidated entities have been
eliminated. Refer to Note 18 &#8212; Related Parties for further information regarding the Company&#8217;s related party transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis
of Presentation </i>- These condensed consolidated financial statements reflect the financial condition, results of operations and cash
flows of the Company and have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S.
GAAP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed consolidated financial statements and notes thereto are unaudited, and as permitted by the interim reporting rules and regulations
set forth by the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;), exclude certain financial information and note disclosures
normally included in annual audited financial statements prepared in accordance with U.S. GAAP. The condensed consolidated financial
statements reflect all material adjustments of a normal recurring nature that, in the opinion of management, are necessary for a fair
presentation of the results for the interim periods. These condensed consolidated financial statements should be read in conjunction
with the audited consolidated financial statements and notes thereto for the year ended December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 266; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Accounting Policies &#8211; </i>The Company&#8217;s accounting policies used in the preparation of these condensed consolidated financial
statements do not differ from those used in the audited consolidated financial statements as of and for the year ended December 31, 2020,
unless otherwise noted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use
of Estimates </i>- The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to
use judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net sales and expenses during
the reporting period. Significant accounting policy elections, estimates and assumptions include, among others, allowance for credit
losses, valuation assumptions of goodwill and intangible assets, useful lives of long-lived assets, and measurement of income tax assets.
Given the uncertainty of the global economic environment and the impact of COVID-19, our estimates could be significantly different than
future performance. Actual results could differ from these estimates. Historically, the aggregate differences, if any, between our estimates
and actual amounts in any year have not had a material effect on our condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principles
of Consolidation </i>&#8211; The accompanying condensed consolidated financial statements include all entities controlled by the Company
after reflecting the Restructuring previously described.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control
exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity that most
significantly impact the entity&#8217;s economic performance and the obligation to absorb losses or the right to receive the benefits
from its activities that could potentially be significant to the entity. In assessing control, potential voting rights that are currently
exercisable or convertible are taken into account. The accounts of subsidiaries are included in the condensed consolidated financial
statements from the date that control commences until the date that control ceases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Currency Translation and Transactions </i>- The Company&#8217;s functional currency is the Moroccan dirham, and its presentation currency
is the United States Dollar (&#8220;USD&#8221;). The functional currency is translated into U.S. dollars for balance sheet accounts using
currency exchange rates in effect as of the balance sheet date, and for revenue and expense accounts using a weighted-average exchange
rate during the period. The transactions in foreign currency (that is a different currency than the functional currency of the entity)
are converted at the exchange rate prevailing to the date of the transaction. The assets and liabilities denominated in foreign currencies
are evaluated in the current period on the date of the closing or at the opening rate, when applicable. The translation adjustments are
deferred as a separate component of equity in accumulated other comprehensive income. Gains or losses resulting from transactions denominated
in foreign currencies and intercompany debt that is not of a long-term investment nature are included in (Gain) loss on foreign currency
exchange in the condensed consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
Risk</i> &#8211; Financial instruments potentially subject to concentration of credit risk consist primarily of cash and cash equivalents
and trade accounts receivable. At times during the periods presented, the Company had funds in excess of Deposit Insurance programs in
Morocco, on deposit at various financial institutions. Management believes the Company is not exposed to significant credit risk due
to the financial position of the depository institutions in which those deposits are held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s trade accounts receivable are unsecured and geographically dispersed. No single client&#8217;s trade accounts receivable
balance as of September 30, 2021 and December 31, 2020 exceeded 10% of the Company&#8217;s consolidated accounts receivable, net.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Variable
Interest Entities - </i>Effective on April 30, 2021, the Company completed a share purchase acquisition of MDS Mali and has been since
actively involved in their operations and has the power to direct the activities and significantly impact MDS Mali&#8217;s economic performance.
The Company also bears the risk of losses and has the right to receive 70.35% of the benefits from MDS Mali. As such, in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) 810-10-25-38A through 25-38J, MDS Mali is considered a VIE of the Company and the
financial statements of MDS Mali were consolidated from the date that the control existed, April 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 267; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with Trigola, an entity incorporated in the Republic of Angola. The Company has a direct majority ownership
in Trigola and has been actively involved in their operations and has the power to direct the activities and significantly impact Trigola&#8217;s
economic performance. The Company also bears the risk of losses and has the right to receive 75% of the benefits from Trigola. As such,
in accordance with ASC 810-10-25-38A through 25-38J, Trigola is considered a VIE of the Company and the financial statements of Trigola
were consolidated from the date that the control existed, November 5, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on July 30, 2021, the Company completed a share purchase acquisition of Moulin du Sahel Burkina (&#8220;MDS Burkina&#8221;) and has since
significant economic exposure to MDS Burkina. The Company also bears the risk of losses and has the right to receive 78.21% of the benefits
from MDS Burkina. As such, in accordance with ASC 810-10-25-38A through 25-38J, MDS Burkina is considered a VIE of the Company and the
financial statements of MDS Burkina were consolidated from the date that the control existed, July 30, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Method Accounting</i> &#8211; As of September 30, 2021, the Company owned 37.10% of the outstanding capital stock of Grands Moulins du
Tenere Niger (&#8220;GMT Niger&#8221;) which was accounted for as an equity method investment. The Company applies the equity method
of accounting for the investment, as the Company owns less than a 50% ownership interest and cannot exert significant influence. As such,
this entity is not considered a variable interest entity. Equity method investment is included in other assets, noncurrent, on the accompanying
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Controlling
Interests</i> &#8211; Non-controlling interests on the condensed consolidated statements of operations and comprehensive loss
represent the portion of a majority-owned subsidiary&#8217;s net income or loss that is attributed by non-controlling stockholders. Non-controlling
interests on the condensed consolidated balance sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling
stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Not
yet adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the FASB issued the Accounting Standards Update (<i>ASU) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the
Effects of Reference Rate Reform on Financial Reporting</i>, which provides temporary optional guidance to ease the potential burden
in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying GAAP to transactions
affected by reference rate reform if certain criteria are met. These transactions include contract modifications, hedging relationships,
and the sale or transfer of debt securities classified as held-to-maturity. Entities may apply the ASU from March 12, 2020 through December
31, 2022. The Company is currently evaluating the impact of this new ASU on its condensed consolidated financial statements and related
disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
RESTATEMENT OF PREVIOUSLY ISSUED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determined that the previously issued
financial statements for the period ending September 30, 2021 should no longer be relied upon due to errors in such condensed consolidated
financial statements related to the Company&#8217;s acquisition of MDS Burkina previously disclosed as an asset acquisition. The Company
determined the transaction represents a business combination as MDS Burkina meets the definition of a business per ASC 805, Business
Combinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 268; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following reflects the restatement adjustments
recorded in connection with the Company&#8217;s restatement of its condensed consolidated financial statements:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of September 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
    PREVIOUSLY REPORTED</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADJUSTMENT</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
    RESTATED</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable, net of allowance for credit losses of $13,827</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,933</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,030</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    due from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,852</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,565</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,975</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,603</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,242</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,298</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets, current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,208</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118,702</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    plant, and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,618</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">267</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,885</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,190</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,190</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,915</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">349</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">349</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets, noncurrent</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,630</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,691</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,853</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,763</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES
    AND STOCKHOLDER&#8217;S EQUITY</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    liabilities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lines
    of credit &#8211; working capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,407</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">343</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lines
    of credit &#8211; wheat inventories</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,497</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,497</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">658</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,945</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,811</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,646</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,444</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of long-term debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,095</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,658</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    liabilities, current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,323</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,323</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,888</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,531</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">199,419</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,603</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
    loan</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,686</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,399</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,853</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,769</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
    and contingencies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder&#8217;s
    equity:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, $1 par value; 120,000,000 shares authorized; issued, and outstanding at September 30, 2021 and December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(77,933</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(77,933</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    other comprehensive income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,039</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,039</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
    interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,888</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,888</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholder&#8217;s equity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities and stockholder&#8217;s equity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,853</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,763</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 269; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </b></span><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    months ended September 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
    PREVIOUSLY REPORTED</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADJUSTMENT</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
    RESTATED</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from operating activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    to reconcile net loss to net cash used in operating activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of property, plant and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">881</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">881</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad
    debt expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">523</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">523</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,193</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,193</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in operating assets and liabilities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,602</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,602</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,762</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,940</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,214</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,214</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,852</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,852</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables and liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,941</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,941</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,200</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from investing activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    of business, net of cash acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,350</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of equity method investment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,098</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,098</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,465</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of property, plant, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,505</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    of property, plant, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
    to intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in investing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,418</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,240</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from financing activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
    on long-term debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments
    on long-term debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,188</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,188</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by financing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,587</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,587</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of exchange rate changes on cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(612</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(612</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    increase in cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,357</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,357</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents, beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,683</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,683</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents, end of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    investing and financing activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidation
    of variable interest entitiy related to asset acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidation
    of variable interest entity related to business acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,751</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value of assets acquired in business acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,067</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,043</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value of liabilities assumed in business acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,077</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,139</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,216</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    cash flow disclosures:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,651</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,651</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    income taxes paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,362</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,362</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operating leases for real estate and vehicles. The Company has finance leases for equipment and construction land space.
Leases are classified as finance leases because ownership of the underlying assets transfers at the end the lease term. Remaining lease
terms for these leases range from less than one year to four years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not record leases with a term of 12 months or less on the balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 270; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
balance sheet information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">Balance Sheet</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Classification</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold"></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; font-weight: bold">Assets</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 42%; text-align: left">Operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: left">Right-of-use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,479</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,818</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Right-of-use assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,711</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,816</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,190</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,634</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">661</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">729</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Current portion of long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,478</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Noncurrent liabilities</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">948</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,216</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Finance leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,590</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,566</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total noncurrent liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,538</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,782</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,539</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,260</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets and their corresponding lease liabilities are measured and recognized based on the present value of the future minimum lease payments
over the lease term at the commencement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Discount
Rates</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the majority of its leases, the Company uses the rate implicit in the lease. For leases without an implicit rate, the Company uses its
incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments
for those leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average discount rates for the Company&#8217;s leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted-average discount rate</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finance leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.1</td><td style="text-align: left">%</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Payments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company includes lease payments under options to extend or terminate the lease in the measurement of the right-of-use asset and lease
liability when it is reasonably certain that it will exercise such options. Fixed lease costs represent the explicitly quantified lease
payments prescribed by the lease agreement and are included in the measurement of the right-of-use asset and corresponding lease liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term of the Company&#8217;s leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"></td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; font-weight: bold; text-align: center">2021</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; font-weight: bold; text-align: center">2020</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average remaining lease term</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
                                            years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
                                            years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finance leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
                                            years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
                                            years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 271; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of lease expense were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Nine months ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Operating lease cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">591</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">473</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finance lease cost:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest on lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">423</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,294</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, future maturities of lease liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating Leases</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Finance Leases</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 64%">Remainder of 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">191</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">681</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,711</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">674</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,762</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,311</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(380</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,608</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,931</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
information related to leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Nine months ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Operating cash flows used for operating leases</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">591</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating cash flows from finance leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Financing cash flows from finance leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">334</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCOUNTS RECEIVABLE</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross and realizable value of accounts receivable are detailed in the chart below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">44,857</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">41,014</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Allowance for credit losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,827</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,532</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">31,030</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,482</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 272; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in allowances for credit losses consisted of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Allowance for</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
                                            thousands)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold">Balance at January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(7,248</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current period provision for expected credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,516</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at January 1, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,439</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current period provision for expected credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(549</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,544</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,532</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current period provision for expected credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(522</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(13,827</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
OTHER CURRENT RECEIVABLES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
current receivables consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Government subsidies</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">8,649</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,222</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Value-added tax receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,578</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,575</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,234</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,737</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,142</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,283</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVENTORIES, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net, are detailed as follows: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Merchandise</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">18,601</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7,424</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Raw materials and consumable supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finished products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,928</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventory reserves</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,126</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,145</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,298</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,545</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 273; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTY PLANT AND EQUIPMENT</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-indent: -8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">25,697</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">23,133</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,663</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,870</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,284</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,211</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,558</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,361</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,211</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Less accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(42,918</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34,934</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign exchange difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(558</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,344</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">101,885</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">89,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $2,713 and $2,670 for the nine months ended September 2021 and 2020, respectively, included in cost of sales in the in the
condensed consolidated statements of operations and comprehensive loss. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOODWILL AND OTHER INTANGIBLE ASSETS</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the establishment of reporting segments for each reporting period, the Company allocated goodwill between reporting units
using a relative fair value allocation approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
on the condensed consolidated balance sheet resulted from the acquisition of MDS Mali and MDS Burkina in 2021 and the acquisitions
of wholly owned subsidiaries, the Tria Group in 2016 and Maymouna Food Group in 2015. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the carrying amount of goodwill allocated to its reporting units for the nine months ended September 30, 2021 and the year ended December
31, 2020 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Soft</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Durum</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Couscous</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wheat</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wheat</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">and Pasta</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="18" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold">Balance at December 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,384</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,760</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,477</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">44,669</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,324</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">287</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">461</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,331</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,403</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,708</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,047</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">48,072</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,656</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,656</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(304</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(306</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(782</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">33,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,981</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,403</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,502</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">61,946</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 274; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the carrying amount of intangible assets for the nine months ended September 30, 2021 and the year ended December 31, 2020 are as
follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intangible</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
                                            thousands)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold">Balance at December 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">448</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">278</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(262</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(149</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">48</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, the weighted-average remaining amortization period for intangibles other than goodwill is 8.6 years and future
intangible amortization is expected to total the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 80%">Remainder of 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">180</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>.
ACCRUED EXPENSES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Accrued government subsidies and taxes</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">8,143</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,498</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,451</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accruals to social agencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">577</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,856</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">539</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,646</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,410</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LINES OF CREDIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lines
of Credit &#8211; working capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into unsecured revolving credit agreements with several financial institutions to fund working capital requirements
(&#8220;WC Lines of Credit&#8221;). The WC Lines of Credit provide the Company with the ability to borrow funds under consolidated lines
of credit of up to approximately $58,800. Interest rates range from 5.6% to 6.4%. The WC Lines of Credit renew automatically on
an annual basis. The Company and certain of its subsidiaries are borrowers under the WC Lines of Credit, and their obligations are cross
guaranteed by certain other subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 275; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lines
of Credit &#8211; wheat inventories</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into credit agreements with several financial institutions for asset-based credit facilities in order to fund wheat
raw material purchases (&#8220;Wheat Credit Facilities&#8221;). The Wheat Credit Facilities provide the ability to borrow funds under
consolidated lines of credit of up to approximately $130,000, subject to certain borrowing base criteria. The Wheat Credit Facilities
are secured by the Company&#8217;s inventory. Interest rates range from 1.4% to 6.4% per annum. The Wheat Credit Facilities must be renewed
on a semi-annual basis. The Company and certain of its subsidiaries are borrowers under the Wheat Credit Facilities, and their obligations
are cross guaranteed by certain other subsidiaries. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LONG-TERM DEBT</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
long-term debt of is presented as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Loans</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,722</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,254</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,539</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,260</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total outstanding debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,514</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,658</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,371</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term loans and other financial liabilities are evaluated according to the amortized cost method using the effective interest rate of
the loan. The loan issuance costs and premiums are determined at inception and are amortized over the useful life of the loan via the
effective interest rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term
Loans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains term loans with several financial institutions (the &#8220;Term Loans&#8221;). The Term Loans are unsecured and have
fixed monthly payments ranging from approximately $770. Interest on the Term Loans range from 5.8%-8.0% per annum. The Term Loans mature
and will be fully repaid throughout 2022 and 2029.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owes $7,539 and $9,260 related to its leases as of September 30, 2021 and December 31, 2020, respectively. Lease obligations
are payable in monthly installments of principal and interest and are collateralized by the related assets financed. Refer to Note
5 for additional information regarding the Company&#8217;s leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scheduled maturities of outstanding debt as of September 30, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remainder
    of 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,990</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,597</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,746</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,209</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,564</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    outstanding debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,261</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 276; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME TAXES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s effective tax rate was 20.0% and -2,414% for the nine months ended September 30, 2021 and 2020, respectively. The effective
tax rate was lower than the Moroccan statutory rate primarily due to unrecognized tax losses and Permanent differences not deductible
(taxable) for tax purposes. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods ended September 30, 2021 and December 31, 2020, the Company has $23,810 and $5,660, respectively, as net operating losses
that begin to expire within four years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realizability of these deferred tax assets, management considers whether it is more-likely-than-not that some portion or
all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income in those periods in which temporary differences become deductible and/or net operating loss carryforwards can be
utilized. The Company considers the level of historical taxable income, scheduled reversal of temporary differences, tax planning strategies,
and projected future taxable income in determining whether a valuation allowance is warranted. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintained a valuation allowance of $3,224 as of September 30, 2021 and $5,660 in 2020 against its net operating losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VARIABLE INTEREST ENTITIES AND ACQUISITIONS</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on April 30, 2021, the Company completed a share purchase acquisition of MDS Mali. By way of the acquisition, the Company acquired a
70.35% stake in a wheat milling business in Mali.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the agreement, the Company will provide financial investments to MDS Mali in the form of a capital increase for a total
amount of $9,579, $5,912 of which have already been completed as of September 30, 2021. The amount invested will be used first to recapitalize
the company, balance the financial situation and then finance the working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company thus agrees to fund MDS Mali for operational cash flow needs and bear the risk of its losses from operations and MDA Mali agrees
that the Business has rights to 70.35% of MDS Mali&#8217;s net profits, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents the preliminary allocation of the purchase consideration among assets acquired and liabilities assumed at
their estimated acquisition date fair values:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration
    paid:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,579</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,768</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncontrolling
    interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    consideration paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,384</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    plant and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,273</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,309</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    net assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,626</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    consideration paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,384</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br />
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 277; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of MDS Mali&#8217;s assets and liabilities included in the condensed consolidated financial statements are as follows
at September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,492</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,177</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,466</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    plant, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,624</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,756</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,001</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,415</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operating results from the date of acquisition to September 30, 2021 of MDS Mali included in the condensed consolidated financial statements
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,919</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">334</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on July 30, 2021, the Company completed a share purchase acquisition of MDS Burkina. By way of the acquisition, the Company acquired
a 78.21% stake in a wheat milling business in Burkina.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the agreement, the Company will provide financial investments to MDS Burkina in the form of a capital increase for a
total amount of $6,153, $2,622 of which have already been completed as of September 30, 2021. The amount invested will be used first
to repay the debt, recapitalize the company and provide working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company thus agreed to fund MDS Burkina for operational cash flow needs and bear the risk of its losses from operations and MDS Burkina
agrees that the Company has rights to 78.21% of MDS Burkina&#8217;s net profits, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 278; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents the preliminary allocation of the purchase consideration among assets acquired and liabilities assumed at
their estimated acquisition date fair values:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration
    paid:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,153</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,515</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncontrolling
    interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    consideration paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,382</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">781</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    plant and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,134</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,625</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    net assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,351</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    consideration paid</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,382</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of MDS Burkina&#8217;s assets and liabilities included in the condensed consolidated financial statements are as follows
at September 30, 2021:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
                                            thousands)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    plant, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,386</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,969</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,514</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,140</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
on November 5, 2020, pursuant to an investment and shareholders agreement dated November 5, 2020, the Company entered into an agreement
with Trigola, an entity incorporated in the Republic of Angola and owned by the Parent for a majority for a share in Trigola&#8217;s
equity of 75%. Pursuant to the terms of the agreement, the Company will provide financial investments for the construction, commissioning
and operation of a new industrial facility for the processing of wheat and the production of wheat flour, management services and other
services on an exclusive basis in relation to Trigola&#8217;s business. The Company agrees to fund Trigola for operational cash flow
needs and bear the risk of Trigola&#8217;s losses from operations and Trigola agreed that the Company has rights to 75%
of Trigola&#8217;s net profits, if any. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of Key Terms of the Trigola Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
    is the exclusive manager of Trigola.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trigola
    shall not directly or indirectly accept the same or similar services from other parties.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forafric
    agrees to fund Trigola&#8217;s operational needs and bear the risk of Trigola&#8217;s losses from operations and Trigola agrees that
    the Company has rights to 75% of the Trigola&#8217;s net profits, if any.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -30.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not provide financial or other support to Trigola for the period presented that the Company was not previously contractually
required to provide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, there were no pledges or collateralization of the Trigola&#8217;s assets that can only be used to settle obligations
of Trigola.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 279; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the Trigola&#8217;s assets and liabilities included in the condensed consolidated financial statements are as follows
at September 30, 2021 and December 31, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">29</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,475</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property, plant, and equipment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">44</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,621</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,232</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other current liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">58</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,290</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 9pt; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
$3,025 in accounts payable included above are payables due to the Company and were eliminated in consolidation at September 30, 2021
($2,700 at December 31, 2020).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operating results of Trigola included in the condensed consolidated financial statements are as follows for the nine months ended September
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">1,072</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">201</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2021, the Company acquired 37.10% of the capital stock of GMT Niger headquartered in Niger, which is a non-operational wheat
milling facility. The Company has accounted for this investment as an equity method investment. GMT Niger was non-operational for the
period ending September 30, 2021, as such, no gain or loss representing the Company&#8217;s portion of ownership was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 280; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>.
EARNINGS PER SHARE</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share is computed by dividing net income by the number of weighted average common shares outstanding during the reporting
period. The Company&#8217;s weighted average number of shares outstanding used in calculating earnings per share are 120,000,000 and
3,690 for the periods ended September 31, 2021 and 2020, respectively. Because there was no activity to cause dilution in the weighted
average common shares, basic and diluted earnings per share are disclosed together in each of the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMITMENTS AND CONTINGENCIES</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has commitments with banks to finance its operating activities. The Company has provided collateral and mortgages to banks of
$25,464, as of September 30, 2021 and December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time the Company is involved in litigation incidental to the conduct of its business. These matters may relate to employment
and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related
to alleged violations of laws and regulations. When applicable, the Company records accruals for contingencies when it is probable that
a liability will be incurred, and the amount of loss can be reasonably estimated. Defense costs are expensed as incurred and are included
in professional fees. While the outcome of lawsuits and other proceedings against the Company cannot be predicted with certainty, in
the opinion of management, individually or in the aggregate, no such lawsuits and other proceedings had or are expected to have a material
effect on the condensed consolidated financial statements at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEGMENT INFORMATION</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company manages operations on a company-wide basis, thereby making determinations as to the allocation of resources in total rather than
on a segment-level basis. The Company has designated reportable segments based on how management views its business. The Company does
not segregate assets between segments for internal reporting. Therefore, asset-related information has not been presented. The reportable
segments, as presented below, are consistent with the manner in which the Company reports its results to the Chief Operating Decision
Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal products that comprise each segment are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Soft
Wheat</i> &#8211; The Soft Wheat segment includes the production and sale of soft wheat yielding flour that is used to make desserts
and sauces.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Durum
Wheat</i> - The Durum Wheat segment includes the production and sale of hard wheat yielding flour that is used to make pasta.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Couscous
and Pasta</i> &#8211; The Couscous and Pasta segment includes the secondary processing of products including couscous and pasta sold
to end customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
</i>&#8211; The Other segment includes distribution, trading and logistics, animal nutrition, and other operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the performance of its segments based on sales and operating income. Operating income is defined as gross profit less
sales &amp; marketing costs, direct selling, general, and administrative expenses, and other operating expenses. The amounts in the following
tables are obtained from reports used by senior management and do not include income taxes. Other expenses not allocated include unallocated
corporate expenses (other operating expenses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 281; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information relating to the Company&#8217;s reportable segments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Nine months ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td></td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Sales to external customers:</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Soft Wheat</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">119,178</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">79,861</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Durum Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Couscous &amp; Pasta</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,551</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,112</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,058</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,465</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">185,517</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">145,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Direct operating income (loss):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Soft Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,134</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,497</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Durum Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,532</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Couscous &amp; Pasta</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,054</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,848</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Operating income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,900</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,073</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
LONG TERM EMPLOYEE SHARE INCENTIVE PLAN</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Forafric 2021 Long Term Employee Share Incentive Plan (the &#8220;FAHL 2021 Plan&#8221;) was adopted on June 22, 2021. The FAHL 2021
Plan allows for the grant of awards, consisting of nominal cost options or phantom options to employees, directors and consultants of
FAHL or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, no nominal cost options or phantom options were outstanding under the FAHL 2021 Plan. Following the consummation
of the impending Proposed Merger and Business Combination with Globis Acquisition Corp. (see Note 21 &#8211; Subsequent events) the FAHL
2021 Plan shall be surrendered, cancelled, and exchanged in substitution for awards on substantially the same terms in the Forafric 2022
Long Term Employee Share Incentive Plan.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED PARTIES </b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion summarizes activity between the Company and related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the Company entered into a building lease agreement for the headquarters of Forafric Maroc, a wholly owned subsidiary, with a lease
term through 2024. The Company&#8217;s Parent owns 100% of the company that owns the building. Total rent is approximately $420 per year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Millcorp
provides 100% of the imported grain to the Company. The purchases incurred were $94,015 and $101,208 as of September 30, 2021 and 2020,
respectively. In the beginning of 2021, the Company received management fees of $500 from Millcorp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s amounts due from related parties were $5,565 and $387 as of September 30, 2021 and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains an interest-free loan with no maturity date to the sole stockholder of the Parent in the amount of $15,399 and
$8,683 as of September 30, 2021 and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not entered into any significant transactions with other related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21.
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparing the consolidated financial statements through the September 30, 2021, the Company has evaluated subsequent events for recognition
and disclosure through January 12, 2021, the date that these consolidated financial statements and accompanying notes were available
for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 282; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORAFRIC
                                            AGRO HOLDINGS LIMITED AND SUBSIDIARIES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2021, the Company signed a letter of intent to be acquired by Globis Acquisition Corp. (&#8220;Globis&#8221;). Globis is
a special purpose acquisition company (&#8220;SPAC&#8221;) listed on the NASDAQ exchange in the United States. As of January 12,
2021, the transaction is in the process of being finalized and is expected to close in 2022, subject to approval by the SEC and the shareholders
of the SPAC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the Company acquired a controlling interest in Moulins Sanabil SA&#8217;s (&#8220;Sanabil SA&#8221;) capital stock, for
cash consideration of approximately $3,000. The company is privately-held and headquartered in Meknes, Morocco and is a soft wheat flour
manufacturer. The company offers a complete line of soft wheat and baking flour products. The Company has not yet completed a valuation
of the fair values of assets acquired and liabilities assumed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 19, 2021, Globis and the Company entered into a Business Combination Agreement (the &#8220;Business Combination&#8221;). The
Business Combination Agreement provides for the consummation of the following transactions (collectively, the &#8220;Business Combination&#8221;):
(i) Globis will merge with and into Globis NV Merger Corp., a Nevada corporation and a wholly-owned subsidiary of Globis (&#8220;Globis
Nevada&#8221;), with Globis Nevada surviving (the &#8220;Merger&#8221;); (ii) Globis Nevada will change its jurisdiction of incorporation
by transferring by way of a redomiciliation and domesticating as a Gibraltar public company limited by shares (the &#8220;Redomiciliation&#8221;)
and change its name to &#8220;Forafric Global PLC&#8221; (referred to herein as &#8220;New Forafric&#8221;); and (iii) immediately following
the effectiveness of the Redomiciliation, New Forafric will acquire 100% of the equity interests in the Company from the Lighthouse Capital
Limited (&#8220;Seller&#8221;) and the Company will become a direct subsidiary of New Forafric.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total consideration to be paid to the Seller in the Business Combination will be (i) 15,100,000 Ordinary Shares, subject to reduction
to the extent that the Closing Payment (as defined below) is less than $0, provided that the Seller may be issued up to 1,904,762 additional
Ordinary Shares determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the Closing; plus
(ii) an amount (the &#8220;Closing Payment&#8221;) equal to $20,000,000 minus the outstanding amount of all Funded Debt (as defined in
the Business Combination Agreement) as of the Closing (other than Permitted Debt); provided that Seller may receive up to an additional
$20,000,000 determined based on the amount of Remaining Cash (as defined in the Business Combination Agreement) at the Closing. The Closing
Payment shall be funded by remaining funds in the Trust Account after giving effect to any Buyer Share Redemptions (as defined in the
Business Combination Agreement) and the proceeds of any potential private placement financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the foregoing consideration, the Seller shall be entitled to receive, as additional consideration, and without any action
on behalf of the Company or the Company&#8217;s stockholders, additional Ordinary Shares (the &#8220;Earnout Shares&#8221;), to be issued
as follows during the period from and after the Closing until the end of calendar year 2024 (A) 500,000 Earnout Shares, if, during calendar
year 2022, Adjusted EBITDA (as defined in the Business Combination Agreement) of the Company is equal to or greater than $27 million,
(B) 500,000 Earnout Shares, if, during calendar year 2023, Adjusted EBITDA of New Forafric is equal to or greater than $33 million, and
(C) 1,000,000 Earnout Shares, if, during calendar year 2024, the Buyer Trading Price (as defined in the Business Combination Agreement)
during the standard market trading hours of a trading day is greater than or equal to $16.50 for any 20 trading days within any period
of 30 consecutive trading days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2021 the Company authorized the issuance of convertible bonds of up to $40,000,000 with an annual interest rate of 6.00%
through December 31, 2026. As of January 12, 2021, $9,500,000 of convertible bonds have been subscribed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 283; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    20.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
    of directors and officers and Financial Statements Schedules </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Companies
Act 2014 of the Laws of Gibraltar</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
general common law position that a company can indemnify its directors has been circumscribed in Gibraltar by statutory enactment. Section
231 of the Companies Act imposes certain limits on the extent and scope of indemnification relieving directors of indemnification under
Gibraltar law. Section 231(1) prohibits indemnification for liability arising from their own negligence, default, breach of duty or breach
of trust. A provision in the articles of a company or a specific contract seeking to provide such indemnification is void. However, it
follows that apart from such restrictions, directors can in certain circumstances be indemnified (i.e. for matters not expressly prohibited).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Memorandum and Articles of Association provide that, subject to any indemnity which would be prohibited or rendered void by any provision
of the Companies Act or by any other provision of law, a relevant director of New Forafric or an associated company may be indemnified
out of New Forafric&#8217;s assets against any liability which by virtue of any rule of law would otherwise attach to him in respect
of any negligence, default, breach of duty or breach of trust of which he may be guilty in relation to New Forafric. A &#8220;relevant
director&#8221; means any director or former director of the company or an associated company. Companies are &#8220;associated&#8221;
if one is a subsidiary of the other or both are subsidiaries of the same body corporate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling
the registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act and is therefore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>D&amp;O
Insurance and Indemnification Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Memorandum and Articles of Association, the directors may decide to purchase and maintain insurance, at the expense of the company,
for the benefit of any relevant director in respect of any relevant loss. In this paragraph: A &#8220;relevant loss&#8221; means any
loss or liability which has been or may be incurred by a relevant director in connection with that director&#8217;s duties or powers
in relation to the company, any associated company or any pension fund or employees&#8217; share scheme of the company or associated
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    21.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
    and Financial Statements Schedules. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(a)
Exhibits.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315221031962/ex2-1.htm" style="-sec-extract: exhibit">Business
Combination Agreement, entered into as of December 19, 2021, by and among Globis Acquisition Corp., Seller and FAHL (included as <i>Annex
A</i> to the proxy statement/prospectus) (incorporated by reference to Exhibit 2.1 of Globis' Form 8-K (File No. 001-39786
), filed with the SEC on December 20, 2021).</a></p>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
    of Incorporation of Globis NV Merger Corp. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws
    of Globis NV Merger Corp.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Proposed Memorandum and Articles of Association, to become effective upon the Redomiciliation (included as <i>Annex C</i>
    to the proxy statement/prospectus). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 284; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315220023669/ex4-1.htm" style="-sec-extract: exhibit">Warrant
    Agreement, dated December 10, 2020, between Globis Acquisition Corp. and VStock Transfer, LLC. (incorporated by reference to Exhibit
    4.1 of Globis' Form 8-K (File No. 001-39786 ), filed with the SEC on December 15, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Hassans International Law Firm Limited. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of McDermott Will &amp; Emery LLP. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Opinion of McDermott Will &amp; Emery LLP. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315220023669/ex10-1.htm" style="-sec-extract: exhibit">Letter
Agreement, dated December 10, 2020, among Globis Acquisition Corp., the Sponsors and each of the officers and directors of Globis Acquisition
Corp. (incorporated by reference to Exhibit 10.1 of Globis' Form 8-K (File No. 001-39786), filed with the SEC on December 15, 2020).</a></p>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315220023669/ex10-2.htm" style="-sec-extract: exhibit">Registration
    Rights Agreement, dated December 10, 2020, between Globis Acquisition Corp. and the Sponsors (included as <i>Annex G</i> to this
    proxy statement/prospectus). (incorporated by reference to Exhibit 10.4 of Globis' Form 8-K (File No. 001-39786 ), filed with
    the SEC on December 15, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315222000220/ex10-1.htm" style="-sec-extract: exhibit">Subscription
                                            Agreement, dated December 31, 2021, by and between Globis Acquisition Corp. and the undersigned
                                            subscriber party thereto. (incorporated by reference to Exhibit 10.1 of Globis' Form 8-K
                                            (File No. 001-39786 ), filed with the SEC on January 4, 2022).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.4&#8224;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1823383/000149315222000220/ex10-2.htm" style="-sec-extract: exhibit">Bond
    Subscription Deed, dated as of December 31, 2021, by and among Forafric Agro Holdings Limited, Lighthouse Capital Limited and the
    Bond Investors (incorporated by reference to Exhibit 10.2 of Globis' Form 8-K (File No. 001-39786 ), filed with the SEC on January
    4, 2022).</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Forafric 2022 Long Term Employee Share Incentive Plan (included as <i>Annex H</i> to the proxy statement/prospectus).
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.6*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Agreement, dated March 29, 2018, by and between Forafric
    Maroc and Millcorp Geneve</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.7*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Summary of terms of loans owed by Forafric Agro Holdings
    Limited to Yariv Elbaz, Michael Elbaz, Lighthouse Settlement and Lighthouse Capital Limited</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.8*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lease Agreement, dated January 2, 2018, by and between
    Forafric Maroc and Darafric SARL AU for the rent of the headquarters of Forafric Maroc in Casablanca</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Marcum LLP, independent registered accounting firm for Globis Acquisition Corp..</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-2.htm">Consent of UHY LLP, independent registered accounting firm for FAHL.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Hassans International Law Firm Limited (included as part of Exhibit 5.1). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of McDermott Will &amp; Emery LLP (included as part of Exhibit 5.2). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of Attorney (included on signature page).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Proxy Card for Stockholders Meeting. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Saad Bendidi to be named as a Director. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Julien Benitah to be named as a Director. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Franco Cassar to be named as a Director. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of James Lasry to be named as a Director. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Ira Greenstein to be named as a Director. </span></td></tr>
  </table>


<p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><p style="margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by amendment </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant
    agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 285; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    22</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Undertakings.
    </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by section 10(a)(3) of the Securities Act; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission
    pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate
    offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement
    or any material change to such information in this Registration Statement. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a
    new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
    deemed to be the initial bona fide offering thereof. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b)
    as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than
    prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date
    it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is
    part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
    or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first
    use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
    statement or made in any such document immediately prior to such date of first use. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
    of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
    to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
    are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller
    to the purchaser and will be considered to offer or sell such securities to such purchaser: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 286; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through
    use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within
    the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the
    applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information
    called for by the other items of the applicable form. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant undertakes that every prospectus: (1) that is filed pursuant to the immediately preceding paragraph, or (2) that purports
    to meet the requirements of Section 10(a)(3) of the Securities Act of 1933 and is used in connection with an offering of securities
    subject to Rule 415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment
    is effective, and that, for purposes of determining any liability under the Securities Act, each such post-effective amendment shall
    be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
    time shall be deemed to be the initial bona fide offering thereof. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus
    pursuant to Items 4, 10(b), 11, or 13 of this Form S-4, within one business day of receipt of such request, and to send the incorporated
    documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to
    the effective date of the Registration Statement through the date of responding to the request.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction,
    and New Forafric being acquired involved therein, that was not the subject of and included in the Registration Statement when it
    became effective. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
    of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
    SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
    that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid
    by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
    by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in
    the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
    question whether such indemnification by them is against public policy as expressed in the Securities Act and will be governed by
    the final adjudication of such issue. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 287; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the city of New York, State of New York, on January 12, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Globis
    NV Merger Corp</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><i>/s/ Paul Packer</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Paul Packer his true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, for such person and in his name, place and stead, in any and all capacities,
to sign this Registration Statement on Form S-1 (including all pre-effective and post-effective amendments and registration statements
filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone,
full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises,
as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming that any such attorney-in-fact
and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
and on January 12, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position
    </b>&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Paul Packer</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chief Financial Officer and Director&#160;&#160;(Principal Executive Officer and Principal Accounting Officer)
    &#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Packer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 288; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>





</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Globis NV Merger Corp. on Form S-4 of our report dated March 31, 2021, except
for the effects of the restatement discussed in Notes 2, 3 and 8 as to which the date is December 7, 2021, with respect to our audit
of the financial statement of Globis Acquisition Corp. as of December 31, 2020 and for the period from August 21, 2020 (inception) through
December 31, 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference
to our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melville,
NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
12, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex23-2_001.jpg" ALT="" STYLE="height: 66px; width: 670px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM&rsquo;S CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the use in this Registration Statement on Form S-4 of our report dated December 17, 2021, relating to the consolidated
financial statements of Forafric Agro Holdings Limited and Subsidiaries as of December 31, 2020 and 2019 and for the years then ended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to us under the caption &ldquo;Experts&rdquo; in the Proxy Statement/Prospectus, which is part of such
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
UHY LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melville,
NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
12, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Independent Member of Urbach Hacker Young International</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>forms-4_001.jpg
<TEXT>
begin 644 forms-4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'A J(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\4O%D6F^%-4T/5]&\/:?XBD^SO+&C/=1%6+'[/YI,,MNI6,B;#*&2(Q_<]%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD> =(N9;^]_MKQ3JTHN];UN1-KWMQC'"Y.R)%PD<8.$10.3N)[2BB@ HHHH
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M\+&\$Z5XC_L'7/#'V^-G_LGQ)9_9+^VP[+MFBW-L)VY R>"#WH X_P#X9/\
M@IU'PB\#JW]]?#MH&_[Z\O-'_#*OPA7_ %/P\T*S;LUG:BW8?0QX(_"NC^*?
MQ2TKX2^'[/4M3M[R_GU#4;;2-.TW3U0W%]>7$@2&"/S'2,$DD[G=5 !)8 5P
M7C3]JK3? ?@/Q1XHU;P+XRA7PND,FM:8;6T2YM(Y%<B12]RL4Z+L +022#+@
M*6*N$ -G_AF7P3#S83>*M'8?=_LOQCJ]JH_X ET$/T((I/\ A2>OZ;SH?Q=\
M;:>HZ6]\;'4HC]3<6S2G\)!6+\-?VMO#GQ#\?:-X-N_#?B3P;KVN:(GB'18O
M$$5KY>IV; G?#);7$R[E4;FC<JP!SBNJL?C[X2U#X]:E\((;F9O&&GZ+'KDR
M[5\GR7DV>6&W;O, ,;E=N-LBD$\@ &=_9_QK\._\>^L>"_&\*_=BU"SN=%G/
MLTT;W*$^XA7Z4G_"[-=\-G;XT^&7B71XE^]J6A(NNV?O@6V;GCU:W4?KB3XD
M?M%:!X \>:+X$LM*UCQKX\U6)KJ+PWX;CA>YAM%5BUU.\\L4,,6Y0@,D@+,Z
MA0W..C^'_P 4+/X@7FK6,>C:UH6IZ3Y*WUCK=E]G>&20,=BL"R3 ;3^\B9XF
M_@=L' !-X&^+'@[XE?:%\,^(]/U>XMN+FSAF N;8\<30G$D1Y'#J#R/6NLKD
M?'/PC\&_$IH)/$OARQU2[MO^/:^>/9=VQYYAG3$D1Y/*,#S7(-\/?B%\/P9/
M _C#_A)=/7D>'O'4LD__  &+44!G3MS,MQU/2@#UVBO,/#OQZTN77+7PYXPT
MZ[^'WBJY?RK;3];*_9[Y^>+2[4F&X) )V*PE Y:-:]/H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "LK6/"NB>(%(U31[#4@>"+RU27_P!"!K5HH \]
MNOV=OA3?,3<_#'P;<%NIET"T;/YQUY-X?_9O^$DG[2WCNP;X6^"VL+?PEX>N
M8;5O#UH8HI9+S6EDD5?+P&=88@S#DB- ?NC'TW7E7AS_ ).F^(?_ &)GAG_T
MNUZ@#7L_V??A=ISJ]I\-O"-JZ]&AT*U0C\HZZ_2]!TS0X_+TW3K33TQC;:P+
M$/R4"K]% !1110 4444 %%%% !1110 4444 %%%% !1110 45RGC_P"*7A?X
M8V=M-XBU6.TFNW,=E81(T]Y?2 9\NWMXPTDSX_A12:XQ-8^*WQ*R=+TZT^%V
M@2?=OM:1;_695]5M4;R+<D8(,DDIY(:)2,4 >IZMJUCH.GSW^IWMOIUA;KOF
MNKN58HHU]69B !]:\Q_X:4\-:T-O@O3-?^(\A^Y)X7TYI+.3TVWTQCM#G_KM
M[]*LZ3^SEX-@U"WU3Q!!>>/=<@;S(]4\77)U!XG_ +T,3#R;<]?]3'&.3QS7
MIZ@*  , < "@#R@:]\9O$?-CX5\*^#;9ONS:YJLVI72_[UM;QI&/PN3GVI?^
M%7_$36.=:^,6HV>[[T7A70[&QB/L/M*74@'T?/O7J]% 'E/_  SCH=YSK'BC
MQYK<G=IO&&HVJ'ZQVLT49^FW%'_#+/PMD_X^_"4&JG^]JUS/?'\YI'->K44
M>5?\,H_!9O\ 6?"?P9<?]?&A6TO_ *$AH_X91^#"_P"K^%?A"W_Z]]%MXO\
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M_9[^#.F> [36+G5YH#<3W>L/&L,EQ<SR-)+*L8)6,;G^51G 49+')/B'P/\
MV$?$OP8^(7AGQ@?BC8^(-4T31-1T0M=^&I%:]%U<370N)W^W%GF%Q.S.V?GC
M4+A&S(0#KO@S^WMX"^-VO>"M,TO0O%.CCQA;ZA/I-[K5E!%!,UD3]HC)2=V!
M51NW8,9SMW[U95\W\6?MC:IX[^*7P-O/AW=>(]*\!>*/%4^ARW=]IUBVF^(+
M>%W266!\27$6V1,#S# 65LJK;7*6_@S_ ,$]=8^$WB'X/7LGQ*T_6=/^&_\
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M/8GCD3_NP2 LSGBO7;.\M]0M(;JTGCN;69!)%-"X=)%(R&5AP01W% $U%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5>'/\ DZ;XA_\
M8F>&?_2[7J]5KRKPY_R=-\0_^Q,\,_\ I=KU 'JM%%% !1110 4444 %%%%
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M]PY%=KX2^'7A3P# T/AGPSH_AV)OO)I5A%;!OKL49KHJ /*!XL^,'B!<Z;X
MT'PQ"3CS?$FOF:=1GKY%K"Z'CMYX_K1_PKSXG:ZW_$\^*RZ5"1S!X0\/P6A^
MGF7;79(]P%/TKU>B@#R?_AF?PAJ*J?$MUXB\:R9RX\1:]=W$$GLUJ)%M\>PB
M -=MX2^'/A/P#"T7ACPQH_AV-\!ETJPBM@V/78HS7144 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"BR?#_ /\ "HL?_CM'_#6/P0_Z+)\/_P#PJ+'_ ..UZK10!Y5_PUA\$/\
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M'BW5/AW^RC\0?&WQ UJTT[6_$&OV'B?5;G6IK.QG3?<&WCG572($;&"< C8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRKPY_R=-\0_^Q,\,_\ I=KU
M>JUY5X<_Y.F^(?\ V)GAG_TNUZ@#U6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\*\%:W\8?B58ZQK.F>+?
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M,G_)1?@3_P!CG<_^H]K->JUY5\9/^2B_ G_L<[G_ -1[6: /5:*** "BBB@
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MZ+\;-)\4:_X?OK5[;4O!M[:IJ$-GOMXQ%>B$L(YGD6XWO$(PQR46)3Y2>O\
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M7X$_]CG<_P#J/:S7JM>5?&3_ )*+\"?^QSN?_4>UF@#U6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KRK]FG_DG6K_\ 8Y^+/_4AU&O5:\J_9I_Y)UJ__8Y^+/\
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M+/([M&2S,Q)+$Y)))KTNB@#RK_AD[X(?]$;^'_\ X2]C_P#&J/\ AD[X(?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>forms-4_02.jpg
<TEXT>
begin 644 forms-4_02.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 4O"$P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 2FT^F4Q@*7%"TZD(ADSM..37SI^WA?"S_9_U OP6./T
MKZ,9PK 'K7S)_P %$8]W[.VHL/O+(,?E2I_$.6Q^3WP]_9=?XMZI-<1O( _S
M?+7=7_\ P3]DM9%4S3#->X?L3W+VMJ7*@_N^XKZ/OM8GOYRVU=JG!XKZW"TE
M*.Q\]7K3A+W6?G[_ ,._C_S\S4?\._S_ ,_,WZU]^_V@W]U?RH_M!O1?RKK^
MJ^1C]=EW/@+_ (=_G_GYF_6C_AW^?^?F;]:^_?[0;T7\J/[0;T7\J/JOD'UV
M7<^ O^'?Y_Y^9OUH_P"'?Y_Y^9OUK[]_M!O1?RH_M!O1?RH^J^0?79=SX"'_
M  3]+<?:9OUIW_#OK_IYF_6OOO\ M!^RK^5'V^3^ZOY5/U'FUL-8R7<^!/\
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MGP%'=M]_SF_G7S&94.6HK'O8>MSK4_1NBBBO+.X**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$TTWAR^^PP]@OI1]5J_S![2!T'[-_P -_$_@FSU5=5'R,/DYS7@'Q'U :?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+=JY[XN^ ]:U;QA!XE\/P^;=VWW.*U/!>O>./$5P]GXK@\J#9C@5KRR,7RG
M>#OASJ'QRU;Q"QUN>R%CN955S4GA[Q+=?#GP]J&A7%X][*SE5>1LFIYO#?C[
MX9ZUJ<OAFVW0:@2&)]#6GH'PCU/5]!NK_P 01%-4)W(HK.49B7*>>_\ "&ZY
MXJ+79U*XM[8_, &(%1^$_ ^K>+;F^C&KW$*Z<"V0Q^;%>VZ3X4UFW\.K;O !
M%T''--^'O@'4-';6-T6TW2D+^-8.,^QHI11X59ZW>^)=>C\,G4I$,C>7YVXY
M%=O<?#^Y^%$BW#ZS+?=/E=B>M>?>*_!NI^!?'D;Q1L-2D??$N/>N\TOPYXZ\
M67RR>(;?9IY'#"ERS[#YHDWQ.:3Q!H=B\6L20R..(U8UYK;^/M>^&4ZVSB:Z
M23G>Q->G?$3X1ZVEO8OI,3/L((K#N/A;XM\0S0#4;0 * .!1RS[!S0*.@?#?
M6OBOJ3:]_:MQ9HRY\M6.*PK?6M=T7Q8=/MY9KM+.7$C9)X!KZ.^&GAG5O"<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN7UX)KP[!Q4]U&_V.W?<09$#&H[2P51YC')K00YE+JM*R;,4DTG9>::KE^M
MAU%%% !1116?VT0]PHHHK>M\)IT'M_JJ(>]#?ZJB'O65'9F,=SSS]H?_ )(O
MXE_ZX-47_!*7_D18_P#KJU2_M#_\D7\2_P#7!JB_X)2_\B+'_P!=6KY3-/B/
MIL+T/T=HHHKYP]H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZEX^TVTE;&]\8KH/CQ\'?#V@?"E]3B?;=C!&T\UQ?QTO(M+\76%U"P$L;9W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBBD C4BTK4BU70GJ+7S#_P42_Y-SU/_KHO\J^GJ^8?^"B7_)N>I_\
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MLW\Z^/S#WFVSZO"I61^CM%%%?.GK!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +[-/Z]YC^J+L>D+\8O!*?=\168_[:"FCXO>!E.1X@LP?^N@KSG_ (=7P_\
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M_P!H>8_J9Z/_ ,+>\#]?^$AL\_\ 704?\+>\$?\ 0PV>/^N@KSC_ (=7P_\
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MY^[W_OLUS5L;Y@L,>D_\+B\$[<?\)':%?3S!2+\7O!$?W?$5FO\ VT%><?\
M#J^'_GZO?^^S1_PZOA_Y^[W_ +[-<\,?8VCA$>C-\7O \GWO$-F?^V@I6^,'
M@A@ ?$5F0.G[P5YS_P .KX?^?J]_[[-'_#J^'_GZO?\ OLUM_:'F/ZHCT?\
MX7#X)QC_ (2.SQ_UT%)_PN#P01@^(K/'_705YS_PZOA_Y^KW_OLT?\.KX?\
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M\%><?\.LK?\ Y^[W_OLT?\.LK?\ Y^[S_OLT?VQ(/JIZ1_PM_P $?]#%9_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZF3CJ06TS.K;NU2J<FFF#]VR@XS1;P&%,$[C4N]S56L344451(4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4U
MNM.IK=::$QLO^ID_W3_*OBKXP?\ )4M'_P"OD?SK[5E_U,G^Z?Y5\4_&#_DJ
M6C_]?(_G7J8'>7H<&+VB?9^G?\@^U_ZY+_*K/856T[_D'VO_ %R7^56>PKRY
M;G:OA&2=J$Z42=J$Z5C'XV:_9)%I:1:6M2%L%%%% PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M:W6G4UNM-"8V7_4R?[I_E7Q3\8/^2I:/_P!?(_G7VM+_ *F3_=/\J^*?C!_R
M5+1_^OD?SKU,#O+T.#%;1/L_3O\ D'VO_7)?Y59["JVG?\@^U_ZY+_*K/85Y
M<MSM7PC).U"=*).U"=*QC\;-?LDBTM(M+6I"V"BBB@84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3]O[PJC8\N+_ +^?_7I<LQ>WCW/JO::-IKY3_P"'@'A7_GG%_P!_/_KT?\/
M/"O_ #SB_P"_G_UZ.60>WCW/JS::-IKY3_X> >%?^><7_?S_ .O1_P / /"O
M_/.+_OY_]>CED'MX]SZLVFC::^4_^'@'A7_GG%_W\_\ KT?\/ /"O_/.+_OY
M_P#7HY9![>/<^K-IHVFOE/\ X> >%?\ GG%_W\_^O1_P\ \*_P#/.+_OY_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<$?9^U/ZC3[![>1\_?\ ##WAW_H-W'_?5'_##_AW_H-W'_?5?0<NGW$K Q,
M*6\VVEJR,,W!'!H^HTNP>WD?/?\ PP_X=S_R&[C_ +ZH_P"&'O#O_0;N/^^J
M]_LV^U68B'_'WZFG6EK/N=96Z4?4:78/;R/G[_AA_P ._P#0;N/^^J/^&'_#
MO_0;N/\ OJOH#_528?D4EQ#)_K4.(JGZE2["^L,\ _X8?\._]!NX_P"^J/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3LX6;UI^V)]F?2,5FVG0XD?>6'%5?LYC;$D9YZ$BO!?&7[2?V>;2?L;+*LC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !2-TI:1NE !VK\IO^"H_P#R7_P3_P !K]6>U?E-_P %1_\
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M\/'7PUTWQW<#5I88V=1MR16!X?\ @/I.DSO=I!&K2#&0*/8ASV/F#1XSJ'Q
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M1R3RGDD<U#XP^#>C^++&&06L8>(9'%9.B5[8^5_BPVF>)OBQI%WX=CD6V6,
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M6J.@_P#(!L/^N*_RJ\M?&(^HC\(^EI*6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7EKXQ'U$?A'TM)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(HY6'.@6*6/)+\4OVH+&21FDDN#)'M H^R[M/=N]58S;UN#HS1B0=#3&N5C
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2EI&Z4
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M#]2-@RK/+NVX4\T>U0>R9UOE&-MH[U,K/&XA;@&N5U+XHVNAPVMY-:L\<PW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&Z4M(W2@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 4C=*6D;I0 =J_*;_@J/_P E^\$_\!K]6>U?E-_P5'_Y+]X)_P"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W
M2EI&Z4 ':ORF_P""H_\ R7[P3_P&OU9[5^4W_!4?_DOW@G_@-;T?XB,JOP,]
MO^'O_)/X?]T5IK_J169\/?\ DG\/^Z*TU_U(K]%P_P */BJOQ#*K:UI*^)M.
M.F$>7N_Y:#K5FDU+5(-)TUYU.+E02*UJ[#H[G,?\,\Z5Y*>9.&D[D]:KW7[/
MNFB16$PVCK7D8^-WBK5O&-WI]FX*1M@"NWO/%_B^STF2>X "!<DUY?4[9;&]
M=? ?0V7F\6/W%36G[/NC+'O^T+(,<,:X[4_'%S+\,I=4#G[6KXKIO /Q,MKO
MPW9?:YAYS#!YJW%,YE)H63]GS3+N<2BZ">6?NCO4]S\ ](N(-[2*C?2NX?48
M([3[6CCR5&YCFL>S^(FB:G?"V\X9Z=::@A\S.7@^ FF1[?*G#DGD"K>K? ;0
MK%H6$Z*Y&2,5U6L>*-+\.PBX#_*U-TCQ1H'C*%W2;=-'T&:UC30O:,Y:Z^ >
MAWVFF8W2QR_K4(_9MM;RQC\B8OCDL*[ZUTMKUC&I)2O'OBA\:O$'@>\.G:,R
M[U;:=WI5.FK#C4=SKK3X Z2MN\<ETL<H&,5EV_[/VE1WX^T70">K5D^$O$_B
MC7I[:\NR/+.&?!KUR\\5>&GTWR;B8"]QT!K)4T=+D<7>? 7054&.>-O]K K0
MT3X?6?A-A]F<2[JT6\5:%IEJCW$I$9Z<U8A\2:3K.U].E#!>N370HI&#1;G;
M]SY13'O3;Z1ET^-5&<&J.H>.-!TUO)O9@)O8U=T>YC\09>U8-;@9Z]JV5C&4
M M[H,JHPY/%.O-\<)BC&<]ZH:AXS\-:;<?999O\ 2L[0,]ZLKXLTNQMS<7<@
M$7UK)J+8*+-".XC33EC&%F[GO6:ML\+,TC%2WW<]ZIZ;KFG^+-09=)D#,.<$
MU>US4%TFRDNM2(5;89_*MHJ([%^SMI_LYE$9\T=*/,8<W-N"?]H5\Z:[\>O$
MGB#6@GA/]Y;*=IXKU7P#XZNA:A_%OR''...:4HQ"QUNI-')+"83M /*BGW4G
MF;<1!8\<D5D6_COPS?7CQ6DV6)P,FK&J>*K#12$NY%$#<GFLN5(J*+5ZKWMJ
MD,0("G.5J6:[62V2#:$=1C(ZUFVGCC2)H]UE("G^T:CC\=>&YYBOFYG!YP>]
M)I%N)J0L+>U:-U\USTW4W5'@DTR-/,\F4'[@K+O/B#H&F2#[3+B3MS5ZWO-#
MU2 :C)*/);GK0HQ,F6(;E888EF;((XW5!/-*;Y$A@W1G^("J.I>,O#>JS0VU
ME+NDC.#@UMPW#>6J6PRY'%=<8Q,AM\ES:VZO! ;B0\%/2I5M8['3W,S[7N%^
M:,]J\H^)'QDU+P?,]M9D?;0<$$<5!\.?B#?^))FEU\X5N5VUC)*YNEH>CZ5H
M5GI5A/+;0()R=P*CFK5K,S0A[EB&]&JK<>._#VAR)Y\NV/'/-6I-4TO4+,:K
MY@.FM]T@UG:)7*-:ZEF;"[G3^56H[I=GV5ADO_'W%8]CX[\/_:#;P3#<3@9-
M:US=:;8J)[AP.,CFH:B'*R+R]LAMP<@?QU/H\P4W"$>8<<9KPWXA?%JY@UG[
M-HD@+;P#]*]4&OPZ;X&BO\XU%X=S?[V*J$H0W(E>)M6EG=B9KD6A$:GKBEO%
MFO)/,2,CZ5\ZM\=O'5OI=_(3']BC8C/?%>I?";Q[?^*O#D5W(5);J33E6@1S
M,[:*\>%6CV^<W3![5':[[>;,R^6A.2?2JC>)]+-UY5M*IN\X<9[U>U35K6RM
MP=4=40C/!K-5H!S,=-Y<UQ^X FI#<!OENHQ;A>F>]9<?C#1/)":+*'N<]":U
M=2O+*.SM[C6W"*<'@XK?VT+!S,<MY:S(8MX68\*OK3(+,Q3$3G8?>O%OB#\3
MK"W^)FCVVA390D C-=J_B74[WQ$!<D" @5A[1!8[&$B[N'1#N"5(LT4D@25M
MAZ5G>(?%FB>$-(^TB4><Z\\UXHOQ9?7-4+V\F8U:CVB$X'T#<6ZQKF-MU5FW
M*O*U@>$=>DU*%"QS733R*RXK1.YDXV(H<2*23@T4J0X4GM25U+X&..P4445Q
MT?C#J6;'K+_N-7Q7\*/^3HM9_P"OG^M?:ECUE_W&KXK^%'_)T6L_]?/]:\C-
MOA/6PNZ/V1T'_D V'_7%?Y5>6J.@_P#(!L/^N*_RJ\M?&(^HC\(^EI*6@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6_#(N+U+GS@K':<UZ+\1/$$UAJS06[E'"#YA7/:-X*\0>+O%FF:IJD,T9M,
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MJC]C]!_Y -A_UQ7^57EJCH/_ " ;'_KBO\JNJ:^,3Z'T\?A)*6DI:8!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $$TC+(H'0U(RB1<-2L
MH/)%#?,O%  JA%P*_*O_ (*B+&W[0G@;GYOEK]5,' K\J?\ @J)'M_: \$,#
MD_*<5T4/XB,:WP,]G\"QE?"D)']T?RK9DN"R(M9'PY26;P?!E&^Z.U:5U9RH
MRG:>OI7Z%"2Y4?&2B[LEN(2NUJ8DCYR*MS0R/&HVGIZ5"L,D8P4;\JKF1/*R
MS#>%%YBC/U6B:[9NB*/H*J_O/[C?E1^\_N-^5',AVD"S.LF[ J?^T3WBC/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 (:%^444;1C% $<LI7&T;B37Y0_\ !53SM'^-_A#5W'[F##<],5^L
M(C .:\?^.7[+?@W]H">VF\30R2/ NU"E7"7+),F2YE8^!?"G[8NF:7X6B4K"
M-H K1D_;2TNXA0@0_G7TI_P[/^$OV0VXBNA'G/WO_KT1_P#!,[X2QH%$5U@?
M[7_UZ]I9A9'E_4]3YG?]M33%D0$0_G4LG[:.E%ND'YU])2?\$S/A+(P8Q761
M_M?_ %Z#_P $S?A*3GRKK_OK_P"O3_M$7U(^;/\ ALS2C_SP_.D_X;,TH<_N
M/SKZ4_X=G?"7_GE=?]]?_7I?^'9WPE_YY77_ 'U_]>C^T0^I'S7_ ,-H:5Z0
M?G2_\-G:3Z0?G7TE_P .S?A+_P \KK_OK_Z]'_#LWX3?\\KK\Z:S)">!/FW_
M (;.TGT@_.C_ (;.TGT@_.OI+_AV;\)O^>5U^?\ ]>C_ (=F?";_ )Y77YT_
M[20OJ)\T+^VAIQD(VP[?K5D_MK:1&N"(!^-?2*_\$T?A.JX\JZ_.HI?^"9/P
MEF()BNO^^O\ Z]']I(/J)\VM^V=I4S9 @_.E7]M+2S\F(/SKZ3C_ ."9OPFC
MX$5U_P!]4?\ #LSX3;BWE77_ 'U1_:2#ZB?-O_#9NE>D'YT?\-G:5Z0?G7TG
M_P .S?A-_P \KK_OK_Z]'_#LWX3?\\KK_OK_ .O1_:2#ZB?-G_#9VE>D'YT?
M\-HZ3Z0?G7TG_P .S?A-_P \KK_OJF_\.R_A+_SRNO\ OJC^TD'U$^;_ /AM
M'2?2#\Z/^&T-)_Z8?G7TA_P[+^$O_/*Z_P"^J/\ AV7\)?\ GE=?]]4?VD@^
MHGS<?VT-);M!^=)_PV=I7I!^=?28_P""9?PF'_+*Z_/_ .O1_P .S/A-_P \
MKK\__KT?VD@^HGS;_P -I:2O:#\Z3_AM+2>F(/SKZ2_X=E?"7_GE=?G1_P .
MR?A+_P \KK_OJC^TD'U$^;O^&SM)](/SH_X;.TGT@_.OI+_AV;\)O^>5U^='
M_#LWX3?\\KK\Z/[20?43YM_X;.TGT@_.G1_MG:1T/D?G7TA_P[-^$W_/*Z_.
MF_\ #LKX2[\^5=9_WO\ Z]']I%1P5CYRD_;,TB-=W[C\ZK-^W%I.=H$!_&OI
M:?\ X)F_"62)@8[H<==U?,_Q"_8?^'WAWQYIVFVLDWV>><(_S=LUTTL<JFQR
M5L'9DT/[9&DS_/\ N,?6I6_;6T>'Y?\ 1_SKZ*L?^"9_PFCLX=L=T2R D[NO
M%*__  3%^$DC;C%=_P#?7_UZQEF4>AK3P+6Y\X?\-F:8_P RK"?QI1^VMIR\
M%(?SKZ6C_P"":?PFB7 BNO\ OJD;_@FC\)F.?*NO^^O_ *]9K,NYM+!7/FK_
M (;0TIN2(!^-'_#9VD^D'YU])'_@F;\)F.?*NOS_ /KT?\.S?A-_SRNOS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5_.CSDS_ *Q?SKX__P"%H^-!Q_95S^1I?^%I>-/^@5<_D:/[._O![1]CZ_\
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M+W_#+,?_ #UG_P"^J/\ AEF/_GK/_P!]5]0X-&#1_:57L'U./<^7O^&68_\
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MYNE3'<;&TZFTZM&2A:***104444 %%%% !1110 4444 %%%% !1110 4444
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M_P"AF3_OG_Z]'_#;WPA_Z&9/^^?_ *] 'NNWWHV^]>%?\-O?"'_H9D_[Y_\
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M?]\__7H ]UV^]&WWKPK_ (;>^$/_ $,R?]\__7H_X;>^$/\ T,R?]\__ %Z
M/==OO05]Z\*_X;>^$/\ T,R?]\__ %Z3_AMWX0_]#,G_ 'S_ /7H$=+\=KI;
M?PM<[T#?NF_E7$_L=W F\(ZHR1[1YYZ?4URWQ7_:V^%/B;09;>#7%F;81QQ7
M-_L[_M4?"SP+X;OK>XUI82\I?G\:[G_"2//BOWES[-DN#%"'VY/I4RMYD:MT
MS7A2?MJ_"6Y@#IXA1_\ 9Q_]>D'[;GPC48;Q(BD=MO\ ]>N"1Z,3W4*?6G%?
M>O"?^&W?A!_T,R?]\#_&C_AM[X0_]#,G_?/_ ->E%#9[IM]Z=M/K7A'_  V[
M\(?^AE3_ +Y_^O3O^&WOA#_T,R?]\_\ UZMD(]UV^]&WWKPK_AM[X0_]#,G_
M 'S_ /7H_P"&WOA#_P!#,G_?/_UZ11[KM]Z-OO7A7_#;WPA_Z&9/^^?_ *]'
M_#;WPA_Z&9/^^?\ Z] 'NNWWHV^]>%?\-O?"'_H9D_[Y_P#KT?\ #;WPA_Z&
M9/\ OG_Z] 'NNWWHV^]>%?\ #;WPA_Z&9/\ OG_Z]'_#;WPA_P"AF3_OG_Z]
M 'NNWWHV^]>%?\-O?"'_ *&9/^^?_KT?\-O?"'_H9D_[Y_\ KT >Z[?>C;[U
MX5_PV]\(?^AF3_OG_P"O1_PV]\(?^AF3_OG_ .O0![KM]Z-OO7A7_#;WPA_Z
M&9/^^?\ Z]'_  V]\(?^AF3_ +Y_^O0![KM]Z-I]:\*_X;>^$/\ T,R?]\__
M %Z/^&WOA#_T,R?]\_\ UZ /="RKG')I(_GR66O"E_;8^$&XE/$B%C_L_P#U
MZ]#\ ?%SP]\5-/N+CPY>+>+'P2#0!V$R"9?+Q\M/AV1J(U.=M5;.66.WW7(V
MG-3PPIO,J'.Z@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD?\ WW7Z"[B(]Q],XJ..3SU.&VF@#\_O^';"_P!R/_ONC_AVRO\ <C_[ZK]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+'<?M[_^A&@#],Y TDBQ/RN*GB95/EJ,;:7 V@XYQ3E4=<<T .HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH _([_@D;]S4?\ KO7ZW_Q#Z5^2'_!(W[FH_P#7
M>OUO_B'TH 9'_K&IZTR/_6-3UH =1110 4444 %%%% !1110 4C$ <TM,F4M
M&0.M  S!1D4DFYHS@4QOEC4'K4F\+M![T 16\11=S<&I^OO7'_%;Q4/!_@^Z
MU#."@X-?$6B_M&>/?&_CJ33M(OY/LZR8VCTS0!^@N9BVTK\IH: 0J67K7*>%
M=0O])\+K<:[=+YYCW?,<<XJ#0_B5IM_=?9Y+N(MG'WQ0!V,<:HWF9RQ[4Z>W
M\YD;TK)UWQ9I?ARS6[N[B-87^ZQ88JE8_$#3]7L9[BTD5TC&25.: .H=BJ\=
M:BNKN*TA$EPP1?>N(TWXO:+-(89KA4ESCEA7SW^W1^T0?AWX'T^;2KC;)<S"
M,,A]:5QV/K*#4+;5T9;:02;>N#4D-O'9(7D; 'K7S3^R7KFMV?@V77?$^HI+
M;740ECRW(!&:]#\??$./Q1X!O9_#MVJSJ2H;<.M.X6/5+?4H;J0I$P8_6IEB
M,:N0,MVKYL_9V7Q9+KLL^LZI'+;!2=I>O8'^+FAMJC:;'.K76[8,,,9H$=9;
MS7&[,RA5]:=% _VII<CRSTYKR']H[XI2_"/X87^MSR%C&NX%*^3-+_:R\82^
M$+3Q.MY(NDSM\JGTH _1AV/(CP6ID?G;?F"YKXFA_:2UWQUX3N=2\/S21/8Q
M;YV]<"O//A;^UAXY\?:Y]ECO)619-A_.@#]%_-N/,QMXJ<PA@"W!KFOA[)J-
MUH,$^HONE89YK?N)FCD [$T 644*,#FG4U""O%.H **** "BBB@ HHHH ***
M* "BBB@ IDW^J?\ W33Z9-_JG_W30!^2'C__ ).6D_[" _\ 0J_6/0_^0'IW
M_7O'_P"@BOR<\?\ _)RTG_80'_H5?K'H?_(#T[_KWC_]!% %^BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT/X1S6_P+U#PUL;S9OX>]%@/@M?CWKW@FX\VVN9IEN#Y6U6/RYXS7T+^S_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:EX.3X9_%[1]/75%U&>1AMN0V2*]G^(G[)NLZ(MO<^'H)?M#G,GE\5J?#/\
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M"\ :'+H'A^VM9<[D4 YKI&'S"@ VG=G-.I*6@ HHHH \X^/G_),]<_Z])/\
MT$U\"_\ !)'_ )#7C_\ Z_W_ /0C7WU\?/\ DF>N?]>DG_H)KX%_X)(_\AKQ
M_P#]?[_^A&@#]/O^68^E.7[HIO\ RS'TIR_=% "T444 %%%% !1110 4444
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MSAOB,22*0.>] 'UA'^\D\P<#I277F2+MB.#GFLR'Q7I<FEI>2WD5O"R@EV8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q1_P %&/\
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M _3[_EF/I3E^Z*;_ ,LQ]*<OW10 M%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCVT[>;=1K/)_>8=*N*J0P@( J#H!6)X@\0):Z7+- P9E]ZS?#/C*#5(5CN9
MC?6@#H[>U*222GGO4I;[9"R_<;H*ACU2.XD5+5EDP<'FGWTT5DOGS,$C7J<T
M <A#\+M/CU^35;B)+B1NN1S77:?8VE@K?9K=81WVC&:EL[B&]B6XA??&W0YX
MJNVO6$=QY/GKYI.-N>] %6[T.WU34([N9 3'P U:C0QM"%P$3TII95D!E.UC
MT%.EC^T<9PM ",R?*K)N Z&N/\8_#^R\3ZI#=W$*3*@Y4BNV5 J!:1$"\=:
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M*<OW10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?'S5[_PS8Z1H$S1ZL\(1F[;\5P\WQS&M>&=-\%-)L6U8(;@G@UV[>!= \/\
M]G7+ZM;3RS*&W;Q\E "?#>T^+/AGP7+J_B"]$T8)8!3DXKS7P?XU\=?$?XH7
MEB;ORK2-\KYIVBOJZW\5>'] \%O)=:U;7T2CFV,@.?PKY!^-WC*U\2:A;_\
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M6@ IDW^J?_=-/IDW^J?_ '30!^2'C_\ Y.6D_P"P@/\ T*OUCT/_ ) >G?\
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MM% %273[:]C03VT;@#A64$"FKI=E:KF*R@!_V8U']*NT4 0+;QLF1$L;?[(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,8VA?2K\T;/'YH'[Q1D"K5% %6U5Y0)91M?TJU110 4444 ><?'S_DF>N?\
M7I)_Z":^!?\ @DC_ ,AKQ_\ ]?[_ /H1K[Z^/G_),]<_Z])/_037P+_P21_Y
M#7C_ /Z_W_\ 0C0!^GW_ "S'TIR_=%-_Y9CZ4Y?NB@!:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>:?KA\23W6AZ4MUM^8;4H ]%^*WC#QII/BK1;G3[RZ-MJ$@8QQYPH)Z5Z?\
M$2S.L?"J5M3C+7[*"))!S7D/@/XJ>(=5U^SM?$>D);FW<+'O6O:OCCXB@N?
MLF-L4NT81>* /5_V?[<6?PKTB'/W5//Y5Z(F?PKS;X#RFZ^$ND[3EMO/Z5Z1
M"P9 ,\CK0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3
M)O\ 5/\ [II],F_U3_[IH _)#Q__ ,G+2?\ 80'_ *%7ZQZ'_P @/3O^O>/_
M -!%?DYX_P#^3EI/^P@/_0J_6/0_^0'IW_7O'_Z"* +]%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAD)#2 DUXOX&F\0? 769[R]TW]W=-E#(O6O=/$'C_6OBA\)]3B73%S(F/E%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!?[_\ H1H _3[_ )9CZ4Y?NBF_\LQ]*<OW10 M%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\CO^"1OW-1_P"N]?K?_$/I
M7Y(?\$C?N:C_ -=Z_6_^(?2@!D?^L:I%J./_ %C4]: '4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4R;_ %3_ .Z:?3)O]4_^Z: /
MR0\?_P#)RTG_ &$!_P"A5^L>A_\ (#T[_KWC_P#017Y.>/\ _DY:3_L(#_T*
MOUCT/_D!Z=_U[Q_^@B@"_1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!^GW_+,?2G+]T4W_ )9CZ4Y?NB@!:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /R._P""1OW-1_Z[U^M_\0^E?DA_P2-^YJ/_ %WK];_XA]* &1_ZQJ>M,C_U
MC5)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,F
M_P!4_P#NFGTR;_5/_NF@#\D/'_\ R<M)_P!A ?\ H5?K'H?_ " ]._Z]X_\
MT$5^3GC_ /Y.6D_[" _]"K]8]#_Y >G?]>\?_H(H OT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!\4?\%&/^0#:_\ 7(UUG_!.7_D@X_Z^#_6N
M3_X*,?\ (!M?^N1KK/\ @G+_ ,D''_7P?ZT ?52_=%1S.NW8W\7%2+]T4V2,
M.IXY[4 1PV_V>$K'U[9KX(^/FJ:-=>/]2M_%1E>S1B56,FOOFW5E3#')KX=\
M=3:9I/QLUBX\0:;_ &A8,QVHXR* .*^!WB#1QXOMAX.:6*PCE N/.)'&:]L^
M//[5O_" >(K6QTZ?]QY:[MO/->/_ ! FT_7-2LH? .E'1FD.)&@7&?RKB]1^
M&.HR>/+2S\12&=I #YDW:@#[&\/_ +3VCZIX%@OA*WV[9E\UY5<?M@:EKFK/
M_9,C?9+1O](X["G^(OA';>$?!EK=6;QW"/@>7&<UT'PO^&NAR?#[Q)>'2%AG
M$#,25Y8XH ],\.?'W1M:^'\_B.:7]Q ,.>^:^9/C3^TA?>)H4C@=SHSOB/ J
M*UT.]_X4CKD]K$Z6B3,#"H//)J'_ (3[PM=?![2=(;PYNU2-@&EV\T >O_ >
M:RL_!&I7=R6_>P[AD^U=OX#\>6OAOX::GK0?_1H)&R3SZUY]\.X7D\"WR+;-
M&)(,(N.G%<SJ%CJ>G_ 77;012.7D)" 'UH Y?XV?';5?$>FQ75J[FQDDPI ]
MZ]6^!FK177@F\N+AFW>1D_E7EEE\1_"^G_!73-(N] %QJR-AOERV:]%^$GF1
M^#=6E-D\,<T),<97':@!GBGPGX9\6?!S6]0F#->1N0K9]Z]F_9GM(K/X/Z3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\CO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4R;_5/_NFGTR;_ %3_ .Z:
M /R0\?\ _)RTG_80'_H5?K'H?_(#T[_KWC_]!%?DYX__ .3EI/\ L(#_ -"K
M]8]#_P"0'IW_ %[Q_P#H(H OT444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!\4?\%&/^0#:_]<C76?\ !.7_ )(./^O@_P!:Y/\ X*,?\@&U_P"N
M1KK/^"<O_)!Q_P!?!_K0!]5+]T44+]T4M $?EGS,@\4[!W'GBG44 1HA&X,<
M@TGD[1A/E%2T4 07$4DD:A&VMW-.:W615$@W$5+10 Q8U1=H&!3MN!@<4M%
M"8R,'FHWAQ&5C^4^M2T4 5K>QCA8R;1YI'+4EO;R)([2MO!/'M5JB@!NW(YY
MI0-M+10 4AY%+10 U5P<TZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \X^/G_),]<_Z])/\ T$U\"_\
M!)'_ )#7C_\ Z_W_ /0C7WU\?/\ DF>N?]>DG_H)KX%_X)(_\AKQ_P#]?[_^
MA&@#]/O^68^E.7[HIO\ RS'TIR_=% "T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'Q1_P48_Y -K_UR-=9_P $Y?\ D@X_
MZ^#_ %KDO^"C)_XD-K_UR-=;_P $Y?\ D@X_Z^#_ %H ^J5IU(OW12T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G'Q\_Y
M)GKG_7I)_P"@FO@7_@DC_P AKQ__ -?[_P#H1K[Z^/F6^&NN!1D_9)./^ FO
M@;_@DC_R&_B!_P!?[_\ H1H _3W_ )9CZ4Y?NBF_\LQ]*<OW10 M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?&7_ )XR?]]&@#]%_P#A=G@K_H/VO_?5'_"[/!7_ $'[7_OJOSH_X8R^,O\
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M_?5?G1_PQE\9?^>,G_?1H_X8R^,O_/&3_OHT ?HO_P +L\%?]!^U_P"^J/\
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M_A=G@K_H/VO_ 'U1_P +L\%?]!^U_P"^J_.C_AC+XR_\\9/^^C1_PQE\9?\
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MH_X8R^,O_/&3_OHT?\,9_&7_ )XR?]]&@#[D^*WQ=\#MX!\0!=>MY99+.0!
M^>=IKX>_X)-ZB8?$'CY[<>;%+?N58>FXU5D_8G^+-_#/#=0R%'4J?F-?1?["
M'[+FJ? &TU7^TK?RI+F3><T ?7_G2R0C*;215F'/EC/6F-(QX7K3X]_\5 #Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "OGC]G?_D=;W_L'O\ ^C(J^AZ^>/V=_P#D
M=;W_ +![_P#HR*O5PO\ N];T7ZGEXK_>*/J_T/H>BBBO*/4"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 1J1J5J1J3V&A5Z57O?^/.Y_P"N;?R-6%Z5!>?\>EQ_
MN-_(T1W1#/C'PROE_%2X][G^M?9,?^HB_P!T5\>:*NWXH2G_ *>?ZU]AV_,$
M7^Z*][-?AAZ'!#=EA?NT1]_K0OW:(_ZUX$/A/27PDM%%%4(**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "OGC]G?_ )'6]_[![_\ HR*OH>OGC]G?
M_D=;W_L'O_Z,BKU<+_N];T7ZGEXK_>*/J_T/H>BBBO*/4"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 1J1J5J1J3V&A5Z5!>?\ 'I<?]<V_D:G7I4%Y_P >=Q_U
MS;^1HCNB&?&NB2%OBE*#_P _/]:^Q;?_ %,?^Z*^.=#_ .2I2_\ 7S_6OL:W
M_P!1'_NBO?S7X8>AY\/B+"_=I4H7[M"U\_#X3TUL244450@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *^>/V=_^1UO?^P>__HR*OH>OGC]G?_D=
M;W_L'O\ ^C(J]7"_[O6]%^IY>*_WBCZO]#Z'HHHKRCU HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBHY)EC(#'!- $E%(K!AD4U959BH/(H ?12!@:6@!&I&I>#Q3=P;I28QR]*@O
M/^/.X_ZYM_(U,&YQ5>[8-:W('41M_(T1T:)D?&VA_P#)4I?^OG^M?8UO_J(_
M]T5\;Z.XB^*4H;@FYX_.OLBW_P!1%_NBO>S36,+=CSH?$65^[0M"]*%KP(_"
M>FMB2BBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C,%Y-*X"T4U6
M#<BD\U<XS1=,!]%)NJ-KA$.">:8KHEHI@D##(Z4W[0BR!"?F-.PN9$M%(32;
MJ10ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J
M-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;N
MHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NI=U "T4Q
MFQ1Y@H'9CZ*8'I=PSBIYDPL.HINZD,@7K5;!8?13=U&ZC<!U%-W4;J!#J*;N
MHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZOGC]G?\ Y'6]_P"P>_\
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M1110 4444 %%%% !1110 4444 %%%% !1110 444E #5;+$4V2%9&!/:B/\
MUA--G8[@!0!+PB\=*JW<JVRAP/F8U97Y4^8\5#'"&D9C\R=J %:8($XY:IAQ
MU-0V\PG9@5QMIEQ:-))YBN1_LT 3E@S$#K3-IC5CWI\:_)[U%<;MZX'%2OB&
MMPCDPA=J9<LOV.X<#K&W\JEDCWQ[1Q4$@_T.>/N(S_*KE:Z)GL?&=N"/BMG_
M *>?ZU]GP?ZF'_<'\J^--OE_%9/^OG^M?95O_J8?]P?RKVL=M#T//ANRSVIL
M?WC]:=2*,5X9Z2^$DHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:/J+_F0?7'V/M3[5#_SU7\Q1]JA_YZK^8KXK_P"%B>/O^@1=_D:/^%B>/O\
MH$7?Y&CZB_YD'UM]C[4^U0_\]5_,4?:H?^>J_F*^*_\ A8GC[_H$7?Y&C_A8
MGC[_ *!%W^1H^HO^8/K;['VI]JA_YZK^8H^U0_\ /5?S%?%?_"Q/'W_0(N_R
M-'_"Q/'W_0(N_P C1]1?\R#ZX^Q]J?:H?^>J_F*/M4/_ #U7\Q7Q7_PL3Q]_
MT"+O\C1_PL3Q]_T"+O\ (T?47_,'UM]C[4^U0_\ /5?S%'VJ'_GJOYBOBO\
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MXZ3Z'VM]HA7_ ):I^8H^U0_\]5_,5\6M\1/'K8QI%W^1IO\ PL3Q]_T"+O\
M(UR1P+MN;_7'V/M3[5#_ ,]5_,4?:H?^>J_F*^*_^%B>/O\ H$7?Y&C_ (6)
MX^_Z!%W^1J_J+_F%];?8^U/M4/\ SU7\Q1]JA_YZK^8KXK_X6)X^_P"@1=_D
M:/\ A8GC[_H$7?Y&CZB_YD'UM]C[4^U0_P#/5?S%'VJ'_GJOYBOBO_A8GC[_
M *!%W^1H_P"%B>/O^@1=_D:/J+_F#ZV^Q]J?:H?^>J_F*/M4/_/5?S%?%?\
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MM4/_ #U7\Q7Q7_PL3Q]_T"+O\C1_PL3Q]_T"+O\ (T?47_,'UM]C[4^U0_\
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M/^%B>/O^@1=_D:/J+_F#ZX^Q]J?:H?\ GJOYBC[5#_SU7\Q7Q7_PL3Q]_P!
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MHO\ F#ZV^Q]J?:H?^>J_F*/M4/\ SU7\Q7Q7_P +$\??] B[_(T?\+$\??\
M0(N_R-'U%_S!];?8^U/M4/\ SU7\Q1]JA_YZK^8KXK_X6)X]_P"@1=_D:/\
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MD7V&W_YX1_\ ?(H^PV__ #PC_P"^14M)1>8>SB1_8;?_ )X1_P#?(H^PV_\
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MD?V&W_YX1_\ ?(H^PV__ #PC_P"^14E+1>8>SB1?8;?_ )X1_P#?(H^PV_\
MSPC_ .^14M)1>8>SB1_8;?\ YX1_]\BC[#;_ //"/_OD5)11>8>SB1_8;?\
MYX1_]\BC[#;_ //"/_OD5)2T7F'LXD7V&W_YX1_]\BC[#;_\\(_^^14M%%YA
M[.)%]AM_^>$?_?(H^PV__/"/_OD5)11>8>SB1_8;?_GA'_WR*/L-O_SPC_[Y
M%24M%YA[.)%]AM_^>$?_ 'R*/L-O_P \(_\ OD5)2T7F'LXD7V&W_P">$?\
MWR*/L-O_ ,\(_P#OD5+247F'LXD?V&W_ .>$?_?(H^PV_P#SPC_[Y%24M%YA
M[.)%]AM_^>$?_?(H^PV__/"/_OD5)11>8>SB1_8;?_GA'_WR*/L-O_SPC_[Y
M%/DR5^4X-8WB3Q1#X6TV2[N(VE6-2Q"CGBB\Q^R3V-;[#;_\\(_^^11]AM_^
M>$?_ 'R*^;;C]N[PG;RW*/IEXGV=BK,R\?RKV'X?_%;2OB)X+'B6S/D67/\
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M.)']AM_^>$?_ 'R*/L-O_P \(_\ OD5+11>8>SB1?8;?_GA'_P!\BC[#;_\
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ME+?%2)55@%N?3WK[+@CQ##_N#^5?D--_P4$U2/Q[#=_\(@X!GW?=]Z^@YO\
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MCH!5_P#97&[X4:<W:O+OCA^T;X"\9>!;[2['Q#92W,H^54D!)J?X#_M%>"/
M_P /++3-1UVS@EBZ[Y *[Y7]GRHX8Q]Z[/JW[WX4K,-N>M>+C]K/X:7"D?\
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M\>_X:M^&7_0W:?\ ]_EH_P"&KOAE_P!#=I__ '^6J15CV*BO'?\ AJ[X9?\
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MG[@J[<?L8^!IY59D;(&/NBO?0V[-(B@G<>M '@"_L5^!E<G8_P#WR*/^&*/
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M#97_ )#.H_\ ?T_XTD/_  2-\-*>=8U$?]M3_C7Z3;J0FKA*VQG)7/SNT?\
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MYH _-O\ X= ^%?\ H-ZE_P!_C_C1_P .@?"O_0;U+_O\?\:_23FCF@#\V_\
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M-'- 'YM_\.@?"O\ T&]2_P"_Q_QH_P"'0/A7_H-ZE_W^/^-?I)S1S0!^;?\
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M_C7Z2<T<T ?FW_PZ!\*_]!O4O^_Q_P :/^'0/A7_ *#>I?\ ?X_XU^DG-'-
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M3*S3KD[:8':I(I^56W$=:?5&PM6MY968_>-7J "BBB@ HHHH **** "BBB@
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M]F3XX>+O&7Q/\6#4XMNB6-RVR0G^ 'K7O?QR^(&E>)O 5V?#][Y]\!@*A[T
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M%K\,_#%JUTT>D6VZZ.93L'S9IH#\=M;U*3QA\,]5-[97$FL"7"-L.>M?I/\
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M? KX?O\ #WPZMA)+YA1 N?I7I2R #YC@T 2T4@8-T.:"<4 +129I: "BBB@
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M 'T$*6FJ"!S3J "BBB@ HHHH **** "BBB@ HHHH **** /S<_X*V?\ '_\
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M10 4444 %%%% !1110 4444 %%%% 'G?QV_Y)_J'_7)_Y5_.+\5/^2C>(?\
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M@P-Q->8^#O#_ ,2?"MG/9S:!YHF&T-(F361J7PE^)27W]J)I<Q53GRL';^5
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MGL?"]G:W-NL#QQA3@8/2@#M<YZ4M,CC$8X.:?0 4444 %%%% !1110 4444
M%%%% !1110!^;G_!6S_C_P#A_P#]?:_^A5]D_LT_\DUTS_KWC_\ 017QM_P5
ML_X__A__ -?:_P#H5?9/[-/_ "373/\ KA'_ .@B@#UB/[M.IL?W:=0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7X\?MU?\ ):K#_L(K_P"A
M"OV'K\>/VZO^2U6'_817_P!"% 'ZP_#/_DGOAW_KQA_]!%=%_P M*YWX9_\
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M>K_$3]K/3-#TNVET=XKR[>/<T;#.&]*\+TGXHVWQ<\;))XKBBTRU;AI47!%
M'1^%;RQ\>?%^_OKL)-;RR96)N>]=A^U-X/T+2;?2[ZRM(=/N8H]R,H"DFN'^
M*7_"$_">SM]7\%:K_:.I,^6CW9K$L_BE'\>M2TV+QG+_ &;;6V%!7C(H TOV
M<9++QC\1K=M6MEOYQP/,&3BNP_:+\#Z-;^(;4V"PV$GGKYBJ .,BN(\6:AI/
MP1\71ZYX'G&I)&G?D5F:;X^M/C!J-]J'B&Y-I=[#((U.!NH ]Z^*&O>%-%\
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M41OS[5A_#[1_B!\)?$%QH.G:6T^B7\Y>6X89VY)_QKT#P?\ #G5+/XJ3:K+
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MW[:5EX%\4/I-QH[,%?89"2/QH ^E&MH;G:S1J2O3(I[*&_=E5*$=,5R?P_\
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M/_X?_P#7VO\ Z%7V3^S3_P DTTS_ *]X_P#T$4 >L1_=%.IL?W13J "BBB@
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M*QYM8T_2;H07NH112-R%D8#-:\$T<\2O"RO&W1E.0: )**** "BBB@ HHHH
M**** "BBB@ HHHH *\E_:J_Y(/XJ_P"O8UZU7DO[57_)!_%7_7L: /B__@G+
M_P C2OU;^=;W_!6+_CT\"_\ 7T/_ $*L'_@G+_R-*_5OYUO?\%8O^/3P+_U]
M#_T*@#Z:_9)_Y)I:?]<T_E7N5>&_LD_\DTM/^N:?RKW*@ ILCB-2QZ"G4V1E
M5"7.%'7- %<K#(OG%:D6,*NY!C-?-7Q(_;)B\"^/)/#-IH4FI2IWB!/\J]%^
M%/QKD^)'F)<:1+I6U>LH(_G0!Z9);K<2!VYQ3RBP?/VK.M]4T^Q9D?48G=C]
MTN,U4\3^,-.\+:2=1O+F..#.,N<"@#4>X-X0L/!4\YJR\@CCPW)Q7)Z;\2-)
MU;36NM.FCN#MW8C(-4M#^)$-YI.H7UY']GCMB<M)P* .XBV>7O H=1/@>E<A
MX5^*WA_Q+'B#4+<MG&T.*Z^.2.2,R1.'7&<K0 YU2-=Q'W:;%,ETIP.*J0ZM
M:R!UDF1"#C#'%3K)!Y#-$ZD*"WRF@#R3XE?!'_A/KH_:%#P[L@9KCY/V6[;3
MXPMM H0CYL5KZ7^U=IEY\0+[PO+ L4UN^P2,>IKU[5-<3PSX9N]9N9/,BCC\
M[!/&* / K7]E&PBN/MRV_P"]]S3W_9-TRXF:=+=5G;[QK:^&O[6VD_$CQHOA
M^TLPKDD>8&S7M.H:SIRS>0^I16TJ'E=P!H ^=3^R=81R#S8-TA^Z<\5.W[*=
MM"FZ2)2/]DU] ZMK"0Z#=7<1\TQ)D%>]>5^ _C%<^(/%(TR>!PN3RU '*6_[
M*>E@,]Q;[E8?*"<TMK^RO8P6TZ20+YK_ .JQVKV#3?B4FH>*+G2#9LGDG'F'
MH:Z>^ADGEAF23:B\D4 ?-&F_LLWL=QLN0K6N?NYS6@?V5=/M9B]M;A7;AC7T
MB^;B$['VGUIJN8HPARS?WJ /G2;]DW1C&8Y+529?O8JC8_L?:78W@46X^Q]2
MN:^E;.![=F,DGF[CQ[5.T^V8(1QZT ?,LO[).D37C[K4>2.4J1/V5XI.)(LP
MK]T9[5])&\_>E A('>A69LDMM'I0!\U/^R-IMPWFQVZJWY4^W_9CLY&:V-NN
M5ZFOI*9)+B$A',5.AC6UA&X[GQRWK0!\S+^R7:^<6CA51GGFI/\ AD73%NUN
MWME,J^E?1;O-=S*8RT:J>?>M#JO6@#GO _A>+POHL-I&NT(,8KH I(8'O0&X
MQ5>.9_,P0<4 2QE8FV=ZFIGR[AG[U/H **** "BBB@ HHHH **** "BBB@#Y
M0_X*2_\ )M/B/_KG7*_\$M_^3=M'^IKJO^"DO_)M/B/_ *YURO\ P2W_ .3=
MM'^IH ^V:^7?^"BO_)M/B7_KD:^HJ^7?^"BO_)M/B7_KD: /.?\ @EA_R0W3
M?J:^Y5^\U?#7_!+#_DANF_4U]RC[S4 ,D5^QXI8U"KN/WJ$8KG-(J_O"Q/'I
M0 V.1+AB&0';ZBH;G[5'.AAVB ?>&*\D^,G[1%K\*6B1+'[;([8V+UKCO"O[
M8D?B#7+6ROM'?28Y2/FFR/QYH ^E5F5ES44?D1R.8UP[=>*YCQ-\0+31-!CU
M6U"WD+D#]V<]:T]+UF/6M+MKYA]F$@W$&@#7\[#!) ,GI4:WR_;/LX'3O56;
M4;&\^2&[C:8< *P)IOV^QTV,?:;B-)^^X\T :4L$4C*SHI*G()%</XR^%NF^
M,_$5EJEY$)&ML &NQ6\#P^:HWQ$9W]L>M9L6JZ9<70":M$6SS%O% &A9Z?%9
M6JV]NH6$#&,4L=O;V\FY5^<UQ>H_&#0K/Q4=!EO889?[S.*ZTZE9VMM'<-.C
M0OTDSQ0!H38\O.!GM4:J+B'$H##W%4H]4L-1G3[/>QS'^ZC U+>26]JVZ:Z6
M >C'% %B.'&58 QKT&*\W^*'P3T'XINL]_;B2:(84UZ+;ZC:31YCN(Y% Y(;
M-4VUS2FEPNI0(P/*B04 >(^!?V5/#7@WQ NKM9@,O2O=K.+R8Q'M7[*!A 13
MH=2M;QO+CE688_A.:\T^*OQPLOAEY0O$6-&;"ECC- 'IUR6A 90!&.H I]O,
MES#NC&%KDOAK\1K/XEZ2]W;(!&N,X.<UYQ\6_P!JO1_A+XD_L66U6>8$# ;U
MH ]SA:-I&51\W>G1[8]U8?@WQ=;>+/#-EK2J(4NE!"FM>>XB61 9  U $Z2*
MW2HQ($D.:BO=4M--MS--*B(.Y-<]KGQ,\/Z':K/+?V_S?[8H Z?;(6!SQ4K9
MV\=:YGPK\0M'\50O):7T+[3T#BM'_A)M.%^+;[9&9".FZ@#5&=OO57=(%=)#
MDMTIMQ+%&/,:X5$ZYSQ45OKVF7T@AAO899>@56&: +%K9I;\L1O^M2?:4WE>
M]>'^-OBI)X<^)L6B2R%(V&<D\5ZUX>\1:=K%LHAN8Y90,LH/(H V$C !!Z-3
M6M4VD*,&J%QXHTRUD\N6[C1NF"U6K>1+Q1/!,)(_530!8B4JH6F- @RS#I7G
M_CCXPV?@NYBAN H,CA.3762>)K&.SLKB>XCA2Y4,-QQUH TU,6WS0.E/VI.H
M;'%5K?4K.\PEO-'*#_<.:+[5[/2T'GSI&.@R: +,;K*I4=!Q4;7$=O((P.:J
M_P#"0:=''O\ M,84\]:?;7=IJ'^D13*ZCN#0!;:))ERPS44;!7VQ\#O57_A)
M=,6X:!KR))!_"S 5A>//%\7A?1)[V$"?:A;Y#F@#J)$F-TK*?W?>K->;?!?X
MF/\ $719;HV[1A'*Y->DT %%%% 'G?QV_P"2?ZA_UR?^5?SB_%3_ )*-XA_Z
M_'_G7]'7QV_Y)_J'_7)_Y5_.+\5/^2C>(?\ K\?^= 'Z&_\ !(W[FH_]=Z_6
M_P#B'TK\D/\ @D;]S4?^N]?K?_$/I0 R/_6-3)(2UPC#H*?'_K&IS,?NC[W:
M@#Y(_;DT*VU'PU,UW,T,)89(-0?L^?#_ ,!:3\/;2ZLO$4DNH/#\T/F=#Z8J
M_P#M46,_B!9]+N4:6(\X45\R>';/5?!]P([..9(5[8- 'M4/PTL?%WQ5TR74
M9V81S_NU8Y##-;6N>"+?3?VH+6RLV,<?D@^4O Z>E<3H/Q >TO;?4IX9O/MC
MD'::NK\2IM0^(J>,&BF,B+LW;30!WG@FUT.U^+FLVVKP06YW860J,D_6M+XB
M:!)I_P 4?#7V&1I;>20$<\8KP7QYKNJZYXD.KZ?'*LCR;V.TUU,GQ,U::\TN
M[N%E,UF!@[3VH ] ^*FBZ5:?&ZUNM9BCAM?+4&1@*9\=_!FF^'?"MGK^CS[8
M9#N1HS@&O+OBQXPO_B1'YBQRF[X ;:>U9OCCQMKFM_#C3?#@64R6XP?E- 'I
MWP 6;XMWR7^I,QCTU@!N.>!7U/9Z]H7]L1V=O)&+D+@!17PW^S7XBU;P!J0T
MR[201WS@'Y37V=H_@FS36H=65"&VYH ^9_VU?BMJMG]CT_P]']KO$G :,?45
MX]XVUOXKMJGA35[GPU]EL+95>254QQZFOO/5/@OX8U;6FU6]M?,F+;P3ZUO>
M(-*T_7]%?29(@T13RU7;T&,4 ?%6BZEI7QD^*EB][<_Z1L"F+MFNH^+G@.U\
M"SV\FE?+(T@#;!CBO:O _P"S9X<\&Z\NLQVVVZ4Y!KIO%WPWM/$7G22Q[LC*
M?6@#XQ^.?BZY\+0Z(MF@O9)D!82<X-7?"?@.WUGPV?&%U(;35(_NP)P*YO\
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M-7OV?_"_B_6_BQXA\1ZJ2;6\A;;N'J#7J7P'\*W_ (8\5ZS/(F(9)RQR.V:
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M5,T)#C;3)+<&-5!SBI68R+\M.7Y5YZT 'RH@!XXI$PRX4Y%.($G6A4$8P.E
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M27<,#WKF+OQAXX^*0M]'>1VM&41LI% &UH?BS4-'^"-FRAKB/S0N]^>]=_\
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M.G6O2_VB/@?XEO/$/AP:,-L)C7S=M=-XL^%>L6'P;%B$S?;AVYH M2?$2_\
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M-#UY&M[:499V-%YX)UK4?'L,T2CR8Y\MQVS6UXW^&WB#5O']I+886(1X..*
M/%?C-XJUBW^)&I1:)+)/;PDL"K&MKX/_ !FU3XB>'=;T_4DYMD*'-<YKVBZO
MX5\>:HNH1O()%* A<UI_ OX3ZY;VOB*XB0Q_:]S)N&.M 'TM^S1']A\&SJJC
MR?-+%J]D1Q(H93D5Y/\ L]^'M1\.^$YK'5.79R17K$<:Q*%48 H =1110!YW
M\=O^2?ZA_P!<G_E7\XOQ4_Y*-XA_Z_'_ )U_1U\=O^2?ZA_UR?\ E7\XOQ4_
MY*-XA_Z_'_G0!^AO_!(W[FH_]=Z_6_\ B'TK\D/^"1OW-1_Z[U^M_P#$/I0
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M![7129XSVI%D#$@'F@!U%)0#GI0 M%%% !1110 4444 ?FY_P5L_X_\ X?\
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MIHELBHJ\Y45UW1<XR:@CM09O./WO2@ DE6UC1#SGBI((Q&O'?FH)K7[5)E^
MIXJVORJ!Z4 +7,_$S_DGOB/_ *\)O_0#735S/Q,_Y)[XC_Z\)O\ T T ?EE_
MP39_Y*9XI_[";_\ H1K]<6^[7Y'?\$V?^2F>*?\ L)O_ .A&OUQ;[M 'RE_P
M4$_Y)[9_[S5S?_!-'_D2-=_Z["ND_P""@G_)/;/_ 'FKF_\ @FC_ ,B1KO\
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M?^A4 ?37[)/_ "32T_ZYI_*O<J\-_9)_Y)I:?]<T_E7N5 !36;:I-.IK?=-
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MF9=I]*)O-CQY2AAWH S['2]-TLK%:621#I\JXJU)I<?V@2H CU90AE)3!?\
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M*Q/!FN2Z_H\%TZX61 RMZUM285@YX44 2[1Z4M,$F]0R<BG"@#Y1_P""DO\
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M'G:,C'M0 ZBBB@#SOX[?\D_U#_KD_P#*OYQ?BI_R4;Q#_P!?C_SK^CKX[?\
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M\;/BF_B35+6?P[X;GTR:7YGDC0CD]Z -%OACXR^#/P]-S:R_Z*O4(V3S77_
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M[3SS0 I&: -M0,S+(!U%3T +1110 4444 %%%% 'YN?\%;/^/_X?_P#7VO\
MZ%7V3^S3_P DUTS_ *]X_P#T$5\;?\%;/^/_ .'_ /U]K_Z%7V3^S3_R333/
M^O>/_P!!% 'K$?W:=38_NBG4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5^/'[=7_ "6JP_["*_\ H0K]AZ_'C]NK_DM5A_V$5_\ 0A0!^L/P
MS_Y)[X=_Z\8?_0171?\ +2N=^&?_ "3WP[_UXP_^@BNB_P"6E $-U>16^!)D
MYXKFOB9'/_P@NJFU;:IA)/KBNEO&CC4%H_,YK ^(5O-J'@O4D@R&,1P@')H
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M<XC620 Y/:O)OCU^TIXG\(Q>'-/T>61+[4E5=X'&XUYOXX^,&O?&2WL=,L=
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M=;W_  5B_P"/3P+_ -?0_P#0J /IK]DG_DFEI_US3^5>Y5X;^R3_ ,DTM/\
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MNUCXQ?M$66K:;I]QI$$)*%RI X[UD>+/$&K^%?B]KEMJ^DW&M6NPJKE"0>*
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MYU_1U\=O^2?ZA_UR?^5?SB_%3_DHWB'_ *_'_G0!^AO_  2-^YJ/_7>OUO\
MXA]*_)#_ ()&_<U'_KO7ZW_Q#Z4 ,C_UC4R1F61<#Y>]/C_UC5(0&!':@#F]
M6\&V&L7WVF:WCF/^TH-47^&^A765%M#O'\(4<5V*((UP.E11V<<<S2*/F/6@
M#CK?X9Z-YP>6S@#*?E&P<U+=_##0[B;SGM88_8(*Z]X5D8,1R*62-9EVMTH
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M0QS)CI65K'A&PUJ?S[B".9O1U!K8DA\QE/I7">-_C;X=\ 2M#J4K+(O55ZT
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M&Z/J/V.>:3S,XRHXKNO"?CK2O&4(GTY]X89S0 D'@?1&O!=_8H&ESN(*#K7
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M )&E?JW\ZWO^"L7_ !Z>!?\ KZ'_ *%0!]-?LD_\DTM/^N:?RKW*O#?V2?\
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MPV[I!)UDI&W6+;MP\CT[T 4M)T'3]+9I8;*&V:3@[$ JQ]ECT^3=!;(=QR6
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M=@XJ#3_ NBV;/*VGV[2R')W(./I6CI>K6FI6,>H6[!HINA!J[,T>W>Q! ]Z
M/$=9_9WTG5/BI;>(6P5C_P"61'RUZU:Z+I>EMLCL+>W&,;T0 FM" Q3?O4X
M]:DN(8[A/GY"\\4 9C6<>FW"&WM(W60Y9MO(JW<6MF\HEEM8G./]8R D5CZA
MXZTW2W\N1L!>#FK>E^(M,\0P[+>56!_ASS0!EW'@O2M8U)IGT^WV9R'V#FMJ
MZT.UDL?L\,211@8VHH (K03RX4$88+CMFN6\5>,H/ T+7-^V8<;N/2@#2T/P
M[8Z1&6BLX8YL_>50#2WGAO2M0F:66R@DN&^\S(":S_ OCK3_ (A:>=2TQ\VZ
M-M/UKIUA02&0=30!BZ'X:L-"\XPVD, D^]M0"I%T>TDOEN(HD*CJ .*UW0.I
M#]*BMUBA&R/@4 4M0T.UNERD20R9Y=% --:QM[&)8TM(Y588=BHK5VC.:/+&
MTC'!H YA/ >B2:FE_'96[,O\.P=:TI_#]A-(',,:#^Z% %:4%NENI5!@4K0J
MYR10 V$1K'Y<6 %&,"ECCVY)I8X5BSM%/ZT -$BLVT&GTQ8E5MP'-/H ^4/^
M"DO_ ";3XC_ZYURO_!+?_DW;1_J:ZK_@I+_R;3XC_P"N=<K_ ,$M_P#DW;1_
MJ: /MFOEW_@HK_R;3XE_ZY&OJ*OEW_@HK_R;3XE_ZY&@#SG_ ()8?\D-TWZF
MON5?O,*^&O\ @EA_R0W3?J:^Y5^^U "'$:G')JO<7,L,88)FK14%L]Z&4.,$
M9% &'KGA/3O%$,1O;2*0KS\R@U4M_ ND::ZR6UM%&Z] J@5U&T!<=J8+=%;=
MCF@#G[SPQIEPOGR:=;S7/?<@)K6L;.TB@"16T4(Q@JJ 5<\L;]V.:1855F('
M)ZT 8%YX)T2_O$NY+&WRG)_=CFKJQV]F@6ULXEBZ?*H K1,*E"F.#UHCA2./
M8!\M %>&SM6C<I!&C2##86JUGI-MH]O,L$*9D.=H'6M)(UCZ"AHU9@QZB@"G
M;0PK'YGV6-)>APHS6+K7A:P:>*XCTNWEF9LLQ09KJ-HW9[TM 'CGQ"^"%EXV
M\6:7J4]Y);/;@8B0X%>A2>$[(Z"FD2*)XUQ]\9K:ELXIIED899>E2>4OF;\?
M-0!GZ?I%IH]FD%K:QQC&#L4"LZZ\$:'?72RS6<#R9S\R"NCVCGWJ(VJ%MV.:
M *5GIEKI\WE6]C##%ZHH%20VD%O/*RP)&7XW*.35^FL@?K0!0M=+MX5DWPHP
M8Y.Y0:S)O!6C27WV[[+"C>RBNB90R[3TIC6Z-'Y9'RT 9S>'[*=4)B0JO*\5
M;DL;:15::".3RQ\K.H.*L+&JJ% X%*Z"1"IZ&@"BUC;SL)0%\O\ N@<5F:QX
M&T;6E4O86V\'.\1C-;T=ND<>P#Y:>JA1@=* *&FZ/9:/9F*UMXT3'*JH -8<
MGP_TB_U8:BUK$DH_A"BNK5 N<=Z00JK;@.: ,R2WM_E@-E%*B'@,H.*MS6\$
MZH6@20IT##I5A8U5BP')I50)G H K?9X+B/9) @_V<"LJZT>PO)!%>6$/E(<
MJ605O;!NW=Z9/;I<* XS@YH RKOP[IFK6_DSV,.P#"_(.E1V7A?1M*M?LR6=
MNN>_EC/YUN;!@#TZ5%+9QS-N8<T 4;?2[6P8M%&L8;C*CK5F"WM;4GRX8X2_
M4J,9J=K=&C"$<#I2M"K;<C[O2@!RJ%&!3J** "BBB@ HHHH **** "BBB@#S
MOX[?\D_U#_KD_P#*OYQ?BI_R4;Q#_P!?C_SK^CKX[?\ )/\ 4/\ KD_\J_G%
M^*G_ "4;Q#_U^/\ SH _0W_@D;]S4?\ KO7ZW_Q#Z5^2'_!(W[FH_P#7>OUO
M_B'TH 9'_K&IZTR/_6-3UH =1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!^;G_!6S_C_^'_\ U]K_ .A5]D_LT_\ )--,_P"O
M>/\ ]!%?&W_!6S_C_P#A_P#]?:_^A5]D_LT_\DTTS_KWC_\ 010!ZQ']T4ZF
MQ_=%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\>/VZO^2U
M6'_817_T(5^P]?CQ^W5_R6JP_P"PBO\ Z$* /UA^&?\ R3WP[_UXP_\ H(KH
MO^6E<[\,_P#DGOAW_KQA_P#0171?\M* $D98?FV\FL7QT6/@[5=AVMY!P:V2
MRS,5]*P_B )/^$+U41+N?R#@4 ?FMX8L_$OAWX^0^('O93I\<G*Y..M?9/QT
M\=-=?"=+JPO US<1%2J'D9%>5Z3X/O\ 7?"%XWV+%SO8@A>:X/X$0^)O''Q&
MU_POK=O)'I]C$QB9\X)&: ,K]B;2?$>@ZEXHN=2U"2>.XF+*C$],U]3^&O%E
MEI_BB)I8!Y@'4UY%\'=$U?3?$&M6XLBEM',R[L=LUUUQHNH:AXVB2UA9AM_A
M% %#XD?M*:DWBZ72]+L+B?8^#Y0)XJ]X^\2W5_X"GOKVSD$BP;MK@YZ5P7@G
MQ\WPS^-6I_\ "1:?$EHYV)),O>O8/C#XJC\5^'U72+:.:":/G8.Q% 'S+\)_
MVA=8\'V,VHIIER--BEPV%.WK7UQJ'Q&D\;?"ZTU^QN/[/D==Y&<$^U>>VOA%
M+7]F/5K9-,B-VSDAM@W5PVM6OB;3_@WH\%E9R%0P$NT=%[F@#)@_;$N=+\86
M]C<12&.&78\A/#<UV_Q/_;(M9/+@TJ,B4H.8S7@GQ.\+^']4M=/C\/7:WFLR
M*!/$GWE?T_.LKX>_"6\T/Q3;S>+@]E89RTDHX H ^O/@!\?O^%@?;=-OD9I%
M@8_.?:H_V<A#)X_\1>9#@_:&V$CWJ7X2_"[PCIVI7NK>&=5%]/)"?W:'CI5C
MX$V-XOC;6/MT!MOWYV'&,\T >$?MA>)KK2OVB-+LY8GOK%T4M .0:]T^":Z1
M>6=P]CH7]FW#0G]YLQVKR+]IJ:31_P!I;2+R[MU?3E12TKC('2OHKX:?$KPM
MXBMKFRTJ>%KL0G*1CGI0!YY\'=!,+>/)KZ9;K&\HIYQ7A5O\2=8T75KBTTVP
MN)1YIP8E)[U[E\,=-U2QNO&^^)OWQ?RP>]>=>!?B-<?#GQ>8M:TB%8S(3NF3
MWH ]J^ /QVE\933>'=0LY-/N[>(L9IAC/YUY9\1/C]J/A/Q-?-'<NT%K(20I
MX8 T_0_$FK>//BAJMUINFK;:>T9*S0+@&O-5T/3/$EUXIM_$=W]BN(]XA5NK
MF@#W/PM^T=>?$[X?W>KZ?!+']G^4[<\D5E?L_P#[2.L>+OB9-X;N["Y5(\_O
M7!Q7A'PM^)6K?"'P?J.DVNG+<V4DA/F,O;-?1_[-OB[0M8U!-4,4$6IRC#*J
M@$4 ?4LUQ]G"%ESN_2J6L0RO;M+'+M4#.VJ7BKQEI/AE;;^TKE;<S_ZO<>M9
M_C'Q?9Z3X!O=7$Z_9XT)WT ?-/PWNM0OOVFM7A6Z9HT1B$S69\7OCSJ_@[Q-
M=*EU(\5M(=Z*>PK(^#&H:Y<?&+4_%NE6;7EK/&P# 9'>N2U338O%&O>+IO$+
M?8YB7,:-W- 'TU\(OVDK7QY\.KS61;F-[;Y3GN17C'BO]KS55\026UKHMTT2
M'/VA5.T_C65\!?#VI6_P;\006,#2HTC;2![FO3/!]L__  K]+.[T:$W0!S(T
M8W?RH XJZ_:RUCQ@UG%IEC<PM:$>>5!Y^M>\V7QD_P"$@^%%_J2!H;R!,9[Y
MKR_X(^%?LK>*Y?[.CD8QMC*#BN>LY-7M? >OA;5E'F-A0..IH R-%_;$O- U
M06VH1RLA?;YK]*[WXG:POBMO"^I0R@"ZD5L ^IKYV\7:#I7B?P/;1F58=8\T
M%HU'S=:]>L?#.J?V+X3C6-W2W*<T ?:VA6ZV&BV:$Y_=+G\JO,OG1\<5G:&S
M7FCVGF#:RQJ#^573(83L R* )HV_A]*?2+RH-+0 4444 %%%% !1110 5S/Q
M,_Y)[XC_ .O";_T UTU<S\3/^2>^(_\ KPF_] - 'Y9?\$V?^2F>*?\ L)O_
M .A&OUQ;[M?D=_P39_Y*9XI_[";_ /H1K]<6^[0!\I?\%!/^2>V?^\U<W_P3
M1_Y$C7?^NPKI/^"@G_)/;/\ WFKF_P#@FC_R)&N_]=A0!]GR$1_/2_ZQ0122
M8D^0TO\ JU '- "&0+(J=S7Y[?M8:]/HOQY.^%KVTP,VJC.?PK]"C&&D5^XK
MX,_:'G_L7]HX:M?0JVFJ "[C*T >H?L\ZEH^O:?<W$>D#2);>(R%G7;NP*X/
MXF_M"ZIK>DZU;Z?87%U#9EHSY2D@XKTOP_XAT+QAX4O1HL\:7(MV(6'@DXZ5
MXS\$?B$?A[H/C.W\2Z="MY)(_P!F6=,E^3ZT 7_V5?%[0J/$.I1-9(I.8)N#
M^M7/BK^T)XAN]8U.'1[*ZDM7#+NA4D8Q7+^'=/\ %7Q0M7N+32&L[,L3^Y7
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M03,%#2@@<U]7>-+PZU\+[V_B.QI+,S+^5>!?M)>'YW\$:(-,TF..47"%FC0
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M":\X\5?"'Q)?>#]-EVW$FG*P89R5Q7H/PV^&_@G7K[2C?ZFEMJ%J5 CZ$D4
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MNW$XJ[J&I065HLTTRVT9_OG%,TG6M-UA6.GW45PR??$; T <WXW^#OAOXBW
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M-I\1_P#7.N5_X);_ /)NVC_4UU7_  4E_P"3:?$?_7.N5_X);_\ )NVC_4T
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M[U^M_P#$/I7Y(?\ !(W[FH_]=Z_6_P#B'TH 9'_K&IZTR/\ UC5(M "T444
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MRA_P4E_Y-I\1_P#7.N5_X);_ /)NVC_4UU7_  4E_P"3:?$?_7.N5_X);_\
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MOX=Z+INAC2C:1M9@;1&1P*L_\)AI$FH+IS7<8U%ONPY^8UKRP&6 +(VW'?-
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MLC KUAIG#8V\5(?E4D#F@!8UVHH]!BG5%!(TBDL,&I: "BBB@ HHHH ****
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M#1_P]I^%'_/>X_[X->J?\._OA'_T*UG_ -\"C_AW]\(_^A6L_P#O@4 >5_\
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M72[#1])MX].2-(HXP!Y??B@#0N/+1LR=*F60;1CIVIL>VXB!=?SJ4*H  '%
M#=VZG#%+M'I10 UCNX%(L?K2[.>M/H 3A:C9FSQTIQ4GO3MHH *6BB@ HHHH
M *YGXF?\D]\1_P#7A-_Z :Z:N9^)G_)/?$?_ %X3?^@&@#\LO^";?_)2O%..
MO]IO_P"A&OUK.]ID!^YBOR4_X)L_\E,\4_\ 83?_ -"-?KEZ&@#Y,_X*%H7^
M'=G@$[2Q->0_\$^_C?X:\&^&-9LM4N/(D:7(_"OL+X\?"$_%[PW_ &:)%C;!
M 9O>OB2/_@F+XPTV\N9--\30VT<KEMJOB@#[2_X:<\#_ /00_E2']IWP./\
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M_P $V_B+_'XPC/\ VTIO_#MKXC*V5\81C_MI0!]H+^TMX,ZF]P/J*CD_:?\
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MU 'ZW;7_ +PHVO\ WA7Y(_\ "._M$?\ 0TW_ /WTU'_"._M$?]#3?_\ ?34
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MW_\ WTU'_"._M$?]#3?_ /?34 ?K=M?^\*; LP+>:ZL#TQ7Y)_\ "._M$?\
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M-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)_P"&GO!'_/\
M?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AOC_[^?_7H ^R?
M^&GO!'_/]^HH_P"&GO!'_/\ ?J*^-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^
MAOC_ ._G_P!>@#[)_P"&GO!'_/\ ?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\
MOY_]>C_AV[\1/^AOC_[^?_7H ^R?^&GO!'_/]^HH_P"&GO!'_/\ ?J*^-O\
MAV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)_P"&GO!'_/\ ?J*/
M^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AOC_[^?_7H ^R?^&GO
M!'_/]^HH_P"&GO!'_/\ ?J*^-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_
M ._G_P!>@#[)_P"&GO!'_/\ ?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]
M>C_AV[\1/^AOC_[^?_7H ^R?^&GO!'_/]^HH_P"&GO!'_/\ ?J*^-O\ AV[\
M1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)_P"&GO!'_/\ ?J*/^&GO
M!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AOC_[^?_7H ^R?^&GO!'_/
M]^HH_P"&GO!'_/\ ?J*^-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G
M_P!>@#[)_P"&GO!'_/\ ?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_A
MV[\1/^AOC_[^?_7H ^R?^&GO!'_/]^HH_P"&GO!'_/\ ?J*^-O\ AV[\1/\
MH;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)_P"&GO!'_/\ ?J*/^&GO!'_/
M]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AOC_[^?_7H ^R?^&GO!'_/]^HH
M_P"&GO!'_/\ ?J*^-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>
M@#[)_P"&GO!'_/\ ?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1
M/^AOC_[^?_7H ^R?^&GO!'_/]^HH_P"&GO!'_/\ ?J*^-O\ AV[\1/\ H;X_
M^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)_P"&GO!'_/\ ?J*/^&GO!'_/]^HK
MXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AOC_[^?_7H ^R?^&GO!'_/]^HH_P"&
MGO!'_/\ ?J*^-O\ AV[\1/\ H;X_^_G_ ->C_AV[\1/^AOC_ ._G_P!>@#[)
M_P"&GO!'_/\ ?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_\ OY_]>C_AV[\1/^AO
MC_[^?_7H ^F/BS^TIX*NO!=_"EWYCO$P'(]*_ SXI74-]\0M>N(,^5+=.RY]
MS7ZLO_P35\>W*E+CQ9')&>"I>L6;_@D9>7,C22ZI;/(QRS9'- 'Z@4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?CQ^W
M5_R6JP_["*_^A"OV'K\>/VZO^2U6'_817_T(4 ?K#\,_^2>^'?\ KQA_]!%=
M%_RTKG?AG_R3WP[_ ->,/_H(KHO^6E $/F/-,R%=H'0U3U32TUS1[O3;CA)U
M*$_6M"4LC9 I)9$7!?K0!\M:Q^PGI]WJS7]IXBN;(EMWEQD@5ZUH/P1@TO0;
M73Y[Y[T0X^:0YS7H@:6XF_Z8]Z/M2-(T,'WTZT <=KOPMTS4M'DTZ658HY5V
M$UX@?V%=.74OM-OK\_V4MN-N"=IKZ:D^SZFVR3.]>*DA>+3?W/- '"ZG\&]$
MUOP);^%Y%C_T=<"3:-P/K7D>B_L+Z9INO)J,_B"ZNPC[TAD)(7V%?3"P)YQF
M@^^W6K*@2#/\0H \.^(/[+]CXWT_[%]M:VBVXRM<G'^S+)\,=#4Z7JUQ<N!M
MVY-?3#231S9(_==Z+RW%Y", -W% 'C?P%\,ZQ9Z;K5OJ_G)]H!"229R/I6=9
M_LGZ?%X]B\376JRW<D;9\F3)%>Z6YG48=0JKTP*>UPC_ +L'YC0!YG\6_@3I
M7Q4\/Q:8+C^SA&<^9",&N.\!?LBZ=X,OH+B35I=0\D@J)LG&*]\M[<Q2%C3;
MO[1D>3TH X?5/A7:WGC2SUJ,"-X%"C:*L:O\+;'4K^2\E8.[]=PKLH?/\OY_
MO4GG!F*R=10!XEX^_9;TOQE&J1WS6#'C='P:R?"O['.D^&K%X9=1DOW)SYDW
M)'YU] 17%OJ#E5.6CJS(RA<&@#C]#^'=EHNCK8)+\@&VL:V^">FZ>UX8Y<?:
MLAN/6O1A C+GM32T4V?^F= '$6?PMM='\&WFB0MOBN#D\5=\,_#VUT;P[]@4
M!-RE<@>M=9!,+A"R]N*;]H*R8?I0!\RC]B&R7Q%?ZK%KUQ:O=.7*QDCK7H7A
M[]GV#0=+>T?5)KY&ZB4DYKUDNMP/D/(I8?-VG?UH XK7?AM9:IX-CT25%\A>
M@(X%>.S?L1Z;/JT-]_;DZ(CA_(7.WZ5]+,&8_O/NTF7X$?W: /$_$7[,^DZM
M-!%;A;5E3;Y\:X;ZUS%O^Q'I,>H/=S:U/<.PQ\^37TO*SM"3']_M4<,9\L&;
M[] 'S!I7[#.F:7K1O[?79HSOW;5S7T#X9\,_\(G8I;BX>Z"C&7-=%%"L>2O>
MDF:-6R_6@".0-<0# VFIXU*QJ#UQ3#(6C!BJ5<[1GK0 M%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQE_T#O\ Q^C_ (>G^,_^@?\ ^/T ?MPUY!;Q_O)U;\:7[5;O@K.@'UK\1O\
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MS4M% #5;=D8IU)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>forms-4_03.jpg
<TEXT>
begin 644 forms-4_03.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 4O"$P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 2FT^F4Q@*7%"TZD(ADSM..37SI^WA?"S_9_U OP6./T
MKZ,9PK 'K7S)_P %$8]W[.VHL/O+(,?E2I_$.6Q^3WP]_9=?XMZI-<1O( _S
M?+7=7_\ P3]DM9%4S3#->X?L3W+VMJ7*@_N^XKZ/OM8GOYRVU=JG!XKZW"TE
M*.Q\]7K3A+W6?G[_ ,._C_S\S4?\._S_ ,_,WZU]^_V@W]U?RH_M!O1?RKK^
MJ^1C]=EW/@+_ (=_G_GYF_6C_AW^?^?F;]:^_?[0;T7\J/[0;T7\J/JOD'UV
M7<^ O^'?Y_Y^9OUH_P"'?Y_Y^9OUK[]_M!O1?RH_M!O1?RH^J^0?79=SX"_X
M=_G_ )^9OUH_X=_G_GYF_6OOW^T&]%_*C^T&]%_*CZKY!]=EW/@+_AW^?^?F
M;]:/^'?Y_P"?F;]:^_?[0;T7\J/[0;T7\J/JOD'UV7<^ O\ AW^?^?F;]:/^
M'?Y_Y^9OUK[]_M!O1?RH_M!O1?RH^J^0?79=SX"_X=_G_GYF_6D;]@"5>8YI
MG-??W]H-Z+^5']N/9?-M7GVH6$\@^N2?4_/[_A@*5OORS+4J_P#!/L-UNIJ^
M_/[6FN^0JX^E)]JDC^\J_E2E@?(KZY+N? 3?L K'_P O,QI)/^"?KCD3S&OO
M_P"W1-]Y1GZ4#6B#C:N![5G]1\B?KD^Y^?Z_L O_ !3S4B_L!EI-IN)A7Z#+
MJ@E& J_E5:XFE4[E5?RK>."787UR?<^"+C_@G[Y&W%S,=U*W_!/EBF5N9C7W
MW:7CW%O(9%7*CCBH+#6)8Y=LBKMSZ4W@UV&L;+N? J_L NS;3<3 _C3W_P""
M?LD?_+>8@]Z^^;[5&$FZ)5S]*='K3R *ZKGZ4OJ:']=EW/@3_AWXWE[A=35#
M+^P/+:QA_.F(/%??E_JDUM&0JK^53R:EYVE1%U7.?2G]30?79=S\_8_V 9I-
MK--,%-2M^P&L=PJ_:9MM?H-=:Q&UK&D2KNQZ566919NTJKYO;BE]3783QLNY
M\$-_P3[5FR+J;;5;4/V!3;21*MQ,=QK[YFU1XK5"%7KZ59-['.8'=5^7VJ?J
M:(^O2[GP%/\ \$_65E N)LD4+_P3_7[K74P:OO\ U;78H[R,HJX ]*KQS37U
MP9$5=OTH^IH/KTNY\%3?\$^2L>Y+F9C56#]@>1CL::8&OOMM8GM)MCJN,^E2
MR:INF5@JX^E'U-!]>EW/@.'_ ()_NUP4:XF"^M2'_@G^$#D74S8K[_N-3\R'
M]VJ[_I3--DE\N9IE7&..*/J:-/KLNY^?4/[ <USEA-,%'6EG_8$D@4.)YB*^
M_O\ A(!:Z?,B*N[/'%6M(U**XL0;E5_*CZH'UV7<^ K3_@GS]HCW-=3+44W_
M  3^\ML?:IJ^^;G6FAEVPJ-F?2I/MRSQY*KN^E'U-#^O2[GP&O\ P3_1ER;R
M:A?^"?FXG_2IJ^]TF8-RJX^E27-X\* HJ_E4O"6Z#6,D^I\ W'_!/V6/E)YF
M%,@_8)D;Y7FF%?H#9^(#]V55_*I9M2C?[BKGZ4UA?(3Q<NY\ M_P3[V@'[3-
M4?\ P[_;_GXFK[^_M"3'(7'TH_M!O[J_E5+"KL2\9/N? 7_#O\_\_,WYF@_\
M$_S_ ,_$WZU]^_V@W]U?RH^WMZ+^57]578GZY/N? 7_#OX_\_,WZT?\ #O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?3;> 1S31^;C')%5?LZ-+O21?+^M?%5C\1O%/C+Q-KX6&9(M-9F3;G#8KI_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]=6J7]H;_DB_B7_K@U1?\$I?^1%C_P"NK5\IFGQ'TV$Z'Z.T445\X>T%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M']ABW+"%$WM2M(?NCO!O@$^'?AS/=7>L.DG7YFKY]\;#6=-U7[?87T]U&7R
MK'%?6_C[PHNK?#6>QLLG4F7 45\YO\+O'MM80PPV8?:W.X46D/W35T7Q=>^.
M=%2#54:!X4PI?J:Y"S^#DGB+QM!*FHO"<\;37J.A?#?7&6#^T(/+(QNVBC6O
M!?B;2?$$5UHT&]%'6HM*YO%QL5OBY"^E^"K;0["_9KV$@,RM\U>4>'O$^O\
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M )(OXE_ZX-47_!*7_D18_P#KJW\Z^4S3XCZ?"]#]':***^</:"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+2[.RBE345:1^#\U7[.,M68NI*.B/((_V=1%&^"E1C]EJVO+<W,RQLU>S1K
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M=#]':***^</9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(!&I%I6I%JN
MA/46OF'_ (*)?\FYZG_UT7^5?3U?,/\ P42_Y-SU/_KHO\J=/XD*?PL^0OV(
M_P#CTD_ZY&OH:13)-*J]2U?//[$?_'I)_P!<C7T.X8W$H0X;<<&OO\#\*/D<
M5\0@V6<?[X\TVQU WBW45OR=I IT<8:;9=?/3;:..QN)&@7;FO4G:QSQ/!_%
MGP9UCQ1>7,S0L1N)%8>D_ /5M+D\Q;=BP]:]_P!?^*]AX(5OMHWYYVXY-4M!
M^/FC>+)!;6EI)'*> 2M>=**.E'C5[\,?&VI'R!;/Y"_=YJN?@WXNTUA%-;N&
MDZ9KZ@L6U"]S)#=)$J_-M;BFR:M<:K?1&29083@DTXV0FSYQL?A'XUMG\N.W
M?D=,U@WWP!UZ^U*22]MV63.<U]7:K/JLUT#97:#CJ*;#JCS?N+AP;D<%S52L
M97?0^8[7X2^,+2TDLH;9WMI!AB?2JL'[.5_HT1OTB<78.=M?45Q?W6DL%:=9
M _3;S4BF:X7SII5$7HU1[HKL^6]4^"OBG7+>$WULPME.4-6[KX-Z[=6L<#V[
M>0HVD^U?3C:G+,@A$JO"OW0M)YCY"F9 AZBCW0O(^6['X!ZUILGG:3 SR]JO
MVOPG\46<TEQ=6S>>1T/K7TA)JCZ?<!;9@/>N:\6?%^P\$)]IU8BZ#G 5.2#1
MH.[/G^X^$/C3Q/=%M0MY%MXS\N/2MKPK\"]5TG7HKU;<M;I]XFO:O"/QDL/%
MUM*MLOE!ONAA71VJWDUN46ZC2-N<$U44A.YDV]G#I]G']E1?M7\2XHU+0K#Q
M);'^T542*..*FAC,%ZZD[GZ;ATJP+9+&0/=2JRL<A<UK=&=I%+P_H-OX=M";
M&)6E!XR*CN=!LKVX:ZO(D$S?>XK1N89;R<26<RPQ>A-.6T^S_-=3+(#Z&LY)
M&BNBO9V]E90O!81H7DX.!5,^&=,BDVZM&B2-STK2DTU$83VLJ*5YQFA[8:U(
M)+IAD<?-3C%6#4J-HT-O'BVA0V9X!QVJM!X9T&SF\R%4,S'+#'>M.X,D2BWC
MD!B7L*K7*VUM:O<;.8QEC5<L1:DGV&$W"^8 EOW Z50NO"]L;PW%M;1NF<Y*
MTS2O%MEXDLWM8& FS@'-:NG6=S9_NY+E,8Z9HY8AJ%Y'9S1PQJBKMX8**RKO
MPAI4UTM]&%$J^@K6+06,A25<M*<!J<VG_94WF52O7;GFCE2#4JW%S;V]HGEQ
MH9@?2GO&NM0HT\:[HQ\O%6VM;-;<3-MR?X<\U"L9F8&$^6@ZYHT'J4YM/AOX
MS#=Q(>PR*=#I.GZ9" D48 [[:EU*QEF8/#,K8_NFKVEI;R0^3=%2^.]&@:E2
MQAT>_60NP+IVQ69>:?;WD_EI!&R?[M7(=-@T][J=2KH.?E-4=,\5:==S&*$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYF^:5T?781:(_1VBBBOGCU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"1%C_Z[-_.OB<8]6?6X78_1VBBBO%/2"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-O\ \_D'_?8KXZ_X9M^+'_05U#\VH_X9M^+'_05U#\VH_M,/[/\ (^Q<P?\
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M/P5"FH3.6#9*N,5X.(Q/.['K4,/RH^TJ***\X[@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_GVB_P"^!_A1]CMO^?:+_O@?X5-11SH-"'[';?\ /M%_WP/\*/L=M_S[1?\
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M[#:_\^T/_? _PH_L^U_Y]H?^^!4]+BJO?86A!]AMO^?>+_O@4GV&U_Y]HO\
MO@59I"!4N_0"K_9MF)-XMHMW^X*'TNSDY:UA)_W!5GCUI<4)R"R*S:?:,I4V
ML)'IL'^%.MK6*S39#&L:^BC%3;:-M5H.XZBBB@04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M +^?_7I/^'@'A7_GG%_W\_\ KTN678/;Q[GU;M-&TU\I_P##P#PK_P \XO\
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MO1_P\ \*_P#/.+_OY_\ 7JW&:=K"]O'N?5FTT;37RG_P\ \*_P#/.+_OY_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=3H6FS>'(UM<80?+53QCX9M=<M'A<$EA52B["4D>&6>S_A"8?](*M]:Y#2]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]V3TKS;1_AMXIM_B%=:Y>ZF9M*F.4@)Z5T13.=L] \?^,+/PKX-NOGPQB/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR3#GJ*TM#^+0\->!$TJUC:"[4X\SI5C2;'Q=X?@O]/33)YK>60]CC&:[6'X
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M$$@&\JW/M1S1#E8OFOZ4OG/_ '0/PI-LG]QORHVR?W&_*CFB+E'+,R]45O\
M>%.^V-_SS0?\!J/;)_<;\J/*?^XWY4<T1\K'?:G_ +H'X4?:GQ]T#\*;Y+_W
M&_*CR7_N-^5'-$+,L0WQ4',49/KMI6OF_N*1]*JM')_<;\J/+D_N-^5'-$.5
MCY;MF& BI[J,5!Y\FX'&*E\ES_ WY4&%\?<;\J.:(<K)EU @<Q1M]5I/M[9^
MZH'ICBJOER?W6_*CRI/[K?E1S1#E9;_M _\ /)/^^:5=2?H(T/\ P&J?E2?W
M6_*I(T=1RC?E0I1-::=RPU_(.?*3_OFF'5I3P(D'T6F99CCRV_*I/LK8SY;?
ME6$K-G/6YKCX;R16WF-#]144NJ223$^6@^@IKR,OR;&_*A;9V7.QORK2#BAT
MTR+5K3^U+?!&..<5D:+X9AL;H.R <YS6V@E#8VM^5.N;.=ER@8'Z5I*<32<7
M8FDO!#)M5%9?]H9IC:@3TC5?]T53CAF5<.K%OI3O*D_NM^52I1(29;74".L:
M-]5I#J!/1%'T%5?*D_NM^5'E2?W6_*GS1'9EO^T#C_5)]=M)]O;^ZI]L55\J
M3^ZWY4>5)_=;\J7-$+,M'4#VC1?HM,^U/G.*@\N3^ZWY5*L+X^XWY4^:(69)
M]L/_ #RC_P"^:;]J?/W0!Z8XIODO_<;\J/)?^XWY4<\0LR3[66X\J/Z[:3SV
M_NC\J88W7^!ORI-DG]QJ.>(69)Y[?W0?PI1<$=45OJ*BV2?W&HV/_<:CGB%F
M2&\;M&H^@I/M3^@_*F^2_P#<;\J/)?\ N-^5'-$.5D@O&[QH?J*8]PSG[BCZ
M"D\E_P"XWY4HC?\ N-^5'-$.5C/-?LN/H*/,D]*D\M_[C?E1Y;_W&_*GSH.5
MD?F/Z4WYZE,;X^XWY5'MD_N-^54JB'RL3YZ/GI=LG]UORI=LG=&_*LIR5AQB
MT7--AN;EI8XQG]V?Y5\5?"7[6G[4VMQ.!A;K^M?:OA^UO5U.28,RP^6W'X5\
M6?"MY1^U?KQ)R/M7]:^:QD>9'KX=V9^QVB870['_ *XK_*K2R OM[U0TE6DT
M?3B#C$2Y_(5IJJ[LXYKY.4-;GTD9:#Z***L84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M )Y77YT?VD@^HGS?_P -H:3_ -,/SH_X;0TG_IA^=?2'_#LOX2_\\KK\Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4C4M(: (\FC)IV/:C;[5.I0W)HW&G;?:C;
M[4:@-W&C<:=M]J-OM1J FZES2A:./6I=Q7$S1FEX]:./6EJ%Q,T9I>/6CCUH
MU"XF:,TO'K1QZT:A<3-&:7CUHX]:-0N)FC-+QZT<>M&H7$S1FEX]:./6C4+B
M9HS2\>M''K1J%Q,T9I>/6CCUHU"XF:,TO'K1QZT:A<2FY^:G_C3&/S5$KV"X
M3?ZB3_=-?%GQ>_Y*EH__ %\C^=?:,S?N9/\ =-?%WQ>_Y*CH_P#U\C^=>Q@X
MN5SCJS6A]G:?_P @^U_ZY+_(5,QXJOI[?Z!:_P#7)?Y"K1KSJE['3%HCW<TY
M:-M+C%8TF^IJPR:,FEH_&K=[DW$S1FEX]:./6EJ%Q,T9I>/6CCUHU"XF:,TO
M'K1QZT:A<3-&:7CUHX]:-0N)FC-+QZT<>M&H7$S1FEX]:./6C4+B9HS2\>M'
M'K1J%Q,T9I>/6CCUHU"XF:,TO'K1QZT:A<1C3<FG\4FVJ5QIH;DT;C2[:7;3
MU'H&^@-12[:G40E*O6C;2BCE$+1116@@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,_4/_?5+_PT;H?_ #]0_P#?5'U"MV'];B>R\4<5XU_PT;H?_/U#_P!]4?\
M#1NA_P#/U#_WU1]0J]@^MQ/9>*.*\:_X:-T/_GZA_P"^J/\ AHW0_P#GZA_[
MZH^H5NP?6XGLO%'%>-?\-&Z'_P _4/\ WU1_PT;H?_/U#_WU1]0J]@^MQ/9>
M*.*\:_X:-T/_ )^H?^^J/^&C=#S_ ,?4/_?5'U"MV#ZW$]DR#2%:\?\ ^&B]
M _Y^X?\ OJFM^T9H7:ZA/_ J/[/K=@^MQ/8U]Z.*\7D_:.T;M<0_]]54E_:6
ML8WQ&L<B_P!X&CZA5[!];B>Y\>E''I7A/_#35K_SR3\Z/^&FK7_GDGYT?4*W
M8/K<3W;CTHXKPG_AIJU_YY)^='_#35I_SR3\Z?U*JMT'UN)[MQ1Q7A/_  TU
M:_\ /)/SH_X::M?^>2?G2^IU.P?6XGNW%'%>$_\ #35K_P \D_.E_P"&FK3_
M )Y)^='U.IV#ZW$]UXHXKPG_ (::M/\ GDGYTO\ PTS:=XD_.G]3J=@^MQ/=
M>#1LKPK_ (:8M/\ GDGYTQOVFK;M"I_&E]3J=@^MQ/> OJ:-M?/TG[3:9^6V
M7\ZB_P"&I&'']G@T_J=3L'UR)]#;:-M?//\ PU(__0/%'_#4C_\ 0/%+ZG4[
M!]<B?0VVC;7SS_PU(_\ T#Q1_P -2/\ ] \4?4ZG8/KD3Z&VT;:^>?\ AJ1_
M^@>*/^&I'_Z!XH^IU.P?7(GT-MHVU\\_\-2/_P! \4?\-2/_ - \4?4ZG8/K
MD3Z&VTG\0%?/7_#4C_\ 0/%+)^U%(EJTHTW=BCZG470I8N+/H%MRB7)^7:<"
MOBGXT2LWQ6T01J0!=#/YUZBO[4$T]H9!IG)'%>">./B)J&L>+;+4%TECY<N_
M[OO7HX?!S=^8X:^+5]#[ZLV/V&S(/'E+G\A5OS W:OF&/]J#4;2UA3^QF<J@
M'0^E(O[66J#_ )E]OR-<D\%5CNC2GC$SZ>W#TI?-'I7S%_PUEJG_ $+[?D:3
M_AK#5#_S+[?D:R6#GV-98N)].[PQZ4G%?,8_:RU0?\R^WY&E_P"&LM4_Z%]O
MR-'U.IV*6+B?3?'I1Q7S)_PUGJG_ $+[?D:/^&L]4_Z%]OR-'U.IV'];B?3?
M%+QZ5\Q_\-9ZI_T+[?D:/^&L]4_Z%]OR-'U.IV#ZW$^G,CTI=HKYB_X:SU3_
M *%]OR-)_P -6:MU_L)OR-/ZC4ET%];B?3FP^M*%QU-?,#?M6:QCC07_ "-5
M9OVJ]?;[N@2'_@)IK+JO],?UR)]5<>M&!7R5_P -6>)HCE?#DK_\!-'_  UE
MXH_Z%B7_ +Y-5_9U3N+ZXNQ]:X%&!7R5_P -9>*/^A8E_P"^31_PUEXH_P"A
M8E_[Y-+^SJ@?7(GUK@48%?)7_#67BC_H6)?^^31_PUEXH_Z%B7_ODT?V=4#Z
MXCZUP*,"ODK_ (:R\4?]"Q+_ -\FC_AK+Q1_T+$O_?)H_LZH'UR)]:X%&!7R
M5_PUEXH_Z%B7_ODT?\-9>*/^A8E_[Y-']G5 ^N1/K7 I-O%?)@_:T\3KR?#$
MN/\ =-+_ ,-;^)I.GA>4?\!-/^SZJ_X<?UR)]9_+W.*3*?WA^=?)+?M/^*[C
MIX<F'_ 34+?M!^,)NF@7 _X":U66SZR%]<1]=^8G]X?G1YD?]X?G7R-'^T-X
MOA7:WAZX8^NTTO\ PT5XN_Z%V?\ [Y-5_9LOYA?7#ZX\R/\ O#\Z/,C_ +PK
MY'_X:*\7?]"[/_WR:/\ AHKQ=_T+L_\ WR:/[-E_,+ZX?7'FI_>%'FI_>%?)
M'_#17B[_ *%V?_ODT?\ #17B[_H79_\ ODTO[-?\Q/USR/K?S4Z[A1YJ?WA7
MR1_PT5XN_P"A=G_[Y-'_  T5XO\ ^A=G_P"^31_9K_F#ZYY'UOYB?WA1YB=-
MPKY(_P"&BO%W_0NS_P#?)H_X:*\7?]"[/_WR:/[-?\P?7#ZV\U>@84WS!_>'
MYU\E_P##1GBQ?O>'IQ_P$TUOV@O%D_30IQ^!I_V:_P"8I5G+4^MO.7_GHOYT
MGGQ_\]5_.OD23XR>,;K[NCW _ U#_P ++\:2'/\ 9=T/P-/^SO[P_:/L?87G
M)_SU7\Z/.3/^L7\Z^/\ _A:/C0<?V5<_D:7_ (6EXT_Z!5S^1H_L[^\'M'V/
MK_ST_P">B_G1YZ?\]%_.OD#_ (6EXT_Z!5S^1H_X6EXT_P"@5<_D:/[._O![
M1]CZ_P#/3'^L7\Z//3'^L7\Z^0/^%I>-/^@5<_D:/^%I>-/^@5<_D:/[._O!
M[1]CZ_\ /3_GJOYT><F?]8OYU\@?\+2\:?\ 0*N?R-)_PM+QI_T"KG\C1_9W
M]X/:/L?8'G)G_6+^= G3_GJOYU\@?\+2\:?] JY_(TG_  M+QI_T"KG\C1_9
MW]X?M'V/KXS)_P ]%_.CST_YZK^=?(7_  M3QHHQ_9-R?P-1O\1O&]QP-*NA
M^!I_V4GJYB]H^Q]@?:(O^>R?]]4?:(?^>\?_ 'T*^.)/$_CJXZ6%VOX&HAJW
MCMFR;6\ _&C^RH_SH?M'V/LS[1%_SWC_ .^A1]HB_P">\?\ WT*^-_[3\<_\
M^UW^M']I^.?^?:[_ %H_LJ/_ #\0>U?8^R/M$7_/>/\ [Z%'VB+_ )[Q_P#?
M0KXW_M/QS_S[7?ZT?VGXY_Y]KO\ 6C^RH_SH/:OL?9'VB+_GO'_WT*/M$7_/
M>/\ [Z%?&_\ :?CG_GVN_P!:/[3\<_\ /M=_K1_94?YP]J^Q]D?:(O\ GO'_
M -]"C[1%_P ]X_\ OH5\;_VGXY_Y]KO]:/[3\<_\^UW^M']E1_Y^![5]C[(^
MT1?\]X_^^A0+B+_GO'_WT*^-_P"T_'/_ #[7?ZT?VIXY_P"?:[_6C^RXK7G#
MVK['V.]U$Q&+B/\ [Z%/?<Q#(V5[XKXKOO&GB[PYMGN8;D(.3NS7T)\ _B%+
MXZT"268$.AQS7'4HNGUN.-3F9ZFMRO0]:6,.&))R.U(T(;GI4@/  KBD^QVQ
M'4C#O0#2FLT F:=3*=6HD+1112&%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1358-0T@5<]
M: '44T-E=U,@N!/NP,8H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** $:FTZDQ31+N-)J"\;;8W)](V_E4W2J]]_P @^[_ZY-_(U1C?4^$[72!X
MV^(&IVK7$I N"N Q]:]8?]E^ Q)*)9LD9^\:X/X1+&/BEJ^1S]J/\Z^T0,0(
M>VT5WSGR62.6SE<^9IOV7X[B%5\V;_OHTJ_LJP1J-DLY/?YC7TS]U U209;-
M9+$.F[H:H\VC/F/_ (99C_YZS_\ ?5'_  RS'_STG_[ZKZAP:,&M?[2J]BOJ
M<>Y\O?\ #+,?_/6?_OJC_AEF/_GK/_WU7U#@T8-']I5>P?4X]SY>_P"&68_^
M>L__ 'U1_P ,LQ_\])_^^J^H<&C!H_M*KV#ZG'N?+W_#+,?_ #UF_P"^C1_P
MRS'_ ,]9O^^C7U :3GUH_M*KV-514=#Y@_X99C_YZS?]]&GV_P"RK;S3!)II
MQ&>OS&OISGUHY]:/[2J]A^R/G3_AD#0O^?FX_P"^J3_AD'0O^?FX_P"^J^C.
M?6CGUJ/[0K#]DCYS_P"&0="_Y^;C_OJE_P"&/]#_ .?F?_OHU]&<^M+S2_M"
ML)T(RW/G/_AC_0_^?FX_[Z-'_#'^A_\ /S<?]]&OHSFCFI_M"L3]5@?.?_#'
M^A_\_-Q_WT:/^&/]#_Y^;C_OHU]&<T<T_P"T*P?58'SG_P ,?Z'_ ,_-Q_WT
M:/\ AC_0_P#GYN/^^C7T9S1S2_M"L'U6!\Y_\,?Z'_S\W'_?1H_X8_T/_GYN
M/^^J^B)KCR<9[T[S,8]Z?]H5BOJT#YU_X8_T/_GYN/\ OJK%I^QWX:DS]HN+
M@CMAJ^@]QW8I>:EYA6:M</J\#P/_ (8W\(?\][K\_P#Z]'_#&_A#_GO=?G_]
M>O?.:.:S^N5OYF5]7I]CP/\ X8W\(?\ />Z_/_Z]'_#&_A#_ )^+K\__ *]>
M^<T<T?7*W\S#ZO3['@?_  QOX0_Y^+K\_P#Z]'_#&_A#_GXNOS_^O7OG-'-'
MUVM_,P^KT^QX'_PQOX0_Y[W7Y_\ UZ/^&-_"'_/Q=?G_ /7KWSFCFCZY6_F8
M?5Z?8\#_ .&-_"'_ #WNOS_^O1_PQMX0Q_K[K\__ *]>^<T<T?7:W\S#ZO3[
M'@/_  QGX/\ ^?BZ_/\ ^O2K^QKX07_EXNOS_P#KU[X-U+S1]=K?S,/J]/L>
M#K^Q]X07_EO<?G_]>M"U_97\+6L6Q9)B/<U[/L]J505H^NUOYF'U>GV/'/\
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MN5[**V,R/P]8)]VWC_[Y%6!H]JHXMH_^^:N[ .E)AO6I=63W8_9HH_V+:?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPA_Z&9/^^?\ Z] 'NNWWHV^]>%?\-O?"'_H9D_[Y_P#KT?\ #;WPA_Z&9/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M (;>^$/_ $,R?]\__7H ]UV^]&WWKPK_ (;>^$/_ $,R?]\__7H_X;>^$/\
MT,R?]\__ %Z /==OO1M]Z\*_X;>^$/\ T,R?]\__ %Z/^&WOA#_T,R?]\_\
MUZ /==OO1M]Z\*_X;>^$/_0S)_WS_P#7H_X;>^$/_0S)_P!\_P#UZ /==OO1
MM]Z\*_X;>^$/_0S)_P!\_P#UZ/\ AM[X0_\ 0S)_WS_]>@#W7;[T%?>O"O\
MAM[X0_\ 0S)_WS_]>D_X;=^$/_0S)_WS_P#7H$=+\=KI;?PM<[T#?NF_E7$_
ML=W F\(ZHR1[1YYZ?4URWQ7_ &MOA3XFT&6W@UQ9FV$<<5S?[._[5'PL\"^&
M[ZWN-:6$O*7Y_&NY_P )(\^*_>7/LV2X,4(?;D^E3*WF1JW3->%)^VK\);F
M.GB%'_V<?_7I!^VY\(U&&\2(I';;_P#7K@D>C$]U"GUIQ7WKPG_AMWX0?]#,
MG_? _P :/^&WOA#_ -#,G_?/_P!>E%#9[IM]Z=M/K7A'_#;OPA_Z&5/^^?\
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M-2J\MNI] 'Y[_P##MA?[D?\ WW1_P[87^Y'_ -]U^A%% 'Y[_P##MA?[D?\
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M5/EJ,;:7 V@XYQ3E4=<<T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _([_
M ()&_<U'_KO7ZW_Q#Z5^2'_!(W[FH_\ 7>OUO_B'TH 9'_K&IZTR/_6-3UH
M=1110 4444 %%%% !1110 4C$ <TM,F4M&0.M  S!1D4DFYHS@4QOEC4'K4F
M\+M![T 16\11=S<&I^OO7'_%;Q4/!_@^ZU#."@X-?$6B_M&>/?&_CJ33M(OY
M/LZR8VCTS0!^@N9BVTK\IH: 0J67K7*>%=0O])\+K<:[=+YYCW?,<<XJ#0_B
M5IM_=?9Y+N(MG'WQ0!V,<:HWF9RQ[4Z>W\YD;TK)UWQ9I?ARS6[N[B-87^ZQ
M88JE8_$#3]7L9[BTD5TC&25.: .H=BJ\=:BNKN*TA$EPP1?>N(TWXO:+-(89
MKA4ESCEA7SW^W1^T0?AWX'T^;2KC;)<S",,A]:5QV/K*#4+;5T9;:02;>N#4
MD-O'9(7D; 'K7S3^R7KFMV?@V77?$^HI+;740ECRW(!&:]#\??$./Q1X!O9_
M#MVJSJ2H;<.M.X6/5+?4H;J0I$P8_6IEB,:N0,MVKYL_9V7Q9+KLL^LZI'+;
M!2=I>O8'^+FAMJC:;'.K76[8,,,9H$=9;S7&[,RA5]:=% _VII<CRSTYKR']
MH[XI2_"/X87^MSR%C&NX%*^3-+_:R\82^$+3Q.MY(NDSM\JGTH _1AV/(CP6
MID?G;?F"YKXFA_:2UWQUX3N=2\/S21/8Q;YV]<"O//A;^UAXY\?:Y]ECO)61
M9-A_.@#]%_-N/,QMXJ<PA@"W!KFOA[)J-UH,$^HONE89YK?N)FCD [$T 644
M*,#FG4U""O%.H **** "BBB@ HHHH **** "BBB@ IDW^J?_ '33Z9-_JG_W
M30!^2'C_ /Y.6D_[" _]"K]8]#_Y >G?]>\?_H(K\G/'_P#R<M)_V$!_Z%7Z
MQZ'_ ,@/3O\ KWC_ /010!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>W)49W=:^3_AU'XV@^.1.L:K'/:8_P!6'KZ*\4>.K#P:\37US&PG;:JAAD4
M= L,,<3Q[CANM26\*V\&V,[A5*WUO2[JU6YCN86C9=VX,#BN<_X6;IAU[^SX
MID<_[)R* .RAW;CFG21YYIL4@FA61.C#-)#(7R#0 Z-NQJ6F[1G-.H ****
M/./CY_R3/7/^O23_ -!-? O_  21_P"0UX__ .O]_P#T(U]]?'S_ ))GKG_7
MI)_Z":^!?^"2/_(:\?\ _7^__H1H _3[_EF/I3E^Z*;_ ,LQ]*<OW10 M%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\4?\%&/^0#:_]<C76?\ !.7_ )(./^O@_P!:Y/\
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MG+]T4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!^1W_  2-^YJ/_7>OUO\
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M&U.V$S_=3S!DT :U%9EQXETJS&9[^"(?[3@5'8^+=&U1G%IJ=M<%/O".0'%
M&O163-XLT:!MLFIVR-Z-(*L_VQ8_91<?:HO(/_+3=Q0!=HK#'CCP^TGEC6+0
MOTV^:,UIV^I6MU@0SQR$]-K9H LT56_M"V^U&W\]//\ ^>>>:L9% "TR;_5/
M_NFGTR;_ %3_ .Z: /R0\?\ _)RTG_80'_H5?K'H?_(#T[_KWC_]!%?DYX__
M .3EI/\ L(#_ -"K]8]#_P"0'IW_ %[Q_P#H(H OT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=RDXQ0!5DO)%N%0 ;3[4^:W;S/-A($O3FG1J(U9R,D57AM97O#<F0A#_  4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT[_KWC_]!%?DYX^_Y.6D_P"P@/\ T*OUCT/_ ) >G?\ 7O'_ .@B@"_1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q1_P48_Y -K_UR-=9_P $
MY?\ D@X_Z^#_ %KD_P#@HQ_R ;7_ *Y&NL_X)R_\D''_ %\'^M 'U4OW12TU
M*=0 4444 %)2T4 %%%% !1110 4444 )2T44 %0R;)B4)YJ:JPC\NX+F@"2.
M-(> >:^$/^"@WVG^T4\I,CRQS^5?>)0,P85\C_MI_!SQ/\1+>2?1& *I@4 >
MD_LDP20_L^:2S_ZQHG/Z5\B^#?C-JUQX\^(=G/ L:VCR")@.>*])_9I@^*/@
MGPXN@ZK<EK18V15QTS6'HO[*OBS1]<\3ZI=%6_M8LT>/>@#R'PO9^)?B<E[?
MR37"PQR,-RL?6I_AK8>)?&WQ$O?!PGN&M[6,R!@QSQ7T/\(?V?\ Q7X)\*ZA
M%=LNR1RV*F^!OP#\5>%?C'J?BB1E6QN(611WR: /'_@K\8O$7A&]\>:+/NE%
MBCHGF'/05D>!]6U7XI_"/Q3=W:& I*X'E\=S7J'A7]FWQ)#XM^(%[=X(U(R>
M1^/2M3X"_LW^*_"_P\U_1M093)=S,R#V)- 'EW[#_P #8F^($^I3WDWR1LX!
M;CBLGX__ +1GBOQIXZU#PAI*L8M.F,2M&2"0#BO6?A#\*?B#\,?BE=23S8TA
MT*!5]ZYCXN?LE>+]-\8_\)5X?98_M4WG3^I&<T <]\*/&'Q6^%\T6H/I\LVE
M+\\LDF2 *U-%UKQ)^U!\7;ZPNWEM=.\EF#0L1R!7M_P]TW6/$%G#HNIKNLF7
M9,I7KQ7COBOX&?$_X6_%Z[UOPA<"VT&12J(/>@#C?V5/"]_X1^/?B72]1C*6
MUO<%(I&ZMS7Z?6W_ ![Q8Z;!_*OA;]G[]GWXC6?CJ\\2>)YUEBNY/,'KUS7W
M5;H8X(U/55 _2@!]+110 E+110 F!Z4M%% "44M% !24M% "4M%% !1110 4
M444 ><?'S_DF>N?]>DG_ *":^!?^"2/_ "&O'_\ U_O_ .A&OOKX^?\ ),]<
M_P"O23_T$U\"_P#!)'_D->/_ /K_ '_]"- 'Z??\LQ]*<OW13?\ EF/I3E^Z
M* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M27[/*N8?[IZ4D=E;:*@CL[98B_!*BGWFJVMO\CRJ&SZU9:YBBA621@%(X)H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIVBOJZW\5>'] \%O)=:U;7T2CFV,@.?PKY!^-WC*U\2:A;_\(?(NC78F!>2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*3*Z?;Y/\0C7_"K#01Q$-' @;L0H%6** *:Z? 9C<-"IE/4XYIITRRF8L]C
M6'.3&I/\JO44 <9XR^'%CXXM&@N2UM$1@I&, UI>#/!UKX*T.+2[0DP1]":Z
M&B@!!Q12T4 %%%% !3)O]4_^Z:?3)O\ 5/\ [IH _)#Q_P#\G+2?]A ?^A5^
ML>A_\@/3O^O>/_T$5^3GC_\ Y.6D_P"P@/\ T*OUCT/_ ) >G?\ 7O'_ .@B
M@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6X@U"QM[B1E&X9&XXKF_BEXQB\'>"[[5T<%H%RK)SB@#J+BSM)CFXM89/>1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\L<8IEMHUK:6\L$<8$<GWAZU>HH XN;X1^')K[[6UGB;KN%=)8Z%9Z=&J0Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^3Z4 ?%MU\"_B]?64=K-/&88^5&ZI(?A3\:+:-;<W"^6.%&:^A_$'Q:CT+Q
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M _3[_EF/I3E^Z*;_ ,LQ]*<OW10 M%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!H;S.*=VQ2*@7I3#OW>U #B?+IRL&&12,H8<TJJ%&!0 M%%% !1110 4444
M><?'S_DF>N?]>DG_ *":^!?^"2/_ "&O'_\ U_O_ .A&OOKX^?\ ),]<_P"O
M23_T$U\"_P#!)'_D->/_ /K_ '_]"- 'Z??\LQ]*<OW13?\ EF/I3E^Z* %H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _([_ ()&_<U'_KO7ZW_Q#Z5^2'_!
M(W[FH_\ 7>OUO_B'TH 9'_K&J1:CC_UC4]: '4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4R;_5/_ +II],F_U3_[IH _)#Q__P G
M+2?]A ?^A5^L>A_\@/3O^O>/_P!!%?DYX_\ ^3EI/^P@/_0J_6/0_P#D!Z=_
MU[Q_^@B@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\CO^"1OW-1_Z
M[U^M_P#$/I7Y(?\ !(W[FH_]=Z_6_P#B'TH 9'_K&IZTR/\ UC5)0 M%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,F_U3_P"Z:?3)
MO]4_^Z: /R0\?_\ )RTG_80'_H5?K'H?_(#T[_KWC_\ 017Y.>/_ /DY:3_L
M(#_T*OUCT/\ Y >G?]>\?_H(H OT444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ_+-$T7[PG:P]S7NO[-\@G^$FE,!@$'^E 'IH.U<-T[5%Y;,_'W.]6=H(Y%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#\CO^"1OW-1_Z[U^M_P#$/I7Y(?\
M!(W[FH_]=Z_6_P#B'TH 9'_K&IZTR/\ UC4]: '4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4R;_5/_NFGTR;_5/_ +IH _)#Q_\
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M4]Q4Z*JK\H 'M0 ZBBD/2@ S2TQ3\U/H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /./CY_R3/7/^O23_T$
MU\"_\$D?^0UX_P#^O]__ $(U]]?'S_DF>N?]>DG_ *":^!?^"2/_ "&O'_\
MU_O_ .A&@#]/O^68^E.7[HIO_+,?2G+]T4 +1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!^1W_!(W[FH_]=Z_6_\ B'TK\D/^"1OW-1_Z[U^M_P#$/I0 R/\
MUC5(!BHX_P#6-3UH =1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^1W_  2-^YJ/_7>OUO\ XA]*_)#_
M ()&_<U'_KO7ZW_Q#Z4 ,C_UC4]:9'_K&IZT .HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **2EH **3(I: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "F3?ZI_]TT^F3?ZI_P#=- 'Y(>/_
M /DY:3_L(#_T*OUCT/\ Y >G?]>\?_H(K\G/B!Q^TM)GC_B8#_T*OUBT+_D!
MZ=_U[Q_^@B@#0HI,TM !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?%
M'_!1C_D VO\ UR-=9_P3E_Y(./\ KX/]:Y+_ (*,G_B0VO\ UR-=;_P3E_Y(
M./\ KX/]: /JE:=2+]T4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!YQ\?/^29ZY_UZ2?^@FO@7_@DC_R&O'__ %_O_P"A
M&OOKX^9;X:ZX%&3]DDX_X":^!O\ @DC_ ,AOX@?]?[_^A&@#]/?^68^E.7[H
MIO\ RS'TIR_=% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?&7_ )XR?]]&@#]%_P#A=G@K_H/VO_?5'_"[/!7_ $'[7_OJOSH_X8R^,O\
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MG_?1H _1?_A=G@K_ *#]K_WU1_PNSP5_T'[7_OJOSH_X8R^,O_/&3_OHT?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!]&@#]%_\ A=G@K_H/VO\ WU1_PNSP5_T'[7_OJOSH_P"&,OC+_P \9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 P2=:7>-N:%0+FFR1^8N,XH B>Y:-LD94U85MR@BFK&%4*>:%CVYYH =S
M1S2;:-M "\T<TFVC;0 O-'-)MHVT +S1S2;:-M "\T<TFVC;0 O-'-)MHVT
M+S1S2;:-M "\T<TFVC;0 O-'-)MHVT +S1S2;:-M "\U\\?L\?\ (ZWO_8/?
M_P!&15]#;:^>?V>.?&E[_P!@]_\ T9%7JX7_ '>MZ+]3R\5_O%'U?Z'T/S1S
M2;:-M>4>H+S1S2;:-M "\T<TFVC;0 O-'-)MHVT +S1S2;:-M "\T<TFVC;0
M O-'-)MHVT +S1S2;:-M "\T<TFVC;0 O-'-)MHVT +S1S2;:-M !NZ^U1+<
M"8,%X/2IMO6HX81#G'>@!L,1CY8Y-$<<BS,S-E3T%/:+<V<XIZC Q0 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 UJ.QH/6@=Z3&-:JU[_ ,>-S_US;^56&JK>?\>5
MS_US;^5:HY)/4^-/!?\ R56Z_P"OK^M?:$?^KA_W1_*OB[P7_P E4N_^OG^M
M?:,?^KA_W17775N4RHO<L?PTJTG\-"UYK^([^@ZBBBK **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OGC]G?_D=;W_L'O_Z,BKZ'KYX_9W_Y'6]_
M[![_ /HR*O5PO^[UO1?J>7BO]XH^K_0^AZ***\H]0**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M )'6]_[![_\ HR*O5PO^[UO1?J>7BO\ >*/J_P!#Z'HHHKRCU HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** $:D:E:D:D]AH5>E5[W_CSN?^N;?R-6%Z5!>?\>EQ
M_N-_(T1W1#/C'PROE_%2X][G^M?9,?\ J(O]T5\>:*NWXH2G_IY_K7V';\P1
M?[HKWLU^&'H<$-V6%^[1'W^M"_=HC_K7@0^$])?"2T4450@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *^>/V=_^1UO?^P>__HR*OH>OGC]G?_D=
M;W_L'O\ ^C(J]7"_[O6]%^IY>*_WBCZO]#Z'HHHKRCU HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** $:D:E:D:D]AH5>E07G_'I<?]<V_D:G7I4%Y_QYW'_7-OY&
MB.Z(9\:Z)(6^*4H/_/S_ %K[%M_]3'_NBOCG0_\ DJ4O_7S_ %K[&M_]1'_N
MBO?S7X8>AY\/B+"_=I4H7[M"U\_#X3TUL244450@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *^>/V=_^1UO?^P>_P#Z,BKZ'KYX_9W_ .1UO?\
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MI*8Q:*3<*,T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA[.)']AM_P#GA'_WR*/L-O\ \\(_^^14E%%YA[.)']AM_P#GA'_WR*/L-O\
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MM_\ 4P_[@_E7L8[:'H>='=EFBBBO#/26P^BBBF 4444 %%%% !1110 4444
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M;?M7_#/=_P C;IX_[;+2?\-7_#3_ *&[3_\ O\M 'LM%>-?\-7_#3_H;M/\
M^_RT?\-7_#3_ *&[3_\ O\M 'LM%>-?\-7_#3_H;M/\ ^_RT?\-7_#3_ *&[
M3_\ O\M 'LM%>-?\-7_#3_H;M/\ ^_RT?\-7_#3_ *&[3_\ O\M 'LM%>-?\
M-7_#3_H;M/\ ^_RT?\-7_#3_ *&[3_\ O\M 'LM%>-?\-7_#3_H;M/\ ^_RT
M?\-7_#3_ *&[3_\ O\M 'LM%>-?\-7_#3_H;M/\ ^_RT?\-7_#3_ *&[3_\
MO\M 'LM%>-?\-7_#3_H;M/\ ^_RT?\-7_#3_ *&[3_\ O\M 'LM,;[U>._\
M#5_PT_Z&[3_^_P M12?M<?#2.0)_PE6GM[^<M T>RLVWDTUNF:\;D_:X^&T:
MY_X2>P/_ &V%1+^UU\-Y%/\ Q4UA_P!_A6D4WL8U"O\ M2?O/ASJ#CH!5_\
M97&[X4:<W:O+OCA^T;X"\9>!;[2['Q#92W,H^54D!)J?X#_M%>"/ _P\LM,U
M'7;."6+KOD KOE?V?*CAC'WKL^K?O?A2LPVYZUXN/VL_AI<*1_PEFGI_VV6I
MX_VJOAI;V+R'Q;I[D=O.6O/EHCT8'L4?S+FG;37B]O\ M:?#2:,.?%FGI[><
MM2_\-7_#3_H;M/\ ^_RUCRW+/8]IHVFO'/\ AJ_X:?\ 0W:?_P!_EH_X:O\
MAI_T-VG_ /?Y:.4+GL>TT;37CG_#5_PT_P"ANT__ +_+1_PU?\-/^ANT_P#[
M_+1R!<]CVFC::\<_X:O^&G_0W:?_ -_EH_X:O^&G_0W:?_W^6CE"Y['M-&TU
MXY_PU?\ #3_H;M/_ ._RT?\ #5_PT_Z&[3_^_P M'*!['M-&TUXY_P -7_#3
M_H;M/_[_ "T?\-7_  T_Z&[3_P#O\M'(%SV/::-IKQS_ (:O^&G_ $-VG_\
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M (:N^&7_ $-VG_\ ?Y:.4+GL&TT;37C_ /PU=\,O^ANT_P#[_+1_PU=\,O\
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M]JLEJW)2J7AGX5>'O!]XUSI5DMO(W7O6M_PFVA?]!6U_[[H_X3;0?^@K:_\
M?='*A\S(/%'@71O&2JNK6HN0HP :A\._#O0_"*_\2FS6V(Z5<'C70?\ H*VO
M_?P4?\)IH/\ T%;7_ONI<;A=HM7VC6VIJOVN,2%>:CFTJRU:S>TGB#P8V[2.
MU0?\)IH'_06MO^^Z:?&?A^/_ )BMLO\ P,41IHF4F+I/A^Q\,V[V^F0K!'@D
MJ*^1_!IE'[1.NMI9\F\+GS6]1FOK9O&?A]E;_B:VW0_QBOD?P+KV@VO[0VNW
M/]JPA7<\[AZUZ-"*>YQU-3[)TF-5M$./WI'SGU-7=IK!MO&6@+"FW5;;&/[X
MJ7_A-M"_Z"MK_P!]UQSC>1U0TB;.TT;36-_PFVA?]!6U_P"^Z/\ A-M"_P"@
MK:_]]U'*7<V=IHVFL;_A-M"_Z"MK_P!]T?\ ";:%_P!!6U_[[HY0N;.TT;36
M-_PFVA?]!6U_[[H_X3;0O^@K:_\ ?='*%S9VFC::QO\ A-M"_P"@K:_]]T?\
M)MH7_05M?^^Z.4+FSM-&TUC?\)MH7_05M?\ ONC_ (3;0O\ H*VO_?='*%S9
MVFC::QO^$VT+_H*VO_?='_";:%_T%;7_ +[HY0N;.TT;36-_PFVA?]!6U_[[
MH_X3;0O^@K:_]]T<H7-G::-IK&_X3;0O^@K:_P#?='_";:%_T%;7_ONCE"YL
M[31M-8W_  FVA?\ 05M?^^Z/^$VT+_H*VO\ WW1RA<V=IJ&:X$#*",[JS/\
MA-M!_P"@K:_]]TT>,] F/_(4M6(_VZ.4+FR3A=W:A3N7-84GCG01<+'_ &G
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M_P!_EH_X:N^&7_0W:?\ ]_EI<B"[/6UA+*5?D&B.W$:[5X6O)/\ AJ[X9?\
M0W:?_P!_EH_X:N^&7_0W:?\ ]_EHY$%V>LRV27&/,&<=*0V\FX 'Y/2O)_\
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M&LVT \\5^DMQ^Q3X#G8,8W!Q_=%?#/\ P2)@FFL]4*-A5G_K7ZQ*&\Q0W/%
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MS9_X= ^%_P#H-ZE_W]/^-'_#H'PO_P!!O4O^_I_QK])N:.: /S9_X= ^%_\
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MOS8S3N: /S;_ .'0/A7_ *#>I?\ ?X_XT?\ #H'PK_T&]2_[_'_&OTDYHYH
M_-O_ (= ^%?^@WJ7_?X_XT?\.@?"O_0;U+_O\?\ &OTDYHYH _-O_AT#X5_Z
M#>I?]_C_ (T?\.@?"O\ T&]2_P"_Q_QK]).:.: /S;_X= ^%?^@WJ7_?X_XT
M?\.@?"O_ $&]2_[_ !_QK]).:.: /S;_ .'0/A7_ *#>I?\ ?X_XT?\ #H'P
MK_T&]2_[_'_&OTDYHYH _-O_ (= ^%?^@WJ7_?X_XT?\.@?"O_0;U+_O\?\
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MA6X8,=;U$<?\]3_C47_#H'PK_P!!O4O^_P ?\:_2)-V.:=S6+=V,_-O_ (=
M^%?^@WJ7_?X_XT?\.@?"O_0;U+_O\?\ &OTDYHYI ?FW_P .@?"O_0;U+_O\
M?\:/^'0/A7_H-ZE_W^/^-?I)S1S0!^;?_#H'PK_T&]2_[_'_ !H_X= ^%?\
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MW]HW_H#W'ZU^LNZC=0!^37_"K?VC?^@/<?K1_P *M_:-_P"@/<?K7ZR[J-U
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M- 'G/_!*]1_PHW3<#NU?<J_?:OAK_@EA_P D-TWZFON5?OM0 ^BBB@ HHHH
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MY-S')MZ[3G%++=". R1_O1[5\N_LWZ_JGVSQ%_PD;-#;"=MC,?X<U[!+\</
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M?^2::9_U[Q_^@BOC;_@K9_Q__#__ *^U_P#0J^R?V:?^2:Z9_P!<(_\ T$4
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MF7MXCGJ:_2#P;XZLOB5\,UU_24:*UN;=G4,,'&.:^+9OV<?$7QH\2B/6YIS
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M(I6&?GIX-\)>(?V6M5_X2G2Y#;^'E!RJGCFO1/V;?&%MX^\<>+?$NFN!J%S
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MO$/_ %^/_.@#]#?^"1OW-1_Z[U^M_P#$/I7Y(?\ !(W[FH_]=Z_6_P#B'TH
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M !7X\?MU?\EJL/\ L(K_ .A"OV'K\>/VZO\ DM5A_P!A%?\ T(4 ?K#\,_\
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M,^G:@!7C6:$Q]L8JI:Z?%93;A5X*%Z5'/'N7CK0!*"#R*6FQKM0"G4 %%%%
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M'6@")XMN=E/C;C!^]380R-AS4C +E\<XH 9NFW?=&VGLHR">#7SC\:OVE8_
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M,9S7S3-\)_B!K7B-+^]TR2&(R!O+ ^7K7WA\+8)['PO9VMS;K \<84X&#TH
M[7.>E+3(XQ&.#FGT %%%% !1110 4444 %%%% !1110 4444 ?FY_P %;/\
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MGVG@.YTO^S=0@E4/-(,$\U]E:#X \,W'P:AEETVU>1M/+&X*#=NV]<U\D_\
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M0;U[B_M3!(R'/&*RO 'PUOH_%WC&2:!HTO0X1L=<T >._LD_L^ZK')K&LCQ
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M^'P5?GR[A67Y7/->Q6OPIU[4/BY8:G>V;1V<<V3QP1FO/?VFOV9]9USXO?\
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M23S7C7!8]ZMY5.!42QHS9W9/>G-B1@0>E #Y&"+N(ID<WG9!7 I9E\R/ HC
M*;>AH 3<K9PN2* 3(N.AICAK?[@SFEA:1N6&#0 ID:/Y2-U*L:Q]!C=UJ-I9
MM^-O%3MT#'C% "2,(4SBDCD$BY(Q4<DT=PI16RU(JLRA2,8H G.S/-.W#UJ*
M0+)@YX7K3$,2MN#T 3AE+8!R:=5>.W59FE!)W4OVA22K<4 3;AUSQ1G/2JX9
M=WE@YS3MPA.": )J,BFC"J6[4U<2?.#S0!)14;2(@^8XI-P:-MAR: )<B@'/
M2J\*M)$5DXJ>-?+4 4 .HHHH \[^.W_)/]0_ZY/_ "K^<7XJ?\E&\0_]?C_S
MK^CKX[?\D_U#_KD_\J_G%^*G_)1O$/\ U^/_ #H _0W_ ()&_<U'_KO7ZW_Q
M#Z5^2'_!(W[FH_\ 7>OUO_B'TH 9'_K&I2&+<=*2/_6-3\CIG!H JWUY:Z7&
M9IW6-?5CBJ6FZY:WLS,ES$5;IAA7SO\ ML>*KW1_A[<065\UG<;N)%."*\P^
M!/P]U[Q%X>TK4V\;;FX=XO-Y^E 'W1-.D8VOR&]*9;N/,V1C"5X/\3/VHK#X
M0I8Z<UK_ &K=; OR-RQ%7_AW^T]8^.HBLM@=/NRI(AD/S4 >SD6\\Q5&7S%Z
MC-+<:E#9R1PR.!(_"C-?!_A7]LC78_C]K7AZ30KI[*.78LVT[>O6OH;QAJ4T
MWBCP_J$=_@2$.UN#^E 'MS,N=N]1+V!/-$RJ4 FY%?$?QJ_:DUKP;\<K>PMM
M/N)+4(,JH.#7M_P__:+M_&4<,-[;?8';&3)Q0![7Y(CMV\CANU)9^8L&9SE\
MUPGQ ^,-EX&GL8(XA?-<CC8:/"_Q&N?$VM16[:?);1L.K T =[&K([2,VV/K
MS4$-Y8ZHQ:.2*9XCV()%<G\8O$C>'?"=P8I/+FE1E3'7.*^,?V??$WBWPQ\1
M+J+7+ZX>VOKG,2RDXP3VH ^_A,EX&B=<JW7(IT<26X\N!%4CVKQ[XM?M'V'P
MOD6V%G]KN2@;8IYKG_A;^UY:?$#5C97&E-IQ'_+20D"@#Z!6W,V3<*K8Z<4L
M@D$6+<*OX5X]\8_VCK;X7_93!8'5!,,_N^<5SW@#]KBR\::E';S67]GNW_+.
M0X- 'T,B&2$"95)[\<53OY[:UMI)V108AG.VOG;QI^V4GAK7I--M/#\NH^6V
M"\>3QZUWGA_XN6'Q4^'NLSPXLKE(&S&3RIQ0!WWA_P 4VGB&-EW([9QCK6TR
MQPH,(H'TKYI_9_COK3SKJ:Z:X"RL=N:/'W[:5EX%\4/I-QH[,%?89"2/QH ^
ME&MH;G:S1J2O3(I[*&_=E5*$=,5R?P_^(FG?$G1TO=.F0G:&9%;.VNIC4M"5
M)PU "^5'&-L:*#]*>L8V_,J_E44,/V=BSO\ G0JM(S<\=J '?986;<L:[O7%
M/52WRL%V^F*(U$:X+9--VG>3G H 9)$\3#R%50>O%28+X#JI_"G[AV.:A?=Y
MZXZ4 -NH(?+ >-<9]*>L<<<.5& !3O,61BA&:9"WS,IZ4 +:S"="1V-3TU%5
M1\HP/:G4 %%%% !1110 4444 %%%% !1110 4444 ?FY_P %;/\ C_\ A_\
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MW$@=N<4\HL'S]JSK?5-/L69'U&)W8_=+C-5/$_C#3O"VDG4;RYCC@SC+G H
MU'N#>$+#P5/.:LO((X\-R<5R>F_$C2=6TUKK3IH[@[=V(R#5+0_B1#>:3J%]
M>1_9X[8G+2<"@#N(MGE[P*'43X'I7(>%?BMX?\2QX@U"W+9QM#BNOCDCDC,D
M3AUQG*T .=4C7<1]VFQ3)=*<#BJD.K6L@=9)D0@XPQQ4ZR0>0S1.I"@M\IH
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M#^%XO"^BPVD:[0@QBN@"DA@>] ;C%5XYG\S!!Q0!+&5B;9WJ:F?+N&?O4^@
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M;:9G9 .F*]4\6_LFZ/J>O274$&+=CD &O1_!/P6T/P;HLUK#!M\Y<-0!X_\
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M]L_]YJYO_@FC_P B1KO_ %V% 'V7.OEGS%Y-$**H\QC@M4DW^KYJ*92T:;:
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M-6D\P5-0 4444 1[FW=.*<6 ZT;A2&/=UH /,':A&+9R*/+5:<".U "T444
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MO R:5>@IBR=CUJ2@#Y0_X*2_\FT^(_\ KG7*_P#!+?\ Y-VT?ZFNJ_X*2_\
M)M/B/_KG7*_\$M_^3=M'^IH ^V:^7?\ @HK_ ,FT^)?^N1KZBKY=_P""BO\
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M?Q]TCQ%XA338;M'=WP #0![7129XSVI%D#$@'F@!U%)0#GI0 M%%% !1110
M4444 ?FY_P %;/\ C_\ A_\ ]?:_^A5]D_LT_P#)--,_Z]X__017QM_P5L_X
M_P#X?_\ 7VO_ *%7V3^S3_R373/^O>/_ -!% 'K$?W13J;']VG4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5^/'[=7_):K#_ +"*_P#H0K]A
MZ_'C]NK_ )+58?\ 817_ -"% 'ZP_#/_ ))[X=_Z\8?_ $$5T7_+2N=^&?\
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MVJ.M9O\ PCNA7C&ZGTR%IU/!9?F_"MQH9)I/G&U1TYIMS8B2195^\O\ #V-
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M ))5M8T0\YXJ2",1KQWYJ":U^U29?@*>*MK\J@>E "US/Q,_Y)[XC_Z\)O\
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MJ64_G0R]#G(H MS6<;+Y5V@N$?C##(JE#X%\/6MP)HM)MHY>N\)S6R-S M(
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M^"BO_)M/B7_KD: /.?\ @EA_R0W3?J:^Y5^\U?#7_!+#_DANF_4U]R8W,XH
M:R"5MP/2DDE:'MNH$?V:)MO)I+>223/F)@4 9^J>'--\0QC[9:I+_O"H-+\$
MZ+HK;K:PB1\YW!>:Y?XD?&CP[\/$":E?);ROPH8XR:P_ ?QRT_Q9>+;VUPLK
MR'Y .] 'K-Y;P75N$GC#1_W33;B.&.".,P^9%T"XX%/F7SK<B3Y6 W=:\E\
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M>5SVJ'7KY['3WGC&0HSFO/\ X:_%A_&GB'5-,D"@68))'7B@#T62UM;S;)+
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M%%% 'YN?\%;/^/\ ^'__ %]K_P"A5]D_LT_\DUTS_KWC_P#017QM_P %;/\
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MR/P^WQ#\1Z%<7,T]Z;57XMV!Z>E>NZ=\9-:USP/#X0MM%NK2[M5^>XV$;@*
M.!\0?M6>.]!\:3V-W=,VFK,5 4?PYKK=2_:EU>YC2'0[AE++R/>O,YM=Q/>6
M=[X7FN[IB5$IC).?6N<L;Y_ ^J+=WNE/D'<+=EY(H ]STWXB?%_POY/B/7[S
M/ANY8*B]^:YO]J[QC<ZEJ'@V7PLS+J-XZEF_VC5W7/CQ=?&[PA9>$+'PU<V(
MA93YVPXXK=UCP;/H>K>#X[G39+U@Z#?MSY?/6@"#P]\4_B3X+\9Z3H/B.[XN
M(U9>>,8K)^+G[0'Q%\+^)IA!>;],4Y CYXKM?VL/#NH:IJ%C'I%K(U^8%V74
M:G*<5X3X<U[5/ :2P^)-$N-?E*E<,A8T ?4G[)O[0)^+T=[;7$C/=6X^;=ZU
MQ'[2$*K\?-$="PGV*1SQVK"_8OBN=-UKQ-K9T.;3+=B9%B9"N1Z55^(OC34/
MBI\>=)BM-&N+>*/$?V@J<#'O0!WWQ6\>>+O _@U+W3+I5<#H#S7!?LV_M=:Q
MKWB*XT_Q1.[EGV)N'O5?XM6/B'P3JTC7L4^JZ?T$(!(KB-!TD^+/$6FS:7H,
MFG.)5+L$([T >W?'SXQ^-;?QUI_AOP9<>5+>H"OIS7G5C\<OBW#XGF\(7-YN
MUF!=SXKU*71KC3_C/X<6?3Y)CY:_Z5MX7@=Z;X9\'R-^U9K%]<V3-:-"<7#+
M\IZ]Z -3]F_XG^,O%-SKUKXGN0\EH"(]QZ&O(_CC^T=XW\#^)&2UNF**W!3D
M8S7?S>&=8F\0>*&TJ*6Q52Q#*"-_TKP_6/%%UHVAZEI^M>&+C5K]V(CN&C)(
MH ]7M?B[>?'#X8VNGW<N[4=P9B>*]X^ -O\ 8=+-H?OQ(%-?)/PO^'^M7^CP
MZI:VTVG!C_J=I!%?7WP1TZXL+65;E&$FWEF'6@#U:BBB@ KR7]JK_D@_BK_K
MV->M5Y+^U5_R0?Q5_P!>QH ^+_\ @G+_ ,C2OU;^=;W_  5B_P"/3P+_ -?0
M_P#0JP?^"<O_ "-*_5OYUO?\%8O^/3P+_P!?0_\ 0J /IK]DG_DFEI_US3^5
M>Y5X;^R3_P DTM/^N:?RKW*@ J"\+"VDV?>QQ4]5-69DT^9D&6"\8H ^.5^'
M/A[QM^TQ/%K,+S2LIR,\&JO[0GP-T_X6:MI&J^"(C97,TX,P+=LTSQ!\3KOX
M;_&:;5G\/W%V "/,5#S3=:\>:S^T[XBL;:VT^XT."QF5R9%(#@'I0!Z%<>)Q
MJVM>'8-:9FN?+4#\A3?VAOB1XG\%^&_(\'3^1>9 'TIOQ+\-73^//"JVMHZQ
MP(JR2JO&1WIOQ8\,WUU>HL<#W"_+RHS0 [P!\1_$_@WP*-=\83;[FXAW*W^U
MBO ;?]M#Q=<?$*.%YY'TSSL$*,_+FOJ/XI?#N;Q9\'M-@AS%+;PY9,<GCI7S
M=\!ETGP_XFDT[7?"IN7,VT321^_6@#VGQY^TY+JW@T6_A65H=?8#!88J/X5Q
M_%Z^T/4+[Q+<B2UF@8I^5<3\;/"#>#_$7_"7:1IC26"@$6L*YKU#X)_M&/\
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M1[N<?VQ%:F-U)YSBOBF'X=M??'[3-4U#>9/MF^([CC[U=CXN\ ^,M+^-EW-
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M_P#6-4A 8$=J .;U;P;8:Q??:9K>.8_[2@U1?X;Z%=946T.\?PA1Q78H@C7
MZ5%'9QQS-(H^8]: ..M_AGHWG!Y;. ,I^4;!S4MW\,-#N)O.>UAC]@@KKWA6
M1@Q'(I9(UF7:W2@#CC\,-!C7<;2 YZ$H*6/X<:'M*2VD&6^[\@KKFMT9%4CA
M>E$ENDC*S#E>E '(_P#"K=$6(C[)"3ZE!3Y?A_HQA2..R@8KU^05U[*&&#TI
MD<"1L2HY- ''7WPMT2\V8MHHB.H51S4EO\-=!L8]IM(,>I05UWDKNSCFFRVZ
M3?>% '&Q?"C0H[A[A;:-MW(&T8J2U\!Z7(LD4NG0*IX!V"NP6,*H4=!3BH-
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MR1< H&Z=320J+>,A6,A]S4L<*QEB!][K2K&J]!0!'YDFS.WFG0LS9W#%2T4
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MO3+N*TR17C<$'$7>@"AX@TVUUBU\B:WCN>?NNH-9EG\/]%L)(Y19P0R Y&U
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M_83?_P!"-?KBWW:_([_@FS_R4SQ3_P!A-_\ T(U^N+?=H ^4O^"@G_)/;/\
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MTJ/[+'YHDQ\PH S=+TBRCME3[)%"W]Q5  K1M[6.WSLC5/H*D\I?,WX^:GT
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MHHH **** "OQX_;J_P"2U6'_ &$5_P#0A7[#U^/'[=7_ "6JP_["*_\ H0H
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MX)\3O"_A_5+73X_#UVMYK,B@3Q)]Y7]/SK*^'OPEO-#\4V\WBX/96&<M)*.
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M1110 4444 %%%% !7,_$S_DGOB/_ *\)O_0#735S/Q,_Y)[XC_Z\)O\ T T
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M&O'M%^'>L:EX?\>BVMWA$CR8$8QWH F;]N!])UXQ>1)=PA]OF*<CK7V1\/\
MQM%XX\'66KK'C[0H.WTKX5^ WP8\$_\ "%SVOBK5EM=9,Q(CE^]UK[%\)ZUX
M8^&?A>PM4U%&MCA(V)ZT =EXG+67A;47D.[,9(]J^.?#/BJ[T3XC+?AF-NCG
M*BOJ7XM^,[/2/ EW/YJXG@+1^_%?*'PQTS4?&PFNH+8R+O;Y@* /IWPO\9K?
MQ9+>0+8L7MXRY;'H*YKPE\98_B3X>\76+0-";,/&-U>)^$?B[<_#?QGKNGW-
MLJGRF1=P[X-6?V9)=5\1Z5X_O+NT-N)6=HL#&Z@#O/@2]GHL,TS6HFD\QCD"
MFZA\6H/ OC74=1G'EQ2 A58XQ5_X"Z==PV,_GP?-O; 85XE\9/!GB#Q]XZU&
MP%K)#:1$D2(,4 7[G]KBZF\>6-M;,[V\TV&VG@#->J?%S]JA?"]BEG9VCW-R
M\8/[OD]*\'^"OPE\&V?B(0:]JXM[P2819#SG->E^,/ .GZ5\6-/2S<:A;;1]
MX9!H QO 7[56JVVK0S:EIES!!,P4-*"!S7U=XTO#K7POO;^([&DLS,OY5X%^
MTEX?G?P1H@TS28XY1<(6:- #C(KVZ\\VW^":Q.O[]M.";??;0!^?DGC];O0]
M1TM]!EN[]IF"WP0G;SZU]"_LX^-X/!.AM-J5TH81']T[8(XKB/ ?C31O"OAW
M4=/U:WMTO))6*F11NZUSVJ?"W6O&%Q+JFDB8V<@W?N\[<4 =#'^V1=W7Q.^Q
M(L@M?M.W.>",UZQ\8OVHQX5MX9[&UDN7\L'RX^237AOPF^%/A&_\0>3KNI+9
MWL<F,-USFO1O%W@.#1_BAIMK9+_:.ELHW2.,B@#+\$?M5:Q#?Q:SJ6EW45G<
MML"R*0.:]B^,GCRTC\+V&H1V?ERWD>]#CGD5R?[1&EW<_@/2K/1M%B_=S*2T
M48!ZBE^,5MJ5[X5\$VPM,.L:+(H'M0!\V>'?&GC";XW:=LEN39EO]6,XQ7TU
M\8/BMJGA'PXETLLD<N!E<X-<7877_"$_%?2);RPCCMPH+2,M9WQ.UZX^('CZ
M_AU2 6?AG;F*Z PI- %WX7_M5?VUX7\0V>J!IG>%E7>?;%>4> _C1KG@_P"V
MC2M,NIK=YBVZ%21UKF)/"HM=4NX]"<W-ON(9E]*^O_V>-&@T?X1:A,FEPWUZ
M"2!(@)_E0!U?P-^/2>/K2&PN;9XM04?,K_>_*O:46-B24VGWKXW^&NK1>$/B
M]=:YK(738Y<KY/117U[INKV7B"S6>RG65&&05H O29VY4U'&XE^1US]:=;QF
M-2&]:/.03%> : )0-HP.E+110 4444 %%%% !7DO[57_ "0?Q5_U[&O6J\E_
M:J_Y(/XJ_P"O8T ?%_\ P3E_Y&E?JW\ZWO\ @K%_QZ>!?^OH?^A5@_\ !.7_
M )&E?JW\ZWO^"L7_ !Z>!?\ KZ'_ *%0!]-?LD_\DTM/^N:?RKW*O#?V2?\
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M#;X;^"=>OM*-_J:6VH6I4"/H210!WWQG_:KE\/ZY%H6DZ?-+<2H&'E DUG_
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M;]37W*OWVKX:_P""6'_)#=-^IK[E7[[4 /HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \[^.W_)/]0_ZY/_*OYQ?BI_R4;Q#_
M -?C_P Z_HZ^.W_)/]0_ZY/_ "K^<7XJ?\E&\0_]?C_SH _0W_@D;]S4?^N]
M?K?_ !#Z5^2'_!(W[FH_]=Z_6_\ B'TH 9'_ *QJD Q4<?\ K&J1: %HHHH
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MSBV%QM;Z4S3/"^G:?#=PVD:B.Y),PQUS6@89H9-Y8NI[4EY8R321O"_ECN*
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M.DL>C0;!*-KACGBNLU76+3P_9FXO;A(8\XW.<"I-+U:RU:$36<\<RL,Y0YH
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M M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#ND:[;1LCK$)<H/;- &O_P % /%=^VBRV&CW,B2R("/*8@UT7[-_Q"U3X;_
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M\D]L_P#>:N;_ .":/_(D:[_UV%=)_P %!/\ DGMG_O-7-_\ !-'_ )$C7?\
MKL* /M*FJW)%'F?O-M-52&:@!8VW9KQG]I7Q#<1^#[G3M.9OMK= AYKV2,B-
M&8U\,?M$>,O$WB7XM/X;\*!CJK#Y<CY: (OV1?[:\$>.-3U'Q7=7$-I< B(3
ML<9]LUZQ\8OVJ[SP#JMO8Z;9QWDMR?W0(R37SAX]\,_%SPCIMA<>*U M8V!_
M=#FNI^'\NC_%[QQX>EFCD>6S95;<.XH ]M^$7[3U[XW\51>'=:M$L+^09$>,
M&D^-7[3.K?"._D2?3U^QJV%E<=:XWQSX9TWPW^TG;76GQNEXL(QM''2O.O&'
MBR+QQXQUO3?'ZN^EPAOL^U>] 'TI\!_VF-.^+6BWM]<M#!]FYXK@/'7[86H6
M7C]?#WA^T2_#' 91S7@G[/-I96?B:ZL-%65=%FGVRAL_=S7>?'63P'\)]4&K
MZ*D@UA0""1GF@#Z5OOC)>>%_!<.L:_;K9-(F5#^N*\D\"_M5>-O'GBQ;/1O#
MXO\ 2_-VR7"KG:N>M0^#_&-I\9/ L*^-@S:<L>Z+:,<XKR+2?BM>?"'XB6VD
M>"E*Z5=3;9MRYXS0!]I_&>\O;7X=3WEL&6_V@^6IYKS;]F>\EOM8GFO+AS=L
MIW1,>AKN_'6J7.O_  KDN[89OB@/(]J^>/@A^T'X.\)^,+^PU8RIK" AOEXW
M4 >O?M%?'CQ'\&[^S&FZ0+ZSFY>1AG:*S/A+^UG8?$W6(M&N6BMKR3K&O!KQ
M_P".GQHG\4>);&&X!;1'?#?+_!7 ?#?1?#I_:3TVY\-),MOLRV<XS0!]/_%_
M]I;5O MU/I_AS3EU6YM_OKC) K ^$/[8NH>.+'4Y]3L8[5[/.]<8QBO'_'GB
M6?1?BYK26K#S),J^[TKN?@[X3\*+X%\62S#-]=1LQV_WC0!U5G^T]XB\2>(U
M_L;3_M=D."Z#BL;Q?^VIXB\)ZL+.?18P X5BR]!6U\"M#T[PO\)M1NK6)O[1
M61BA85X5=:QIFN>-M6'BB-BFUBF%[T ?2]Y^U7I\_A^*^M)(VNO+W/&IZ''2
MN'\/_MB>)-1UQ'N=)6/1 V'NL<"OF#P/I\6I>+;JVMTF-@TN "#]W-?6_B_P
M-H6C_L_7T=M"1<,,].<T >B?$K]H;3/!_@&U\113QLLW3GBO/OAG^VEIOC36
M(M/U.6&R>9@L('&^OGSXH>$]4O/@GH2WJR'31*.!G.,UW'PL^$?PTUJ;P]=1
M1S#5+;:?3YJ /O&W97@1U.590P/UJ6J]C%Y-G#'V5 !],58H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\E_:J_Y(/XJ_Z]C7K5>2_M
M5?\ )!_%7_7L: /B_P#X)R_\C2OU;^=;W_!6+_CT\"_]?0_]"K!_X)R_\C2O
MU;^=;W_!6+_CT\"_]?0_]"H ^FOV2?\ DFEI_P!<T_E7N5>&_LD_\DTM/^N:
M?RKW*@ HHJEK&IQZ/IL]Y+_JXEW&@#YA_; U36/$VDS>'M"\Q[Q3NQ$>:SOV
M,_$FI:?:ZC8:])(DMC$<B4^E>4>+/$7Q%\6?'^YG\)#=8LI5=XXK&%O\3/@I
MX@U35O&:[+'4<@>6.QH ]Y\=?ME7>D:E<6.C6<=Y*CE% &3UKN_@K\?+CXE$
M:;J4*VFK%2Q@'!KQO]GGP?X-^(!N-8$4C7"R;CO'>K/EQ>$_CQ)<Z.KI.L9'
M3B@#>^)G[8&K^ ?%5QI$>F1RI;OL9V':O2/A_P#M%6'C+P?=ZP[QH]LN60>M
M?)6I:UH_B+QIXL;Q$CM<;7,>!_%BM?\ 8UTZPU#POXJM]5606;3,%S_=R: /
M3&_;&\1:MXL_LK0M&COH]V-RKFO2/BQ\<+WX>^"]*U6^MUMKVXQNB/'/I7RW
M\1/%.E?"/4/M/A!'%\KCJN:]H\=Z_H/Q;^#FA7/B!7;4D0.V!CYL4 =1\,?C
MYXD^(5] /[+VVI(S(H[>M=+^U)J4^D?"N>\@=HYU9?NG%?+?PO\ C!?>&?'F
MG:%IH86DL@3[O:OIC]K"<#X*W$\P).58[1[4 ;'[/NLWFK?#NQN+E#(WE9!;
MG)KS7XT?M4:]\+=0:!]*7R<G$C#M3_@5^T5X5M_AS!IL;R)?VT!RNWJ<5\_>
M/OB##\2KS41KZN\*.PCPO\.: /JKX%_M)V'Q.TX/>RQPR$'BN*^)7[4_B#PO
MXBO;/1M,6]MX"<-C(Q7AG[/MKI5OXR2TL5E2RP3\W%97B#Q3J%G\6=4L4=39
M&38<^E 'TE\-/VLM1\8>#]:U:^L([673P3M QG%5O!?[5'B3QE9O=V6D+- I
M(W*OI6!I_A70['X?ZDNGK\EU$3/M]3UK6\.:5:?#_P#9KO-5T.,K=+(>HR:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX9\"Z>;O39)M/N2(D7:<+GC->4?%;X1#P_XD\/ZSI&HPM]N99?*B<$IGG!H
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M[2_X:<\#_P#00_E2']IWP./^8A_*OC)O^";?Q%W?\CA'C_KI2_\ #MOXB?\
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M#];PB YS2LJR]\U^2CZ!^T&T>T>)[X'ZM5:#PS^T1&Q)\57Y'U:@#]=%"1\
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M#3?_ /?34Y?#7[1+.K?\)5?X7W:@#["_X*+1!OV</$5JLB;Y(SA<\_E7+_\
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MO!'_ #_?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_P#OY_\ 7H_X=N_$3_H;X_\
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M/_OY_P#7H ^R?^&GO!'_ #_?J*/^&GO!'_/]^HKXV_X=N_$3_H;X_P#OY_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !3"X8'#<TX\\5&(5CR10 WS'7C&:
M&@AF7][$C9_O#-/63GFDDD3^*@"H-"TTY(LH#_P 4O\ 8.G?\^4'_? JS&X<
M?N^E2?-0!2_L'3O^?*#_ +X%']@Z=_SY0?\ ? J[\U'S4 4O[!T[_GR@_P"^
M!1_8.G?\^4'_ 'P*N_-1\U %+^P=._Y\H/\ O@4?V#IW_/E!_P!\"KOS4?-0
M!2_L'3O^?*#_ +X%']@Z=_SY0?\ ? J[\U'S4 4O[!T[_GR@_P"^!1_8.G?\
M^4'_ 'P*N_-1\U %+^P=._Y\H/\ O@4?V#IW_/E!_P!\"KOS4?-0!2_L'3O^
M?*#_ +X%']@Z=_SY0?\ ? J[\U'S4 4O[!T[_GR@_P"^!1_8.G?\^4'_ 'P*
MN_-1\U %+^P=._Y\H/\ O@4?V#IW_/E!_P!\"KOS4?-0!2_L'3O^?*#_ +X%
M']@Z=_SY0?\ ? J[\U'S4 4O[!T[_GR@_P"^!1_8.G?\^4'_ 'P*N_-1\U %
M+^P=._Y\H/\ O@4?V#IW_/E!_P!\"KOS4?-0!2_L'3O^?*#_ +X%']@Z=_SY
M0?\ ? J[\U'S4 4O[!T[_GR@_P"^!1_8.G?\^4'_ 'P*N_-1\U %+^P=._Y\
MH/\ O@4?V#IW_/E!_P!\"KOS4?-0!2_L'3O^?*#_ +X%']@Z=_SY0?\ ? J[
M\U'S4 4O[!T[_GR@_P"^!1_8.G?\^4'_ 'P*N_-1\U %+^P=._Y\H/\ O@4?
MV#IW_/E!_P!\"KOS4?-0!2_L'3O^?*#_ +X%']@Z=_SY0?\ ? J[\U'S4 4O
M[!T[_GR@_P"^!1_8.G?\^4'_ 'P*N_-1\U %+^P=._Y\H/\ O@4?V#IW_/E!
M_P!\"KOS4?-0!2_L'3O^?*#_ +X%)_9-@N1]AAQ_US%7OFJ.2<#CO0!372].
MWY%C"#Z^6*N+!' N8HE4_P"R,4Z-1UI)?,_@H CM7D9WWK@59J*$R?QU+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %?CQ^W5_R6JP]/[17_T(5^P]?C9_P4DU!O"_CH:A$N^1;K< ?7-
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MUN-LK QW2)^(I\=U BB-[A';ZU^)'_#U#QG_ - __P ?I/\ AZ=XR_Z!W/\
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M0\9_] __ ,?H_P"'J'C/_H'_ /C] '[>_:H?^>J?]]"C[5#U\U,?[PK\0O\
MAZAXS_Z!_P#X_3O^'J7C/R6C_L[KWWT ?MU]J@Z^='_WT*YSXEW$7_"O?$9,
MJA?L$W.?]@U^,B_\%3/&2V_E_8,MGKOJ#Q%_P4^\7>)/#]WI<UCY:31-&6#^
MHH ]8_X)L_\ )3/%)['4WQ_WT:_7*OR2_P""5-J?$FJ:KJDIV2M=%V ]<U^M
MM "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>forms-4_04.jpg
<TEXT>
begin 644 forms-4_04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# ,<# 2(  A$! Q$!_\0
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M1XWC_B@_X)&Z!\4?^"\'_!;;XC?\%#/VAO#EWKWP _9ROF\6>&/!WB6>XO\
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MX]^(NJ^<=,\!^#O$WB[4([9<W$UGH&BWNIS00D<B23[,NTC@L%#?+FO\A/\
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MH!'%#-=/+*8%C"#&, '^>K_P5$_X.B_VC_V@?V:?BM^RW'^PQKW[,&C?M$>
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M:3")I+OR8I(E\P9#2?Q3^!/^#?K_ (*;_MS_  4_8<_9W^)_P#^$G[ ?P/\
MV6O"OC&QUCQOXF\4P>+/C1\1?&7Q!\2V7C#QYX\U/POHS2ZK8ZKKL^E):^&=
M!N)H['PZT=^;J8PSDC^\7]@K]C#X4?\ !/W]F#X<_LJ_!F/4)/!?PXL;A?[:
MUA;8:QXIUW6+J74]>\3ZJUFB6OVW5]0N))GBC7S(46-9FD9A+( ?8W<_0?S:
MBEHH R=:TNSUK3KW2M2M[:]TS5-/O]*U"PO8$N+&]M=1MVMY[:^@:2,W-E<0
M-+:W%F"1=)<;6"A0Z_D_^S__ ,$//^"8?[,WQIUS]H#X1?LK>"M,^)6KZU=>
M)-+O_$IU7Q;I?@:YO;C[3<?\(%H/B![JS\*>7*\LMK::>JR6SSEE>(QVHC_7
M:B@#-"+A&$LKK&B-&4<F6<QF1]OGE8S,]PL8,]N&*H($!"HV3_F<_P#!83_@
MW0_X*7V?[</QF_:,_98^'&H?M$?#WXU?%WQ'\8?#VO?#K7/#^D>-O ?B;Q-X
ME?7QI.L>'-5U32M5T^31+K4TN;#6-%-Q;2+87<]Y+;M;61G_ --BJY@&XD'K
M^'3/'0\#\* /Y7_V1OV)_P#@NI^TY\%=!^#7_!3']KW2OV?/@CH>B:1H.J>%
M/V:Y="3]I;X]>%;.VCM[W0OB5\=M'OM3_P"%?Z3JM@W]E^*-0\&+!XHO40V,
MRC[1OM_W\D_9P\,^"_V7M0_9>_9UOO\ AG_0K/X9ZE\,OAAK?AG18=<N/APE
M_HMWIUKXIATG7)2VJ:Q;W6IS3:C>WTIU'4+Z\.I:E<E[E;F/ZHC39GG.<?IG
MV'K4E 'XG_\ !'W_ ((S?"O_ ()->%OC$WAWXF>)/C9\1_C?X@TW7O&?Q(\6
M^';'1;U+71%UA-.TS1M(LY9VTL2_V[?W6I;Y7-Y)-;;-T-NRG]HG1BLBX("!
MXXU60++Y;QJBND@!EADR)3'Y>"<<D,!B]10!_(Y\#O\ @V(T_P $_P#!4?Q#
M_P %!OBO^U#KOQ%T73OC[X@_:%^'_@#3?#VL:5XH7QSJ?B^]\7Z%IGBWQEJ$
M\]O)H&A7%]'%'%IL0-XNZ":2) SG^C3]LC]G2Q_:T_95^//[,EYXJU;P/I_Q
MQ^&/BCP WB[PP;M=1\/1ZYHC6,5WIUO:KC48HY$M%EL695O].?440*(]A^KB
MH;&<\5&T0;&">,]3]/:@#_.G_9-_X- ?VZ_!'QYM/%_C#]LSP9^S_P"&? NJ
MWDWACXP_ 2]\3:O\4M7A%WJ"V]SX3TQ+[PM9>$Q=V\L7VR'4]8#V5Q/)##;:
MBBS22_T0^)/V"?V-_P#@B1^QU^T=^W!X2T=_BO\ M6_"WX)^,=:U#]J;]HOQ
M-JGCGXI>-_&TFGZ@-$T^TU+4;F;2_#>IZ[XIU'2[2SM-"TRPFO#=00W]WJ<=
MG$UO_1BZ)'M$F=I=!ZJ2[" (V1_&9P .^">,<_Q ?\'@7[8EUK?AG]FO_@F5
M\(GU/Q5\6OC%XWT/XC>/?!_AF.VN;ZXT>WOSX=^&?AE;2=&D?6_%7BV\N;O1
M)+?/D_\ ".W'F[6D C /A7_@ST_95UCXT_M<?M-_M^?$;2H-:L_AG9W_ (-\
M-:SJTBS:E<?&SXG7R^)?$M]93OM$]SIOA*#4YKYE5VA.O6+#F4L?]&V  %@#
MR/E). SD/(7E(!X$DAD(& ."0,$ ?DM_P1+_ ."?O_#MW_@G[\'_ (!Z]##_
M ,+7U2VF^)'QNN(9K.\@C^*'C,17VO>']/OK2*+[1HW@U4@\*:8) Q":3-.K
MN;IV;]<* "OG/]K/PM\>_''[/?Q3\(_LP^/?"?PN^/&O^%+_ $_X;_$'QSI=
M[K/ACPMK<\EO'+J-_8:47U5I5TU[Y+2XL[2\-K,WFO"6$=?1E1R)OQSC&?UQ
M['TH _S3-"_X-(O^"L_@WXL)\0?!/[3_ .S_ .'O&=AK^K^(X/BOX:^(GQ0T
M7Q'_ &PFL)<'7+4VW@+2M3MKC6;U[B:*VDFE1OLTC2F-9D\W^K[]B;_@GC_P
M5 \&:MX&\5?M[?\ !5[XH?&FT^'>MZ5K5E\'?@KX9\->#_"?B6+2H7>?3/BO
MX^?PO!\3/B##=R0:?')I:75K 8Y+_P"T27!OXBG[X^1[_K_]:GK$%SDGG'?Z
M^U '\(W_  <I_LJ_\%;/^"E?[77P\_9O_9X_97\?:S^RU\%M!TOQ+H?C4:EH
M.E>!/%_Q&\86UT?$?B_4O$6I>)ELGCT"Q^P>&].TQ=/%_I#IJ<EW %OUKU'_
M ()D_L;_ /!T3^S!\+_AU^SC8_$O]C_X-?L_^%?#][:^$D^,>E>%OBEJ7@RT
MU75)-6D\/6FF_#O3;#Q-J6H.U[>W45M>^(OL/F[4NK@E6=/[:M@]3^G^%-:(
M-C!/&>I^GM0!^81\3_'7_@GY^Q5^T=\?/VL_VAM7_:Z\<_#_ ,->-_BW<:UI
MOPJT?X;Z7I^GZ=I$$NB>!/"OP[\+"ZNX--74HKBW2_UC6M1O6A,4F8#]J$W\
M-'_!MC^RY\8_V[O^"L/BS_@H9^TCX,\8>*/!7@F^^(GQNG^)?C#P]>GP_P"*
M?C=XLU"&+PI9V^KWR""]NM!AUC4/%4$=NTJ6B:%!&SGSES_IAW^GV=[;RV=_
M:Q7]G>6\UI=V5S;VUW:7-G/L2XBN[6X4B>W==JR1JKA@V'1@0*@\.Z#H?AK3
M8=(\-Z1I6A:+:H%L]-T*PL=-TB$%Y&=[6SL8XXHWD+#SVVX=E5@2V]B :T/6
M0$_-N&XGAG8*$,NW)*(Y0HB],1$@G)J>BB@ HHHH **** "BBB@ HHHH **I
M7K.BQLAF&QFDQ JEF*KMVN\H^RQQ;'D9VN&4 JICS(HQ_ #_ ,%>?^"]G_!6
MC]CG_@I!J>E^#/@WXC^$7[-'PBN(-"T;X?\ Q!^'TFM^%_C_ .&)9D&I>.=1
M\?6NFWD#6OB0VKP>$)] OC_8<;7IO)9[IC$ #_0+I#U![ '^G_UZ_BQ^%?\
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&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>forms-4_05.jpg
<TEXT>
begin 644 forms-4_05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- N,# 2(  A$! Q$!_\0
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MO@;.-L=2O],D:2PO;BUD<;6:"0H2/0D5>_X2SQ)_T']3_P# I_\ &O3OA?\
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MV(# <\@5VMWX$\-WVCV6DW&FJ]C9$FWB\QQLSUYSD]>]9W_"I_!/_0$3_O\
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M/I5NTU33[^66*SO[6YDB.)%AF5RGU /%>4:U+)#IFMR1/)&/^$?TL3O$2&6
MRN)2,<_<+5ZAI.FZ+8PQMI%I8PQM$H1K:-1NC[<CJ* *GBWQ&?#&B&]BLI+Z
MZ>18K>TC;:TSGD@'GHH9OPK2L-1MM2TJVU*WD!MKB%9T<GC:PR"?P-<;K5]J
M5[\1(%TS23J<&AVY:51<I"$N)AA?O=2(PWT\RN5^T26GA:3PSJ]NUE9V&NVZ
M7<#2A@FGS.7C#.."FX[">F%(H ];MM7TV\MY;BUU&TGAA_UDD4RLJ?4@X%)'
MK&F36+WT6HV;V<9P]PLZF-?JV<#J*X[QA8:/:S^';5K:TM]%N=31;Y8HU2.3
M$;F%9,<%2X7KQT%.\1:?I4?B[PM8S6MK%I,L]P[PB-5BDNA&OE!QT)V[R,]P
M/04 =I#?V=Q:I=0W<$ENY 65) 48DX&"#@\\5(]Q#&Q62:-6"%R&8 A1U/T]
MZ\EUM;*PU#Q5'8".+2K>[TF:=8\"**X\\>80!P#L$9;\":U_%]S!+XGUJ*.5
M'EB\)79D53DJ&88S]<&@#O(=4T^XN)K>&_M9)H1NEC292R#U8 Y ^M4=(\4:
M3K,=]):W<6RSF>*4M(O\)P7X/W3V)KCK31=,TW_A7DEG90PR29BD=$ :5&M)
M&8.?XLL 3GN*K6<NG:%X=U]K?1M/N)KKQ!)81PR(J1DO* @D..$&<XQ].M '
MI%OJFGW=JUU;7UM-;J=IEBF5D!],@XI(M6TV<7!AU"TD%MQ.4F4^5_O8/R_C
M7CVL6TT4/CNQNCIB2-IMCY\6EH8XT8R..03]_;CGCC%=M<:)I6F^/M#MK+3[
M:""XTV[@FB2,!98U,156'\6,GKZGUH W-)\6:/J^B'5H[V"&U5V5VFE1?+PQ
M4;CG SC(]B*U[>XANX$GMYHYH7&4DC8,K#V(X->7:#X8BU+P%H\NF+IL5]:W
M\]PL-S"##<LLDJ;9 .>%8X/)4@<5W'@_58-9\,6MW;V,=BFZ2)K>(@HCH[(V
MTKP5W*2".H- &[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>@]HO/[F=A8^&=#TVS:TL]*M(;=I5F:-8A@NI!5CZD$#![8J?4M&TW6/L_\
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MW(^:3GYOKR?S-:]K:V]C:Q6MI!'!;Q*%CBC4*JCT '2N _X2_P ?_P#0@?\
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M1_PE_C__ *$#_P GEH]C+R^]![1>?W,]%HKSK_A+_'__ $('_D\M'_"7^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>forms-4_005.jpg
<TEXT>
begin 644 forms-4_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "K F,# 2(  A$! Q$!_\0
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M>*&)2\DDFBWBJB@9)),6  .]2?\ ";Z/_P \-:_\$=[_ /&JS_&W_(A>(O\
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MV/HX_&#P,.NL3?\ @ON?_C=6;3XH^$[^58K.\OKF1NB0Z5=.3^ BKYK6V)P
MH+M@*/0D9I!X>\2"W:_M_M$]NC;R89"'4CN/<5E4PO)U*C4N?4O_  F6E_\
M/KKG_@BO?_C-!\9Z6!DVNN8_[ 5[_P#&:J_#N\;4/!5A='5I=3213MFG0+*N
M."CXZL#D9[UT\O\ J7_W37);6QIT,#_A-]'_ .>&M?\ @CO?_C5'_";Z/_SP
MUK_P1WO_ ,:J[16OLEW,O:OL9T_C[0K:WDN+A=7BAB4O)))HMXJHH&223%@
M#O4G_";Z/_SPUK_P1WO_ ,:K/\;?\B%XB_[!=S_Z*:MVCV:#VC*7_";Z/_SP
MUK_P1WO_ ,:JM+\1_#4$HBFFU*.0ML"/I%V"6QG&#%UP0<5K5YWXC4/XPMAC
MI=,2/4B!"#6&(?LH\R.S!4EB*C@]+*YU*_$_PHY0+=WQWDA<:5=_,1U _=<X
MH_X6AX3V[OM=]MV>9G^RKO&W^]_JNGO7FEA;3_8M*N@G[J*.Z<MGJ>:A+?Z
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M\LCCZBNCKE/"Y==2F3:=GE$YSW!%=77M87^&>77^,****Z#$PO&W_(A>(O\
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M/_HIJW:74?0*49["DI<MC Z5G5V+I[B.,FN;F\.VMT+M6NW,LMTTTK1D9Y7
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M-&F2_P"I?_=-/IDO^I?_ '36RW,'L9M%%%=1RA1110!A7?\ R/ND?]@N^_\
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MS1*Q>4GY3A\<<=ZELU$5VP]4R?SIT/C*GI$M:%YG]KWF_@;1@9]ZWY?]2_\
MNFL'19!)K=YC Q& 1G/<UO2_ZI_]TUZ^%^!>OZG%7^)F;1117I' 87C;_D0O
M$7_8+N?_ $4U;M87C;_D0O$7_8+N?_135NTNH^@4].#3*7<%QN.![UG5^$TI
M;E&X#-?A]X6*(A>!DLQ[?RJH93=2(T. HBWDD?WL\_F#5N:;3[9Y/,E@3+;B
M6<#)JL^LZ7&0!=PYQP$YX_"N;GCW-U&781&6&;RMY9W.Y@HY^IJN@,\&T&X4
M32%"V,'"@\D'IG!_.A_$>EJ3B5F(Y)$;<?CBH7\366\HL<[-MW8"=1ZX]/>E
M[2/<KV4WT+,Q:XM]NV3]XPC.#C /4_E4(><3R2F"0A7PJ@XR"=I_(<U2NO&.
MEV<1>Y=HSV3@NWT _KBN=N_&.M:H&72+ VT./]=,,MCU I.K%'12P5:IK:R[
MO1'5WNKKI\;37:)% 'VAG?!(!.3C\,_B*YFX^)EI'-&MO:/-'O"R2G*J!WV^
MM<_>6-O#F[UN_>\FRV4=\9_NX'7D\57NF?6;:&SL].6W@+@133'8"?0>IZ_G
M6,ZTNFAZ5#+J*LYW:[[+_-GL:.LB!T8%6 *D=Q5V'_4K7FVD>([FPTJQLLQ3
M$3&S29@1EAT!'H!QFN[T"^;4=&BN7 #EY$8 8&5=EZ?A75AZBE*R/&Q>&G25
MWM<TJS-(_P"1]UK_ +!=A_Z-NZTZS-(_Y'W6O^P78?\ HV[KHJ?"<E/XCJ**
M**P-SG_'?_)//$O_ &"KK_T4U6ZJ>._^2>>)?^P5=?\ HIJMUK2ZF57H%%%%
M;&(5Y3XLO+:V\9W9PDLJ&-VC8<?ZM< ^OK7JU>/>-IU/B^_ARH*M&<CK_JTZ
MUQ8[^&O4Z\'_ !'Z&1J%_-=2/(\FYB>I.>W0#L*QI=+M;MBTB@CKGIBIS=)&
MP1E^=L@*HRQ)ZTUY<J[$2#R\[CL/R\5Y<5+='K*$WJD4UT6RCX\G>PZY-7+2
M-89)$A1$"]%C7!;/3FGK+ #L$\B29&5,3$\BKEEID<ZRRG5H5C!_>JT;J1Q]
M*U@W?W@<)K=,FO+&2ZT^&2.)$W')D>0?*._%<G?J-*U@13I'-&OSIE>,D8)Q
M_3UKH;V^2T:VLX=1AGM0?G"J<[<YZFJDCZ?=7EW(/+9I48 \<\+CK^-="<-T
M81A-2]Y:"6,=UJ%I%!8V02+.)'Z #J,GWJ\AE@9F8'<,JR$<@@U:_M5-(TDP
MO(6LI5RS0C+*JD9'OUI^K7D=U=QE"OE)'\LF/O[L'(]L8_6IJQ3CS"E-N=K:
M'9^!3G69B,A6MBV,=]RYKT"O.OA_+NU4H6+D6C8<]QO3_P"M7HM=^&_AH\RO
M\84445N8F%XV_P"1"\1?]@NY_P#135NUA>-O^1"\1?\ 8+N?_135NTNH^@44
M44Q!3XO]<G^\*93XO]<G^\*3V&MS2KE?$:HVK6Q8D; &&/6NJKDO$X)U*''7
M8,?G7(U<ZA^=Z[>HJI#ID45T\X^\_P!X^HJW%]T4\@DTA-)[D%W(;> R(A<@
M@ >I-9POII7/EZ:\OKNXYJY?M>[56T53S\Q8XQ5:2UU":=66X6,;!E03C=]*
MB6IT4U%+6P^7^T7CB:WA2$[060XZY.1_*IK5KPRR?:6B$:CA4ZY]35<Z?(9/
M-%VZ90*0G?'O4!TZTM!Y]Q<NS%QAI7P,]A[T6:&W%JWZ%VX;>WTKJ-(7;I<
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M3Z9+_J7_ -TUV+<\9[&;11174<H4444 85W_ ,C[I'_8+OO_ $;:UNUA7?\
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M_P"C;NO1J?"?)4_B.HHHHK W.?\ '?\ R3SQ+_V"KK_T4U6ZJ>._^2>>)?\
ML%77_HIJMUK2ZF57H%%%%;&(5\Y?%%B/B%K*@X#"#/\ WZ2OHVN)U_X7Z)XB
MUJYU2[NM02>XV[UAD0*-JA1C*$]%'>LJT'.-D=6%JQI3;EV/G<RL&!SR$Q^&
M*8&8^6/>O>/^%)^&\Y^VZMTQ_K8__C=.7X*^&U*G[9JIVG.#+'S_ ..5S^PF
M=WUVE_2/!XXI91\B,WS?A5G[!,V[[@W'C+5[O_PJ'P_LV_:]2QZ>9'_\10WP
MAT%RNZ]U,A00!YD>/_0*7L*A:QF'ZM_<>!W$3PF170J>,9[BJ[\;^_ %?0,O
MP=\/S0+"U[JFU6R#YL>1[?<Z5 ?@GX;;=F^U;G_IK'_\;JE1F92Q=*^C_ \"
M/7Z)0IP4QV7->^'X(>&CG_3M6YX_UL?_ ,;I!\$/#0.?MVK=,?ZV/_XW1[&9
M/UNF<A\$3_Q5]T/^G"0_^1(J]ZKD?"WP[TCPCJ4E]87-])*\)A(G="NTLK9X
M4<Y45UU=%*+C&S.+$5%4GS1"BBBM# PO&W_(A>(O^P7<_P#HIJW:PO&W_(A>
M(O\ L%W/_HIJW:74?0****8@I\7^N3_>%,IR':ZL>@(-)[#6YIUPOCF273]1
MLK\IOM67RI0>W.0:[+[9'Z-^54=7M[75].FLYT)61<9(Z'UKEE"36AV4JE.,
MTY;'A%U-'-?W$B$[&D+#CG%0G'8-CUQ78_\ "NM8CD(BN;$QYX+.X/\ Z#4<
MOPYUMONW5@?]Z1__ (BO(EA*[?PL^QAF>"C%+VB_KY'&.P%0DC-=I'\+]8=O
MWU]9(/\ 8+M_-16G:?"R!3F[U&1_:-0*N.!K/=&<\YP<=I7/.59<&FF1,A=P
MSZ5[)9_#WPY;$&2"6=O61L_UK=MM#T*T&(=.B7W""M8Y?/J<E3/Z*^!7/)/!
M>FW\_B6QN((9/*BD#,Y& !WY->\BJ<3VL(Q'#M^BBI?MD?HWY5V4J#IJR/#Q
M>-^LSYGH6*9+_J7_ -TU%]LC]&_*FO=(R,H#9((Z5LH2OL<CG&VY4HHHKH.<
M**** ,*[_P"1]TC_ +!=]_Z-M:W:PKO_ )'W2/\ L%WW_HVUK=I(;"GQ?ZU/
M]X4RGQ?ZY/\ >%#V!;FE1117*=1YK\1?AUJ7BK58M0TJ]MH#Y BFBG0D28)P
M?R)%>8W?P8\;0L3%#93_ /7*?;_,>U?3%%:QK3BK(EQ3/E*X^&OCF#.[0IGZ
M\HZMWSZUGS>#_%D.[S/#FHCKTA)Z\]J^O:*M8F8O9H^-)-(UN%LS:-J"?-DY
MMG[C'I5.2*[1<26=RAV8^:%AT/TK[6P#V%-:&-OO1H?JHJEBI"]FCXF:X8,Q
M97'S!N5(IHN0&4$GAF_45]K-86;_ 'K6!OK&*B.CZ8W73[4_6%?\*/K4NP>S
M1\:PWGFJJJN75,#'4\FO0/"?PA\0>(!%=7I&F:?( P9^9&4^B]OQKZ)31M,C
M<.FG6JL.C"%01^E7L8I2Q,GL-01B^%O#%AX2T5-,T[S#$&+L\C99V/4G\JUY
M?]4_^Z:?3)?]2_\ NFN>]W=E/8S:***ZCE,+QM_R(7B+_L%W/_HIJW:PO&W_
M "(7B+_L%W/_ **:MVEU'T"O%?'49D\;ZB20%7RN?^V:U[57BGQ" _X3&]"-
MRWEEQZ?NUQ7)C?X:]3WN'?\ >I?X7^:,!;E0^U?NKR36Q9^/M8M(;;3;4VRH
M&VB65-Q )[_2N9D=!PIPH]>]$$UK\GVB>Y0*Y.V(#@8&"">_7]*\V$FG=,^K
MQ%*G4C:<;G82>)M?NW!?6K=(^2HCMLGC.#C''2LU]:U6>.0W7B"^90Q4+'\H
M)S@<GIQS6/-<Z20S+_:$K[3M+RJN&[=!TJ$7FGK'*O\ 9Q=F;*,\S':/3'>K
M<WW...%BEI'\$6Y+F)I!]JGGF^5?-#W!!W8.<8SQG'ZTB3Z:JXCLQ(^<!LN^
M?\^E4O[52-\PZ?:(,@X*;N1]:FD\1ZC*AC^T"-"=VV- HS@CM[&IYC7V4NB_
M'_(UK:]F#LW]C&4.<HWV< 9;D=1SP*R-0T^6U3S7LKR .<@RJ OX<55>]NWQ
MFYE.  /G/;I3#/<W1V22R/Z!F) I-W-*=-P=U^HP=:]]^')SX"TP_P#77_T:
M]> K(T0SD<]CZ5[]\.',G@+3&.,GS>G_ %U>NK!?Q'Z'D\0.^&C_ (OT9U-9
MFD?\C[K7_8+L/_1MW6G69I'_ "/NM?\ 8+L/_1MW7H5/A/DJ?Q'44445@;E/
M5M-AUG1K[2[AI%@O;>2WD:,@,%=2I(R",X/H:QO^$5OO^APUS_OU9?\ R/72
MT4TVMA-)[G-?\(K??]#AKG_?JR_^1Z/^$5OO^APUS_OU9?\ R/72T4<S[ARK
ML<U_PBM]_P!#AKG_ 'ZLO_D>C_A%;[_H<-<_[]67_P CUTM%',^X<J['-?\
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G+Z35+[4+FZBBA9[L1#:D9<J (XT'65NN>U;5%4VV9))!1112&?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>forms-4_006.jpg
<TEXT>
begin 644 forms-4_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# '$# 2(  A$! Q$!_\0
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?Q /Y445]7"C3@ERQ2^2/D)UJDV^:3?S9/1115$G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>forms-4_007.jpg
<TEXT>
begin 644 forms-4_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #  D(# 2(  A$! Q$!_\0
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M -@VZ_\ C=>3>-I-.U37UU#3+I&$L8$^58?,. <8],?E6&%39AY6+KT*I_\
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MI_X)KS_XU7FJ>(KJ6R^T(#MSM+D H/Q.*A;Q3<+;"19(I65L/&L9#*OK2]M
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M'8G-:MAK>H7-A:(L[!I58[5 X [9-)58N3BMT'.C</CK15;:T>L@^AT2]_\
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MZBV!_7-'UJIT2^\7U9K<[%?B!H#?=_M8_31KS_XU0WQ T!#AO[54^^C7@_\
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MJ,J>YQ7"ZTI.[/96!I0221NW'C>T^3RM-D#*, _*,#K5-_&DJ99-, '][?\
MX"N99B>OWEI&O1 "NW<S#.".,5/M9%?5*2U.PTOQA<WNJ6EG]ACC6:54+[R3
M@GK7H'A:8S^'H92,;I)O_1KUXQX7D:36H[ACM2U1Y\?0<?J17K'PZD,O@/39
M&.2WFD_]_7KJPS;NV>9CJ<*;48ENT_Y'W5_^P78_^C;JNJM/]2?]ZN5M/^1]
MU?\ [!=C_P"C;JNJM/\ 4G_>K>?PG'#XCC?&,L-Q?/9W$;O&+?("#YB^>,?E
M7*V?EV75291(J 2@;@#ZXZ_6MWQ'<M-XNEC!PUM&A ]5;.?R.*Y^2VM[+4A
MHGF*XE('4>G)KQZ[M)R/=PRO!1U+\5O,TT=XZN(A&6(1?NGIP*7'G(OE(1-(
M=AF,>TXQS44:D0K>6\BHA; 8,Q<GTQGK4[ZF8K]6>)]JJ-Z28R1_>!%<WNQO
MS:7_ %.KWI6Y=;?H,N78V29\UESA88C]P=B?<U7FE>/RC)"[W CW/N<CY>W
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M_P"@FN:TB/$P)Z"&)?R05TVE?\A&+\?_ $$U[U+:)\E7^*7S)[3_ )'W5_\
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MI:@G35[6_I_Y#5UR[M]/LFMX4+.^R1FZ;_[OM5MM=U*.T$4\4<=S)*41F&%
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M\=5W9-:?\C[J_P#V"['_ -&W5<[\5(@-/TFY/1;EHV&>Q7_ZU=%:?\C[J_\
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M5Q]X129_O1CG\:CV*OH_O.A8Z35IQ^XY1FT>;4WO$O&F=^8[;R-J9VX"EB0
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M[:MJ?PLQJ?$CQ_3;\K'\Q '')P!7HFF3>;;H?4=Z^>+>\:&S2UFB:ZCCEW;
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M)QL)]^V17*Z<Q#*%=LCID9.:ZRV\HYD0QY++A20-QSUQ7(CL9=C\A))!#N*
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M9&/N[<CG/>LX:)J,\PDNKR&3YO,P+<J=Q&.3N-:T]VS2((KA A'J.:B;4)$
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MSR>?\\4 [3@]J:\,<Y=6NIE23[R* ,\8ZXS3BE?4'*25D/O)8(KB-$6(ORI
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M$BM\'/GCS6.7%Z6B5K3_ )'W5_\ L%V/_HVZKI N_3IU]0P_2N;M/^1]U?\
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M%<KH/@]=*U"2]FN!+*YW!0,*IQUKJA6D7*7O25F>7BZ[K3NW<Y"'_DH>M?\
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MPHJM<>$4V[([Z0G')*#BE9E+%T>YR5]=$)Y*."1WKTGX6+MN;H$Y/]EVG/\
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M%G_0>T7_ ,$\O_R30G!; _:/=_U]QQ/_  I3P]_T$M8_[_1__&Z/^%)^'?\
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'^BBB@H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>forms-4_008.jpg
<TEXT>
begin 644 forms-4_008.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !D 2\# 2(  A$! Q$!_\0
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M:1'<I)%^[<GC"G^]CL:XCQYXOD\-V=A8Z'IK7VOZE?&QTZQ@.T23M_$S'[J
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M2J*=*[6I^P<.YK4Q,U0JSU1Y)JFMS1%$V91F"+%"O5B<#/\ C7TE^R/X%OO
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+*\6R2;2')MO4_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex23-2_001.jpg
<TEXT>
begin 644 ex23-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  H@# 2(  A$! Q$!_\0
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MTXMV<5UW/3Z***\T[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_"&>*?^B@ZC_P" <5'_  AGBG_HH.H_^ <5=S11[67])?Y!R(X;_A#/%/\
MT4'4?_ .*C_A#/%/_10=1_\  .*NYHH]K+^DO\@Y$<-_PAGBG_HH.H_^ <5'
M_"&>*?\ HH.H_P#@'%7<T4>UE_27^0<B.&_X0SQ3_P!%!U'_ , XJ/\ A#/%
M/_10=1_\ XJ[FBCVLOZ2_P @Y$<-_P (9XI_Z*#J/_@'%1_PAGBG_HH.H_\
M@'%7<T4>UE_27^0<B.&_X0SQ3_T4'4?_  #BH_X0SQ3_ -%!U'_P#BKN:*/:
MR_I+_(.1'#?\(9XI_P"B@ZC_ . <5'_"&>*?^B@ZC_X!Q5W-%'M9?TE_D'(C
MAO\ A#/%/_10=1_\ XJ/^$,\4_\ 10=1_P# .*NYHH]K+^DO\@Y$<-_PAGBG
M_HH.H_\ @'%1_P (9XI_Z*#J/_@'%7<T4>UE_27^0<B.&_X0SQ3_ -%!U'_P
M#BH_X0SQ3_T4'4?_  #BKN:*/:R_I+_(.1'#?\(9XI_Z*#J/_@'%1_PAGBG_
M **#J/\ X!Q5W-%'M9?TE_D'(CAO^$,\4_\ 10=1_P# .*C_ (0SQ3_T4'4?
M_ .*NYHH]K+^DO\ (.1'#?\ "&>*?^B@ZC_X!Q4?\(9XI_Z*#J/_ (!Q5W-%
M'M9?TE_D'(CAO^$,\4_]%!U'_P  XJ/^$,\4_P#10=1_\ XJ[FBCVLOZ2_R#
MD1PW_"&>*?\ HH.H_P#@'%1_PAGBG_HH.H_^ <5=S11[67])?Y!R(X;_ (0S
MQ3_T4'4?_ .*C_A#/%/_ $4'4?\ P#BKN:*/:R_I+_(.1'#?\(9XI_Z*#J/_
M (!Q4?\ "&>*?^B@ZC_X!Q5W-%'M9?TE_D'(CAO^$,\4_P#10=1_\ XJ/^$,
M\4_]%!U'_P  XJ[FBCVLOZ2_R#D1PW_"&>*?^B@ZC_X!Q4?\(9XI_P"B@ZC_
M . <5=S11[67])?Y!R(X;_A#/%/_ $4'4?\ P#BH_P"$,\4_]%!U'_P#BKN:
M*/:R_I+_ "#D1PW_  AGBG_HH.H_^ <5'_"&>*?^B@ZC_P" <5=S11[67])?
MY!R(X;_A#/%/_10=1_\  .*C_A#/%/\ T4'4?_ .*NYHH]K+^DO\@Y$<-_PA
MGBG_ **#J/\ X!Q4?\(9XI_Z*#J/_@'%7<T4>UE_27^0<B.&_P"$,\4_]%!U
M'_P#BH_X0SQ3_P!%!U'_ , XJ[FBCVLOZ2_R#D1PW_"&>*?^B@ZC_P" <5%=
,S11[67])?Y!R(__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>glaq-20210930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSCabP9z5Z8OekhvWBzbemKTyshFgQmly8B0rNWodYE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:GLAQ="http://globis.com/20210930" elementFormDefault="qualified" targetNamespace="http://globis.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://globis.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" id="StatementOfChangesInStockholdersDeficitEquity">
	  <link:definition>00000005 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" id="StatementOfChangesInStockholdersDeficitEquityParenthetical">
	  <link:definition>00000006 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StatementOfCashFlows" id="StatementOfCashFlows">
	  <link:definition>00000007 - Statement - Condensed Statement of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" id="DescriptionOfOrganizationAndBusinessOperations">
	  <link:definition>00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" id="RestatementOfPreviouslyIssuedFinancialStatements">
	  <link:definition>00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/InitialPublicOffering" id="InitialPublicOffering">
	  <link:definition>00000011 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/PrivatePlacement" id="PrivatePlacement">
	  <link:definition>00000012 - Disclosure - PRIVATE PLACEMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000013 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/Commitments" id="Commitments">
	  <link:definition>00000014 - Disclosure - COMMITMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000015 - Disclosure - STOCKHOLDER&#8217;S EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/IncomeTax" id="IncomeTax">
	  <link:definition>00000016 - Disclosure - INCOME TAX</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/FairValueMeasurements" id="FairValueMeasurements">
	  <link:definition>00000017 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000018 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" id="RestatementOfPreviouslyIssuedFinancialStatementsTables">
	  <link:definition>00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/IncomeTaxTables" id="IncomeTaxTables">
	  <link:definition>00000022 - Disclosure - INCOME TAX (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
	  <link:definition>00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" id="DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative">
	  <link:definition>00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" id="ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails">
	  <link:definition>00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" id="ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical">
	  <link:definition>00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" id="RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative">
	  <link:definition>00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" id="ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails">
	  <link:definition>00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" id="ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails">
	  <link:definition>00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/InitialPublicOfferingDetailsNarrative" id="InitialPublicOfferingDetailsNarrative">
	  <link:definition>00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/PrivatePlacementDetailsNarrative" id="PrivatePlacementDetailsNarrative">
	  <link:definition>00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/CommitmentsDetailsNarrative" id="CommitmentsDetailsNarrative">
	  <link:definition>00000034 - Disclosure - COMMITMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000035 - Disclosure - STOCKHOLDER&#8217;S EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
	  <link:definition>00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" id="ScheduleOfIncomeTaxProvisionDetails">
	  <link:definition>00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="ScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
	  <link:definition>00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
	  <link:definition>00000039 - Disclosure - INCOME TAX (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails">
	  <link:definition>00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" id="ScheduleOfCondensedBalanceSheetDetails">
	  <link:definition>00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="glaq-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="glaq-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="glaq-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="glaq-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="GLAQ_GlobisAcquisitionCorpMember" name="GlobisAcquisitionCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_TotalStockholdersEquityMember" name="TotalStockholdersEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PrivateSecuritiesMember" name="PrivateSecuritiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" name="GlobisSPACLLCAndUpAndUpCapitalLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_GlobisSPACLLCMember" name="GlobisSPACLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_TrustAccountMember" name="TrustAccountMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_UnderwriterMember" name="UnderwriterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_RedeemableCommonStockMember" name="RedeemableCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NonRedeemableCommonStockMember" name="NonRedeemableCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PlacementUnitsMember" name="PlacementUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_UpAndUpCapitalLLCMember" name="UpAndUpCapitalLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PrivateWarrantsMember" name="PrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_SponsorsMember" name="SponsorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_AdministrativeSupportAgreementMember" name="AdministrativeSupportAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_SponsorMember" name="SponsorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" name="CommonStockPriceBelowNinePointFiveZeroPerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" name="CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NotePayableMember" name="NotePayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_LenderMember" name="LenderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PromissoryNoteRelatedParty" name="PromissoryNoteRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockRedemptionShare" name="CommonStockRedemptionShare" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_FormationAndOperatingCosts" name="FormationAndOperatingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" name="BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" name="BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" name="StockIssuedDuringPeriodValueSaleOfPlacementUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" name="StockIssuedDuringPeriodSharesSaleOfPlacementUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" name="ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" name="OfferingCostsIncludedInAccruedOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" name="InitialClassificationOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_DisclosureInitialPublicOfferingAbstract" name="DisclosureInitialPublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_InitialPublicOfferingTextBlock" name="InitialPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_DisclosurePrivatePlacementAbstract" name="DisclosurePrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PrivatePlacementTextBlock" name="PrivatePlacementTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" name="CommonStockSubjectToPossibleRedemptionPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" name="ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CashHeldOutsideTrust" name="CashHeldOutsideTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockRedemptionShares" name="CommonStockRedemptionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_ChangeInSharesSubjectToPossibleRedemption" name="ChangeInSharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_InitialSharesSubjectToPossibleRedemption" name="InitialSharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_AccretionForCommonStockToRedemptionAmount" name="AccretionForCommonStockToRedemptionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockIssuedValue" name="CommonStockIssuedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" name="NumberOfSharesOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" name="ChangeInValueOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" name="NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" name="NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockSharesSubjectToRedemption" name="CommonStockSharesSubjectToRedemption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_NoticePeriodForRedemptionOfWarrants" name="NoticePeriodForRedemptionOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PercentageOfProceedsFromBusinessCombination" name="PercentageOfProceedsFromBusinessCombination" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_MarketValueOfCommonStock" name="MarketValueOfCommonStock" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_PercentageOfExercisePriceOfWarrants" name="PercentageOfExercisePriceOfWarrants" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" name="ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" name="RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember" name="UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption" name="WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption" name="EarningsPerShareBasicAndDilutedNotSubjectToRedemption" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption" name="EarningsPerShareBasicAndDilutedSubjecttoRedemption" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>glaq-20210930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globis.com/role/Cover" xlink:href="glaq-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheets" xlink:href="glaq-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheetsParenthetical" xlink:href="glaq-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementsOfOperations" xlink:href="glaq-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfCashFlows" xlink:href="glaq-20210930.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOffering" xlink:href="glaq-20210930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacement" xlink:href="glaq-20210930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactions" xlink:href="glaq-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/Commitments" xlink:href="glaq-20210930.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquity" xlink:href="glaq-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTax" xlink:href="glaq-20210930.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurements" xlink:href="glaq-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEvents" xlink:href="glaq-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxTables" xlink:href="glaq-20210930.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurementsTables" xlink:href="glaq-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="glaq-20210930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:href="glaq-20210930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="glaq-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/CommitmentsDetailsNarrative" xlink:href="glaq-20210930.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:href="glaq-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="glaq-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="glaq-20210930.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:href="glaq-20210930.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="glaq-20210930.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:href="glaq-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCondensedBalanceSheetDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PromissoryNoteRelatedParty" xlink:label="loc_GLAQPromissoryNoteRelatedParty" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_GLAQPromissoryNoteRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_FormationAndOperatingCosts" xlink:label="loc_GLAQFormationAndOperatingCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_GLAQFormationAndOperatingCosts" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:title="00000006 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfCashFlows" xlink:title="00000007 - Statement - Condensed Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:label="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/Commitments" xlink:title="00000014 - Disclosure - COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDER&#8217;S EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTax" xlink:title="00000016 - Disclosure - INCOME TAX" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxTables" xlink:title="00000022 - Disclosure - INCOME TAX (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurementsTables" xlink:title="00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:title="00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:title="00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/CommitmentsDetailsNarrative" xlink:title="00000034 - Disclosure - COMMITMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000035 - Disclosure - STOCKHOLDER&#8217;S EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:title="00000039 - Disclosure - INCOME TAX (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:title="00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>glaq-20210930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globis.com/role/Cover" xlink:href="glaq-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheets" xlink:href="glaq-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheetsParenthetical" xlink:href="glaq-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementsOfOperations" xlink:href="glaq-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfCashFlows" xlink:href="glaq-20210930.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOffering" xlink:href="glaq-20210930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacement" xlink:href="glaq-20210930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactions" xlink:href="glaq-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/Commitments" xlink:href="glaq-20210930.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquity" xlink:href="glaq-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTax" xlink:href="glaq-20210930.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurements" xlink:href="glaq-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEvents" xlink:href="glaq-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxTables" xlink:href="glaq-20210930.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurementsTables" xlink:href="glaq-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="glaq-20210930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:href="glaq-20210930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="glaq-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/CommitmentsDetailsNarrative" xlink:href="glaq-20210930.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:href="glaq-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="glaq-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="glaq-20210930.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:href="glaq-20210930.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="glaq-20210930.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:href="glaq-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCondensedBalanceSheetDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAssetsAbstract_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_30" xlink:to="loc_us-gaapAssetsCurrentAbstract_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_30" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_30" xlink:to="loc_us-gaapPrepaidExpenseCurrent_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_30" xlink:to="loc_us-gaapAssetsCurrent_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_30" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_30" xlink:to="loc_us-gaapAssets_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PromissoryNoteRelatedParty" xlink:label="loc_GLAQPromissoryNoteRelatedParty_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_GLAQPromissoryNoteRelatedParty_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapLiabilities_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapCommitmentsAndContingencies_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapStockholdersEquityAbstract_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_30" xlink:to="loc_us-gaapPreferredStockValue_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_30" xlink:to="loc_us-gaapCommonStockValue_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_30" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_30" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_30" xlink:to="loc_us-gaapStockholdersEquity_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_30" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_30" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShare" xlink:label="loc_GLAQCommonStockRedemptionShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQCommonStockRedemptionShare_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_30" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_50" xlink:to="loc_us-gaapInvestmentIncomeInterest_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_50" xlink:to="loc_us-gaapNonoperatingIncomeExpense_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_FormationAndOperatingCosts" xlink:label="loc_GLAQFormationAndOperatingCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQFormationAndOperatingCosts_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:label="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock_50" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TotalStockholdersEquityMember" xlink:label="loc_GLAQTotalStockholdersEquityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GLAQTotalStockholdersEquityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:label="loc_GLAQStockIssuedDuringPeriodValueSaleOfPlacementUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GLAQStockIssuedDuringPeriodValueSaleOfPlacementUnits_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:label="loc_GLAQStockIssuedDuringPeriodSharesSaleOfPlacementUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GLAQStockIssuedDuringPeriodSharesSaleOfPlacementUnits_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:title="00000006 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfCashFlows" xlink:title="00000007 - Statement - Condensed Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapInvestmentIncomeInterest_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:label="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapPaymentsOfFinancingCosts_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" xlink:label="loc_GLAQOfferingCostsIncludedInAccruedOfferingCosts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_40" xlink:to="loc_GLAQOfferingCostsIncludedInAccruedOfferingCosts_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_40" xlink:to="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption_40" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="loc_us-gaapErrorCorrectionTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapErrorCorrectionTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialPublicOfferingTextBlock" xlink:label="loc_GLAQInitialPublicOfferingTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQInitialPublicOfferingTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivatePlacementTextBlock" xlink:label="loc_GLAQPrivatePlacementTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQPrivatePlacementTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/Commitments" xlink:title="00000014 - Disclosure - COMMITMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDER&#8217;S EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTax" xlink:title="00000016 - Disclosure - INCOME TAX">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSubsequentEventsTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_GLAQEmergingGrowthCompanyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQEmergingGrowthCompanyPolicyTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUseOfEstimates_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapMarketableSecuritiesPolicy_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:label="loc_GLAQCommonStockSubjectToPossibleRedemptionPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQCommonStockSubjectToPossibleRedemptionPolicyTextBlock_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_40" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" xlink:label="loc_GLAQScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxTables" xlink:title="00000022 - Disclosure - INCOME TAX (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurementsTables" xlink:title="00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GLAQGlobisSPACLLCMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TrustAccountMember" xlink:label="loc_GLAQTrustAccountMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GLAQTrustAccountMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FranchiseMember" xlink:label="loc_us-gaapFranchiseMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapFranchiseMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees_230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_230" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_230" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_230" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingCostsAndIncomes" xlink:label="loc_us-gaapLiquidationBasisOfAccountingCostsAndIncomes_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLiquidationBasisOfAccountingCostsAndIncomes_230" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice_230" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_230" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CashHeldOutsideTrust" xlink:label="loc_GLAQCashHeldOutsideTrust_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GLAQCashHeldOutsideTrust_230" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent_230" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_WorkingCapital" xlink:label="loc_GLAQWorkingCapital_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GLAQWorkingCapital_230" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent_230" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_230" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_230" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketableSecurities_230" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapCommonStockValue_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStockholdersEquity_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShares" xlink:label="loc_GLAQCommonStockRedemptionShares_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQCommonStockRedemptionShares_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInSharesSubjectToPossibleRedemption" xlink:label="loc_GLAQChangeInSharesSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQChangeInSharesSubjectToPossibleRedemption_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnderwritingIncomeLoss" xlink:label="loc_us-gaapUnderwritingIncomeLoss_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapUnderwritingIncomeLoss_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialSharesSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQInitialSharesSubjectToPossibleRedemption_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AccretionForCommonStockToRedemptionAmount" xlink:label="loc_GLAQAccretionForCommonStockToRedemptionAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQAccretionForCommonStockToRedemptionAmount_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_280" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockIssuedValue" xlink:label="loc_GLAQCommonStockIssuedValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQCommonStockIssuedValue_280" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNumberOfSharesOfCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNumberOfSharesOfCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:label="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock_280" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQChangeInValueOfCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQChangeInValueOfCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_280" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:title="00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwriterMember" xlink:label="loc_GLAQUnderwriterMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQUnderwriterMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:title="00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_RedeemableCommonStockMember" xlink:label="loc_GLAQRedeemableCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GLAQRedeemableCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonRedeemableCommonStockMember" xlink:label="loc_GLAQNonRedeemableCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GLAQNonRedeemableCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_80" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:label="loc_us-gaapConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PlacementUnitsMember" xlink:label="loc_GLAQPlacementUnitsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPlacementUnitsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateWarrantsMember" xlink:label="loc_GLAQPrivateWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PlacementUnitsMember" xlink:label="loc_GLAQPlacementUnitsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPlacementUnitsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_140" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorsMember" xlink:label="loc_GLAQSponsorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQSponsorsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorMember" xlink:label="loc_GLAQSponsorMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQSponsorMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_LenderMember" xlink:label="loc_GLAQLenderMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQLenderMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AdministrativeSupportAgreementMember" xlink:label="loc_GLAQAdministrativeSupportAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GLAQAdministrativeSupportAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateWarrantsMember" xlink:label="loc_GLAQPrivateWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GLAQPrivateWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_200" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/CommitmentsDetailsNarrative" xlink:title="00000034 - Disclosure - COMMITMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwritingAgreementMember" xlink:label="loc_GLAQUnderwritingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GLAQUnderwritingAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000035 - Disclosure - STOCKHOLDER&#8217;S EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PublicWarrantsMember" xlink:label="loc_GLAQPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_GLAQPublicWarrantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:label="loc_GLAQCommonStockPriceBelowNinePointFiveZeroPerShareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_GLAQCommonStockPriceBelowNinePointFiveZeroPerShareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:label="loc_GLAQCommonStockPriceAboveSixteenPointFiveZeroPerShareMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_GLAQCommonStockPriceAboveSixteenPointFiveZeroPerShareMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSharesSubjectToRedemption" xlink:label="loc_GLAQCommonStockSharesSubjectToRedemption_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQCommonStockSharesSubjectToRedemption_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NoticePeriodForRedemptionOfWarrants" xlink:label="loc_GLAQNoticePeriodForRedemptionOfWarrants_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQNoticePeriodForRedemptionOfWarrants_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfProceedsFromBusinessCombination" xlink:label="loc_GLAQPercentageOfProceedsFromBusinessCombination_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQPercentageOfProceedsFromBusinessCombination_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_MarketValueOfCommonStock" xlink:label="loc_GLAQMarketValueOfCommonStock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQMarketValueOfCommonStock_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfExercisePriceOfWarrants" xlink:label="loc_GLAQPercentageOfExercisePriceOfWarrants_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQPercentageOfExercisePriceOfWarrants_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_GLAQClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_150" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOther_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsGross_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet_20" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_20" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:title="00000039 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NotePayableMember" xlink:label="loc_GLAQNotePayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_GLAQNotePayableMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:title="00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:label="loc_us-gaapTemporaryEquityIssuePeriodIncreaseOrDecrease_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquityIssuePeriodIncreaseOrDecrease_20" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>glaq-20210930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="GLAQ_GlobisAcquisitionCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisAcquisitionCorpMember" xlink:to="GLAQ_GlobisAcquisitionCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_GlobisAcquisitionCorpMember_lbl" xml:lang="en-US">Globis Acquisition Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TotalStockholdersEquityMember" xlink:label="GLAQ_TotalStockholdersEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_TotalStockholdersEquityMember" xlink:to="GLAQ_TotalStockholdersEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_TotalStockholdersEquityMember_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="GLAQ_PrivateSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivateSecuritiesMember" xlink:to="GLAQ_PrivateSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PrivateSecuritiesMember_lbl" xml:lang="en-US">Private Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:to="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember_lbl" xml:lang="en-US">Globis SPAC LLC and Up and Up Capital, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="GLAQ_GlobisSPACLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisSPACLLCMember" xlink:to="GLAQ_GlobisSPACLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_GlobisSPACLLCMember_lbl" xml:lang="en-US">Globis SPAC LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TrustAccountMember" xlink:label="GLAQ_TrustAccountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_TrustAccountMember" xlink:to="GLAQ_TrustAccountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_TrustAccountMember_lbl" xml:lang="en-US">Trust Account [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FranchiseMember" xlink:label="us-gaap_FranchiseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseMember" xlink:to="us-gaap_FranchiseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FranchiseMember_lbl" xml:lang="en-US">Franchise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwriterMember" xlink:label="GLAQ_UnderwriterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UnderwriterMember" xlink:to="GLAQ_UnderwriterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_UnderwriterMember_lbl" xml:lang="en-US">Underwriter [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_RedeemableCommonStockMember" xlink:label="GLAQ_RedeemableCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_RedeemableCommonStockMember" xlink:to="GLAQ_RedeemableCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_RedeemableCommonStockMember_lbl" xml:lang="en-US">Redeemable Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonRedeemableCommonStockMember" xlink:label="GLAQ_NonRedeemableCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NonRedeemableCommonStockMember" xlink:to="GLAQ_NonRedeemableCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NonRedeemableCommonStockMember_lbl" xml:lang="en-US">Non Redeemable Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PlacementUnitsMember" xlink:label="GLAQ_PlacementUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PlacementUnitsMember" xlink:to="GLAQ_PlacementUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PlacementUnitsMember_lbl" xml:lang="en-US">Placement Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="GLAQ_UpAndUpCapitalLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UpAndUpCapitalLLCMember" xlink:to="GLAQ_UpAndUpCapitalLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_UpAndUpCapitalLLCMember_lbl" xml:lang="en-US">Up and Up Capital, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateWarrantsMember" xlink:label="GLAQ_PrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivateWarrantsMember" xlink:to="GLAQ_PrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PrivateWarrantsMember_lbl" xml:lang="en-US">Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorsMember" xlink:label="GLAQ_SponsorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_SponsorsMember" xlink:to="GLAQ_SponsorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_SponsorsMember_lbl" xml:lang="en-US">Sponsors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AdministrativeSupportAgreementMember" xlink:label="GLAQ_AdministrativeSupportAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_AdministrativeSupportAgreementMember" xlink:to="GLAQ_AdministrativeSupportAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US">Administrative Support Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorMember" xlink:label="GLAQ_SponsorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_SponsorMember" xlink:to="GLAQ_SponsorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwritingAgreementMember" xlink:label="GLAQ_UnderwritingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UnderwritingAgreementMember" xlink:to="GLAQ_UnderwritingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_UnderwritingAgreementMember_lbl" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PublicWarrantsMember" xlink:label="GLAQ_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PublicWarrantsMember" xlink:to="GLAQ_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PublicWarrantsMember_lbl" xml:lang="en-US">Public warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:label="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:to="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember_lbl" xml:lang="en-US">Common Stock Price Below 9.50 Per Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:label="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:to="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_lbl" xml:lang="en-US">Common Stock Price Above 16.50 Per Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NotePayableMember" xlink:label="GLAQ_NotePayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NotePayableMember" xlink:to="GLAQ_NotePayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NotePayableMember_lbl" xml:lang="en-US">Note Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_LenderMember" xlink:label="GLAQ_LenderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_LenderMember" xlink:to="GLAQ_LenderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_LenderMember_lbl" xml:lang="en-US">Lender [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Current liabilities - Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PromissoryNoteRelatedParty" xlink:label="GLAQ_PromissoryNoteRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PromissoryNoteRelatedParty" xlink:to="GLAQ_PromissoryNoteRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PromissoryNoteRelatedParty_lbl" xml:lang="en-US">Promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Common stock subject to possible redemption 11,500,000 shares at redemption value at September 30, 2021 and December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; (Deficit) Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,050,833 shares issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at September 30, 2021 and December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; (Deficit) Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShare" xlink:label="GLAQ_CommonStockRedemptionShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockRedemptionShare" xlink:to="GLAQ_CommonStockRedemptionShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockRedemptionShare_lbl" xml:lang="en-US">Common stock redemption, share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest earned on marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Benefit from (provision for) income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_FormationAndOperatingCosts" xlink:label="GLAQ_FormationAndOperatingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_FormationAndOperatingCosts" xlink:to="GLAQ_FormationAndOperatingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_FormationAndOperatingCosts_lbl" xml:lang="en-US">Formation and operational costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Redeemable common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Basic and diluted net loss per share, Common stock subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted earnings (loss) per share, Non-redeemable common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:label="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:to="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_lbl" xml:lang="en-US">Basic and diluted earnings (loss) per share, Redeemable common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Founder Shares to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Founder Shares to Sponsor, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:label="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:to="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits_lbl" xml:lang="en-US">Sale of 100,833 Placement Units</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:label="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:to="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits_lbl" xml:lang="en-US">Sale of 100,833 Placement Units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Sale of 4,188,889 Private Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Equity participation shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Equity participation shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xml:lang="en-US">Redemption adjustment for Common Stock to redemption amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterest_2_lbl" xml:lang="en-US">Interest earned on investments held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:to="us-gaap_PaymentsToAcquireTrustPreferredInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments_lbl" xml:lang="en-US">Investment of cash in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:label="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:to="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_lbl" xml:lang="en-US">Proceeds from sale of Units, net of underwriting discounts paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from sale of Placement Units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds from sale of Private Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of advances from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Payment of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash &#8211; Beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash &#8211; End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-Cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" xlink:label="GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" xlink:to="GLAQ_OfferingCostsIncludedInAccruedOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_OfferingCostsIncludedInAccruedOfferingCosts_lbl" xml:lang="en-US">Offering costs included in accrued offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Initial classification of common stock subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="us-gaap_ErrorCorrectionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialPublicOfferingTextBlock" xlink:label="GLAQ_InitialPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialPublicOfferingTextBlock" xlink:to="GLAQ_InitialPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_InitialPublicOfferingTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivatePlacementTextBlock" xlink:label="GLAQ_PrivatePlacementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivatePlacementTextBlock" xlink:to="GLAQ_PrivatePlacementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PrivatePlacementTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDER&#8217;S EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_EmergingGrowthCompanyPolicyTextBlock" xlink:label="GLAQ_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_EmergingGrowthCompanyPolicyTextBlock" xlink:to="GLAQ_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Marketable Securities Held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:label="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:to="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl" xml:lang="en-US">Common Stock Subject to Possible Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" xlink:label="GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" xlink:to="GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONDENSED BALANCE SHEET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INCOME TAX PROVISION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xml:lang="en-US">Expense Related to Distribution or Servicing and Underwriting Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">Business Acquisition, Description of Acquired Entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingCostsAndIncomes" xlink:label="us-gaap_LiquidationBasisOfAccountingCostsAndIncomes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidationBasisOfAccountingCostsAndIncomes" xlink:to="us-gaap_LiquidationBasisOfAccountingCostsAndIncomes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiquidationBasisOfAccountingCostsAndIncomes_lbl" xml:lang="en-US">Liquidation Basis of Accounting, Costs and Incomes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Business Acquisition, Share Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CashHeldOutsideTrust" xlink:label="GLAQ_CashHeldOutsideTrust" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CashHeldOutsideTrust" xlink:to="GLAQ_CashHeldOutsideTrust_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CashHeldOutsideTrust_lbl" xml:lang="en-US">[custom:CashHeldOutsideTrust-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_WorkingCapital" xlink:label="GLAQ_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_WorkingCapital" xlink:to="GLAQ_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_WorkingCapital_lbl" xml:lang="en-US">[custom:WorkingCapital-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Taxes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xml:lang="en-US">Common stock subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CommonStockValue_3_lbl" xml:lang="en-US">Common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Total Stockholders' (Deficit) Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShares" xlink:label="GLAQ_CommonStockRedemptionShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockRedemptionShares" xlink:to="GLAQ_CommonStockRedemptionShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockRedemptionShares_lbl" xml:lang="en-US">Common stock subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInSharesSubjectToPossibleRedemption" xlink:label="GLAQ_ChangeInSharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ChangeInSharesSubjectToPossibleRedemption" xlink:to="GLAQ_ChangeInSharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_ChangeInSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Change in value of Common Stock subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnderwritingIncomeLoss" xlink:label="us-gaap_UnderwritingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderwritingIncomeLoss" xlink:to="us-gaap_UnderwritingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnderwritingIncomeLoss_lbl" xml:lang="en-US">Underwriting Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:label="GLAQ_InitialSharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:to="GLAQ_InitialSharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="GLAQ_InitialSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Initial value of Common Stock subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AccretionForCommonStockToRedemptionAmount" xlink:label="GLAQ_AccretionForCommonStockToRedemptionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_AccretionForCommonStockToRedemptionAmount" xlink:to="GLAQ_AccretionForCommonStockToRedemptionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_AccretionForCommonStockToRedemptionAmount_lbl" xml:lang="en-US">Redemption adjustment for Common Stock to redemption amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_2_lbl" xml:lang="en-US">Basic and diluted net income per share, common stock subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Basic and diluted net loss (income) per share, Non-redeemable common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockIssuedValue" xlink:label="GLAQ_CommonStockIssuedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockIssuedValue" xlink:to="GLAQ_CommonStockIssuedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockIssuedValue_lbl" xml:lang="en-US">Common stock issued value</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">[custom:NumberOfSharesOfCommonStockSubjectToPossibleRedemption-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:to="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_2_lbl" xml:lang="en-US">[custom:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">[custom:ChangeInValueOfCommonStockSubjectToPossibleRedemption]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">[custom:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" xlink:label="GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">[custom:NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Gross Proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Common stock issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_2_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Allocation of net loss, as adjusted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_4_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_3_lbl" xml:lang="en-US">Basic and diluted net loss per common share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:label="us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for Rent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_2_lbl" xml:lang="en-US">Prepaid Expense, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from Related Party Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSharesSubjectToRedemption" xlink:label="GLAQ_CommonStockSharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockSharesSubjectToRedemption" xlink:to="GLAQ_CommonStockSharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_CommonStockSharesSubjectToRedemption_lbl" xml:lang="en-US">[custom:CommonStockSharesSubjectToRedemption-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NoticePeriodForRedemptionOfWarrants" xlink:label="GLAQ_NoticePeriodForRedemptionOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NoticePeriodForRedemptionOfWarrants" xlink:to="GLAQ_NoticePeriodForRedemptionOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_NoticePeriodForRedemptionOfWarrants_lbl" xml:lang="en-US">Notice period for redemption of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfProceedsFromBusinessCombination" xlink:label="GLAQ_PercentageOfProceedsFromBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PercentageOfProceedsFromBusinessCombination" xlink:to="GLAQ_PercentageOfProceedsFromBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PercentageOfProceedsFromBusinessCombination_lbl" xml:lang="en-US">Percentage of proceeds from business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_MarketValueOfCommonStock" xlink:label="GLAQ_MarketValueOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_MarketValueOfCommonStock" xlink:to="GLAQ_MarketValueOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_MarketValueOfCommonStock_lbl" xml:lang="en-US">Market value of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfExercisePriceOfWarrants" xlink:label="GLAQ_PercentageOfExercisePriceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PercentageOfExercisePriceOfWarrants" xlink:to="GLAQ_PercentageOfExercisePriceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_PercentageOfExercisePriceOfWarrants_lbl" xml:lang="en-US">Percentage of exercise price of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xml:lang="en-US">[custom:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Startup and organizational costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets, net valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory federal income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_3_lbl" xml:lang="en-US">Common Stock issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_3_lbl" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:label="us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:to="us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_lbl" xml:lang="en-US">Temporary Equity, Carrying Amount, Period Increase (Decrease)</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:to="GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_RedeemableWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_doc" xml:lang="en-US">Units, each consisting of one share of Common Stock, and one Warrant to acquire one share of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockParValue0.0001PerShareMember" xlink:label="GLAQ_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockParValue0.0001PerShareMember" xlink:to="GLAQ_CommonStockParValue0.0001PerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockParValue0.0001PerShareMember_doc" xml:lang="en-US">Common stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember" xlink:label="GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember" xlink:to="GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneRedeemableWarrantToAcquireOneShareOfCommonStockMember_doc" xml:lang="en-US">Units, each consisting of one share of Common Stock, and one Warrant to acquire one share of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockRedemptionShares" xlink:to="GLAQ_CommonStockRedemptionShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockRedemptionShares_doc" xml:lang="en-US">Common stock redemption, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_FormationAndOperatingCosts" xlink:to="GLAQ_FormationAndOperatingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_FormationAndOperatingCosts_doc" xml:lang="en-US">Formation and operating costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_doc" xml:lang="en-US">Basic and diluted net loss per share, Common stock subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:to="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits_doc" xml:lang="en-US">Stock issued during period value sale of placement units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:to="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits_doc" xml:lang="en-US">Stock issued during period shares sale of placement units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_AccretionForCommonStockToRedemptionAmount" xlink:to="GLAQ_AccretionForCommonStockToRedemptionAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_AccretionForCommonStockToRedemptionAmount_doc" xml:lang="en-US">Accretion for Common Stock to redemption amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:to="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid_doc" xml:lang="en-US">Proceeds from sale of Units, net of underwriting discounts paid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:to="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption_doc" xml:lang="en-US">Initial classification of common stock subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivateSecuritiesMember" xlink:to="GLAQ_PrivateSecuritiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PrivateSecuritiesMember_doc" xml:lang="en-US">Private Securities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:to="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember_doc" xml:lang="en-US">Globis SPAC LLC and Up and Up Capital, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_WorkingCapital" xlink:to="GLAQ_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CashHeldOutsideTrust" xlink:to="GLAQ_CashHeldOutsideTrust_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CashHeldOutsideTrust_doc" xml:lang="en-US">Cash held outside trust.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockIssuedValue" xlink:to="GLAQ_CommonStockIssuedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockIssuedValue_doc" xml:lang="en-US">Common stock issued value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockSharesSubjectToRedemption" xlink:to="GLAQ_CommonStockSharesSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockSharesSubjectToRedemption_doc" xml:lang="en-US">Common stock shares subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:to="GLAQ_InitialSharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_InitialSharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Initial shares subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_ChangeInSharesSubjectToPossibleRedemption" xlink:to="GLAQ_ChangeInSharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_ChangeInSharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Change in shares subject to possible redemption.</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption" xlink:label="GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption" xlink:to="GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_WeightedAverageNumberOfShareOutstandingBasicAndDilutedSubjecttoRedemption_doc" xml:lang="en-US">Weighted Average Number of Share Outstanding Basic and Diluted Subject to Redemption.</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption" xlink:label="GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption" xlink:to="GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_EarningsPerShareBasicAndDilutedNotSubjectToRedemption_doc" xml:lang="en-US">Earnings Per Share Basic and Diluted not Subject to Redemption.</link:label>
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption" xlink:label="GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption" xlink:to="GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_EarningsPerShareBasicAndDilutedSubjecttoRedemption_doc" xml:lang="en-US">Earnings Per Share Basic and Diluted Subject to Redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_EmergingGrowthCompanyPolicyTextBlock" xlink:to="GLAQ_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging Growth Company Policy [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:to="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_doc" xml:lang="en-US">Common Stock Subject To Possible Redemption Policy [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NonRedeemableCommonStockMember" xlink:to="GLAQ_NonRedeemableCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_NonRedeemableCommonStockMember_doc" xml:lang="en-US">Non Redeemable Common Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialPublicOfferingTextBlock" xlink:to="GLAQ_InitialPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_InitialPublicOfferingTextBlock_doc" xml:lang="en-US">Initial Public Offering [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivatePlacementTextBlock" xlink:to="GLAQ_PrivatePlacementTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PrivatePlacementTextBlock_doc" xml:lang="en-US">Private Placement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PlacementUnitsMember" xlink:to="GLAQ_PlacementUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PlacementUnitsMember_doc" xml:lang="en-US">Placement Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UpAndUpCapitalLLCMember" xlink:to="GLAQ_UpAndUpCapitalLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_UpAndUpCapitalLLCMember_doc" xml:lang="en-US">Up and Up Capital, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PrivateWarrantsMember" xlink:to="GLAQ_PrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PrivateWarrantsMember_doc" xml:lang="en-US">Private Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisSPACLLCMember" xlink:to="GLAQ_GlobisSPACLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_GlobisSPACLLCMember_doc" xml:lang="en-US">Globis SPAC LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_SponsorsMember" xlink:to="GLAQ_SponsorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_SponsorsMember_doc" xml:lang="en-US">Sponsors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_AdministrativeSupportAgreementMember" xlink:to="GLAQ_AdministrativeSupportAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_AdministrativeSupportAgreementMember_doc" xml:lang="en-US">Administrative Support Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_SponsorMember" xlink:to="GLAQ_SponsorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_SponsorMember_doc" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_UnderwritingAgreementMember" xlink:to="GLAQ_UnderwritingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_UnderwritingAgreementMember_doc" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PublicWarrantsMember" xlink:to="GLAQ_PublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PublicWarrantsMember_doc" xml:lang="en-US">Public warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NoticePeriodForRedemptionOfWarrants" xlink:to="GLAQ_NoticePeriodForRedemptionOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_NoticePeriodForRedemptionOfWarrants_doc" xml:lang="en-US">Notice period for redemption of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PercentageOfProceedsFromBusinessCombination" xlink:to="GLAQ_PercentageOfProceedsFromBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PercentageOfProceedsFromBusinessCombination_doc" xml:lang="en-US">Percentage of proceeds from business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_MarketValueOfCommonStock" xlink:to="GLAQ_MarketValueOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_MarketValueOfCommonStock_doc" xml:lang="en-US">Market value of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:to="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember_doc" xml:lang="en-US">Common Stock Price Below 9.50 Per Share [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_PercentageOfExercisePriceOfWarrants" xlink:to="GLAQ_PercentageOfExercisePriceOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_PercentageOfExercisePriceOfWarrants_doc" xml:lang="en-US">Percentage of exercise price of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:to="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_doc" xml:lang="en-US">Common Stock Price Above 16.50 Per Share [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_NotePayableMember" xlink:to="GLAQ_NotePayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_NotePayableMember_doc" xml:lang="en-US">Note Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_TrustAccountMember" xlink:to="GLAQ_TrustAccountMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_TrustAccountMember_doc" xml:lang="en-US">Trust Account [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_CommonStockRedemptionShare" xlink:to="GLAQ_CommonStockRedemptionShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_CommonStockRedemptionShare_doc" xml:lang="en-US">Common stock redemption, share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_GlobisAcquisitionCorpMember" xlink:to="GLAQ_GlobisAcquisitionCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_GlobisAcquisitionCorpMember_doc" xml:lang="en-US">Globis Acquisition Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_TotalStockholdersEquityMember" xlink:to="GLAQ_TotalStockholdersEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GLAQ_TotalStockholdersEquityMember_doc" xml:lang="en-US">Total Stockholders Equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:to="us-gaap_PaymentsToAcquireTrustPreferredInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Trust Preferred Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_2_lbl" xml:lang="en-US">Payments of Financing Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderwritingIncomeLoss" xlink:to="us-gaap_UnderwritingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnderwritingIncomeLoss_2_lbl" xml:lang="en-US">Underwriting Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:to="GLAQ_InitialSharesSubjectToPossibleRedemption_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GLAQ_InitialSharesSubjectToPossibleRedemption_3_lbl" xml:lang="en-US">InitialSharesSubjectToPossibleRedemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>glaq-20210930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globis.com/role/Cover" xlink:href="glaq-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheets" xlink:href="glaq-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/BalanceSheetsParenthetical" xlink:href="glaq-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementsOfOperations" xlink:href="glaq-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:href="glaq-20210930.xsd#StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StatementOfCashFlows" xlink:href="glaq-20210930.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOffering" xlink:href="glaq-20210930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacement" xlink:href="glaq-20210930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactions" xlink:href="glaq-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/Commitments" xlink:href="glaq-20210930.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquity" xlink:href="glaq-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTax" xlink:href="glaq-20210930.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurements" xlink:href="glaq-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEvents" xlink:href="glaq-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxTables" xlink:href="glaq-20210930.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/FairValueMeasurementsTables" xlink:href="glaq-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="glaq-20210930.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:href="glaq-20210930.xsd#ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:href="glaq-20210930.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="glaq-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="glaq-20210930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:href="glaq-20210930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="glaq-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/CommitmentsDetailsNarrative" xlink:href="glaq-20210930.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:href="glaq-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="glaq-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="glaq-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="glaq-20210930.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:href="glaq-20210930.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="glaq-20210930.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:href="glaq-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:href="glaq-20210930.xsd#ScheduleOfCondensedBalanceSheetDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PromissoryNoteRelatedParty" xlink:label="loc_GLAQPromissoryNoteRelatedParty" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_GLAQPromissoryNoteRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShare" xlink:label="loc_GLAQCommonStockRedemptionShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQCommonStockRedemptionShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_FormationAndOperatingCosts" xlink:label="loc_GLAQFormationAndOperatingCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQFormationAndOperatingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:label="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TotalStockholdersEquityMember" xlink:label="loc_GLAQTotalStockholdersEquityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_GLAQTotalStockholdersEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:label="loc_GLAQStockIssuedDuringPeriodValueSaleOfPlacementUnits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GLAQStockIssuedDuringPeriodValueSaleOfPlacementUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:label="loc_GLAQStockIssuedDuringPeriodSharesSaleOfPlacementUnits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GLAQStockIssuedDuringPeriodSharesSaleOfPlacementUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical" xlink:title="00000006 - Statement - Condensed Statement of Changes in Stockholders&apos; (Deficit) Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StatementOfCashFlows" xlink:title="00000007 - Statement - Condensed Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireTrustPreferredInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:label="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_GLAQProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_OfferingCostsIncludedInAccruedOfferingCosts" xlink:label="loc_GLAQOfferingCostsIncludedInAccruedOfferingCosts" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_GLAQOfferingCostsIncludedInAccruedOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="loc_us-gaapErrorCorrectionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapErrorCorrectionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_GLAQDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GLAQDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialPublicOfferingTextBlock" xlink:label="loc_GLAQInitialPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQInitialPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_DisclosurePrivatePlacementAbstract" xlink:label="loc_GLAQDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GLAQDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivatePlacementTextBlock" xlink:label="loc_GLAQPrivatePlacementTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQPrivatePlacementTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/Commitments" xlink:title="00000014 - Disclosure - COMMITMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDER&#8217;S EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTax" xlink:title="00000016 - Disclosure - INCOME TAX">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_GLAQEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:label="loc_GLAQCommonStockSubjectToPossibleRedemptionPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQCommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" xlink:label="loc_GLAQScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_GLAQScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxTables" xlink:title="00000022 - Disclosure - INCOME TAX (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/FairValueMeasurementsTables" xlink:title="00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GLAQGlobisSPACLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_TrustAccountMember" xlink:label="loc_GLAQTrustAccountMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GLAQTrustAccountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtProductOrServiceAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FranchiseMember" xlink:label="loc_us-gaapFranchiseMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapFranchiseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingCostsAndIncomes" xlink:label="loc_us-gaapLiquidationBasisOfAccountingCostsAndIncomes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLiquidationBasisOfAccountingCostsAndIncomes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CashHeldOutsideTrust" xlink:label="loc_GLAQCashHeldOutsideTrust" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GLAQCashHeldOutsideTrust" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_WorkingCapital" xlink:label="loc_GLAQWorkingCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GLAQWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketableSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapCommonStockValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockRedemptionShares" xlink:label="loc_GLAQCommonStockRedemptionShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQCommonStockRedemptionShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQInitialClassificationOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInSharesSubjectToPossibleRedemption" xlink:label="loc_GLAQChangeInSharesSubjectToPossibleRedemption" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQChangeInSharesSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnderwritingIncomeLoss" xlink:label="loc_us-gaapUnderwritingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapUnderwritingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_InitialSharesSubjectToPossibleRedemption" xlink:label="loc_GLAQInitialSharesSubjectToPossibleRedemption" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQInitialSharesSubjectToPossibleRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AccretionForCommonStockToRedemptionAmount" xlink:label="loc_GLAQAccretionForCommonStockToRedemptionAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQAccretionForCommonStockToRedemptionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQBasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockIssuedValue" xlink:label="loc_GLAQCommonStockIssuedValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQCommonStockIssuedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNumberOfSharesOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNumberOfSharesOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:label="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQBasicAndDilutedEarningsLossPerShareRedeemableCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQChangeInValueOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" xlink:label="loc_GLAQNonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_GLAQNonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical" xlink:title="00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwriterMember" xlink:label="loc_GLAQUnderwriterMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQUnderwriterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:title="00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_RedeemableCommonStockMember" xlink:label="loc_GLAQRedeemableCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GLAQRedeemableCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NonRedeemableCommonStockMember" xlink:label="loc_GLAQNonRedeemableCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GLAQNonRedeemableCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:label="loc_us-gaapConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_GLAQDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GLAQDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PlacementUnitsMember" xlink:label="loc_GLAQPlacementUnitsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPlacementUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_DisclosurePrivatePlacementAbstract" xlink:label="loc_GLAQDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GLAQDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateWarrantsMember" xlink:label="loc_GLAQPrivateWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PlacementUnitsMember" xlink:label="loc_GLAQPlacementUnitsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPlacementUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateSecuritiesMember" xlink:label="loc_GLAQPrivateSecuritiesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_GLAQPrivateSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:label="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCAndUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisSPACLLCMember" xlink:label="loc_GLAQGlobisSPACLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQGlobisSPACLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UpAndUpCapitalLLCMember" xlink:label="loc_GLAQUpAndUpCapitalLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GLAQUpAndUpCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorsMember" xlink:label="loc_GLAQSponsorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQSponsorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_SponsorMember" xlink:label="loc_GLAQSponsorMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_LenderMember" xlink:label="loc_GLAQLenderMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GLAQLenderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_AdministrativeSupportAgreementMember" xlink:label="loc_GLAQAdministrativeSupportAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GLAQAdministrativeSupportAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PrivateWarrantsMember" xlink:label="loc_GLAQPrivateWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GLAQPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/CommitmentsDetailsNarrative" xlink:title="00000034 - Disclosure - COMMITMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_UnderwritingAgreementMember" xlink:label="loc_GLAQUnderwritingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GLAQUnderwritingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000035 - Disclosure - STOCKHOLDER&#8217;S EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PublicWarrantsMember" xlink:label="loc_GLAQPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_GLAQPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:label="loc_GLAQCommonStockPriceBelowNinePointFiveZeroPerShareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_GLAQCommonStockPriceBelowNinePointFiveZeroPerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:label="loc_GLAQCommonStockPriceAboveSixteenPointFiveZeroPerShareMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_GLAQCommonStockPriceAboveSixteenPointFiveZeroPerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_CommonStockSharesSubjectToRedemption" xlink:label="loc_GLAQCommonStockSharesSubjectToRedemption" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQCommonStockSharesSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NoticePeriodForRedemptionOfWarrants" xlink:label="loc_GLAQNoticePeriodForRedemptionOfWarrants" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQNoticePeriodForRedemptionOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfProceedsFromBusinessCombination" xlink:label="loc_GLAQPercentageOfProceedsFromBusinessCombination" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQPercentageOfProceedsFromBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_MarketValueOfCommonStock" xlink:label="loc_GLAQMarketValueOfCommonStock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQMarketValueOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_PercentageOfExercisePriceOfWarrants" xlink:label="loc_GLAQPercentageOfExercisePriceOfWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQPercentageOfExercisePriceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_GLAQClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_GLAQClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/IncomeTaxDetailsNarrative" xlink:title="00000039 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_NotePayableMember" xlink:label="loc_GLAQNotePayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_GLAQNotePayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails" xlink:title="00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="glaq-20210930.xsd#GLAQ_GlobisAcquisitionCorpMember" xlink:label="loc_GLAQGlobisAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_GLAQGlobisAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:label="loc_us-gaapTemporaryEquityIssuePeriodIncreaseOrDecrease" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapTemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658363834184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Globis
NV Merger Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001903870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPrimarySicNumber', window );">Entity Primary SIC Number</a></td>
<td class="text">6770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-2703418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7100
W. Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 302-48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca
Raton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-3248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7100
W. Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 302-48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca
Raton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-3248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPrimarySicNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primary Standard Industrial Classification (SIC) Number for the Entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPrimarySicNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sicNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366905208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 8,413<span></span>
</td>
<td class="nump">$ 202,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">150,653<span></span>
</td>
<td class="nump">283,333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">159,066<span></span>
</td>
<td class="nump">485,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities held in Trust Account</a></td>
<td class="nump">116,155,627<span></span>
</td>
<td class="nump">116,150,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">116,314,693<span></span>
</td>
<td class="nump">116,635,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Current liabilities - Accounts payable and accrued expenses</a></td>
<td class="nump">646,729<span></span>
</td>
<td class="nump">65,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_PromissoryNoteRelatedParty', window );">Promissory note &#8211; related party</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">1,346,729<span></span>
</td>
<td class="nump">65,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common stock subject to possible redemption 11,500,000 shares at redemption value at September 30, 2021 and December 31, 2020</a></td>
<td class="nump">116,150,000<span></span>
</td>
<td class="nump">116,150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (Deficit) Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,050,833 shares issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at September 30, 2021 and December 31, 2020</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">509,304<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,691,695)<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; (Deficit) Equity</a></td>
<td class="num">(1,182,036)<span></span>
</td>
<td class="nump">419,773<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</a></td>
<td class="nump">$ 116,314,693<span></span>
</td>
<td class="nump">$ 116,635,401<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_PromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_PromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658363973640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - Globis Acquisition Corp [Member] - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">15,050,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockRedemptionShare', window );">Common stock redemption, share</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">15,050,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CommonStockRedemptionShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock redemption, share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CommonStockRedemptionShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658363013032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 892,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,607,436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(892,144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,607,436)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on marketable securities held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,627<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,627<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(890,359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,601,809)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from (provision for) income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_FormationAndOperatingCosts', window );">Formation and operational costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (890,359)<span></span>
</td>
<td class="num">$ (89,886)<span></span>
</td>
<td class="num">$ (1,601,809)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, Redeemable common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">1,520,661<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption', window );">Basic and diluted net loss per share, Common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">2,658,912<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted earnings (loss) per share, Non-redeemable common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock', window );">Basic and diluted earnings (loss) per share, Redeemable common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted net loss per share, Common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_FormationAndOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Formation and operating costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_FormationAndOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658362625512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statement of Changes in Stockholders' (Deficit) Equity - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Aug. 20, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 20, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Founder Shares to Sponsor</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">24,712<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Founder Shares to Sponsor, Shares</a></td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">24,712<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2020</a></td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Aug. 20, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 20, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Founder Shares to Sponsor</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">26,195<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Founder Shares to Sponsor, Shares</a></td>
<td class="nump">3,047,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits', window );">Sale of 100,833 Placement Units</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">1,008,320<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,008,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits', window );">Sale of 100,833 Placement Units, shares</a></td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sale of 4,188,889 Private Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,141,670<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,141,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Equity participation shares</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Equity participation shares, shares</a></td>
<td class="nump">402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Redemption adjustment for Common Stock to redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,666,841)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,666,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
<td class="nump">419,773<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(363,959)<span></span>
</td>
<td class="num">(363,959)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(453,845)<span></span>
</td>
<td class="nump">55,814<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
<td class="nump">419,773<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2021</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(1,691,695)<span></span>
</td>
<td class="num">(1,182,036)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(453,845)<span></span>
</td>
<td class="nump">55,814<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(347,491)<span></span>
</td>
<td class="num">(347,491)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="num">(801,336)<span></span>
</td>
<td class="num">(291,677)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(890,359)<span></span>
</td>
<td class="num">(890,359)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2021</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 509,304<span></span>
</td>
<td class="num">$ (1,691,695)<span></span>
</td>
<td class="num">$ (1,182,036)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares sale of placement units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value sale of placement units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367118984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">4,188,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">100,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658361243128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statement of Cash Flows - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (890,359)<span></span>
</td>
<td class="num">$ (89,886)<span></span>
</td>
<td class="num">$ (1,601,809)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on investments held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,785)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283,333)<span></span>
</td>
<td class="nump">132,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">581,101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307,591)<span></span>
</td>
<td class="num">(893,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments', window );">Investment of cash in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock to Sponsor</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid', window );">Proceeds from sale of Units, net of underwriting discounts paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from sale of Placement Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,008,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of Private Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,141,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of advances from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of offering costs</a></td>
<td class="num">(10,035)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,841)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">14,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,659,659<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="nump">14,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,068<span></span>
</td>
<td class="num">(193,655)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash &#8211; Beginning of period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">202,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash &#8211; End of period</a></td>
<td class="nump">14,965<span></span>
</td>
<td class="nump">$ 8,413<span></span>
</td>
<td class="nump">202,068<span></span>
</td>
<td class="nump">8,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_OfferingCostsIncludedInAccruedOfferingCosts', window );">Offering costs included in accrued offering costs</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption', window );">Initial classification of common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial classification of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_OfferingCostsIncludedInAccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_OfferingCostsIncludedInAccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of Units, net of underwriting discounts paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTrustPreferredInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366488664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zug8xCBl6Um8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_82C_z32o1Osg5AD7">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
December 31, 2020 relates to the Company&#8217;s formation and the initial public offering (&#8220;Initial Public Offering&#8221;), which
is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public
Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd">11,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Units&#8221; and, with respect
to the shares of common stock included in the Units sold, the &#8220;Public Shares,&#8221; which included the full exercise by the underwriter
of its over-allotment option in the amount of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd">1,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z1rkB3eYjKzj">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit), generating gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0">115,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd">4,188,889
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants (the &#8220;Private Warrants&#8221;)
at a price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd">100,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Placement Units&#8221; and,
together with the Private Warrants, the &#8220;Private Securities&#8221;) at a price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z04xPkbrn9c8">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#8220;Up
and Up&#8221; and, collectively with Globis SPAC LLC, the &#8220;Sponsors&#8221;), which is described in Note 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20201213__20201215_pp0p0">6,541,841</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consisting of $<span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20201213__20201215_zbKXbSz3nxff">2,300,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of underwriting fees, $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20201213__20201215_pp0p0">4,025,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_pdd">402,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#8220;equity participation shares&#8221;), and $<span id="xdx_901_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20201213__20201215_zTEeBnAvfDmi">216,841
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215_pp0p0">116,150,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_c20201215_pdd">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#8220;Trust Account&#8221;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company
must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding
taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The
Company intends to only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its holders of the outstanding Public Shares (the &#8220;public stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated
to be $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201215_zfvQcOdG03Sh">10.10</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to
pay its tax or dissolution obligations). There will be no redemption rights upon the completion of a Business Combination with respect
to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentNet_c20201231__srt--RangeAxis__srt--MinimumMember_pp0p0">5,000,001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated
Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares
irrespective of whether they vote for or against the proposed transaction or do not vote at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and the Company&#8217;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#8217;s obligation
to allow redemption in connection with the Company&#8217;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#8220;Combination Period&#8221;). The Company&#8217;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. <span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zD3SKOqznv57">Pursuant
to the terms of the Company&#8217;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#8217;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) <span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHUQrr1GFJZ">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#8217;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $<span id="xdx_901_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_uUSDPShares_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TrustAccountMember_zFgnDrJK8KS4">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#8217;s tax obligation and up to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20201231_pp0p0">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#8217;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of December 31, 2020, the Company had cash of $<span id="xdx_905_ecustom--CashHeldOutsideTrust_c20201215_pp0p0">202,068
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held outside of the Trust Account, $<span id="xdx_909_eus-gaap--MarketableSecuritiesNoncurrent_iI_pp0p0_c20201231_zhIV7Sux7OQg">116,150,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held in the Trust Account to be used for a Business
Combination, and adjusted working capital of $<span id="xdx_904_ecustom--WorkingCapital_c20201215_pp0p0">432,087</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which excludes $<span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_c20201231__srt--ProductOrServiceAxis__us-gaap--FranchiseMember_pp0p0">12,314
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of franchise taxes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#8217;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#8217;s working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#8220;Note&#8221;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#8220;Lender&#8221;), providing for borrowings from time to time of up to an aggregate of $1,000,000.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential transaction. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient financing
or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if the Company
extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There is no assurance
that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period of time to consummate
a Business Combination up to two times, each by an additional three months).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zse8mEBwkXD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_826_zoXiMxnmmlk2">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Globis
Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
September 30, 2021 relates to the Company&#8217;s formation, initial public offering (&#8220;Initial Public Offering&#8221;), which is
described below, and search for a Business Combination. The Company will not generate any operating revenues until after the completion
of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRu0RtU0UvDh">11,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Units&#8221; and, with respect
to the shares of common stock included in the Units sold, the &#8220;Public Shares,&#8221; which included the full exercise by the underwriter
of its over-allotment option in the amount of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znXXZJHbPxzj">1,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPoJm1SakIhj">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit), generating gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGMatMH8AuP2">115,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDhkhYNgn2zc">4,188,889
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants (the &#8220;Private Warrants&#8221;)
at a price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkuvIYEi4ljk">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z6GkzvESGua3">100,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (the &#8220;Placement Units&#8221; and,
together with the Private Warrants, the &#8220;Private Securities&#8221;) at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z4HgLKqDTDZk">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#8220;Up
and Up&#8221; and, collectively with Globis SPAC LLC, the &#8220;Sponsors&#8221;), which is described in Note 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20201213__20201215_zCo6hms5r5R5">6,541,841</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consisting of $<span id="xdx_90C_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20201213__20201215_pp0p0">2,300,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of underwriting fees, $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20201213__20201215_zM1gUI1fGg58">4,025,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_z7RUJocVOEd4">402,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#8220;equity participation shares&#8221;), and $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20201213__20201215_pp0p0">216,841
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215_za1q969izmpk">116,150,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201215_zeFs74mXsoj1">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#8220;Trust Account&#8221;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward completing
a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201215_zDy1rS3YUZ9">80</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post-Business Combination
company owns or acquires <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20201215__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z40snssKk4a1">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for
it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment
Company Act&#8221;). There is no assurance that the Company will be able to complete a Business Combination successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_903_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z7HVgMPEHHsl">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax or dissolution obligations).
There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentNet_c20210930__srt--RangeAxis__srt--MinimumMember_pp0p0">5,000,001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated
Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares,
without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and the Company&#8217;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#8217;s obligation
to allow redemption in connection with the Company&#8217;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#8220;Combination Period&#8221;). The Company&#8217;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. <span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zISDycSwuO3">Pursuant
to the terms of the Company&#8217;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#8217;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) <span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z8RLYhJmHKf4">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#8217;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($<span id="xdx_90F_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z2wtKFROcli3">10.10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $<span id="xdx_90C_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z5E8ME6jUsl7">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#8217;s tax obligation and up to $<span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__srt--RangeAxis__srt--MaximumMember_zETfveNxxHxl">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#8217;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of September 30, 2021, the Company had cash of $<span id="xdx_90E_ecustom--CashHeldOutsideTrust_iI_uUSD_c20210930_z0Hp3Y7lDGkl">8,413
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held outside of the Trust Account, $<span id="xdx_906_eus-gaap--MarketableSecurities_iI_pp0p0_c20210930_zUvcjSiCa9L1">116,155,627
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held in the Trust Account to be used for a Business
Combination, and adjusted working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapital_iI_pp0p0_c20210930_zGLBc8sb0AV">1,037,663</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which excludes $<span id="xdx_902_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930_zcUDT8fBxSX3">150,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
franchise taxes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#8217;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#8217;s working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#8220;Note&#8221;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#8220;Lender&#8221;), providing for borrowings from time to time of up to an aggregate of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930_zANvfeb5EIF5">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On July 19, 2021 the Note was amended to increase the principal amount of the Note to $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719_z5pCEFgCBZTa">2,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and on October 13, 2021, the Note was further
amended to increase the principal amount of the Note to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9n92k8GRDm5">3,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential Business Combination. The Company cannot provide any
assurance that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient
financing or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if
the Company extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There
is no assurance that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period
of time to consummate a Business Combination up to two times, each by an additional three months).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position and/or search for a target company, the specific impact is not readily
determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from
the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658365534328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--ErrorCorrectionTextBlock_zCf6KFDBqi2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_825_z69zMpFSac9c">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of the Company&#8217;s financial statements, management identified errors made in its historical financial
statements where, at the closing of the Company&#8217;s Initial Public Offering, the Company improperly valued its common stock subject
to possible redemption. The Company previously determined the common stock subject to possible redemption to be equal to the redemption
value, while also taking into consideration a redemption cannot result in net tangible assets being less than $<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231__srt--RangeAxis__srt--MinimumMember_z9ZeBuY4NwId">5,000,001</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become
redeemable subject to the occurrence of future events considered outside the Company&#8217;s control. Therefore, management concluded
that temporary equity should include all shares of common stock subject to possible redemption, resulting in the common stock subject
to possible redemption being equal to their redemption value. As a result, management has noted a classification error related to temporary
equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption
with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the change in presentation for the common stock subject to possible redemption, the Company also restated its income
(loss) per common share calculation to allocate net income (loss) evenly to all common stock. This presentation contemplates a Business
Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been no change in the Company&#8217;s total assets, liabilities or operating results.&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zdSJWd6i1zQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B7_zkIKDrkP2O16" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br/> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 15, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zr1tDu8D9RW8" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">111,652,086</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zFV3u6dZ6BWf" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">4,497,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215_zJLo6pZ96RJ5" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--CommonStockValue_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1u8FSmwjWM2" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJOqUaBUI63k" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">(45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201215_zuIWn2qiL2Vk" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">356</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxDCFwdezsa4" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">5,007,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYOyO3xsgATd" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">(4,497,869</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215_zGOkQMf6ARyf" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">509,303</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zv3zt32REHO2" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(7,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pdp0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGVNovl30gug" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215_zV4cW22ADfQ6" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(7,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPWGodXf84Xh" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">5,000,002</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdBCTW7la5M9" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">(4,497,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215_zMOh0PQL3tRl" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">502,088</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeHAy5RxokO1" style="text-align: right" title="Weighted average shares outstanding - redeemable"><span style="font-family: Times New Roman, Times, Serif">11,054,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zc9V3ongOX33" style="text-align: right" title="Weighted average shares outstanding - redeemable"><span style="font-family: Times New Roman, Times, Serif">445,338</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockRedemptionShares_c20201213__20201215_zpItKGo9Qibc" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3hCgC3NyId6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIdULU9bX9C" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231_z5vCs9Oi8ct1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zI9bzOwDKgQ7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZFQN4mV307j" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--CommonStockValue_iI_pp0p0_c20201231_zhsKRPsyW40b" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">5,089,487</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">(4,580,183</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(89,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdp0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0297">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231_pp0p0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(89,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsCMFzqndTr2" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">5,000,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJ0EEjklCdEk" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">(4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231_zDthzg4HYMgb" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">419,773</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVAnRbarvAWa" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,046,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOFlAOLeikU9" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--CommonStockRedemptionShares_c20200821__20201231_zT5AFZISJ2g" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Cash Flows
    for the Period from August 21, 2020 (Inception) through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial classification of common stock subject
    to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJqUiheK12oc" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">111,652,086</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zV6CbUeMo0Ug" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">4,497,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231_zuctQ6H3xln2" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of Common Stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBrsLUkQHPDl" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(82,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zrWKWotoa70a" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">82,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231_zSHAD2BlVR9l" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0323">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity for the Period Ended December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVSUk9SIENPUlJFQ1RJT05TIEFORCBQUklPUiBQRVJJT0QgQURKVVNUTUVOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200812__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zmnvanOuGuLi">11,500,000
    </span></span><span style="font-family: Times New Roman, Times, Serif">Units, net of underwriter discounts and offering expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuagBQBjeCIb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,483,159</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQt2KkRywt22" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(112,483,159</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231_zkrIjxg6sjyj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0327">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial value of Common Stock subject to redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zi7rWRC82HM" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsAXSHlgE9vi" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">(111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231_zlXdo4sdqXRi" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Redemption adjustment for Common Stock to redemption
    amount</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkefGMzoB9rj" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0335">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGXkCxbnnht7" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif">(3,666,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231_zgiqOcjTOiyg" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif">(3,666,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Shareholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA0KxRLCfqN1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwPbyZLu3rj9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20201231_zxtHWY01aUU7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">419,773</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations
    for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlTYmScAaj0c" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">11,054,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAv4YhHVd6x3" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(9,534,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231_z6k8fmmfMKHi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">1,520,661</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share, common
    stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8oW5nThcxSc" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSfWobUqQ03e" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231_zP5Tgjnyfxs2" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK5MhbdHWop" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">2,717,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAwuKtSYp0i9" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(58,887</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231_zEnwjDGUhTsi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">2,658,912</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss (income) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWSzpoOfsvd" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(0.03</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpyFsn5E87f" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231_z8ZL2LXcelB9" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_8A8_zr9nkrRJjDU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80E_eus-gaap--ErrorCorrectionTextBlock_zkGsWlC47ESe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. <span id="xdx_829_zM90Ne9C0Y81">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of the Company&#8217;s financial statements as of September&#160;30, 2021, management determined it should
restate the Company&#8217;s previously reported financial statements. During the quarter ended September 30, 2021, the Company determined
that at the closing of the Company&#8217;s Initial Public Offering (including the sale of the shares issued pursuant to the exercise
of the underwriters&#8217; overallotment) it had improperly valued its common stock subject to possible redemption at the closing of
the Company&#8217;s Initial Public Offering and at the closing of the sale of shares pursuant to the exercise of the underwriters&#8217;
overallotment, it had improperly classified certain of its common stock subject to possible redemption. The Company previously determined
the common stock subject to possible redemption to be equal to the redemption value of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDG9Jn5jRej6">10.10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock while also taking into
consideration that in accordance with the Company&#8217;s Charter, a redemption cannot result in net tangible assets being less than
$<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210930__srt--RangeAxis__srt--MinimumMember_zoUEsSdNwwe2">5,000,001</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Management determined that the common stock issued in the Initial Public Offering and pursuant to the exercise of the underwriters&#8217;
overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company&#8217;s
control. Therefore, management concluded that temporary equity should include all common stock subject to possible redemption, resulting
in the common stock subject to possible redemption being equal to its redemption value. As a result, management has noted a classification
adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common
stock subject to possible redemption with the offset recorded to additional paid-in capital and common stock&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the change in presentation for the common stock subject to redemption, the Company also restated its income (loss) per
share of common stock calculation to allocate net income (loss) evenly to the total shares of common stock. This presentation contemplates
a Business Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the
Company.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ztL7HMMfxEtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the restatement on the Company&#8217;s historical financial statements is reflected in the following tables:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z66gJO8ihi5k" style="display: none">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br/> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of March 31, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,205,807</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,944,193</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(49</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,453,448</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,144</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,845</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,845</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z7ZMviKeQx41" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,007</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaucjXCM2nf6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zlPWpAOopgn5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,010,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_iI_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdAuiM6EF805" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"/>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of June 30, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,858,319</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">407</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--CommonStockIssuedValue_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,800,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,629</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(801,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(801,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXSrn6VFAUla" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2V50EAetD4i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zAzJ1HCZt7Cc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(291,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,976,071</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">523,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Operations for the
    Three Months Ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,046,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0869">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9HOzaPkD5ch" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,004,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMUOI7B614Ja" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331_zbyHglaM1fLd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Three Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,010,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,040,357</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z15QRe16Jyl1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Six Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,028,394</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">471,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0893">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,022,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z81HmPth73Mi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(471,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed
    Statement of Changes in Stockholders&#8217; Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Previously<br/> Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNrNrVN931W3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,065</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(363,065</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0904">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPEEhjpw1dhg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,007</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMSKAiQ3SETe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zNweztXwqS4c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">347,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(347,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0910">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoWdwOwYvAv8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgwNwPg2HhJa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zwyMLKaWmlB7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(291,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash Flows for the
    three months ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z53O2SOLHaqc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(363,965</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPc3ZV1v4fgk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,965</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331_zyORfDhwfJrh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0916">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash
    Flows for the six months ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zonMlT5P5895" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(711,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z569YmicyXO6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">711,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630_zi9WICxPqBGg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0919">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367179768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zXIkZKYA2QZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_821_z5m8VbrtIb96">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zCnvjBgUYuWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zrEQ3p7X0co5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_849_ecustom--EmergingGrowthCompanyPolicyTextBlock_zl590eHjqXjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zKcn2m1iBIv4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--UseOfEstimates_zCq2olwPhwA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B6_zFMc5EVybYAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzS17IVvVYh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z3TbZ5bZehce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20201231_zJm8zmHz7X91">no</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t
have any cash equivalents as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zSejwylhHry8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zGosV4OqdYid" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_zqq9Q259rzT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zK2T3MJVoGgk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated,
see Note 2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Gross
    Proceeds</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Add:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion of carrying
    value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p id="xdx_8A3_zMuBfS88iyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zLIGKREPJ3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zKyLgmOsCDZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized
tax benefits as income tax expense. There were <span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pp0p0_do_c20201231_zU8VFDXPC6s7">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing
authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zGbK81JcrmC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_869_zlRrQYOdgkui" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss per Common Stock</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated, see Note
2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200821__20201231_pdd">15,789,722
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of December
31 2020, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    from August 21,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020 (Inception)
    Through</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss, as adjusted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,703</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(57,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,520,661</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,658,912</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p id="xdx_8AB_zmTqGAuFrHCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zqzJccsZiRT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_86E_zVRw6LOq6qhe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_903_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20200821__20201231_pp0p0">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8vNJCJOEvJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86D_zc0ARhiAXMea" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuWxNENHOFB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zoZqII0npHK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zBNrbSO2R59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. <span id="xdx_82C_z23TcnWnswHi">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTnS6kZ5mtK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--EmergingGrowthCompanyPolicyTextBlock_znhzZULg3Oz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--UseOfEstimates_zlOEoyvaeqL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zI5qRXATKyPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zWfDyVHltKs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company&#8217;s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_z2Q5FTxthpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock
resulted in charges against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zv9YHgHVfzl" style="display: none">SCHEDULE
OF CONDENSED BALANCE SHEET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    proceeds</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock issuance costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion
    of carrying value to redemption value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock subject to possible redemption</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_z53XnCl72Jv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zYRX9qwmfYO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were <span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210930_zfEuY5fs1hac">no</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized
tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company has been subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_z3iVPmfMrpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210930_pdd">15,789,722
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of September
30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/>

<p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period
    from</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months
    Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine&#160;Months&#160;Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August 21,
    2020<br/>
    (Inception)<br/>
    Through</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,&#160;2020</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic and diluted net loss per common share</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of
    net loss, as adjusted</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(680,303</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(210,056</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,223,906</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(377,903</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted
    average shares outstanding</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss
    per common share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.00</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<p id="xdx_8A7_zO33tm4aT123" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2h0h0Gfvm44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20210930_pp0p0">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zudSSrgYVNSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zsziBPSVIyL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify; text-indent: 19.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zakXvEAARJl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658365661144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p id="xdx_806_ecustom--InitialPublicOfferingTextBlock_zAnwuB3UewHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_ztA3hnsND2o9">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS4VWs9VmN3c">11,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zd5CcWhxcfI6">1,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at a price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_zEwntago3pRh">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_uUSDPShares_c20211231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z18GGFdmLym2">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zyupDZFdjnQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_z5bqmd0WpVB">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ElRHWzflSe">11,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyhwMiWPkZSl">1,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, at a price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zBZpoKsR5CDc">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAD5ROBE7XYg">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367175624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p id="xdx_808_ecustom--PrivatePlacementTextBlock_z2JcZqPdqxt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_829_zfKTJn7HzvJ5">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq4KPmnGmE01">3,688,889
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxqFmu2YXw9h">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pip0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq0WPEPlObcg">2,766,667
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Up and Up purchased <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zTQT3cXqJZUi">500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_z4wa6vKUpMLj">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z9LbNaoaqoij">375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z6bcPzZkIyp7">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zP6srB2f3Bgi">100,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Units at a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Placement Unit, or $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkQKH0e6Bk5i">1,008,333
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the aggregate. Each Placement Unit consists
of one share of common stock (&#8220;Placement Share&#8221;) and one redeemable warrant (&#8220;Placement Warrant&#8221;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zKoSSrRtAzI">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_ecustom--PrivatePlacementTextBlock_zOrwb9fBUqLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_820_zrFVgzJqNy1">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zBjr1TsGV9R3">3,688,889
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zt0zUUETBvb6">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_znIq3ufEpmOe">2,766,667
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Up and Up purchased <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkebEe4foRvg">500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants at a purchase price of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxbmBKvbgqY">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Private Warrant, for an aggregate purchase
price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zJHl0sBU8Nhd">375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zbuq7tqIKoTj">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_znukqKkhVaTc">100,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Units at a purchase price of $10.00
per Placement Unit, or $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zEjyHTbNpZuk">1,008,333
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the aggregate. Each Placement Unit consists
of one share of common stock (&#8220;Placement Share&#8221;) and one redeemable warrant (&#8220;Placement Warrant&#8221;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z1IpqYTHD3f1">11.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private Placement [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658365545544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdnoTEf4Keqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_827_z5JncVu0RfU4">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2020, Globis SPAC LLC purchased <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pdd">2,875,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock for
an aggregate price of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0">25,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On December 7, 2020, the Company sold an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pdd">172,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stocks to
Up and Up for an aggregate price of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pp0p0">1,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
resulting in a total of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_pdd">3,047,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock being sold to the Sponsors
(the &#8220;Founder Shares&#8221;) and being issued and outstanding, of which an aggregate of up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201205__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zEFRyV7eMuJb">397,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
<span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6PDN21JrOMl">21%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Company&#8217;s issued and outstanding
shares after the Initial Public Offering. As a result of the underwriters&#8217; election to fully exercise their over-allotment option
on December 15, 2020, no Founder Shares are currently subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $<span id="xdx_903_eus-gaap--PaymentsForRent_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0">10,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#8217;s liquidation, the Company will cease paying these monthly
fees. For the period from August 21, 2020 (inception) through December 31, 2020, the Company incurred $<span id="xdx_903_eus-gaap--PrepaidExpenseCurrent_c20211231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_pp0p0">5,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in fees for these services, of which amount is
included in accrued expenses in the accompanying balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances
from Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 2, 2020, the Sponsor advanced the Company $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_zPmo2npWYsqd">50,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund certain offering cost in connection with
the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#8217;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#8217;s discretion, the notes may be converted upon completion of a Business Combination
into warrants at a price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20201231__us-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zOYaFl3WPJah">0.75
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant. Such warrants would be identical
to the Private Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside
the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital
Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z8kNKU3obTt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_829_zLp2kv6zgzm8">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2020, Globis SPAC LLC purchased <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zYx5fPRCoFU6">2,875,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock for
an aggregate price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zXPA4pFb7rJ7">25,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
On December 7, 2020, the Company sold an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zq2UxGoEly6d">172,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stocks to
Up and Up for an aggregate price of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zmQcTpOT3Xea">1,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
resulting in a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKlTFQkeV3Fa">3,047,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock being sold to the Sponsors
(the &#8220;Founder Shares&#8221;) and being issued and outstanding, of which an aggregate of up to <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201206__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0tmZpKt9Ql">397,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
<span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zNUMU23jNe2d">21</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters&#8217; election
to fully exercise their over-allotment option on December 15, 2020, no Founder Shares are currently subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $<span id="xdx_90F_eus-gaap--PaymentsForRent_pp0p0_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zX14Yq7WKyJ9">10,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#8217;s liquidation, the Company will cease paying these monthly
fees. For the three and nine months ended September 30, 2021, the Company incurred $<span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zKHU6ydsd23a">30,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--ProfessionalFees_pp0p0_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zsivcrxwtTxl">90,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in fees for these services. At September 30, 2021, $<span id="xdx_901_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zV7CvlL7pfpe">5,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is reflected in accrued expenses related to this
agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances
from Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 2, 2020, the Sponsor advanced the Company $<span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_pp0p0">50,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund certain offering costs in connection
with the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#8217;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#8217;s discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20210111__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. On
various dates during the nine months ended September 30, 2021, the Company drew a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20210930__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0">700,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under the Note in accordance with the Working
Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2021, the Note was amended to terminate the option for the Lender to convert the amount outstanding under the Note into Private
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2021, the Note was amended to increase the principal amount of the Note to $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719__srt--RangeAxis__srt--MaximumMember_zhkfLUitk6n5">2,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2021, the Note was amended to increase the principal amount of the Note to $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_zlc5VAe4knx2">3,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367148216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">COMMITMENTS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--CommitmentsDisclosureTextBlock_zqvGhN1nlKqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_825_zOfHRYHF19Ol">COMMITMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are entitled to receive the <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_uShares_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zHVwbETODlRk">402,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholders&#8217;
equity. The fair value of the equity participation shares is estimated to be $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zwW7orhs03Yk">4,025,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
based upon the offering price of the Units of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zODzMPk7Ykub">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsDisclosureTextBlock_zIhtXf3dEINb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_829_zZ3CkGSvowYj">COMMITMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are entitled to receive the <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd">402,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholder&#8217;s
equity. The fair value of the equity participation shares is estimated to be $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pp0p0">4,025,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
based upon the offering price of the Units of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd">10.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366510696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER&#8217;S EQUITY<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDER&#8217;S EQUITY</a></td>
<td class="text"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7l4fZBCsbHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span>STOCKHOLDERS&#8217; EQUITY</span></b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated,
see Note 2)</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_827_zUGePfJpVAq5" style="display: none">STOCKHOLDER&#8217;S EQUITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20201231_zKqx3BCiUSf5">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of preferred stock with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zSCVB2wRhf28">0.0001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share with such designations, voting and
other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At December 31, 2020,
there were no shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20201231_zEKbKFbbmawi">100,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zFPBjZ7rjNz2">0.0001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. At December 31, 2020, there were <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20201231_zLFM9aATovLh">3,550,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued and outstanding,
excluding <span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_c20201231_pdd">11,500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock subject to possible redemption which are presented as temporary equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i>&#8212;</b> The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of our initial business combination, warrant holders may, until such time as there is an effective
registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise
warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that
such exemption is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrants become exercisable, the Company may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $0.01 per warrant;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time while the warrants are exercisable;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than 30 days&#8217; prior written notice of redemption to each warrant holder;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201231__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zudK1PDt8loj">16.50
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a <span id="xdx_90C_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20200821__20201231_zOqJobQ64Pgj">30</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-day
    trading period ending on the third business day prior to the notice of redemption to warrant holders; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless
basis,&#8221; as described in the warrant agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_90F_ecustom--PercentageOfProceedsFromBusinessCombination_iI_pid_dp_c20201231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVzTZhjYZYDd">60%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the total equity proceeds, and interest thereon,
available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and
(z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior
the day on which the Company consummates a Business Combination (such price, the &#8220;Market Value&#8221;) is below $<span id="xdx_90D_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z9MppzZfHH9b">9.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_900_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0gJtvSBZKha">115%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the higher of the Market Value and the Newly
Issued Price, and the $<span id="xdx_90A_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zGIOVlfbhMt9">16.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to <span id="xdx_90C_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk5yhe4pjsU5">165%
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the higher of the Market Value and the Newly
Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8YfPPEiyugg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span id="xdx_825_zkwPe3u6haF9">STOCKHOLDER&#8217;S EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_c20201210_pdd">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of preferred stock with a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201210_pdd">0.0001</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share with such designations, voting and other rights and
preferences as may be determined from time to time by the Company&#8217;s board of directors. At September 30, 2021 and December 31,
2020, there were no shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20210930_pdd">100,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock with a par value of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20210930_pdd">0.0001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. At September 30, 2021 and December
31, 2020, there were <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkI6IXZVVWr3">3,550,833
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issued and outstanding,
excluding <span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_iI_c20201231_z1hydEqWImza">11,500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock subject to possible redemption which are presented as temporary equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i>&#8212;</b> The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of the Company&#8217;s initial business combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration
statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrants become exercisable, the Company may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_iI_c20210930_zvQC2mQJgeH1">0.01</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
    warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time while the warrants are exercisable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than <span id="xdx_904_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zOmPxPoGp2Oc">30
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">days&#8217; prior written notice of redemption
    to each warrant holder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MinimumMember_pdd">16.50
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-day trading period ending on the third
    business day prior to the notice of redemption to warrant holders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless
basis,&#8221; as described in the warrant agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_909_ecustom--PercentageOfProceedsFromBusinessCombination_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTRY2qkOVXt5">60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation
of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading
day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the &#8220;Market
Value&#8221;) is below $<span id="xdx_90A_ecustom--MarketValueOfCommonStock_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_pdd">9.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_90A_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_zNSxZ3XCQRu1">115</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the higher of the Market Value and the Newly Issued Price, and the $<span id="xdx_908_ecustom--MarketValueOfCommonStock_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd">16.50
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to <span id="xdx_902_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0NPV7RbQBu">165</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658364704776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zpgHjNlbXsQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. <span id="xdx_825_zYlZ9b0Uoy4b">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zAOCj6NRkip8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B7_zG4jNxgfhux7" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF DEFERRED TAX ASSETS</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zGiXYoajXVib" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzMY0_zitPGfSa5tFf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carryforward</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,586</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzMY0_zcSzChQ3J4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Startup and organizational costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">16,290</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzMY0_maDTANz7zZ_zB3FbCQTQVc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz7zZ_z4TMDZa1MPoc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz7zZ_zMUzXXTuRmi1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets, net valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A6_zjuaNoTzJ9qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCrupi9qzu9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BF_zo0LW4fK0Ihj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF INCOME TAX PROVISION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200821__20201231_z8oSl5bK2Sr6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Federal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,876</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">State and Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Change in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A1_zW8Wbftk193" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0">89,886</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
U.S. federal net operating loss carryovers available to offset future taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
period from August 21, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $<span id="xdx_90A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20200821__20201231_zo9YPivOYeF3">18,876</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zej2VLh51Uu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</span></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B3_zErat1bBduCa" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200821__20201231_zsWxVwPsUMvg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_z06zX7JoNHol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory federal income tax rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zNZLSViTun7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">State taxes, net of federal tax benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_zlr9o2nUi9B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zAVdZMRWRol1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<p id="xdx_8A0_z6XqdUDoJac8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The
Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York to be
a significant state tax jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366566616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_zpY0RgT1MLxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10. <span id="xdx_82F_zIjtWBjhsxxl">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zUmwt2pocHu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December
31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B4_ztrBuFYRINVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvMOUe6wZYTd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Marketable securities held in
    Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AB_zMgQCKWkPMp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zlyRJqI9p1Kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9.&#8201; <span id="xdx_82E_zCUvpl57yn52">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zX0f0TdQIdF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zadfUy38R0i4" style="display: none">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable
    securities held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"><span style="font-family: Times New Roman, Times, Serif">116,155,627</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AB_zqogmnYf5pE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367217592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zgugRdOjtUM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11.&#8201;<span id="xdx_822_zJSpmhaBOXw9">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have
required adjustment or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20210111__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_pp0p0">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. At
the election of the Lender, all or a portion of the unpaid principal amount of the Note may be converted upon the consummation of the
Company&#8217;s initial Business Combination into a number of warrants of the Company, with each warrant being exercisable for one share
of common stock of the Company (the &#8220;Conversion Warrants&#8221;), equal to: (x) the portion of the principal amount of the Note
being converted, divided by (y) $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20210111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zQ0hqdQZ8mJb">0.75</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
rounded up to the nearest whole number of warrants. The Conversion Warrants are identical to the Private Warrants issued. On February
2, 2021, the Company borrowed <span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210202__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zmCqwADl3Kec">$100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in accordance with the Note.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zTHHcqlcWHhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10.&#8201;<span id="xdx_823_zDbllZquseQ1">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than described below and the restatement discussed in Note 2, the Company did not identify
any subsequent events that would have required adjustment or disclosure in the condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the Company increased the principal amount available under the Note (as defined in Note 1 under Liquidity) to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z48IjUkTsqGf">3,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658362501512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zCnvjBgUYuWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zrEQ3p7X0co5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTnS6kZ5mtK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p id="xdx_849_ecustom--EmergingGrowthCompanyPolicyTextBlock_zl590eHjqXjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zKcn2m1iBIv4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_ecustom--EmergingGrowthCompanyPolicyTextBlock_znhzZULg3Oz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_847_eus-gaap--UseOfEstimates_zCq2olwPhwA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B6_zFMc5EVybYAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--UseOfEstimates_zlOEoyvaeqL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzS17IVvVYh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z3TbZ5bZehce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20201231_zJm8zmHz7X91">no</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t
have any cash equivalents as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zI5qRXATKyPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities Held in Trust Account</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zSejwylhHry8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zGosV4OqdYid" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zWfDyVHltKs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marketable
Securities Held in Trust Account</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company&#8217;s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock', window );">Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p id="xdx_847_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_zqq9Q259rzT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zK2T3MJVoGgk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated,
see Note 2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Gross
    Proceeds</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Add:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion of carrying
    value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p id="xdx_8A3_zMuBfS88iyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_z2Q5FTxthpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock
resulted in charges against additional paid-in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zv9YHgHVfzl" style="display: none">SCHEDULE
OF CONDENSED BALANCE SHEET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    proceeds</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock issuance costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion
    of carrying value to redemption value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock subject to possible redemption</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_z53XnCl72Jv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zLIGKREPJ3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zKyLgmOsCDZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized
tax benefits as income tax expense. There were <span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pp0p0_do_c20201231_zU8VFDXPC6s7">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing
authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zYRX9qwmfYO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were <span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210930_zfEuY5fs1hac">no</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized
tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company has been subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#8217;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) per Common Share</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zGbK81JcrmC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_869_zlRrQYOdgkui" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss per Common Stock</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Restated, see Note
2)</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200821__20201231_pdd">15,789,722
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of December
31 2020, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    from August 21,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020 (Inception)
    Through</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss, as adjusted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,703</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(57,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,520,661</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,658,912</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p id="xdx_8AB_zmTqGAuFrHCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_z3iVPmfMrpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210930_pdd">15,789,722
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock in the aggregate. As of September
30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/>

<p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period
    from</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months
    Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine&#160;Months&#160;Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August 21,
    2020<br/>
    (Inception)<br/>
    Through</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,&#160;2020</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic and diluted net loss per common share</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of
    net loss, as adjusted</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(680,303</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(210,056</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,223,906</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(377,903</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted
    average shares outstanding</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss
    per common share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.00</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<p id="xdx_8A7_zO33tm4aT123" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBIS
ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zqzJccsZiRT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_86E_zVRw6LOq6qhe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_903_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20200821__20201231_pp0p0">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2h0h0Gfvm44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20210930_pp0p0">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8vNJCJOEvJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86D_zc0ARhiAXMea" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zudSSrgYVNSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuWxNENHOFB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zoZqII0npHK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zakXvEAARJl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zsziBPSVIyL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify; text-indent: 19.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Subject To Possible Redemption Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366880648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zdSJWd6i1zQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B7_zkIKDrkP2O16" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br/> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 15, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zr1tDu8D9RW8" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">111,652,086</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zFV3u6dZ6BWf" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">4,497,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215_zJLo6pZ96RJ5" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--CommonStockValue_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1u8FSmwjWM2" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJOqUaBUI63k" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">(45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201215_zuIWn2qiL2Vk" style="text-align: right" title="Common stock"><span style="font-family: Times New Roman, Times, Serif">356</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxDCFwdezsa4" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">5,007,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYOyO3xsgATd" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">(4,497,869</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215_zGOkQMf6ARyf" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">509,303</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zv3zt32REHO2" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(7,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pdp0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGVNovl30gug" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215_zV4cW22ADfQ6" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(7,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPWGodXf84Xh" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">5,000,002</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdBCTW7la5M9" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">(4,497,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215_zMOh0PQL3tRl" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">502,088</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeHAy5RxokO1" style="text-align: right" title="Weighted average shares outstanding - redeemable"><span style="font-family: Times New Roman, Times, Serif">11,054,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zc9V3ongOX33" style="text-align: right" title="Weighted average shares outstanding - redeemable"><span style="font-family: Times New Roman, Times, Serif">445,338</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockRedemptionShares_c20201213__20201215_zpItKGo9Qibc" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance Sheet as of December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3hCgC3NyId6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIdULU9bX9C" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231_z5vCs9Oi8ct1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zI9bzOwDKgQ7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZFQN4mV307j" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--CommonStockValue_iI_pp0p0_c20201231_zhsKRPsyW40b" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">5,089,487</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">(4,580,183</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231_pp0p0" style="text-align: right" title="Additional paid-in capital"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(89,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdp0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0297">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231_pp0p0" style="text-align: right" title="Accumulated deficit"><span style="font-family: Times New Roman, Times, Serif">(89,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsCMFzqndTr2" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">5,000,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJ0EEjklCdEk" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">(4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231_zDthzg4HYMgb" style="text-align: right" title="Total Stockholders' (Deficit) Equity"><span style="font-family: Times New Roman, Times, Serif">419,773</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVAnRbarvAWa" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,046,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOFlAOLeikU9" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--CommonStockRedemptionShares_c20200821__20201231_zT5AFZISJ2g" style="text-align: right" title="Common stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Cash Flows
    for the Period from August 21, 2020 (Inception) through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial classification of common stock subject
    to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJqUiheK12oc" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">111,652,086</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zV6CbUeMo0Ug" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">4,497,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231_zuctQ6H3xln2" style="text-align: right" title="Initial classification of common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of Common Stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBrsLUkQHPDl" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(82,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zrWKWotoa70a" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">82,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231_zSHAD2BlVR9l" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0323">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity for the Period Ended December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVSUk9SIENPUlJFQ1RJT05TIEFORCBQUklPUiBQRVJJT0QgQURKVVNUTUVOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200812__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zmnvanOuGuLi">11,500,000
    </span></span><span style="font-family: Times New Roman, Times, Serif">Units, net of underwriter discounts and offering expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuagBQBjeCIb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,483,159</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQt2KkRywt22" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(112,483,159</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231_zkrIjxg6sjyj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0327">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial value of Common Stock subject to redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zi7rWRC82HM" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsAXSHlgE9vi" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif">(111,569,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231_zlXdo4sdqXRi" style="text-align: right" title="Initial value of Common Stock subject to redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Redemption adjustment for Common Stock to redemption
    amount</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkefGMzoB9rj" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0335">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGXkCxbnnht7" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif">(3,666,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231_zgiqOcjTOiyg" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"><span style="font-family: Times New Roman, Times, Serif">(3,666,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Shareholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA0KxRLCfqN1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwPbyZLu3rj9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,580,228</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20201231_zxtHWY01aUU7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">419,773</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations
    for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlTYmScAaj0c" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">11,054,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAv4YhHVd6x3" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(9,534,001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231_z6k8fmmfMKHi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">1,520,661</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share, common
    stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8oW5nThcxSc" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSfWobUqQ03e" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231_zP5Tgjnyfxs2" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK5MhbdHWop" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">2,717,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAwuKtSYp0i9" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(58,887</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231_zEnwjDGUhTsi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">2,658,912</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss (income) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWSzpoOfsvd" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(0.03</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpyFsn5E87f" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231_z8ZL2LXcelB9" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ztL7HMMfxEtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the restatement on the Company&#8217;s historical financial statements is reflected in the following tables:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z66gJO8ihi5k" style="display: none">SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Previously<br/> Reported</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Adjustment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    Restated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of March 31, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible
    redemption</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,205,807</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,944,193</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331_pp0p0" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(49</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,453,448</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,144</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,845</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,845</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z7ZMviKeQx41" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,007</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaucjXCM2nf6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zlPWpAOopgn5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,010,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_iI_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdAuiM6EF805" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"/>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right; width: 14%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Balance Sheet as of June 30, 2021
    (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,858,319</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">407</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--CommonStockIssuedValue_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,800,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,629</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">509,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(801,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(801,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXSrn6VFAUla" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2V50EAetD4i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zAzJ1HCZt7Cc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(291,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Number of shares of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,976,071</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">523,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Operations for the
    Three Months Ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,046,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0869">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9HOzaPkD5ch" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,004,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMUOI7B614Ja" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(453,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331_zbyHglaM1fLd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Three Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,010,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,040,357</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z15QRe16Jyl1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(489,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Statement of Operations for the Six Months
    Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,028,394</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">471,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    common stock subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0893">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,022,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z81HmPth73Mi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(471,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,550,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income (loss) per share,
    Non-redeemable common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed
    Statement of Changes in Stockholders&#8217; Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Previously<br/> Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNrNrVN931W3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,065</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(363,065</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0904">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPEEhjpw1dhg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,007</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMSKAiQ3SETe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,944,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zNweztXwqS4c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Changes
    in Stockholders&#8217; Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">347,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(347,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630_pp0p0" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0910">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Stockholders&#8217; Equity (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoWdwOwYvAv8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgwNwPg2HhJa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,291,681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zwyMLKaWmlB7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(291,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash Flows for the
    three months ended March 31, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z53O2SOLHaqc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(363,965</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPc3ZV1v4fgk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,965</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331_zyORfDhwfJrh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0916">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Condensed Statement of Cash
    Flows for the six months ended June 30, 2021 (unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash investing and financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in value of common stock subject to
    possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zonMlT5P5895" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(711,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z569YmicyXO6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">711,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630_zi9WICxPqBGg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0919">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658365534200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock', window );">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Gross
    Proceeds</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Add:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion of carrying
    value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    from August 21,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020 (Inception)
    Through</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable
    common stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss, as adjusted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,703</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(57,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted
    average shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,520,661</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,658,912</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif">The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period
    from</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months
    Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine&#160;Months&#160;Ended</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August 21,
    2020<br/>
    (Inception)<br/>
    Through</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,
    2021</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September&#160;30,&#160;2020</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-redeemable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common&#160;stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>common
    stock</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic and diluted net loss per common share</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of
    net loss, as adjusted</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(680,303</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(210,056</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,223,906</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(377,903</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted
    average shares outstanding</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,550,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss
    per common share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.06</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.00</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">SCHEDULE OF CONDENSED BALANCE SHEET</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zv9YHgHVfzl" style="display: none">SCHEDULE
OF CONDENSED BALANCE SHEET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    proceeds</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock issuance costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(2,516,841</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Accretion
    of carrying value to redemption value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,666,841</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock subject to possible redemption</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366895832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Tables) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zAOCj6NRkip8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B7_zG4jNxgfhux7" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF DEFERRED TAX ASSETS</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zGiXYoajXVib" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzMY0_zitPGfSa5tFf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carryforward</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,586</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzMY0_zcSzChQ3J4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Startup and organizational costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">16,290</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzMY0_maDTANz7zZ_zB3FbCQTQVc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz7zZ_z4TMDZa1MPoc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz7zZ_zMUzXXTuRmi1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets, net valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF INCOME TAX PROVISION</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCrupi9qzu9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BF_zo0LW4fK0Ihj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF INCOME TAX PROVISION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200821__20201231_z8oSl5bK2Sr6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Federal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,876</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">State and Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Change in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,876</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zej2VLh51Uu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</span></p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8B3_zErat1bBduCa" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200821__20201231_zsWxVwPsUMvg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_z06zX7JoNHol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory federal income tax rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zNZLSViTun7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">State taxes, net of federal tax benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_zlr9o2nUi9B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zAVdZMRWRol1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax provision</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658366844056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</a></td>
<td class="text"><p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zUmwt2pocHu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December
31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"><span id="xdx_8B4_ztrBuFYRINVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvMOUe6wZYTd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2020</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Marketable securities held in
    Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zX0f0TdQIdF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zadfUy38R0i4" style="display: none">SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable
    securities held in Trust Account</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"><span style="font-family: Times New Roman, Times, Serif">116,155,627</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"><span style="font-family: Times New Roman, Times, Serif">116,150,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356496280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2021</div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 13, 2021</div></th>
<th class="th"><div>Jul. 19, 2021</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,541,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Expense Related to Distribution or Servicing and Underwriting Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,516,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CashHeldOutsideTrust', window );">[custom:CashHeldOutsideTrust-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable Securities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,150,000<span></span>
</td>
<td class="nump">116,155,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_WorkingCapital', window );">[custom:WorkingCapital-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 432,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,155,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Franchise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Globis SPAC LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Trust Account [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidationBasisOfAccountingCostsAndIncomes', window );">Liquidation Basis of Accounting, Costs and Incomes</a></td>
<td class="text">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Subsequent Event [Member] | Globis SPAC LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Business Acquisition, Description of Acquired Entity</a></td>
<td class="text">Pursuant
to the terms of the Company&#8217;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#8217;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidationBasisOfAccountingCostsAndIncomes', window );">Liquidation Basis of Accounting, Costs and Incomes</a></td>
<td class="text">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,188,889<span></span>
</td>
<td class="nump">4,188,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,516,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember', window );">Private Securities [Member] | Globis SPAC LLC and Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CashHeldOutsideTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held outside trust.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CashHeldOutsideTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidationBasisOfAccountingCostsAndIncomes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of costs and incomes accrued in the statement of net assets in liquidation and the period over which those costs are expected to be paid or income earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686388-199418<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiquidationBasisOfAccountingCostsAndIncomes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_FranchiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_FranchiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GLAQ_GlobisSPACLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GLAQ_GlobisSPACLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GLAQ_TrustAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GLAQ_TrustAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356160936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common stock subject to possible redemption</a></td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="num">(356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">509,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="nump">$ 509,304<span></span>
</td>
<td class="nump">$ 509,304<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
<td class="nump">$ 509,304<span></span>
</td>
<td class="nump">509,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(7,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,691,695)<span></span>
</td>
<td class="num">(801,336)<span></span>
</td>
<td class="num">(453,845)<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
<td class="num">(801,336)<span></span>
</td>
<td class="num">(1,691,695)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' (Deficit) Equity</a></td>
<td class="nump">$ 502,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,182,036)<span></span>
</td>
<td class="num">$ (291,677)<span></span>
</td>
<td class="nump">$ 55,814<span></span>
</td>
<td class="nump">$ 419,773<span></span>
</td>
<td class="num">$ (291,677)<span></span>
</td>
<td class="num">$ (1,182,036)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockRedemptionShares', window );">Common stock subject to redemption</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption', window );">Initial classification of common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInSharesSubjectToPossibleRedemption', window );">Change in value of Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnderwritingIncomeLoss', window );">Underwriting Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialSharesSubjectToPossibleRedemption', window );">Initial value of Common Stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_AccretionForCommonStockToRedemptionAmount', window );">Redemption adjustment for Common Stock to redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,666,841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">1,520,661<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,500,000)<span></span>
</td>
<td class="num">(11,500,000)<span></span>
</td>
<td class="num">(11,500,000)<span></span>
</td>
<td class="num">(1,520,661)<span></span>
</td>
<td class="num">(11,500,000)<span></span>
</td>
<td class="num">(11,500,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption', window );">Basic and diluted net income per share, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">2,658,912<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="num">(3,550,833)<span></span>
</td>
<td class="num">(3,550,833)<span></span>
</td>
<td class="num">(3,550,833)<span></span>
</td>
<td class="num">(2,658,912)<span></span>
</td>
<td class="num">(3,550,833)<span></span>
</td>
<td class="num">(3,550,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss (income) per share, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockIssuedValue', window );">Common stock issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption', window );">[custom:NumberOfSharesOfCommonStockSubjectToPossibleRedemption-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock', window );">[custom:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:ChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption', window );">[custom:NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common stock subject to possible redemption</a></td>
<td class="nump">$ 111,652,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,569,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="num">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,007,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,933<span></span>
</td>
<td class="nump">5,453,448<span></span>
</td>
<td class="nump">5,089,487<span></span>
</td>
<td class="nump">5,800,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(7,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801,336)<span></span>
</td>
<td class="num">(453,845)<span></span>
</td>
<td class="num">(89,886)<span></span>
</td>
<td class="num">(801,336)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' (Deficit) Equity</a></td>
<td class="nump">$ 5,000,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,004<span></span>
</td>
<td class="nump">$ 5,000,007<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockRedemptionShares', window );">Common stock subject to redemption</a></td>
<td class="nump">11,054,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,046,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption', window );">Initial classification of common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,652,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInSharesSubjectToPossibleRedemption', window );">Change in value of Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnderwritingIncomeLoss', window );">Underwriting Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,483,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialSharesSubjectToPossibleRedemption', window );">Initial value of Common Stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,569,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_AccretionForCommonStockToRedemptionAmount', window );">Redemption adjustment for Common Stock to redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,010,476<span></span>
</td>
<td class="nump">11,046,512<span></span>
</td>
<td class="nump">11,054,662<span></span>
</td>
<td class="nump">11,028,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,010,476)<span></span>
</td>
<td class="num">(11,046,512)<span></span>
</td>
<td class="num">(11,054,662)<span></span>
</td>
<td class="num">(11,028,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption', window );">Basic and diluted net income per share, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,040,357<span></span>
</td>
<td class="nump">4,004,321<span></span>
</td>
<td class="nump">2,717,799<span></span>
</td>
<td class="nump">4,022,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,040,357)<span></span>
</td>
<td class="num">(4,004,321)<span></span>
</td>
<td class="num">(2,717,799)<span></span>
</td>
<td class="num">(4,022,439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss (income) per share, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,858,319<span></span>
</td>
<td class="nump">$ 111,205,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,858,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockIssuedValue', window );">Common stock issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption', window );">[custom:NumberOfSharesOfCommonStockSubjectToPossibleRedemption-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,976,071<span></span>
</td>
<td class="nump">11,010,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,976,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock', window );">[custom:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:ChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347,488<span></span>
</td>
<td class="nump">$ 363,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (711,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common stock subject to possible redemption</a></td>
<td class="nump">$ 4,497,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,580,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="num">(4,497,869)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,291,629)<span></span>
</td>
<td class="num">(4,944,144)<span></span>
</td>
<td class="num">(4,580,183)<span></span>
</td>
<td class="num">(5,291,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' (Deficit) Equity</a></td>
<td class="num">$ (4,497,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,291,681)<span></span>
</td>
<td class="num">$ (4,944,193)<span></span>
</td>
<td class="num">$ (4,580,228)<span></span>
</td>
<td class="num">$ (5,291,681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockRedemptionShares', window );">Common stock subject to redemption</a></td>
<td class="nump">445,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption', window );">Initial classification of common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,497,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInSharesSubjectToPossibleRedemption', window );">Change in value of Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnderwritingIncomeLoss', window );">Underwriting Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112,483,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_InitialSharesSubjectToPossibleRedemption', window );">Initial value of Common Stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111,569,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_AccretionForCommonStockToRedemptionAmount', window );">Redemption adjustment for Common Stock to redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,666,841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,524<span></span>
</td>
<td class="nump">453,488<span></span>
</td>
<td class="nump">9,534,001<span></span>
</td>
<td class="nump">471,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489,524)<span></span>
</td>
<td class="num">(453,488)<span></span>
</td>
<td class="num">(9,534,001)<span></span>
</td>
<td class="num">(471,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption', window );">Basic and diluted net income per share, common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,524<span></span>
</td>
<td class="nump">453,488<span></span>
</td>
<td class="nump">58,887<span></span>
</td>
<td class="nump">471,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489,524)<span></span>
</td>
<td class="num">(453,488)<span></span>
</td>
<td class="num">(58,887)<span></span>
</td>
<td class="num">(471,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss (income) per share, Non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,291,681<span></span>
</td>
<td class="nump">$ 4,944,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,291,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockIssuedValue', window );">Common stock issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52)<span></span>
</td>
<td class="num">$ (49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption', window );">[custom:NumberOfSharesOfCommonStockSubjectToPossibleRedemption-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,929<span></span>
</td>
<td class="num">(489,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock', window );">[custom:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:ChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (347,488)<span></span>
</td>
<td class="num">$ (363,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">[custom:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 711,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_AccretionForCommonStockToRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion for Common Stock to redemption amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_AccretionForCommonStockToRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted net loss per share, Common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_ChangeInSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_ChangeInSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CommonStockIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CommonStockIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CommonStockRedemptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock redemption, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CommonStockRedemptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial classification of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_InitialSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_InitialSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderwritingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the price paid by the public and the contract price less the related expenses. A broker-dealer may underwrite a security offering by contracting to buy the issue either at a fixed price or a price based on selling the offering on a best-effort basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderwritingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367306824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">5 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_UnderwriterMember', window );">Underwriter [Member] | Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of Stock, Number of Shares Issued in Transaction</a></td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_UnderwriterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_UnderwriterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658361303912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658362997032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross Proceeds</a></td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common stock issuance costs</a></td>
<td class="num">(216,841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,516,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,666,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Amount, Attributable to Parent</a></td>
<td class="nump">116,150,000<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross Proceeds</a></td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,516,841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,666,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Amount, Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356419096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net loss, as adjusted</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (890,359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (89,886)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,601,809)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">1,520,661<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">2,658,912<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GLAQ_RedeemableCommonStockMember', window );">Redeemable Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net loss, as adjusted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (680,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,223,906)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,520,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GLAQ_NonRedeemableCommonStockMember', window );">Non Redeemable Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net loss, as adjusted</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (210,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (57,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (377,903)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,658,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,550,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GLAQ_RedeemableCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GLAQ_RedeemableCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GLAQ_NonRedeemableCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GLAQ_NonRedeemableCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658365685128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash Equivalents, at Carrying Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Income Tax Examination, Penalties and Interest Accrued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">15,789,722<span></span>
</td>
<td class="nump">15,789,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356336984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details Narrative) - Globis Acquisition Corp [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">4,188,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,188,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember', window );">Private Securities [Member] | Globis SPAC LLC and Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember', window );">Placement Units [Member] | Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,833<span></span>
</td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658362686648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Sep. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember', window );">Globis SPAC LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember', window );">Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateWarrantsMember', window );">Private Warrants [Member] | Globis SPAC LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,688,889<span></span>
</td>
<td class="nump">3,688,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,766,667<span></span>
</td>
<td class="nump">$ 2,766,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateWarrantsMember', window );">Private Warrants [Member] | Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember', window );">Placement Units [Member] | Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,833<span></span>
</td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,008,333<span></span>
</td>
<td class="nump">$ 1,008,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember', window );">Private Securities [Member] | Globis SPAC LLC and Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">100,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PlacementUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=GLAQ_PrivateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658357591768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 02, 2020</div></th>
<th class="th"><div>Sep. 01, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 13, 2021</div></th>
<th class="th"><div>Jul. 19, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,653<span></span>
</td>
<td class="nump">$ 283,333<span></span>
</td>
<td class="nump">$ 150,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from Related Party Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayments of Related Party Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Administrative Support Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">397,500<span></span>
</td>
<td class="nump">397,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,047,500<span></span>
</td>
<td class="nump">3,047,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from Related Party Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Lender [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayments of Related Party Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember', window );">Globis SPAC LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember', window );">Globis SPAC LLC [Member] | Administrative Support Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember', window );">Up and Up Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GLAQ_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GLAQ_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GLAQ_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GLAQ_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=GLAQ_SponsorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=GLAQ_SponsorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=GLAQ_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=GLAQ_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=GLAQ_LenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=GLAQ_LenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_GlobisSPACLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GLAQ_UpAndUpCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658357514232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=GLAQ_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions</a></td>
<td class="nump">402,500<span></span>
</td>
<td class="nump">402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="nump">$ 4,025,000<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GLAQ_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GLAQ_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356110664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER&#8217;S EQUITY (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="nump">15,050,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_CommonStockSharesSubjectToRedemption', window );">[custom:CommonStockSharesSubjectToRedemption-0]</a></td>
<td class="nump">$ 11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NoticePeriodForRedemptionOfWarrants', window );">Notice period for redemption of warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">[custom:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">3,550,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Public warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_NoticePeriodForRedemptionOfWarrants', window );">Notice period for redemption of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_PercentageOfProceedsFromBusinessCombination', window );">Percentage of proceeds from business combination</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Public warrants [Member] | Common Stock Price Below 9.50 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_MarketValueOfCommonStock', window );">Market value of common stock</a></td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_PercentageOfExercisePriceOfWarrants', window );">Percentage of exercise price of warrants</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Public warrants [Member] | Common Stock Price Above 16.50 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_MarketValueOfCommonStock', window );">Market value of common stock</a></td>
<td class="nump">$ 16.50<span></span>
</td>
<td class="nump">$ 16.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GLAQ_PercentageOfExercisePriceOfWarrants', window );">Percentage of exercise price of warrants</a></td>
<td class="nump">165.00%<span></span>
</td>
<td class="nump">165.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember', window );">Minimum [Member] | Public warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 16.50<span></span>
</td>
<td class="nump">$ 16.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_CommonStockSharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_CommonStockSharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_MarketValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Market value of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_MarketValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_NoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notice period for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_NoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_PercentageOfExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_PercentageOfExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GLAQ_PercentageOfProceedsFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GLAQ_PercentageOfProceedsFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GLAQ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=GLAQ_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=GLAQ_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356087704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS (Details) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 2,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Startup and organizational costs</a></td>
<td class="nump">16,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">18,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="num">(18,876)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net valuation allowance</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658362676328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX PROVISION (Details) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658367123208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal tax benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658509163144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Details Narrative) - Globis Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 89,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="nump">$ 18,876<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658368040440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Globis Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities held in Trust Account</a></td>
<td class="nump">$ 116,155,627<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658363878104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 13, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jul. 19, 2021</div></th>
<th class="th"><div>Feb. 02, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Note Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member] | Note Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=GLAQ_NotePayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=GLAQ_NotePayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139658356303208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CONDENSED BALANCE SHEET (Details) - Globis Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="nump">$ 116,150,000<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common Stock issuance costs</a></td>
<td class="num">$ (216,841)<span></span>
</td>
<td class="num">(2,516,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Temporary Equity, Accretion to Redemption Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,666,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Temporary Equity, Carrying Amount, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=GLAQ_GlobisAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>forms-4_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:GLAQ="http://globis.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="glaq-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_PrivatePlacementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCAndUpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCAndUpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TrustAccountMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:TrustAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FranchiseMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:UnderwriterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-12</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-30</startDate>
            <endDate>2020-09-01</endDate>
        </period>
    </context>
    <context id="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-05</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="From2020-12-052020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-05</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="From2020-12-052020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-05</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-07</instant>
        </period>
    </context>
    <context id="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-12-02</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_MinimumMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceBelowNinePointFiveZeroPerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceAboveSixteenPointFiveZeroPerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-01-11_srt_MaximumMember_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="AsOf2021-01-11_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="AsOf2021-02-02_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GLAQ:NotePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-02</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GLAQ:TotalStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-15_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-07-19_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-19</instant>
        </period>
    </context>
    <context id="AsOf2021-10-13_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-13</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:RedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GLAQ:NonRedeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:GlobisSPACLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">GLAQ:PlacementUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GLAQ:UpAndUpCapitalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-06</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="From2020-12-062020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-06</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="From2020-12-062020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-06</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-01-11_custom_LenderMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:LenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_LenderMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GLAQ:LenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-19_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-19</instant>
        </period>
    </context>
    <context id="AsOf2021-10-13_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-13</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GLAQ:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PublicWarrantsMember_srt_MinimumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceBelowNinePointFiveZeroPerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">GLAQ:CommonStockPriceAboveSixteenPointFiveZeroPerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">GLAQ:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-10-31_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903870</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">GLAQ:GlobisAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Days">
        <measure>GLAQ:Days</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-09-30">0001903870</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-09-30">false</dei:AmendmentFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0057"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0110"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0112"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0114"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0149"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:ChangeInSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnderwritingIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:InitialSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:AccretionForCommonStockToRedemptionAmount
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0350"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:PromissoryNoteRelatedParty
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0623"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0631"
      unitRef="Shares"
      xsi:nil="true"/>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0635"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0643"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0686"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0698"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0700"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0701"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0703"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0705"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-20_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-08-20_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0710"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0714"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0720"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0748"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0754"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0765"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0769"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2020-08-20_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0781"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0789"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0840"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0869"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0881"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0893"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0904"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0910"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0916"
      unitRef="USD"
      xsi:nil="true"/>
    <GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember"
      id="xdx2ixbrl0919"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-09-30">S-4</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-09-30">Globis NV Merger Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-09-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPrimarySicNumber contextRef="From2021-01-01to2021-09-30">6770</dei:EntityPrimarySicNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-09-30">85-2703418</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-09-30">7100 W. Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-09-30">Suite 302-48</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-09-30">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-09-30">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-09-30">33433</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-09-30">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-09-30">847-3248</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">7100 W. Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">Suite 302-48</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">33433</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-012021-09-30_dei_BusinessContactMember">847-3248</dei:LocalPhoneNumber>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-09-30">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-01-01to2021-09-30">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">283333</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">485401</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116635401</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">65628</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">65628</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:CommonStockSharesOutstanding>
    <GLAQ:CommonStockRedemptionShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:CommonStockRedemptionShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116635401</us-gaap:LiabilitiesAndStockholdersEquity>
    <GLAQ:FormationAndOperatingCosts
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">89886</GLAQ:FormationAndOperatingCosts>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1520661</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2658912</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3047500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">305</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">26195</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">26500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_PrivatePlacementMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <GLAQ:StockIssuedDuringPeriodSharesSaleOfPlacementUnits
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</GLAQ:StockIssuedDuringPeriodSharesSaleOfPlacementUnits>
    <GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">10</GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits>
    <GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1008320</GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits>
    <GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1008330</GLAQ:StockIssuedDuringPeriodValueSaleOfPlacementUnits>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4188889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3141670</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3141670</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">402500</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-08-212020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">40</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-40</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2020-08-212020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3666841</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3666841</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:NetIncomeLoss>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">283333</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">65628</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-307591</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireTrustPreferredInvestments
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:PaymentsToAcquireTrustPreferredInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-116150000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">26500</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <GLAQ:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">112700000</GLAQ:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1008330</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3141670</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">216841</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116659659</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zug8xCBl6Um8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1. &lt;span id="xdx_82C_z32o1Osg5AD7"&gt;DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Globis
Acquisition Corp. (the &#x201c;Company&#x201d;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2020, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
December 31, 2020 relates to the Company&#x2019;s formation and the initial public offering (&#x201c;Initial Public Offering&#x201d;), which
is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public
Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd"&gt;11,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;units (the &#x201c;Units&#x201d; and, with respect
to the shares of common stock included in the Units sold, the &#x201c;Public Shares,&#x201d; which included the full exercise by the underwriter
of its over-allotment option in the amount of &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd"&gt;1,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, at $&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z1rkB3eYjKzj"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit), generating gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0"&gt;115,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which is described in Note 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd"&gt;4,188,889
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants (the &#x201c;Private Warrants&#x201d;)
at a price of $&lt;span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant and &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd"&gt;100,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;units (the &#x201c;Placement Units&#x201d; and,
together with the Private Warrants, the &#x201c;Private Securities&#x201d;) at a price of $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z04xPkbrn9c8"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#x201c;Up
and Up&#x201d; and, collectively with Globis SPAC LLC, the &#x201c;Sponsors&#x201d;), which is described in Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs amounted to $&lt;span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20201213__20201215_pp0p0"&gt;6,541,841&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consisting of $&lt;span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20201213__20201215_zbKXbSz3nxff"&gt;2,300,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of underwriting fees, $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20201213__20201215_pp0p0"&gt;4,025,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;representing &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_pdd"&gt;402,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#x201c;equity participation shares&#x201d;), and $&lt;span id="xdx_901_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20201213__20201215_zTEeBnAvfDmi"&gt;216,841
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of other offering costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20201213__20201215_pp0p0"&gt;116,150,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;($&lt;span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_c20201215_pdd"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#x201c;Trust Account&#x201d;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company
must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding
taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The
Company intends to only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide its holders of the outstanding Public Shares (the &#x201c;public stockholders&#x201d;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated
to be $&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201215_zfvQcOdG03Sh"&gt;10.10&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to
pay its tax or dissolution obligations). There will be no redemption rights upon the completion of a Business Combination with respect
to the Company&#x2019;s warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentNet_c20201231__srt--RangeAxis__srt--MinimumMember_pp0p0"&gt;5,000,001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#x201c;Amended and Restated
Certificate of Incorporation&#x201d;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares
irrespective of whether they vote for or against the proposed transaction or do not vote at all.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors and the Company&#x2019;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#x2019;s obligation
to allow redemption in connection with the Company&#x2019;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#x2019; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#x201c;Combination Period&#x201d;). The Company&#x2019;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zD3SKOqznv57"&gt;Pursuant
to the terms of the Company&#x2019;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#x2019;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) &lt;span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHUQrr1GFJZ"&gt;as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining stockholders and
the Company&#x2019;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#x2019;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.10).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $&lt;span id="xdx_901_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_uUSDPShares_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TrustAccountMember_zFgnDrJK8KS4"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#x2019;s tax obligation and up to $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20201231_pp0p0"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#x2019;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of December 31, 2020, the Company had cash of $&lt;span id="xdx_905_ecustom--CashHeldOutsideTrust_c20201215_pp0p0"&gt;202,068
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;held outside of the Trust Account, $&lt;span id="xdx_909_eus-gaap--MarketableSecuritiesNoncurrent_iI_pp0p0_c20201231_zhIV7Sux7OQg"&gt;116,150,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;held in the Trust Account to be used for a Business
Combination, and adjusted working capital of $&lt;span id="xdx_904_ecustom--WorkingCapital_c20201215_pp0p0"&gt;432,087&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which excludes $&lt;span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_c20201231__srt--ProductOrServiceAxis__us-gaap--FranchiseMember_pp0p0"&gt;12,314
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of franchise taxes payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#x2019;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#x2019;s working capital needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#x201c;Note&#x201d;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#x201c;Lender&#x201d;), providing for borrowings from time to time of up to an aggregate of $1,000,000.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential transaction. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient financing
or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if the Company
extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There is no assurance
that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period of time to consummate
a Business Combination up to two times, each by an additional three months).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4188889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">6541841</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2300000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4025000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">402500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">216841</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">Pursuant
to the terms of the Company&#x2019;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#x2019;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:LiquidationBasisOfAccountingCostsAndIncomes contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law,</us-gaap:LiquidationBasisOfAccountingCostsAndIncomes>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2020-12-31_custom_TrustAccountMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <GLAQ:CashHeldOutsideTrust
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</GLAQ:CashHeldOutsideTrust>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:MarketableSecuritiesNoncurrent>
    <GLAQ:WorkingCapital
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">432087</GLAQ:WorkingCapital>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2020-12-31_us-gaap_FranchiseMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">12314</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:ErrorCorrectionTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_804_eus-gaap--ErrorCorrectionTextBlock_zCf6KFDBqi2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2014; &lt;span id="xdx_825_z69zMpFSac9c"&gt;RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the preparation of the Company&#x2019;s financial statements, management identified errors made in its historical financial
statements where, at the closing of the Company&#x2019;s Initial Public Offering, the Company improperly valued its common stock subject
to possible redemption. The Company previously determined the common stock subject to possible redemption to be equal to the redemption
value, while also taking into consideration a redemption cannot result in net tangible assets being less than $&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231__srt--RangeAxis__srt--MinimumMember_z9ZeBuY4NwId"&gt;5,000,001&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become
redeemable subject to the occurrence of future events considered outside the Company&#x2019;s control. Therefore, management concluded
that temporary equity should include all shares of common stock subject to possible redemption, resulting in the common stock subject
to possible redemption being equal to their redemption value. As a result, management has noted a classification error related to temporary
equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption
with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the change in presentation for the common stock subject to possible redemption, the Company also restated its income
(loss) per common share calculation to allocate net income (loss) evenly to all common stock. This presentation contemplates a Business
Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
has been no change in the Company&#x2019;s total assets, liabilities or operating results.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zdSJWd6i1zQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span id="xdx_8B7_zkIKDrkP2O16" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Previously&lt;br/&gt; Reported&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance Sheet as of December 15, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible
    redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zr1tDu8D9RW8" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,652,086&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zFV3u6dZ6BWf" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215_zJLo6pZ96RJ5" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CommonStockValue_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1u8FSmwjWM2" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJOqUaBUI63k" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201215_zuIWn2qiL2Vk" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxDCFwdezsa4" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,007,172&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYOyO3xsgATd" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,497,869&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215_zGOkQMf6ARyf" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zv3zt32REHO2" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pdp0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGVNovl30gug" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0267"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215_zV4cW22ADfQ6" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPWGodXf84Xh" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,002&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdBCTW7la5M9" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215_zMOh0PQL3tRl" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;502,088&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeHAy5RxokO1" style="text-align: right" title="Weighted average shares outstanding - redeemable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,054,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zc9V3ongOX33" style="text-align: right" title="Weighted average shares outstanding - redeemable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,338&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CommonStockRedemptionShares_c20201213__20201215_zpItKGo9Qibc" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance Sheet as of December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3hCgC3NyId6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIdULU9bX9C" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231_z5vCs9Oi8ct1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zI9bzOwDKgQ7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZFQN4mV307j" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CommonStockValue_iI_pp0p0_c20201231_zhsKRPsyW40b" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,089,487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,183&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdp0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0297"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231_pp0p0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsCMFzqndTr2" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJ0EEjklCdEk" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231_zDthzg4HYMgb" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVAnRbarvAWa" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,046,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOFlAOLeikU9" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--CommonStockRedemptionShares_c20200821__20201231_zT5AFZISJ2g" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Cash Flows
    for the Period from August 21, 2020 (Inception) through December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial classification of common stock subject
    to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJqUiheK12oc" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,652,086&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zV6CbUeMo0Ug" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231_zuctQ6H3xln2" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of Common Stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBrsLUkQHPDl" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(82,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zrWKWotoa70a" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231_zSHAD2BlVR9l" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0323"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Changes
    in Stockholders&#x2019; Equity for the Period Ended December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sale of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVSUk9SIENPUlJFQ1RJT05TIEFORCBQUklPUiBQRVJJT0QgQURKVVNUTUVOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200812__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zmnvanOuGuLi"&gt;11,500,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Units, net of underwriter discounts and offering expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuagBQBjeCIb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,483,159&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQt2KkRywt22" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(112,483,159&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231_zkrIjxg6sjyj" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0327"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial value of Common Stock subject to redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zi7rWRC82HM" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsAXSHlgE9vi" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231_zlXdo4sdqXRi" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0333"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption adjustment for Common Stock to redemption
    amount&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkefGMzoB9rj" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0335"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGXkCxbnnht7" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231_zgiqOcjTOiyg" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Shareholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA0KxRLCfqN1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwPbyZLu3rj9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20201231_zxtHWY01aUU7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations
    for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlTYmScAaj0c" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,054,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAv4YhHVd6x3" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,534,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231_z6k8fmmfMKHi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,520,661&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income per share, common
    stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8oW5nThcxSc" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0350"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSfWobUqQ03e" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231_zP5Tgjnyfxs2" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK5MhbdHWop" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,717,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAwuKtSYp0i9" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,887&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231_zEnwjDGUhTsi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net loss (income) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWSzpoOfsvd" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.03&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpyFsn5E87f" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231_z8ZL2LXcelB9" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A8_zr9nkrRJjDU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2020-12-31_srt_MinimumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_892_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zdSJWd6i1zQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span id="xdx_8B7_zkIKDrkP2O16" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Previously&lt;br/&gt; Reported&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance Sheet as of December 15, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible
    redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zr1tDu8D9RW8" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,652,086&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zFV3u6dZ6BWf" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201215_zJLo6pZ96RJ5" style="width: 14%; text-align: right" title="Common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CommonStockValue_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1u8FSmwjWM2" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJOqUaBUI63k" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201215_zuIWn2qiL2Vk" style="text-align: right" title="Common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxDCFwdezsa4" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,007,172&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYOyO3xsgATd" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,497,869&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_pp0p0_c20201215_zGOkQMf6ARyf" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zv3zt32REHO2" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pdp0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGVNovl30gug" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0267"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_c20201215_zV4cW22ADfQ6" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPWGodXf84Xh" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,002&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdBCTW7la5M9" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201215_zMOh0PQL3tRl" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;502,088&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeHAy5RxokO1" style="text-align: right" title="Weighted average shares outstanding - redeemable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,054,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--CommonStockRedemptionShares_c20201213__20201215__srt--RestatementAxis__srt--RestatementAdjustmentMember_zc9V3ongOX33" style="text-align: right" title="Weighted average shares outstanding - redeemable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,338&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CommonStockRedemptionShares_c20201213__20201215_zpItKGo9Qibc" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance Sheet as of December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3hCgC3NyId6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIdULU9bX9C" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_c20201231_z5vCs9Oi8ct1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zI9bzOwDKgQ7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockValue_iNI_pp0p0_di_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZFQN4mV307j" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CommonStockValue_iI_pp0p0_c20201231_zhsKRPsyW40b" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,089,487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,183&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AdditionalPaidInCapitalCommonStock_c20201231_pp0p0" style="text-align: right" title="Additional paid-in capital"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdp0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0297"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20201231_pp0p0" style="text-align: right" title="Accumulated deficit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsCMFzqndTr2" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJ0EEjklCdEk" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iI_pp0p0_c20201231_zDthzg4HYMgb" style="text-align: right" title="Total Stockholders' (Deficit) Equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVAnRbarvAWa" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,046,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CommonStockRedemptionShares_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOFlAOLeikU9" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--CommonStockRedemptionShares_c20200821__20201231_zT5AFZISJ2g" style="text-align: right" title="Common stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Cash Flows
    for the Period from August 21, 2020 (Inception) through December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial classification of common stock subject
    to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJqUiheK12oc" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,652,086&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zV6CbUeMo0Ug" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,497,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_c20200821__20201231_zuctQ6H3xln2" style="text-align: right" title="Initial classification of common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of Common Stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBrsLUkQHPDl" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(82,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zrWKWotoa70a" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangeInSharesSubjectToPossibleRedemption_c20200821__20201231_zSHAD2BlVR9l" style="text-align: right" title="Change in value of Common Stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0323"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Changes
    in Stockholders&#x2019; Equity for the Period Ended December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sale of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVSUk9SIENPUlJFQ1RJT05TIEFORCBQUklPUiBQRVJJT0QgQURKVVNUTUVOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200812__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zmnvanOuGuLi"&gt;11,500,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Units, net of underwriter discounts and offering expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuagBQBjeCIb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,483,159&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQt2KkRywt22" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(112,483,159&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--UnderwritingIncomeLoss_iN_di_c20200821__20201231_zkrIjxg6sjyj" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0327"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial value of Common Stock subject to redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zi7rWRC82HM" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsAXSHlgE9vi" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(111,569,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InitialSharesSubjectToPossibleRedemption_iN_di_c20200821__20201231_zlXdo4sdqXRi" style="text-align: right" title="Initial value of Common Stock subject to redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0333"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption adjustment for Common Stock to redemption
    amount&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkefGMzoB9rj" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0335"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGXkCxbnnht7" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccretionForCommonStockToRedemptionAmount_c20200821__20201231_zgiqOcjTOiyg" style="text-align: right" title="Redemption adjustment for Common Stock to redemption amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Shareholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA0KxRLCfqN1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwPbyZLu3rj9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,580,228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20201231_zxtHWY01aUU7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations
    for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlTYmScAaj0c" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,054,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAv4YhHVd6x3" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,534,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_pid_c20200821__20201231_z6k8fmmfMKHi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,520,661&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income per share, common
    stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8oW5nThcxSc" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0350"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSfWobUqQ03e" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption_pid_c20200821__20201231_zP5Tgjnyfxs2" style="text-align: right" title="Basic and diluted net income per share, common stock subject to possible redemption"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK5MhbdHWop" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,717,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_pid_di_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAwuKtSYp0i9" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,887&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200821__20201231_zEnwjDGUhTsi" style="text-align: right" title="Basic and diluted weighted average shares outstanding, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net loss (income) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWSzpoOfsvd" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.03&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpyFsn5E87f" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200821__20201231_z8ZL2LXcelB9" style="text-align: right" title="Basic and diluted net loss (income) per share, Non-redeemable common stock"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">111652086</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4497914</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">401</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">45</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">356</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5007172</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4497869</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509303</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-7571</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-7571</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000002</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4497914</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">502088</us-gaap:StockholdersEquity>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-12-132020-12-15_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11054662</GLAQ:CommonStockRedemptionShares>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-12-132020-12-15_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">445338</GLAQ:CommonStockRedemptionShares>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:CommonStockRedemptionShares>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">111569772</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4580228</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">400</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">45</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5089487</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4580183</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4580228</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11046512</GLAQ:CommonStockRedemptionShares>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">453488</GLAQ:CommonStockRedemptionShares>
    <GLAQ:CommonStockRedemptionShares
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:CommonStockRedemptionShares>
    <GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">111652086</GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4497914</GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</GLAQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:ChangeInSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-82314</GLAQ:ChangeInSharesSubjectToPossibleRedemption>
    <GLAQ:ChangeInSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">82314</GLAQ:ChangeInSharesSubjectToPossibleRedemption>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:UnderwritingIncomeLoss
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-112483159</us-gaap:UnderwritingIncomeLoss>
    <us-gaap:UnderwritingIncomeLoss
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">112483159</us-gaap:UnderwritingIncomeLoss>
    <GLAQ:InitialSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-111569772</GLAQ:InitialSharesSubjectToPossibleRedemption>
    <GLAQ:InitialSharesSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">111569772</GLAQ:InitialSharesSubjectToPossibleRedemption>
    <GLAQ:AccretionForCommonStockToRedemptionAmount
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-3666841</GLAQ:AccretionForCommonStockToRedemptionAmount>
    <GLAQ:AccretionForCommonStockToRedemptionAmount
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-3666841</GLAQ:AccretionForCommonStockToRedemptionAmount>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4580228</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11054662</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">9534001</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1520661</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption>
    <GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2717799</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">58887</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2658912</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zXIkZKYA2QZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2014; &lt;span id="xdx_821_z5m8VbrtIb96"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zCnvjBgUYuWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zrEQ3p7X0co5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--EmergingGrowthCompanyPolicyTextBlock_zl590eHjqXjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zKcn2m1iBIv4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--UseOfEstimates_zCq2olwPhwA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zFMc5EVybYAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzS17IVvVYh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_z3TbZ5bZehce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20201231_zJm8zmHz7X91"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;t
have any cash equivalents as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zSejwylhHry8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zGosV4OqdYid" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Marketable
Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_zqq9Q259rzT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zK2T3MJVoGgk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Restated,
see Note 2)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019;
equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Gross
    Proceeds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying
    value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p id="xdx_8A3_zMuBfS88iyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zLIGKREPJ3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zKyLgmOsCDZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, &#x201c;Income Taxes.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized
tax benefits as income tax expense. There were &lt;span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pp0p0_do_c20201231_zU8VFDXPC6s7"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing
authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#x2019;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zGbK81JcrmC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_869_zlRrQYOdgkui" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Loss per Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Restated, see Note
2)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase &lt;span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200821__20201231_pdd"&gt;15,789,722
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common Stock in the aggregate. As of December
31 2020, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    from August 21,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020 (Inception)
    Through&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,703&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,183&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,520,661&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zmTqGAuFrHCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zqzJccsZiRT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_86E_zVRw6LOq6qhe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_903_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20200821__20201231_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8vNJCJOEvJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zc0ARhiAXMea" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuWxNENHOFB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zoZqII0npHK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zCnvjBgUYuWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zrEQ3p7X0co5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <GLAQ:EmergingGrowthCompanyPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_849_ecustom--EmergingGrowthCompanyPolicyTextBlock_zl590eHjqXjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zKcn2m1iBIv4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_847_eus-gaap--UseOfEstimates_zCq2olwPhwA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zFMc5EVybYAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzS17IVvVYh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_z3TbZ5bZehce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20201231_zJm8zmHz7X91"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;t
have any cash equivalents as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zSejwylhHry8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zGosV4OqdYid" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Marketable
Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_847_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_zqq9Q259rzT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zK2T3MJVoGgk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Restated,
see Note 2)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019;
equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Gross
    Proceeds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying
    value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p id="xdx_8A3_zMuBfS88iyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock>
    <GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock_zWfUxegZtJXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2020, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8BA_zrGLK7AfV275" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTlWlPIqvCa2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Gross
    Proceeds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PaymentsOfStockIssuanceCosts_iN_pp0p0_di_zIBAsfyVYjhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--TemporaryEquityAccretionToRedemptionValue_z3bBJKVTe8Uj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying
    value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_c20201231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

</GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2516841</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3666841</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zLIGKREPJ3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zKyLgmOsCDZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, &#x201c;Income Taxes.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized
tax benefits as income tax expense. There were &lt;span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pp0p0_do_c20201231_zU8VFDXPC6s7"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing
authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#x2019;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zGbK81JcrmC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_869_zlRrQYOdgkui" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Loss per Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Restated, see Note
2)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase &lt;span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200821__20201231_pdd"&gt;15,789,722
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common Stock in the aggregate. As of December
31 2020, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    from August 21,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020 (Inception)
    Through&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,703&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,183&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,520,661&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zmTqGAuFrHCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">15789722</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zyJuv18Xce3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.55pt"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zU8OXLqpeOOg" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z6TQUrjbSml9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20200821__20201231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zfQaY9ExjFVd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    from August 21,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020 (Inception)
    Through&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-redeemable
    common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkV9EI5So1Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,703&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,183&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_z4U16G8Tri6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,520,661&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_zJclB3bQHewe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-32703</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-57183</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1520661</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2658912</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-12-31_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zqzJccsZiRT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_86E_zVRw6LOq6qhe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_903_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20200821__20201231_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">250000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8vNJCJOEvJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zc0ARhiAXMea" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuWxNENHOFB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zoZqII0npHK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <GLAQ:InitialPublicOfferingTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_806_ecustom--InitialPublicOfferingTextBlock_zAnwuB3UewHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4. &lt;span id="xdx_827_ztA3hnsND2o9"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Initial Public Offering, the Company sold &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS4VWs9VmN3c"&gt;11,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zd5CcWhxcfI6"&gt;1,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, at a price of $&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_zEwntago3pRh"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_uUSDPShares_c20211231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z18GGFdmLym2"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:InitialPublicOfferingTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <GLAQ:PrivatePlacementTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_808_ecustom--PrivatePlacementTextBlock_z2JcZqPdqxt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5. &lt;span id="xdx_829_zfKTJn7HzvJ5"&gt;PRIVATE PLACEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq4KPmnGmE01"&gt;3,688,889
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Warrants at a purchase price of $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxqFmu2YXw9h"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant, for an aggregate purchase
price of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pip0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zq0WPEPlObcg"&gt;2,766,667
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and Up and Up purchased &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zTQT3cXqJZUi"&gt;500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Warrants at a purchase price of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_z4wa6vKUpMLj"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant, for an aggregate purchase
price of $&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z9LbNaoaqoij"&gt;375,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z6bcPzZkIyp7"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zP6srB2f3Bgi"&gt;100,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Placement Units at a purchase price of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_pdd"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Placement Unit, or $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200821__20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkQKH0e6Bk5i"&gt;1,008,333
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in the aggregate. Each Placement Unit consists
of one share of common stock (&#x201c;Placement Share&#x201d;) and one redeemable warrant (&#x201c;Placement Warrant&#x201d;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zKoSSrRtAzI"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:PrivatePlacementTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3688889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2766667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">375000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1008333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-31_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdnoTEf4Keqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6. &lt;span id="xdx_827_z5JncVu0RfU4"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 1, 2020, Globis SPAC LLC purchased &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pdd"&gt;2,875,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock for
an aggregate price of $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0"&gt;25,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
On December 7, 2020, the Company sold an additional &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pdd"&gt;172,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stocks to
Up and Up for an aggregate price of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201205__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_pp0p0"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
resulting in a total of &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201205__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_pdd"&gt;3,047,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock being sold to the Sponsors
(the &#x201c;Founder Shares&#x201d;) and being issued and outstanding, of which an aggregate of up to &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201205__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zEFRyV7eMuJb"&gt;397,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares were subject to forfeiture to the extent
that the underwriters&#x2019; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
&lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6PDN21JrOMl"&gt;21%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of the Company&#x2019;s issued and outstanding
shares after the Initial Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option
on December 15, 2020, no Founder Shares are currently subject to forfeiture.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#x2019;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administrative
Support Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $&lt;span id="xdx_903_eus-gaap--PaymentsForRent_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_pp0p0"&gt;10,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#x2019;s liquidation, the Company will cease paying these monthly
fees. For the period from August 21, 2020 (inception) through December 31, 2020, the Company incurred $&lt;span id="xdx_903_eus-gaap--PrepaidExpenseCurrent_c20211231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_pp0p0"&gt;5,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in fees for these services, of which amount is
included in accrued expenses in the accompanying balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Advances
from Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 2, 2020, the Sponsor advanced the Company $&lt;span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_zPmo2npWYsqd"&gt;50,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to fund certain offering cost in connection with
the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related
Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#x2019;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital
Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#x2019;s discretion, the notes may be converted upon completion of a Business Combination
into warrants at a price of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20201231__us-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zOYaFl3WPJah"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per warrant. Such warrants would be identical
to the Private Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside
the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital
Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">172500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-12-052020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-052020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3047500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2020-12-052020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">397500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsForRent
      contextRef="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:PaymentsForRent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-12-31_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_807_eus-gaap--CommitmentsDisclosureTextBlock_zqvGhN1nlKqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7. &lt;span id="xdx_825_zOfHRYHF19Ol"&gt;COMMITMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#x201c;piggy-back&#x201d;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriting
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters are entitled to receive the &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_uShares_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zHVwbETODlRk"&gt;402,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholders&#x2019;
equity. The fair value of the equity participation shares is estimated to be $&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200821__20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zwW7orhs03Yk"&gt;4,025,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
based upon the offering price of the Units of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201231__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zODzMPk7Ykub"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">402500</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4025000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7l4fZBCsbHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8. &lt;span&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Restated,
see Note 2)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_827_zUGePfJpVAq5" style="display: none"&gt;STOCKHOLDER&#x2019;S EQUITY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt; &#x2014; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20201231_zKqx3BCiUSf5"&gt;1,000,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of preferred stock with a par value of $&lt;span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zSCVB2wRhf28"&gt;0.0001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share with such designations, voting and
other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. At December 31, 2020,
there were no shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20201231_zEKbKFbbmawi"&gt;100,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock with a par value of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201231_zFPBjZ7rjNz2"&gt;0.0001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share. At December 31, 2020, there were &lt;span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20201231_zLFM9aATovLh"&gt;3,550,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock issued and outstanding,
excluding &lt;span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_c20201231_pdd"&gt;11,500,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock subject to possible redemption which are presented as temporary equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
&lt;/i&gt;&#x2014;&lt;/b&gt; The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of our initial business combination, warrant holders may, until such time as there is an effective
registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise
warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that
such exemption is available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
    whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    a price of $0.01 per warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    any time while the warrants are exercisable;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
    not less than 30 days&#x2019; prior written notice of redemption to each warrant holder;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201231__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zudK1PDt8loj"&gt;16.50
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a &lt;span id="xdx_90C_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20200821__20201231_zOqJobQ64Pgj"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-day
    trading period ending on the third business day prior to the notice of redemption to warrant holders; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#x201c;cashless
basis,&#x201d; as described in the warrant agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent
more than &lt;span id="xdx_90F_ecustom--PercentageOfProceedsFromBusinessCombination_iI_pid_dp_c20201231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVzTZhjYZYDd"&gt;60%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of the total equity proceeds, and interest thereon,
available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and
(z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior
the day on which the Company consummates a Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $&lt;span id="xdx_90D_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z9MppzZfHH9b"&gt;9.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to &lt;span id="xdx_900_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0gJtvSBZKha"&gt;115%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of the higher of the Market Value and the Newly
Issued Price, and the $&lt;span id="xdx_90A_ecustom--MarketValueOfCommonStock_iI_pid_uUSDPShares_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zGIOVlfbhMt9"&gt;16.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to &lt;span id="xdx_90C_ecustom--PercentageOfExercisePriceOfWarrants_iI_pid_dp_c20201231__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk5yhe4pjsU5"&gt;165%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of the higher of the Market Value and the Newly
Issued Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:CommonStockSharesOutstanding>
    <GLAQ:CommonStockSharesSubjectToRedemption
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">11500000</GLAQ:CommonStockSharesSubjectToRedemption>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-31_srt_MinimumMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">16.50</us-gaap:SharesIssuedPricePerShare>
    <GLAQ:NoticePeriodForRedemptionOfWarrants contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">P30D</GLAQ:NoticePeriodForRedemptionOfWarrants>
    <GLAQ:PercentageOfProceedsFromBusinessCombination
      contextRef="AsOf2020-12-31_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.60</GLAQ:PercentageOfProceedsFromBusinessCombination>
    <GLAQ:MarketValueOfCommonStock
      contextRef="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">9.50</GLAQ:MarketValueOfCommonStock>
    <GLAQ:PercentageOfExercisePriceOfWarrants
      contextRef="AsOf2020-12-31_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">1.15</GLAQ:PercentageOfExercisePriceOfWarrants>
    <GLAQ:MarketValueOfCommonStock
      contextRef="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">16.50</GLAQ:MarketValueOfCommonStock>
    <GLAQ:PercentageOfExercisePriceOfWarrants
      contextRef="AsOf2020-12-31_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">1.65</GLAQ:PercentageOfExercisePriceOfWarrants>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zpgHjNlbXsQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9. &lt;span id="xdx_825_zYlZ9b0Uoy4b"&gt;INCOME TAX&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zAOCj6NRkip8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax assets are as follows:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8B7_zG4jNxgfhux7" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20201231_zGiXYoajXVib" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzMY0_zitPGfSa5tFf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzMY0_zcSzChQ3J4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup and organizational costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzMY0_maDTANz7zZ_zB3FbCQTQVc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz7zZ_z4TMDZa1MPoc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz7zZ_zMUzXXTuRmi1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets, net valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0480"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zjuaNoTzJ9qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCrupi9qzu9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BF_zo0LW4fK0Ihj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF INCOME TAX PROVISION&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200821__20201231_z8oSl5bK2Sr6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0484"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State and Local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0488"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0490"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0494"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zW8Wbftk193" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2020, the Company had $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0"&gt;89,886&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
U.S. federal net operating loss carryovers available to offset future taxable income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
period from August 21, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $&lt;span id="xdx_90A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20200821__20201231_zo9YPivOYeF3"&gt;18,876&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zej2VLh51Uu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the federal income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8B3_zErat1bBduCa" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200821__20201231_zsWxVwPsUMvg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_z06zX7JoNHol" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zNZLSViTun7k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_zlr9o2nUi9B7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zAVdZMRWRol1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_z6XqdUDoJac8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DECEMBER
31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The
Company&#x2019;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York to be
a significant state tax jurisdiction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zAOCj6NRkip8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax assets are as follows:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8B7_zG4jNxgfhux7" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20201231_zGiXYoajXVib" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzMY0_zitPGfSa5tFf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzMY0_zcSzChQ3J4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup and organizational costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzMY0_maDTANz7zZ_zB3FbCQTQVc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz7zZ_z4TMDZa1MPoc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz7zZ_zMUzXXTuRmi1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets, net valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0480"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2586</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">16290</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">18876</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">18876</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCrupi9qzu9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BF_zo0LW4fK0Ihj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF INCOME TAX PROVISION&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200821__20201231_z8oSl5bK2Sr6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0484"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State and Local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0488"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0490"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0494"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-18876</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">18876</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">89886</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">18876</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zej2VLh51Uu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the federal income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8B3_zErat1bBduCa" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200821__20201231_zsWxVwPsUMvg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_z06zX7JoNHol" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zNZLSViTun7k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_zlr9o2nUi9B7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zAVdZMRWRol1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">-0.210</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_zpY0RgT1MLxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10. &lt;span id="xdx_82F_zIjtWBjhsxxl"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zUmwt2pocHu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at December
31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span id="xdx_8B4_ztrBuFYRINVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvMOUe6wZYTd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities held in
    Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zMgQCKWkPMp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zUmwt2pocHu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at December
31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span id="xdx_8B4_ztrBuFYRINVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvMOUe6wZYTd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities held in
    Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zgugRdOjtUM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11.&#x2009;&lt;span id="xdx_822_zJSpmhaBOXw9"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have
required adjustment or disclosure in the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20210111__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_pp0p0"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. At
the election of the Lender, all or a portion of the unpaid principal amount of the Note may be converted upon the consummation of the
Company&#x2019;s initial Business Combination into a number of warrants of the Company, with each warrant being exercisable for one share
of common stock of the Company (the &#x201c;Conversion Warrants&#x201d;), equal to: (x) the portion of the principal amount of the Note
being converted, divided by (y) $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20210111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zQ0hqdQZ8mJb"&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
rounded up to the nearest whole number of warrants. The Conversion Warrants are identical to the Private Warrants issued. On February
2, 2021, the Company borrowed &lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210202__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NotePayableMember_zmCqwADl3Kec"&gt;$100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in accordance with the Note.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-01-11_srt_MaximumMember_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-01-11_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-02_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">8413</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">150653</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">283333</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">159066</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">485401</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116155627</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116314693</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116635401</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">646729</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">65628</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <GLAQ:PromissoryNoteRelatedParty
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">700000</GLAQ:PromissoryNoteRelatedParty>
    <us-gaap:Liabilities
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1346729</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">65628</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">15050833</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">15050833</us-gaap:CommonStockSharesOutstanding>
    <GLAQ:CommonStockRedemptionShare
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:CommonStockRedemptionShare>
    <GLAQ:CommonStockRedemptionShare
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:CommonStockRedemptionShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1691695</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1182036</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116314693</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116635401</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">892144</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1607436</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-892144</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1607436</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1785</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5627</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1785</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5627</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-890359</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1601809</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-890359</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1601809</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.06</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.11</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.06</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-89886</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">419773</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-363959</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-363959</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-453845</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">55814</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-347491</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-347491</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-801336</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-291677</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-890359</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-890359</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1691695</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1182036</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">288</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">24712</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">24712</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-24000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">24712</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_custom_TotalStockholdersEquityMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-24000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1601809</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5627</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-132680</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">581101</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-893655</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">700000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">10035</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">14965</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-193655</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">14965</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">202068</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">8413</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">14965</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <GLAQ:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000</GLAQ:OfferingCostsIncludedInAccruedOfferingCosts>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_803_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zse8mEBwkXD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1. &lt;span id="xdx_826_zoXiMxnmmlk2"&gt;DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Globis
Acquisition Corp. (the &#x201c;Company&#x201d;) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
September 30, 2021 relates to the Company&#x2019;s formation, initial public offering (&#x201c;Initial Public Offering&#x201d;), which is
described below, and search for a Business Combination. The Company will not generate any operating revenues until after the completion
of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRu0RtU0UvDh"&gt;11,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;units (the &#x201c;Units&#x201d; and, with respect
to the shares of common stock included in the Units sold, the &#x201c;Public Shares,&#x201d; which included the full exercise by the underwriter
of its over-allotment option in the amount of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znXXZJHbPxzj"&gt;1,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, at $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPoJm1SakIhj"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit), generating gross proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGMatMH8AuP2"&gt;115,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which is described in Note 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDhkhYNgn2zc"&gt;4,188,889
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants (the &#x201c;Private Warrants&#x201d;)
at a price of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkuvIYEi4ljk"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant and &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z6GkzvESGua3"&gt;100,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;units (the &#x201c;Placement Units&#x201d; and,
together with the Private Warrants, the &#x201c;Private Securities&#x201d;) at a price of $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateSecuritiesMember__dei--LegalEntityAxis__custom--GlobisSPACLLCAndUpAndUpCapitalLLCMember_z4HgLKqDTDZk"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Placement Unit in a private placement to
Globis SPAC LLC and Up and Up Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (&#x201c;Up
and Up&#x201d; and, collectively with Globis SPAC LLC, the &#x201c;Sponsors&#x201d;), which is described in Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs amounted to $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20201213__20201215_zCo6hms5r5R5"&gt;6,541,841&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consisting of $&lt;span id="xdx_90C_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20201213__20201215_pp0p0"&gt;2,300,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of underwriting fees, $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20201213__20201215_zM1gUI1fGg58"&gt;4,025,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;representing &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20201213__20201215_z7RUJocVOEd4"&gt;402,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock issued, which the underwriters
are entitled to receive upon the consummation of a Business Combination (the &#x201c;equity participation shares&#x201d;), and $&lt;span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20201213__20201215_pp0p0"&gt;216,841
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of other offering costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201213__20201215_za1q969izmpk"&gt;116,150,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;($&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20201215_zeFs74mXsoj1"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit) from the net proceeds of the sale of
the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the &#x201c;Trust Account&#x201d;),
located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself
out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by
the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account,
as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward completing
a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least &lt;span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201215_zDy1rS3YUZ9"&gt;80&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post-Business Combination
company owns or acquires &lt;span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20201215__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z40snssKk4a1"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for
it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment
Company Act&#x201d;). There is no assurance that the Company will be able to complete a Business Combination successfully.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account (initially anticipated to be $&lt;span id="xdx_903_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z7HVgMPEHHsl"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Public Share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax or dissolution obligations).
There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#x2019;s warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentNet_c20210930__srt--RangeAxis__srt--MinimumMember_pp0p0"&gt;5,000,001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;immediately prior to or upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business
Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the &#x201c;Amended and Restated
Certificate of Incorporation&#x201d;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange
Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC containing substantially the same information as would be
included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required
by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in
Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares,
without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors and the Company&#x2019;s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#x2019;s obligation
to allow redemption in connection with the Company&#x2019;s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders&#x2019; rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the &#x201c;Combination Period&#x201d;). The Company&#x2019;s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_zISDycSwuO3"&gt;Pursuant
to the terms of the Company&#x2019;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#x2019;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
such payments would be made in the form of a non-interest bearing loan and would be repaid, if at all, from funds released to the Company
upon completion of a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) &lt;span id="xdx_90C_eus-gaap--LiquidationBasisOfAccountingCostsAndIncomes_c20211213__20211215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z8RLYhJmHKf4"&gt;as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining stockholders and
the Company&#x2019;s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company&#x2019;s
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($&lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z2wtKFROcli3"&gt;10.10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $&lt;span id="xdx_90C_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlobisSPACLLCMember_z5E8ME6jUsl7"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Public Share or (ii) such lesser amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust
assets, in each case net of the interest which may be withdrawn to pay the Company&#x2019;s tax obligation and up to $&lt;span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__srt--RangeAxis__srt--MaximumMember_zETfveNxxHxl"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for liquidation expenses, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be
unenforceable) and except as to any claims under the Company&#x2019;s indemnity of the underwriters of Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of September 30, 2021, the Company had cash of $&lt;span id="xdx_90E_ecustom--CashHeldOutsideTrust_iI_uUSD_c20210930_z0Hp3Y7lDGkl"&gt;8,413
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;held outside of the Trust Account, $&lt;span id="xdx_906_eus-gaap--MarketableSecurities_iI_pp0p0_c20210930_zUvcjSiCa9L1"&gt;116,155,627
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;held in the Trust Account to be used for a Business
Combination, and adjusted working capital deficit of $&lt;span id="xdx_90A_ecustom--WorkingCapital_iI_pp0p0_c20210930_zGLBc8sb0AV"&gt;1,037,663&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which excludes $&lt;span id="xdx_902_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pp0p0_c20210930_zcUDT8fBxSX3"&gt;150,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
franchise taxes payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company&#x2019;s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company&#x2019;s working capital needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the &#x201c;Note&#x201d;) to Globis SPAC LLC, or its assigns
or successors in interest (the &#x201c;Lender&#x201d;), providing for borrowings from time to time of up to an aggregate of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930_zANvfeb5EIF5"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
On July 19, 2021 the Note was amended to increase the principal amount of the Note to $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719_z5pCEFgCBZTa"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and on October 13, 2021, the Note was further
amended to increase the principal amount of the Note to $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9n92k8GRDm5"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
None of the Sponsors, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance funds
to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional financing. If
the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could
include, but not necessarily be limited to, suspending the pursuit of a potential Business Combination. The Company cannot provide any
assurance that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient
financing or raise additional capital, it only has until December 15, 2021 to consummate a Business Combination (or June 15, 2022 if
the Company extends the period of time to consummate a Business Combination up to two times, each by an additional three months). There
is no assurance that the Company will be able to do so prior to December 15, 2021 (or June 15, 2022 if the Company extends the period
of time to consummate a Business Combination up to two times, each by an additional three months).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#x2019;s financial position and/or search for a target company, the specific impact is not readily
determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from
the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4188889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_PrivateSecuritiesMember_custom_GlobisSPACLLCAndUpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">6541841</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2300000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4025000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">402500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">216841</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-15_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.80</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2020-12-15_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">Pursuant
to the terms of the Company&#x2019;s Amended and Restated Certificate of Incorporation, in order for the time available for the Company
to consummate a Business Combination to be extended, one or both of the Sponsors or their affiliates or designees, upon five days&#x2019;
advance notice prior to the applicable deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of
$2,300,000), on or prior to the date of the applicable deadline, for each three month extension.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:LiquidationBasisOfAccountingCostsAndIncomes contextRef="From2021-12-132021-12-15_us-gaap_SubsequentEventMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember">as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes
payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law</us-gaap:LiquidationBasisOfAccountingCostsAndIncomes>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2021-09-30_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_srt_MaximumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <GLAQ:CashHeldOutsideTrust
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">8413</GLAQ:CashHeldOutsideTrust>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116155627</us-gaap:MarketableSecurities>
    <GLAQ:WorkingCapital
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1037663</GLAQ:WorkingCapital>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">150000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-07-19_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-10-13_us-gaap_SubsequentEventMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ErrorCorrectionTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_80E_eus-gaap--ErrorCorrectionTextBlock_zkGsWlC47ESe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2. &lt;span id="xdx_829_zM90Ne9C0Y81"&gt;RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the preparation of the Company&#x2019;s financial statements as of September&#160;30, 2021, management determined it should
restate the Company&#x2019;s previously reported financial statements. During the quarter ended September 30, 2021, the Company determined
that at the closing of the Company&#x2019;s Initial Public Offering (including the sale of the shares issued pursuant to the exercise
of the underwriters&#x2019; overallotment) it had improperly valued its common stock subject to possible redemption at the closing of
the Company&#x2019;s Initial Public Offering and at the closing of the sale of shares pursuant to the exercise of the underwriters&#x2019;
overallotment, it had improperly classified certain of its common stock subject to possible redemption. The Company previously determined
the common stock subject to possible redemption to be equal to the redemption value of $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDG9Jn5jRej6"&gt;10.10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of common stock while also taking into
consideration that in accordance with the Company&#x2019;s Charter, a redemption cannot result in net tangible assets being less than
$&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210930__srt--RangeAxis__srt--MinimumMember_zoUEsSdNwwe2"&gt;5,000,001&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Management determined that the common stock issued in the Initial Public Offering and pursuant to the exercise of the underwriters&#x2019;
overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company&#x2019;s
control. Therefore, management concluded that temporary equity should include all common stock subject to possible redemption, resulting
in the common stock subject to possible redemption being equal to its redemption value. As a result, management has noted a classification
adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common
stock subject to possible redemption with the offset recorded to additional paid-in capital and common stock&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the change in presentation for the common stock subject to redemption, the Company also restated its income (loss) per
share of common stock calculation to allocate net income (loss) evenly to the total shares of common stock. This presentation contemplates
a Business Combination as the most likely outcome, in which case, all shares of common stock share pro rata in the income (loss) of the
Company.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ztL7HMMfxEtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
impact of the restatement on the Company&#x2019;s historical financial statements is reflected in the following tables:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z66gJO8ihi5k" style="display: none"&gt;SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Previously&lt;br/&gt; Reported&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Balance Sheet as of March 31, 2021
    (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible
    redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,205,807&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockIssuedValue_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,453,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,144&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,845&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0840"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,845&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z7ZMviKeQx41" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,007&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaucjXCM2nf6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zlPWpAOopgn5" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,010,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_iI_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdAuiM6EF805" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"/&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Balance Sheet as of June 30, 2021
    (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,858,319&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;407&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--CommonStockIssuedValue_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,800,933&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(801,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(801,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXSrn6VFAUla" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2V50EAetD4i" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zAzJ1HCZt7Cc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(291,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,976,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;523,929&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Operations for the
    Three Months Ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,046,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0869"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9HOzaPkD5ch" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,004,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMUOI7B614Ja" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331_zbyHglaM1fLd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.07&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations for the Three Months
    Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,010,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0881"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,040,357&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z15QRe16Jyl1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.07&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations for the Six Months
    Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,028,394&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;471,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0893"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,022,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z81HmPth73Mi" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(471,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed
    Statement of Changes in Stockholders&#x2019; Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            Previously&lt;br/&gt; Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            Restated&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNrNrVN931W3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;363,065&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(363,065&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0904"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPEEhjpw1dhg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,007&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMSKAiQ3SETe" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zNweztXwqS4c" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Changes
    in Stockholders&#x2019; Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;347,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(347,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoWdwOwYvAv8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgwNwPg2HhJa" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zwyMLKaWmlB7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(291,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Cash Flows for the
    three months ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Cash investing and financing
    activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z53O2SOLHaqc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(363,965&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPc3ZV1v4fgk" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;363,965&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331_zyORfDhwfJrh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Cash
    Flows for the six months ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Cash investing and financing
    activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zonMlT5P5895" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(711,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z569YmicyXO6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;711,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630_zi9WICxPqBGg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0919"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-09-30_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-09-30_srt_MinimumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ztL7HMMfxEtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
impact of the restatement on the Company&#x2019;s historical financial statements is reflected in the following tables:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z66gJO8ihi5k" style="display: none"&gt;SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Previously&lt;br/&gt; Reported&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Balance Sheet as of March 31, 2021
    (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible
    redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,205,807&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210331_pp0p0" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CommonStockIssuedValue_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockIssuedValue_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,453,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,144&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,845&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0840"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,845&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z7ZMviKeQx41" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,007&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaucjXCM2nf6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zlPWpAOopgn5" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,010,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_iI_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zdAuiM6EF805" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"/&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Balance Sheet as of June 30, 2021
    (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,858,319&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;407&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CommonStockIssuedValue_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--CommonStockIssuedValue_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,800,933&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionalPaidInCapitalCommonStock_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;509,304&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(801,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(801,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXSrn6VFAUla" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2V50EAetD4i" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zAzJ1HCZt7Cc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(291,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,976,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;523,929&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfSharesOfCommonStockSubjectToPossibleRedemption_c20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Operations for the
    Three Months Ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,046,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0869"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9HOzaPkD5ch" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,004,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMUOI7B614Ja" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(453,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210331_zbyHglaM1fLd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.07&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210331_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations for the Three Months
    Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,010,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0881"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,040,357&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z15QRe16Jyl1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(489,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.07&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_c20210401__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statement of Operations for the Six Months
    Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,028,394&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;471,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0893"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsLossPerShareRedeemableCommonStock_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,022,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_iN_di_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z81HmPth73Mi" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(471,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income (loss) per share,
    Non-redeemable common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasicAndDiluted_c20210101__20210630_pdd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed
    Statement of Changes in Stockholders&#x2019; Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            Previously&lt;br/&gt; Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            Restated&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNrNrVN931W3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;363,065&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(363,065&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210101__20210331_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0904"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPEEhjpw1dhg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,007&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMSKAiQ3SETe" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,944,193&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210331_zNweztXwqS4c" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Changes
    in Stockholders&#x2019; Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;347,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(347,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInValueOfCommonStockSubjectToPossibleRedemption_c20210401__20210630_pp0p0" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoWdwOwYvAv8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgwNwPg2HhJa" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,291,681&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20210630_zwyMLKaWmlB7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(291,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Cash Flows for the
    three months ended March 31, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Cash investing and financing
    activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z53O2SOLHaqc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(363,965&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPc3ZV1v4fgk" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;363,965&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210331_zyORfDhwfJrh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Condensed Statement of Cash
    Flows for the six months ended June 30, 2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Cash investing and financing
    activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in value of common stock subject to
    possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zonMlT5P5895" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(711,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z569YmicyXO6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;711,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption_pp0p0_c20210101__20210630_zi9WICxPqBGg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0919"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">111205807</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4944193</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">404</GLAQ:CommonStockIssuedValue>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-49</GLAQ:CommonStockIssuedValue>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</GLAQ:CommonStockIssuedValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5453448</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4944144</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-453845</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-453845</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000007</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4944193</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">55814</us-gaap:StockholdersEquity>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11010476</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">-489524</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">110858319</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5291681</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">407</GLAQ:CommonStockIssuedValue>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-52</GLAQ:CommonStockIssuedValue>
    <GLAQ:CommonStockIssuedValue
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">355</GLAQ:CommonStockIssuedValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5800933</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-5291629</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">509304</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-801336</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-801336</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-5291681</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-291677</us-gaap:StockholdersEquity>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">10976071</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">523929</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</GLAQ:NumberOfSharesOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11046512</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">453488</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4004321</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">453488</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11010476</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">489524</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4040357</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">489524</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-04-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11028394</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">471606</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.05</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock
      contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.05</GLAQ:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">4022439</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">471606</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.18</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.13</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.05</us-gaap:EarningsPerShareBasicAndDiluted>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">363065</GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-363065</GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000007</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-4944193</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">55814</us-gaap:StockholdersEquity>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-04-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">347488</GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-04-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-347488</GLAQ:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-5291681</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-291677</us-gaap:StockholdersEquity>
    <GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-363965</GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-03-31_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">363965</GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-06-30_srt_ScenarioPreviouslyReportedMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-711453</GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-06-30_srt_RestatementAdjustmentMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">711453</GLAQ:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zBNrbSO2R59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3. &lt;span id="xdx_82C_z23TcnWnswHi"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTnS6kZ5mtK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--EmergingGrowthCompanyPolicyTextBlock_znhzZULg3Oz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zlOEoyvaeqL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zI5qRXATKyPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zWfDyVHltKs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Marketable
Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_z2Q5FTxthpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019;
equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock
resulted in charges against additional paid-in capital and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zv9YHgHVfzl" style="display: none"&gt;SCHEDULE
OF CONDENSED BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z53XnCl72Jv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zYRX9qwmfYO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were &lt;span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210930_zfEuY5fs1hac"&gt;no&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unrecognized
tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company has been subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#x2019;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_z3iVPmfMrpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Income (Loss) per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase &lt;span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210930_pdd"&gt;15,789,722
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common Stock in the aggregate. As of September
30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period
    from&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nine&#160;Months&#160;Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August 21,
    2020&lt;br/&gt;
    (Inception)&lt;br/&gt;
    Through&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,&#160;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 30%; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of
    net loss, as adjusted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(680,303&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(210,056&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,223,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(377,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net loss
    per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.00&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A7_zO33tm4aT123" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2h0h0Gfvm44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_901_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20210930_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zudSSrgYVNSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zsziBPSVIyL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify; text-indent: 19.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zakXvEAARJl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTnS6kZ5mtK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <GLAQ:EmergingGrowthCompanyPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84E_ecustom--EmergingGrowthCompanyPolicyTextBlock_znhzZULg3Oz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zlOEoyvaeqL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zI5qRXATKyPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zWfDyVHltKs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Marketable
Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_846_ecustom--CommonStockSubjectToPossibleRedemptionPolicyTextBlock_z2Q5FTxthpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019;
equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock
resulted in charges against additional paid-in capital and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zv9YHgHVfzl" style="display: none"&gt;SCHEDULE
OF CONDENSED BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z53XnCl72Jv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_897_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zTDTlHFHlutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zv9YHgHVfzl" style="display: none"&gt;SCHEDULE
OF CONDENSED BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210101__20210930_zBb21gPXlcJ6" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_c20210101__20210930_zn70YqxXaKol" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Common Stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,516,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930_zevVmEokhR3c" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,666,841&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common
    Stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20210101__20210930_zjfBdhh1OSr2" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2516841</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3666841</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zYRX9qwmfYO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were &lt;span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210930_zfEuY5fs1hac"&gt;no&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unrecognized
tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company has been subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company&#x2019;s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_z3iVPmfMrpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Income (Loss) per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase &lt;span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210930_pdd"&gt;15,789,722
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common Stock in the aggregate. As of September
30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted
into common shares and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic
net loss per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period
    from&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nine&#160;Months&#160;Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August 21,
    2020&lt;br/&gt;
    (Inception)&lt;br/&gt;
    Through&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,&#160;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 30%; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of
    net loss, as adjusted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(680,303&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(210,056&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,223,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(377,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net loss
    per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.00&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A7_zO33tm4aT123" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"/&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">15789722</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zKE7yIpoLrz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_8BD_zVClbkfHqL52" style="display: none; font-family: Times New Roman, Times, Serif"&gt;SCHEDULE
OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zbPriWj6s18i" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210701__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zn3c3tOmUt86" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3pPtsgEW1qc" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210101__20210930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zuEuLG6h4qlj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200821__20200930__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zHze9CBH5icg" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period
    from&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nine&#160;Months&#160;Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August 21,
    2020&lt;br/&gt;
    (Inception)&lt;br/&gt;
    Through&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September&#160;30,&#160;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common&#160;stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;common
    stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_zqMWq06ZwBw7" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 30%; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of
    net loss, as adjusted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(680,303&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(210,056&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,223,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(377,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_z4oUoom7TZx1" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,550,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EarningsPerShareBasicAndDiluted_zIpSMH0HFFN5" style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net loss
    per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.06&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.00&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-680303</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-210056</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1223906</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-377903</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">-1000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.06</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.06</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-012021-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-08-212020-09-30_custom_NonRedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2h0h0Gfvm44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_901_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20210930_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">250000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zudSSrgYVNSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zsziBPSVIyL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.25pt; text-align: justify; text-indent: 19.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zakXvEAARJl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <GLAQ:InitialPublicOfferingTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zyupDZFdjnQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4. &lt;span id="xdx_827_z5bqmd0WpVB"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Initial Public Offering, the Company sold &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ElRHWzflSe"&gt;11,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, which included a full exercise by the
underwriters of their over-allotment option in the amount of &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201213__20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyhwMiWPkZSl"&gt;1,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units, at a price of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zBZpoKsR5CDc"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit. Each Unit consists of one share of
common stock and one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each Public Warrant entitles the holder to purchase one share
of common stock at a price of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAD5ROBE7XYg"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:InitialPublicOfferingTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-132020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_OverAllotmentOptionMember_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharesIssuedPricePerShare>
    <GLAQ:PrivatePlacementTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_805_ecustom--PrivatePlacementTextBlock_zOrwb9fBUqLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5. &lt;span id="xdx_820_zrFVgzJqNy1"&gt;PRIVATE PLACEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zBjr1TsGV9R3"&gt;3,688,889
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Warrants at a purchase price of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zt0zUUETBvb6"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant, for an aggregate purchase
price of $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_znIq3ufEpmOe"&gt;2,766,667
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and Up and Up purchased &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zkebEe4foRvg"&gt;500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Warrants at a purchase price of $&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zxbmBKvbgqY"&gt;0.75
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Warrant, for an aggregate purchase
price of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateWarrantsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zJHl0sBU8Nhd"&gt;375,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Each Private Warrant entitles the holder to purchase one share of common stock at a price of $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zbuq7tqIKoTj"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).
In addition, Up and Up purchased an aggregate of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_znukqKkhVaTc"&gt;100,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Placement Units at a purchase price of $10.00
per Placement Unit, or $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zEjyHTbNpZuk"&gt;1,008,333
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in the aggregate. Each Placement Unit consists
of one share of common stock (&#x201c;Placement Share&#x201d;) and one redeemable warrant (&#x201c;Placement Warrant&#x201d;). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__custom--PlacementUnitsMember__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_z1IpqYTHD3f1"&gt;11.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to adjustment (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GLAQ:PrivatePlacementTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3688889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2766667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-09-30_custom_PrivateWarrantsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">375000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1008333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-09-30_custom_PlacementUnitsMember_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z8kNKU3obTt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6. &lt;span id="xdx_829_zLp2kv6zgzm8"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 1, 2020, Globis SPAC LLC purchased &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zYx5fPRCoFU6"&gt;2,875,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock for
an aggregate price of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200830__20200901__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zXPA4pFb7rJ7"&gt;25,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
On December 7, 2020, the Company sold an additional &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zq2UxGoEly6d"&gt;172,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stocks to
Up and Up for an aggregate price of $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201206__20201207__dei--LegalEntityAxis__custom--UpAndUpCapitalLLCMember_zmQcTpOT3Xea"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
resulting in a total of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKlTFQkeV3Fa"&gt;3,047,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock being sold to the Sponsors
(the &#x201c;Founder Shares&#x201d;) and being issued and outstanding, of which an aggregate of up to &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201206__20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0tmZpKt9Ql"&gt;397,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares were subject to forfeiture to the extent
that the underwriters&#x2019; over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately
&lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20201207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zNUMU23jNe2d"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters&#x2019; election
to fully exercise their over-allotment option on December 15, 2020, no Founder Shares are currently subject to forfeiture.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#x2019;s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administrative
Support Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $&lt;span id="xdx_90F_eus-gaap--PaymentsForRent_pp0p0_c20201213__20201215__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember__dei--LegalEntityAxis__custom--GlobisSPACLLCMember_zX14Yq7WKyJ9"&gt;10,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per month for office space, secretarial and administrative
support. Upon completion of the Business Combination or the Company&#x2019;s liquidation, the Company will cease paying these monthly
fees. For the three and nine months ended September 30, 2021, the Company incurred $&lt;span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zKHU6ydsd23a"&gt;30,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_904_eus-gaap--ProfessionalFees_pp0p0_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zsivcrxwtTxl"&gt;90,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, in fees for these services. At September 30, 2021, $&lt;span id="xdx_901_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AdministrativeSupportAgreementMember_zV7CvlL7pfpe"&gt;5,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;is reflected in accrued expenses related to this
agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Advances
from Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 2, 2020, the Sponsor advanced the Company $&lt;span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_c20201130__20201202__srt--TitleOfIndividualAxis__custom--SponsorMember_pp0p0"&gt;50,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to fund certain offering costs in connection
with the Initial Public Offering. The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering
on December 15, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related
Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company&#x2019;s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital
Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#x2019;s discretion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$&lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20210111__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination. On
various dates during the nine months ended September 30, 2021, the Company drew a total of $&lt;span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20210930__srt--TitleOfIndividualAxis__custom--LenderMember_pp0p0"&gt;700,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;under the Note in accordance with the Working
Capital Loans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 28, 2021, the Note was amended to terminate the option for the Lender to convert the amount outstanding under the Note into Private
Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 19, 2021, the Note was amended to increase the principal amount of the Note to $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210719__srt--RangeAxis__srt--MaximumMember_zhkfLUitk6n5"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 13, 2021, the Note was amended to increase the principal amount of the Note to $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211013__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_zlc5VAe4knx2"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-08-302020-09-01_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">172500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-12-062020-12-07_custom_UpAndUpCapitalLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-062020-12-07_custom_SponsorsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3047500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2020-12-062020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">397500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-07_us-gaap_OverAllotmentOptionMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsForRent
      contextRef="From2020-12-132020-12-15_custom_AdministrativeSupportAgreementMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:PaymentsForRent>
    <us-gaap:ProfessionalFees
      contextRef="From2021-07-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-012021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">90000</us-gaap:ProfessionalFees>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-09-30_custom_AdministrativeSupportAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2020-11-302020-12-02_custom_SponsorMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2021-01-11_custom_LenderMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-01-012021-09-30_custom_LenderMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">700000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-07-19_srt_MaximumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-10-13_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_806_eus-gaap--CommitmentsDisclosureTextBlock_zIhtXf3dEINb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7. &lt;span id="xdx_829_zZ3CkGSvowYj"&gt;COMMITMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain &#x201c;piggy-back&#x201d;
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriting
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters are entitled to receive the &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd"&gt;402,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;equity participation shares upon the consummation
of a Business Combination. The equity participation shares have been placed in escrow until the consummation of a Business Combination.
If a Business Combination is not consummated, the equity participation shares will be forfeited by the underwriters. The Company accounted
for the equity participation shares as an expense of the Initial Public Offering, resulting in a charge directly to stockholder&#x2019;s
equity. The fair value of the equity participation shares is estimated to be $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pp0p0"&gt;4,025,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
based upon the offering price of the Units of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd"&gt;10.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">402500</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-01-012021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">4025000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-09-30_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8YfPPEiyugg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8. &lt;span id="xdx_825_zkwPe3u6haF9"&gt;STOCKHOLDER&#x2019;S EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt; &#x2014; On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_c20201210_pdd"&gt;1,000,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of preferred stock with a par value of $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201210_pdd"&gt;0.0001&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share with such designations, voting and other rights and
preferences as may be determined from time to time by the Company&#x2019;s board of directors. At September 30, 2021 and December 31,
2020, there were no shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20210930_pdd"&gt;100,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock with a par value of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20210930_pdd"&gt;0.0001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share. At September 30, 2021 and December
31, 2020, there were &lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkI6IXZVVWr3"&gt;3,550,833
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock issued and outstanding,
excluding &lt;span id="xdx_906_ecustom--CommonStockSharesSubjectToRedemption_iI_c20201231_z1hydEqWImza"&gt;11,500,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock subject to possible redemption which are presented as temporary equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
&lt;/i&gt;&#x2014;&lt;/b&gt; The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of the Company&#x2019;s initial business combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration
statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
    whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    a price of $&lt;span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_iI_c20210930_zvQC2mQJgeH1"&gt;0.01&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
    warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    any time while the warrants are exercisable;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
    not less than &lt;span id="xdx_904_ecustom--NoticePeriodForRedemptionOfWarrants_dtD_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zOmPxPoGp2Oc"&gt;30
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;days&#x2019; prior written notice of redemption
    to each warrant holder;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, the reported last sale price of the shares of common stock equals or exceeds $&lt;span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MinimumMember_pdd"&gt;16.50
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (as adjusted for stock splits,
    stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-day trading period ending on the third
    business day prior to the notice of redemption to warrant holders; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
    at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
    date of redemption.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#x201c;cashless
basis,&#x201d; as described in the warrant agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent
more than &lt;span id="xdx_909_ecustom--PercentageOfProceedsFromBusinessCombination_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTRY2qkOVXt5"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation
of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading
day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the &#x201c;Market
Value&#x201d;) is below $&lt;span id="xdx_90A_ecustom--MarketValueOfCommonStock_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_pdd"&gt;9.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to &lt;span id="xdx_90A_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--StatementScenarioAxis__custom--CommonStockPriceBelowNinePointFiveZeroPerShareMember_zNSxZ3XCQRu1"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the higher of the Market Value and the Newly Issued Price, and the $&lt;span id="xdx_908_ecustom--MarketValueOfCommonStock_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd"&gt;16.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to &lt;span id="xdx_902_ecustom--PercentageOfExercisePriceOfWarrants_iI_dp_c20210930__srt--StatementScenarioAxis__custom--CommonStockPriceAboveSixteenPointFiveZeroPerShareMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0NPV7RbQBu"&gt;165&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the higher of the Market Value and the Newly Issued Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GLOBIS
ACQUISITION CORP.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(UNAUDITED)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-10_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Shares">3550833</us-gaap:CommonStockSharesOutstanding>
    <GLAQ:CommonStockSharesSubjectToRedemption
      contextRef="AsOf2020-12-31_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">11500000</GLAQ:CommonStockSharesSubjectToRedemption>
    <GLAQ:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="AsOf2021-09-30_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.01</GLAQ:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <GLAQ:NoticePeriodForRedemptionOfWarrants contextRef="From2021-01-012021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember">P30D</GLAQ:NoticePeriodForRedemptionOfWarrants>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_srt_MinimumMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">16.50</us-gaap:SharesIssuedPricePerShare>
    <GLAQ:PercentageOfProceedsFromBusinessCombination
      contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">0.60</GLAQ:PercentageOfProceedsFromBusinessCombination>
    <GLAQ:MarketValueOfCommonStock
      contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">9.50</GLAQ:MarketValueOfCommonStock>
    <GLAQ:PercentageOfExercisePriceOfWarrants
      contextRef="AsOf2021-09-30_custom_PublicWarrantsMember_custom_CommonStockPriceBelowNinePointFiveZeroPerShareMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">1.15</GLAQ:PercentageOfExercisePriceOfWarrants>
    <GLAQ:MarketValueOfCommonStock
      contextRef="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="USDPShares">16.50</GLAQ:MarketValueOfCommonStock>
    <GLAQ:PercentageOfExercisePriceOfWarrants
      contextRef="AsOf2021-09-30_custom_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember_custom_PublicWarrantsMember_custom_GlobisAcquisitionCorpMember"
      decimals="INF"
      unitRef="Pure">1.65</GLAQ:PercentageOfExercisePriceOfWarrants>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zlyRJqI9p1Kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9.&#x2009; &lt;span id="xdx_82E_zCUvpl57yn52"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
    and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zX0f0TdQIdF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zadfUy38R0i4" style="display: none"&gt;SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable
    securities held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,155,627&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zqogmnYf5pE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zX0f0TdQIdF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zadfUy38R0i4" style="display: none"&gt;SCHEDULE
OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable
    securities held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,155,627&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Marketable securities held in Trust Account"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116155627</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">116150000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember">&lt;p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zTHHcqlcWHhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10.&#x2009;&lt;span id="xdx_823_zDbllZquseQ1"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than described below and the restatement discussed in Note 2, the Company did not identify
any subsequent events that would have required adjustment or disclosure in the condensed financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the Company increased the principal amount available under the Note (as defined in Note 1 under Liquidity) to $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z48IjUkTsqGf"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember_srt_MaximumMember_custom_GlobisAcquisitionCorpMember"
      decimals="0"
      unitRef="USD">3000000</us-gaap:DebtInstrumentFaceAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[ 5P?B6E.>[8&Y3K;L-_ 5!+ P04    " #KABQ4W)+FEQ@%  #!$0  &
M 'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*58;6_;-A#^*X17# G@Q*)DR7+C
M&'"<M#66KEGM;AB&?: E.N8BB2I)Y66_?D=)D5]$,^D2!(DDWQV?>WC'>^31
M Q=W<DVI0H]IDLGSSEJI_'VO)Z,U38D\Y3G-X),5%RE1<"MN>S(7E,2E4YKT
M7,<)>BEA66<\*I_=B/&(%RIA&;T12!9I2L33!4WXPWD'=YX??&6W:Z4?],:C
MG-S2.57?\AL!=[TF2LQ2FDG&,R3HZKPSP>^GKJ,=2HO?&7V06]=(I[+D_$[?
MS.+SCJ,1T81&2H<@\.^>3FF2Z$B XWL=M-.LJ1VWKY^C?RB3AV261-(I3_Y@
ML5J?=\(.BNF*%(GZRA\^T3HA7\>+>"++O^BAMG4Z*"JDXFGM# A2EE7_R6--
MQ)8#[A]P<&L'][4.7NW@E8E6R,JT+HDBXY'@#TAH:XBF+TIN2F_(AF5Z&^=*
MP*<,_-1XRK,8-H7&Z((D)(LHFNM8$IV@CPE?,HDFT?>"25:2/N4B1W]]INF2
MBK_!Y-O\$AV].Q[U%$#1 7M1O>Q%M:Q[8-DYS4^1YW21Z[C8X#ZUNU_2"-QQ
MZ>[LNO> @(8%MV'!+>-YAU@HA*"90D1*R-T2T&L">F7 _J& 1*Y-K%1>?NFE
M.^Q^'/:Q-^K=;^?>-M)I!F%CM@.IWT#J6R'=")H3%B/ZF.L-ER9X581@:V7L
M.X&_#[!MYH8>_)@!^@U WPIPP15)T/-63 Q;48'T#2"'3A#L@6R;]4._[V S
MR* !&5A!?B;BCBJR3"B2-"H$] 65:$V3&+$,+01T+'1,Q(M,F; ';>PXP+X?
MN(,]^ <L'?@Q9S!H,AC8:?ZRF%RCR7Q^M9B;( Y,"WNX'PSWR\!H&7B'20X;
MB*&U':]GDXO9]6PQNYJCR:^7:+[X,OWETY?KRZNO\Y]_"ET\.$-'EU<?9M/9
MXAA=_?9MMOC3TK3#9MFAO6GKTDL86;*DVMF3Y]V4*"=/Y;Z3+(;I$XF"VIMI
MV*(GZ <#=[C'HL$,RN% LV-G<ZX[+[0[3YF47#RAC"N*2M[P&8S>A"A GA.A
MGHP'M],"-'!VRJX^H:WK:_GQ7N8DHN<=T!>2BGO:&2/++N&MD85?4<%;16),
M [>KTS/Q;S"T;<!FI&#77DT\39D"Q0.EHTL&)JUBV2W-(F:N%WN\5Q%:9_3V
M0+LY;Z8>?F'L0<X@$T"U1'>@#)?_@%A#BJ.<2\ET[P@:TS0OM03&73C-NE!8
M2*X) $%$;7]^3Y*"ZF>@%52I.!K!4/()&J!^:M0!-:?>*X[1FK77F.[RLAF]
MN&\]T.::D#5/8BKDY@"C*Q8Q!0<8"*S]7MQ=:#-"L7V&PI!?43C%XFH/NNB=
M<PKXL6[WBM$SA#7G.[P7:LT%^Y?&9W!6/#^%PT.?<)IJD/]2P064KY%D*Z8?
M*=RW!]KE;3/5L7VL;Q>NF;2*LD.T8;_K^$X75)"=/G1$'Z.D*"_;#6#OF.,W
M-T-;4WB^O]\&=J-=?C>: ]M%QR2.RS<($'A:A)Z 5HI(SD#P&8&VE87O##VG
MOX_U1;M=N!O]@4,[W"@JTJ(:E''5ID:<86O]$QP,X;?%JL$R'(9A< #I1K)@
MNV:I1/./GR]U FWQ<8)QZ#K>OIHV6/;Q<# XH/G=C4YQ[3JE-<S_I^*K$JH7
M\W</<:-Z-9L:Y6MOZ_U:?[D!+P&W+),HH2OP=4X'$$14WQ=4-XKGY2OWDBMX
M@2\OUY3 [F@#^'S%09+5-_HMOOG69OP?4$L#!!0    ( .N&+%2!WI>[*@,
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MUQ/;]BS]&YGK[;RU,*PQ]RKF7B/S#!<<"(&E,U?<?^P0K!C"!;:HPLX[&F5
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MY9''A$G)LO)R#C0&K@3P_90Q^7ZC##3G<H/_ 5!+ P04    " #KABQ4B#H
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MR]V#_MV%%D7Y)'LNM!99^7;%*"R>1@"^7PA87:H+XZ#^N67\+U!+ P04
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M>(&^:3.D $N9;+K$S8P3T0VC<,RT,3L6A>8(K,=[[#DZ]=9"* YU9N@(:_-
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MJOUVH_+!]("E%7A^C0BKS>#V'28([\8:FX@2A@WP,2")\[MY,=,,(\3PH=9
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M$V7L..$M)R !&D"4&4S84ZP&X]1<--^:(9"VT,!%YDTICL-T)B!L*VJ]_+/
MPH>J0'C>OG;D1^M=T1/!P2K4'L60)_IK^)@V&(]#>.O7K?I,ZL)5Q)K(*6@!
M>?AVC<.VF@5G.7Q?R=<IYJOF:U&E392I"EE!FM%KGL?G!7,]R3NY600<+-R<
MZQI.,JDQJ3+51/PH5ZO4HLPNRTMU$PY1^'!5&KQ*-\7\K5B &EC_@&MKZ$X
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M&<&P"8';I!G^2\!Q!<R+00$O_+DF<U^K41N(QP1/EFBO-CD@@Z!UV1D":_-
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M!^#W60:ZTWS "1"PT?)>_0]02P,$%     @ ZX8L5+=)G6I\"P  +2\  !@
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M*=NIAX^!/"15!%\%<EJ5]' 2+T@ RBR@]U/M@1().!*7)T:ZD PQ6$1PY!&
MB1R/BU+#DQ8F3_YF<;Z0J@2Y,B+N(XBDL8Q[TWWC^*;RJ0(^[%X^)OK)\$!
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M9/EAH!QHD=N[]5)HNJG;UQ@9.6 $:'TE*#&K@5&P^SK3^QM02P,$%     @
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ML.3)7@4EIQCI"S%^N2V5.1%<R#*H1^Y7MB3CN-FWHUS$YAA..A:7]?!*++Q
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M;[VA8X$N;[S*%ZMR=VD4*&M5ZAYC%$0>;Z#O*Z7L[H4-U->._7\!4$L#!!0
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MIPK5;:),@F @;D1?''Y:!ZWQ<:=VF:A]1?Q"1JJ8)F0K: )TSDL+/Z>,"U(
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M;8?/A8J-B_\Z$5%"*&0@@NY-L5C *$<:&,#Q%47Z\,BM^]$54!J%T\TRE4O
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M[3;@^T(INWEQ!JJ;W\5_4$L#!!0    ( .N&+%1H.B'Y[04  & 7   9
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M=V]R:W-H965T<R]S:&5E=#$X+GAM;-U7VV[C-A!]UU<,W*#8 (8MV4DWS<5
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MLJ>]=!EMKL$Y"4P7-)GS<H($RI*<V,3(F&;&+)==#[YT*I4I*.U I@0OIR_
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MR%8\RGO+M,4K/3''183;C8B>KY\THO5-CWGQ<!4RVO4;T467??>< ..Z10$
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MJV=/H<]ZUJW@J1U=2\%V_A;ZW"'V+*#/<P#G%GUS%8(Z(F';,1%K] ;:$F%
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M5H'.%U*:[<8ZJ!Y;_?\!4$L#!!0    ( .N&+%3"'O0!< ,  'D)   9
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;-5676_:2!1]YU=<>5>KK81B8T*2
MI8!$@+1((8UP:!^J?1CL"Q[%GG%GQJ'IK]\[8T.I"M;NPZZT+W@^[CGW8PYW
M9K"3ZEFGB :^YIG00R\UINC[OHY3S)F^D 4*VME(E3-#4[7U=:&0)0Z49WX8
M!%=^SKCP1@.W]JA& UF:C M\5*#+/&?J]18SN1MZ'6^_L.3;U-@%?S0HV!8C
M-*OB4=',/[ D/$>AN12@<#/TQIW^I&?MG<%'CCM]- :;R5K*9SN9)T,OL %A
MAK&Q#(P^+SC!++-$%,:7FM,[N+3 X_&>_<[E3KFLF<:)S#[QQ*1#[\:#!#>L
MS,Q2[MYCG8\+,):9=K^PJVQ[9!R7VLB\!E,$.1?5EWVMZW $N G. ,(:$/Y=
M0+<&=%VB560NK2DS;#10<@?*6A.;';C:.#1EPX4]Q<@HVN6$,Z.[\7P)'\?W
MJQDL9N-HM9PM9@]/$?S^Q-89ZC<#WY 7:^O'->-MQ1B>8;R$A10FU3 3"28G
M\)-F_!\->)^R.Z08[E.\#1L)IQA?0+?3AC (@U/Q-,,C+ @>.'BG(9SNH>)=
MQW=YAN]=)M=<PSC^4G+-G98G4A7P>8'Y&M6?#2XN#RXNG8ON&1=+U$:5L2D5
M%UMBUP:82("64;T@?+XG>Y@;S'63M][!6Z\QH6CR?C9=W<_@PQT<R6D<13,2
M4JVJ*7QX@.5LLEHNYP_OX'8<S:-3VFIT95M:7Q<LQJ%'/<MEXXV>4FQM9$;]
MR&9KK&[![0JC@8NJT[F6L:8V!B9%*DE>,/'ZVR\W8>?ZK0:F-9*Q21E52B'D
MR'2I, &:;QA7\,*R$L%R4.N*2^4*2^V##I),2&'N[%I[E;5=O;E(>,P,:N?S
MB"?EJ)B*TU>0&[=GEZL8N2A*HX^#A-+PC'^C8(RD!F50Y?;X=!FG1YQ]V!]#
MZY\>0VN*.E:\</[O\06S'Q)JC5UQ^JT%4\]8E5?;&I!V*;44,YMIZTE1LR)5
MQ[(4!CKP*W0Z5^U.+V@'00"G_G;_RZ.F;F#JTM0MP1WUOF#P'RN@]6\IX$2>
M/ZG\A#):/RL#SBFCU[X*KQMU4K4C_^AVRU%MW:6OP=%5%]UA]?"N&+OKU/]N
M7CU**- M%QHRW! TN+@F#:KJHJ\F1A;NKEQ+0S>O&Z;T-D)E#6A_(Z793ZR#
MPVMK]!=02P,$%     @ ZX8L5'6T\OXX"@  03$  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL[5M=4]L\%K[G5VC8[DX[DX*_"5W*#!!H\TZ!#.G'
MS'9ZH=@*T=:V7$GF8V9__![)3I006S&T%[EXN8#8T9$>'1T]YT/BZ)[QGV)&
MB$0/69J+][LS*8MW^_LBGI$,BSU6D!R^F3*>80F/_'9?%)S@1 MEZ;[G.-%^
MAFF^>WRDWXWX\1$K94IS,N)(E%F&^>,I2=G]^UUW=_[BAM[.I'JQ?WQ4X%LR
M)O)+,>+PM+_H):$9R05E.>)D^G[WQ'TWC$(EH%M\I>1>+'U&:BH3QGZJAV'R
M?M=1B$A*8JFZP/#GCIR1-%4] 8Y?=:>[BS&5X/+G>>\7>O(PF0D6Y(REWV@B
M9^]W^[LH(5-<IO*&W7\D]80TP)BE0O]&]W5;9Q?%I9 LJX4!04;SZB]^J!71
M1<"K!;PG F[0(N#7 GY7@: 6"+H*A+5 V%4@J@6BK@('M<!!5X%^+=#O*G!8
M"QQJ<ZC63R_^ $M\?,39/>*J-?2F/F@+TM*PYC17QCZ6'+ZE(">/!^?CLYOA
MZ//P^@I=7Z#KFP\G5\/_G.CGDZL!.OTR'EZ=C\?H>G1^HU^/T>L!D9BF EUA
MSK$RUC?H+?J0L@D5Z"3^55)!M26?,5Z@[Y<DFQ#^ YI\&0_0ZU=OCO8E(%?C
M[\<URM,*I=>&DL1[R U[R',\MT'\K+NXTR ^Z"#NNZWBYW;Q,2E W&D%?V$7
MOX[E8O0F\0\=Q%V_5?RC7?RO,@7QPU;Q80?5.0=-JML'2UV8J[<P5T_WY[?T
M!YR6X@FKK Z=@/GEMP2X5R*<)RO/UW)&.)(SK,QP6>C[)^@3#27)Q \+(G^!
MR->(@K;5G6%.!!H*49*DAT:<Q@2-8&C]19.M5OWU=7_*%]T=N\X>Z/:N 46P
M0!%848PXBPE)!)IREFDP. <<PQPV(D[1J)RD-$;7TRGA-+]M0E7U'RZC<B,W
M=.!G :VR]J:6NMU2RY5)A(M)A'95XI0@-D5CR>*?/5@V<*D)4<L&7')#8@++
MER#X_!F666#M+9NF4HT2+0&,PL#M!RTZCA;P(BN\\P>(, 0!)"F6 $0R-*!"
M<CHI-4(&:T[X'8U!P]H<O^2 _I[#$L"+"T)$$]AH#:SG6W1YL ![8->ETF%M
ME6A0JE575DD9V.A7G):D-_]RNL#=#/!@;;D#QPM; ?87 /LO!ECMJ<X(^VLJ
MK! V SQ< #RT;RG\J(A$+"S2;*LS)F0CDL,U77ENM&QXU0XZ7%_S<+7="F+7
M,<[<L6(>D(F$30]&62KL/72! >Y)QLI<-OH]9WTO.PU;OFX7K;5[TO!C0X>>
MC1K<I3C%M4[M>Q4,O3O#8O:1I,EU*14[?.;P^JWSHS$H<-?U#&XHZC^=W7H[
M6 N_!;%Q5:YG17R)^4\(E"9 :F,2EXH'E%%?L1P>.&E9$6]=TRT\W-8TC+R#
M%NS&J;EVKS;7]C?(5&!GGN&"2IRVZ=E?IPC?<_H'3P'[#5;D'T11FZJ-]W/M
M[N\S?@ ?##M6:;LQ0@O6APXM9FE<EFOW6><0[<I'=$GDC"6P]>Z(D-76N[[/
M"1<S6BA:B^$5Y(Z-VK,/T'?V'.>?ED#%-?[+M3NP1H-LU%;4' Q8+,OX)=?N
MF"[ =\<S"GYTGAC8YF:\B=O?DL#0-0[$M7N0358Y<-?]A>OY;M"L8\^X <_N
M!NI4;#PZ.4.?/IUUT;1GB-ASMT33WE)68*?:TU+ &[&2?=9A1!61-UEYW6>W
M0-PSU.G9J;,9B^$ %4]\93HF'.:20* CZ[:<)$T$L6&\<!-!>(9&O0TTJIPI
M8(E5O-#):@Q/>N&V6(WA0\_.AR^QFD'=9T>K,;3H;8C7RXD@OTJE@/,[TE'[
MAAV];6%'S["C9V?'3Q24GE3)W2D65 ?:M>W!YNA54;8&.,QCEC6ZJM,-@V"Q
M4T!&7,CT$6&!.,&"Y4#'CZA@0E#E"B%[0SF3*&.P['KBDN3PMK:-!#\*I)1"
M\!1V:P_Z2 C)U*MY6CU/5S"H$Q6$OQ7:A IE0CU45/R_0W,40^S:0[#,D))#
M]JBZP+>WG-Q"/HFPCM+5RUSEN D!A%0B$%/M5K<FS>.T3!2%T)I"T.O[&8UG
MYADPI"F:$)03J30KE3/:J<%HK9:% O$* OD>!$*JS4(8WD-+E% A6%IEMZ3*
M?L6;'KR^@\@[09-'#2TOE:'J,31V",PE]*\3NE4%51"5 F%%H-.=>PH886V+
ME$@"BT(>U-+#7IRAHA(5*O.:L10R:?&O?_0]]^#?B*L"ME#KN?PM>FVTHF#I
M5FHFO*H<H&G)M7&G<\.#ALE2 B]Z.W0*FGF$*8IR\E\2:W%<% !$:RW%]SU;
MR<@X:/^/YFD?_/6TRK>E5;[QYKX]K6KE'?0_]((PPC<NV]^:2MY2*>\EKGM
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M8A^$ZX>-UL/ST%!X:*?PZSO(/4[2E,G*V*J,OXNI+UUPV98J>&@8.[17P?^
MJ:_?8;%;NF'N< -S/YOTPO68UFV#8;@WM'/O;Q_R#C<,X+D;SG!"0\^AG9[M
M5@RQV3/<?F0X/-H6#H\,AT<;./S9QE-WN'*VX^ZU>,S(\'6TB:_IG2I1F$-W
M6Y55WQPKYG_JFQ>]K@78R)!OM"U1=&0H.+)3\.]S4=1PT<-Q^G[+%9/(4'>T
MX7+B\ZTIW$Q%^TLWM]4_%UQB?DMS@5(R!2$5KNU6E9CY@V2%OLP]85*R3'^<
M$9P0KAK ]U/&Y/Q!W0]?_-?$\?\!4$L#!!0    ( .N&+%0;8IGI10P  ,12
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;,U<W6[;N!)^%<$XP&F!
MNA8EDI**)$#J^&_1)D'<[KDH>J'83**M+'DE.=F^_:%DQ;3($4T[3KO%8O/W
M<3@S')'?S% ^>4JS'_D#8X7USR).\M/.0U$L/_1Z^>R!+<+\?;ID"?_+79HM
MPH+_F-WW\F7&PGDU:!'W'-NFO448)9VSD^IWU]G92;HJXBAAUYF5KQ:+,/OY
MD<7ITVD'=9Y_<1/=/Q3E+WIG)\OPGDU9\75YG?&?>ALI\VC!DCQ*$RMC=Z>=
M<_1AX@7E@ KQ9\2>\JWOK=*4VS3]4?XPF9]V[%(C%K-948H(^9='UF=Q7$KB
M>OQ="^ULYBP';G__+'U8&<^-N0USUD_C_T7SXN&TXW>L.;L+5W%QDSZ-66T0
M*>7-TCBO_F\]U5B[8\U6>9$NZL%<@T64K+^&_]2.V!J <,L IQ[@F YPZP&N
MZ0!<#\"F T@]@)@.H/4 :CK JP=XI@/\>H!O.B"H!U3QU5NO7[7X%V$1GIUD
MZ9.5E6@NK?RFBJ!J-%_S*"F#?5ID_*\1'U><3?OCP<773P/K:F@-;FZN;JS^
MU<W-H/]E<G4YM<XO+ZSKFPG_[?6 ?[FPSB_^^#K]\GEP^65JO;E@11C%^5NK
M:XWB]#;*K?/9WZLHCZHP[J?9TOKVF2UN6?:=0[Y.+ZPW_WE[TBNXVN7DO5FM
MXL>UBDZ+BA=L]MY"Y)WEV(X-#._KAT_9\KWEVJW#+\R'(V#X0#_\CU6B'3[4
M#_\<9GPX:AT^,G!=/1RR??PRY2<'NZ['PW03J\XF5IU*GMLB[Y)OG>>S6;I*
MBBBYMZZS-.'?SQC?>XO<2C.K_Q F]\R*DB8L2F;1,F;6MT]<H#4IV"+_KE''
MW:CC5NK@%G7ZZ6+!XYP_HK,?_+"X_8OOWU:16LLTSZ-;/E_&YFRQ+!\&*.C7
MPDDEO#R2'L\0HHC8_-])[W$[0(V1(V/DQ 39\ K>> 4;>P4R>SV:;DWL$BH9
M#&&(9*H!9J+'-,PC&_/(B\PCRI1=U3X0)!MH IKL #5,I!L3J=;$\_F\VL'#
MV%J&T;S+'Z=9N(R*,(8,IHH&Q Y<VY5,;H'A)FQ E;"$8$,SV,ALTK&9M,E.
M:0UO>QMO>WIOSV:KQ2H."S8O25HTBPK(S9ZZT![QD.1E (5HP/^3XF8  'T;
MN:X4J4, AXGK8SE8(7F![TOBQH;33@SL:#C;WSC;USK[2\JCV)J6#^]#&L]9
MEO^WI#&5U]]: TY>BI^0]WT@0AS;]R7WJ[ N0KYCR_8- *##S?,\R?W O,1'
M<IBK*(P"SY,>P;'AI!,#*QK.#S;.#PXZ+_7'9*"$ EH?4_+99P!LJ(UL09%M
MK>*3A.^'/&YF<<A/=AXL845PTSMK]B(*,*KGW>,41EN\'NF]O>%"CV&\8J6V
M]0),#]56.V&9E7_(E^&,G79XVIVS[)%USBP-ST*"]R%':\O7A#^J3UE4\;E)
MPKW.K#>?N-90-C'2"SM 3T$(D9X1/@?*3H_O<+1VE@,,$-P-Z<G;S48O*YS_
MQ;//DEI;=R6UWK:D88$5+DJJ#1J"U:W$I93Z&+6$MZ!A2,_#/H9Y-+/"A!^:
M4;PJ#\^GJJ[!OPD?61;RT,\?0NX>*UT5><&!/';>O?"![>N5,EJ9.N=4B1N\
MK0V,D4-CY A"$L>F5.(38V.1$Q-D<ZD%'45Z/OJ;EEJKU#Y+K?+&;MM:&T.'
MYM 1"(67VUCHQ C:7'#!B)&>$JL+GK""GV35OK]DV7JY7[K"HUH+?]L$^[WM
MM*@O.";2D\P#X_4R3;JEPFP1EKK/](EFOU9B>P$<:*4N "!/$6W?=>7H,P0.
M38$C2$=*_  Y<N 92IP8 )NK)L@ITK/37[1J*DOMMBP;@&Q9-U/DT!@Y O6$
ME\Y4YL0$V:P+"H;NZ!DZO&/$?!^PWJSWC;?;&\>>BZ:??(^CH!8D[SAR=M@"
MDSP_-(.-S&#C%IA<<()AJ(7/.2)=<?3IRHU8#KXZLS0ILC2.UWR_8-RMQ;LZ
M/W]7<U'^-<RRGR7DO(V!#NI9#2JB0W/HV C:=,16C5N?ZS2RY"C/5SR8JWP"
M-,]1%%%JA$,3T'@'J&F,2(@<?4+T;=W!^G"Y*KM 5W?3:@>]NEL;6243T_6Y
M_26]KD]MD8-T[>^@T:XI(S9&CDV031^(G,K1YU3//JCVJ/-D?K'>H09AEO#8
MS<LT]IIEE6?$0[#E(,@'??V<^VQ)V&Q+@F'*EF0$&[? E+T&A+7N-2)W=/2Y
MX_.*K$LDD^3/\O$R#4HX)(^4%PZ/(*CI%)%E.?HL:_.HIDD_S!\FR2/?<WF
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M<E%V+A<BWW61[VSD_KEKJG:2IE27S0W$A"'P/<2*)Z_P\JQ=8:XPEY<"#;I
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MR)$6UVY%@]--?HFSH)S3.']<$QR0- .(]TM*^5LC&Z"Z_!S_!U!+ P04
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M$N8W[.U<SX%P*R2++5@QB&F2'?$/^R . *A5 O MP*\+:%I LRZ@90&MNH#
M H*Z@+8%M.L".A;0,69E3]=8,\82#WJ<[8'KV:J:/C'^&K1RA":Z%>>2J[M4
MX>1@>C?].AW>PNSQZG8Z@OO)Y/IA>G<#OX^)Q#02<(<YQ[I=_H!/<!.Q!14P
M#+]OJ:"FET:,I_#W%Q(O"/]'3?D-7! ;S(GHN5(1U,NXH25SE9'Q2\B,2=@
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MKVQ,T*$@N/F7'L._U"Z?0>9-NT0Z NR3D$02/$7TL[H#I0*":A80E H(JEM
MT*$N0,?IN.[^9I7:Y5-(Y0.5R,>'R\T[?/^(F1VD4&Z8SR'5%%2B*=E=KM;A
MK</_N6#CH,.K6-V46>632D4&51.9&?'5KDA*"E_!3%>=VURI]*":I0>ETH-J
MEIY+="@I14WCII+B?K*D7!J'^>+?HV%GOI7IK[/WF+_02(" +!5(:XL%^.Z#
MY^Y"LG7\^6S.I&1A?+HB>$&X-E#/EXS)]PO]12[Y[#SX#U!+ P04    " #K
MABQ4\-P"<R(&   ^'0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6RM
M66V/VC@0_BL6NI-Z$EWB9,-+Q2*Q@6W9LH!@V^ITN@^&&(B:Q*GMP%:Z'W]V
M" 0VB>,MY0,0\#.>QS-^9IQT]X1^9UN,.7@)_)#=U;:<1Q\:#;;:X@"Q&Q+A
M4/RS)C1 7%S238-%%",W 05^PS2,9B- 7ECK=9/?9K37)3'WO1#/*&!Q$"#Z
M\Q[[9']7@[7C#W-OL^7RAT:O&Z$-7F#^)9I1<=4X67&] (?,(R&@>'U7Z\,/
M4ZLI <F(KQ[>L[/O0%)9$O)=7HS<NYHA/<(^7G%I HF/'7:P[TM+PH\?J=':
M:4X)//]^M/Z0D!=DEHAAA_C?/)=O[VKM&G#Q&L4^GY/])YP2LJ6]%?%9\@[V
MZ5BC!E8QXR1(P<*#P L/G^@E78@S +PM 9@IP-0%6"G T@7<IH!;78"= FQ=
M0#,%-'4!K130T@6T4T!;%]!) 1U= #2.D3.T(:=@:T<;'L,-M>,-CP&'VA&'
MQY!#[9C#8] /"=\X9'RR70:(HUZ7DCV@<KRP)[\D>R[!BUWBA5(>%IR*?SV!
MX[WY<-Q_'@[ K#]__AL\S_N31=]Y'DTG"_!N@#GR? 8FB%(D=_%?X#WXZ).E
MQT!_]2/VF)=L<8?0"/SSA(,EIO^*(5\6 _#NC[^Z#2X<E-,T5JDS]P=GS!)G
M!GAU Z!=!Z9A&@5P1P-NM$KA@^O@0QVX60I_4,,7.!)P6 K_J &WC%+X)WTX
M+("/-+A;Y<X_7C?[9_W9B^!C-7RZXDKXDP8<6J7PB1K^&/L"WBF%3RO@*!3P
M0N<;0@I.>F">],!,[-V6V!N*;<U_@B?,M\0%HW"'&1?= *^#Z3[$E&V]",PP
M78F?1/=0M,75]MO&C6'\J7#4.CEJ*0W-*(Z0YX+AB^B4&*X#)Z94>%64^P=+
M=F))]DN['K2-IFUU&[OS',\/,]N6>%T.>ZRT=L'G]L3GMH(/66'L,K"F) !S
M["..73!#5$1C@)=%O#XJ+<K&\@.+T K?U43GR##=X5H/%&WN@YWF&2/;$*]7
MO/.C6L;%L O>]HFWK>0]%V'\*3., ;+6XSVR*_R]<*1Y<J2I=$1.)A*><1H?
M$OY!+!WH!R0N3JIFS@EH&/EE&S7SZ5(P[%'3W"1OSC0486B=V+>4[!?QDN$?
ML2 .ACOY?JSGBJW:/MEN_\Z5?6KG*%HJBIV3&QVE&T_HQ0OB0(<9-++VR?B=
MW":I.>WXP;-&#KZ)'O@/_$I0858IH%K*WTA]G)I3Q36MM]4#+UW.:@:L*AK>
M3N@+^"8[6BDY.@N2*3A42WAN01PBZB?EWM+'QXOD6"W<6!75SE$Z0?N,N7'3
MLDMH9Q(+U1K;=\79P1-^)5V\2(LH(I2#_H9B'.CF1::C4"VD;ZG,,"][=EX;
MM49]AGEIM,MS)A-&J%9&49C7F,FX(1\\8,P*>;2*4_8UD5:.2$>1UYG 0K7"
M3D5FO>_[/DEZ-3"-DG.93E0S\81J]5QPLOH.1HS%HCP/8NJ%&]D(>L2M@\46
MB0:C#B9X?QA1M$;WZ007)<Y6;&LS$V%3+<*'^5/G,G>2S_?RYI%L*)(F _3E
MQM_@5+ (76-/]!M%9\UTSG-WK4[+?AW30?6X2U:9H)MJ0;^Z%7<J)C!AOA=/
M.;T=>$GR[+BA+B*+B(2,4"TE-C.=-]4Z?W6R.ND$%U$U;HO"7SWPDD163DQU
M.4F71FMELE)@JDO!+QPSAJG)U\):1C K%*:Z4(QQZ&(]?IE:FVJU'HMK>9!P
M*'8]+EL2SQ>[J Z.[=$]H<*H3 @'B<.1^*_HT&WF]?QU.W[I8";5IEJJ?^&\
M\VCF.V+5T<O,1-U4BWIZ,V\QZSM@/'9T0F%EJFQ5J/*UF_#!RDNKV6Z5%W4K
MTU9+K6 JW[XB/\:5KL%\'Z]P+--#2ZV'91$1W?SOZ.*LL]LK%:WR,4O70H+F
MQ>W;O55P+Z0\+ZU,^BRU]'V)  I=(#[$)O4X\NO:Z9DIH:56PNMKA)6_#P%;
M9KY$5(^[I) )J*46T&NSV+$*;DX4^%\QZN!]X^PAA'RR^(3HQ@L9\/%:P.0Q
MI@;HX6'=X8*3*'DNL22<DR#YNL5(5 0Y0/R_)H0?+^2CCM,CT][_4$L#!!0
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M09W6N0K,B]9:3"1+3;/9,*E:EQE&ZC4"7!NH_2UC<C?1 :KWS?@W4$L#!!0
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M8!P')*C #^WX8PO>48G)LX.>LG..K Y'Q&\"#QX!Y"*WBH\=/B4K!7<-'%;
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M[6#;+1N62!_GI(^MI._2#G>2DC?<4^;39/:WVDK<L&L2D&BEV\P[]VM5".D
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MT5?C)Y#3-[*N5;$F58WH=D9?Z((E./)H"+OOV0MAWU?L[PP%.U_OF%KR7(/
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M\7"]5Y_:WG4O*R(QX-D?FJC-P/GE0((I*3.UX-L;W/5S:?1BGDG["]M=K.=
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MWS14+L#N+Z4TVX4C:%[)^#=02P,$%     @ ZX8L5)N5E-V+ @  904  !D
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M( IVT).OZ1,L3Z 5.'JX3?<I*TUJHB8UD=-K[=&[1VU4E9I*\6).46H#K,B
MEE$M$9ZO"0]7!H5^^6*W5K-;R^W6WK/;6,D4,=,P4U+ E=85*U+2+RC)+(=Q
M-<UY"G>S&5H[NY);ZW><OKV\RWX8QF$GH%_77V[F<1?2X3:06T&TFR#:7P:1
M2"&H(B9&IJ_ /V)(*75ZE^/V)Q_'41B?ML-__-:X> O7V09NV>TT=CM?VGU
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M09D!  !U&0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=E-CH)
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MDO5=Z]5?_TMHU[A697/T9]T/F_DG4$L! A0#%     @ ZX8L5 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #KABQ486!_S>X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #KABQ4F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .N&
M+%3X)A>Z=00  (,3   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #KABQ4W)+FEQ@%  #!$0  &
M        @(&X#   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ ZX8L5('>E[LJ P  V H  !@              ("!!A(  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .N&+%1E9.;JW@0  *,3   8
M              " @685  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " #KABQ4B#H *$\&  !X)   &               @(%Z&@  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ ZX8L5*E+J"!N @
MHP4  !@              ("!_R   'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( .N&+%0 4>.F(@8  'H9   8              " @:,C
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #KABQ4Q(K6
M,$\;  "^E0  &               @('[*0  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ ZX8L5+=)G6I\"P  +2\  !@
M ("!@$4  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( .N&
M+%022PYY"QP  ,%Q   9              " @3)1  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ ZX8L5'3D(I>K P  )0H  !D
M         ("!=&T  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " #KABQ4_L/7IK8$  "I$0  &0              @(%6<0  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( .N&+%2\K!".^P@  )4A
M   9              " @4-V  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ ZX8L5#\"!C>,!0  @A0  !D              ("!=7\
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #KABQ4AHA.
M$)$+  "9,P  &0              @($XA0  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( .N&+%3B5\\T! 8   4.   9
M  " @0"1  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
MZX8L5&@Z(?GM!0  8!<  !D              ("!.Y<  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " #KABQ4VN;5(/8$  #D#   &0
M            @(%?G0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( .N&+%3",#S[,QT   M[   9              " @8RB  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ ZX8L5!\*,\'"!P
M=!X  !D              ("!]K\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " #KABQ4[XYU*G(%  !O$   &0              @('O
MQP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( .N&+%1@
M;0>XR ,  '@)   9              " @9C-  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ ZX8L5,(>] %P P  >0D  !D
M     ("!E]$  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .N&+%0^+8KJ4@,  *4*   9              "
M@73Q  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ ZX8L
M5,HL^;R-!   "!4  !D              ("!_?0  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " #KABQ4-<C@MU0#   O"   &0
M        @('!^0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( .N&+%1@!P="QP,  % 0   9              " @4S]  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ ZX8L5"CV;WU>!   @A8
M !D              ("!2@$! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " #KABQ4\-P"<R(&   ^'0  &0              @('?!0$
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( .N&+%0 -D'A
M\P(  .L(   9              " @3@, 0!X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ ZX8L5,J0_NX#!0  1!8  !D
M ("!8@\! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #K
MABQ494UH\*<"  !$!@  &0              @(&<% $ >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .N&+%04HFL0^0(  $4*   9
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M970T,2YX;6Q02P$"% ,4    " #KABQ4<A5?[],"  "M!@  &0
M    @(&+)@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M .N&+%3UWJ=9#0,  (T0   -              "  94I 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ ZX8L5)>*NQS     $P(   L              ( !
MS2P! %]R96QS+RYR96QS4$L! A0#%     @ ZX8L5#>VX*\5!   6!P   \
M             ( !MBT! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .N&
M+%2^RS-!F0$  '49   :              "  ?@Q 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .N&+%0CU6X-J $  +@9   3
M          "  <DS 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     R #(
*E0T  *(U 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>163</ContextCount>
  <ElementCount>287</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/BalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity</Role>
      <ShortName>Condensed Statement of Changes in Stockholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical</Role>
      <ShortName>Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Condensed Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StatementOfCashFlows</Role>
      <ShortName>Condensed Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/InitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/PrivatePlacement</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/Commitments</Role>
      <ShortName>COMMITMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - STOCKHOLDER???S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDER???S EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INCOME TAX</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/IncomeTax</Role>
      <ShortName>INCOME TAX</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://globis.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - INCOME TAX (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/IncomeTaxTables</Role>
      <ShortName>INCOME TAX (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://globis.com/role/IncomeTax</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://globis.com/role/FairValueMeasurements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails</Role>
      <ShortName>SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails</Role>
      <ShortName>SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/InitialPublicOfferingDetailsNarrative</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/InitialPublicOffering</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/PrivatePlacementDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/PrivatePlacement</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/RelatedPartyTransactions</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - COMMITMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/CommitmentsDetailsNarrative</Role>
      <ShortName>COMMITMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/Commitments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - STOCKHOLDER???S EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDER???S EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/StockholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails</Role>
      <ShortName>SCHEDULE OF INCOME TAX PROVISION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - INCOME TAX (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>INCOME TAX (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/IncomeTaxTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://globis.com/role/SubsequentEvents</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails</Role>
      <ShortName>SCHEDULE OF CONDENSED BALANCE SHEET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-4" original="forms-4.htm">forms-4.htm</File>
    <File>ex23-1.htm</File>
    <File>ex23-2.htm</File>
    <File>glaq-20210930.xsd</File>
    <File>glaq-20210930_cal.xml</File>
    <File>glaq-20210930_def.xml</File>
    <File>glaq-20210930_lab.xml</File>
    <File>glaq-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>forms-4_001.jpg</File>
    <File>forms-4_005.jpg</File>
    <File>forms-4_006.jpg</File>
    <File>forms-4_007.jpg</File>
    <File>forms-4_008.jpg</File>
    <File>forms-4_02.jpg</File>
    <File>forms-4_03.jpg</File>
    <File>forms-4_04.jpg</File>
    <File>forms-4_05.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "forms-4.htm": {
   "axisCustom": 0,
   "axisStandard": 17,
   "contextCount": 163,
   "dts": {
    "calculationLink": {
     "local": [
      "glaq-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "glaq-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "forms-4.htm"
     ]
    },
    "labelLink": {
     "local": [
      "glaq-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "glaq-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "glaq-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 337,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 63,
    "http://globis.com/20210930": 15,
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 80
   },
   "keyCustom": 32,
   "keyStandard": 255,
   "memberCustom": 21,
   "memberStandard": 15,
   "nsprefix": "GLAQ",
   "nsuri": "http://globis.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://globis.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - INITIAL PUBLIC OFFERING",
     "role": "http://globis.com/role/InitialPublicOffering",
     "shortName": "INITIAL PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - PRIVATE PLACEMENT",
     "role": "http://globis.com/role/PrivatePlacement",
     "shortName": "PRIVATE PLACEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://globis.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - COMMITMENTS",
     "role": "http://globis.com/role/Commitments",
     "shortName": "COMMITMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - STOCKHOLDER\u2019S EQUITY",
     "role": "http://globis.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDER\u2019S EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - INCOME TAX",
     "role": "http://globis.com/role/IncomeTax",
     "shortName": "INCOME TAX",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://globis.com/role/FairValueMeasurements",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://globis.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Balance Sheets",
     "role": "http://globis.com/role/BalanceSheets",
     "shortName": "Condensed Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "role": "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - INCOME TAX (Tables)",
     "role": "http://globis.com/role/IncomeTaxTables",
     "shortName": "INCOME TAX (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://globis.com/role/FairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "role": "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)",
     "role": "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
     "shortName": "SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AdditionalPaidInCapitalCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)",
     "role": "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
     "shortName": "SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-122020-12-31_custom_UnderwriterMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)",
     "role": "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)",
     "role": "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
     "shortName": "SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "GLAQ:ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock",
       "GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_us-gaap_IPOMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:TemporaryEquityAccretionToRedemptionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)",
     "role": "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
     "shortName": "SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-07-012021-09-30_custom_RedeemableCommonStockMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Balance Sheets (Parenthetical)",
     "role": "http://globis.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)",
     "role": "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
     "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - PRIVATE PLACEMENT (Details Narrative)",
     "role": "http://globis.com/role/PrivatePlacementDetailsNarrative",
     "shortName": "PRIVATE PLACEMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "GLAQ:PrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_PrivateWarrantsMember_custom_GlobisSPACLLCMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_PrivateWarrantsMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - COMMITMENTS (Details Narrative)",
     "role": "http://globis.com/role/CommitmentsDetailsNarrative",
     "shortName": "COMMITMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_UnderwritingAgreementMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - STOCKHOLDER\u2019S EQUITY (Details Narrative)",
     "role": "http://globis.com/role/StockholdersEquityDetailsNarrative",
     "shortName": "STOCKHOLDER\u2019S EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-10_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "role": "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)",
     "role": "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
     "shortName": "SCHEDULE OF INCOME TAX PROVISION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "role": "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - INCOME TAX (Details Narrative)",
     "role": "http://globis.com/role/IncomeTaxDetailsNarrative",
     "shortName": "INCOME TAX (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Statements of Operations",
     "role": "http://globis.com/role/StatementsOfOperations",
     "shortName": "Condensed Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)",
     "role": "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
     "shortName": "SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://globis.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-02-02_us-gaap_SubsequentEventMember_custom_NotePayableMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-12-132020-12-15_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET (Details)",
     "role": "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
     "shortName": "SCHEDULE OF CONDENSED BALANCE SHEET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "GLAQ:CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-01-012021-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity",
     "role": "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
     "shortName": "Condensed Statement of Changes in Stockholders' (Deficit) Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_us-gaap_CommonStockMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_us-gaap_WarrantMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical)",
     "role": "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
     "shortName": "Condensed Statement of Changes in Stockholders' (Deficit) Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_us-gaap_PrivatePlacementMember_custom_GlobisAcquisitionCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-09-30_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Condensed Statement of Cash Flows",
     "role": "http://globis.com/role/StatementOfCashFlows",
     "shortName": "Condensed Statement of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInPrepaidExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "role": "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "role": "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2020-08-212020-12-31_custom_GlobisAcquisitionCorpMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 38,
   "tag": {
    "GLAQ_AccretionForCommonStockToRedemptionAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion for Common Stock to redemption amount.",
        "label": "Redemption adjustment for Common Stock to redemption amount"
       }
      }
     },
     "localname": "AccretionForCommonStockToRedemptionAmount",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_AdministrativeSupportAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Administrative Support Agreement [Member]",
        "label": "Administrative Support Agreement [Member]"
       }
      }
     },
     "localname": "AdministrativeSupportAgreementMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_BasicAndDilutedEarningsLossPerShareRedeemableCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted earnings (loss) per share, Redeemable common stock",
        "verboseLabel": "[custom:BasicAndDilutedEarningsLossPerShareRedeemableCommonStock]"
       }
      }
     },
     "localname": "BasicAndDilutedEarningsLossPerShareRedeemableCommonStock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "GLAQ_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basic and diluted net loss per share, Common stock subject to possible redemption.",
        "label": "Basic and diluted net loss per share, Common stock subject to possible redemption",
        "verboseLabel": "Basic and diluted net income per share, common stock subject to possible redemption"
       }
      }
     },
     "localname": "BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "GLAQ_CashHeldOutsideTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash held outside trust.",
        "label": "[custom:CashHeldOutsideTrust-0]"
       }
      }
     },
     "localname": "CashHeldOutsideTrust",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_ChangeInSharesSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in shares subject to possible redemption.",
        "label": "Change in value of Common Stock subject to possible redemption"
       }
      }
     },
     "localname": "ChangeInSharesSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_ChangeInValueOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ChangeInValueOfCommonStockSubjectToPossibleRedemption]"
       }
      }
     },
     "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights-0]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "GLAQ_CommonStockIssuedValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued value.",
        "label": "Common stock issued value"
       }
      }
     },
     "localname": "CommonStockIssuedValue",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_CommonStockPriceAboveSixteenPointFiveZeroPerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Price Above 16.50 Per Share [Member]",
        "label": "Common Stock Price Above 16.50 Per Share [Member]"
       }
      }
     },
     "localname": "CommonStockPriceAboveSixteenPointFiveZeroPerShareMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_CommonStockPriceBelowNinePointFiveZeroPerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Price Below 9.50 Per Share [Member]",
        "label": "Common Stock Price Below 9.50 Per Share [Member]"
       }
      }
     },
     "localname": "CommonStockPriceBelowNinePointFiveZeroPerShareMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_CommonStockRedemptionShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock redemption, share.",
        "label": "Common stock redemption, share"
       }
      }
     },
     "localname": "CommonStockRedemptionShare",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "GLAQ_CommonStockRedemptionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock redemption, shares.",
        "label": "Common stock subject to redemption"
       }
      }
     },
     "localname": "CommonStockRedemptionShares",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "GLAQ_CommonStockSharesSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares subject to redemption.",
        "label": "[custom:CommonStockSharesSubjectToRedemption-0]"
       }
      }
     },
     "localname": "CommonStockSharesSubjectToRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_CommonStockSubjectToPossibleRedemptionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Subject To Possible Redemption Policy [Text Block]",
        "label": "Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "GLAQ_DisclosureInitialPublicOfferingAbstract": {
     "auth_ref": [],
     "localname": "DisclosureInitialPublicOfferingAbstract",
     "nsuri": "http://globis.com/20210930",
     "xbrltype": "stringItemType"
    },
    "GLAQ_DisclosurePrivatePlacementAbstract": {
     "auth_ref": [],
     "localname": "DisclosurePrivatePlacementAbstract",
     "nsuri": "http://globis.com/20210930",
     "xbrltype": "stringItemType"
    },
    "GLAQ_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company Policy [Text Block]",
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "GLAQ_FormationAndOperatingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Formation and operating costs.",
        "label": "Formation and operational costs"
       }
      }
     },
     "localname": "FormationAndOperatingCosts",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_GlobisAcquisitionCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Globis Acquisition Corp [Member]",
        "label": "Globis Acquisition Corp [Member]"
       }
      }
     },
     "localname": "GlobisAcquisitionCorpMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/Commitments",
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/FairValueMeasurements",
      "http://globis.com/role/FairValueMeasurementsTables",
      "http://globis.com/role/IncomeTax",
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/IncomeTaxTables",
      "http://globis.com/role/InitialPublicOffering",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacement",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactions",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
      "http://globis.com/role/StatementsOfOperations",
      "http://globis.com/role/StockholdersEquity",
      "http://globis.com/role/StockholdersEquityDetailsNarrative",
      "http://globis.com/role/SubsequentEvents",
      "http://globis.com/role/SubsequentEventsDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_GlobisSPACLLCAndUpAndUpCapitalLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Globis SPAC LLC and Up and Up Capital, LLC [Member]",
        "label": "Globis SPAC LLC and Up and Up Capital, LLC [Member]"
       }
      }
     },
     "localname": "GlobisSPACLLCAndUpAndUpCapitalLLCMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_GlobisSPACLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Globis SPAC LLC [Member]",
        "label": "Globis SPAC LLC [Member]"
       }
      }
     },
     "localname": "GlobisSPACLLCMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_InitialClassificationOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial classification of common stock subject to possible redemption.",
        "label": "Initial classification of common stock subject to possible redemption"
       }
      }
     },
     "localname": "InitialClassificationOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_InitialPublicOfferingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering [Text Block]",
        "label": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingTextBlock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "GLAQ_InitialSharesSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial shares subject to possible redemption.",
        "label": "InitialSharesSubjectToPossibleRedemption",
        "negatedLabel": "Initial value of Common Stock subject to redemption"
       }
      }
     },
     "localname": "InitialSharesSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_LenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender [Member]"
       }
      }
     },
     "localname": "LenderMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_MarketValueOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market value of common stock.",
        "label": "Market value of common stock"
       }
      }
     },
     "localname": "MarketValueOfCommonStock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "GLAQ_NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption]"
       }
      }
     },
     "localname": "NonCashInvestingAndFinancingChangeInValueOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption]"
       }
      }
     },
     "localname": "NonCashInvestingAndFinancingChangeInValuesOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_NonRedeemableCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Redeemable Common Stock [Member]",
        "label": "Non Redeemable Common Stock [Member]"
       }
      }
     },
     "localname": "NonRedeemableCommonStockMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_NotePayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Payable [Member]",
        "label": "Note Payable [Member]"
       }
      }
     },
     "localname": "NotePayableMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_NoticePeriodForRedemptionOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notice period for redemption of warrants.",
        "label": "Notice period for redemption of warrants"
       }
      }
     },
     "localname": "NoticePeriodForRedemptionOfWarrants",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "GLAQ_NumberOfSharesOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfSharesOfCommonStockSubjectToPossibleRedemption-0]"
       }
      }
     },
     "localname": "NumberOfSharesOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "GLAQ_OfferingCostsIncludedInAccruedOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs included in accrued offering costs"
       }
      }
     },
     "localname": "OfferingCostsIncludedInAccruedOfferingCosts",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_PercentageOfExercisePriceOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of exercise price of warrants.",
        "label": "Percentage of exercise price of warrants"
       }
      }
     },
     "localname": "PercentageOfExercisePriceOfWarrants",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "GLAQ_PercentageOfProceedsFromBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of proceeds from business combination.",
        "label": "Percentage of proceeds from business combination"
       }
      }
     },
     "localname": "PercentageOfProceedsFromBusinessCombination",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "GLAQ_PlacementUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Placement Units [Member]",
        "label": "Placement Units [Member]"
       }
      }
     },
     "localname": "PlacementUnitsMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_PrivatePlacementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement [Text Block]",
        "label": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementTextBlock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/PrivatePlacement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "GLAQ_PrivateSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Securities [Member]",
        "label": "Private Securities [Member]"
       }
      }
     },
     "localname": "PrivateSecuritiesMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_PrivateWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Warrants [Member]",
        "label": "Private Warrants [Member]"
       }
      }
     },
     "localname": "PrivateWarrantsMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid": {
     "auth_ref": [],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of Units, net of underwriting discounts paid.",
        "label": "Proceeds from sale of Units, net of underwriting discounts paid"
       }
      }
     },
     "localname": "ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_PromissoryNoteRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note \u2013 related party"
       }
      }
     },
     "localname": "PromissoryNoteRelatedParty",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public warrants [Member]",
        "label": "Public warrants [Member]"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_RedeemableCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Common Stock [Member]"
       }
      }
     },
     "localname": "RedeemableCommonStockMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN BALANCE SHEET"
       }
      }
     },
     "localname": "ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetTableTextBlock",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "GLAQ_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor [Member]",
        "label": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_SponsorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsors [Member]",
        "label": "Sponsors [Member]"
       }
      }
     },
     "localname": "SponsorsMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_StockIssuedDuringPeriodSharesSaleOfPlacementUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares sale of placement units.",
        "label": "Sale of 100,833 Placement Units, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesSaleOfPlacementUnits",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "GLAQ_StockIssuedDuringPeriodValueSaleOfPlacementUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value sale of placement units.",
        "label": "Sale of 100,833 Placement Units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueSaleOfPlacementUnits",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "GLAQ_TotalStockholdersEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Stockholders Equity.",
        "label": "Total"
       }
      }
     },
     "localname": "TotalStockholdersEquityMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_TrustAccountMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trust Account [Member]",
        "label": "Trust Account [Member]"
       }
      }
     },
     "localname": "TrustAccountMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_UnderwriterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriter [Member]"
       }
      }
     },
     "localname": "UnderwriterMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_UnderwritingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting Agreement [Member]",
        "label": "Underwriting Agreement [Member]"
       }
      }
     },
     "localname": "UnderwritingAgreementMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_UpAndUpCapitalLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up and Up Capital, LLC [Member]",
        "label": "Up and Up Capital, LLC [Member]"
       }
      }
     },
     "localname": "UpAndUpCapitalLLCMember",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "GLAQ_WorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital.",
        "label": "[custom:WorkingCapital-0]"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://globis.com/20210930",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r417",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://globis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r167",
      "r193",
      "r223",
      "r226",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r387",
      "r389",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r167",
      "r193",
      "r223",
      "r226",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r387",
      "r389",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r125",
      "r210",
      "r211",
      "r345",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r125",
      "r210",
      "r211",
      "r345",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r167",
      "r193",
      "r212",
      "r223",
      "r226",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r387",
      "r389",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/StockholdersEquityDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r167",
      "r193",
      "r212",
      "r223",
      "r226",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r387",
      "r389",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/StockholdersEquityDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r81",
      "r82",
      "r84",
      "r86",
      "r87",
      "r89",
      "r90",
      "r102",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r81",
      "r82",
      "r83",
      "r84",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r102",
      "r136",
      "r137",
      "r235",
      "r260",
      "r284",
      "r288",
      "r289",
      "r290",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r81",
      "r82",
      "r83",
      "r84",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r102",
      "r136",
      "r137",
      "r235",
      "r260",
      "r284",
      "r288",
      "r289",
      "r290",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r3",
      "r72",
      "r74",
      "r76",
      "r77",
      "r81",
      "r82",
      "r83",
      "r84",
      "r86",
      "r87",
      "r89",
      "r90",
      "r102",
      "r136",
      "r137",
      "r235",
      "r260",
      "r284",
      "r288",
      "r289",
      "r290",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r85",
      "r91",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "SCHEDULE OF CONDENSED BALANCE SHEET"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r85",
      "r91",
      "r150",
      "r224",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r126",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Current liabilities - Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r232",
      "r233",
      "r234",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r163",
      "r205",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Sale of 4,188,889 Private Warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r66",
      "r117",
      "r119",
      "r123",
      "r131",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r275",
      "r277",
      "r299",
      "r328",
      "r330",
      "r362",
      "r377"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r37",
      "r66",
      "r131",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r275",
      "r277",
      "r299",
      "r328",
      "r330"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r222",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/Commitments",
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/FairValueMeasurements",
      "http://globis.com/role/FairValueMeasurementsTables",
      "http://globis.com/role/IncomeTax",
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/IncomeTaxTables",
      "http://globis.com/role/InitialPublicOffering",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacement",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactions",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
      "http://globis.com/role/StatementsOfOperations",
      "http://globis.com/role/StockholdersEquity",
      "http://globis.com/role/StockholdersEquityDetailsNarrative",
      "http://globis.com/role/SubsequentEvents",
      "http://globis.com/role/SubsequentEventsDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r222",
      "r225",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/Commitments",
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/FairValueMeasurements",
      "http://globis.com/role/FairValueMeasurementsTables",
      "http://globis.com/role/IncomeTax",
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/IncomeTaxTables",
      "http://globis.com/role/InitialPublicOffering",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacement",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactions",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
      "http://globis.com/role/StatementsOfOperations",
      "http://globis.com/role/StockholdersEquity",
      "http://globis.com/role/StockholdersEquityDetailsNarrative",
      "http://globis.com/role/SubsequentEvents",
      "http://globis.com/role/SubsequentEventsDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
        "label": "Business Acquisition, Description of Acquired Entity"
       }
      }
     },
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r29",
      "r59"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r14",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r54",
      "r59",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash \u2013 End of period",
        "periodStartLabel": "Cash \u2013 Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r54",
      "r308"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net Change in Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r63",
      "r66",
      "r93",
      "r94",
      "r95",
      "r97",
      "r99",
      "r104",
      "r105",
      "r106",
      "r131",
      "r152",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r191",
      "r192",
      "r195",
      "r199",
      "r299",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r208",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r208",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r35",
      "r149",
      "r367",
      "r382"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "COMMITMENTS"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r72",
      "r73",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r330"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,050,833 shares issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at September 30, 2021 and December 31, 2020",
        "negatedLabel": "Common stock",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r109",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r67",
      "r254",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r67",
      "r254",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r65",
      "r70",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r317",
      "r363",
      "r365",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r166",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r164",
      "r182",
      "r183",
      "r316",
      "r317",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r34",
      "r65",
      "r70",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r67",
      "r255",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r67",
      "r255",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r252",
      "r253"
     ],
     "calculation": {
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating loss carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r252",
      "r253"
     ],
     "calculation": {
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Startup and organizational costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted earnings (loss) per share, Non-redeemable common stock",
        "terseLabel": "Basic and diluted net loss per common share",
        "verboseLabel": "Basic and diluted net loss (income) per share, Non-redeemable common stock"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Net Income (Loss) per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income tax provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r68",
      "r240",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r240",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r240",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r41",
      "r42",
      "r43",
      "r72",
      "r73",
      "r74",
      "r77",
      "r87",
      "r90",
      "r103",
      "r135",
      "r205",
      "r207",
      "r232",
      "r233",
      "r234",
      "r259",
      "r260",
      "r288",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r392",
      "r393",
      "r394",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to distribution, servicing and underwriting fees.",
        "label": "Expense Related to Distribution or Servicing and Underwriting Fees"
       }
      }
     },
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r173",
      "r182",
      "r183",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r292",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r173",
      "r213",
      "r214",
      "r219",
      "r221",
      "r292",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r173",
      "r182",
      "r183",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FranchiseMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right granted by another party to operate business using grantor's name, merchandise, service, methodology, promotional support, marketing and supplies.",
        "label": "Franchise [Member]"
       }
      }
     },
     "localname": "FranchiseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r117",
      "r118",
      "r121",
      "r122",
      "r124",
      "r361",
      "r369",
      "r372",
      "r384"
     ],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r68",
      "r241",
      "r244",
      "r250",
      "r261",
      "r265",
      "r267",
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAX"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r69",
      "r89",
      "r90",
      "r116",
      "r239",
      "r262",
      "r266",
      "r385"
     ],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Benefit from (provision for) income taxes",
        "totalLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r237",
      "r238",
      "r244",
      "r245",
      "r249",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r47",
      "r115"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://globis.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Interest earned on marketable securities held in Trust Account",
        "negatedLabel": "Interest earned on investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Marketable securities held in Trust Account"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r66",
      "r120",
      "r131",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r276",
      "r277",
      "r278",
      "r299",
      "r328",
      "r329"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r66",
      "r131",
      "r299",
      "r330",
      "r366",
      "r380"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiquidationBasisOfAccountingCostsAndIncomes": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of costs and incomes accrued in the statement of net assets in liquidation and the period over which those costs are expected to be paid or income earned.",
        "label": "Liquidation Basis of Accounting, Costs and Incomes"
       }
      }
     },
     "localname": "LiquidationBasisOfAccountingCostsAndIncomes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable securities held in Trust Account",
        "verboseLabel": "Marketable Securities, Noncurrent"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities Held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r54",
      "r56",
      "r58"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r38",
      "r39",
      "r43",
      "r45",
      "r58",
      "r66",
      "r76",
      "r81",
      "r82",
      "r84",
      "r85",
      "r89",
      "r90",
      "r96",
      "r117",
      "r118",
      "r121",
      "r122",
      "r124",
      "r131",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r290",
      "r299",
      "r370",
      "r383"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://globis.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Allocation of net loss, as adjusted"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r84",
      "r91",
      "r102",
      "r128",
      "r129",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r151",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r319",
      "r346",
      "r347",
      "r348",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r117",
      "r118",
      "r121",
      "r122",
      "r124"
     ],
     "calculation": {
      "http://globis.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r7",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payment of offering costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Common stock issuance costs",
        "negatedTerseLabel": "Common Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireTrustPreferredInvestments": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.",
        "label": "Payments to Acquire Trust Preferred Investments",
        "negatedLabel": "Investment of cash in Trust Account"
       }
      }
     },
     "localname": "PaymentsToAcquireTrustPreferredInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r330"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r138",
      "r139"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses",
        "verboseLabel": "Prepaid Expense, Current"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "verboseLabel": "Gross Proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from issuance of common stock to Sponsor"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from sale of Placement Units"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from sale of Private Warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from promissory note \u2013 related party",
        "verboseLabel": "Proceeds from Related Party Debt"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r15",
      "r16",
      "r140",
      "r330",
      "r374",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r220",
      "r322",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r220",
      "r322",
      "r325",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r320",
      "r321",
      "r323",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://globis.com/role/StatementOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of advances from related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/Commitments",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://globis.com/role/FairValueMeasurements",
      "http://globis.com/role/FairValueMeasurementsTables",
      "http://globis.com/role/IncomeTax",
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/IncomeTaxTables",
      "http://globis.com/role/InitialPublicOffering",
      "http://globis.com/role/PrivatePlacement",
      "http://globis.com/role/RelatedPartyTransactions",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementsOfOperations",
      "http://globis.com/role/StockholdersEquity",
      "http://globis.com/role/SubsequentEvents",
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r207",
      "r235",
      "r330",
      "r379",
      "r396",
      "r401"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r72",
      "r73",
      "r74",
      "r77",
      "r87",
      "r90",
      "r135",
      "r232",
      "r233",
      "r234",
      "r259",
      "r260",
      "r288",
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF INCOME TAX PROVISION"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED TAX ASSETS"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/BalanceSheetsParenthetical",
      "http://globis.com/role/Commitments",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://globis.com/role/FairValueMeasurements",
      "http://globis.com/role/FairValueMeasurementsTables",
      "http://globis.com/role/IncomeTax",
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/IncomeTaxTables",
      "http://globis.com/role/InitialPublicOffering",
      "http://globis.com/role/PrivatePlacement",
      "http://globis.com/role/RelatedPartyTransactions",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://globis.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://globis.com/role/StatementOfCashFlows",
      "http://globis.com/role/StatementsOfOperations",
      "http://globis.com/role/StockholdersEquity",
      "http://globis.com/role/SubsequentEvents",
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r62",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r63",
      "r66",
      "r93",
      "r94",
      "r95",
      "r97",
      "r99",
      "r104",
      "r105",
      "r106",
      "r131",
      "r152",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r191",
      "r192",
      "r195",
      "r199",
      "r205",
      "r299",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r36",
      "r41",
      "r42",
      "r43",
      "r72",
      "r73",
      "r74",
      "r77",
      "r87",
      "r90",
      "r103",
      "r135",
      "r205",
      "r207",
      "r232",
      "r233",
      "r234",
      "r259",
      "r260",
      "r288",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r392",
      "r393",
      "r394",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical",
      "http://globis.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r103",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r22",
      "r23",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r205",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of Founder Shares to Sponsor, Shares",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Equity participation shares, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r36",
      "r205",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r205",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of Founder Shares to Sponsor",
        "verboseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Equity participation shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r26",
      "r27",
      "r66",
      "r127",
      "r131",
      "r299",
      "r330"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Total Stockholders' (Deficit) Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total Stockholders\u2019 (Deficit) Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 (Deficit) Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r64",
      "r192",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDER\u2019S EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r315",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r315",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r315",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r315",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r331",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://globis.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/PrivatePlacementDetailsNarrative",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetailsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r18",
      "r364",
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Accretion of carrying value to redemption value",
        "negatedLabel": "Redemption adjustment for Common Stock to redemption amount",
        "verboseLabel": "Temporary Equity, Accretion to Redemption Value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r152",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162"
     ],
     "calculation": {
      "http://globis.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Common stock subject to possible redemption 11,500,000 shares at redemption value at September 30, 2021 and December 31, 2020",
        "terseLabel": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "verboseLabel": "Common stock subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheets",
      "http://globis.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": {
     "auth_ref": [
      "r13",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.",
        "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)"
       }
      }
     },
     "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/CommitmentsDetailsNarrative",
      "http://globis.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnderwritingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the price paid by the public and the contract price less the related expenses. A broker-dealer may underwrite a security offering by contracting to buy the issue either at a fixed price or a price based on selling the offering on a best-effort basis.",
        "label": "Underwriting Income (Loss)",
        "negatedLabel": "Underwriting Income (Loss)"
       }
      }
     },
     "localname": "UnderwritingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r236",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r107",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/IncomeTaxDetailsNarrative",
      "http://globis.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://globis.com/role/InitialPublicOfferingDetailsNarrative",
      "http://globis.com/role/StatementOfChangesInStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Basic and diluted weighted average shares outstanding, Non-redeemable common stock",
        "negatedLabel": "Basic and diluted weighted average shares outstanding, Non-redeemable common stock",
        "verboseLabel": "Basic and diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).",
        "label": "Basic and diluted weighted average shares outstanding, Redeemable common stock",
        "negatedLabel": "Basic and diluted weighted average shares outstanding, common stock subject to possible redemption",
        "terseLabel": "Basic and diluted weighted average shares outstanding",
        "verboseLabel": "Basic and diluted weighted average shares outstanding, common stock subject to possible redemption"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://globis.com/role/ScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://globis.com/role/ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetails",
      "http://globis.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r406": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r407": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r408": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r409": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r410": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r411": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r412": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r413": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r414": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r415": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r416": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r417": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r418": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r419": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r420": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r421": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r422": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r423": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r424": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "i",
   "Publisher": "SEC",
   "Section": "3",
   "Subsection": "10"
  },
  "r425": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r426": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r427": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686388-199418"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0001493152-22-001056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-001056-xbrl.zip
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MOA>Q'*O97[0"V F/Q%87X\!W#E&1]<_CHEBV,T]))9B&\]L=VS+3;@V/>X/
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M' .\HQ:-+ _$])V:E6)/.$UZPU=,/--BZ[M#>G5J=X?[OP%02P,$%     @
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M.R+9^0*0U1_=D>L!=?E"A*;<!8+H&CA\Q7:&UVS08<Z>9O1^VP,4*!B(/"
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MF.Y#['QBMB%9QR97 >*,XUV 2/,YV(X<*?ANXC4&?"1X"?<=3-\+O2(_#RU
M?BA .BN<%;&YQXP?YR,7Q#G7Q0!10""!A&\%_P"D[!ZE0N4+\54/%O,T-%'0
MY&O5>@8\R6O-!?5HRKT>8*#+7/$+UJ(J/QGNWF=\)G;3GS[$CJ^N[4/\XK82
M:^8/5=U0I)&:C40*97,<8XAC3-GXJA&'UR'T/@>GXP-'?+-0NO&BQ((4%]Z
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MPC3/'-D0?GWQ@5WHXV24H&N(3\PX_*</QM-' ),]<KK,Q8_HDS[3>W0Y/WV
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M[T#&W&,LRP"%86YB1<RD AOQHC)>-Q'#II)"?$L'*@#+&A_:CWBCW5$'<-U
MA[&2X! EF;L[?+0PZ:25R 7PV=R1\V \1.N6P#A\=>K[O_)Z*^'WHS$[D4 _
MO.WJAC!^CJ16YE"QE""("7,@)J.(X!/FHA_&XQ=^OA"IR)8B84KJWG9W<#9E
M'\]''$EA>I\"O!Q.B7@\&"XTF%8-"@O#4Q3  * ::A1L.(3+-[D3\L675LG$
M9+/( AXH^LG7,(S>&U.@*\"'2NQH2*Z#L,HK%![[P%GAIE7TH>'!9@5+4+&,
M9[F'>!7Q%!Q+!#B2]UX7LD $;=75IG1W[?=4!GHB*_Q(5%+"_^)*C^'G+XKD
MSE#5&$I-XB&W5")JY(&<8*&$LKL3GRP[>R$\#?!7?3-,(Y6T*2)MO&12M)82
MW-)H_:0,!JCH\!]V"*SG$'YB-IL!8"6Z;T?;483Z4,CF%/Z*,Y-%!L/$K.&W
M..3U)6(H=3(08^N"O:YTW^[.\[7[HBEYP6Z22X2%Y>&XLE9$:((-[>[,4L-*
M)U?E9)KIOZA5K9H%;OF1SEQN!DKV%U*T *]Y+087] L/I0X/0V9!] ]G!(A%
M!0J'MF_90C;E?,?U0\,'>H_)\?G$Y" =)YVF8(3^OD,%N>(Y!L<10!*F8XAO
M_+ARS<&Q!<72],ER:<G'\Q[/9!(Z?GJF<CX)#-T7#AZFG]#(,M3CH2N,JB\Z
MOSNH\&']#X,KRBX#"DDZ+A(D#@S*FS/'.%2H\@#.HWPG >67',2$/! @_-1<
MTLUXO*!]EPFR-C VT#3%PNE3RI<PF?(:K03?0_ BV0SC!=^SQ6)H5JA.6<R+
M\^$3K&-.A(IF_4S@TWN0;:9'@172*+ T"FPI6/?*+<QS@\H4YPSHQ:T"J%XK
MD4]=^P'M4L52)G=TE#DZ.XHRMHP6^-<FF!X2=L)JHJUJ*=='M4ZB,D+ 1Y)Y
M:5:K>1H9^@!]C2%1?60.&3Z-B"U[7A3/'T1,<;(R=5LUR1%AMQ\M;HM]HF(0
MP'"*Q>R1KWJJ7.N9PFHP;^% !*51,35__%(IF_O%%VGF&[(HAH3]NVB:#JS%
M<F]X[$-&9Z^8L/?94]<<A2:1,K=O1N8%5>_N@,&(D>-,X,!^Q6G@8()]D,I\
M#OS%/2#3)GM"M.+6A$F0GF4++]U_B>^_66M6M1HH-2ZMS@?M438P$\0/1A*^
M&$UFAB%DX('H"[Q.<0@Z !E/-ZQGH00K/3H(0X:,TRJ>[>X4LF?/K%8I3XN"
MU/$!'Z_%3+H,33B+L79E XV*CJZ5 ,@)@Q/L0]8+C(-$X0+N+>"-CB(C*K Z
M7&M02T"<%,4Y0A?&O^8PA>&@\,<&0[J.+;2_N DY=PG&3[\4<L\FP<_3?S*N
M=&*"Q@BP.5IY%=3RY"*KH?+)D\!%TZ):!)&T1B'OJ1BIF+0B28FS41\@8?Q+
M':@L5BB!GV3]W]WI&50R&@5 D-)%J"A!G( HDE.#(\%3!;#WC2$(D8B%'"6C
MV9I  _!H0 G%E8:<#G >ZM.@SX@=^TO);K.,M^%[(K]!@(-DAW+@>U=ZTS0*
MR%;09(;JGV&<CN>?G$!2L47NC0#.P5F:U[=C;E=8&."%L(11VD^GPM=];"6:
M5N56726"&V>;$$)$C91'6W/A7@  ;/?CLLYYE0U;9E %7A56\;P><8IJQ&3T
MQ425D?C^?3'E0^+B$%1=(KG73Y[?'>7A8'!8-\+PM[WCJ(XT8S]%/R1B<8+W
M4J(LRL@*R%:LS?%/W8[$96CKOL] ;G C2Y\?35*<6@9.7?.BTIN,6-0 ..\W
M 'XMFLW<UO159)$VI38T_55[$587YL#JF#GC%BS=-3- +K8QZ\9M^)=WM-?T
M<%^VUU<U.W;N._N%7"E3*)YF"D='!S&40PAJI=(O<>;;.!-72&&/$L'PEL7@
MA5\2X!^Q#,<N(?[@?6-RY!W103+HK9+TXOQSK7X7:":<:_T3./=F2]]HN.>R
M\RW_ER7V)5]8;](8>29D\:T%-EZ^B MI@N1WO'# &SA-MC6>>CJS'DD<^F?R
MI=-,L5A\OKU\>,QE+>@L6WA^*;^\.[#DB]G2S'!9%C_[?(M&G$<';I&S[ V7
M<@5D+VL#_[5 R[4#RLEJ<#)*N&4$*!'-4D0P6MINCS+Y>'GGK>"/#LDUP,K\
M<:: U#(W S:L!C#'9VM +9,G#GM!.18?K0J+,R?Y IS7A-#[5F=UM!XXG,D?
MGV:.CH\W$2P;)Q1/.-?Y'3A>K>R;!UI^E"F<Y=?ES O9L[6X"FL&EE)V!C'\
MS8CY@F_%9(@(7T/HHIRL^J*42B#\',_ 4U>%$>L@C:\=6([G ,MD=>I7.N!7
MZ73?I*8=Z]F?(P+A.$2<?96Q<<K^TA>\<FX(7U)OD80.*XM,9L/(/+_7G.[%
MM"AO*_FC3'8WB^D0''Z<!NO:([/'^SM@N@)/EHF-Y</Y8^/Y_"9HNI*CX 0Q
M@DHB Z!ECL>-/C-=?(C=8ONXKDG+JV5?K(5>I<(F7Z6:B/_ER_8MMK%A;8"9
M(O0<$RI=)?C3C[@,92 EH/%$)XX;)4A7=)P5V60."TU,H:0R-RVRC-#,\%5W
MY&!,I]JW8M;\U<6UE4NOT_S7J;C)UZGZI%XG7PF<(4IT\E(%:06A>C R9ZTK
MBB;P3,6D.BP'LG%.3!R_?G='EY#Y-0FDGRV] 6]Y TIO< ->H+3$CA[*9UN2
MQ#?K/S"W/J#D"4#O%AL SA./TMU^W(V:7I7F0*-^&TRKF+8[=Q"A+P]&EJ'3
MU6NSH<<K5A5SO&)5..LTO85O< N/TEL8A4E35)*8#_>C&?=^"EM[U,&*8L/P
M1<OX'8(QY]S52MDSGBB&'662"HK,LYZ),AZ\/8ZG_^0Y?4K2U>RI3KBD^9;A
M"!NE6KXJO?9O?NV/-UG\;+$A8#3S&X@CM@:FCM<)H:E,^)9H>9*BY01:3GIY
M9M24^"IBU:65=1LOYK+'T7+7V])_9\FYH*%8[]T=+* #3T\4OPF*+V!U6M\<
M9&)=+)+%Z[K;T_]6&L^[XT''-OW"?U^NRO^]S<@B@<J'\B.<1?GXFWP6._P1
M0E$5RFRH&AG6FAE3=J?);689D6H?=,D3BH8'4)A>VR&2S^JGE$X4.0B!(V[G
M?CG:" C*EZU:S&[Q8W^W6FBSVX5JVWA]J(>5*("28#4*2K"&4NC5PGI>'SLQ
MZM2!2NV&I7= ,)\J)HOJ7/ \B-V\!$J'^06 4;KG[U/72QU+L#*R+</L\:NA
M7EK, I'=P4H!8WN$5\IA>H]7*<9Z54 ">G9WQ!6,(*<;YRE;%GM"VT*P-OFH
MJTU6!D7]!#X=86DT7A)6E(#@TWAPW[_#"MP^>9%TT[65%_PRQU2!RW!_4DT$
MC&P/5U>69?6,SRU\Z)(_].F#X3< Z## )S(DH#L)]UT4_>>GUF5.FV9NV-;J
MU=K-5VQ7@>T=VM7*;:MV4^/]2[3JGY6OY?J7*G9[N*ZUV]CLH=YH:=BU@KH1
MJ2^TJE]NK\HWC=9WK?RE6J]\U[YBMXMFL]7XHWJAP6L7M;;_)\YVTRK7VV7J
M,-$.FDCL[M3J]'6Y(CID8'NC2'.O#T%;F8S6++?;,.1ML\%?O*ZVL/<&S'A9
MKK6H747C,KE]!3S7JEY1KPUU1=C296+H\D7UO[=EV!M"H0)[I]_YX+"]RE6C
M?=NJ:O/M($L ;56;K6H;ON&KNFG0$)5&'1:%[<W@M_9-[>;V!@]' UAAW[,K
MF/RR6F]7M_#>O4DGCI5R0:"DO*, W^JB_LN[O"'SV.1&+ ! !-^=X;B>J.8_
MX.* 7R(]MO@_*G&.$!,6"]=$>._N(,!7> 57VWAD>OG&8EJ^<3/*-V)*]:;5
M<-RD^[.:%H6KW]<)8/KNSK>L5H$Q+%MK,=V$%T:&!SI!KG!8.LUL^ [/[:Z^
MN]/2/31Z7)JV8_1TK5@L86;I1F_LC?26A19F$V6HV[&J^=*JDVT5N5N5Q/[=
M'NWNB%Y=/8.*NQO6@R%*E:(]1K2">,[T$BG]'SK[:_Y.J.A_; \Q;-TT2Q.Q
M0)845DC?8QO7M$*QI/#669D9^KB A*A[VIFF9P>PGJJ.G1,L@B:UA%BB:$JJ
M0$:8O+ T*996I0MTW;U@S@"$+^T;VHW_K0] \*D.F#/6KJZ:F@DTT>/&LH;%
MM#]TM.5V#-/3R@_,&L'"2T>4Y^+U>9H+$D[;X6UFOMO.S^ W%)7R)QD4RQ\,
M70-2^V X5+!3G#]]I6,'F&Y?]N*2L%$^0UV)]SL*/4KE\Q'!>,59/#6)5Z(A
MF][[RQXY%O5XWZ;[MHTTA!K) #ZZ$]6C0?3HV:..1R?Z2 U0>B._X8)PP,!3
M#PQ[LCBVI0.:C4*=KRJ-/VH7A_FS$/&XY_V:AHCA ZQ<3+T&."'#%DB.(7I_
M&9; -?AE@'T=U$Y6+@^X(*,O7Y$.MP6+;O+N<[U1UX,7#X>P'T!K@:$N=;[#
MJL]X)0%)L1M#5Q_)$>]UAP>@R)5GM$=&#B=8"3?/^AW_;-<UY)1]8>..7(0^
M: F:N'Q G+$J.3U60]G#8EY&ZPCC^K _=E$MXG1 =NI2AZ0S<2C<3%K4_6>)
MOM\92#XZ, G5Z85U4]5A,B # 1S25KC/RK+LD=7E'1]Z\"JY8CT\;U 6.=%
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M-X.4F,.5]>A0A?! <16HQ^!28/M4\<=W 8JCG=?B)X@SCT6Q1!P#E\GERUU
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MC7&M G=W)@H6P1IY7!5*8<+#! .YC_K0![!_<"+ 4X"19[]:] B9++$\'..
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MXGHV.2 4OHUKA<.)B6V(&/^5"/L@VFX _S7XR7&3T>S8"0IP4.;'B&UHJ(0
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MG,RC?1VC='47=JJ07$>X.I%EP_'KV%S8@1O+YR0.O R$U)+P$;7*F1!2Q4?
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MM/;7<JO:UN _-%#UNGI!)**L-5L-K56^@5\:+1J]<0FO5[7+V_I%6_M:O;H
MB:A.']VT<+9RI=*XK<-/F/*F6K^HMOA,8HJ;AO;EJG%>:TO[XDVK7&]?PE/E
M+U5\[4:[JI9AG)MO#>W\MEVK5]MM[:+\O0U+J<&28 "<[(_&314?QM_;-XW*
M[U\;5S!7&_22:A4WF<4--UHX/[PR"[#J5=@U/%N[@(74+K_3L^WJU:56!M!H
MY]5Z];)6J96O-#X7;1'@\P>\P,>]JGZ!;^OEZVH&E/JOC7I5J]]>GXM'RQ<7
M+=P,K(N>QM, "(GSR?(#*W^/@]KY=ZU:@ZVVX.&KVA_5%IYB\(!6J<+AP.+*
M-_#P?@U67/]^@)/N[C3H-67'<*[7;0G&"/0!OC!5[!QMK7I5K=RT&G68YNKJ
MNX9G\X4&N:@V&^W:3:/U7>! I7'=A!6((X;C^U:N[.[LB^>T;["5BU;Y&\ *
M3K ";S0N:N7Z@=;^WKZI7L/)<1SSCQ_&.Z_5R[3\6ENK-_@45]6;ZD4&'R4$
MA-,5*_U6N[J"\X)=W]RVZOQ4$;J-UNX.[4@@*<V$7^"!<E3B \ 1M6]:@$C\
M,.D9&M3'D3I\?UOA^"=1'I"L<GL#H-/D]3HOUW\GH+8:OW-$E'L'L3F8[K+5
MN-;4A<V!NRFU7OL]-2PTW_1U\TZ*6U/=,UI-6*E,XZ?H[ ["$I>V0 KAHLIH
MB*HX<6_3MG_B-X\BOH8,.:,N1HIR%Z"L+.]'IL>&TF\7S./Q*'#XJP[^: #
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M86\-TFMN6_0['QRV5[EJM&]!=YUO!UD":*O:!+T)ON&K$LILI5&'1;6^[^[
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M6((>2-,4<![;QP17XU=H]0+IEX?FQB\0!6YV*+M0!Q&X8E=MUG5 TN9<C/"
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M])9MOE?JO$B6S"2.4I"O8Y5E=*S9%GZ3HN4?#(!2Z"WW)TASQXAG.FZKZW/
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M^MNG#F;OU<'L%Q7,]@C7O:H6T/V/'@R@>97K8\J=(FB_:2;.( *=>X$:NMD
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MW]K:HO\)4ZEMH#IS1Q]_#0[]F)/@GNG*DXI4(4(H(2HH!@CU\G[J)0$SR!>
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M2@K'IB:IJ"G 7]_^F4YEG9S V>4Q7)&Z5:94RD05OO344%ZW= T>WBU0W+_
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MJ>9UC!N,^J\V&S9"\O/6'P6,XU"Y-"?H3:*)5HJ8&>2'3A(77BZEP<FB(QJ
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M]4KP'GPDH5]BZ04B2?PAB(Q4?S+]A4G@XW5L%CWAQ#&S5%F_<5[#1,3H&Y6
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M#R=^E"$XET'T1/C((E%EWLLU:&?+^3S5ZE4CB'Z0*8:/<I\/QG$Q),7?<Q]
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M%G]',89MU+@@"O$/D^B.L_;0B6(.RR\C,N:]8=K#E$?O=$"(DY@P* </9OB
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MMC?6>NU%CL!YYJ7['/TLW !FZ=!T8+0:ZH!C -Z^HQQ@"NACFC5=1_J<G[O
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MS<P47#>7YY.NO AJ^KGKJGK^5@HV1PI2>3_5$K$(&*K4)%_9'KRE(C":X"@
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M/@GS8U,BPR>,'NQZ1:?V@+$5"6].STJMPJ"8WM7%N3/)XB0#;5ZCDL620,Y
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MYZC0'M',CO$E6)FE7'_1'!RE/+*1XRKI/!<>2D$E10%*Z<39*QI$]OUHF,D
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MX3$<RNX:#F7]Y+[EQ$9Q8N?4[?36$5RRG&@Y\6DR\<CMG*S#"+.<:#GQ:>Z
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MB<,(Q#ZR)E&<BJ\$6X[[$@'U,0SH98S''V/L,6;FZ],]!4):>2'"0365^.Q
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M6>$14L^:&9"F5V;D,ZCBTF:91HJED)_,^.];ZO,=/:?JDP&QOEO$^K<#8GU
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M=O@$B8XK'U9L/2M26RUD.?5:X@$H)NEJ"^7TFV5L^5GRE^*2[,YRM/41&@5
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M$+*2QL@<:_"AO<WGN:\R;+A9]G%5/NYF.:_!@[O]/$(>\.V3DA"B7Q2YOU:
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M\F9;FF/=":J0R4IKIFM5H:)Q#?)RST[F_9&7A^QA=O)SN;Z=]&2)($@J.;)
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M-0Y1Q.ANXHL\+L-A,.?V<56.P_42=&7&0)"<7I&:PV'HA/UJ7DCW2EN)N:)
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M2)#!3[FOBS?X*?=M1>)"):WH&T.J4'2978DKTGQ%"T,%091K9C1JA"_EL*
M.9<]-4$871'K<0&/$:6S2S\ %#[^:G??#\F7NTV^_'I(OAR2+P=-<= 4.PC
MM><KT:M*@+4N[>5ZA\*@3^[K$@_ZY+ZM2*Q/IA4CSJR4:N8@-Q!?K=+*K%U"
MX1M=E[0VBFBE0&:LZ+ )+1ERH.>H/YT;W/A,H%:%Q QF74YSP?JR+Q?+/$M1
M"ASJZ,N<U-25DKM+/UTUZ&R-K!OD!\15\<ITOJ@K3?ZI[,J4:$EXLBHEN5*D
M'6G$/]G,7!K'[TQ_#Z]PQ6^NU^U9H?H9359-635&\'4H6ST'4H_&ZB%^.M<.
MW2?H.C18Q?-!O]*EZ:Z#ZQ(-F+G#U,$4<6]Y"FJ=!!YNJ"G.M;T]CQ,*!N9A
M ?&L)$OH_.@2>U865V10 98MT,2#JZ;K.C?]P[/DYZ9$OLB2TT6VQ1M;G%9Q
MUJ*:,J$/G0_>H K(U@%LZ7P;L/[0DRI6UFI?)!3D<2#.49C^V4-2?R_.DF_Y
M%X^?_-"3<MK74=QR$8&<(D.G,A58U)Q^NN0&!ASFO@G>^W,5'K(VZOV6#,GF
M)#>Z^RI(7!(-;<Q7,:,KBH'0^=2GB%:>CI&$5*Z"@(D-!ZCF0>R#^W-.#T5E
M/:]\AFC':3F*3VC5<T1)B[$KE#LCS2R<4+!>3M&<\D!#$YK/H2J)OOET]/CK
M[T9/GSYMI?33+]HY^CX7G75AJ H?TJ6H:$\>_X?K;EI5#0J%4=]BLH 681!I
M$)'^&$N=7VWM%8YSZJ*%2C"Z1C"%D?)7G9ABC[%!(P&9*O0.$795YL;YB<%=
M9"X*)::UG4P]H<JXK8 < ??:MY:>@=9,5%%&[*C5NVE3!JVTU.IK8(1\^?J5
M,QX*6G XN-[;.M*.T10IW15['5E?GRR,9GJW/K$JTZ)TRQ [R)4$P>\VIX#=
MZ%+0OG&'I6]:&\&\1SI/ N4WR=+WV#P>;1PT5)<@Y)*8,(6<+1UO4"%>\,RS
MG;6+E^V\?P$X:UNJC#]^-GKT[-'H.W\&\,)$YDGHVT-D(=K69U?AF(]+>@YW
MVCZNRB'KGC^I[2]!<J"?[7+%^N,;]F=L\&-W>><&I7)?%_C^',!#42HC9O^W
M:J5]<W;N\5I:(U<J#]/MA@OU*J_DJ*TW:#XQD_!OQ] [YV!D<?K:$IEW.O6E
MZGJ#LEA1#^HFUU( +#AJIM?7:YO4*"B-$;O7]KY)/UH=))7IGRIMG",W2Y=I
MS;^FZ84O<F*J!3BE31:1]E.7.>@72;'798HHL2MO,@(KN'-=DL:CHFQI-!XD
M;EKT/E9UW"<XXUA+;?*OHP^)(D0/-QGS4SD$A+F YIV3[D7JRCQ%]T Q09+U
M >E3OH  JTZH25.R"]>M#LWXFX9>>6J>/?[J\8/YPP>/'WI0_@?2)O,Y;9Q)
MS3_4['C:K'\D3>K1(_K?XYLL03S[@P]OWX3&_1'CA[0J(B!5EL=2$F6-*FO?
M7R,9)4;")Y9.X^5"&/=J%$5A&QDR#L;FW*#TP1727%_UYFG.M8"I&3:I-G)'
MV_94KU',WW76<*OW8OIV'A>#/$C"#O&9L&\UINZ*N'"??,3%]],OSW^5V)%0
M]$?"/S.7; A+-VB>FTPN#C)!R1[?O-E\$9UJJ[')-5P% )3(+OW\?RI%"3@\
MD@?U91%H0J9F7;G>;:-(>QAQHN$9CE8RY8==&I?BOT! =2%E77PPL!*2$-VW
M(02$.S6A]3 !]<?7L'=JF:60?Z!@#,W@U )?43NO1(LA9"1W%_PEM?E@*WEI
MVEB.<V)+K^D"79F4+G#U4X3KK.6HZSLDX?J/KNX^#2>JD49O3.RTP?#]RXQ6
ME'I"3+W9U@!T6A U96X_+NCVL?N;58-J4J9C.,8L]6H$7Q!_<LJ'KA6"Y=[:
MJ0 N-6K9,\U@FA-O3:QB929=:KJY_+Z&?XA52R8=O> S#_(YZF??M$5STIT.
M,2)'6\0=#Z<5]+^AV&NS[_0V9X+TZW6E]LL^%F:.19!GUI9?R?Z>IE5-Z]'P
M]WVHN3V_-.G<"="F0N;A45P(-..9UW590Z.YG=-@&$N0TWV<KGA78,MSI)X:
MD84AJ=4KLYQXC=+^'3<HZ\9*7!;*>G&=Y#1RJ6ZGYU7"I;/D9Q1$+;B<M8_R
MCCCD'*++O82,+L:\X4\XB^+)1\4\<#6PEYX?@+T[!?8^&X"] [!W /8.P-Y6
MKW]SCIPX:C;:%JH<^<C9R,'2*JUSEI;,K T6$*B &KF+2M?U(2WZ;M3_[:)3
M@Y-\'[?-_?&N'(J3W)-D70&QN/T)AA;N3W&[<!**"93IA8 H<CLOZI1U\;HT
M>67B<MPPBS?B_8E-:ZD2J+YXCQ%@G$/&204CK4T W9AMA\T:F<+O+VYDR;-#
MLY>H7>N*V$Z];*/!;:K6;9M0IV_4-UD.4]N>(T>8/FG*TK*UN%RFM>!!:5"K
MC L:%&1SS$EC\&8F&ROQ9''K'E@!PP$N&(56P-_-S7D\;27@XGS=UY+8@%/C
M2F,(GO@#/0LS&GW[+_HW1R>;2ETDA?K2:$.Z^$$T2C7ZPN6P!;D2W#];I/W/
MYW_Y-?F11N'*D02.5YFAJG=V1F&H 1#BS+G(+H]"'A&BFJQ>>KY2+SY:<JAT
MH.17D5<R,MEX'5 BES:CF(J"&,XR+<0;A3IT9ZP#!R_#17KZG,ZZ/X&93*NQ
M2,>IS]L<KVFG.A]<\EO2( :V$;\0WURKN7YO8Z?2AV$<?VDF7+2#3*:\N"1K
M>,X[(PG%-]QX?<D4.7.T%AG*,L]I^+4#7RI 2PWML W>:OE8QH,G69'/M7L;
MM8T9TU+,W%R*/T']0X!"": \KDX-;UO/@7XITH8.=5ZW\%?TWVLE(@NBKDS4
M7ERIVEPK#46$]<8(%^KU-AG95M.U+Q&S48I;_4/=,8]T,VZN516P1G%20VDO
MBO?.RRXRV"HM4B6_YVA>[,>.-YL;JH;_PGC#KE8'CCBR(<4"D@OO3ZPZSPS[
M26B8$W5SM?U'WEV*X&D4A>LZ3/V&O=9KNKM8W9ZH*/='&3MD&^NE]V-:+O?-
M%Y5+B<F;Y;A5W?TEGQ\YA0-6:%]7]OZ<O$,Q@UZ8R4*ASQOW["C4:&-M%,J9
MO](35::U=KF42>/'Z')>;@M^<7+>A'WWHNY"<^:F*A?O4Y?_O"R:E<L($PS+
MS %8'*KI\=,'TX</GO9#5491Z0&$5/A298T"<?-V%"E&(;J KH<B/GGT'XD+
M4'1P2^Z>YV@S*MBM5>T6H>1X24S?3%"3?4/U5[L/)_%4HA,3LVJ5K/#1TK$#
M2]X@]AS0.SRNGO&P)(5VI2NR"==JCVZ1+C$8;(,X?LOQH2/$^>RQQ+U/ O:0
M59NH(@(I+MY@6:XW1=*@R^SK4MZ?HW8HNDR,.-[F-7"8N9:]WKG^8/LJ7BDZ
MCW#&F-IY_)[]Z=&C9'6V/!LE+TQ%/\ZY=\PDL3?0K0=/'MX6OD7W^0/S4#D<
M)/LON2SIKS9WA!K.L?<.KIH93<CYW,.5XR6( <Z;RZ$>I:HS^4YQ&"4/Q@_C
MJK/9FKVLM&54>>1VK^R2= ,M1LOHW(FWTDVO5$L=?FJ[8BH=:0.IO48M"G3,
M;M'-A=D"%\3^?#!Y2#W(:'Y*Y13J;N>1#QPLUA7DBW-".0]66>3RXZ1A;-5/
M[Y[[M?GI[^?/D[=KVM]+CXB[8BF+E2!W^C=(*XL@WGW2'U_6^/X(UN&Z&U;E
M$Z_F?.V$K0C"MK3#=30AQ=),[38[=,3FGEJ4D#S3TESF\I[> N(!5ZD354>,
MF7)4GW5Y)E7R0%S)\(87&<,:)R7C:!^BL14>$WGBOBE4-"K5O;AVX]*ZA!PR
M0H=)<Z8/T(V>68V7@MKFH0N1Y9X[AJFHUT7CQ"3^KN)6+Q0&QZ+#'.AZ&,&]
MHWX@R%5U[Y(K;ATN:LCJPM1.TJG=+OT\F-$%:R"46VN(WHMW4R\[ET3=$;!1
MO<0X=_I!D/R;0O_A6?(/;9X#<*U;E;8,\U=-E$3+QMI&Y^/:I=4"O*W./8O(
MT+3TSHPLK32RP>$F#H-*L%5IA<X&^;)?\F60^ONX*E[J3XJRE&@AU&;6+J=>
M75<3AH[8IJ/3U:%6+'?D0G217CJ1)$_ MKR9!!++,NF($&Z0 ,E=A.8:/'V]
M50Z>);_[=)&.O'4.79(Q1=FJU"N]Z*BC'RGD.; \MCR#?&70EQYL*-$]HM0S
MW/7(9AHPB-3J:V93B^==,3M'A6;?=6]=LU=!Y!\/$/G=0N2_&2#R>PF1_[PG
M>8#+WRU<_I#TDZU9RR[RN@'3ZE%1^(9>U?JXL]X^[DZ7KFC->KJK"V1G K^6
MLN>21L.(VC&#.-T=W_Y*E(K7OM@!OM,&!+OE^KH^2U[6@?I;U1+I"L,3/6&:
MI(NV*'&EJ_0%6TKV'G>ZI45<TF16']MO-90]E%=M>2[1#4-4T'6Y&(!ED;G\
M3 '&3B2-=LKT7F8MJ9P>JDB[R/?O3-R0+>!>D;43OCW$5WVL55V2LI/D=-$X
M3VN450Q_J%0"J4-R-[4U-OE[VI/CLGBOJ$39"WD!AX2MXDQY%Z"/9FKJO:)!
MZVOK=YJTR6YBZ@.M@JFJ8B(X/NT(_:Y&%BY[8^.)8@@>[0U0C?F/.AIXESI9
M1KY<KTEB]4K&CN)1]LA6[)&5C/C.=A1NS_5*E52R"<JY96[K)?) DYFU3M4,
M'94Y<POJ\8_-JJ71ZE,N#=:1 !1T7;,2SCF=E4"T"H6X(@+  ,L@!7K@IMM2
M1(4/6=-$1ZXG0J02<:"8/&8*YCX@N37>=YJFZEPDXI:/D)J#A;M?-\C@=]C'
M57DY<R"MGN@9^-=M23)';/<6T+P5)S-CNDLX>42<LU=)@'#ZW0T% =>*+T8"
M-$IKJ-MD(1$@Z2UGS@MIA',H@/(! Z"GF74??ML;$AGYG QX:;U2PT[F'M0Y
MXZWQI$^LEZ @9"2_T\X9\A14S#\@T"]WSQ:7>2OSWD4[P2WA+I:!>ND0CM4@
M[/9Q59RPPVDUC$#O$7HXES<Z^&D=H)M!<U&O(FM#K@4Z\EDAF1W0O_]N2M+P
MZD#J4?MX$/K X9O2/R4?@<Z>YL+Q03(FYF8.\L'$W2QF?>+'2YVQ)6GH^PA+
MW^OL?2EK P?<86[Y01#MXZK$@BC-8;6Q>0,@6\\)[H!_O*Z1*S7Z)X7!/:)J
M6=TX)'(M%&@ID8T.&Q7#!ZY,PVVK7FS:2\&G=BHK"Z1@<D=3Q2EOJ;"N.9^-
M_^4G3,TH64G1' V>_VD0='MVI 9!MX^K\C?6K*1_3F",DE]_?3Z<GSU;J5>Y
M(\^ 7*8_X; =)4\?D0+X<U:0/!U6;+]6C)Z4SOVC*-^/^$7\#8&U1U\/J[5G
MJW4.  ^TBC])'__G?X85VJ\5>O'5TJ09+<^VI3F@8O%#[+[=X:__8TA45 X&
M-3U?)F:9F(BKYJ]Y"J_6A+X6)3#>J*P+OSJD->[KPM\?T^A0TAI_+SQ8P[/L
M;ZF\QV=+P+V21L".(BT #$>(/)#FZGIA&$K&&77M-#PTK#_QKF5VVJ@;NNAG
MX]YV['LX$YS;!F 0=KBXKG$X7XFN07>DN ,@XY ,R!3Y)G\_"DXQ'F]>8-ZE
M*44JZ)/!:;[S.1GY2GEI-!QIL+1SI#N4XLOB?B%D!U3+*'1;741]3C+AVF+F
M;C11U64C#R[9CT>C*+I%$:0ON@B.O$QP#TQEY>G*@C#G7J2H(HGIHX[;;,:I
M-64JZ9] NT348U'@PQ7TP6@S.P<W' ^.<T"D*YH(PK6G)1-DBT<PA1>.*=N*
MY(+.TC1S;#Y1B0#)58%?3C-4Q*4Y,8V+O+17S*%7QJ&&MIR9 /'I[\UX?1@)
MOK=,[HTG^9J(U<81CJ973?\KH3,'I/Y>@Q=_,N#%=XL7_W; B^\E7GS'YH,;
M3*3B[RCIHSVELC%W;?MP8^GT?_WA=_,_CQX]^X,;Q)N7;__OZ<G/Y\_?O7KS
M-KG#T:5<V?E/ /#O&+__WZE?FW07O>]1?[_ D$@S.#U1V/2$;J99P_C7(J]2
MUE<R85T-^(<RK=XG,Z-LIAVFL\QS7DF<+V:YO3XR2?=TX&'FKZ:YR5E]:E4X
MT0N;,X3QZ )5@;1Z-2<UJ\['=Z^DV#&@8V($XJHEDT6]]@65?0P5O;@VB)KL
M:!<,>_C3A_0.B8P74#9\&#K-+TC/9;V]#>V[&<:FC_&YHE%R3!LIXW0(4' -
M>0L2@U\6] '>]*<GM'?R>271@I^+TLS*=.*S*YWN.8IVMR?;9BU;<$YLKP(:
M:K0\VDL!-FFO&06^488J*2:3IN0OD[3M?IHV>OU5[W"]0LS9H[Y?KB>^,)69
MTE5=609[*M]NF@>.:]5[N0I\JJ^=GD2(<YS9C+Z$PGC@)5#RWFAJ1XY+MRZ-
M4&J#PQ>C[IW-RM)X:>K4SH1]Z"F=N75P:D,NG9Z (]V4=<\6$7,P%FP;\PKC
M"1BTW"(UP92T5<D46!CL><[XF'K &VEEU+R9BY5$"PC)Y0U9"!=\-YV; /[J
MF/QN-6S5H:T!I_G=2)Y]5F*N%S([[OT;G.[3DS=6>/%I53#Q?L_]&!^6>%?2
M7VZ"(AYTG[VY-SA!J&AJEMF>3F/D,N1#C0?JAZ0[*54[.Z"H@]$CZBNJ4$YO
M1B(H!_6XTR2T9>PES=;"EAJY/"W]V:5U/SD]T1^15M1YB 2)^TD 5%4IS8(I
MM7X#=\#M6\U/8I@_*74I"2_;R9[OO1.X2"<]T-KAKBTHB##2>4I:#4L6P#SE
MPLJ:V7?%9^Y4D>KNL#O>4EO<))\XGMN,Y16\N%<I&'P-]BH8X9)WUSEN^<W[
M'GQ(00U112@'J816\^#+N'-_GB7G(=.L%/&*ZW1%7:$!4/LH#<''HV'OL'A;
M+ZVK=L+Y,7!J+EWOA(")%/>"?K@R*=VN-/AM.I57<&*-ZMV";8[6!G>*'RD"
M+CW1^%(R^45:%GGP!I/"H@Q0-)"I4"7[<JUTSQ?9!=)KNHHCNBY3R%K0Z8G[
MZ-BNBW# D#]Z)MOH\QZ(0[JKCTW3P GV<O+NO4!W%@*/U86#'<1;)'F3;:EB
MD.21X=LV%$?2@BBF2A8DJ'#&)2&YXC>1O\O 9E4:Y#IDP3LGK9ZDU*4![]L\
M$F91ELN'VN85S O)$:S7IR=3LR3+8B2_0]5B+]@ <2_+1KG/A%B>'2?_;$IG
M'HFNP&DR',[AQD3HGFTB"S[C7?SH[-F=TC[LZ"J^Y7!@5?*RB*I#J^&,61+Y
M"VN8Y8"A_. A8/L3H288BM$M]7/63%RU8JG.S*6@F6QW99$Q"C-2=R:6M:H1
ML9NGUI>YX?9I$TT;5SN+6SD]&9M*3/C?N2+V^=)B#X^2YQ9EF[+D18.=)W%(
MTI4U(5]"-6^MP;6^[61(9@'IOG0$7%8] H[3A*Y%&DV&ZM5BZ],!F],SM.V;
MDF_NY;*8RJ^G-+_EFAGUC/"L3JA'=#NG6:.Y_]'U*L'/!C?WPI0PLZO8TV!4
M&T7F:[-::8@8:X*&L2I,-]#7%TRF4TE0_4A4'C8,>,&"TI6C6I 0[T;?FT _
MJ"\QRZJ'S-H?"JMSN2CHG$=!2E9"&AXK-!VP(= 7S5BF,!!91-0<3:XD"C03
M\Q+5NAE%!'H(23,6E\<%J>R1<Q94"V3#:'8'[U72%V4+Z;;S"H^/LDN78!C)
M3-"J,^C U8CR_IM95L U5=DE&0XY;;*5J6K#$TFJ9X7_?4YMQXF<XQ-SASF4
MG=VU-[I)DQM>I*<G'W&3OFI)<-<9)'KE*K,YP(H7;6#3 90"Q<?D0%:VO$#Q
M,A28GZ:5]D="$_U/C@1SHJ.&C-^4R8[=!0Z+:*;:(C08?9&XB6ZDH]AN1W1R
M@FF=K4=RAZT*!L+C7G'L1K*6?/%,LA16M#)?LM/:6^^\*[$Q+HS<N\!CP4WS
MCCD30L-.EYVT*CY*DQ7O4]P[,X0$5Z:&$H2[F*E]JP4V[QQC\BP.E35)1@<Y
M:_T01]J_KH N/LJXD$=R=[B':[OD/4IZ@;:$N6!=B>FK^G8UU*AJFX- "K5F
MQ<3[P_3YH+YOT5OD,H^\:&V-(V+IW*9LG"7/VXND@\!IS:R15%8DC,Z%0L1]
MCF]TIQDPHU0QI<54/X,T$N2BW,U!']OR50&*Q?-+RUTB55/FSB^TKGX23;OK
M;%9<(GL6  S9';\5I*%,BMB':9?I5]3_:?(;E"4+K*!%E5A@&EGRJI8R:] )
MI]GI!I1%+<UE"$?Q:M$NN2!MT4T*/O>OQO!H3T]D4[>W<N0!8^6JV>(P&R59
M2MH2+SCSC:S26F)@] HD]U$(EX^!?CT=H%^[A7Y]-T"_[@/TZUC<9J3_GIX$
M?;I%,#4+W@Q!K???H!%50"S1I:#OJ*L"JZ 'Z^-\[1]B1=Y6]>E)R3P$>N=:
M&KR&%29K1R1E$WZ&T0?6X%9A(@)Q6) 6Y' !R!H =ALW >L/PO+8JV>H^1]I
MSZ GU+MD,Z_IZ&Z)PQS*.:DGB#N)IR,LL-WNV=# 4UHM[-0I8Y54M'2*DE-=
MA.EQUMK5<)7!<A.7BFHRIR?J3Y$9.69MXC"'<M="+A(^\LS5(NCTQ#E'^D5;
MJT\CMFHR;U %![73X-F=V#58;BH.6SC.F2F7L%$RDTMB##S4>H* X*RD0W,0
MY4IH-<P6^VOFI5F*\%Z1;CAAPT_-+T"I<NK(VIN.D6DU3HM9@Q_B/ ?O./N/
M(Y=(UR!#]V3DQ6S$<$$I,Q-[@N6A,>VSNN%;XQKY3X?970!)D/\'>;<?IX(B
M7CGVG*^<'WO#OZYF8UMVWX-[_$N$S=Q<JV!QE^KIB8MY\3K5[2?;"P/ +%WD
MTR(BYIY,-)5ND<X7\:L<WACA><>6#9>'S4D<<E &PO7TA*2KS?^]7HJS=5*4
M8T"B)JF@/N89"8-\)&4RH4,:_@S\Q)!.^(SS/"B;:IM]N7*,8SZ %#Q5L=YX
M7"&2043U#N+O"(5PDH.33' F(HS 2!$@F==R4:70#<IBJ>XPVL(^'CA&AG.M
M4"[)S6!W5G1.!OFU\^&\1(WXQ]^Q-&$7$(?8D51KR$RXL%^MK2F]>C4OK>07
M<YCW-Y( )%=6R2]DS)(@>GN>/%#<I_N5@C\?HL+LHF#^P,L\1F%Z<-Y;4K-
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M.*&&,UY2AQ)*J[#6TY%H:"0^TF+*.X/=>;HG.%+ O\)OD+P=_4(3NG0G30Q
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MEO-UZ/>#H*J.TV+6X!Y"\@!(5A^.. <#%*YB!$?(YF*6!@(5#G%D1L1X%,%
M[B0=+MS"=,6KT*L$\];J?80UJ!?65R01/Q"\JF@4B9AA:9$E8E6,KCR(LPC
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MR#J0H JDS+5&]ELDF5CYEG!#V+\S,T%!(DWYYW::LK1L1?J]#0A\!"9W&W1
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M#V,'';ODZH&&7U5E:=A@@X@:1-1^[:#[(*(B''R4BWGP7H>]ZJ'4MWJC)3U
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M]\)N5X0I9_O2A>,KNSL4MZ (WD.%*R*)5M!8%@M7U",3HB=GXQ>WCEA$&+!
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M@N:V\D'^SNZ(W\V;5<'7773N\(U,J1_AXL'$TNPJ5Q,W_>/G>""_\4:U+UJ
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MT$W6KJI=P>2?*95MD"!P"!E.- CJ38IZZ[/:#VW_.,*6.?%_)#]"6<5B!>H
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MHNK3:TY<9[]UC8#M[M1*FWP4P+?_WONH']4LJGTPL2ZJ1.(&1R]>/*_++)X
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M&806NF*W3HEV2K13HE^]N(+VQ3'/X.&7X>HW.M%^./OP)CI++W51$MC4=C=
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M=KEO3I<:C8P!V;_@V,P7;,XI1!^+.=K)JM4JAS\D.M)VBMGBNH^>/@8"TQK
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MH30"<3/W7N_]#XX1\84Q6K&.J^P(-Z<=$!YMV'V$-J<VS&J5,:-.#=$L9S1
MF3%GKY4SR;3N-!%9;!:1RF95LE);:N)XV*'@8@9KBBO(K=BD^S7-C:8MQFN_
MQZ]76C8JY-SM)[;)E#JI]>CF0J5_5%G!1W8J((U(;&=^<T%L-600"B/8"73>
M5V3RN#::5#1:G"B]IF#2%ESC)KA2I??!/B<7AW:JNL=.CB9G<8/MSF_P/,S"
MO^2L.G4X903>8(A]+C1J=X3W=09LM=:CSE"UUA7.O4EHU6Y.=T5$Q2R:@S:?
M_@5[3>%_R&CPPVN.J"A36]OKTBM$A)/]=#K/FG_=!%H0VVWJ UM@-O7^'NWZ
M Y^,,](O@<S^)0;RS!W(JK+&U_47^N&C5_Y6O_=!ZIVZOD"/<2Z57#$3S>TP
MAM[I1WH;OC>%'MCUZU=JIEQ^2"/O&TE0^Y>[9(&.V;B)J8?KA$N():YC<.+Y
M<CY*P9:0AJ=_?!C^[V?5ZM3Z3'V$0[(^_C)07ZC6V>/FXFXW5>$*-EY$LD_R
M$#1"0 $@]H.BC'!Y,%6P.VJ=<*M,'Q80 \SRU,1J2_,(*V",JZ(?"<O$JV*O
MA)Z>575"W1U@-97X-N6$L7G]]KA4$^-^KSH!%SG2\':*B)K95E[2\-WY2<,+
MP8^_^.H+$XR.EYU _^&C_ST8?[W*L(7'ZA!N)^8?XUQ4=Q.T'KU1'"1?P=,,
M022C,.)NV5;_1W->L=V+YG<K!!^C.\Q@Y]#R"J&Z2#YQN'^XW]2#IUK&-J?8
MMR_9&JPW(DO!YR@O9_]RL1B9<<ATF@<;E'DX).2/GZ16"L!T2L\C6*D@:P1;
M<TJ'T.2K-[/5AU9:6)M8G7!28!PPFRN1N!>'R148I"H+1NZH,OTM\YTKFN)8
M.*%(,?1[5KY-YUH"2HORB$U+&WZ/&;),69ZO>E,C?59-4-$9$=/9SV%CPAYA
M$M&OZ"IPB"+G[ BE!\6!CTWG6W*<5RM$NVFP.^[Q+$N3-$ZOEJ8?%6V5C&&,
M ;S:]*JDW&2VI  0_$<NP$;JLJ?<K"C,5\46K7=GY3/=17T:9_M.2*J##DEU
MOTBJEQV2ZM=$4FVIU#A-^CW#O\3D1_N:0<J)T(,2P/)=9"@_H-Y96/5,3HZ-
M5:]\U9#:\J9E'!M,!W_8[]GEPCHV!'MN#X/S!4OP!:OM8W095U.1<]<R,1PL
MBD7J[H7MO< FX.)QBS><<M!X&\E6BY/J<W2)*=&=;UI(S!F<<PLR\\0L!^7E
MR!S9E-?\:6S$IW2H* XM[C]EL9 7@M]SBJV)W49NAK>?"?JYTS!YW&"]Y81!
M'Q.O&6\*A5+8]W981YA*>VGY-V:R#-K.>!"B/-?VGAZ J@[='7@7T1R.9Y"$
M:9G'R]7P>:K@%],U#V*=W19!T" X @4+Z_<6MV[%5*'ZWQ^\>M'<XL <5@'/
MBU%HZ*C-NO9[#0O[S#]X?N"_?/FJPF;W>7'7_@WK^S;(.3>-&YR?K.O5((+P
MN[HSZ$96M854=V];:%69G%NB+[^%S&MJX"#.8"?IMF4N\.I>*K)'[4,C9DL?
M+=US5 D.JVA.LD25"T5:>%I8Y$8B:7#J#6' %FD>%:%+.-/OJ8+A,$<+,\IG
M5E23D;1%/=$G,'$[G=7MMT<WES/$$A$$J4D_B8F*K7D9@*2LOH2I$BC3F]!E
MHW 6Q%.?HMP!X1XQ_+6*JPESI<%$P& CA*G@95A71VQ-3(U--0:Q#C\A.,6O
M5;"!Z$L)U]]& D _X+%W>_#1S67(Q.LBT[3)$R97X+!.,)ZR1&[@(]R<,9ED
M.Y+)^*_1W^5;#(]+1F/7IN600&P4ZOSW)^PWY TQX1)0Y8K.?QL<D-E.O&D%
MK-P<\U3C6R#[1B;VF0J'X3E*8)YF' /O5 1U]2%FYM\(_HA\91H( :-_H42\
MOI?/6(NIT&^A#,=V'4SQ$>1?K=6C^A :H#;%"+=ABG@8:C&O4%].RZP@-GKD
M#9M$L#,8"L(7(^Q2Q2")YWY1"!')=03O7Q5]-C]1S]?"'M.+H)8C.!D-UQ@C
M)'Q"=M642>!6'GCS4E"R4,P(TYM$6 (KRO1R;3%D>CKLV^ J[(RD1SD7C+&\
M"T=9B2G2@\,*2[=^AQ;U&\):6"0$!.@-3 *"0O;6)J&?2BG5I!K:MM!"W"7'
M,,4%6.<<>%F:SJ5]_55 P$RVV.T1M-3.D1IUF P[E?5(YW*)$2FB[O4YJ0,O
M\CH 6PKK'\?C@,,#Q2RCVK6/P5*V* HT(UI@E,&<]A1M.L,'Y,W#0A=JLFRG
M*V@K35SUHO"F6!1E]@RK +V-K3V+TC:(XG!BY2B;=B,]D,2Q@$$G%OC/_@D!
MW,,"]&F.&. 2' 8]'0S07"/%)RL#_%RE],Q65]$/!LR3HN8YHUM!]!NH-7\7
M26T._@LAM\??FR7^B+AE:B33[RD3 D%WQJI4]F/M9-.PS0JLUS)O^0V1CL,J
M7#M<@RK&UI\N<E+?KZ966?G-"'=<2%1H+LS\K%8I2TCF>,V$Z$3%HYL+*BO>
MG:Z>TJ3@L-]@3TRN(R*\^SA^"[906A3>%T0A_3_!?/$W[W@>PH;_\.',MGP_
M?CEVK%[<R^X)<V_=[[T/\AR-HA,T*GD/8^>-X,9[%V5S[P.6F<&6M9Y!F_$(
MG/\\C)V'@;;+0/[!(XJ""]*XM/H6QP<M[4;CBY/;]IIIZ*N11125F^C.2*F=
M^L>8H0GJ5LL(U<*/I7,I12A\[\^'^_HG6#P1Y#/?-ERI?1,"W"G@YCX>8V[6
MST<4QA3HLN$.ICMD*'T3KF4P&#CV?GB6X:1QN:BHZ0;KA()<[/,K7'!W),ZC
M[920.W<-)K,#2$6Z-PKWC#%>E5D@BO?8F%%>$9/75Z!\[<@0_19!6Z4<*:"E
ML,B4S/:Y0L5!C("P<V-8\[UR(90%E!]S^?H-GW#N[9CD&2:"\G&6WI@"%J%*
M#+_!-7ET#=:@+P@(J3-&^,I3EJ/K( R''83A?B$,KSH(0P=AV"*I@18+M<Y^
MIBP6 S2SS6BEOMM]9*71_2:[9,QF!=LM =FVJ+NJ%@4%IYM,)OF]C96@DEZI
M^I-PG_:^76L!@WS8(<PU'!R=[-DJ&8R5IL R_!PLC8.-+ VV')ZR9MG2N;@Y
MD+P<27Z?@[YJ7RXT-X3Q,+UR,6%*%G1?"?.C8;UR!(3M@3=CS0FM>IS]WFJ;
MV=[LS$@2%&7#CG.]2N5@,\]S6@L_FY+D;G<^NKEH:?RR+HTEN.#L*WS9C3!I
M"^#;[(.N$\B*/@NE7KL\'U3N;8_=\@ T+:9S)Z8V,%=I*+(CP,$QR<#(NDFS
M3IP^OKE(H$YV[2LK2$<?'.A];"/.U4ZV::ZP3J)B#/@FNB]1"8[^?3GV=<'#
MA$,3Z$M.A19'N]=71"M2L6.40%1GPXC8)FK?JN>).[/(RK%*?'%G@'F  U<D
M5WSG?D_[O9Q;JTAI3)-S)Q:.*%^EU9$:3<',<8*X1(N'0[$F0L#I!T[YZ2"%
M>/IXD(7X1$>/NX/TZ.:B)7_SD='IK::#XNW@IR:0]T%_?T+?V\$\U3]7Q]8(
M4ZQ#/VX]CVTLT.:NWIF#.UAQE):%/6"E$$3T:Q%>.V4@^XL]98>;,) .D[$]
MA"890XPDC]'MX$<W%Z0I:.P[G!394M?NUK:07ZWCXGP2[QOA8E12E-@X*<U#
M+!+)TA7MF6,+^<1V:3%L$IV)YO!L0A;AYF*"&;LOB15BY*CA1PK4#QUZGUV7
M2EZBK-P'3$9C;C,ENR?4;4S-<T?EDCIKES#AV'O^PIL$R]SJ&RK,V 917%W.
M[F \NKE8K9$V>H4.N(&PSYS4R2UK@FOQ7)O"X' X#&/VF_(N?;;>?8(R8*:"
M"2;18PR^N7=S,A#N<\9!'-LN;0>?><1S8;LB7GH'RJP ^]F;A#&V,F3\O6JI
MQ$F^S4IYQ9=S#'/'N?M\X68D^[VC%)FF+X,2BZ4N%E%XC:D$SGE^":Z0F/=L
M<#2P,Y)'EQ=?;..EVU^/;BZ6 QASGTU=$%<#:EF*ON:_;5A!GN@?P'_^!3.T
M7($=JCL@0F<<Q3&"1B:*R-:6A4TD'-['< X?)9.2X5Q#3'3$?,]AGJ?CR$IL
M*NB/C,/,1%Q0EL[]7L42=L(TE.&U\Y S+!GWZ]$/C]U-(@XG>&@T%Y@,VPW7
M81+0!+'.3Z5'IR3.LRC_RG@EM''PIDQP"4]!%U(5$N&E@NN'V[29X^+B@I$S
MAL?C[^S6.ZK;B"%P5B[QT]CD3^G NC6K&J>B>OH1(X/R"PF'%%P'45QI_VQW
MQFOG&4N]CT$&OJ: MPZ1&5#*3L@:^O.!JGX11L$R4ZV(V3RA8C(X#_\JDZI3
MP<01-JXX@R688&<8Z[9,P@$KAUIJ7#*>+L60?PKR ;R+4,CH$8"\0 .*B_A,
M%9S<_>)L>$25:VS4,PTRFO%F/L)RRP@0[>Y4YH,")"$R:^1M2/84Y!OQ,4&F
MJ"W1WBH7DD>HUFDT=R+L3MJCFXM[TE[Z]4S1/"R$4!\-]WK61D&$6EM/&BRI
M<SW&<V+D\YR2;7<=:E5HZ3%G)!3'X7'H]!>IM#R-2^E)8?'=(WWJ)%T(B7UM
M7EB@)HWH00,QSVI3+& #;:^[KUJ^MH7%#!7?2C7+89P2T,0*&5L;:!9BQ;RN
MT.>,Q%H0*U+JX(^NI+^JQ&>-7E[$02(5Q*HH2I0[U_*SIIQ&1'V_-J-'17ZY
M_HT&:07Q,L?]5WN9)5P3S4F2X29PZRTB%G;K^#&YQ0@6%TK]/GNM!/6S@R,B
MI'C?2C1&FF\I>!J[O=H8T]M,*E?*8I8BA4Y;?U0<"FUHN*86E7P:DN+I2KTW
M:X/9:[B/GL:BW F;]ZS#YMTO-N]UA\WKL'E;)#4<46I*"KCDE!K3$_B-U+GJ
M>9F GS%6ME&CH^!=@+XE EA3UZ3[GE.M4*!88H4F'FE]# <^>/;!>*8>X0Y%
M6:*/0:AWS*/6Z!5W)1F(VJ ]AY=&?<6$WV%8:<[P<\E)'Z58<([\_N!%E#A3
M>?")8)8U1"0(>QH5>]@XA0W>YIAKZI5%W^8OZ;23"Q2STD$I%[FIM%2#.ZEB
MF.()R(#AKQPY*>&NV*:->(5T8-8']ZJ@A&\LI4E%RI.0:RWO8A3&Z0T%AV(,
M/!KN%.Z810S*V!P10[4A]QM3-[%&UM#V&*>M5G=UT^/Z^B*9!6>LU3/0UUI@
M$T30S!P_8Y='78<QTOFBH,__C?W4D</ 9K] -E?82.P$HQM_$W*@5<%7P;-$
M<)*>'7IX_5Y45*:9A2*Q<7[*(0QT06=>+E#,FPO&5*#3\%XE/F!?Q?@CRC*J
M<J0@CCD$[E2.ZC"B4A)JT*;E"R7IG=TS6L+#*IQ2Z#:#/X^=]=P&$]0#X0K6
M"2M D:D+=S,O&2%^S8?R:)PA4S" PZY?>5:1BHU2D%Q7F*=J1VHF:J9#/C;<
M/Y<MA@(8KKN!E=R+T_0K\_EZ<$<,'\ =?=;):%OZ7CXSS1<#NAEM=LT#6#L5
M#E/Y4<!-4[.E]PGCC>>FUE=&\(%'T.]=J/[<N6(V_W7%^X\=]N_TJI&SV#F?
M?+ :)+AYUUQ"+<V'5%!)2'R,*->*O@U\6$6#_77KEO!^%7O5P+<].]+N%8=Z
M_[[#!&]>OGKS-Y@ S\>[XZW_]'=#K*WXJ%FRNM -O3\J- 4&>\KE_?HZ"7$J
MZ#E8B_^2QJ]VBI7BB:@J.)*=+E3T\#K,?_*KVJ8-8N^'VAWL;8,*AQ)M$HR=
MIBD&5Z^R: QR072+EZ?3@JN3)@P\!CT*T\B6]JL#=05:!2,)]@L&@7.5I3?(
M@5* _IQ8;[%[F??\,MTR;&.+JGB_H9X"VT@QB.CCV[V8^Q3#+C;:DG:&;&4D
M)$(5YZ03<_?R JJ234#@V*0'I1551.3"6(VU#^A>+,(PLYC@++]5<6/:#O-"
MM;;O--,#"#-D1HX6,3:\@'5'W@?)?19IR=63"DU%APA\&H0H16&G8.[U&&D9
MYGLV\+<(OOG>R25K>CI9>]+'&#W.!LJB[HC<R^N0&@:%P$- +L8:.-[F+CB^
MFWK:\-?QRG[LL"\Q:-4:R%3A12N:N. Z#VGNV1XLRH4_/8Z7;=$VZIVLBU78
M]EB=1O%-K;?=9QJ+!,+Y(E9UE5DX6KK% "UA5EUIK ,+,DU&D:)#MTAA<'D7
M)7@<<N0#2&G:+]Z761@4WL<HQFX: U:FU-XJUI<(0$S(4-DCE X$@1THOZ%;
M36-2T/"[CVF6@L[ X<Q3N'U@?<@0)Z;7I3N>!7D1"*;_"-3Z&%6[>SW^J;(
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MP/A*J3LF>AP^,KWK*"[FAKF9S8K)Z2D[,_YW&?% NGWWJ/;=1XPQ[RUPUVB
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M2((@D">B&"WQ!.D4R#0=E^+-AWE:9F#M,>Z=71HU M;5^IF5\\X< F.DO:8
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M(LP%8YPR\T2%\D-^A3CF[8OMB_#$J:PB;Q_G.MGJ.2Q1-(7MG12PZV;@;J'
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ME\6"V928L\GE/9$-W,W5<J]VQ61+C)P5DU;!!B>5=C(8B-.+_(R+ENL5@:#
M9#YXDD1W/GC"4B,7^,1CR4T\YNP>_5!J]#SE >6CHFR*1IHO:=@G8T268F\N
M/L.2#'-NX=TKWJAHB$EFQ?N"EI]"82GP(MQSA"NB-:#NI1$48=4O)C0$[SY$
MJQL FQ,9(3#?X,V=;L"<^=/S#:J]Q0F'3EQ2RVB@15R3XT22Q:I^].W6@[H@
MI@6O6NE.'J1X',<Z@]M;"&F ( NB5.)?[R$#6R!JM4QMB1X%-\UJX:L"P\P
MHZ[O!-5<=NR*LHSV71N)A0AONT6G8Q)21 D47E1C,>U.#UK1S1IZ-U:NW:*E
MF[8!Q*RN.7*[\#RE:[$-BV2N-2_8K#,20GH8*B23WN/")LJ6"N['JG3!5']0
MY0C<ZJ;=.AD2^@>P-%4Z6H_2>NYLUDG1)F%/%G;(:?Q4OZ*XJEK_6.OQM#6M
MB .T6PX'=;:)RY5'E%+11F.3)9S#8&FWGF&Q>(LU6)1/O2Y9B6G8EW<-]F7!
MV)?=!ONR]MB7M8F5'.6A"GL'W8PD]XTJ-'J48KPJ*("F]8#9$2M,=&F>F2GO
M!VH!,(MB*N@5%__&C%'5275?.LF&FD)8,[++EK1H8B$@('Q\[VCU!DK('K;9
MJH'< N5(!/UD--8M/J$''P2'P09/<1TQJF3F3]NM2;WIID)PYXB%N4V(]5"%
M=;R?DU)3ZGRQ!^,@?J7> =D$@ CR:!8;(AMX(Z3$([Y#]4*5B\D8KXQ7!-O3
MW@*PGJ)CV5@8<2@:L%UUK.LD_T%E>N 6'^$S1TX\CAJGJNL3!T<,.2K3Q\(,
MA%N=A553)7<K&85#Z6]:&1^T9VV4E7SB9 1$H''3)K2HS ODZ]8R1<&PFO&"
MVMWYVB,(+CC>U6X=FH5^%J]W+>>V-M*8,DMA.D 5&@9":%0%'R4W,N=]">4X
M"+6,G3%L!M_7OFM)[LG7<0Y)1PYT;^=RL&!22M<HE\% 859(A]N2GULG5XO^
M7H "RY+]L\A\*W+9L=:/5@- 63@[K)G%<8Q2'#%8/?TH+O9@E!D=$IC%\M;)
MD>0'JLZZDZV3*]I#MEN!7:-K510C'JQ$97GCXQ:'/P*HNN+21#U983&+%V$/
MR'(IDKOC,FKG*@8Z;+"*R%8WH3J,!:J, FPT.[Y+D_SVC@"J-!!Y &8[OI"X
M45%'L6I)%TZ6"]] W'JTWILR#83F+1JKUDH:S/6$KU/\]=3M.9.P.T6RH.PG
M9D*>GCPR2(0E;K"@T;-">UA;M;N4NA!ZA38-TRIH+<9F,!:XSVCU*5-+76A4
M%ECV&XT.]T;:<":&D1,;@:KG+EP5G'759=&MA\LD[?8E4%+,BGJ7DP+RC>89
ME*>]?KY)_>T4*H=HMV:IAZC=!-?,6#'C,T7A]30G0><*!T+MI$3 )E-58]G?
M(AB;\@9EE]-#+4)2"B73$MIL$$;UZ(BI0ANA!< K]F<#K[1;PII A_31?G$5
M(<[4YLQE_]"@R*GXMF8T8 /QL4"D<\,(FX:$OB&A;TCH)YZI8$QCBX5I,/;>
M'?PJ6] 0PX9!,H)&!-TO*(//3*JP#6DZ2L/"H(N  CR9:DR3QR!&WJX-KL.#
MXBK\.U//I\9GQ)'3?5T(_8TFF[#?L+P?;5M@"\-:DBY#E0EM3(TIU#<+E6ML
MR-]27_H4K&B@R)2J&49",]L$"?G3,BHVU)<UV:C:"IR#[5]E3$5Y*\C!01=T
MHQMD5!H+42"Q*8'J] 6$/*D0-L)RP&^J/HWTU4T)7;#$5L!=@RCFC 2<B7P7
M6EW"%X8"SJ)\ RLC#0GPH&GX$MFQ"L(GUA<:PLV5,>0_)=A7VF0R<M$]%J)2
MR0.R_,!1M.-$7%1D'C74-QP0FO -@N'* T7L>:0$70;UW(:T F 69R>F MHX
M#7MCZ/F<0H1+_NA[NZ#QN=)YH\MW296N9- VNGY!@K4YO!\#A-PSC,#J[BC.
M3"\:X8$!G\XP;O0Q\\T3"D&^0'49+)X2^ 2<76 &C_I1D$8PKE+-E*(I[H9Q
M%(*\&[L3>]-\.,]RX>#-1F6(<N5\&4J4S87,FC3(]*BB-&I,J8;'O0X1TDH7
M;AC.?(\P0@L:XR8?YVFX)N=_&I;M?8-E6S"6;:_!LC58MKJHFC-(S@G)!Z F
M'_I $A/NM(@CROG(:B3,UOIP"&D)Q&Q+BA/Z2" 5E7Q'@$0OQ<:M'I0MZQ<$
M2,$+C[2?P\'2$5.J^E 5 !5?'%Z )!WE!0M:LBK'9Y!ZDO+TJ:R+2E;LO HJ
M3!WPY<\;0#W'>TO/]ZJ>7GHR$726E#0%.:(!I=DB5/OXR#QC7E)SO7K(9A,_
M4@@:^Q[#1@'MHJ(3[L4)Y14Q26^SC%^+QT*U@@G_8TC@K7" L"^T&$?5^2E$
M>86VW=W>W?&8WAQL8E*ZA;=:_/.RLYG5%1:&5-T[C"&/X*'Q.<N'61B#G2#^
ME.$R"^-X% V)=-9&258]%:< Z?J<S!B8"E&UE^?0X !?3[9]&V(?;!L"Z$RH
M8#FET9N CVE O#MTR:B>SDKJ/@P+T+DIW&&Z4,+AC6*"2.=%Q&C&T3 /N3ZK
M+'U+O+X&^PX6)AG<L(]4B8W(U8UH$[.0UML!&=(+,>I"[Y,K(&MI9*=2JQ D
MR%B6@/2*%%SEOXX_*5I6F7#:"$K@RTW=&/PF2K-Q(9MC=OJ[4PN.]5-EAH&)
MNU#I(S_ :K9;E F#IJER(B"3A:'UAF6SXIAUS8*9XIF'7H6)[,5'8IN-7O4:
M@L[CY9-E8H'NA:$&(#$(YHG&,F&*Q,_RB(A>6"QF9 D-!+]V,6,2DXLX.?$I
M$=4.( )Y5C'$_?J![@P15.YX">H %6E 5DU$W.H*^.P2,Z\=*D1<!V/Z;FS'
M76ACNPM[NN5UE%*T5K3=<BVI/P464[BH^EC/L%L/\HX9_5TX0\W]-=49YRO+
MU[QXUL%XP/F.T0@ :T2N8Z.B7C=,63*W2-G,9(,7#Y>[9G,&)67H!*VD2O6]
M;,89=PGIY &(!-2'B+$O#4E<4#[IT!$ARRQTDZT@;L"5:+=8LFI4E'G/%74F
M7OA T=J9R;X-@RC2&\5A_W9ZK2^\A.0K1G(Q!$?%O10^0_#[C0L&8M552B1H
M]<<G%!FC__( B4ENQ.T!IZ7PD[BFFGP?C<+/9HIN;4JO91YC1<]J R(%9$9C
MHR8MN?X1_>'84CH'9F=@GZ62/U>7@/+Y@YZ'F=32[188&DE:J:W+K8]-]GAK
MR$:E;HD+-3*Y4/7UA/#^+=Y'M#&%0-C9/5!I+9FU8G^X^EU%CE>9P,(X_%T"
MN2[YS/%=&E;U@<J\A$U=SD$H .",/%M/.QJ</8,1$?.'38FO>W28:,MRX-AQ
MB(#X41H[XCJ4Q$P#\FE /@W(9^*9&LMVDRX9+6E8560FCI,>WL<T@&,G#/5[
M-H$7($$4S,<I1GY>!$<#M:G)1M7QVC-1CK[9Y7J,4H>><NS%M$T,.B?XDR1K
M5?8,E4Z5A(VZ_3P 3>\VHWBA1)@1*N) 0E6$UAE/HE&X(T&1CBFX8"%2F)%M
M_7O3&+L6%Z$166LALC \8O?OP!M-!$@I.^= 4I'<* B3*;6"H:(TU$1,=TZ!
M0Z.0)!KE: <&H[FIGVSV4(C^ZJX4&?4?5:E-*@O5;<ZXBA&FI^&*X" G.:,E
MB9)BDMRF=8G&(977&FE&I%JS$-R-W*K';6CD5NWDEBR \'K"W;D-W5T-H8T&
MA#2XQ7 F.X)*.2,[=B0EN\A)X$.EOAP(8O%I )V5Z%3WOX$GO]*PC41T9;C4
M5ZQ#<23;E2 V C5B5K#BK<C?2&@K95O+L)M5^I*ZK?)>,.0V+\G-#3"R0NQS
M^.@A)R7A1L7IHE9$OE%?LP'=5^&;]*?-4C<K"LG/U%C+D7?P]+A,7F>S>Y*/
M1 L>J,I;!T.A^)^G9N;-5Q'^IDF/+6G8AY0Y87X,B[<)J#J$>(1N[%9!;E$N
MAO_.X>)(<<R,IQHV19!H#;^'7[D]0O%&8E6S4/2>":)7:0 8:"%-XALIDM/D
M(4S?7$<A%=U:F1'$R+GIU31W!C-"%(>H8,^(]4]2D]*3?&7"(V'WE!3Q85I1
M859#+<VCYH6090GPQ@@OBDRA6WGGP"M,J]"H:5Z^-=:3)IK=V'].(R9E%BME
M"9O;O"97=AIV^T.#W5XP=GN_P6XWV.VZ@$=.;LI /B.0&908:!14R*'LO. ^
MB;"#95! FE6:K"6R"@_1&3/E]L'4' 3?": ! $MPE81NMH"$A($ S!?E]*%S
MNQB7@HQH%?M?QY],K=IN:<@>T$+(7IW0(SX1HF\3EH5YJ<JM#P%E('YMPAA+
MAL9T-,40L!(.K"F3G&4%9I$2>IY>*=$D-^+A0\R 1T,A6 :T29@5QP6B[3*<
M37SZ-5#_Y- PQ0"R%)'JY@-Y<'T#3]:A,9T8G[J25&4S62\VFDF!^M!808@A
M;__W8?*@D#J(=R>(M5%P8)DU205."A_,SY2,<DR%I*9@]&<EE#:6*MP$48P
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M*EP8[QAWF'*+B$GJ 4+:/3:M)]M48#!!)3C$$$$HX&O[4V_K)+E/)E7Q^^(
M2ZE"T9 )PRQI$N\L&<,0H--!7Y$LFF^@=Y+T$N*.\"-BH-7EGQGK7;/M.Q-?
M4T<'"7CYCLT:A ?4ZV' P&1&*_OA&ANEC&)[G+@4)L<"+@N8F0Y6A3D624:A
M[$)2SZPCK3#.@I)\FFP.<(;>I$ACBZ $AZGL,*X*,RLK+6<H?Z\@);#2&Q P
MS--;FNX$3 "QR%3@ 6C:MU"7-$2L[G0K3CY.O,=@9.A%:2\?4,..=3&0IF %
MH U8@Q58*%;@H,$*-%B!NE@_UX!4MH,=G*I($ @&RHM*(MYT']\8/[*'BVYJ
M N>;R&,X)"GLE>0[>K9H'X_O-+?*4#G;)Y=7A4@, ]K$<\W4_$+R[D8P6_A!
MF.V'Z(H=>1;*16CF-!)F/*0==.29E0^T%YU0G<:!XYL(^C,:61,K'65%0JJC
M(%O>93A.$^*XM[>H.!E)W48\;OA^)KA(DS'' '47,5PYCN_BZ##G<Z,0!>2"
M :E^1"\#'3T Y&_*9E#55CX/YW<?1+$$.&.<V]EH-:U:%&UMK+].KZ.@Z>B6
MO]B$U]V^QJ 7FWB;L6=7-,['*F1',4E4B$A3[>"/43'EP)8Y!K:GBC)$H4+F
MX1=S^@R9;D58"LD78Z71F"'KX <BJZ;R#,2O-Z?3UG"=AV1X*K"5)#0_#_+8
M5K0:G:X2J,OVPS#16 PPD6]0M8CSRFQQ2DHL*(6H2PG>H'.$SR1,PC=/]LXA
MXTA9:JOG&JTAQ<*,GM?.5FR3=U!Y=XJ!$PN+IM9I*X8&Y2K/EHW7+^R&0E@@
M@[T,AMD$G 4\BTD6\8 \B?U0=D.0)[UB60I#G%H<<J^$/"PH7%YC1=TK5AB[
M"H^J,6:E": J+67W90U,X8 C)@1ST!.';I::5ED0QB'FZAV+,]3K<-6/^2S^
M3D[%1)/S:P\A1'HRKM"G<3"/KJ3+(OU?Z) SF8ZI'  %VE,+J;.EOX4%J+J7
M&@6?XBS1<6U*AN#FP-P-YB+8@<+\\'%5:R_!--;DN6@ OUBL4"HLQES+8)^7
M H@%+Q&^TF"E[X5,CE!UJK3BF7BTC/A@^614('3:K1DA.O)J&&&W-+Q!S>'8
M#LG] %.=64=H'(GO0$Z5413?W<"W0B[0J;?L9J)F]W3SG5-O,Z"*5=<\V,@1
M[3B(C]2))=.@9=D+2]Y<#3O"&[#E'5+\$NVDB7T&57&:D=L);*]I5F5,,M6=
MXVFLYE=USZNV$.QE\IIB=OY 6E38P^JPJFZ\^&M5ST61:$AL8 LUXFW7AU;<
MT!^]NV!X:^@(>@7A-MC"!J1$!=;<C'5O35,H.$9P/*ESAZ0?;K?B"&40W,X@
MZP?_]DN?T@2)7G$-IB;2H7ZU&EJ%2V67IE8)2]Z$XJ+*/7",(PL-UEY)Q%MY
M>4%B !VFB?)A.\NR!&^LCN=E]EAP$A L&L=5?D(F4P&3$8G($EU8_RFNV90\
M!L\'8BX<;5!)  @O%6 V$@+3;GT,">)6O7RZCA@7 5T&1X$H:*)BC68QJ4[]
M!BP<EI&E0)^N*G132C7-@69Q^E*R!K6$)=23(%+KS)&!YLII3.!/$#AJP1IL
MR4HJC.D@P4H.<P3GV=G0H&0^;<Z,*RR,X\D<H]-QA:\&$IS5MIH*G+30A<^2
M"P;498(BJ+*^76 \713F(G!V6?\&2(9P@QX8NRBHQ<^J@X>A;U#/4&*;5;^#
M<%^O+^VD0:_O3UF5@M U3.WR'B,VRY%^*,QT0IN%V:*#3TE#B/\#=2B>.?#>
MO]W=H4"YRCK0]P/DFQKHM$M%O&C^[(0X*"H]T8CX5VM?@M4HL^=9#.Q$,<<B
M;( HE;]()JA^.WYR%S+IAL;*Z>K%X70CJCD\KY>&L0.WN.=H<W,BT:P=A#PF
M!+EMD>,H=$4I5"@>80(Z0W@%6?$E6,>D))1R%(^@PFA,=<2?=.DM"DN,'\OO
M<^01 VY]7:(SQL!O' VB,4.K[$A,,:G0;N5"V<;512]@:MP(41EE=YHM]7DI
M3[@6:8B136@Y3B\=4.=SK@Y]M *B U=_(F4"K<F-F@96VFG 2@L&*[UMP$H-
M6*DNR@NCH9)B)(B53\(Q#:BQE3:O\&-]1S6/BH(2;MMIZQ#B19R>1VS6&(<_
MJ" )&+/0_&7%)0LUH!$E"/=(5WZ2S(8,9*GHJ 1_%<Y*,KP5<EY<O"2'YB#3
MP+!*BQ!4>RI#UKIA8O[154>Z^T<=1W_&_4V5%5_+B:R76,ED<R"X371OY#95
MIM]<D)N**JE/I5AWI&)KY%]YQ5/A#<( :TJZX1 9(*B2/P2&:UTF1?T<Q6^S
MNVCD8=-42=4'/\#[;PGXER7(0BNDE5@'[),U2XLH=/'FH<PL- &*9FM%13$9
M4SH:D:>FIT_3TZ?IZ3/Q3 4T-.P(!]UJD2P_@H2.HIWW/4-L*/XPX>,"W%>8
M+?\3,E&)?()*RN&M+/"A2$:>\,<H&&.HLFG74X-STG#(U^Q&@U,M7F'VB_A=
MJ-R?=@>;JU:3C:KO50NQ6 ;Q)ZEX6<46-NT17GK876AWHU.W"L@@0?\.S^CA
M+L&"^6X8(@H54KG#6XRI,.H:"IMRHM\+")4%G^OF632$Y#$$D$Q\-CI4D(25
M5A2^(D+(;48UYOK#X.CLO-\#%AQTBP;0G"P:EK/QNOWIK.ABK+YRNUD;$GYJ
MP8^+3$J(*WM,<HHY85=XVSB$OQ4R&.)75NBI&'FJ<NJ*95O,I4"9CGXX&%%J
M/KJ]&Y>13)#:$.M[F P&2"D+N#W.4.,>HY^+R4N]>D]W4FL8_8K4?8[J%S02
MHR]%O[QC?3XN]?FX-,['Y<3S4<N5J*E0QF"9$4<*5)'/U!"/I&O06XQ"N!!F
M4Q 5ER"P@3QB((H"TVJ&YI))Q2%+Y$)0&M",@_$M%*6D.J?R JXKV-W^7987
M6('$11SX+4YEU.X$K0VI\Q5%1)!$B]4YAW-)YX(>[!$GB=<->M_S$>XM R 1
MR5 ^@1)QS_SFLF,2/-]]!A%( "DN5,N%RT0 "7UKW-RVKON2I.9@Z5=#)Q%6
M4*+1 _YR?:52LRHE'T=0;P6(1ZB%BH:88\L1!5$U%-WXBI'HR5"M"=D^F+73
MJ39:?2Z(*]Q#<3/Q/9_X/2?TGFOQGL."V0+//[=,CJ,Y#+9B,L!H)>7(+1A=
M"E0*PB:+UF2(#M/1<32VO*_"_$RPTE$=D%*206%R9CD2L^Z_>9XCY^", NY,
M 86A%H_YM0PH/L C 1ED3I3%LM4)P/$(>7B-V,DD3=5N256U)<<L3E(4WH<R
MEX'I#,Q4B,T%/X/ND_ U3+HY(==[(2+R#?#3C..KGSVZ-FE @LX7!2CWL(;F
M;]D=GIX*,=POG?Q"F;G<Y=!&*&^(7QG9/!#X!*O$>T+FQ!4G)_>V=^45.TSZ
M(7.Y.66^?:4#\=5?2P)]0\I3Q<U([.1]:OBG^&Q!=INLYS"K1S7EXNM5(Y.
M3SHF&X1.ZP5CU<.# -:ZG2%C[^CMN$@;>983>I\0APJ%^->;]Q^/ST"OT+_>
M'!?ZYVYNRFK>VQ24C&;E9\FI%[]<LFO]&?Q\H) 'L2N,3::5@YA KY</H)H-
M>M!P,P-<$#'CFVB<L6U(C3I4&Y9*"SD5/T2C6'93-(Z-K!45?Y$]6+B6N*_I
M[M.0ZHDE.!OX1)/AD$KB--]+E:$]9TBD4RC0;;?@Y4J@$_6,JG$MUH93!460
MT6;#AU772%+;_Q.FR:;K8*GQZDIDL7:RB+G=@F/E4C5\3H?% FU>16.[J2 [
MF_/EOBJHE\7D[9;2TQ.KZG$$3G'"+2O*Q*+:R.$M 3+^VS08W7G18!#V(1$'
MG(0(-FJW.J9 LJ21VB!QU7D(*">*MUD1,CWO<*%(FW:ZAA$\$[L(9=X&\Q(%
M0Y?L(1.)JC^+W6U9UPK)(\0^[#0$=+MQE-T!#@*H"<0I_$&4$Z%B[]2M)XI+
M8!S^S1D-ZH*DU9?77BP%]4"@6106FCMIN8DF!,6\@-D"$-$F9E@)2[N6I" U
MCP]/( PH[FD8 +FT)46X2*JJGKY"=/G4$U:S1VE.#5\6_V3!(#24GUA]<5[[
M.1Y%(ZZ*-?.6RI&OE9;JQCBY#?$>X2IUH2KW3DI<&@V88:CJX&G8^Y)Y%V15
MOM$:"W6<!0U7Y\L7XS"N.B@H.4%LJ:Y]M])9,36]6(;-^AETM8?7G7QJM_YY
M_LWK7!Y['>_L_(QWZ/STZ/C2.__D66_#\0BY-,S 6O_-RT="< !]_B]_D%SD
M)? .S[]^/3_SKJ[/#_^/^.'L^OCKQ6GG^N3LLW?\W\>7AR=7Q_!P\>9+[_+X
M2/SU^N3\K-VZ//G\Y?K*]_XZ]KY=?CZ&#WC7Y_"$JV^GU_3YZ\Y_>YVC/T^N
MSB_A#X?'EV?PW.LOQW0%/HGG779.Q;2O.]?"WCD]/X2?.F='WJ?SR^.3SV?>
MR9D8X#'^ZEQ\CYX)+SG^KV_'XHE7[1;\^OC\TU8]-[;N<6\2^$N/.WBNL(.!
M/*WA8M8T=/[<>"$$&#:B3</R!\4+;FF2ZJ#"AB[819L\S:E:V^;485L0]9SA
M26"=$YFJRM#4-,YWPFZ YVKR'$L_6Z'N><\Y=,98X$%W#NQ">(-8U7MH+HQ%
M_&-W"Z7^8:DDWL,?G5;R#'W=C$SD1B1VT?(8J-M!V6%0Q(#SI(K%POR]$I2+
MG<.*PW?41U>;?ZHAF^H)ZX@54V2A >XVP-T&N#OQ3&&Z! 8GB=,T.]A$IWM2
MC&*.@([I<M,X-I#2V:BR+3M*)7_<'8<T^V)4..,82Y/Z1#OEJOD##,@9'1 R
MB6(DZ(7AVH'K940"-AN89"TN0 .3K(NH@B KC UA= '1J\J$H%L"8#1D4DU"
M"49G77(GGHX8;O1(I@'KP$RTN<VMR!FSFV\U(,]5@55\#N"@$?FJX;&4(M^4
M2>CF<1R.O5$2P?%""$ZY,]>,R6T,9O+O,+0OG)(QI_60R(^"E, :5!4FMX)_
M1&M;3K 'CM@EA2Y33I%!"'/#BEZV6]/"ER6MC&DP8F=QVA%T;R<&.NL7O5R;
M=#1=@]*IST*P[ES'?H[#/N6L%2+EU&YZREF3.2L^[<G-318B=H.*QY(\[86.
MSN4NK;&!3(307_V6[%RM+U3C1 AM")62(MFX4B^R7LW4(IM&\L7U-H!Q &Q#
M->ZH6C2BRR+S&1!.-O473:FY+Z];Q5VU=YIN?"+DU&PW*895I-OA((HO\>CH
M@;L_J]!>U&7-%77QRUR@LX)9K>E02EL./#5'93#5VE.@ 5F#L9++19+LY\;Y
MVJT7"F@[!\;PVM#W3FDM4@-F2YGHRLVU@'C<<#"6LLC"#P08>T4 37GY"0_'
MY([21)44RCXMB54FH1L:1^+\4WN.(H6(3/D#)HDX-&7R/V,=@%R^E<?;9/WG
M.*-8#1<RX8DT!XWT>U7IMT!8_J3PDOLR%NE6GRC-YL#D&_UYI\DN#7=]5I)B
MP2#@^8779,7DDEU#U:3>G!;5;YG8H&0BE-"%/"+_2^./S/H'1[:H H#=;KUN
M)M0!P,;.&$0RCZ>Q>*T:,?=J8JX,7Y^'='&4@.*.T.*:X,Q$$N\-OHPDM;S!
M@(3PHQ$"2@S1M3L'DZ ]T[@7=QONQ05S+[YKN!?7GGNQ_F Z38/;;ETJQEK0
MK1\)H_*73OW7<I)KHQRMK7*3"]NTPH@=X@*7/F%83$/3B4S78"'U11GDJZ#)
M*W4\T%:I4*Z$N%?/8N]T'G<T9%+.4J$"9[(5V95PD(1=)UZ?Y&,(&&I4-WX*
MNT927DL7Y%@30Z. ^@W!,L&HHU%$ &SR6S(S_)]M;LD[8L!CVJV-GNSO90=B
M=_=_W;0WB!XJ>_X99%QLGM\$49R9U-L0I>V)Q\,3A3TS"AXA"P>'4./(A_F@
M"_F$#1U^*E78?#!BI@G7&3SBO;\UXZP.IZR;)M_#=)/)-W1ED1&5+F/;H%*!
MZU@'(PN@9M; P!CH%,_(&3'5.U#G3]9KM%O($FM$:NQ*UOF#)>7LCTDLKF^I
MT6%:C*S=&DFL&BZR8\F>V6ZY3!J+SW,.CK!YY3'4U0Q>5XE/^0D'DW\WY-R&
M@@YQ)W-.!LJF-2292[RGY3/L. N)[(:;P5!,G2)QD?Z$T*2[GCD+A2R+T"%+
M9-O72;?-EQ7B>)6+P0Q)X:_[86@?T)P)R3@*D/ :%BIQ,MER:RA?097(7%03
M9%8=#I254CN;0@VC7_S%FV.89Z%FIU#=J+(/Q>EI6:L@5BCF6%M1<[0CI;X1
MS#JI4]%L$E,Q%,PN&F535LOT4!+("5 =WZ48@9?):?C;FS2,N:1P& R1! IK
MQK$*+HVFR5[31*H0;WR8G(4^JLI5_ -F?U/(D*I%A^V:H;Q+2'Q8VGX."U/J
MS08#U/MK/ZYPDBUS3[9S;D3WJHEN,@PA5J[W1)$+*")YZ"H>_-!]G_'3D% $
M$5/>5#[P/2&R, ,>8!/AL<1)H3FH1&X5IEOS;="Y"[0E"<]/NGAX(41_DU-?
M+P"!<?.MH#A0'0^N.H18=HD)^'9+-;&RFF!YO3B(!IS<XM=:F@S;6))TU\U5
MRGU<ZG?<:Q\^N/YRS%EY+F&3=6I0G79T<G7X[>KJ!*KJCJ^ADNWZB]?Y>/[G
ML7=R!1\\_79TC!5NWN?C,_RVN0[=I^,N3\[$0[]VJ$#O_.STGU@W][7S3^_L
M_-K[>.QU+BY.3PX['T^/H58/2O:.CB^.SXZ@*N_;A1@PENU=="ZO3PZ_G78N
MO:N3ZV_XO"U/UAY"M=]1J=3O_*\SJ]SOKQ,QZ<OCJXOCP^MV2WP:BOZ*M7MR
M$.>?\,\?OUV=G!U?74%-XL>3,WROCW^94(GH42&B]4)X[GS5D.+<T?*;Y9!4
MB<B#$Q,\OKSZ<G*!OQ1[?'$N%@<&(#YP=OP7[&?GT^7)H7=^*=:S<_E/[^J+
M6*\K_+SU@;\ZEY>=,RB>[%P96^+SV1";@46-Y>7Z=@:EGG:QI"R4M"LD3SM_
MT8OAA^O+8[&6/!)XL!CZU0D<@N-/G\1R7<$4#K]TSCX?P_DD$2KV$!\GAL+/
MTW*F6Z_;6F]9<TD-IA.P,+\&XS&X+DN;2\&(V-V'Q,>J6SZO-1=$*WR4]2B'
MR: K3'B%UD9K!410P/UXH!FJL*;)VF>2!N>W.[=I2,TN)">*B;H55H%A5RG+
M!Z"/2/B;JO-C&M%8H@*VR#VPI$+])?.MWB"/1(S4+\H:^1QUQ4/'04K9:N&A
M/.!00K".P)<2 Z& 98XQ.O&5R["?#**>>!([ O!-+!&LG"?:._QJ9>@ >"(1
M7@!WO1/[#"GK(,X ZI'E@/H2+[\4)I>WLQ^\V5%40L>RLWNG-VY,I%<06V+;
MF$F'8C5_)G#0OT%):"._5G$N*+]N\CC&%VD$E=Q(CKF- B1@CJBP.HGCY&'Q
M);'-;CY_+@A0$A;H^>F?QT<^=^!$J.=PG#X: <EHR*'#R>K']Q E@-XG:!X,
MQ!P)'0"9%V_G@^_M;N_N>!L0V!.?[T,KTY1HYY&89S2*\3E8H$_5W#KZ,TCZ
M5 %"(;AH@$PY\+]4A"61;]T_)@\21(LL=?>IG*0/_KMPH&FVPF3N?#FE= 0\
M^"J,8T *2SQ9/I!MJ6\6H;/-5N.(^L] :?44U6?0$XI.\GU+_#\] ]8FQ$B#
MD5L,4W3\X0F:XXKIYY*N.&(!9YK4E^F?70J?!V-<99^5/_ZKGXPPK#+$3,M-
M!+%&")UX01S+,&I66V+>YZ"#]AITT(+10>\;=%"##EIU>0&6*L""V 4!EZC#
MOE*)Q[Q2 URDR2C)Q#<:8W<5YX+&KO2 I3*>O)$(&V?'E'3W#2C+ /EV[A."
MNP1B<O]*4NQ420^%OR#1[EA:#$B">\=I:*X51X4KM#LP0F\P42:"'V1?&/I<
M+R1TS7V4CJ'2?!"&D.M#9$H:\K/(-A%3^_$HZ0JOS%=^I2]M"=>XER!Z(H:L
MB"=CH<;X5%[E1K>LQZFJ%R2I^IV: 29W'X2HQ22O,"2Z&6*4$^;Z%I^6"<J
ML368=,:G</86<!V*5&J&C;D+[B$XPG$(";F:^$6Q &I@F:H*Z$&NA]*W&DA
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MBVAHMV2D3@< JRQ[+9]NT^1!S R>M52[_I>Z7\YU$C3E^/I=8!A:Z.H^L-D
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MX2X$\Y$^\R:&U$9?B4&&B1KGV#A4<UAERI945Q_Z7Q,[:##DVF9ZI^^6LJ9
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MWF7,>>QC(S2(!8]5>V/0IKUH'"CZ6!GZAW@XHT-4WM$';F; 23 ((NCF!';
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ML0=LI SL@H$,@G\),W?\*%_/3Y<_EL?9'-D5'T,CIFJSYZLJIAS&43@$Q,1
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MA 5^#VDTGC")G:W=B4]V3L%!@UAZ<KMU,&70I4=+_AS)@#<*4FR;.VUUJJ<
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MYDY72?%Z;.-J+%]'\Q?.=4$<9#"KM;S-+9GYEBQW+U\!3M_!%M630V'&ZD]
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M-H>"NUM39'4H,I,)-K_N"^#PA,_#2 Y%A%D'L>--8,9]T>470+3$Z6" R.3
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M;];O%SZ%I 1]EG>9RU!)7Q$M9QEP@_>(F2!21#A!)QZ#-VH6SX010M94OFQ
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MT>^C')]O<^9EWGK6[6I+VK*@F94'J&ZU GM)J?H?8==+=.G.EQL'JWD-]V%
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M#H$(Z]D]4G9WQC5)"7-7F&N@6+0G\\?1]>>Y)'3 <@\_BJTOB4@R5TE/>%B
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MDKK5EZICH!;H(>B7W.<(:\U!L\%R:ZNBI8]9-=1R*L6.\DFBRS!XX#W]2:U
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M87H=$B;=]E,L0^@!8 D/B"2:K=S%F5:SPGF_#[83'>-?,N[#E>SN /:#,@I
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M4_XZZV0?;>7;?M0V)92KZ(_]6XR(ICSF[*L<HELX0$T/8$XM$-5O< >(6_]
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M(F9?1;FR#@JJ?0#%H;M.$ ;O1AY0U<?<88"5X]$>T 7KVN[[0/U]I<X?)7-
MEU(F:G1"V7=J5*MYPYI=V!KQ!M46SS &,HJ'/F5;U"ZSFB(WY,+6B"*MHOC,
M:98KTC C;'&>E1:?V)1\@IO;V;.G'<2AGVH?'.CT5EU\6R:/.  B'PTO\ZIG
M2X,B+R+=0FHT(/[6>.>&:81%NSPC&V/>JF<!1LQY%*]22?A=9D5D^M/A:B2N
MN<Z:7=@:<1V3IFS8#K7=Z*98FJ\IF)K0#1,7^YA@!PX]I2N2(AFH"1MD^6-'
M&:MG'5@*:6RQ"='I8$<Q[(RDN]W[UB]I7D@48J^U3"6A$72<4!L)+!O'9M$1
MLAJ5<9,M/SU[ANKBL^^9(#T>9^NQMF8S:W9A:\1F1MP0^39ZV#ZGT#*QX&48
MC+2O&FF"E#4'*G1(W-]Z3*E)>\TN;(U(>].3:E69Z-J7VE 3@9)B+!X79KI%
M<AT2%U=Q-$?&&7Q-87Q6AK?:DO57JDA:IP+0BUQO@KJNM>((5SZW)U<^.K97
M!Q8C6B6KQ5AL\25[KLCGD>+2W1V[NM198G&I^F)Y;6G6P7?<F<O_-KX.T\F5
M8>;!9)-+24&F'FNXW169KW*FNART=,,K*P==H-6PSI6L"LG>87N1GYR#_9,C
MTP;JE;+C"NQQSZ.VQ&^I_Y#O%V5!L=MM#CI;9EUM@#F\-HA</$&-;)7=ZZ:Q
MS7%,,,<\=12 ,Z%P4O88=%V1)^#5N[*=U%W9%MR5K55W95O+KFR+-G_JUCFU
MK52YK:^]T/=PU!,Z\O/F4A>3J6),%BCD!G@!,O>")H#E?\G3N[; 3JV1'*38
MH9]UA EJ0170?9WP>YWV6IM,:WZ!-?><=@01JW:3O'$K<DLQ5N"M3Z;N*\]%
MAU'X_2D+HS+7Y4YJ*I438\-^2!/)5&UU,=Y:X_8V[+5FI&M^@34CG<I(BZ5V
M%'8$=CB4$7"_V,.)QN:7-,UY*)XXJX62^WGBLO[[:.Z_&D"7GRZ(.;ICW%PZ
M \::/Z.'2-4L>$VHHF;!-;+5+'C6(P #[J:=C 6;DJ)@G/.?BX['-^%5^NR(
MJELH&*B1>AOV6G/0-;_ FH-..X()H+J\<_D@_%3P4.O1_N<\RPL6P^P35'Z'
M$<XN='5C])P'%?74DC%7KQ%@W:8<NL6FJ>KL<!H.J69CQ^53T:R,TX%XHMFR
M-*4V]"6YA2+)X];4:'3 #AY<R1WYNM@2A*>IC2Q*,]9%D !^^O*>S*0TB*5/
M*Y#]A"_'^%\RF132^4]V)\"L<R"W04"9[LY1;&U&P*MO[>,DED?Y@ ,\.$+K
MR.!>W*M*9RZ()!KB@]%HSO%' V5%%4<6CIA-]56?=B?.HZ-!I7J6<6E[5,KN
MM<]2:-TB>/J*W1SQ.AOQAX_<7E[450!52OO(C4*_#O6@^GJJ9T71#<<9=T-*
M+.>I5(Z9Y1FHV[/'>B+-A^E]'Z=:81UU0/.LL&T2,94(;!Z<J,25/=2,#2FU
M;"6:/0Y_>^S+P%#X[@ZL!MO! <#4"!49CR)Y-07I*J ZZJB;M7JC69]'QXVC
M?'F0'L!5G/!>/F@;A$6F9>"X45-?0/N7S+N!&ZK2+]AA^2 MKA0H&2/5EKX'
MK-J26^4[Z>#E KQBYH >3GNFP>0XE=PI#"5_X@87X5#2F''>(//_+'-W]#!<
M6J77PQL4NC_'%!P D7-GC5?'&OF0V3V->>YX0T0!)4^U!,A$FP&QR/J!C&X-
M:QT^3YH_QA4BL)-GH -Z1U'JY$:LYT>IG5-Q2$15:D$XC20>"S14BO!:A?$H
MJ-^1M>"J_)E(]2PA9,)V4D6-AF.0N(.XTJ5)Z@;5<1B3QF^AF4?>W1,G8>=;
M/_2[Z##OII0Z0FB:X!9IK!R@Y!/7%$GYC9M3A]C?IIL13J*0E3YG.)5B-@$
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MK83PM"XA7' )X4%=0EB7$&ZVS%VX017T0+PD,5E55\HL7O=3;:H^=!4\P.V
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MB2(,<-%B]W,$34FV^FE[HMR>^?2B %R0U2I4H6LAQ?[UDR<S[ZU;A0))V=Q
M(:+=DDB@ZJZYGCP9E>BBL5G^C=A<BYW:C'4SUIN^K9M%O9-%_:8$X%$255-U
M3;1-X3=^P&Z#S_6'P_48Z-K<VLV*WO**?E-"<)UDR6:L:S;6C16XEHOZ30G
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M<-]4Z9I,>D)7<NI%)"R0(R7K[H04=1X))PG, 5+<E< P -<0T$*6 M\O#)F
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M-QJWJ%DYL>O"](26R='F"J=NYX)BDBV T$3LS6X^D'; <GKKP-^*$U:''4K
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M&^O%/IEV3NU79I]S)%#DL,AT():V\=*MBVV)?"Y]28*#5SU2SNC<1-IV4^D
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MO!)_?A=JX)&GM2QQ4SUY9R1QIB+ELNB"^X%?9)7F$FIPBE4"DD"(8+[%,WQ
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MS21#D<\D..'>';6F\F6S[3T[)]F>QUY3$">/W8Q4LNN$K%"?F@2,XL:Z-O6
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M#"317Y+;5-ATPT1=(HE!_!J/\R@I2;)(/@-7-8G.)9!D?S<(_C <_\G-25S
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MX93WE.8ZE70@;=QG4[KOL*0EKRNZ>(N5VYSV!SZE3]F4/>)SLS*V_F<?31J
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M+%CT1<Q(<0SY2J.F$R3J<[WM*!Z.+%1_)TC*(D,"D:;NCTPX+D97==QU+Y*
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MXR7@A/*BTVZ9HM]]*!T_2 (G8)*3E&[7XH)G^9)'X%_GR/**Z +A9D0QLM#
MA3<-96=MIL^@DWZ#CR2X--RTP[6?&83]F!@9> _2^H;$^2*+DA2%$Z+"2-+
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MF4PZ(<=TQ@YI/$_9#,REX^%5, UC1O)%5[4..DD3J82 "D8CY@X_ O*0#LG
MRV<XNJG)_BKC/"[\?LF+Q<]F0$!_J5_RHZ9?,KY<8K_D9TV_Y 4H4JO3+_FN
M;MY:\8^W888F#^A(^;)J%%ND08.:O]JK^'O\VXLPIV-CK.78Y'__6_S;!BS*
MGLX]+&:FK\%V=\E:MVOAP^HKFA#$N:@S(3=C"7*&S8:*-*$K5]+%- O:47-<
M[LGS/,@_2@>@0OJS$!&P!I2E)!R@!D'E1A^7\WC,+8"ZT)>)QTI?@W]9'5O:
M*X=)@L8LU3S0,^C8Y#FZO;J.CW^$X43+1WD(S3L(+@UQC9\5I;$3_*SE>OR;
MGS70V[$V *UA?-4-N,M#?3S8 CIF]P:#8OF9F:#AS1?&K@W-P\@V!-B%=DM-
MA0VBM<7.BC7C!3VFR7;K(,Q'P0NQ%W\$-O?="_H*DCM*[%6P1O=V)SC.NNV6
MNV9D@H?H)F4B-K?H+-AVAW'U\R-4N6UW\43@/V!HZ!A:*JD2Z,2";DOZF.L[
MQ6RG0+\J=*;"ZZ:9V;*> Q.AB1,W>Y>>],0-+N((3(IX';> @7H],60O]FD/
M+D=Q7QD1'LMB'F40V'=\-%>U!_&^?EBD63[[^F$:CHG_T,[4>L (K_06ZOX
MF^*7X&^OPEYF8T*TT)[=C]I.DJU XY;3N4UA<5'?%=;(OG=3#KYV4]HMWI7
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MT<;?F-J.LT0L4TS"'%N*X!*M=  86RS$"T?CT<4^VAZ0KTIBT:-E&FS/.IY
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M%F_01^<AN[/<T+>!__=9VJWYU+@D<6]?#+1W 2":V)VC&>$M[AA^BZ8X\K\
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ME6C=4@G7+7/NU!6_(=4G!ON=X:&,B7F'CGJ0'9(R<L&"RF7?=5C,RX=P L9
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M:M5DEA2-YN)WD[3=X!("JVL-*;D1-\L1Y;G_C=W$RH4*KWBJ(2<<WS3AB_6
MZZMB!-4(/*8PO_#X//B59J-)55\DQW7L<<M$E5<+)N"-)-ME!WTE6YCV'A'K
M= (/8_@F68S(BNO2D(Y=*:O<T;@;9S7OOAYR,3UEEEW"Z0)$QL@JP8F"7/ C
MZ5B1<B,IKAM?KN)Y0'*+:4Q0CR0US#,S,6%#%P05^IIX&T]P',E\YV+AR;<
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MP^PHS^*S[# +BBC$9(9-F=XT'FG$.W-2KCMJ P8H%;9%]2DRR0JSEDS&HVM
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M2A0<)RXNL0,N=>)AP_A^.K-H5FM'I<LF%DOAZK[ CI90H\J[>-SR_I;Y7GK
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MI_]8=Y:MP=6(BB)J2.S3HW#C]*8>,ZEZ"+M.X^94VQL9]XYV"EOI8R81<NZ
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M>WPBFDL%FQA8OB^GJ=']X.$RS;BR3UIH(( B9H8T]#Y"V&FP!BQW3#X;IJ?
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M Q\%C,)93)I"U*2][&@MQ KEX>@\[ $GH-%4-103<(.@&W=0(=,UAD,,D)^
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MX._/QOZ:H$"6HJ8(\F5?]FSFH%S;RHA_3I)_&7;D+N]<&UL(JS]24X^PAT=
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M',MRP*!L@,5([=;AEQ[8>(1-DO.TB?&</>Z6@YO'^_/;\CXKU\^RJWUP'ZE
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M;?ZF71JWP&I:[$?(G"[\L%+>_:A1?0XLHFUO2Y9J6G?SQZ[Y":,G#@@4A.0
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M5]^=/R-VI8KS; +%3GPA,\]B!HQ$FF;B'EWM5[[8GT];EWM+$T"<*N>HQUR
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M8;M[^;#=&*L7,FSW(!^V&]_QFQRVNTHB7AR7[<#_/.W7WS=M3NGD5."#=_(
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M-]#8H$7*\E!SGYF\E,E[H"RZ'O;4H=*S#+@GN!%FP/U8[A#W"B^P3#9"<?Z
MRP5#"-:-42..WA[,2?89(^M76$ :D33=_(T+=Y=7]T]F;8K* \'(ZH.QA,\/
M5?ME1$4K_HI7IZ*N_5O9T]_/7=]*%[FGBV]H 1]5+@VWZ!%EB%: 1M3)VMR=
M>E]S@X%7= I?5+L\^MJ#BVK9EJK1D%N;^;TEHO!/EG7C#PB!H:B#@2&0,"0E
MQ,FO!"G%PZNSQ110N#'L8<DY]C(X0]7$IX'T"+0SA%Z+K@964!/GPII;C*\4
M?N(U/_CEH?6DVEK ZZ %Q=(_57/C,QW%M+!GPK5IY#=)@" S4Z$WO@V[P^'%
M@KE8$E\Y;AL<20<+'$>ADO%TJH\\-.O[/?612WM%[79MUL5SZZBZ+27/(P8=
MB*^'(-M4>&(Q^Y<\,FI$<KB CN-<98])]&60*.HSPY''(]H:555283J(%).$
M^>3WWXNJ>&4(9.F]%)8I8_V\=4KT39E>*T#B#02Z8^ARJ<V U,BL<]+YRP?@
M6NP/_4"I)\JM)Y/D/G5EH7-[A,<DFJG$RD&V(^GQXWBTAEP9>:I4?&H(+(ZC
MHVWNUCQAQ:KW5)7,&QNL;-$O)FO\@U]UW ZPEBX+Q?4AM2UP*K89/4GXSUA<
MCM6OJL./;T)#D0,^1760^BL=9DF%@(5&_!+4^O%?V[6);8H4YP)'#(:A$FBT
M1S")-4FT2JC>.G3-HOF&XCCB 7X_I4PU6X,!F%UH-H\X^6G R$!\*(-MS.;!
M7WT] #(H_+Y F&<.@X/I%!1 (T5'-C5-;NE) RZP5&E!I5/@2(G8$DA[.!-&
M[XM]OF5S>Z8U(L/2X4LAC2%"$5P<H]/@D 5$PN:IQ_/O$S+?8>PAN"@X%UJ"
M:DS9)"P"+3ZW/8R\V],C?55C$8,Q@X7TC)O.>.&^JN8KCKE+K)KCSPO'W_ "
M8^^JPR_4A@^IP^C-2K<>_FDFZ TAR5%#FR(PA\VS7(9-.)A'\Q8;#'0MH>!@
MW'G\VJYK'[.%1N^-.9]AUU-9J.^93@7O/0.NH.N0X^-=O:>CPGJ>F_O)E@/:
M=:BU!C9[U*ER$SL#<:"#%FD-I)0_F!5$RV!D(%, 20.-"_\"UM?E78OOI1DF
MJ=FT L!Y'/KMI7(FMJTE:B++<L'EZ[NE*X]8)<@A,KBQQSY,!ZTZVH%6+1BT
MZF0'6K5HT"H2HI*>=Y;I4D"#_NWX3QN]H34A.JU'?6WA/F)].(Q=2?]F6A3#
M1WEP*.P%_EV74(1%0"<8[IDPMLOAQ!L8@</1M0'63=G4L MA@,[^%1M*X[J0
MN[]W[.'^_@VBU_ 27/KY$HS\OMM_86M:XONFCK& %]Z'W[>2@=NB VV5Z7"]
MWV<:5K,::(3K"!1@H4E,5BVBNX2J)*CQ.3EDGXE2#'JI3LAWEEYJAI(BORR9
M% ET=S]:F+7 D"K_%QC\'?41 UR=D']-!.W'ZVJ=B)N.W^81U*$?QP+?UE"?
MO'257*AF,?Y!O"B-0JGXE+@GHJ\JX8[@I.!(R$,WL&Y<P1ER<%Z9"8<]@VA+
MF >FR!KZ'F41_L*EX&P6RFI5T( AK&<* ]8\7*EH(4K<M^% IGS=KT^1,0!>
MGBS]&2>T0HH/!B,$MFOX04=*H072>K@*.3"/KJ4/'A4M658E5RM^*P!\N*,;
MD>=K5MNEBA4_  1?(B95=9Z("X7B>12?@$P"("_P;<LU,.F33H6@]E'>/8\"
MF!@>L4NW#</:":'@6B<#Y/#$'A%F*XZ:O6!L(-0+E">I+IWB9)=1PD <@MIX
M6+F%^XQ_>H3D9M&:.%$_Y,(9"T\$S_.7:X9"6^)DP%=JZQRY;X(2^$<X"7BN
M]DQJ(9Z<$ <(]A2SQ]BH6SSV#=&&*'/'C(0(\I.G3RS*0TSG%@]'R_@C904[
ME++409)1 ?PQL(/?*1#[245\D#:.NPB'KB2(FJ9H+J].L0-@/DGI<BG3N$"E
M,YA&@,UHRP#?M>%8\5N?4J;F;4/&[01MP!<I+1$2M[-75M9X AEY,J,P%13&
M9$ 0)/U(H73T]#@@4*@M8B.B5R(0_QSYXA>/N O<X@PE=2(VGA9B/PSK6$2H
M]#7L/S*,70)A'<8G,!#RLY_,HJ!NRWID+S 89A0+Z$-?ATO]-ENW(?MYXHH+
MEI>K99$-<7AV5HVA?WARJ)&.$/0";40@$M'2"FX;21SSA/0E,&(=*12?>E9?
MF?@XHO>U!;P7[K_-;,H)4FV(T,$XOL3K+ K*."$F96E+KB#564##2^WN9_$*
MAXE9O."'I=K'1B011K6]272\"HD+!%H\PO8(41"M Z#4*!RQ&<X^PUKRD[G3
M,-0/G1R6RG!IH?,\B,-,.6! TM]./JS-.?44>L0T]X+B%F:IF?B !F95>X@?
M)Z(B)0@T_9YR9BHJC\E ?5QA2=A&R*13$\8 OBVL\2D+P7-D_3BSY65%3JWW
M,MTNU!C\.ITBKI)5"Z\32U1OA6RCP1UR<YD;T&V";1WJ_4"I[<1A>UD02E(@
MQ-53\$@3MAU]S+0*"]H*RBDT>[W].M,V/-W!4:R@S8L1747 =(7O+Z)R FIC
M>DV'3.'B;A%JSR.D@*!&54".#^%24IF=-9'FAJ.1-&GA=]B^/"?/R ^"[4K8
M3"RLHWK!P.K3J8#VB<W%SLBGQZ9C8_T$U,ZH=KRKV@G+S8CDD2_ :RZC9?&Y
M.6K"_I$&C!9P<B,\XF?5A94#YA;8].D4\DVH_$SBW20Q$<C-B46&/5AX;@8_
M!H3HY63Y:EH6UL_!#[[TAW6BDTT%ON1E3[1&PVTPH5$$W"P^#0O$YEJO.R"!
M]&31=QSAXK1&9(1XO@\\'A50'RZK!Z;+'GR+7\AGUV1RG_DY+@.LI !Z,A6_
M,E *.ADJ@??)\E?QH7 R'%9GF4 E&#6P$*B[$W:9>1!"MWT;E'X'0@0HF45*
M=8*'P;O3O&JL8/V@)_(CLL<P/"()UH*03P;O# DA)RA]PI$ *7SH-AWR/*=U
M[\FC#01JSZ@@F+17O5/F!7(:QWF@T'/.:_/(Q4!*4))T6'V$_\'D:@0N)_()
MB2?A_5UTVUZ#.SX*M$T[IZ/@7Z; 34AHB;-"XTO]]]A\/#KQ8M]3QDSDO#Z2
M7 1Q)W[%<<@1+XA_AX/O+[N#=Q^NA8?F545@@;F39*"\V![*(%U1BMF#PR4I
MH#ZJND'R*X*22^N8+2!XC1&7,BA"!2K^JQ@OP\/N';1?L4- [!;,0>V1[#;@
M)$10\6*7Y$CSDFC<@<94S8 E9A0JYI6BPQ,3X6Z+_^1DNX^R]Q\L!5)D=TA&
MB+V(HY5._<?KO'Z/.^7F2V MFCCYQ'7A&9,$#0C, %/+Q(>@Z>75(I7Q?DFB
M#$2CI!<XYC5P$7ALE4"TO>*D%E,IC&=8*K=CO2_;;*#J/!'"0TX9[N-R@9U0
MDY1.T;W/XS3LC*YU&%VU3AC06D?8]GEK[@,]19/*E*@GI#-%U%)6E*H!YXAJ
MUU[G#6+QN[2$$ H&/A23.$"?L8T4RCL=//Q^G";"!CZ0N)A&0M'K)YU7^[J#
M#/>/IH$;7N@@]/FTH%/5T1U4 R2-Y"CGLJG5J-#?69)6'G^Z_6K;N8_GGW\N
M787.I2=?<"3O/J@.>7S@A6.MJR-R0$")(W^V;\OE%?Q^P SNW7<MJ?4,O55&
M:8I,P :+ALUX.)/9^V29<?BNC.S)X.DDU>EE,-V -K#01Y[&"-;M @GZZBC&
M9N7)NE"7PIY$YA8_PR)$&2;C<3OL$*%:3N)$Y 6NMOZ3XSHJ--<  RSJ*%3J
MR3@6B@.Z3-/) Y*ESZ9+#@K79&9R4;L$'_ C(Z+T6<H$N!<@*/@>T$%<9B0:
M#U C!O2>?RZ4K<5/!;$,.J[-L\^2B."#P78Y#&FA*C)'8<\BH)PQ+QG5N\JR
MR@U$7Y_^GII(9E%R1[:'<^/?/^4)+RF:B(V:BS;KRRQR\'AA.2'![GU^TM7,
M"-)YY)0F#YSY2Q%TW5;YF*:VH;HX#XEDHK?OA$$E($G]NF,1D/>&2&'! H\/
M4M<%"F%XN,Z-XS:<BCX,!DY%UIE;-1[<0?C&IU8VIU-^="J1L&+#J4F%S))/
MZ'7 =CJ^&GMJ*9X5"39TP"!W2-7]D6;=64IK"T]%>H(BB7B*J$?#[)$T/H_A
M&[YJ3 KB\TQ87& WG9*$]&<6VH'R*1(5\U,5W(6=C)X&:P#2J42H:%I\^,MQ
MC3/)/.@U\4>4:0Q#"7?VCPXBH0PA<FO<Q4VXNU#@'-\SK51ASP$?D<HO3MY+
M\8ICD\(]L','\/W=A4K' I8X!0EXH E?DY$1;SQ5_VZ\PB(_M$XB=E:3"D5.
MO8Y=&7>@BZ&._7 ]5FPJ\P#,^L QP$=HA4&JR&!P%DQ\3XMZ3</HWG-+SFO3
M'7IMN7@Q4D>&8R*A]GNY?)&(4*>C0G# 5QE64/;^0RU';Z&/\R4M+,>[%I8%
MM[ 4=RTLNQ:670O+KH5EU\*R=DY960P6NP\H?\-]X2$3)>S2/$LTO"(5PX&*
M(9Z\,709R@W%>#O<HQ9F*@9/L<\8_ KA?&,26 $S3+-X2LD1,)U@PZ&-C,W+
M5!&"M8A\&EWD%1E%MKU[):\"DL,+UHF2/PEP&>C$2:>P$=]U,)L0G0@=K(/U
M\$\HT.>V6>#,T ),!E+BIX.%/Q@6G@IH&9/K(WN5VMVG=-)CL\\?94EIP6*]
M,L![WC7/[,]?BE\:A[,:A*:N>VJ'D(CSQKS_C:+&!=T0KQ2*G ]T!3# Q$EJ
MHLM_6M>^%R(()@Z#GJ/X5?AKFLM$ 9/+*40^W7=K\/,88G0(C%\W>=*10G,R
M>MQC?G"8<QA6J;<8\9QFJT^FC!G'1;8(.< +V06#SU$^.0OPR1EK#6LFN%/4
MZG*NMEF93BW #W,UMB4]9QZ272Z&Y,IQN3M6.-8@@_H9F;/B0"HTC8OD-I4)
MJ9@&LS4*.XRPIAK'?;9=:CSC80S>_\!'G5,V3 0Q,.:$V"LJ 6E)B1[%L7ID
MU#U)_"$>1P,80!(+@+!TRC49MBZU&6H?'B).6'( 5VFRPE)C?3/01!>*SU :
M, &PD3=0@#83)9BH!75#X)_Y:8? KP/+"%2&^P7AA<2"\/#'_0*B2_"]$(@Q
M0\FD8'@'4T^F?RGQ9ZB$CM#K"0E=;ISR%P5)&(E"Z'Y?^:=30L^+NY>;YR/+
MZ3;IT?N<;OCMQ(S>)@J1(HIK7!Z.X0_S(C+A95$T#;L#^9UV!*YBK/"+2P
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M"!?KHFH^,U6&"708;X2?8.'@XE>-L_R6N4.^;NX&Y)-= _*"&Y!+NP;D+6Q
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M%-43 )10"]UOZ%[Y>E0:]?GV>"E0_5INMVV&.SZW[$ Q>-/R3XT//%V".?C
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MCG#L3$<W5;.-**N><^ H8)@H WZ=8/[I)O(>FCLX^.Y)'_84U2-O^!P8A?K
M@'5TF<ELU3!&^'<V$-_%%EJ<AB.'[3G8:ULFGE;3J3V4A?GL/Q_+Y6OZ9^Z?
M]V1\#ES;<4'V8S$$/L)V\17X%YMU75Y;2X_"/S:JE8/MDGLMCZXFN62-VIOJ
M/JKP(CB'[D?;>AKV*IQ8IHO DE]K,\^W[\?&42G+/OWZ_?V7M@+Y=W0__M(V
M\_V<?EI[/%RD_).[3:?X?A6QX95)P.4;DULJYL1%*#I*#46(&2:N2^GRVQ*2
M,"-$CZ(ZX+R!3.2BJ\&XBYG?4]][H@8('<>5P(+*[6$&O]&W-#!4X2NM$7WD
ML]L?@#2UATK=M=.I4]>!!X+[W,#?N0/Z(CX.O7!E#[\A5O>Y?MK /TI!F"%Y
MIP_A/.')Z@-35.T19"+FI.#[;68/55@F>Q;%5@X'*7C$H*KK@*#$:"KNUF8@
M 6PNW=.I84\=DHQ7!P-@2_+;0<I:L!(;Y&[+("F#!X.[]#YM6D,E_OSP8Z %
M#)>GQEKND#YLZ'T2^T,K0S^W6& M&JS#HN\;0JG@02!-#!@1!LIYW1DR^*A<
M5$#M='2[KZC#(<6T\(Z"6\3#D7=WF#WTKDZU6RK<Q'[]V6 C<0OI5#Z;S6>P
MSLYM,XW&LQF6X\*&+7AI5R@:6(QJ:WQ0&U# 4'^D6 ?.;./OAWO0X<T# HN
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M6WY8\O3X?GQ^V3ZJWHU:/\K:(L.2L"]*RGA;V\4CUQV/'-@, RTD1X1\B!6
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MWX\5-;\4<)L-F?'I'5_V,)!$N+:M-F.:@V9%S<'F[#:KF3H&;*^I3K..]0;
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M/3S"2""1JT\JAX7A?W5<SP!!;##8"2D,#D;!H2G@_2$\"@]P.,.7"2=,\!=
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M<D7+.'B2.JD>,_I=.::-%PDA] )J#7 P39>B7X1S[#_8(< %A#R1&3??AHI
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MX_:C!-8-":]D)$L+S,(1O:?3T0T=OD/"+9H6"#C?4[L(KM4199W!);B!_\X
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M0_Q]+A0*E?X_V);V,!B!"WX$V9@+7OPQ88:M!*!Q$C=(C$IKY)I>2(!+U7Z
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MB8H^1)I]EW?I,J@K'#$J(4<=KJ0NG].3/C(>$5+LN>\S$:Q&>4:'R=/U6P1
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M2P.Z%F#"_D?M($@X67'>XYC<4/]*U\!X<_)Q,MUK94B5R+5Z>',^);SYSN=
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M1)&@$%P^ERE5(@DI) \%&'DDS8PJ%EZ%&67YP_0;<0[%T#5%PI]H)I*N7!L
M!&5OT2_?UDOS/\U*=91FBRI87H:?Y6L#EBY]1L%+K"N1 C@\V<HFR^[,=9([
M679?L;T+X1[>!UH1,@(OI'.J+!O'SJ@S=NJ,-G?G:"8^[ZS]7#RK4 ,R<[J]
MQ:#4,(;RS?1FD3JW0)[?L2-B^.S)2>/=FJ<33\_4U+';'4XM'1QXRT:B3Y3<
MD=R3X_2H5/.94K$8(U..%MEB:HO,2/Q(27Q7;TV)C\!;<Q"*B:M90.2.E\-;
M7LRIRF*&#(D8$L5A9YYMMS,O:(_QM0T!/E^,QK*X*-Q.2RDP-Z.5@H%= !P
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M'G?];.[]9D.0TPEH\KJBZU_O"^)65?=YF]B=:OPKBXN@BO$2E%52:B$Y5K*
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M;ANN61!U76>4L  B ,_?IN+S4%J0P1;H0*:=;U<P@5Y"4<!Q9FS%%D*3*^P
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M0"/U9P9M&42=!AZ3W+DQ*,Y2>,;!EH5J;U&<U1L7H_K9?UTQ[(,M9_$+8AD
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M+UE2162TBY<+*-H(!1-I(?  $X:!H6M=W> :"?X[;'P,Z!B#**.K;,XS_.;
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M4;L@5#&!A7^FQ&E<#!;)08O!?K;U+H%4ANT  AUQL J)?B<*ZTA;I[Q3AUL
M<=I\>)3I9ZG#%VJVLA\7(5X3<I34YPDRNLO$%[@>>L!FH.6;1]@$20#*"F5?
M=AD*B*!.OV.$==Y=QC7Q0Z&*'Y(N?BC02^%;!WZE\=+O,1I"[!%VU>2J/H)^
M:X]4$.[!VR5D0!A<)52_@R4K'FV&J(@G4C.P)00L+:\+@==Z9KC:);!@"(E%
M%W8[?BX@V^B5L C"/(CFI)_D3L)XC*&!P3(\%</>ZDW1/KEO"8\G^3D'#>];
M:>#DAUIOF1=QSLA1AV'-:0U>[B;$QLKH*GP /<]AYHI=O$UKOJ.0_J.L[^"&
M]XUO4+!QV$O+\K'W)"_X'0)G^6$NZ$YL;4:4Z[ JDVH:7313D9FU!XTC"_*O
M'<]W'"#H+*R03$\.D<8+G/"0A>'B)$"XRB</=">@- T[B"$<*PRCA0JR$!!=
MG#2:6^#)0(!8ZK(8BHX$@DL)'3 '3]A(^Q</]\PY@\GQFF7L=_D&<1?2?8>U
M0%3R'G>%2KAZJ%Z[;G 8[ <$BS8U63P$3 ?RU2&O2;WUM7EVF#\!GH,)CO3>
MD7(3=7(%R(-T2D*ED70K^ B=AO: =YC-IF[#H)&C !24*,P&@H.+OJ2Z/T%Q
MNORYC[0^\WLMD ])>PA-0M:+PVG',D=>/(UU\#"7 _T]_@+#*1)DDYHE\%?R
M(^E#NI>+!_^^#^HDX:B9U/N/4#NQ+)^.=/ZD6HYT$ PWEFA>UR/-70NY_ EW
MH>&F4&02L4TBI8O\6A$EFKYX.M!AZD00WI7 9;VAB<8RB V0-7S*CL4E"=:-
M\IIP?43] Z22 &]S.=9Y%V1"N&Y57&82E1TF'B)$]>#[>Q6G ',8$>REZ+W1
MT_QVL^1(9'ULA M[Z08]/;F+C[=K#7:'KYLC1<Y_C#_BV0)?$LA758F(O).#
M)&*7EY!2*Q"-BF>%7_.>,'QZC%X)K$(>#6QU2-Q*+@O\,6_@ZS*N<"%$$=(^
MU(8!RTFC^AV^_D"_QST9HKKE0[;V@-RVA$- D6\0XQ!$/HA6?>2-0KY.4%@^
MP3>Q6 % &,\P8IV;OAK%VZ12C:O^I$F')3HQ*6MU^MA/H<WYON&Y?N"WUN Q
M"2&PAF:;*(ZNF-T>@G1<' FKAC3()4_>/A7UKU>CP1=[7#=2%A"[9.[^G@B;
M'%S T7^/(D)"D]!J4Q\FXRN5?+F#Q6P;97,T-E!7G&Z=/H6X/=UZY[S6/B5E
M@^/:%,I!7$T> .4*+VID"G&]'L$D72FA#_#J>+^_APPD"Z:'!(U&@"=CS^4]
MH_KZO4XW@SG]K.PH]< P^P.10U"HWX&6XI'B3R#AP< .X84@8H]T#00JSA3>
M)_7&$.X$]\$ZY#U21@PT:XYIH!D] :%,H&VT6EP(O8B 4 3T CQG]72R6D.M
M1WS8!#FQ@1+%H$*]ZE$@Q)&Q,/L6 6(1@SJ!W8@>!=IU",PGM2?R+2K_= 9]
M-A(13-WPN*H?9O)@P_L6(P0C']8GBB[.SP)H6!I!]_,N,!S!WV13#;I1Q18E
MJOM[,Z@B7&V"G] !$5U9QH;6$]WLJ0\<=W_1&RZQT59)%>8FCS$+-/79:86!
M^V-@FRB./H4KU F/@)00P\O>;!+-=\:Q<QJZEFOP5J(P:'(!+&I#G#+4(^HD
M=6@[6H/I6[Q&;HG89+=QO[_,][.6EV\[M:QY>1YR%=%$G'<?\R6U4CU1*X7"
MC-<(-;<(*,/:CDNTYDM@7=[=8=\Y%^5MU!$4A"E\ R0"E3.+YRSW)HRV"1<$
MMTL)%$OK26 M\@"I09L=!+OJ!BQ/G9?@$8R3HH\+C$-KZAX2_2;\"X^OQQ?Q
M49 J6ITF/$ZJ+R3P-B2;+>[^)#0L8$ \J9@;TMO?F__[Z$T80N)*,^Y.LJ^1
M':  24D4H/A,"YE39)2:V3_C'+80$RA<V_G"$6^?_FA4)LVQ=6$_O2I#<RLH
M3G1?^U \"L^Z$- ^$C4L<IG3L1-*]+(3>P 2H(^9&#:\$/0^D&-A/8\[Q-^O
M%?A'DB( YCF[??I:-[K?!Y]_7)0*\<@\STG0GD;QJ5W4;RYJE!8 _SRMM9MU
MI79YIIPU+VXZC3/ELM%1+EKMMG+5N%;JK2]?X(?MS[7KQO2R@XR7<(;+= 9,
ME#1Y($T=.*1KZRHBH=\SS&&!F6JF<SB%7D$9,',S969 =:8(%%^Q$2K,V$CE
MP6;*&6#-^/'_O0-VD(QR?%+BFD\EH@/=!N) >J7J:#2)2N?:H^[<WDJ X6O?
M  I!#7/A=?O4O;+UO_XM._FJ[N_BQC, @AE%S/V-DWB;^W;\ZGV[M,R%6V<6
M>T6W-;IQJ^7M;1U,ZM#^";:O<1MC>JSOV!7'5ZYSU_@K_Z.7';MU[EO^U?NV
M[-AY#>_B4WEX_,/X-SMVZ]Z^<]RT7*Y:X-N76__V?7YB)_73SR6]=_>FMR^N
M%O9-:DOES527IF?0C!3Q4F5;A_M<>'1XC2J?"T81LF.^7M[>VH9VJ)'=%PL;
MV?&9-#"+Y4W=NMLT&723\3EQDO*_WQY)MRAR:MX=Y@H7\BJ?!ZI*OW5MY1<Q
MKX.F3$)\'_X8&-OR[H:98-K,29HJW.O.%NYMOG9$!F7XU(NY@$'R;^JP953?
MK8A+)-7Y'R0,,Q&7SIOM[?JHWK"OX0U2,>/#C ]_4BK^A-=: K09GJ+ YTVM
MC-[HB4D,J?DL,U)G7/V62)UQ]9LE]>KW<AQB[?_4ZXW&^?D:KNPXFN@?3U?/
MP.-U/NEFS!C];_V ]2DD3$;MU ^:43NC]EL=-,74?MWU_S 'L'Z-_3IB] *J
MM=!<F$#&-SM?0WH&S:B=4?NM#II1.Z/V\^][/T,Z5PO5 EXRE\.#(#C([=./
M+W_]R)7_>3A]J+Q[OH8PZR"08XA2K2)6:D7UA<*:]86:85@</TFQ!GP>THO
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M\YA?JW=\LQ[QV;0ZB;_,)R)!F&<QE[?/;\LR,S=K>3PO+W3MQL%BV^!E3)M
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M=3=FU/U<.0?;TX9GSMC8@J-JV1.E:3J>K:'N6;=$&BF\\C^<2O( GN3RJQU
MGR1-GR!?M$=]Y(T:C_!*SV:WO9C>C.-Q;IQ;%LI]U6N?YT-:3Y$5Z,",_IHJ
MW"XM"=?R_ZR-38] +0EQWE!S%--R@2VP^SQ:'7T*76+BL E<HCL^IV&$$]X
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M][\J(19$VXM/S=51@PJ%YVD.D9=H0)&Y+Y+AV0-!!:2.H(SXZKWT_X-]-S9
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M;@0:..OSX(W,8:+OQ?F1LPZFK)&2\KMF>IH]0:<I7EU\ ']@^$'XX;[>)U_
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M=VC9,"V>R82W EA5L<"NC2C" 9\V35K8(/Y0/OY0;I4+:?%8\]$G\ZL)H=>
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MW5KA0MA" ]%5Q._^7C$?TNRD^%W4W6'F9+0"(2Q;UL*E7LR'L\!EG@FWE?"
M6R:FG4QEBX?&EEG@WYOEYM__?/WZEUU\]ID-S6R^7@ 3E9G@LZ_?>#.'4FG;
MW<,79,K%]&#8W^,Y!ZA!Q&A\TC,T0_HV1WKN6-=^"\\H<SSEAY-^X\=?S='3
M7*C!3Q>U/V=W-6;HA;N[3C?A5($RM6/9F9H>V;\0M/;8<AP=TV)"[5-%'PT;
MRT28@Q'9/NI[<"K12+,GPF.])2UJ_2'AMZLOR6I+<IY]%'H2Z4R=H!^N_)&,
MK@!K^)FNE"$E7,E82(T8K,J!]EX$@>)1-*8!50^Z[Y5\P4_8])O^KH8^=#1_
MKJ*G[@##I1,JN0]Z%:PR.01F4> Y0X>'R&4>;AILAU%?LU+GY//\I>6B6BGO
M'YZRC2F =Q9%Z_3!=&Z[G\,*['+/?)R$51+"9W+!0UG?O'^+A-CF2%ZZJ9SD
ME+XV"76]GHZBQO;F$*>B*_FW%T&HX2_U<Y,)J8>':;G?#(UNE-6HG^WOZ3RZ
MZ8-_SR$&(0)QV BTI<84C(-K@$5A?H!,< @I7CS0=#^U7#<I,WKNB[!_@'B3
M&E#1)Y]%D53-H2[92E=S8-)C49\0M->1IY1H&5F&0&JAT'!;)#47060=G+SW
MP9%"G<5K/3=XA-R,1+C@#4BS>U@>[GPF!9(O!5IFC_&C[[/4[)T6]46CYPHE
M/QN%^\3+N^;7G=+G^"B_C3T/<J'#N<_3N='/7G<D-7IN"O4[2EX.)4JO_H*8
ME.IW,A4Z2*-^]H1S1X62;FX[0N3VTS3UDW+E9%USW_!D=9//[0'N20&_;[FR
MF5ID#918GQAN3!/[9?P6PNEW^=RT!<UP&R$/B*$Y3FL@+IR6396R@8>"\EW\
MKQWQO2-](MSC^73_9[TP^O/W._8YO]@G\J*7)< 5NBPRMD9'R1B]FR0P.!DR
M$9&&4Y=.$2$+7!^&8$)%+4E*#0^4UHP+T["QJ>)"7MJ.LT.%B"QNL('-N,(#
M>5E=6BY/O]2M/C6ZDC='<&G<]MVS)1G%L;=0-&.4FV%R3!G3:8VN'J^L3^-"
MJ_?N-2F L:,_\R([=%COU[YG][7)N_ 5NP*)L'G0=$*C8),-Q6[0]20;L?*:
M><R(=9F)6R^4E,#]R>>"9?I:;SCE9LKD4!J.=JKDD#Y0Y7785RS3F"CP">]*
MRK!5#^LK(#!<Q=$,%DUEG^.K93\\T"C1B8]-8EG?6=Q/XWFI[B\57G.@RW0S
MA!2VZ5SXV(D18%ED&MM(BR\?E>(R438I!(.,MP.L].DC*V.B&G8)YJ'0L:&[
MCF!&_A'!$C.S[TRWY.68-#83#7SEI^]5&@\5.^RV:6L4 "?/OP@$:$HQ=P@?
M^%\*#SOC *HBW@8_M?M\(K[S'Q^* )[$R6[\;BHP\ &GFHGM%$C"MR&V;49Q
M$]F-?5Z@29<QHAEDG 6BG6K]#.JU2:&:!S_(33/A^$5D4D5/!<[1+P$T78P<
MQQ]#/V44P;"ZUCWW&*)HU4T/?T<Z$3V(*^4Q9[\VDD]#MM4-WG\4?_P$AL<;
M#2ND.Y34'.SOX=;[D<_IB!(/&E'H))K9/!M?\@.=6/ 0XDK>=9W=PQOT@2AQ
M\$P:T@>(0F\4,"ZJ-+#LH.!5'(( YXON,521..P6AF>U,=QH/1J/SEWXYX;V
MX!PIS4C@60&Q;CAQ<3 <'6&MY-156)>I\5H_GH]!H> 0=#@M@%J_T%1DD)JB
MK ^Z,YR& 9MY(WS?MQ3'XD%A@;4E8\-4ZZ@[JD#<PC!W'PN5]2XO6@YMF+*C
MIH99!/?%& D^7W!MGV(V'B6C@E1]78*&*%3PM3\$0!-P;CW=[GDCS"#I<8@T
MGKZXOR?X"<^IRQ.*HLHA]5F:5@6G%48X,<R^PR78E/N! & :K\K_;#W V+9*
MY@J0/L+,7698#RJ_7!XB&5#HM0DO!04 4<'D2F$4\<[U Q(T(HFB*)V/E)K
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MG^HW]V.C5)F8I0)H&[7FM?*U=G'34+XT:NV;ZT;6-WF=J;6E-5OE9,'*P-X
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MWK9"BB#.46A+O+4,I833HI2\^.9(:3QJ6!I$X4'^74$^Q:NSF/*#A/AB^>V
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MRR#7F=*Z5*X;]9OKZ^;E)^6TUFX&,:]Y+JT5TEU6)^)JB3&Q+JU5Z3I]]?/
M=\SMOSS;ZCFOG<[,$4_SRCB<A=%_,;.\^WA&4 AT:45NF^BU_)*YRFRLF=E^
M4,3.^Q0BVKQB$8M4'^ #_/C_WA6FDZC6M#\QZUMC%H10H#:T-[$;L5X&BU'
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MDD_/&BC-$&9=S>OKV+OSMU^TJ#-_?>7^Z[_<SP^+Q:WO]Z)$NQ0#1VQZK[:
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M=P0[L"T#J A2( 048E-"/NS(D5)SJ-D<-9[WMUW%-TV=?Y!SG'[P-D*3H'W
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MG"Q",F-F#Y$L#["?DI(O9X&=!%[</IP5$SC=?8'3G45Z=G[05G5]C486PB7
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MX+%F)-4;V+:,>Y/$O2^J.0ENT.VDMYZHU9/$( 84U9/9])QD*#:4?RQ$A7+
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MOTY/A"=1ZMQQKR>8/D^&[;NH!#)W[!@C-CD23:C\9%_RK3L]83] 5<84)6$
M1$/OE*A@/S-'!:79@8W$)"9T_LF_5#0O'VVXJE>]GY%\"6E"&=Q("=-(R,Z<
MVRX8I7&;0!@3.")_-,P(D39(Q$ (;!![!,L5I#[H(]=V1C+]P)9)"H\S3W3O
MIH ??CAB%L/L@=,3WFH$3=0 QH53R4V.A>TA/102B1LR,L AG?/7%ME6/-5,
M'!,U_+WR9-.ZR-P&,KC![!G[#II"YA+WA3ECPR6MRR8;@A0B,O_0R0TFO"42
M?;BI>A$<:VD$Q[+M>(J-"!R**,[&8R]6)##.Q5K0="CL35:4@H:RN>XI1/D[
M%@NG_&3#-8"(9J<G5R&2F7 W_9,%H6V@8H[Y6\Y2B: 9<4G/ X)@N0)S&ICU
M,\<44Y&'Y<T<QN#,6MZ,SI3)>-M[. VK^&GUEA>WY9'.AT Q[7;D(SK[=*@G
MTM5FHE3GWCG7PXU$AQG8@:;Q'Y(XZ)-BL52)0 0;8N EQK[HN8GBN_**YT@4
M&'3305ZA245OF#-O9O,X'GU \@DDCN'.X.?HYPH'IMQ@H6XX^G/@5<&T"1TL
M2^[4PDMGQO0)'ZYFMB+53-$PZ/3D6]@QZ$IV#!+2YMN+;8566%(?PQ<B7(K[
MB3_R0;_DR='P^DD(:02/C$+L?.[1Y<DWPE,73>,4L63D-DHWE4-BPN"_085Q
M+Y2/F+ %]UX0J]6C3>?I5M;-L<^CF"&CPRMT:N=B&A83_ UJ]Q/CBH;T(4X2
M3EHO2 /">._41M<PPJ]4C!$VQ4*C7J%5K]'K8J%KG4L_K>)@9 _K[8"TNC7U
M[<$O!5CA0]%6*!X"3(4-RD;]&GA7,:GF+SDRU6X0N-FG]H)7%C9KSQOSG>0
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M_<Q8+.A*QH/]._P/=9FZQ"Q'NBR#[B/B01( ,_D<SX:,2+)UJD>(8AX7<TX
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M1(P5F/[T*=P!!)LIX.3<X+V\80Q=.K++IA7"Z<-UC'V*>,SB6$1]Z<F.L6^
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MW;SC0--!0\E873&%ZP0@6]!]6WF>(>0J-<@+H*&7 60V[YV'K3Y-Q%)ESMB
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M&6L&+"D#MM1>MU'S7\U_!^*_KMIHOSZB5OI5K/FOI/P'%W"[]WH_8.F7L6;
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M$BTT)>15N8+K&RN_2Q!Z>D((AX-!MV;"0T%=8BUF7-F!+Z(UCIZC6ZX^YNA
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M%QU5&U)9QM)@I%,!'\+,'AW=$(?'-DS.3[SS#'P&V@^((3S(\EV?\7$X"GS
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M^JS),G*IY%%VF.?85,V')J(@)TERS&H$Y3$\_5)MB=B>+GJ$D)1_^Q;7YO
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M2]9DZ5HRV2QSVY6N:=H6P)V?S<QDI:6]_:HVK)\<'MR<GYY?W5W^BUS<WOY
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MJ$\Y3Q3M*<E7-7VEVHDJ.25.KN>J*B>58__,*G2M)1] IJ)A1<,S=K8B8$7
M$A,P".&N=#0LHY]HAZ5.,F;<Y#*0P1G(\J*^PZHB!I;U72EM <7G>7:;6E=7
MFI@B86E)N*%UFM*ANRD"5@2<.K]J-:W=DHZ$)7& O79&KBS]5,X)+6>#7T6
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MJ;I[*.K;H?CK-J2#2%5^F>6JBQ\Q2\R8_1HS-U#NE[WE75WKU*7C746 >T.
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M/5;WQSX3H I(*=I3PJ^"NDNU<WANV)A.,*EX/Q06%43>)M]CJ;C>J;;77[*
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M/\&V6OA?/A3LK3\Z(3=L1&TW7?'A 7XLI@X_#=+WPECWC Q\;P2?!##X$,[
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M22M$*^)"AHQ5L)@8]-S:*EX,4:]KM45'[>LJ"*EKW4XQ]2#2;D%K%:M]O[<
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M7D%%K<XWS_=,DR^=AA'B4XJ?CGT;M@\V@%@1([Q]@<],[][E2?@XHN,%O&H
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M9N0(5W?.*O$?W:AIM1K_!R,=AP=UK=6MS57I+[BMDR"&*/L1<(HPB;$ ;W3
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MM^C(BLEO7FZA2YX+WP[VV(&YX@4K.HK^[<TOZQ?H"4FPE1S#!B:1V<_4X?;
M[9"Q,*@0L/-R;6@5_+U$;^+[62H([=5\G?[+I[41"F])^_61Q!26ZM%<QUY]
M&[<#IYVWEMR)OX*]WQ(4=G%;+O.V/ G;M"5*7 5!X-/\/,N7C)6$Y_YTRSU2
MZ*W^%<?>4Y?UA^WOT2;0Z>5 2R0T*D!'=)Y1-,4PS[.FI]''#1$_"H4(U_6N
MIK<7H/8D 3AO=[7.(H#V=L!&5H!YR2..Q1EE0H]E RO7VUJ[7AGL;:.A-6N;
M OB5S<2+TTC#@L(O'\<.R]TBO:,UFVOBOY0X&Y 5>L7 N?/.;HFBPT,-\[-?
M1RE:61$J%1A5KVFU17#4)<K2JC.1;QL,0VNT%@"K-]J&+0@5(Y<P#;'+'$CV
MN948&Y[(EF"J]$Y3:^KME5:Q.5E6?1,:3:U;?Y8W5]J$[>,9GXG \GP FQQA
M,<B[#V7?+L__<)MWW2:SV:%RLFA5E+4Q1[JFUU?HM_"N[(G4M49W0=Y43QG9
MJ<+?TIKKPNV7J.]WJM"FH[K*?K-9;%.6EVCZ6F.K/564HI\G:0U0]!=.864-
M=\%W*-\.Z%JG48RELQ5<V:4*_GP&H.1J;EWK+OIM7I>FW]9J[85.&B_3\PN
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M"I5NOP61NP1TZ= =1GNJ<PG'$MP)>I1-+M62_*N:-UJ6E)W&K\,/G&'A1L=
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MK=8$PAL.;=U MP&>[<>^D4<$9#&'*0+<VV*7".RCMMM2#@+. 1KYKE-G*-X
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M/[4Z&@U*; XZW8N/5&M.GVE;<\3"TS=4!1#!1I.MDVKOSE8]9ZXAWYA2&:]
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MV5+N&GR>>+J<-&AQ$9SH4-9XOF74;#S+;65;4E0#T\%Y'MF79-VH?DCTG\Z
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M3KI+Y;Q"MU\[O$N6M-4T7J%J'TE:XM%BN:"VME!*&UA=9Y[HZ.%$3?6$W.+
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M<RK%.3UE#;?G#]:&/:?A@B"P87SIPU18(PB%U=++018R+M([,\VRR! 6ES"
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M7>YS8;TN*__/@TF\0J=COJ7;[NPZH/:%]4!12*K&.'O6LK61(OQK_N)O+YF
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M<Z+I53;A!? -6^77+30 TDP)UXV'F"0*VBH2U@EC3MBF"+9[_._>^_KL5:E
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M8FP46-,X/6-) X@Y0AJ7K6R"TN7<JY,8W"-OSZY0<BDV$T6Y).X YDU+M'#
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M.GKS19G['3<$4\?*+HU)+$%]8J.-_AMP1QM[BV;"FB^U:MR^<G;;YO)N?@U
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M%4T'[>B,@G$/7:?,Y4"8[\W^;*$.."#]-[50V9E FPS/[1Y2(-4)R,QV%S0
M0E1WU93'_5D [)D'MTG#M5^8@E_&N-^KA05#J </P:>/86L> '$B/B4\6_9(
M<?,?_I$"O/@E5%N*<T2NVP5%WX*76N2Y#]KX51SH"GB44C:<Q<GRS.!(!,=&
M^MU57&+,J,\/CY*VVE"?<$QY#F)X-RZ+Z[6<0TK&-4.W/!=9^H:Q'(<D<X.T
MP/!PSX5'%,W+YC.E6ZDVG]+DZUD'?TG<$)X+=&E/S!*$ETIL'E/SC#3+?-G@
M&.3A^S5;0-LUZ+K@-[OA*S.1M>#"5\I[.?2FW$WR3HZ$T&XYMU(!>P%=N>]Q
M;_2V/RV:T537Y+IY&_)\S#?=?>6OSB.2Z#?)DF4#> P?,8?%Z<M_UEPM.*NZ
MK05=>NO&5E@*NM%M_\[,^W)U@M8%L7O#]T1CZE:6UEJA#G5F[28PE S'-V;0
M T27;\2E2/[1)XMQ,_KI\.+.7W4[&5CCQM_W6:9F7:.MKW"D>,_N&^(B3P\<
MS\9IJ;7K#9="@CY&/%Y3R5;J\#8*SWU2J<_(\U%K+%E2D=E?[?Y]2'FV(%Z2
M3G?-V!"-X,UH KO;]4P0IH8-3?GP4*WS,R?BNLN;W"/RQ=_RNY+5(LRKT?!I
M WD8C05=Z4Z9= >SC]9/!/NT$(WMQ3R(=$BQX2PRP03#(\%TQ'"UT0L J2MU
M/NGFG<['<PR#MT(3FI%AF[UZ%EN$Y:CX2[6@I+BQ&6-J>?\ W#VADR4*\,I,
M/95 V-PX'5FG3ZR[330C'(,)FR'BTPHI^T(DKY;JD67UA8[D9NNG$ZH!(Z*S
M].-5I\TSE>/$JV13R\/+K5J?.@Q9UMD7E\3@LAWUX:H&4W=EMGVZ81>+EH''
MN4/3 S(D,43U9SDNV,XD5_2Z5CFND=L=4N45@TH8K)62/S#BB>"(?>R2CB]?
M;D\ZFI9J [8VQ0"?C702P&LZZNZABA7\EKKXCG'+,^^+_BRS>/\8PV6!V^V5
M;B-APK/XU3#HC]9@H>O?F7"ZJB%1Y?=^!\LOV%N"#$TU-6>I<^W2=+A+V?H]
M]]5M@BW5^U,;RYRIP+"3M7Z_$KS> T@)[\Q;OEN+R8-?4 #&/1Y^X..,(G\4
MU39U <_1*%I[>>[XD?5L52CR0=J/@J%QL5]XWLZ]*-D,D@>R;O:EG1+\3<=\
MZ -=;G:*2\05 <L%6#.B%5%1U!YH]1SVXQQ!DF^P/KT<,]!^.R)G=L  .,3L
MC3$TDI$!DI5JF$4/5_0[F:JR@-Q+" H(O>C5N4"NA%2U,DGGW=(E@GCD(9AV
M?=&;)#0G7?8N^^]+/HORBK^WN,A3"X_VLWL2L,AL;I$6JZG\JA#D(>]M6^A0
MR[-OGA,%7M+5Z>6O,5/PX7=HWRC;T'G1X:B/*RN]K/D"!JJ99EAO.87)ABF\
M?="RJ9?+2..?&W]V02TB)?1[I0F9DB679&D*+,[5KA1AZR\4$V_5]"YQ(YI:
M-$*YDR09H!*$'!)&61I<%11A;0S2RM;/SQ.E^\HY)0;WJM8PAKLLUI=]*..]
M!3$=*6=^V=3D)+PAF( "2G3#=&YMUK('_S'&T_KQXT\>J_Z3Z:3S[Q&Q%&2$
M_R*T[_\$SMA9"P>I>CV,0LX22_7HG\]QKTH+ZYDQ_9QH[&8^]^QH1VCODZ0>
MU.87?MN+%G6\B&J"E8#WH;4X2UCG+]X'C'M\T^FU6F4CPWGG@U3 D<*<%S>2
MD-?4TEBW7:I7?3RE):HT,JB^@:TIK2-B-A6_9D#P7!DS8D4JQ-Q124%:"SWA
M070CI&1-0FY4 XUW<Q-$ES15AEKAE9N%D;^F5.HEJ\;K&01\K]-@].Q;ZMF)
M/!'O^*C;#0[3H+9^KB?J-?&E1F;MVY)['&L"#R_Z_'$<ZP08N)MP],O\DB]_
M!V"3/-()#'[6#>"UQ,[B&?AKBVVZS#\QT3Q^W0.O2D'4B3!3%$O^.?;*8U2#
M^)/?2>NE58GU]-]/QS_JP[QF_K^\]O4GXQ =3<8,[:2Q#&C=VM[U]>6CA> <
MH4X-$(_"H-H4]@!28UPH(/[CW12!U8HI_8U==+0NHY-[THV)H2!)#.OCQW7Q
MZA\:Z@5F/6R"[#_=X1:G$19*-Y=%K\;33JA&>2_\/ARI,1\:_IQFMLZK5R>W
ME^)##4+8 5R_\]5^VBX"BQ,6,1X-)+*W8_JPC\!C7\Z:LX3C5.JQ#Q=0>\F8
M75E9=.#8L3::1(0(:MCW?^ F3_NZIQO!67*M0^ID8;99:S8&AV#]*K9;7'<G
M^D!;+#TG':/ ER%/RS+(HSYHFIMGH_[R0.M^NL0,K/W1C'%>L^LE@JAK&*V"
MCWB-\".BG;$BF.ZG,H2CN9&(6T(2/%3[,7O,:8YIVB-"[S##!B6DEME_$L#F
M>@#!MNXK3M<R<_S9/I<E:!Y YWO1/?IA!V^8>T\[L#IWX<"9UZ<AO'<4.YH\
M"F.#QV3 <0.@II^]B$=MQ+\AV-[4/QNAPJ<WN)_*:,0!CM;<_#8[O$Z0VESH
MP>&2YL)F&64]+,?B5NBBY]6'BG9R;CY4A%/1,/)XH[>E/2LM5Q):G&*V6+[6
MLP)R1!T@IYEWONX@KAZ3_N<6E6Y7RK[):L)-ZR]BXLW.]E! (4R'>+S7[RUN
M3.$@NOK=U3[A#O]S(O#GR"!WTNM9'3JF;I/[$!0@Q/#**O(63>Q8T*_Q_F+D
MM<R[::<>(P;^ >$H2Y2M;L^7DY<5=06J+FH35V+.]:P?"]^K ^F.L<)]^PO(
MWZEXR<AM=/X4;9[#A\?/&!Z5V-L#GC%E8KDT!*;\;*H<>:_XD9#?]KD8T!Z8
MJ\PY<Q_8F8!?TJFJL,CZ''G!^.9E&_7C=1GG4/I'9)HNR9Q6G9J#L9 BW;F/
M^?NFUO@.;E:$DD3EBQ_#31;.AY1"=924&6H6+ ??2@&T$PW#,G9:!<RYCP_?
MW\7P$>@[V 9*%9M=(&F_&5RZ0P(;*"$[,<J=#Q.)[3&J;G+%Q_>RM1FF1+>=
M'$Q'8%2$ABYL0P$#H_ZB]>4UZHDEFEZ?&HL*K+/->G198_TOAZSS$HH6)8A*
M$5/D^OU3A[ZQ"!$:G&,GYMW):^VI<98S,#+NA2JE5-+LON!X_Y-W5H>D:K6K
M^/F^*\)Z OML4OSW!;W(W.BL^=F"]'YVV5?S'>1R+D9>'X[DM:W#%ZV_R*;]
MC'RQ6<AU66!3HM9_AC]BV__6=1L!-7J")!4_L(H9"GCQG(JBB44[W*FMB_S]
M\15H.GU;K4Z/M-3WW4LK,TK!_J6#R28^>"W3/H(-0<>CGFRI3>^@IF$(=KV7
MA1G\T5OYI3P!-3R(RCX^ZH!=IL8PF$RB ^(YH_OR-FKT@MWDX<<])"CB_SZ5
M<\<6Q&P'GQ&)8BFH$Z1  7]T-)7/5AYC1]Y  ;-T![]5EU:)F1-;T>^YTVPG
M?0^_<;"G37[<6CGQ160W!_:ATX8@9P1HC;<E+ME4C[E5;ZGL5NT?-'OX"X1Q
M3^A6)RV@:D?/\@KS$X5"_QM>*"!=TY WL*28Y6UJ\F&+\?.)$!=4]'/S5U*<
M:9"/<&_\W.;MA0O7V]<2MFN^%\"88H:0TC J/\"L/VD&AJP%IM8Y:7SYD_T*
MP=]? U#4$!ZVXW?4RC]'S^D$^O&$21*P#H;:3<S4E9I;T(>X;+\KCX1S61CZ
MP$ A^C3?4R]!7_V+HXR-YTXS>E3@J2K"/L*)@'];C[;6%A[.]V@\ZT&E=L[(
M-]4YN$TU_'%P[<.O*UUZ.,8Y-%1+9)Z>7#ER;WA]\2)"1<O\;EI=N1Z@"5;$
MVL^5!O)MVJ:4H%^7^54UK=.6FKU/:<OKK"W+DKGP[E# &X,KDN!2MRN+HB]]
MIG>!/^NLQ>%+A?#[V(:NN],_O[%9J7>==4B)DC.?M,&*(BNRSKXPJ?*DB$>_
ME3A>Y04O,+T9ZU56Q%!S-TG;X2[[4H9WJ\38O!)NV."#\&U/U/HU*AS5[?#:
MH?N3@^Z0SG=!^)%.\?A<O]\- =1_!RA":?+>_35#[/_G2%'RD*,^5[LVV-;)
M%:OT$(R[SU.:5T_RIK?<0G5P$Y'UBCRRNM\)"T>W(M(X2'&W7VHS/%+H2<7(
M*>P9=[W4AHW8D1CH?G=E.M/ZY1/PPOQBF<IL]BK^64I6ZO!<M07ZW9V4[]62
M %9M^C?>;]RE5-L@IIU>;>M9 CN$'3  #1SJTW8>Q_9V(=KO25PNE)O(8^)^
ML%_#26"!U^,$I[W\J#S*C?J9!K?,@XM->WT1N'YR^XW.X+ PZHO5<(?S,E%"
M+W-IOM>5=!]\>MT&B#V(FPLF%@;,[+8&<PE7?8#6;OEQDGTZJ5A[BCEW^JWK
M0+N"95WO8PW;<!5G9B*+.2O,@<I H4;\J/$F4J8-'9%YJL\:N2HHO"GIX\W'
MK $*NXB.:ZD3]3L&&1GK,3_W#5OW]9XF@'E_H?=D+?_-?U.AR+I#_:"K37)G
M#+@NO+YE\WO!0UVM"<O3SFY/8F=&91&%["^VTK%5SL^;I%8ZO8L/HSK.&;6+
M[3MJE%659GV$BS6JO-@1I[N72&)PQ=BXBTM<M!HDF50)>C=,?P2&A7]#TO4Z
M()954^/<8^"MX#'M0, H>'?$&#5!$F']5#C.?,9'NW7^73FU!73:(YR[V.?Z
MZ94; L8=97AQJZ,?]SZ2)P0[;-U*2/FKLL9EIT7O^"Q[=;N?RH\-.B2E($)W
M%9Q8-0OC /.WOZAD#UOD":-[!7>XB:ON.$8P0A*3SB>WT5EP?#\8$[TV:1VX
M5^F(IUWF-!YMFU+:#L_Z/=KOW:T28-OV<"NCG'Y75[=0']H3;! .>NF"Q",4
M:+Z;0+85KY.F8,18F^YM$=/\LE TS]7'__,,^1/I36#([0ZY$%NJ?]">9H-:
MF&-!&63(B$]7JE#R')-.:%4;((3?WX29HDQ>T,%%/Y)Z-3O:\##(PKN3JS5!
M8*DF!]@G>'6)O=E">1L+NJX_*LX*6K ,?$G[IE7;Z2'[JO2BG<M^\9;#.B<Z
MO(*&8; K1'#G-!\<5"3JH4%/9J**>8/1N-:G::4J;J3":!.#Y7A7!/ZKSHTZ
MC?4OELK8?$JP>]2>T6>^!T,!CC/@0*L)62A ,Z4Z1M'LM^9SIX;[=W?>5+>O
M' 1<7&BBJN7,)+L63E][Z6F&$KPL^ 03FJP-U/U2/D".OG (_I6 3-;RTDKM
M?C@SAKB=2\'BD 4>FZ8<1G+>%'V]I,#/C]YQJL?#%GG-5II[:1[<_%! Y2<6
M_W<&Z0.YEOMO-5-[IS^YJ[27W'=BI(Y]6 C?23?W.^^_URH1L:E<$"6:*OSU
M,-!)(-%#32)UX208P\&(%:OI]22T&ICURR:_P\8*OP/A7EI*P:/^)*D@3R;3
MDYR*%^];^GA*P7L<U02VE3V,, ]@Q>IB_"*+6QOQE9Q0Q?Q'<.<])#V,%E]B
MGENGCV)S9S[N1PEH[^[.'4U2E9&8/>H*?V8O:<*/C[::T7Y!GJG&;XO"6.P7
M0J00*A0@U>T102C,T92T.!RSZ)79E,S" ID3H*UU#TKF=SD7=0'1]V,-&X8X
M]R(!+'7-5YLW^#_I5<9.N<W=@7[QO?K8X3#P]'-,^_%&/E ET3:'AH3ELYUZ
MRI!WV#LZZRI%\&(4%* BGZZH19-5ES+$@"G^T&@4G3UO[\:_$QT>FC5_]-T0
M]_*E[8<V=HFCGG7SPO.5CX38=.>!6X5[Y646#IB2V4T38F%V>9+PY9]9Q&5F
MLEV?Z7&US6N9<$<DG#N3C#>!(&]</CY$T$L'>B'6V>SH]JQ:U#,W$>D[L'PX
MV384RU3^(D8(=UGR4Z_3.PAOB$<<+5EUYG$XZ.];5R?^/MIL1DE_<?$=0IX/
M0Q5XA_0_:;TP[8_]."5,>2KNL(),"S?0\^!,<!WQ]FL119@;J_ +UNQ#X8><
MQWM(]:6*Y]$9&]FRX,Q*A3B<T,TQJ_9MNL_AKX]IV;KBS!;Y3_&BG$DJ*0S"
M^A3A@QY00*!Z<I<@:5T@.60,0VS'NE<>1O86W)TNG7P_:KT#)K \RT%-%F%Q
M@E_S\KMP; )FZ/!R8Y2^?8R=-'3*YUQB6L?BE%PXY($"#I3>F 3S1/1O%5 E
M;E[ ]W::Y'(0$#%55L?[E^8QOH,;L-*5X,<OK&>C)\Z4A#A>RS>>/8T*Q;T_
M=8!T*6H2CKNX?.8Y[VDQ:VWSFH]]Q_9 ^[ZH-]P]9?07<<*I4CJ!;MH&T Z6
M;>1E;F7/;\FA /*(LZN?H"<\(H\A9_E;='J\1[T8%)JL&AZ9_Q]>_1JRP6;Q
MMORH-YJ%NW?88T9/.R%D-B\73J)IAB[[,S?U]KY U^_-)]K[X^+YVL7100OD
MJ$6OW<>)C*F4@G,0KC9)], EBJTD9^R-))=SK:EJW%VN2K&*)HN*'4J.ZT=C
M!,X))Q[V\=>G Q3#KO(J#BO-.E%RD\<4IEE^"*;#N )M?$ P?!EV2+8>$9=J
MT-&7"RF3S:7:LF9S;0N6]Q-\'Y'-".Q0=_QO,0ZTE+;LFA)[@L'<P/@4QW*S
MJE?2;QBBK+-]\"1)H\JI:\<KFA3,J%)?98<-?.4"Q*-W YY O&IG6%GS!$;U
MAJ'D<1+">H,WQ=('456\@6Y23+84EAL"=FJ*RI,\7TR".M8%6@6DM4:=?4D2
MUXD$O*PQ[V;&O[2XG0;HVH0Y=D$!>:LSH^T-MJ"7_(];D&OZ7LT_V':VEM_D
MOXEM>:R4M">*G>I7TR#+M/'OC24):0&7_%,6J2!Q99W[U"R,-,^KC:LRYMM&
M$&-"Q/$TGJ$P8S'=*C$://X:TY56A)S\A5339Q:,,FKN$:",*EO_CN(%T!Y2
MB3O'4;[;0ADEV]0<ORX  L[NV*HF4U\.V2OE5B%*-%Y@1\+WI'AGJ,+5IQJ@
MU,KA1#Y'\G3.T;K&<',XCOM 35E_$&K??R#&);=3YC_"2(DRO55S_5 VW7W!
M($8%JF91T8Z17%4Q;*S]&&U'#M?S[J9XPC/84%F5H(-TT?VS<^$1M^E"^NK'
M.]4ZR[(TKN+Y<XYNNY=@!2\5J@35ACOS5O+LY"[WJB3U<<75W&_.X;0=A(2&
M]MQ$IW3,+V0Z]&K9^H>+*U!9>W&5U,6TI2_3XMM/YY>$:;CI].[4B@@9<1G?
M]@P.5^U0TPIHU1O("^U9>P$A([JMJT6]6Z>D'X8:D&8['8F 0H&NS9,M5FWZ
MO99<$'Y9<[/[;/$<G7F&<(3P'!];;L+MRFYYE;U\W8YL(1,F@T5^N +A_-O(
M)ZL?_+::8LE?1:3K.785_]F0=^-J:_3<NR\Y9BL^ZR18$J8 ;;0W&^M= 2%[
MI>A&^+)*D;US?</G7C*_Y]=R'_\8C/[\<W)JYD3RH0SG[&BI_[8?0ED79T"L
MB\4#\#ZRF*?O?'0%/E(U1)&3-,)HUT+;]62M3&EY;3*-3@VB=I>=Z&;,\XKA
MZWYWPQ'Z&A1PO1SQ/&L^,5BV\<76#BZ%TTBUPS=D0W$-<OLN;\7LS#+-4][O
MITZA++\0[Z& %HN@<*S<@I/MV9"UW0+%L<5U\*G:5P8. BO>$^V4%;E?GQ0R
M]MU-QFLW;HTR: G2MGKW49M!=*"(]:"70RAG7X1I)[/1WQ%&1[*9TR_H>#/C
MZVBK=[%,;)G*=.$^NU7DOD:*X9M>+)?==2-1+U/%,"]2 WKO15OH B;>_43/
MFY6X",&AWXZ-XR=N35]3.6XB,4/[7I-N(NUVTSWB@'G\[5R27  )X,W![,]4
M+<GA458+=&!X:<W5QTZ49GV18@U/Z%S09+%.Q"P;WT=9FW9M;+5@]>/S.W*^
M81"SG::H:-%\#Z7;.JF@I.1 F2(1NVS5^(EE55=5C'B]2IQ-RO% ^#&2 #<N
M/)A#;3VU(;<FD8PL'^V@K4=>J+V"B=_4\GFR7=Z\*,>86(QH_ <46B&[D5(6
M,5I^_?5DX.M;!YGY_H3]AQU?^T^&I6CH[DE-31%$>)[T_,K&ZT<7W/,WZ5_U
MSDGW6J]G8/G>[$KLH'MSN@/Y), %F8?!]$Q!V^^>+U'31\@1R9EW^+[%?]:-
M'BLX3:?\?_LOD&$]+/6H8,U^?Y]VF"Y9R2G+M@B9@>#LII%-ESI)-Y8(4]<M
M-.M'/XLHQ#*@ 8H2'="-.D1$3P46X2M9ZT2E#A;C$IYCD@31^OZX,UANWH!@
MI0==I-?L+[%":H0@7')Z?BT$BN"CI()Y!W\&3RA@(V[DD,K%RSGA,@HIDM:(
MA(S=<R50XP%AJ/'X54]XM4?K(QT)^N'"=;,T<9HAZ%'TU>E78?O&,B<VK-=(
MB<1"ERBZ[9D6>%_W5Q9=B3J!+Z)U4-)8T]:+6@D>3A&]X)E_K: //6N?:<B;
MLO3?[HD^NN%51EI-#UIPMJFV!NT5@QZM"Q02OY<[EF4_HC\3\ X12<'J,1KR
M6+LE7<M.OSS22A.:[H$"NO>0?J&_@D^O-?_+#/'R1"&M/'L2!."CRLU'2 J%
MT-T;NIO"34_&TQ.)T\A<RJO H<N8)JHWU([T514UK@K#RFHZ.EA9&P3L81@*
MRNGO16!%+NI_N<BU)RHM=G_VZO=.H53;%IX8'2&%BE;:EJF$_N_$BYOXARUS
M)-G>*N)JM=53EWO%.R*JHMT2NUX6\?*QFD3?"Y7")^)[ G1D"6=NWI#RX8MT
M1-K)ISB_BM)6,X "4 [4(T7(ZLM9=_R&5V%OPT'8BN94\U"KBO2T1P(%!)>1
MJ4L=/3(\X!J[TG0QF[:617?SP<G'L.OD@%Y>?;59T=-X]UOZ@SBPP6:G%8@\
MC9.&(--)E+I5"X&QE(L40N>X$1Y5;7RS:#8<VY%<#\KTCA4TK=>&?AH+TV(C
M5R4+5N@B5;A?Y4*\VE&F>3SO4^+8[^E7U?AC?[E;/4(HR^O\\/CS<U"'Q0!$
M=QPG9 6=US_#Q=%6LD(3CJ+ON;9TON?SFO>>GKFN%(\D[JK_!\_B+)!?VO0G
MW4CT]L,;^O&J]O^/=JXTJJDK"#^++'4)+E 7-FOP@% ::@S+*8N(+%812!1D
MD2B8B(8]*+(9$1$-Q(@+R"+(HHB81"P1(DI44!;!(%L K3%'!(+LF  A>:\O
M%']H_WCZJSVG?]^9F??--_?.O?/>G%E178?,">9@J8;,Q!S# BKPM$JQD9P5
MC$^!-#8<@J\?. ?-=]=NFN_7<I,H<V[ 9_?&]FA6+3[9.X/*WLM>:B3I4>I5
MNTF-U-]^*HRRWB&:)GA"U]I:^VSI90@0-\9SFV(]VS0\RA@6I>M]<3;8RFG2
M^ZOHJJV9THGS#($-.\\\4>:%&$779)W]V+HB9K*G^E$!PY^((M)I^JV82A]T
M8,^IN&[+^R?>ZU[9Y<Q\%;[A6J/.U9G\ RURX^$@I2Z<]^K7HX[)@P4E_D6P
MTKDL8>(OA/!)E0_.-U,NK+$S.!/:[MG3?( ( 3&=*M+G1LA"$8WORK;=ZRDS
ME+97J?[N]/SNV^C;MTLS=C^NPS6PMHSE/=5;=ORDP]$8Q\SB>B65$P<)-BFO
MQUD%.,<V9)BHV+L4D?JCFY/(LXR*K6T8PBSTG_:I^4%WQ2O<SK:'-<O\AR;,
MO+K$!A.,Z+ENH,]_"4BY4U&$^38MW#<=<YKC[417K4']"YIQ3,IP%I_M28W;
MJ@2NU&JAO8@FU!6/\#4;:(IZ<03.<C$9T_B^5&6.VZSG"$N_\UD>G9WB'%S^
M&A=T2RLP??>;+0;<5DZFCNJBL$+^HV4NI(GX@MC+BWJ'SR)45-0,N/C6AUW;
MBR-YI;788JQ93LBQ%<>S\55A>.\*YQDCY/V&]Q86=3K&&#'#XWBON=^Z:L*2
MW3]1# TLM'-SR'LG?47Z:)3D-*M\&&7$U*JP:\U?E1539P07MJN(08563<?H
M.Z-*R?$O+83^Z6FRY2$[KF;924KZLS_@-UL_43V&"$\=SSE1?LXFJ_3L4"T]
M1^5%-85W PMV. M,19*SFQ"+0GKCCQRV<KK5>,:V7*WEVNN +846R(JRDCZ,
M!#O U9O ,%A$1+,\E8"(H$G"5'S2VLF/[]#L7=,[K/CW'IZTK-]T:_%T^!X_
MR?!X=N8N0*G?^@%NR92YT\&+]6#"U0L;S<F_1;[1X0^:'F7%3T>0WYF80@ ?
M+U\K?F>,W(9.XP6(_.1CPJ;<[]I6OS=H%D' /K\'BIHN^5(M8CH0 E(^'<)]
M^;'V<"<Q#2Y'1MB*Y* NUXKR2W(]/6/TN47(U:/M0&<D:?AG8=%>5'!O15KA
M.E-/;%'J*73B $D+7.XS*M7&\&;%!/@^+&Y]Y6)V?^7V$3)^C"J@M B9%$$I
M"G0J_)N8$WI$N[2LF?+4.!X"[,]P(.#$'>Z,+GW:(90[$,:W'>W(@#'Q=SAH
M\RHCF'48"%!C3,D1:_OETGL0T!MC*]2LAH#\&E\(X'K@9?1])AID&V%CE39?
MMKY"\,F"E#<U^ ).$P,0<-IC%DQ>2@;E7I0)Z\AR]Z;99*.A?SW B*BW:MGN
M=SEE5>-$S@9VD\N2DGM-(8X+EZ>%ICVQ-J+\3]1_!6!$Z+MSN:!6WSBQ,N3
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MZN7#C/7HT'2Y?_"BG8,&=@W4_2=02P,$%     @ ZX8L5+FP-5V["@  7PL
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M:#@C1>)]8B3!JI3&!F(6?)S]CCL1@MW,9_?'&)CYQE53O3*L)2+/>4M*H3\
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MG(AIQ^@35'Z+25H7-&TQ!;;FC_:T5!\EJBU%D1.BV 4 5TI5"(&#&MV=UX3
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M!_6?HY1Q;E_#OCAD57]?5;!,N!GTJ;%6+5>A"D E:W?(F>S<9,29Z;PD,,Y
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M]2YL2*HLV'J\7B=.]28>08R]O2PH9E0RAL"R[EX:N1^OJ-0Z^*K6=0R1M+C
M3L &3C[JT1-2(FH#'G0%>,EF[Z]X,]B_E])'_>08(.\P#-,C"^9:SI*?@SBR
M5SD=;<MJ'.&YJX4S!Q5#>F'[>WH&)K<(A2O?"UH=?GX_=LICI?N1%ZD39MP
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MM>>:4U8+O>%#%N==AQJT\(S<3(2L$O33:?+X$\ "IMMA-^#QYP'5URU:6J9
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MUKG?'UO[8VMF9WKZZKFZ9[HGPX(+#OAOGEC4PM9^HMQ:MPZN+.4 IOK#BNW
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M S*B'6^/CUA>M)6R6BH"!V3([[/D_[1]LJ=5[QLJ8*>8T"F5T_^Z8&@04"O
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MSG]H#5=BBC6?RNA%(;_9$FH5UVPD2]+WFG G=>#M1ID=X:I50\(4:U]\))M
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M;I8]5O\Q!,@?" %X[+,4'- NU/H0*^YB@'@%\7STZ\6% U U.E<O<&9$CR_
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M;S^HA;TOB1 />_\+$<\L[#T@Z_]^$"%_L2-M;A:,6<TTNK1M;:V%%U@(Q*/
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M9=3OE8]79UP^0E\"&^)IK;;"U^ZTI+E,3[H_1-5;.<FF6SA\C2+"CI[2=FM
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M5@^7[' HM%66?LR;T,7 S^C[((L54WQ/+[5[*I!I[4ZO$FR"*BE9MA6$]T2
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M+)7ME1^MO4</_M9>\K#%W.QM8<"HPWA"4/@7@@4/"]\U1:Y?#ZF7Q6"#$L]
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M@V";F>R D;&\N(M'WKJ#M.L@L"QRN'O6(\[8:*\AS?*N+JO$XJ=U0YI@=>A
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M_M+I<)]+-J(5)2XLL&-4D^I\&=MY6'9:$R7X38)#PT;.HC?R:R/B.$J-,B.
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M/GPA.-!,CG;#!O4RR$ZRO(EXFN&-;&DRQT)]R\#TTU:*X:-7S9_Z4V!T@V%
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M ]>90BF@3Z2X4/>.BSP[3)9T&2PORHA93;8L&3 NR\;-F&/)CUW?=)=W+/$
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MIZI%.9$ OIS(;IQ=9K8:+5 '%#R]"X<>O5!=(O!.P\=*.P(*$G=^>V^B*/
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M>[!S#4,F8OTFK3>W6^N;C#GELMDLZ'-BHWA*9V(&UCL6XYM:'Q_ X@4)@-'
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M-$R'+N&OB4L04S)IA2EJW)4V]F8=\Y,[$R+:RX5!>-]-Z&:)/$ZL$7AP5$L
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M@78$@%'L@79B8TWE,S?X*_./GU3?*2)?K>BUS5G6FT?8V%#%E-X\^?[DZ?^
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MAM[KD;M&[&A)N+=N+,[R.-G%P=^>U%93OG+X5_$G+VI+)653Q?>UOEH$0#*
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M3P?RM3XR(G'E^P\"]_) -!!0OX2WE?VE<?X.06YZ;M$NYT=97[MSG(HEM&:
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MLD;;$UW,/>R[X,UA-@4L'.^>7=@KH!IN\*(.D3#C'Q!2*^'[X)7DM?\:0NY
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M@&Y1T.1>GQ1W4R[<:YBS .]IFZ4W;V#&I?_Q34Q(&UVS7<NM53+([SJ1>W0
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MO]SOZJK^(X*B$YUN[XN !DJZCK^QV7:7*(6KX/UTJ08WOO+I\$X5H,][0/
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M7D@RRTS#"*Z!'W!"3>P*6HXHT A?[[8@S/9T'@U& 9Z<MB6LIF8#>?J32!-
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M2E]G,E0RB231;7D/\^^<6#K'25],S&/E3/UT#6-92ZU@(X;$J_:#B>O@$%$
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M2?>\&'Q@$%XA^FB :\>HMB\UG0PZW*N GD22=C'8Q<G T)DF.>%OG]:.7/C
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M'I=D[Z]5@MH+UYL9'SH1I6C^K#[1H:TPP.(69"P)^-SG&+$-?!IK/RDC^.
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MGA-7T8<\94VB=7R:6-)<@1TW49>U]U<B7/4RH&Y:";-&(^LYCD69%)VXR5(
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MNCO]3T%>8PJ\A;R,VGHG4H+X ?\O!V0"Q!JQS>F(6.0B 7;$!7>X:MSW7I$
M4Z[5),!K,EW/M>3VUI, E7WKT.QI=.T8_TYMQPY7$#^2?^,_?9;F?TO8;Z>2
M;J>2MLG.Y*GO-8Y?JR !"NP)(=?-HLC.C:<IHGR\I9.SDQ:/:A":)NB5;U40
M2S:O(CZ3,>EBB(H37,(G"Y  F606-1]>VP]=#MHJ@C[B"MPO<SM@MUAU?.'B
MWA WL61":5*!%QO1J<QT\4\GLS\[_$6F?S"HI-D9I-EIFB<;IE_P( &X8D ;
MK;7AV?T_W+E]O4LYG\*&*WARTC%(QY\$@$#Z:IK*2 !=T&Y*C=R7HR:SU<D$
M2W[:3'ZJ37Y:3>B?#$R>;4"?$1U-O\*RW%&RAL5K:MQ14V;4/_AG-_C/#D)_
MB\>:P+_GU8V[M<L;U2R?/=R16T%@Y#HX,"5(Z(."XI_-___9$*H6+4YY_)CB
M4>W+>:RW= WTK02!IWQ!RB=NVMI0L(=GN\OKNAV85PN^MYXE"L&T8;[X %)G
M'9STEP>D\ELX+Y%9EJ$SY1;</IGLB^K$$&L0^=XACL04R)8RW#&U_"GZ>7(Y
MWVQ86TU+V3<'8+'[>OUHV#D0PVV?)9J+Z\FP=V'UGC"+*_PI61?^'#\\N,Y#
MLF!?IX8!74O:FJ%L*\M5ZDZUMZFPATH//#*$4HP%'B@V<*?++!U\L__TC.2B
MR"UUY9.2\=F,YX(</LMH469E+*>Z O[S-^FCY(F06#RCQP._P;"4%UPQ=]L$
M/2)IZ%/BWSYK8<DWJ#-?UW73?AORSI5QM,<A2>F?EOR/?L;<C=ZU]L4U$H [
M?67/?YP$4%$V*V#9&RM+V=,492+B5'N)@9V,7Z14I?9P*LNX<F11]'RY]?U?
MN>'[? !,KJ'R,YDK^QKF,M@ Z6-B<?L^N3+6G7!X7ODMI=^7!H?T #X+5&:-
M*OXG;A)NMIWO6DZRS,HB3).O8O<%)SRG>K$C\/1KK8Z04V?GBA<Q48>3M4IC
M]*IM[[5#,WX1G1HCTK,E4E8&;< KA]Y>>JXK7W<ECR-=*&#Y7)" 0+"Q@,QA
MB?_IS/8YH/=.(>/@22/68T./28"^8QJO0B>H .KUHIR"^2.Y=Y+?;;_HC=K6
MG9'7$ZMG5[%<.VT','AQXIJ<W0NGGA[IM4.#?J;V&:;&DA$>05.((L5CT;2-
M],6M&5*68XGLA(0-IN:E!;^F*_A'90>GZEGL;G\4'5@^3E]8MII]*PSNI<JT
MWW^/WGWW<?MJ;E3!DP14\_V)L*#!'SPKZSIB!FB+>A49(KV-8(K\2A11CM^>
MP3B+%8!@CC?M=G<0[GNV/4%B9FSSH@\C@O@S_I3Y0-8T2"!;(,(E^[E',3L'
MZ[;R69$9J5.)T7&)[IWLML=.W!_6GTH8=VO[#*PH<$8;/H5,TF%'VS)R9R25
MSL.F]W0Q+$_E]4%#Q4OBDZF6J&@Z-]V4F8)['XP3+81[CE,(4FRDA2=;5K9>
M#=UFPJ4ER.-&##!$7D.OPCG;TMHC\EZ\N<?2;\S.V>T%QLJL@CM#/PNG2IPD
M*)]?TB(!VO4)37"]VB-5\-RPQ:>U+5TD0'TC;FMOGPA92TW.'/-<8_.V1:F#
M[+QS0-N?:U^D_I3)D 2@.8:J73]820@!80OEO4D 17(!W3M/B3=WAA>]LS>S
M$+,Y1(NP$B420,%PC0D')9S1!"$Z3JVL2B)^%J+: UVC[ANW7-+\EI#QFRAD
M$ DP:>&^2_1C082G$IE/A]7.,;AMLX-32( 7X/+=7ZW3^-_7J7.#A= "+OV#
M.>HVR@9V=7],";(+)'HB9X30M?CK"6 2($EY?,KFRW' F)6=_3>(*F%9M3/
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M&PP_?+J:_X>F5WM;_513#G(PF8[G"IE(OU-QV#<@>4;,);2#I0\OGS^L>2U
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M>P,@ETF9,UF=,)2UGO&;URIDPOW8\6OK*'#Z46-PGZ:^RV&G2/^]G?E&:U4
MY,U1@337Z- 'W^+[CNV;PP#3S_GJ" Q#B8?[7-#=SQGW8YZ7#CP%F/^7R9VM
M\G1\^C]+OQ=QM"I+#'($'@S]-W8F0MQ_.]\3I/3\W_=1K/@)#/1$S=W<\V'+
M90*].O%)K#>QA0)PKIM\)[WU--/_69W:[(@Y('!U6^O9IZX7O1/FRLC&W-0@
M7BKR3CFIHJ"5++9*MU_IZ8D' ZA' 1S#WN0Q=OZCI&&K$PIC^K5J]A06&W]+
MY [.]*_7O7^_Z83\?NY=VOHUNHG&\9J'9J.8M>#7C+=Z@WU*(@<;/]@=KSV7
M]<@RH'IR"6!FV$$NC$A%I]SUUP>FF'!X'B%3$<X79M/],'+>BR':!#W&OQ-U
M7W^6 Y8J MV<L?MS-JK8T+UHR'%]_G& "NM-:H#!.!'LX_T<3U8T?+>05KN:
ME/Z6A X<:5?^]!) )_SWM$IVMF)5H<:'1[K)&[=WYD+3T\T4+J_3$GH8;M54
M=6Z!A?0((:A[,$**L, &-^:,ER.XM2NA9X.OQ2YWGR!N.J0J*LU-ZXF8ZM0!
M,[ .^ O9'NBUF<WZ,:FO]+]]HWRZ,$U:D+F'S_'O2SK"4-"_ ?<R7W[T[$2:
MUF%SNRXLNHZ]F.<.*K9B?AUF  ZBA[5Z<FAQ#>&>9GP-C4V3O&8:W[XG>4!?
MXZ/06OC(E8!A*F^2SRPL(\[X_?[E:T1Z'4PLTQF8_CMNOM&MHQ/I@-OHCZ>$
M2^(];F.K"J4I2]>Z"S@VH@!%YXJ;7N:@OMBGX],W(A-U'T>=Y'*:;9Y9AY?"
MV'II%RMKI/)M!Q[L0J_#;^,ORC>)#])Z&Q)"SLWF_JBS2/]UZXN/66+%I87O
MOLY\1AOP1;%&,"<]C\9D52DSGV"%#V6.%982J'Q1F]!O9% E5'%1KL3A1.=X
M;-X\K\X19O=M8+R*0(F3?:_$@->U4J+6\> Y#<DIF6N%'F==Y)OT)?&E%6GP
MA;&J4+?W!RGEC;ZHP<EV-XKPOK=QK'R<Q[/O#N7YLT3?B.V(S,!LZSH*&VNG
MI[\IR#5?PB[O<BHBPW?IWO+ 3#LIM]^;7I7E74YWG)L2Z^3N9]28PT/;%M4>
ML35ESOV^6!O=-KS%YTRHZ)/#-*J.9U #N.(+..7G6ZT!Z3X$H;7XJ)XN+E:\
M9-%6,VF5&U)D06;Z=<:?0"!Q7)[80AT6+_TE@IN2K5ZN#Q" :/'IQ+QG[9?4
MG_NV;!_[BV4A+^-K!>M;.0; LO#9>(6_;\F8,C5U:O^]R?^FY^,KMFMTM8S!
M?="C'=AT^7\>I%$&,_\3JH#XY00M1\@O_>.\0@R4O$=L;R(VC8+_5UTI?;()
MZ'\>F&F5_2^^*Q)5AIB6CU& JZ(_/N69] #JNN>D-#I^GT)"X%K_*EKAN7#4
MXDUIH)1[F?IKIN(^BB>S:@N.UQ;Y5 WIAQO#+&FFA)V-*+GJ2!2Y7\AG&;I_
MYX7ZO1XK<!&=R2.O55-S7\I+[/ )XKJWD\^[I'NU/)(ZG$=H&:?J,LU(;6 I
MST&/)81&B=R$!]A>!(7QL8C\$F5'C9#P>V7>7<;H<^U-):9F5-BY?MN!ZPNW
M^\R*IB8CT>>/8$2I:>$ZRM)C1UH,\R<OW?0\4$&'_2)8.WYU?A%&IR+,_:VW
MUX9QO9T/>Y';FQNQ/M2385JM9=:3^<DD'' 6]1/?M08&^7BOAF2 @H]DFCM>
MR_0I;+2Y0_YIB;9< H!MK<PRFVCAQS\LW]X ^.?N2F/53@8@V#@=NKIA&[KR
M(,DLBL/E\ YF\,HE()9G=.\OORIEL*3H#;^.7KVY$>W1ORU.[[RC#G;7%L:^
M_F0?;Q73Q!>XX#SZ!_FC,-':*%<V0TM:94YPJ)LPW!<72#S;X9T^&$R);-JW
M"M_56;F@U&P8WZ^HY)[8>Q7_5B*H,&.5> _138_-^;EL@C4NOR@HD_Q=L)C1
M6XLO @]4:NE$][^]!-C/6[Q\9"TA -0Z=D\:ZH?05LX;UUN<#@!_L#ZHZCF.
MQBK%NF'8#5Y\G='<0'[Z EB[TQC/Y,RFUP5F5J_RX7(OXW5:3C3+<(NO5!)W
MEIT+CW#5*5KJN1VK2_H'<(*,8CL)E8("9C>],JS:CBZ.OO37] >EO/8<F:Z'
M.(!"MPO@LJDCQL%^/WY_T'C(A@]7Q9>4;1$%,F!!=O75:2=JNH_T87]V98\;
M)_:5.#3?):ESY46C;)XIWX)S8HFYA81 -%W_+,^,W@+C#^+\V4=TCCAV+Y<I
MT(N\]GP!_=%']OA]!Q;1&QU_ZSKU,7KN/)R%KVUD3;1M983=;$M)&'8D/QQ%
M7A!<[=J8!X*,*KSD[[9RGA+]RVSZACPE&9AQ!C'"(3YD=E;#QK>\&IB9(^M$
M1RW<&0_O$'S",80>+9S4K2TLR5>-Z.#WXZW;O3D2D^\N7CLQB1XZIKHUL\KU
MO I2=&H%W?$QZ),OG\ND]*4MC..S).7TJ0#-/J;,5M'*\?GK=%WH/JEREF=5
M.)$9X_,?=ZFM2Q-G!UU :;<>Q1*\JTQ6]G?%_+$3VFD]B6:/GYN]Y4 J9 #.
MS[MM7)-O';06Q'VJM.%:_^;\JYW%IYI@M9H)&V00:O[UW@JF_KO_%QL@<#\3
MF.%I7/-J+.ML*N._W>+U5.6_[^S]Z?@WK< \4#WL]S)> $G(U(M$;"<B2\O_
M\],\D-Q_[N_]G+:!4B.ZA"&_PK8Z#*!OD4O.@ A$H0->H\CR2W/# TZG$2Z:
MW\5"OEV36(T^0* 7$<T^$+L3VE;=9-_XV]"AS;\CZ.]L74>8A#-U45O*I/NU
MN,'@\2;0G.3J<K0(7-WMBR,;]#AX0/834-0?K5* W\>,Q"B(SKD6K(;4Q;^(
M%_ST[5J00G+//^-4[KB"@9-;\?0+L[.EHK>:!ABG"9)6;J8(%KS!L\E?Z>]F
MK*539E96N& S1 H\F=&HFS6&.-G%PSW"4H$$P*7;X_N6[B<YLDFUT=!6HZ5(
MUCIJ]';.OPSP55?$WY*T4/>:C;C?]0MG7?!Y1/$2T"]4*<(OV/Z,_7#7% &J
M0T2 R>&/W/.VYBST/D-_6EN$L<XG(?K;@%V7 !I/+4A4LG--9_?4&J3U1(KD
MT"T$8:_H88YOP"P^!M$]F.61[ZX\,RGTT</0E&!1OR>.,B.!88+M+_N=ERH+
M?-"K'7WD*&J*KKU*9!7"1^,;A<Y+XBR;)(PM+%G<P*U<2O#)?5PJ)NBA&&4/
MDJ"+2VQ!318W5+_,(>_S#P]MY?189;=ZK!4]W;K(VA^8L@$F>;<([0'?J-PC
M#F5#%0IHW*UC5[,]#*;^GO>UAP^E%SR PO7)NL"<2LRY7/!G]5-)CQC[ZCIX
M ^8S9G#\O2,U^$#P#6BNZ*I9H(D"NMJ<< ^- D6GLF7O9JH[<,PJO%&#C2"<
MD+.Y9F@E,42W9J&%QO$E0.SF%=";X\._J!<01+$2_>DW$MSQQFX#\6S+%>:B
MV4X^T[26ROF%9 !W*_XH(OB/7T,/@MSLE&IB[J-H^R<DQT5Y5;)FX[BPZ$+/
MI\>IG.H,)!M<K%AT+!03-P2F6[":VUT\;^ UY)+ #ZVQ#P=N*Z/.C:;Z,F_-
M2^@QUF+),)PE803'5*_GE UV/!)O?:^X&AZ!6;Z!K]GH:R:-: YICM[S?/>-
M-8^4< ^W$=VQ:K1]Z)QH93["QADO<#NJXUR)((V3[06T<S>B^0X:<EAC_=!A
M*SAPO!+[GU2_]5BN;'=>?R,;;?MFO2 B<SM6-C0LC9>=9\G"G6.4K-A)QD%W
M8A65I">]9LFD^&?)Z $C77_,[&+R4M9,XGNR(H"2VLV6B&)UV>P$DVNI=H<\
MG9_%*5PV'4EDA1PHDP2N?VO<=(IC6]ZC6D]E2FQZ&:Q,8>M(?"[[O (&?A2[
MZ"R3ZH*?[]-=!'+=5R;GN6GPH##NT9U?,89O=3B[/QH//1>L%7A^/PJ0M3,B
MM=LS_3E!^)/<JM_$K=[*1D6 +JO6"XX,3Y.X16/[CW3>SR_R-047]*_/AUOB
MU#S&R\.LEDSEAA^^"5G) &3$1#EVE[E.3O7F/E 8O?[1T.7.[=.X>[*DL?4<
M&8"T.T%7[^^NY%6UQ93$PE$ ?6#I%?X<=OQ;I^+VF?P_6_A="3W]*Q#ZQ^78
M]W^['"'_X7(,@J@@5A([/)Y=O7ITMDQ0V8(F@?^USYI'JDZL+M-XM?"N,/["
MQN! WH$T2'#9VGS+/;W$,S; %%/FU/R[<N?'H >M\588XV'';C6F?!&\NMO+
M9#+LX-X2R; 2=0AZ#P%Y[M/Z^#^=G.^?SPSW:5T*_$AR\F2BT 9VP#Z>[KKV
M8Y:EVR28H'U16J%TJR@N:[ICKL'B&B%VB-:$R$F<F%:2CZBH)]-K$=0(4SG4
M)ZM-=%/H>Y;VP[I JH'MH\Q;=:JXZ_'=,>@N(N-%C?0,$0*SYDI^W.PO\'NF
MUN6AWQ$RO_5EF8YLE *D5!WQGIMF>H7XD63WQU!VRZ36#/TPO>#':ZZJ<'5<
M^7'A="L[[OM2][Q>8]+D[>^E#Z1W_V,DQ;$%P:I.)5N__,*K7SM+GPQU>N>A
MU\$#U\G4P%==Z3^ATMUP97R/W8K3SHLX;CB:)S8LGI*@UH2303&V.!U8J/64
M Y4Y=YR_[?+(S)P=ZJOXVGRY[_@KRB'B^':B96Z_&)UL.)S_S:ODH0Q#.VW/
MGT)KX-F3WB41[$"O5BEJ:#N\OKWIA]:]!UV*I<#]50EKTDBTX.+;>V.]J6M#
M[QDUCI%<>-2Y^@Q<+-$E-'=N[RGI3$G&!I&)B$[-O25M8^=>)).E3JA+2!
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M2K)L%YKYMK^ES5W/2.3@JU7[I\_2M%64MA->V;\VK@6Q\NK1@[B-'FWW:7[
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M@HYOGO3E^5A&?VP2I<L;+8Y<9-V%:K*/+'V\J<&Y:6P_*%+GIT\VK'?.X]1
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MJPLG#FV6;2>EW+\ IV)!IY_' BR9S(S-^KD^)I%]K/$*1K@I)1@'2O_ZRU=
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MZ6?T:/0^3[WF<[&G6>R;!SI$11M,]-JY[#\NJCO+2JL<GZJO"RT0))R&^=X
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M[$ <Z6(BHO;%H69%ULRV-6]0T4<=K $4LP$/4>1B1M,$S=,%#A667;)^X/H
M$0Q1V,D@EXGV77+ILU^/1M=7<GCQ1X7DI7%:V$QDU0,CK/%N :.)!+Y[9Y4J
ME@\SV5N_Q-"1"6^0MUT0?L-HW\E&D4D>##_B3CTUZ?DR[][>Q)00?M$1#QO1
MG4%("6H,=(H2^.01X[Q0VM'R4E.5P@%,7O7CH?UR919_]N6>[^AB$G"<T VG
M^W"XTO6T#40 %7;0I5Z 5NX/W_=B*OE:VF8X2(2IG#]].W["M&<"]VL;*:B/
M@L3^2N)C<<";L6"T1B]%52@Z\VG4)7ZTWS%7Q.2;8NO*<?(19OX_$9Q)(5)[
M&6.8XAXAJ[^S^E-";[\2),;WZ8T"7=VB?9;8L3(N*Y)CE?*S3+&_=$[SR*LB
M&M#;")[PC38KU^+Y'/_9.6^0R^&[;U1KWZ9R?[5SCN,H*X3:$V0Q&LP&MA;.
M^(CV G0QW)_%8'](P]![I,Z:1ZZS#^#WZC31-' U69TT__J S?N;T)K)U66'
M3WR*]#=<3PB^#L'_5W.F&<;=9J@D?R3H GTKEA6 DV QC-AMVOCGY*;;[0HP
M1K2>AGMH?_W2/CIXE_L&<$%5-4M[67?.<@,@F+N],AV9>WFOX_JS\TE?^QX@
MH/ &0$CPSX+VUT=@R=O/W,J<1 ZS6U'4W:R-Y>7!)<^#SC*:.K#<";@HQH,K
M;VJ\TZ#)C?T]M?JM&KI^\5KY@<&"L)@/?CKX#>LA+ )KVK%+E.,!9ICQ=R=?
M'86^D95E7)SARY]@1OL7GU]V=M!31AG\,GN^2'3Q5==#X1[FZ-1KK)5G55-
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M@HUTT7';C=>=,])])D3:(GZ94=;#NMR!=HF^^1 Y%8*2KVM @:+,);$FZ*1
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M^S^9$6U@;)TUDHW@[P1P5^]O<[ B,4$T4IR%$UO;:_P.8?Z).PNI+]Q%?*#
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MSY2.;&IV2:PE(YO-P=F,7XO6Y0#+CS,PZ%_6 1CS1$P,W$#"F+^O"&N@=N+
MT>MSCVV8WJ<2O^L(^WNGJP:;;!Z_?X(*(.;4U>+%GY>G[\$H*6*U;=V!2'9!
MH_/,#(Q4QSL1>HA%/Y7C;-H#7R&)651\W1;H?CL')+//@DP\QH7UU]\!N&(B
MC=JO"W \9,@\PKA]XEUR]T.Y U*N@<BK ST%ULFR@"!,<'R ODL^UGSGW=$C
M#OFZTA6+Z"59M$AT':DVV^C&]FX8-:4?>ID4DF'QZ09 75&G+KBT\4)'N3DA
M\[#**AGY.1<F7.MA)2LF_\W:-&KMN5CHC@*K.D85C"'"\<PDX22\PS4&:VX
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M<WELX0A@,T[NZ;CG%1QYS8AA+2Y6Y$YT3'6K<>& '/<IHG,OQ;JE'<?J+$B
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M#J/XGU7N= =)3[3:$N=J!:Z&>RC<(PH]5FFE"[8*+?R-)*&HZPQXCF4JQ.[
M)9HS>Q/['H3\*@, =X;('%L?,V56B<]#<"6_1!G$\8:PSIT9]I^GN"IS\5WH
MEW_:GX.?S]3[\ X_BE:G=D\A^+1G\.K377%;02(.X*@YI$=CW$ZTW<#@F3A>
ML:7U0Q7S#>+%KM5LQ6<5.QT$VT\MF%8M"7XOZG^Q*JC%Q&?Z/T5$I8T$Q60L
MQ[UP#H'DD1U7UX8O]+@XDK$KAAN.4:[K"[8*%#F2V47_HFW\K;3+4-Y<MV:L
MDN(;$+0KFL;I#^9#-R#U(WJ=F3)C? B_?_D^ O TS@W?!6+=?9V9JJ\//^E[
M!N-O,Y**?S%6;CP^)W2CD3GTI>[Q>/A$;TJ'0,.>'+F?BA!]M"(_GG@LGN1(
MVVXN"S,";9:\;CDJ+7I06WK+6A8_NU-*A#R^)&]K#>9JM4$EPSQ.*DQN !3;
MDK]LDV_90[\RKU1EHIHM@6?)]1!;!F?_,"^^I,:$8'[]FTM.G88S&H4[,)<]
MZX;? ]/R'PL.TX:7$S)R_Z]Z>[_ZDA+[I26A4/[+EWR>0H#'15K8+O!V/?7)
ME<7<=AV[)- ]1PF=DOKZ\'O6+-8Z]RI%X,NPB,\XHG+YW-*72*^_#S/&T* ^
MEX?(SQ&79(VBN-^FUM& G0KPY4LZC98WJN8TT4=Z)G]ZG _52:1O +XA0+V^
MI<?UZ,H8B4+/%677)J<^-*AW3Z3_XFT+C.L[#S7>C+8U33=AY^$H^K2"]"#"
M3VZQ>_34X?L7CZ8W)!U(R@=&6)-72?N'^H8IZJ]S_,!"*VS1&3YQXH':NBK<
M2R.1;MTATBUQ)&..(%N)\46>_!*@A1+:-3U?;-3-GOJIFOS;2$+MU>4'QMA<
MS4N#G&"?+ ]C73&U[[K*R\L9@ $W$L<TNA@?($P+D_7Q%Q\B/,8Z8,FQ.GS%
M\_P+E;&8:8_K-D&V38'+C%#+^T,YF3%"(1[%R>-Z1\N:\+F"E5T%_OXYZ\FU
M1<(:EGZND(W<8.XM:T_9AUKM4]\GQ>>$-V4LHWQ$\\CV3'IFC)&TM\F \]AV
M1"@M G8E3&CH.1]PS/GH!D 2TQ,D/"FK=[E#1-8$=_;-E'H]VP:P575(E>0[
M?9:BGS *LZJ42'::[=[M;?>6/Y6J6*:"Q$_V, *G=R,BOU;W64%XD+8)43C9
MBQ(K*P.!#,!?8?$6@<&HC-_L/=GK*HZ3?XQ,71+SXGW9+\/2. ,%0.H8K_"F
M]V.='YPU/WL[::TV'F^$\"\XG/JM<;GM_KA5J?5Y4\;:8>)MK&")F?LOU/Z6
M"!@@E#C]LV(G+:TW.X9)+AD!/;E=S:ZEOINF<\^]<_ 41XQSE6OY!2>U/YNP
MEMVW*IQI5;7]OGVT;,;RL_,IO+6^Y[02;5!8$IC$8"/2XHI\ED>ID:Q>/6EY
MN+?[.-F'T)N"GQS4V2R4*0LMGH?5,&<//+LPB$\K-W8R$/U+N\O(UWS?:7>$
M=7%7$7\I1%;5Z"K[.%L/6=@0:4)H?0-(?1%0MV/0+)Q66#^P*[0'%VV[?\?Y
M.3[U<IL6X*14^''\JGS0\Z,^@!TPR\^EF\E?;=%&RFY^H-R'MMZ--]7$, MU
M9?V(TT#^.PHJJ1$LK-)I3N&TE(84$NM]LMN08LBV.BJ.E_9?V'OOJ*;>;EUT
M(0H* H+T%A4$E"9=:A"EB4B17D6D!HA("Q@(B/02$0$%!92FM @D=(AT%9'>
M2R 1D)X@A@ A7'[[C#OV]WU[WWOVN>?LO>\Y8__Q)B-KC+QKS7>M=\[GF6L6
M__D629N1;(_A#;+'13(KQ'OM)N9%SSJQ,TV/0?E]Y.F*D]L+-WCOUV]D+S9;
M$B0T6)@=<+4NW9N:$O1&-XD;J6E\GN4+J3Z'BZ8LTLNQ.Q4Z[IGV$J+UT.9C
MU-5/E$U%'P'Q=J$CZ)Z^1N7A/Y5O76Y<?!ZD2)?TCN+=H?,[6?GY9]&#:5.F
MM, GAK*9>(GG'U8!/&:6_B/;T/LZFW<"(O.FIZ1OWL0T.A0:GGV].*BM.%95
M5Y7@:F2P:,4;?%72VO.'YW;WD%Q;/JN+!N-[PX]%U&"K]5ZJ.J/=4%X'^;R!
M8 <_VV8,8/62>\6OR/2^.?KJLJ@IO0M[>82##9W>M2NN2#_#HE2N)'5=< 6@
M:% ^?:-DF/NRU0RCXOZ_?S>@]E;^OSO0.@+$L7_L$2N;<>@]Z_+4O8+K5,U<
MK"GAY$-3!N&&!4WUKG.=4-]+SU%@^6A+:2ISH5=EM;V]K@!*N_14D("V0W Q
M<Z#5;*HG?5XSL?OUHU9X=E#SN.;N!3%,N<_&I4A1JT$=N:>ED9;]4M#95"]N
M+JL'C.(5P'TGF/@M;+-1@Y3O]IN\V53OU1ZH>Y2O#]ZF$5X*5)QG>GDEE<U.
M)$8$>1\D#5C'_A@M>/Q<+^5"AXLW)C?=MV#Z^R>=U\^7/84@AB(V^TS\2NYG
MPQ*!$M^SDJ#79)LAIS@F!9O&\9AR?EBER-#&XNL<J2X&R(<I%8\6:0"VW"G[
ME-M)F>2>]=$D]'+-=%3\\WGK=X8+ZB+YQ6F7$@@.X:3LJ<P?5XIM>=VRB@P7
M95]C04J Q\J^;C'2_;G=5 ]O-VO7B9K*9O9W.$>I&MO/VQY@>:9?Y-3P51'O
MF#K7;*#(H]ANY7>H%?E:!T^I!)>H\G/[?DFI,WP1*A(_1_<A%R+0=#KC1G4Q
M#W%,UUS3&VZ4?VWF*C ,)V]5MZ>LOV\4,^U%[Q0K-2I&V!Y+[Z$2MUYB(29Z
MM1G%Y6<DX,5EYRF2W@N25(M._%15^L'T.F?ETUM7P_B!]V/*OS^]/+5]!#0R
M<KTNAPGHC6483=A#&=4[795:A!KUA3]KV85],(L:BI3P:M3,1+H_P-2EG!<L
M_0",">:Q[20=VGA+0SAN@Y])5%:8ROC//=<IG8Y<BE00K:O;NZ]L=CL>=C8?
M7]$'/;D:DV_(%'A6S3(FQ3*)[FN1Q9DW3$ %&28C,BEZ&CSYN;RL0KA]^P;7
MXC,M<\&/#[E:/OG-SKW6;'208%6(S@:^-1$W7Y?9[RE,='PZ*_M%S2+8B6<0
M7>9<<_EMXS(V4V%O;*DM4E/-PGRR1\'/I0\PJQO:\.%%FY6[U']+Q;@S/[$W
MA]>[/L.:%_!]G)KEO_;LD=KQ)IM^K+5U&WA\+-_=?Z7-UG]$0M;:G;^Z9X]%
M"OV#Y_-_U?B?<"3]76[ X']&(PX./9L(W^;L+M*@Z_R&M<O4W(VVBA>]"EP[
MY>#X$R84G3]F')N("_/'0M;%2E&-%G#(YY2H+3<U^./'#=?7G!]2 TG#CG!Q
MHS+FS^,J[%Q7X]+2G*P+*5I'@",QAA">Q*,^\90G>YYV\B8>*@C7&Z?*5DQ_
M%<YS/<_[^O=3/4]Z2;+8$%P_?]5)HF$$<T8\%?_@6[+)G?$1&C_)+3,/'Y]M
MP_B*\9Z3+C'DUN@.[AS$"O^E"!T@O]GC,^[H_WZ5/R[EO9&-;2QN@9/N)EY_
MX\I'E:2BH9TFY@2R%MO+,W@4[*"SSIIV(G>?_./&I;8F2'1N1AM,O*>/V$^P
M*CD"SG#G<=BI3KRXT[(VH76-4@KFHH1;&]2F>HHAWT97<=+]EFU'3/'8$,.3
MIQ*]LD2,$QV4.3?6G!V\0>R%I+KV->.(;L*!EK[C3X^3!]:Y4Q1=:82[IMVD
MXI>4:=6+M2RC'1"K5K%A&LLOHJWM%XMK'!M"/ WY9U^!?8S>RG9SDU78#5QC
M'9$7-524IJDFA]72#[?GAPHNF4>_ZH.)=VXQ4Q 6F&$"\<_4'$1>XGQG7JCS
M\.]R5!SV#%01S#G=AY\G6_'U&DK,,P'[O^<9>[8H-B#?86A:MFX4\D=X*7CR
MRTUQ)%5WZ68T.7;"8/=C! =5AICZ]J/3ZAS?J.[.M@XB."XUPW7>. 5/F;8Y
M"&28WEUVZ5;H V#Z&S%X2(4D.7YH?3%AJ]R1$TW_'#*K=:8R+=3C$5F-A^S;
MH8,(K1$J^X+U^E@X> 1X^5[:WIQUOFMA/E3_14CR%RHVCZ-9&B\)R9&^"K-;
MUWF<EAIFRI@+%QJX(TWXBBJV+X=*E+RQCK&G&HXI.MKAAXT_U;\,+6&X+-[R
M)*M#2,6BJI'42LG9[:)^>C+^%L:#5^KIR.-YA:FXQ)7\Y>Y*^ERD9MD\6X\7
MW$UQ3FA$ZN?PY@9>ROV5*_AMJ$>G"7(*^8QJ#!^<:;H!N2AZ92%2\9"M,[L.
MJ27A76?GEUT[]43O=M^)>?[?E@,[_1R.L&)<9PCB03T2%F-?E@WL@IDC!L?S
MSK>"9E?WX1P]9,3+C7Y1*^OU(^# 8$U8AO):)79S7<92I'_+0=#Z&5R:DE$&
MOTB,*"B<6ND-<!-]MI?<4N.L3^MKE1G I-Q0NLG)[OTX6;XT4A<(-U+JF6SG
M=M@\O)I9=1;E-]0C,TJO[IV5V.Q62''SQ:(KK6;Z:2C_-5N:'"D\-WU>8-;A
M+M8CY0Q.&Z1(56D<D<5Z53AQ-;JGL,??&?/HVD*J8:.;C0,_!HET^5Z<2WS"
M](4B]P&2!>+%@+E7K'Q#(1H^]'1I<PW2]XR3NOAWDXI)S.&I#QRZ4V8&CKG4
M::R7I+,P7*UY3+<A9:/U7NY/ZV08BMP\:MW)86_WJ\Z80_#PG<4&.,4-?HI(
M+H(2H9WG;#X/%1A,&P@OM2BTD?N/X?VAU.:.I_$ H[RB:\AV/NO5-7+UF,;]
M,7^O3)5KF'?"H::A^^/-D_"'1\"SZ 5=6F'4N^8HN=P]E"Q%9,&YNBYQD?8C
M54^N5CXZ<;G\Y^@&G!$5@W$3=G71)GS,/YO"0^YL'E"ZX?M!7_)B>"MDIW(7
M'_RI51+*O&KZ#6A,LP?VL_>FNZ98,_ (^FD]-YL@I")WBG[?6$M83X=:"5GV
M&<%F=FBF1)&.7!OC5\LOG7T^;U8&<;6Y=UF_A^OMNQHG3W+N_:E>_N@]R^&+
MS];I+T6*I6#CAO(,FC\HHO\^)^OO ^?'C?^AE)$V*-/Y7RE2-/XSY%_&UZ/I
MMK.HG.=IAAMY!WT...IY?=JME!!:$],*>#X_;]O$YPB8\UXZ N:SP=NB$.R?
M"5/&R6UV4+\1K>H&YXL')L^'CH R4T9%(%:[^FJ(TM[&@0UD^!=6^"[%CCQ,
MKURJD->.U4EV*;3>E)SOGQ)&K#M/7?<>'RCS*@5D")+:PN\.-%;MM%I*9F;T
M"UDNV<.28]X&;WZN9,-#-YA+(6%W,="2"0?'F^YV"HM7+N!;9#MH%P>:71:,
M!M_W\SLD!5]TF4]/S2" 3T9<!,4ULB5O4(U*=.I>&!P![K;#E_>TT'0(LB7I
MB4Y!I]I+XX>)=^_G1.^/]B=BT>+Q?G]2[@H)?ULULC[;],Y<3\X!&Q?X5Z5E
M4\R3)..+Y>N]YP\R/E=V?,9R56@ 0>%L5I_JGD0QZU7(GYC^Y'D".LEHD0H^
M16E<6II ;W.[?_G)_T?V%%4;,WRL0OLGY2V1UU&RAUD;?X*(>:G++WIZC4I"
MGOD23I(K9F7&K6HH 8_[W.%]R\FFC.SEM!&[Y7@-QY 2KZGP\0S/K@3=ZY]1
MKI2 @SOVL(ZVQO+A6[[BPP-E/-=5N5X3Q3NJ[(4>;#LJ7_%SK_/9O)$;V_Q$
MEQ)2[NT$(OVJK8/=0HJ==!7Z=<+]L!YD.)[L="OK4=STTI4OQR82#B:AG:X3
M@S(KJP@;3*RXVQ3K>94VY,DCH)U'$Y6(<<.,W>F,7SR8A:P[GUESXJ5X+#QA
MMA@QJTCE4#X&Y<%.XM)N"[ZZ/]5K^$2F6E6)_8F5.R;QO1%\*8VJWQ+WL_"X
MY/4=Y G'_J5*\4AT!-7Z&^AL8)]^=SOD@W1R4DOK?0GZ%1PSU;V.]+#NN702
M3UUR@T\8TU+S95(F.$%+F!24I#V0<XV4,HJ/8*<T!1!QW6&;>0$^I?!BW1GU
M^=&\R1>.UIUAUL@MF0V6^HRW[S]WKP);6B=;<I/.#BM]R#:12]4N7@5QYQ-E
M4X*$]/P7NRY<M$R5.S:Z*^./)OJ7VWY#?1BX\,Y\&GQX-A!LS>P3=_5-+W91
M@VA.NHAE<GUC3D^F\MCW+:CBA&])I(+31U( ^8,S\T31V[<%,S/-]VE;Z4/-
MH'E4NS/#)"7^!LH;/T<T?&;+IMH7YIRL05^RXLRMN%/C_\'>%P1[R ]T$WDV
M+$NGO0?Z/GIE7;NA<(I%XD* LS5LB+CFS+P%Q:OS&RG(TRSGG=%9<<N(DY[1
M=X9<4\T>Q60K H1++8V_^^HH8E5JM$/T?$XX>8!Q^6<NV+Z%S6P(=R-S\[#X
M?EW;F>G^BG#F@^N4.;:3OWR5BP+?/=/?O3LADHC78"08"[2W"HT$'MK-S<J*
M9B2^YO1;<R!_)-;9D6(Z&XM?B"D_9L$U_9@Q9;P)VD@+"2*IKQM4,SNC-W[
M1)360+Q8;[D%>YA'%>;%(O43O'Y/=#R6*D:YMR!P!)P+5=LLK VI^IJLXK#4
M(M U1Q^M3WE7/#4I2T[-_*9B0+@4*4]E/["$G,-UE:_:.8Y8A4A_DDK47FI)
M(H@CI46(+;'OA/*RI'\^&2#DZCY&H/6R0L"1.V6: KI)NP%7I#GO"[_/(G#5
M%CU9<#XYS7Q'K3OI4M2&-D@9%M*=>RV'$/RVVC[=W?[0YH><LS'\/J6B%*;?
MD1!8_56PGL]A?IS')>@(.&W2%7[)OO<TH8Z)V:#7%G<>LX:,%];"QEE$VE(\
M_!XTTC,9 XX4YP-+A"_,N5,Y+-_K[8*;X_(TUZ(P/66P$@;>*+@]+%-<%YKD
M%V,H!'F5WOY^W*()J1,0 *V/==M!H8X CQ1^%M "]SMYKT<XIZ<&'!?$]TP9
MK8DJA"'8_I  <XY'DJG9;\G#K6\M1=S*HB^GPM<(B-A&M-,Y2DM0)>1BX,3B
MMSU-3NOQ1C^4&YY9*?=;4 ;O0ZY\YB$//XL1__JLGT']8V^A?"D&4#N-G^>Y
MYOF!ERP%]$72?X/Y_Z/+4%EJVNDA35YG;9W"5UKZ&CJ6%[%7[O8P:X.R0>>:
M[<9 Z.;N(^!.NDWM"OE^$?;V_O!G+<DAM!##FAEZ"%M5Z)ET4A*]L^*LY0Q+
M!='31N]YJXT6ZN!X.WO3G.I(ZEUG2))&H1IR_%\>F']_SBJ7"&QCX[%"2OV<
M,/U.=NF*SK0K;HR,C-E;6 ^VA#$G.@I3]H]WOJ]#TA;K&.J1K%1M=!7%%:_.
M?&!@;=\A=4Z>^@.B/-S>*DI26:=5U^:2=R/\MFH^?.X"K"D=QV=36Z]:O=83
M&-A4_.T"H^<]IWZBS#XS^!G_SV^1"A<][O[$UQM&R-H8_9627U]3EVY9B^Q-
MNYWR&=]X!,300".!N!AAD?KZF(+Z-"-==E!8I-J:2=)SN KEO'@\]^B;LN<B
M3AA\,!8C'@]%501Q?6I*'5IH UWI5G LB5=LT3<_?#5EZ"L7M'P$?#RF$"[B
M<?<Q%*'\ZI7G21WG9K?/+G/2-95'#&3[:#&DWWNAQ'.MH\E+8YEK7HO^L+YD
MC.I>FSYQAQQ3NPD.K@Y"Q84= ?&!++?Q!I<3QZX%)!.XWAV J=>/@2"3K?.<
M_JE?/MM:WL !M'TWJ=+KD;=^?(GCMSB,"]PGTZ"59ZW]A)5>G9N5T]P?H;JD
M9I6%%JUA/:29SJ7V*_UV2UC/?F%;&&*AMLA5L'1W-_/G#5#P,2P'MR$$YZA@
MBJWTGY\IZE*=H7DIX4)%5&,%"K?0_>D&CIYZ9<VR12S#\>82OG"8+>-;^,EM
MY$Y7N^L;][=>!SK>=LY1&W"0THNBOM)0W[0^X E77J<EZ0B(@M^M.',X5/W4
MDZ(:PII'=%\\:X]\U1/T.._4.E0F@HO2.-^6X*;GQEN9M1 >LPX&4/PVMV=#
M4V)Z%.F.GY4=7)QQD-(W&7RAC$D8OE6 -C8N+$[*?PH3W>;WD=E\U1=:TH6,
M53L"DD7K8/,9#PQ5#"R$>33&"ZC7*>'SF?7#NKDE K@V].WH#]#;P"I-/F(T
MQ,XDN8!(SG!13%=C$#85*Z)('A@Y.<.R'56LJK.5#[#-)RV<0$0O)#FSJO'%
MH)_4,QCNTD]+<$*V\CLHZ7$H^E#.M4X!F:WTN=N3?DH+#$OP;17&A3[*VXD_
MPTA$Q4A3;<^"F5&!OP+UD19>"8Y&7GNA?U"-K4JVABKM(UF]O3V0WV>?6/>J
ML24KLMQ<8"''J;4)%VZ_@6.5@"?BT;2K]M3S%.9"[RG,]FKZC#Y:!R15W$SX
M#,(L#I(2;X1SOK#'&1U@_!+/H*Z3K-M!',XPL'&6;V?VXT\N;S*ZPM@ZH+&T
M,^,H= 'B8U'M.V^+T_L<ND ([IBU>S? P96Z[[S4X$,SMZ/B7IY1RB.JD'-&
M_LARFI2L6:F<$Y,[F-<%$>-:D!L*17<R(4\>5$4UC%]"46V&EX75,RH4)S:>
M?]'R'& "!@[?:=SQ"1RKK[[7ZB;U3FV\'TM'=2,8]2>,#7Z1&>L)N7ICVFF!
MY*H[&M'_7D#R7G"7WJ*(TKW/" Y18EV*-#K%R.#IT&)6<CY#I AED#1M3AS+
M)Y/[Q7/.NV68*,6"O8S "4XG1GW]7/IFSF4((%6[[L/>KPX[4BHJ:O._/9>O
MG4F5_*J(H,?90=1R5B3&V0U^;ICUV $;K4P1 XT]'<ZLLUE#F[F==PP?E4#M
M#D+FCX#.7S0Q6/#<OJ)<:-+;XF;[=AK7B]]DWU$I5&#\N\8'CV@VL]2/8(\\
MO@F8V.G WH:Q2WDRP]H@\[Y'8["3?/3W1B,&FGHV5Z3^G%:2M,R=S;04N91=
M(=W^,G!"T_/$B*MWU-NYG?V'<GMF,8S7_R$>Z!N(:.Z\IYSWU]MVM47$?.81
ML.TW!1X9MSP"3ET^ M*]2*##@$IKVAGH$2"V47!H#(37.,L<ZW5=Q,\IN-$1
MX) 2KOL/!X#0_G^.;KYZ2$;%8O^V_AD&T/HK >G?8;"I_[]ZS[ %J/]'S]LO
M^AV5OZ]QG[%W\1^#_8"'B#7^0GHNP;^^[ "[_Y[3ZO_C *N YRORCE44\0B@
MM8X? 3JH:H1[WIY8H\?ADYZ_7%N4:1K3Y!$ .@+8CIG9!F+GZH$XV>L(> $I
M1HPW(_9/Y[/9(#>'/U8=3@7]BPZZ_SBX_M&5AG59(Q'(J\?3C;H< 2Y<1\!
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M)RJ$>!D3B\9@K Y8T%'//89:/H4&KS5:6XI07N%+[2&9C3&$:?L?J2OC7GV
MRRJ.-3"/'18V;#+Z0%90[J3&@44N(R7\'4SL>UO!9Y'XW("^P(J+4WKM-/3$
MK.NSUGZIOWS@$!S0#,*S/'"\2QX.FHF3.N8V(%:JYB#ULJMT:][IQ+D;<<+O
M&^628DZR=;\:,%C7\I%8E:"7O$/<R,U)OQ]EK:JX A=YL-T+?MD*+V"=6+.K
ML=],+C1>S/:!7$8CE!]JC= MUD1\;V5I'LNRK,<$-UG/,;T!()7.L8U,WG*.
MH:KUR2Z&2DU+AA_\+&=9<79P.0W77I^:7*0V9Q#RK#V$>^7D+W[>'Q8/BNSM
MI>T^3V1\-ZMLQWB/J;K6/UJ_/6SW'3V-%S;HUW!5I%L*&U_OF$\)(\[,VLKE
MJ'Y[8QVZD'?**_?\$,-;U]/VCYH>Z7O/@=Y* Z&^/>NX^>FW+ACE&O_@?NPC
MOS^C'<0M@X2TYK??HX'LE5_Y9Z7M.ZH<;7O\XIFN?/E2@H-9]5K&CCC>XIL'
MB6-\S;0%K1J(>3HDQ229=]!67=Y3L-+LW38HVYK=V;![T_A9-F',KV,0]QJ&
M((<2X^(N!F*J59^[)&A"JHE;SP*WF"9:BO-XLLZ_>0[Q2P1(SHF@$^])+\L4
MS6B_8:YUB3O(DQ0KV3._E,EIE:*W@)_CNKK 3;:<'_M:WW/=J?!1)4[@)?IO
MVFK\)T4WZ7*.G7H9I2WL2S"9W&T7UA@3L!@M_Y[E.SJ"KZ08+8#BJ*PO>@IN
M?+JM7.^:*UD^&I1DPC:9DS3]+%:#$/"&*=UHM!SC>6LLH$?^TP_3I4B-S5WR
M(Z(;K;PQN?:.WTV_'[#^H:8G""8OLIWSA$N,U5E7/TG#=VF%+$WT0^E?@NI_
M,U-S7](MRD?T.3'4C(-LE)/K7K3B)^?SBL(T(G@^.6K8G>Y)J^,E5S"XY5U]
M(!I\O=COB:)Z-2W2E,&!QCWT<PA<71@?CE2=3JP1C_41'UJHECL""CJO):W8
MG?M4GZRN7[=F:E^3\_K<HC4&,*TC5B#)QF-O'MSSO=YQUIJOD/:#QCKXYV;X
MJ3)FY&[9(#\?M]O%5KOP/SO\@6)>/VU&0EP3 >(!."K $3:&7R793$AN)F7O
M@+C@%P<T7/U=E0N8#<C>7*J$Q%49)<^Q,567P^VO[1E+A<,5BS&V1>'3#?1#
MD5>\(GBK!S=B*LIOUU*Z9ZS9PP]4*0JF8\6CEZO$5N]E^I"<8H*6[ V7G]HR
M$A/Y564*.$0X^[V!WH%F]B(*U"BW>TRZ=BA9[< ,DF\[88-Y<R5%XTW&;@4$
M]M-/](?FP7!R+SD*NBA4OY8J02_4#"HXS+YU339#?D,C6*GCUQ%0@XQN5BC3
M>N?B0^I7V/)Y\]OIG6"[8;8(.U/+&<%[H\]6._R8B!+TEV095LB[9:&<-@UF
MD2.&"RTJIHWRAKPJP,\W5IT2JUBY/OF%L?%EFUVY'4ZZ>]:#ODIO98R5-T+L
MOS2=)J-DDLCWB((J>@L^K^[8!P<<2HZ;NU[:]'P5KBLG6_=#9"("3?>JE6,8
M_$ED\,Z%R>XF2W\'Z;SUX?DU(0=OL^GK#2S-@D26L(S/GT\^"KB55K-^L2H5
M39<&F=]0PYDG4G5IZ;SM&+&B^5FP5:,*CUPL?+D(:J;-=Q[F-Z07]<QU%QQR
MJ:$/.K\5![^!]\1,-X6/#R8S.)T*L3!ES/8&U6P]4Y*<E"FN<57XXS.*8H.S
M$\=CIVY"?'</=<-8..DR-=3=#E_NA\:'O]ZO@%56'*AVR"8*DZ<T;C2),+3L
M)P)] X$PM*.R *Q;^0,#6G06O;%V]WVD@/!&08A=T#^\NO\OSO<_S/ERT?_4
M[\P _7=]C?Y7CO^I'DF5[']U+(K4?/!7G<4)VJ^2_WX,Q]\GXDB2A;'"8#_4
MGK05B,SN?'C:E'&-K0-\#.2$CO4T+V*'W9&'BJX,^1?).J8GS4L=:C\_LAYJ
MP";R(%PIB/)F*":3@2[.S%$[1L0]8KGB,8@K4XP"P3.T7:U=[UG3!KUIY2;.
M)>&Q/)BQ&OS*.JX/W"3_)@A5BPZWUZ5HSN<\^85!U-Z\]$ LK::>D+@G/K_1
MT];[VEWK:NJ\=X3_K]-;3L@#H]JW'V \'2L+41>'[K\5#/HQH L$@+G!7EO"
MWE-10V(#R6IN"Q-9=(AGNUP;V+/4 "@1->_8-<*1-&MS_M)TP]>O*#5*-,GU
M<]AN'%6UQ*Z[Q_SIJ12:";Y;,F<T&\$&"\>4C:8?7&:U<<4 #ZANA_D:KB2Q
M8</:4<7BH?53WS(R].A^6@_;$>P=8,[M'Y76;KPZQ\&JT 5CZT8F.)TE.;=C
MF74+.I=V-\XTG>DW<VHAQ-]'WB2:J]6*QJB%2]"7DDRZ>IV?S;%FVJN.T8+X
MF):5EL) &V_Q0CJ0D,;!@J=#UDRBTUMF5*N!G6XT^Y=J^4]\7;)=_:=6U!@_
MXUAQ-CKMH9?-GJL>@Z2)5HF(03OQ2 T55_BX&7/3AX[XKUNI&1WPBX=5TJT7
M*.^%A-=O,M^>X%US5H.'$:5_O,]E;QSEOG?_0_E!P"YD1.L,58YX:CD)?7C/
M(/6&/R^P/!:I&4VNKV]&?CX]%5#=)$C/ASI]F$2U_ #3=VB-<VY(YX'&=WY_
MLF\] ,8H%A@3A1*["Z.OW66 X5L#*5U%,S"1CD:])E\!D7(=AWQR'P YUA3:
M&M814U*U_)K?$Z3B3V^_BG;D6<>1F"TH4")(IV'LIKJ!3N:KWWVAW6_JP#Q:
M+#@*P50O?=UX<3%.PVH.K<1V#LXR>-8 ]R"A8Y[UD03]ZH8]_I+^PD&X^:5K
M@WNOJ)*Q8P@O9D?9MJSLC8Z>\_8OE,FH2R-@+UEZXWF#'>8 N=%WT=]$H"17
M+K;('3866,U\<94O/N9YOT*-^# &",EC1GAN\5)OUN>NLK#U#=:>%_J&8FCF
MZ<:BH9U>K3(V7OL12:*U.NNBY?D+UDI%1&>"\?@SN+[L4[2;2T$[4_&]-^&0
M>I)* AH1-R<S5+GUOJWU%8^ZIC$0%M)Y!" ;CX HQ0.C'%\I8]#SBHLB[[H>
MYYTY GPA4+ZU !L(>X=KU9F=I7H<,H^C8 P>6NQ%ID/&%<6'XF0Q,):QE 42
MH;>JJ+"TS?#ZBC;(W!N$L8X7'8=>(BZ]43+R=(AUXP.LA4@!Y*@6DOXS/[O]
M4U4M9C$WVLJQDP5X4'3SN=9+<59GQSE.G!?1&,^ ZS="^2D32LF/A:3SEO;"
M?]%/:G'01B,DB%G1.Q0EE@M"DA&=S<^#^EO"Q0G(Q.S8G/D<:811W8'^:Y[L
M;VJL"DY*A"W&%>Z\&JWD7,.3!H6^3@%=C^<42;78>=P9RN,?IKA)E=,?.OC4
M/>G+B*"--@B^[Y&GW>>XNPUI9-=WJ(\[S)VMPV85N!]1<1SN6%EJP *6X2N)
MYPYV2.25\SG>Y]=GG?/!)ZEN#^;.5@W_3#]45FISVJ%;RL,PQOWQ%;<8Q+SE
M-RQY.F<F/?11]%)T>C;^#UN2]1$@H $IF/@E-61S*XFK\WDN5YS#^&BNQO Z
MKLWN^^/BQ?HZ-U4^C<0]+/D&4>SU?$>IB:\ R[C4S_K^ &T!)V7*<@65!<,?
MF W+'6/OW&::IK =&-G"W5_\\5M,':W0FR_USR:9I&A=@W+ '48"\\Z5J<2-
MLO:5S34?D%VK/M60>A)$ACDLT3,ZFXQ%0+@0B9E</@;7))WH[YB2R<XB?@]^
M+9=N034CZ2R-$1U697Q*YE_]3K8T8:*$&#52*HJ^#,IE(:PXCX D)Z%AJC')
M;\T@4_GJ>1%/?*1FW *J6PC<E2O4//FH0KKP<N/V(PF*/HD?P6\<V@RONFT:
M$43*2\*L8#WRSMU\>*L,6F;XLWC Q$ERO3\RE^U8[:S.9ERL_)R5%^%)/Z*1
M3JXX++U?_R#<*^0L/GMRX_\_F5?HCZ4S:?JO#_K0H^9\'^A<?2=1?(=%\)O^
MH.C-P W5G(V*@8M++2_D1?1<G<]&# K+'V^X"&EP+%6"=[5<RP&9&7GI, U1
MV\Q.2#$Q(SF.=BIG ?'/UOWS?,;+X0\.2[<TZ$NG)U9J_>>,'B,"3W]5^AV'
MA"N0 MK5?&-Z$D>8;29 LZR0CQ2$#)+TI$=8.-/S9ZC/I&4=Z_$]J%O@V=!\
M0D!PZ2[,>@]*R?[D8R<PI!.L-Q3*X"+8-/'A\77O"5N'H$J5'BV^8;C*@>&T
MHQ>IT4E*1$!?2/)'LPO^2[,_00AJ3-IO6GD4>Z UNJ4-N@UG/"Q6W$JRD][X
MTWN3<;(!7\\F%#%A%Y.%'.^8 Z&-B#UT+P.<SAQH3-G:4K)7.W1MK76SPZMC
M^V?[0O*$'A)![>&FWOM7#91B@*=ZH?EL1=!6>2>8<]NC-?[#QDG%A RVM<1M
MDQ.T42=ETG(2=[\>D8(=HLY6.UQ=]EZNN#E_!/!.P1\2I20)]_M*I)Z\GY+[
M(?D%G9<XGG<ZXI*]ES"3>:/ER+3[3 -!D8Z<U_VD=]HY[MZ</8/]8?Z>=RA*
M^?#UUN76,?'L[86^Z2NSYX5CF[!"WEEJ1T![@\Q&+#21_@L9E:MU.F(@@I68
MERR[KN1Z%7+Z-#0K981N#8>V[D&R4P6P-?Q^SV7+EQ9_NKQ]7W.LBL:"0>>#
MXM&0S,2I[;M5QVH802CI3J":X>UY_>A\V7$LV\<X]1&(9<>9-6_*Q+B!.'2G
M]D!^\J^B&R94Y\,B#/3$K$D))>"NH]42;JM27KN<[1FX5N8=(4GH;OC=;G7K
MFA]_NN422<<T%)89SH-?0F>6:WR51S4-->5%MYXGOJ?P=+WXKA >)" W?4C0
M%K+,V]#$RW+ 4A!5Z", ,\G*G(^O:G8^\(8EM8=]JLG33086;*IWN#!$R9O#
MS;+$'+-&3 (6;:4G86,=XPCA=V\@^-K WBM?P22Z/!E@'-K-PSCE@>/PK>@7
MRHW;NQK>88*!E:".(Z!6/$%)R%]XV=!F1WOB2?DCR24V^A62MY-T8VV=84JT
M4>1I<(C2'VP2E>6=YS%K^K,3/)#VJ$-3M0\($^]$30G<(2(B?>&ZG*3JON%<
MR?Y6/MJ4'31%*1Y]>-?&)]>=^;0@%)6G)0$SL6BFB+^37OT2."@Q[W&]+P3$
MK,5.51PK)OX9,?NN9.1;,KR4S];L.^ET,DC5RO3SH;<=RI4GW>-L> 8 NF/Y
M+R.:_[4A^;?^ 2?,W\8/ !0L[4SO$2!R^]!^;VR7RI5$T]1@/H;DQ[!<IQQ$
M$9>EIDC^@2[;XXA6LI0=HNQA.-LA4Z16]M^&"%@N8/_6;Q#))%%JUUTBC"SN
M#Y7=K\_RSV=[A?!AN6=#4DY7B4/+RFUQ;G;J9_\X3*8:?O0B-Z;$MH@F2"?K
M7[JWXF2&[V>'ZY(\>@Y>4T55;*HS' F)W=Q'P'DM)EBTQ6BS>Y-4D&#48FIW
MI.9RCW.MY5S:1P>;7V/^<[=3CRF>)J2)(DG:)N#-^/V*F*:\NXQX&1F:H>10
M(B(ZXH) RGU=$0>IG%327/F>/\R$T)FEIM9XMRIM.!&8H[P^N.]-HR-9=J<)
MOQ;\Z'? -Q&,,J @#G1M8+UMNV$=S9[DWLP;:\Z7O>W&D'A9?EA5\ZW4<0&'
MGBBJ305B8OSNIQ$-67Q9N.5#;E^%4_V[CSWIAP7(W23N"GS_>@6S7NJ^YL1,
M6?8.,@DD*!LA3)&]/0JM&)LB$P3>:P2L.$M3;Y'N9A"1I@<FS]B[MNM7&U">
MI#EL/M6>HOK.@1+EB!'5WHA"YG#2C<#E*'MXDWCK ;;UEMK"Y"\%=16!V&/"
MJY5&K'SR1:C@K6W$2A>\CH@EG-J-A8>6>-IYNGA)16EM>>^[DC^]87M:=_[[
M&54K=7T,X!/1W]BW5$'<[,8OGDU9?,B]+-8\3M#?,$/!I4?X&8>ROG[M3%:_
M1SL5,>C$54<)8,@1^))%'A"LG"OA^KV+;+W00;KZVXQ_OZD]M5U#EK@4J55*
MX3DPG(#?'8Z>ZQ64/P>KE,1;;YC@V9@IB>1^O6%N\MR)1Q-?NF >ZP>0(GO*
M5VDI*XOJ-K *5P:>C7.5&\$=9,09I*QG'*?UDFXGJ\-DJM>,%!?]I\)NOUW=
M-I!X=T#NC27T%&U46)24D3,[Z<6LR&0P4[9BPX^("50'Q>V_6%G;=KQUYR#<
MQ&Z,N)3A13P"R)#FT<#KWV:EXCY\S3\K=).\/A+H?![AMLKO8S5O^*F&+6Q+
M(_3 3C??=F79(%5R+:GP[#V46*L.J:L_5L.X9 KGI']Q[*'/UY@M>S#KCGVX
M2<^<T-/%RY[\NO07")QT.\@.[%2-(XDG^=UPT%LE'VE<F2O7-/S^88DB(JX1
MFN.E87W^"'B4_1N)S&6K)6(3YG/NQ'_<SMI$>A.=$W+9#!77-&]:V]Z1K_]+
M;=ZETAV6/Z14A?JSOO,5RM>;BM%3L1Z2]#^O)VI>R/Y<%QY-9/O<ROVVO&A0
M),BM+4L+\V<F^-/4=*GK(CTGG8C*J_RH+M57E8,&0B+)[+M>-T-?B10!AO^6
M-(+_\D7\LR]"G79&L,EEQ!Z\C2LA.%?D[-ZG^\J'^@JEB)8SU>YN(EN:-_4)
MSN5R,W?'F6(%]9,W\QD[,C*V \Q[<@/,^@2NS$2+O>7>XUD6\#SA,)@-S=K2
MS]K29NWC*]Z+V F-V '6_T\YR(F3G<OR: $B?(YONQ-[)4I+4)=]HC>L*6=\
M"75LHCWLS:#$_MLW+K@K#^X< 8'6?T6H6>MMR[0*-<$_[):J(#Z7K2,FN^=.
M1PBOR,BHY-5<; .O)P)_N.JO(:6>VH]5E/F9>I^"RA,N/F[%N/_')J<(+(6F
MWN/M"4-]G)S&31A[*#ZP<7>L;(DON1DDXM ,%9[HT2OA-K(IS I>%,SS!DC2
M]\CF1,Q2H=_&SJ\+7V>3K2'%5.'!A:',]LTIU8K11Z7Z)S";$2*PQQH= :6Z
M)]\R9;:5)>'[^"K26F=RC<+'9\<B-?##9 BQ*[<8"KH;:US1 %MQ+&X@CFN3
M0+&%0P^'"0<*9T,?6J66$#0E=6]Y58Z(G'UJ[# 4!/$-'G"R^2:&O+YGPDFW
M)"QXF*,A6S0C.Q7XQ:TN?C/E]#S_YA^3TRMA/TUU?#F976JED$V.'%6O[E.+
M"Q<L,OBZ@,<HXI9!XZ=K3O;Z&B4%PA@9U'R*I/E 16!OF67F&,,I$9$H^P3H
M\AUQ*3UP;&&+E,BI8Y#+ZM&9QQIHPN%E9CMCJW^I.\?URXK#<O1?/5_!YO9)
M_H+^'W\,.F4)?N"Z 7TU*J1C?SV'A\?);%>1CB=!0]857W;KZ3Y7KJAZAGTN
M1/G@<R,H/A"WOJ%ODHH_Z9A8>?U$G:]?P0LN[HUEV=W2X+0"G2ZY1 !?3A/\
MI0:*72:V9.8^7ZECE.9'OEQ"H[%Q83(Y[U(DIO3&[ONRIWTN Q-?>7%X,Y<H
MS;B:09M8(USMMC^[14JEU G]UA:6+J!]B^"L&O=#+0W/I_>%K_7<7E/JC]YW
M^_&"K'Q-_\2U;@"EH[M=P-RDX6]:ZW)/1#A<@KY7@YW(TY'+WJI2LS)H&!S6
M6UO;[$^$ZI#*R=;G;3MQ'NI9EYIJ;X0"_9QE'%U\2(1T%Q#:BB&";XR5!Q<5
M&JFEE(FI69V@]84)I>9)5I3K[3V/EA <K[[I)RURI7D!:6=19WF9VOY-[;<V
M2(QZX3!S 4-2KO,OU:GN$'D1U=/RI!9)5&F?"B_3"_QRY_7!1,57VB68Z]UZ
M&.A>7:+IH]XW@B,XXAM/G;XM$6P*WJF0'T!:$"/2E*.Y7_M[IMMU/ZYR+7)?
MQ;'L@#E7)"%!)06%DO'1;$UV]V %AM7#Z7:Y&U9#-V,>P,HR(RX:FU]?'!XQ
M9O[=<"SX-\6\292./0YCY,:37;+X0,W*.CKBW&HC8]=T$@Z=M_X&7A6,RG_X
MG)=\'C,16&AON1TIPG:XN4/G;)G*5V&,KMI+N#"=V'MLBY_NX%@+GYXV5WJ^
M><'?WKOLD?^;]0];TA%#;2$9^6R:I*PV(8$NE900LN?WOM$J$V)=6QXKQ35'
M6NVZ./1/:L&6=7X^][48EOJ#T7CB-P'!;*"MCBB3!GF<969W:08E*:;*.=E\
MOLCXXUL]>TO([[8<P7&=/K2%^JM:?VU!Z^36<Q3G;GD[HS*O8][I-_W>W6%#
M"S/AI7RE>+('RK&>>(W+(IC+Y[$J)P]]$2#O/G5]S>B\GYU.KH=8;EGM/R?P
M_=M>K$]#.U&<Z<,'_XV&5Z26KU<*_.RY34T[7@6H_C+<@&0>^*/PGS(RQL:=
MQ29- Z(2@3U[&A-+.I'VG2[79ESNK_X&C;@%H<>:SR)V]\=M#\(=F:& '3??
MC]5%['QV-3J797Q"'SE'VNH#P@M=]^I"2AZ43O=)#6X&3LUEJ+PZ F;S&?J8
MU9ZSG@JPPK*B>>&WE+"?+HSJ&R4'.-ZN"3/MW%CI QX>DZ<I1*)O:W^I?<4(
M_?MK^(9#G@79V&:5@.65L(?!U<OJ+UVS-T83!!.#@(!M&,B@>23+O*$ZU9XH
MMWQMF>L;K&;>.8ZJJV!,YGU6&>$N4A%FI,#Z-/9!*:MJ/IL:$='&QDK1X]/J
M<^5\K*+^,J0RH!M<TYU.8+'O;\:D/MQQ<>I!SPCF97')[E>E%D=J'-)8?Q%A
MWCBC:DSJS"VYSY4A=PYS%26-[ZHW)4DL9MA?K')J4M"P>2B0L&'>W?62XYHG
MO9H)VY3R*Y\7EVVJ4C"$_9)UU$).G_\?@_*+1G6^_6*J2IMWFV)T&T;NGQU@
MS%S+JR%'E=KT\%7'-T-2,\2?1M!3$!W2Y'H?UT3*"6Y35:X5(L_]$":CA)1F
MW2IM4&X>5P0##&E*^5CN;*^1Z_#LN;;2+^=J7%OXXUD,>]FW)9:9\N@/J$]6
M8S]TSW\]^017)A^='=;%E7L*?3JJ<9TW_VR%;%OCW?1B@>L;YV[A0OT=&%H.
M-#S#?N3O&GEQ*+S)E1SO$4GKL\S$6_I<?6C*2+> ?1K!3>P]H5B?7$)Y.F[R
M 29^=\27]O5RH]+K-9#WS)+!5[<.UT1IVV_4]DC5<,A"95*IIV%1[T.D!V@&
M*<A$H*H0W3MNCG)#(&X)9M77),?X/5A2FBWB%LVUER*YE:82-1FNC')R*"8:
MG>7/_#?%P;%76Q J0GDV[A9IT<$^R'T]D$,YH40.2\?[*&SX2#9J4S9 J:.=
M^78G0D(GM%?E=R62QM2F-0VF9Y.JXOF+2U8&T,[TB>'X3IL\Z&X$4R09BL>X
M:2=/7%BHC/QZ!(1%:F4>IOEI#1)_C*Q?B1]&#;6,-1];T[0B"N1A'R]23IQ^
MQ6FT#Y"V'"DO&/%QJ\L(Z;G09E?3)[AORJB03]4:1$LB,?:VA=9@''TV(HG*
M7$B9FKPP)LVQS750VG&]8D_4[1=:7T3%\MC2.7%37-Y1;M@JEO%N7'+-M.3M
M,Q'O>,MM[+DJ-J3P6$_%-7M5*#'UE+RBU/3$_/'\:92<>?&XS3\BP9GL9\2@
M<X)!E7$&%/ [2HCA"YQQ3>IT'^BZV<AXB)2A')]&(OS9U?MO_+6%5: 'FK^L
M&WNFE 1X-T768KF:RN \0YL5NA5H]BZ_ J97J%N6'/J17G,/N@%I;>%["\Z1
M<\*#0:(M628)E:X^Y:]^6B/P**8)2I-^N#+Y<O9DG,2LI".!XS'+&>$?.W3X
M;+;UX?>_&@M_W_3B] <3HZR5H).$CET.>J%GVBISA(JPC<XY4V'TQX.NK_EL
M8CGS6FE%GM6(AU,]D' T7E=PO$OKZF$VU:$5/"(;,Y-:^3/9'7O'FG[QAW>.
M)]G\S@]B@=P?3KK?<>LX8IE9S9!?_KA@OX!_[>W=7BC]RJ,5Z2),J=:;V?LB
MBV*U+K6QG0]X1^G6WR>(I87)>-)W^6'=L:S.E%C;V+<<]K'?*B6;JBB:"Q5*
M&TMQ=Q-D+ARD,MYT?/&E*Z"&L472-SUR9H!!<_=98-_]V!'IH25MN<Q*:!>(
M,="9PS;)2]KU&FK67,TZ6)K\9E-QNTW?88#Q+85Q(1P5V3SZ]+)IS^*4FC6"
M24%B[O%59^Q45MJ *>!J7M_#B9/Z2"A2]]\I$!\ZUMSBB@':S/_V3[/N\L(7
M 2;+0^]_@T(DNP!XR3$'$FY@.5"FO)!OWO/(/E:_F<?\@O<(*!1_IS1V#'[U
M)Q ="I2,D8?Q??YY1"/>UZUT*_)I;<>*N4+L("%2Q_3B\ERK]['N3RB=B?A.
MNYQB ]U.";_>!;K*RM_J\%<4U<I'WX/KE!?!+^?U[K( CQ!$(XMS<,8AO+B\
MG\;X]+;RS'WK#ASQSG5F./NPS+E-\^Y6?%HB@5X16+7[=^)0*A0*,UP+V]:V
M/;UG_3N+Y*0 ZH2>H^_?M\\;PQ9 D>R*6+8_0('HK7_B4'F)VWQ:(K!H3=UI
MY%BD5OYA-,(+Q1;1O^WP%O$C1=AQV5LX8S=CB\I5MJ"ETZ;98[(9@G(:!;N
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M22+47^@H:XD@0%3J''UM5VJR2<>=Q&#'[G*K- &=:2XT!I]!DQ@Q4/=.8D1
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M&E&W@.]?M+>/:5@.ABC4"FB5@V#MY+%W)_G/@XPUAGIR?!9PSC?>IZ1P"WB
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M"0'/BQ<,[" M;,Y-9=?"5:/-W1JTO$NS1JI)P&\I?[BH/="A6IR00#V1MN(
M8U+.>=T"!)M^@CM-).+22N"&NXX%P)%:IK3ZLFJFM"# 7_3O)>;J;!6- GFC
M%W%!S"?/>X@\4BJ.B:\)I5VO>5+2I*]/#-8-%&62ZZ;ZFPX_;AS= LQ$Y9O@
MQ!?J,?'UOHP'4#KO]J.,2\\<W4@BKT=$O5+G>/MK)44_FPQO 7&+ZJ=!C=]_
M2NCV>H [&\\Q,7O!*1S:@>O4VB)-'A\\1Y!3>:EK.YSQ<.EXN&RX!S=<ZMNX
M >=B..=B-"*=ZL1<5/+H9NOH9IL;+KTJ]?5WHT$#E4$#XZJ4Z-:P=O#ZU<CZ
MU:C18GAGZ*.[(D$CX(6Y ):IZ(X,[;.!ZM4PIA%+/L^0J*/7;N\[:&RK17ZF
M+R;C-_UP[?K^J("CSOFID&>"+NF]Z*\J+"7\9>QL+G&[B86T!CF_5T$Z62:A
MXS<X8-,E?+#!:E&0!HJ\JCS1ND SDL8LZ9*G>=(U23&>?K)XR"INE6W0BS5Y
M[GV5HKQC?5+'LG4S0E'#5)=LI6G%T\W4HG'H1>;3!&'@@![.5(A3,.5+/N;"
M$?:EB':$=NX(65;?@4D8C.^#K]& 7E.%)(#SJ:3]+'6''K%^XN3HCN W*KF4
M6(EVZA>\ \3J$O9.@8"=?K?\=7T!ZA*K$P:0%T,[T*4O!$+T>0:9KC!)'\F>
M$5*;TJX1CAI=(K;.%R.?M233&XXTM;*1T!78F\K1VI&WSUNT;)>FAE/PV+%X
ME^!=O?"RL+8)M32I;E:ZV>D=NU;*LO3(3S)VZ-07:PY:K\ -3B(.7.:/(PNQ
M-G\XF4B>6L1YR.B?/P8S65\(*YXR>Y#09HPE5O+\[)78E[A6F0.!A[WW%5^,
M[FB'6(97BL%J6(="J<A'#H@5J\<_Z\0)\Y<Y)DU.U"O9KBQA#\$P8TAHR:M<
M,O>'&WR$%(![+BQ_Q*D^;<S**+NB...18PS'*_28ZF)%V+:+XUT;V54.R]XD
M]VC%O^9;TD9^V^AJJXV2=H"S=+[5/8%ES[4;:$3N\WN$^N4\_6H6FOD(8)8T
M!AT8/1F/?-LB*@D./Z36K1X7,4Y7JH\B 8_]'.C2ON3L6*(2X4E?A'SN@3RC
M[>J7&:!:?'GJ3FD\]>)PYB9M*Q<!3<K;OHQ-:3"BU18J8^[J!0VB&)&Y8^WZ
MV"F;\K5/(]]IEIO-UMN>V2#[LK>Y%F1_[["N2W,_-;;U0*_)97UXWLF<>FAW
MQ/&VTL68K,-(X;O-A[\Y0\H+](>N/G=NFWSMP@02#4U?FXZDUT=-;KC!7*SS
MH@33Y]J+/@UF*1C)CYW^YKU*I,67GPG5GF![&D_._H--SP&7"''>R?E<;P@!
M?R_/FH-3GR#.#&LLNM(X<_T&/EK/QMM,:6"Z;)>8EEGP\^)?Q* 8D]Y8I8A4
M\QX,Y3B)!#<5@-6,$.0=8J\0_(TO2*/8^1*C;>RF"Z'-D'*JLASS*HAUI7G*
M"R:>)4)/-__BR%/GC:EPO&Z>TRR+&O?'">O2COH8A_ZPSO35(@I*!IF$]P]=
M-=+ =LAHXM8%9G"G:LK;@/%#S<F(WUF<IC /^M-.*'4O)1&J0I^5YQ5<JONL
M*%X$%Q9.>OVFO'KB&?05F_41Q@\\@_?78N,<T1*A%4S]/*[J!='O7Y>9./2K
M_OC\<QT*5Q8CDW+>6F#J:C!/>MD1O [5%BG;_1,NU)RD68G[SM/[SC.Z&DC.
M,U/)_H$*(9XCORS_%5F^_H;_B2S)=[^TM@>_#<(NS";#V2[O*E-K[^1/,5>Q
M%L,YZ->_L'\8YR1*][U'4#Y*#KFPJ#O,637Y].H7K#1M(L2(N-_]?)_=G0**
MZ8P\6T[^+"Z'-J_>#^"V(6'[FP+'Z6<1(;I@2L33G_QOYI71I@Z+\;$(-FFG
MN,?$D59%37AFR^*DN-3OM* +HT4LIK0O?]&_E_"3Y<9C"NQ33U28Q]MI-?H-
M#I4X+P1$@:A:SJ.B[%!P&]I/Q;\%1#N.WP)VTVX!+*/0]I =,-L%[AGM+2!<
M4'PWU@N'\?("LLAWW+4G?0N@BH),L5Q2 4]';P'U(/BA[;R8.!&GFPFADEZ<
M*1DFH9)</R]ZX&"N8;3R96M[@W::RW#N!3&EH;/]5DP^-6KH'JNHI),G@%N\
MRQTJ13%!?JJ:ZZMVN?HT965EPZ:URN#F;"(C;2.;$4K?K@KV,^@MX FC_]I7
MW)A^[@%#(>422QDD9ZO'5+@1$I$G[I\N%5(RN#+'M[]$W/@2Z2]]V%,V^2C.
MAK8]&=,)A8%D]%R!4.GM9-DIA;G!]?U7T>QN0PC*)\L\3<+6-3Y%=GG G#+"
MPIQIUVXX5Z#^Q,MBF; \=SJA<@?\&LO-TR&\7:&JU@66A9GKTF;3AD"T>8"+
M9X'7&%!U55Y#;A_HH6%; ,;U03VOP^$@F3#]'E+)I+IFF?1ZZ)LWWN'Y=Q3%
M+EGFL0S'M0_-<8J]@:@;7+4:L>1S2EY'2E(KH^;>LFM@C_1<66@,7L%N8#EA
M;].3+(',P.J)U6_"*^9^9_O(-NGH6!BXQC$+*=?HCW(/'_U4'J!'TJ9K[W0$
M/P2<%VZNG'_G+2!?\:X\ZVB)FTYIG-@A-BBKK]3'+!ZUS90/#I#I*4P&(H5F
M(;X;8\$L7FGL/D>9>\;B((+.6X")N-^E3<XA>DYUK_@9;#1O0'U%(B:NA[<
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M,V1-,AQ5QP?.,K]9W2Z.G/X3_S:&G/[=LO\7_4EO:)796979-=YY!!MPH?W
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MXWDL%95&NYEYQEBB^L9;!P'?(NF$E77&42N3<<-HDJ5KP<QPV;J*ZCD7 +#
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M7HE_)QG%4\ZMJ.!$13&<Y;_*FU1T9AN+!VRH"LKKUZ: HS4U"1+:YLU46X'
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M,WCZ\F/#HGXS+%$(OO\C0T"Y^_!E'_E?-/S'?(3H_IJ/8QOFOZ?9[DOOAX?
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MO+])35VS=U,I%39, =$GI_E=W^D#UMMV4"4JO5B2O#16E/2C HC[6FJRG<)
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MH$6^SDD\AEUK_PJ5\HN>/CC0T.(6O*& ?)H"^JD6*KS%W^ IH-\-J.XM@<(
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M ;'$RG -8X^AIF'VNK%E^3N7L1'CR!\9F6U$;3DT@7^9XRIO_*_\!KT<LMP
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M$>O)>VK?]L173L&[@<4",%_   -3$C"H3=ZHD2;W$[I)>V;D(CB4.$<.R*.
MC"$%*&#,/.EO^&WOPO^31J1YQ9SE@,BME[5S57!@FO%G6PL."N@OP"*2.P6D
M- S/!8]HDQ]OH?.W_H8;4:0"J&*:.@.!N>QG3"-WMBKW[?^B]U"-'$A3'( H
M4.IE(VTC@$D+W6]RZ' *Z"_4F"198%!WK!U"+)?E^C9@:EJ^K7DRG7K]DLJ/
M5D"'\H6'_K@:H1I"QNLJV1+_]\XW&.XN#_<@0>3S&M.Y!]5M#\MQNIMZ\E<$
M.,L,S-IEY;9O*$*M&<Z\=9/7D3A?OJ!SZ,O!LM0]KGRN6PW5H+[X3E!<AJ[
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M3#55.IV:QV^< . !B)9J8T+L'WO7U:R_2\\.Z#]QAZ5$8ZQI@UC=I:CV"8?
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MCS4YDA(/@<=(O 6(86%HXUB]5*ZK+3(7/)USO"S869VF4WKX$&B6^YGYG%I
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MXP89?I5SA\ )0&>$?\+X!YLH:2P*G>#*F'7YL<*' G6!L7P;+[0?TWU-#C>
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MWJ+HKGW*T[Z/4)%ZJ58H=Q=*,(X- 6M%9)]O\%)<K-U=EPLS__+E^IC/U=4
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M2P=9Z%M:R7IPGX($O-5;Y XD :>N21.KR)TZ%0#(S]3J/[E08I"_["T6M9"
M.D7P5TH[$F <ZI*(O0/9.35%K*;?3*)_1]9OA)W+JSZD;A833M=1T#S.>M#B
M2W:O1^=![E,EY:7=TV%MF,>2J' BCS<94W#%^=(?/_;G/+Z*RC^*_GR(6E&J
MG_6YC)G%VR7E2RD(Q8?W@Y+HD<[PP10,R*<W].@[F1KH9G8/C!'?"BLM+54D
M ;YZ0^)N!Q:Z+^@^HS$.8-H8X3BZ(_N2 F=/!JG@@7[-H789RY,[FN6I@9/J
MS<'6_2,C0M&2FG&[H$802TIGI5P__;. X:%R$ZNF_/GW7U3N4-4>/ +@U_7W
MHV">& /9GLPHN^JV=-0@[""^B,ZG^^LKCCO7_;6>0*R^C'F5,[^ZPYCJ+M,_
MS!E[;8YR4A]NW@'2'P]>U,I^G%MV9V73TW#_C3<_](-YHDZ<1+1PT1U/O>&V
M=G;G2U[^-VX/"'.%/ "K /@,[?W7Q MVA@*&8E_#B_S@SI8Q"OMQ1%ZH.*-H
MX,T16;)7,LZ,KQ^H\] :@=Q.W=@)XT?DX_=3U;SH*C\H5CO5OZGWD:'RIB.8
MQHF(57XL.!;2G+D *D UDH 3-\[TIS+NTWD5EAQVM^9]JDL1('_$JT*JF?GY
M"Q+@X2.KB5??D\0GUI7XC;P[=)(PKK+[1*G+WEF:XI"Q.:PO6R"D="AU=BCN
MT\&;-8MR3#S=]E]??D)<W4K9N]39EBMJ;:+^2:5?-$$V_YF6'8U%$ IWPNC
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M1:S1)/)Y)2V.QC12HSQZ5JWJA7_0+(4R*COJZ^7#)\E1U6C202V.CQKH:BK
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M!1]QMZMPE!E $N3BU0?$^/E@E&E<;*F2X4G&5FMY0IIXL\R6J595,,,M*QM
MUGPTDW+)D9[8,R2;-:$OY)>[M?P*-A!E[/V%/;HL&[QU.W1+59$$W)IZGX$/
MGN0J\8.QV;E8XD9X)MR=7@]<Q]9,Y@6>;UAE-.4Z??^U7)NRJ3[&YYI(0R+(
MV=YNDD#DB8.,R%V>K;:;40\%%_IO/W][:\)-2J2:IS8SUUEZ'*\E]74K7\J0
MM^WH17J9N$#BB55:$QAWMW, =F992YPB;;@=\" !M>XY.02&+).1Z/TEZ0#U
M(E<B)6X:%4!DM_7HA&]8\SZ,[,AUWVXH-54_,'YF6/3!K<O!8:_U1#+U%SS@
MM2:NG0H\,2]>^( ,@6FB.,RU#Z:4WN1BN_+0//*(W#;J+IXM6\%E(KXU.,!^
M3%%]VM3  @>JWX77F8C<JNBD:LX)#=AY/(A2P"O/*$V,&FJ;8]&BO&@V8]<D
M:FA&O3<;SJJNW5$C5L14\2N_U5A5_)95(:)C@AAYP*I5PRFQOO)&/YL]D7IQ
MK?V$PEZ]Z_MML96: MA3N%^<-H7/=>)+BOFD96.).WVLT6T$K\^;5M8\X7*
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MDX0?1ZI$N-1!!>_T'B#NHCXC\69"(37KS>I[<UUDG;' Q1"A+>0)80?V64F
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M)<BJN9S7O_J""CV!0 (,]UC&]V_#5Q#X67D2$)$FM _[]B/[^/Y-\H_;ZY
M[L!$^J#W-:Y1?)"*&P,=#9/7Q/+/,FGJG/H/8/A/+?]5&'>Y_Q%3^^I)0$7_
M!B1K&E,SQK=;T[G+C>!#\6T>^+/A_W^U7+QZ3O_CT4=J@++"F??WP]4,=&,S
M91" %Y.O;UK205O%M F<V@A'VCGAUNZD2A* E$:2[?_'WKJR)KV*>_TEIUP8
M2M9$E12?A^.^;8>=58'L[A"+ML1J=H-(P"@SKCH,(X30"IB(3P!+[9T9_\X!
MV"Y0,Z-UE9F#*43M%0K2=ONC#H /S^<^)\/*VS_' ]<2H?K:74JK(*8O<2:R
MW7A*U.0R2.'<0F@>P['#,[%YSZW3#U,>#7LY7GCFX_'$V)[W9>&"3'[=#JD:
M"Q<J,D?ECB7'EX?V O_[%S$NY!"H^:'FS!$:2UG$/0^3!LFLF=L"4@B'!?E3
MID5&5(%=:J.*"Q(4O=INFN6^__S._^!EO'73ZP 7=!#"8FJVZ.'[;,P>I9!M
MC['@39E*O;TFD-XNZ*;F-Q)K2 T7IM%>AR2:[RZ!_Y&+^,R3NQ<JLECD1OEH
MZ9-CS0_$0)NM:85[M0_ZEFNM_-#RX#=N)30H,]-74ER _XT+]V>2JZKEOF')
M*>LQDJLJYD>N>&BPF,VE"WPW*GERZ_2<3VTZW IDG9)P$<[0E3P?1ZVJ(/%H
M.*&W[Y61Y#6^<_.,FK?7J2Z^=WB9QUJZP)>:+FR=.L+7_M\,:+4T*'4_-&J;
M^YO?4[?]=JRCFKBKM \3A="A2N=W)8]S/P12SIC=U9M6C\5IH _9L"';WF12
M&-[SE9Q^=Q^MK3'<=MZ2RJGXE9-UM_(,?SBQ';BC+W)<JD<\M@_I ;-;\^S5
MXRC)HV'FQ["/\$0>,LF*$:@Q*WTDU3S^*2WB&FZ94X>1?N/JU H/^%/>W?)S
MGB"VX:>R_%;?>56)-+NQ\!'0IVK1X6G"7?7O0$*WYOO?JG)<.S=D\ ZMU[+R
M]Z<V,[3XFJ!6J=6,*GS)L4__#%!,>0E+3TU7[D[7G.FT?F@VS51;$=N+\#:T
M]9JZ:9-ZVW?87B_"TVM<.E-VIJSCN:D "?"3:'"3BD/%=AU=1L5LJH>8"N!T
MX+8]A:T!H4AN?;'1.\%Q9:T7;+V"2C0>'<RDZ8]0] ];%;LB_56O.0*ZCG8R
M0N*C3%;0;].'"'*XI>B<.U%NB6^SM[C-QS_N*4IG%H>T!>*85HO(;L UO75F
MG!;A!FXM#_SA$@G@424!M"?0XQN'*@BA#]^K+;99;&9P"7AE;67"9]\1'R#_
MU@E"$% G6\/.,ZMKHO#Z1MSV_H%O_=47A':>+3KF;V4,O24!"=D["-D^>L(F
MI$VO"8[-E_$B 7+!-1^[?D8%I EO QEY(8M^:*CY ZEJ?A+@_WQJ=?>@"5$1
MB==/D"4!20KC7ZUW@XGW=J>6?F5,(/A_'9)2+V3]U.[P'^M TS]NMJS^0T,F
MKW>@G86:6!0Y.)I\ -TC^K+"PU.(+.>1-7,,;COLLLDD(%:V> ]D^T/#E&4-
M$M"A2VB"Z7W':<WWG/YL C99"1]E2RZAAQ)M XD>J!F^/1WP>A]<&,), GXV
MDI_&YZ5  BY[V6_)]O[04NG'"<:C?AH)^*?AD1?BA9?3'VS_Q^[_QQ?ZV2+R
M?TXTQG])-,S_J"R9@XS_J/#]05GZX\(W /J]PH=\^PL+,7"(!$1G[0S\X[Q^
M+XCG?>%MM_-#G65[]FX*D@#!R'6F> RY;PMYL4N^W1G^\\66@(=G[_J5.;:%
MG@ZQ?^B5-7NC9JT/O/K.IO*9VVYOQUX?[A'^^=32>BIYJE*0&!ID:B]9B#\X
M;.W>&[@F0S5M]TJGN70)6<#[8,W"2J/&L&!6WH==IZ-7KWXH8YD+4\6O):Z>
M]IF3J_14?^YVHR,W1,G>B272+3\ 2EV1/?W8S^%K4$98Y)Q7[E:0'M$PXR=5
M82EI5.<N%OY&-_YG4O-8Z<!R6<WOG\(=]IK,FAG6/ZKPK_YG(6+\ER"B;K/D
MRY[VCRU!WT,%/Z;F9P+Y<SDELW']#_>@SZW^&PKQSXX/KBD@F]W2OO 1.[S5
M]YW#*DM^8J+CVZD1H^<LXWH:MC4^MKY_3Y-^'3W'_R$,--B=12.$0)^U_9!U
M]_4R-O'Q[^5R $26=Q[4_X+%^%4=_ 4K]N_46O@?EJ _WN/G,E?Z'RYSO\OR
M7?G['C=!O]FC^KNI^FXY9$$[2XEDQH_#.\Q_E>^]K]V[D3\Z%4%@\H([CQ<:
M91"*U,E"6//3]'23Z7E-#1Z?5:X ^6;O/H-;)^:UYF_%#-D/DX%I?^/BA?30
M1S<_T?177W3DQN^>;"%^J@3[OHLF 2 9 _='SI/IQNXXK.(QVWZC"P]7SH=Y
M(<ON8J@TGVNO,]7\.&O-^,"I$6IVM4&:+]T_$S -[#&I)V>(I>/ROWOY(7_
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MK[S:P];66?3"JXMYEKEP@:>)R=56:P="O%UF\;SRLBWL[0:1FEO]'6Y-^N_
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M5(2Z9I1,:_86[,$(S2 K:%BF(BCN/"YA=$6O#U=L89U$@1+FM]*>R60\[)5
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MH:8I:>P$R41\E)3H2>8["79;SG1&F=M*Y_6K9YW+MY3U/)HQTQ2IOE^OZ:U
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M<8UGU)MZ\VE?'MMMP0.3?"?='9-:O-MJD.M+PK!S;331S\GZ@K?.%9U2O,G
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M'>,*:E6><6ECT^8;1P(NOSV_-^QGX#1^ O7QKE;+?IM^* Z,SZ0)P-N&TNG
MR+=DF@ 6GT[E[(=3:28*5Z8^+LC8RXZC"-T,M,'3#IUT8&FY_6?DA1(]13K5
M.RT4?KX,^GE-/>__H.C/YCUU^?Y5K$[0>B')%@0B1-LNPN<^M7]A<(0OR8TC
MK5QW&/,#"A8%XP:T7A3G,%R*=L 44(;AM>%01(!3,X*D+;-\>X7\+?G5&4]=
MC2DN^<8E,YP_3=0-B@OWRKS:<QAS<_;((VCJBM+TAG\E8Y:B[?,+8M8RI($F
ML^#D3*B'M]\#!]F+KQ?N&41V"!F];B;?H"@6%$?RPW0M^57]WMP*TR^9&] 5
MU'5GI<@Z5DO]O@^&_"-[L+\CQ)#7;QLA$ ./'-+]'Q%B-#X_ %2Y#1""#E0;
MP<[_B)#KGY0?^[?>^:Y<.H#/Q/#_H-TR?.R?VLVUW]8N'?A)#@:DYH3&/[3[
MSOFK7$)TM!?>"ZQ?&C;IQMS*_^7C@H7MS]- /V_%=RI+MFS33.C"J$ ED;<Z
M^V!MVRF[=:ASF'L.[X\R@'^4+K7>=WZ5BX-T4(-@GA]N>R@3*H1RV[LF3SE2
M:E!.-BAB@2\9O?VWV][4-X]7SR!85O5WKPQ9V,[)9#DG1!<DD21T" M9,>N'
MQO@&[SRS\/PWHG>5VB9.6AN\A_$3,&AP_YG5M9AQ\F1A_M*.&47S3Y6[BJ]:
M &AEAH:R?M90ZQ\:LGV?>5MAPB,>$V5O+9AB\%Q]5D(.M&MF_ZREOLY]7HGV
MCQ8>#"=WK3Z;@C@T,['EWJA?33:%R?;KD)(^@_04[/ ZT4/[1N2F7L)^,7 B
M*MXL$4PZ$)I,1&>7@Z()M3[3.U4=OT%88)HD.C!JKS>V,];)S;<Y^?S4T<MA
M!:M%@6 H5T ;R>.+'%'9MSYBEVB+2/3 #:239A#NU<8%U_,KA@R%/V4($%AM
MS!U+M$#QKTJ?UOH9D$=?XM]\G!=DV*L;'?@)7_A/V.LPW(5EV_/!_]86_KEF
MC91#$NG 3W+\BY ,Q_UO *%QPFR=,RTTK1S^M[:=_!TKS9$3#>C#_\(CCB&9
M#J%E%L_M5JUW<^G7, 0\S+'U?% RLH>T4NTM%2+,:US8=9E?Y-JSS%MSMXHZ
MP>.+:OZ>AV0>^S<Z8=^\9??NO#U">&.CU7NC4.\>*9EVT)Z#YEN(W1@ZHU^2
MQ\"U1YYRO)^7NLL>OE0*QLNU8:<EMM\GUOF-(^XB8WN6\"K[=_"V6[TT\@]K
M&1A9,S27Y4C2S9?:8M]^2=23'R:^.O-P.SF$T@&V0D9#<=D40EY$_##UL7^S
M;WK!S>*\!X:BXZZ<BZ<0?RE#QP1'C,P(5]^,:7/^9?Z6VUM(5,.;U",M]T3Y
M/H (<3:059[M5VQ.TX'G U?H0&(VFKJA<90C[Y"C'^U0W"U[K?QO9$NY<?&*
M)[U(9<P[N\*5.H%C@I?6/\#_9K%>]*X^DSD\+=0KK>#Y>N:QS,>&&6[6>*/
M<I!;K^+-R('Z(<^>HI]EA?\J:_N7P*9Z)8-1<\$Z[<Q,DY?AR8! 8#5V[RIX
M-YJB_;#G:UCT([?>R[\RHG##JVP3Z<!WM#*<BLV3NM=#[3,^4'/.';&P4\C/
M/&W2O" >I,0WD!_6S4HYCF2E[LK&+I7:$E&!#.-]G?V)#GRNW9_VXM7K4KW
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MGE;Y??S _*[@S9J85)/G]7,ZZ[@ QQ-IEVBG)F$0HDXU:J]#4E&/U*'.9L$
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MY#&O;-PB,!J=ZO&B("4=_.N4PGRD'/SU_@@_,Y0OODM)$2.I>[S?QF%A@VW
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M>Q3F-LX$6->!("S8NQS]X]/00AN!SP3"H%E=2@;IMA[:$$A+[D!NRR0Z$/[
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MFX@X"O HQ;B\ #YS>82HQK',0K"Z?\NP)I/>T8]W[%EEOEGY4)6GYX8%$\R
M+1-U=1'WHPQ3?G^-#Y:'.O=*K*&.>^)NPIFPMS%*,;N"%6R[I38Z% M-*;U
M4A7/BTS?4A6:*:]/9VO-<HR/6.>%RE8/RM?8DJI1;:*)2_=ZH\%,SN@R.A_\
MAS;H]"7 ]A+ Y-0T9KYA6,T4I\T&..R]*M@W\@N*;KL_^[]FB/X](]0F^=\[
MG'PD4UQG.5^TXG8C_V<-3"+='V?*<D[JT ?MY@[$53/*.RW1J9D_GIZX1[[I
M^)*3BBEUCW4@%JZ:+75QF/QT*""F!VHA_UF7&P/O>(< JB>U[=$#IMG(=96=
MI!FE7HXIEW46+*>^;8S;\R@Y#<TG"\V46\WZM/RRE\.!&/91#33$FG7(0,]$
M.4T#T)&<'D[T^\4J,=)5BJ"=51)-D?4V.=*.0-P4\ /AE21. G3Y5J;\93^]
MGIKHZR-?*U 14R7H]Y&&Y</CEC-1PA987.-O1RF!2M<>FO?)S2ML2"H\#[3Y
M8LQ)O=% =PC@ \;TNJ3]@/*>=8KO6\*^/=+JS$(FME"<F3S %Y?#%=?9#&3U
MWAXC'?'Q6,9%I9]EKCOUWN^H&J_1$VU(3KFABG^)^CH](@Q/:P52SW?#ZY<7
M4>']*V=:M^P^G/2.M8JAI7K*0=_K0O_8[Y!ZF-<0;3$N6/7SID9&9="H"4!Y
MA[_V<GD)D,';ES)1=30:.HEG:K9&4O#\'G)^6;3*CO$:+'56%;.Z)LU#P@S6
MH9@<-RW_<5=*)V::ZGD)$6T?]ELWK#ZT38PWM$6R/N.>E_=G/_P1DG4*XA2C
M/MBUC>M ;!\G1M_OF1NEF-&=W0G>B['QFPUU,OINU*"D>/%SK 6I@1]TKCB'
M-$SN6(@^;3E=:[%S19GJ_D0F;.YZ25:</3G>4@ 9"[B=!(_<LJ^\6_X@5PC
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MP V;K-6R.GD[[AVOQ.^QGE6!Z&8%=KDRP82F-1' X/OS>JGH&F00Y%:-G,D
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M0YR7@71*G&GL;X/6>A[.L0+.#)<E6Z$E>"Z-V GBTFNZ]87JV]*5 6EL9]-
MC&M'LCP=QC:8U6/(G;4+(.!;VAB2EV2DV:P$N-&7J, CLI0QR=?A[V,7HG^]
MQB,/9;/UC1ZP]EKH_?,>12'W5.C'>"\ZK=Z9G(X#!: Q.1K(<.]Q_0B@GKFP
MVF79FQYPT3D5/?%>4>CZVJ?NG+-<<2*KR)"K_1W^_,M0KQ,@.=*A1T0]EX./
M"/KWR ZTH,(>;7^U\?]*M <OGA)E 0>%_Z%U";HO^P_)'L")QK_9)AZ9&!WM
M$]XZQ)Z$.P*C!3JY);%XNLU'LB.C&6EWL.:\H_R3S5[.@>@LK%Q0V9HLB$[+
MD;@-[6<"^/"0%[ ZEDP2^,:IMCW!SDYED'.2[-!=8HY')&E/@94M3/- Z<D0
MRZ?[KIECZ>N#&PJWQL@IL@O:^7<6<O8[A%:ELZX/\2RUPDHZ'/LAO/3X^L',
MA\Y9UU7GA]TT1>C.S?2JVMW!8T+Z23L*M"_,W*:GVHPO2H_L35G*N!./!90?
M@PW'GXUURI21^%2>M)9VMCO&,'4P-0E< E"HL)DC:IO;XD3:&GC?Y7F-)<X4
M\>0/2J)=S)H*_1+[K<GE_.>JU>-K#8MVU<'[_4O14[\7>YLW:F2!UTS8-R1W
MF88YO-::=UR_70*HR\^E@.%E1^6G\RWFCF&0WFBTOUP<>J03035_?B?#Z/ ,
M:@RNM90<I85^SUPY7*2!4UGGS#X=^Z:=M'9_A2+R]]7U..QHH,DS"*R3B)^'
M!<ZANM/$K5;C'0B*(U>*F5\6T('J K'$80>2 6$)85J82L\"QZ1-Z@)Z72?>
MEHOK@=J0;S6:_Z4PFC?@6%QDCCS\E;5<Z4H[&YP*KR45*6[Z!Z[-W^NRW'8)
M(&[-[,UD!0MB1I9_!'4T?9@0RHVCC';/X"-.V3[.GG& ,$KP:Q@Q\BA)4_(O
MP#WM<S=\.+/+H#=4O.KZQD(2V5=JX3<Q02LX9"X>;7%KX0G=CCVTF/W5],]V
M1GDQF'V/.:BVROFI$JX(UU?B8^<O;1%\ZA*&?8>F-Q?_.II3&SBLR/+B64-%
M-:X,[Y:GECOCM.7,_I8EA0NDWHP1[EH@Q>LM2WO@)21^Q*W=\LETPB)0[K@0
M"T;55/.DVZG,MM229ZR TZ#'@8-=BY1+-0ED,3FUE/YQK=WPN%+8LY4. @\T
MJEPZJ])8U,ZV(]87^KX34>.!:P/5J/7%E%L#A"O(K*_*<8UG;W<+WEZO+G):
M*7TG88>)NCT&\*Z=42)&YGC9)=(9WD@W;"9ZH>2KA3D*P B%/\'B;%<PR%AY
M?B#I%;\93BGXP]K8UE+_9M:X"EJ,!YZI;IUN2[*"ITIN!PLX_5JG)SHB[*R0
M1)+:,P\I0KE\4Z4^6+\-=.KX:MNWJD,"K]Y2K]Q9RU0"B$N:,A?^D_N_VEYK
M>/X!P8"8KD2:_.<8#0!N\=?XA$M ?+Y?^?G6>P+E%6WDS""[*OU7ZB3; /@O
M-I0"2,OO/V=E,(M_Z[0BHW\NNON<#W!5[#5>3*DN^S8WYITIJG;Q]651L869
M856K^#UN3U#_[,GG^&J21G^?SI;-+8O*XS.#CK8DFN6-K'YEL;Z SRCI88C_
MIIMN+U^\[T:U<DQ-LY4_SQ +2Z]/H/(%&@ KK I.]'Z$]I=7OR@%/S4T&'.V
M88FI>*$J=ZT/J8@/PZQTWCR_;_JK9@LF1.@KJR(#)-88".^(9>%--J?8=IX<
M]S<&M'29'5E:R OOD"'QXT95HT*Y,UDJX>:6,S)V_O*Q%VD>OJ*0,%?/,C7J
MKV%<=#>C#5/Q:9TXQ"T_KC1A6D>K;D%[6A=+<W:237[9%8IHN-SR8N@M!WG@
M!&KSXNLL_4'&4=<Y\")G[YP6AS&;S36KI!)QZZ,GVD743']G6V2_!'1(BZN/
M2T2K5P"&W_"/^'&>FR&"".)QBLVC7^B%J'\T,&Q> FY"H')BBF,[^3\7^ ?K
MX]R5.Q^YJF-:>=$Q]=TC;-P9_)&"HI,-CKIOE  >?@PME=CU[K.SK:^)IH,\
M!CSKK5Z@6JF@0T&>18VVJIHP[<9(N;X!X@1H&#[_$G!-N^.]K*_%=Q,D+C9O
M)#G."WIK!/T1P5DK*"G,,GB1YNP<0@;KRZ(1GNG1$&8^5ZYW-IEQ76<'/K1!
M-P-1PM].)=K#G;4".RUY,]JLBDBB(]%@XR)'""G\)6?CDG=/7GRAGY*=8YM\
M#?Y[T:(3YYU&R93WU($2C]B*2!;:^* +]#_A)/;9*$>OX^GCJ5+605;B%Y73
M$)-?%^GR3!4QF 53.1.:+;'DZ[>WH6@.)G1&82$^Q[&"*!G58S'/(DWV&%E:
MLXA:T6[!N]T;4V/W"12:C%$"/,:\ZSSU2\2>F6FPV<190MX8BIVY;NJ9PSH[
MF^#&)[]X1O;<S767%E'D5T+[2A )@15N2,U:0'?97Z4>0Z*;CH/ SO9Y^$KD
MQ)8D'T\L;7<3VA]\"5# !F=>]RS5;QY]:?F-QT"3%OKGPK";0.E*W(W4R$?-
MF9GSC#8_=NXR_!&%18.B#FB$NT85"[^1?[\K1$NA?H"\!1O4'3^JS#-J'LHQ
M;OMCLTYSQ=H+,."(96WZ3:33:\%5Y81'G]\P>Z*_0FRO"7G2"'FO_,R[4=;%
M0NPVU03"6T2L_'5?>L,G1\7^7HV\V6-R*>Q"HT50>TWK7J>6J 6MDNUU-=N^
MMRW[#B1[>]=CFC05!_9C9:QJH]^GW2E-P%NB>['O0IV1W#H56PEDGN6@%+8/
M5P6V[36MXZ1)?Y2R^Y:!PS\]QY7D-_ ?O3QHR;^Z?_[R,\@4Q%+.7^FB>Y>
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MJAIF7+2!F:#3GD(Q4)/\L1/@A NW.EI>"Z+1G'87?YC,<GL"5+U^Q0>)'"%
M9Z&R%B7NIJ#. \4U#_E/5[]%K5(TX;;Q8?-'1ROPLA*\?WE6SO#[,;'LHS55
MPSH:P'M]"(T _"764#-%]\LG%<CN9*PB]=14XU*4KQ0NJ[:JVIK=3U7^.4;&
MQY NZUSAO<:LKSK,[F G]C'*:?-</4T''YGQT*% ].[V?,THA?=2VDO::?1:
MM7/I=[+&^9 /1?T0DS%\1)9:X;DN9OJ7C:/SZH>;(\Q(,NQ:<\E6!K=,6R9[
M*5=_:^SX2\U,.@E'I'AS<\C'(3MRVG&4OQP)NB JWP3N4MLT917+9B'X.-Z_
M /X.8Y>VO$@YLW4*/K/\L*L<O<2ZOQ?%^; ='P_Z5#G@@B>JRYA,6XEC@Z8N
M=L9(=0;8BII&@SY>;5PXP+A-</$>(>^'];@14<-Z@(7>S!:*"=?EY;6O+/1D
MB8P!L[@]C18T_<;Z85QH[#''@;^?GH6] ^%ZM983A[%.Z&PJX"03-XDO+YFY
MB-/&'"*@+6K?''HG#.-@LZ;X"E1AB,3[3!K?Y(Z9%ZM)>NP^J6<C^GCAY1A3
M$V<#W/2/3W48[7)76)#Z^-$%P^'GNS0WM04-71]'ZU!TFPCEY\-M\,56Q_60
M#3;B3\UV37%1&22U& '<OJ.%0,QMFJ_6D3@D"6$H@QWCTM+TPVO6Y>,JZT;+
M2\S">)>Y1T)O,]?]HRQ@M)\TOFF]8_1/E%T@3NT#XRWW($,X[Y*LKWVG?0_3
M<S:MYY!FXC?\:1=Y\HSX7C6LQ,=/PD[(LZ^YCQC^9%:/A'K.OS.KJYD,XF"/
MEKFIP'8)H (_7M(20A-6S%N"S37HA&84P.C&Q3#&R@?XIA7U!D?G GL;D@+^
M2;#I&<^?TXS6>Q,WK.9C%<A;0=\A9#40\C_5)IWDB])O)HA6KK[LR XSTGDV
MI.8'7?6:9=FSD(=UG*GA0]#.3[1OJ-=I!RJ32R-;/1 AIW*M'Y-WR*VLWM;^
M-A>]^ 2'E&[=&F) 4CN0^%^5:02J+I,WXG8L6B/J)3XF?3UZ^M=SAK/GT4O3
M1)BP9<&PCEG^ ,<;<4,L$HO?BM\LN,A;*E"Y$36>L/W6'582<.]9;(ZI9U@:
MNS?Z/C0R6=:H?.8+N5A_%J!$H'/MY.+^VM/X2/LUCN*0'-?%E:2B*0<2[RSX
MD *5_7$>RY#Q;"UL==);A);ED:!V<#LV%?!:)U[ZPW$QZYWTT_%9N9*[5713
M_NPD7 !I^F-NVOML;WNG4U_+C@@J4&YOYI*DWK6S':1F?5O)/6[JAXUK_OM8
M]/]OZ<Q@Q.DU9$S[4GGF%<I@+@&$MNE+P!-D%<(N\X0GU?[B?>_?TIGTF_\Z
M5.3_'/S_I2W3KW-ZI7=G\A)PKZ23T'%%AK(I 1>6>/N_<EJ=[4<K0$(@?\XE
M(#EI^!^Z-P&OHA7OO/69%L0Z^OW$+)I3OO'[\:O;XT").V;Z=QDP@O'6(@QH
M5%</:H,Q"T_Y0V3D;SAQRHV#%; ;G)Q:SQ:'(2WQ8@MMR1?9;;?QN<N7@(YY
M5AR-A'.M;+W1:@2YY%J+Z?)BY-72KS>'%5#?.5 [RSC:0K"XU+9'9;",GH?T
MJTW^<NYU4^ TILW&DG08HI0K[]7TL)57U:'?B UI85>4)]OX'01+G^[G=_A+
M]KA9:,!5,1=KV4LO68?I.>$& V&Q>*1H.\8PO 6"Z=A<BEL@[UM)!=C['\Y;
M?VN_=N@M;*#<1R+*6HB5TFC#M@>Z1KMR:Z]^:3/N=9JK3+/ KG=>2&FR+-)>
M)[5J2D.0;^9^DRG)NCC7^?!H+Q)P@EQF"CZWQJPL2Q#JG5*8;G6+W#%*7&C]
M20"#,ZD\/CO_!J+O7S/>.1B8U/9/[2GVS9W#VYL^'U7=^6#0 GH\ML=]45#[
MDI';O? QCZY;KPG@%-F92MN(_K0C[,*HV@GH)6^&1/HXH<YYVNOB1^9^QYD?
M\4:T*$D%.1_*\NNHI&>;$N?C2PL6H(LTNUE!GU=U'$B67,/D&5KQUEA*;?K9
M?NX/SRX!DBO?6)">%X5@-T>LXO*VEPS-"(H[8:Y\-/KB1ZS316_'_).M;U#G
MWY> ?%*YYFFF,ZES()8L-F7%8B=)8+<<YSQ?1$*%,YS' )<(A6!:6X1$FO F
M5!]FCV;J@N:B!]G>A]9\V"-3ZR'SX*3 \Z/EK+_[Q$:]@7@+E!F"W5+75_%Q
M6.#R?4Y@W>O'-_=[^]/M8VN(%F#V*W7-4L&>I4!^S[7,F\];]\G>0@#"YY8K
MONH6-YWB-6C*;GWEY65FF(2!EJ;#Q2\H]"=VOQT<&0T2N U+SDDP20M!2[([
MG!<*J896CZ[@D@[[+K)%"6O=<]S&-)Z@2/-UKIQE/5([!$)?&Q=\S%J.C"11
M^/K;ZD![H=L&5JJ-M>@ 1LJ$UA:Z&-D.1%,?E0.I\"1&>'S],6O.[VENQA.?
M47*I* EM!L)/3I[( \U8_;$/VXYWN(DB<1:,L&H]/#_&9WB80<SLHF.D?ZWE
M.=L( V'8CSM.(_KAV.>JS=+4H\6(MUK8D67?/)\'HIO7GD8;6><#WIA38"RB
M6G0]FN9*W]0=@$1B5_SY/UYD@]6\E[?RHM2;DS5J+8XLXTRVX/Q8X>X%CK%\
MS-H:78XWU^^]L98M$\QNJ669+[(K'CQ>.5=&#A,G>J]\40S6@V((LRJQ-*>?
M9-4S6S5#_.Z]O%9[UGQ_)1*R2/L,Z--?C^=%O]0PBNLR<:*OC/^NH^3KRAF'
MG(-+G;&GO:/R;94K(M' ^>*SO;%4WP]>;JK>;:R3-U_,0I+BLU> -^#Z^&SW
MI2%Q54:N!N81B6U(M6&0RZ$%C9.N.0V2NTQE)16SR(9'=$,H_:068'4_;CK?
M03T44^"L7RZ8\J/"FV\[41+<PH,/:-^ZF<OE(3HLL _06UV5W4);QK23>M^1
M-F'/)]H>P@S^+-P7$WA:.!CK9LZ?#8OJO@30ULPK*@2]G3.3WL>TZ%!(H;51
M43V,I]4P351FS7V4BD]Y!:S^"B.I9K4;8U&.M#7?WW1A,]5;ES/]";SMV+?X
M4D.M ]49P<AC8%P;<.)<VW7IQ?@-X-<?,<(< 5E , 81W6*Y= F(\.'\4O:8
M^^&BE6+S0MFY$G8]$NZ,+=GJD(&[O$Z2XL]&:N'KEUJUNT W6^X7*;0WU088
M:-(N46+*W_=(95!?9 NMUQO0D?9XK?G+"@/P*=V+%& U 9F66U3\83-M>NG4
M4Y =R(K&9PFH%&9^<*XFG"7)Z*C< O@+-K)25^HCE'9\@Z._P:I1F!UF<'R%
MDA&"RQ,YWFR5NJF \B4(RKV+P/9S6BV5>H$HIGPJ8=@U/$.TI6U*:'LM<.J&
MK;*9OXI)AVMPV^VK+=!3GM_33W)#69E_:P3PQZ3&_%KSN$O@2:8]'PR7!4R7
MOT486^"? #M#\UZ:.H_=TA;RO@0T43#L.&.MCDWPE9> :[AD^9\%SA1#[ ?F
MVB5P603QN236(.?N;!&Y?4SEB,D&PJH=N+!IHBG/-ZE?\Z/+Q7((X.N8VRL@
M^4W]H4+I5]FV=]$^S[6:E P4>TT\1".88B>([OW_H,\Z1>;$_H>YUHV<H@/F
MI5HUJ=,VI_L?:QSK_._%BG"^<4\]W[\H%I;0@N!B#L2-Y!=] Z+L6$!)?F$J
M7[(X:S&+.X(YF^9L^#'X"RC;0QWIJS_F"!$L4QBM'8)TJ=4&*ME@9U/(=&@5
MD%\\,NEA!VB[?*1%M^M#+4D[RJ)G#VG>U_O[26XN"&%VNOVI[SFH[W_:%#&!
M5*<$>H)H\897*_VUII;7=G_\5BI@?_ *8!*[%T@2E2:X8#:O8X$2<6>/SGFQ
MC&$K6E8X/7#R9DC*^UO\$^?"F.DNJ8P[]J_(VGF92T TYX_17WC1*N$UI8%^
M/3?CY<WY2*#JV"A\HMI4S0F]BAN+S<M6+?CZ,B*8\UX#?H9C_?/;N[\K&]!M
M'_"NF!$]9ZO3-=TXR>>=$)/UVAT]<XQ]3Q$7X"*1^9$Y'W%OIW",24;$2OF[
MQUCBB]2Q*<D;?1=& :8@X+DV\EPYS23FKO7K*M%<8;?4 ^#LW04(\$^39'-!
MSZ!OT;-2?K[5U<A3JB67**D0>6::IT(SA?6WTF/=KR0X%#.MT#CJL::1,+-U
M8-AS"6#<;=%RPVJ;: ,W B_J.277V@;PONC[YTH%??;#V_%C;8;XD"(H@0B?
M5+S)&+E@%NT6,@1X Z+)-+[B3^&,6SV,[3-T96DYFM:>ODQ+B(CI-CY\N:WM
M]47'WT=#L)V4,+@&]KC+BXD6&/]ZQ4\9E=DSY;/X?2^2L5"3.MMZ,U><:-/M
M7&W255X$%J9,"2]5LC/WY1\P[>$4QW_!/E@8ZT IVD+=J@SBP-23>U<KL(,@
M/$40@(5U^13S3.TSSC;X!)GG8T =]01FK'DU."+<)KVR;R<5@$6@V+K[,89H
MCH+*-XK,N6:?I==:^9= ,9Z9$4/RS0*V'C/6PG3"BB\0#B,SA)45E;@["4;G
M0URO:-O0V7C0,H0.+C+MZL%T I>CMQ5<Z54'+(Z#;;U]T?Q%%4M&?B/W;WZ0
M/Y;X#6( NZUD,L*-:C!UF5#>7W;F-IK390[R)%-Y4\CU9I8#;A[0\)=E"^(M
ME'U/%-795^H',FA_</OR7M>\16>;Z$0++YKWO2G4:+B??5_+6RI&_BZ^4 OK
M@8I-'=>R=[[_9N;1-XFM]AJI#LA-6!!:.;?8T=KE(,$P\J#4E7K32T9K]XLO
MG417GPY'ZQ^2+4@0Z%8!OAOCM'FZM]H037_B6_H[1M@,ZQ>'S3FE 2IIZ91:
MKVO-V;7%7*2T,'DN@X)D0M(W#=94!++.QN L^/=E?RX!#$<T5G^ 50.THGS$
M4Y5HFF?:%'.(#D6[IGN=3[W*K%V>\:_R6T2;''<N,E-%2=LT5AM+VW/'UN(,
M=[266RW,?UKZ0B[T'V@$3+4]K<>DPH(4&\?&IK1W[.'\#,=90#_\--:^QP?Y
MS5?8?+0,O!653(2C#8J%?L1KE_/$+\\<?='6B9=P WW&>2'0/6[F0:M.(* \
MP+&.M>DD0)DX(-%":@XNBRWL$GR<V?D[.R#N3@/:7_:L".Z)K6-I>>SJ*EI;
M[:P4G7Z#?[K='A)E,K]0 V8I-SUQ1R$77%O-(=GX\9Y%HIJ#K/EDT<&1_\7<
M>T8UV85MHD$45)J@]!*5*E6:]( B B+2I)>(2 D10B= )(C2FX#":Q "TD2:
M]!9 "$6:="*A)A2E)](BA'!X9ZV9\WUKSISY<V;F_,B/_2/K>?:SRWU=^][W
M=?4W<6X :Q;>U G:=P\O,:W<V&84.2.5XV%5'T?X@Q\^*DV[E:1PK\,8H#UH
M/N,_!,I+5H9H=EC\E\JL\V%9P8]O=4=L/" 8N,Q-1;#=#LKCJ?>3^#,)^98\
M :C]/W*3VV+JVIUL57&/F:D*2Z^']('NTD:3T1+TN^!NNYCX/30^S9U$2VNN
M?%K15/EYOY*#@KY+>H'#-=^#''I=\OK<^(N3X*0 NXH G>2Y399/1GW]';3:
MZK;48[?3K77'/D3A7LGWF;, 0Q!B(7.G("P+-G+$;ALW/$Z-3_SXE&^M31B*
M/^R6FQYQ< K)&/]PAQK#T%IZ%E[?>.^U1]*DQ@@I7G/?O9H$-U D-';.#OQ:
M_#[FT?PEIKU<YO;I&,)P+()_L7C">PHB,]3D"F'U[X9BRQPIQX3@A#'E/VF"
MZT/ \Y:G@.@<*3(HSP5)<!/1@UY*='U9&D8PB?0.T*:C%!LUFBPLU'!2/>A7
M=EXC+V)L79[A*U#>WD]M+\W:I(+O4K4IA!)(N_?83J97%_M;SN9?G$:+Z-C
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M1Q@+P@?:!91-XD"<D^7[J@<G;T/<09,3" V41DH\Y-K#Q@Y-ZQQ:?_BYUI&
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MJ:T*4D/AMQ"*9$WD):J4++I[LLDZG;3:N.7<=IUJ2%:)J3>8D;[7,Q-3" A
M"X#$X&-:<$A04') O>FC 0>5+ACC+"6]H][$^:4F*H%M_GX%O/(Y^3!>Z13
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M7J.;5# 8NV2HP4@:J__]AR*MW;+F9+]X"L!?O4M^XQ4("1;(N&R@<+EO\A0
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MZU)C^<V6GU,'VX*<,?2<\W9KMW]ZC$!2>S3?)^I'J';;9XP8\141SQWQ=4R
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M7V\]"P+TJPOM_PI7H/Q=W#D'S6AVCPVTV923!;Y@KW'QK3@%&&'JI_*2CZ;
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M\L@<.X-C%?^(W'UI;$^)(QKF4UY!R5S&0K9I4Z+@FBTU5<X8XDYR,+@V9CI
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M!0TL_"%L*P)8/J@4H^P?/X2C.^7A_B:C*ZER=:*6\XS\22'MR:#;T 5>F<V
M <%SV]CO[VVSG'D!N'*$*=DJ$XB=DYW_U3GD6SIC'Y6\V+LK13<5H;E!+$HA
MM]A3' -E?A1>+?O"<R'<!_KU)#.@/>Z(+=(EO<OZ(3[T_J,0K8WO5-#"%:I^
MGH/#D-9:G35Q[M7:FE-+,>+Y5-TP/9; Y,6U/K8]&1Z6],;[7(0J\$KX9([&
M" *BE30W?@=5PTFG3UIMGC,Z*)S<=C$(T(@V'_A^6*F8Y=AUF!'<QHW:7HLS
MNY68CK;[)0U#?SOZ-#>_9O(VF"G(R2"7S7_\;':"2>WI1*WP71!_T]//K7\K
M8 <5Y*0?A9_A=\!,BK+Y\'7;=KQRL .%'$ANZ>1RNE)%FAR*C7KW=X95M7S.
MI:/F=VC#ZZ6F\>>M3W^K; UG#ML!7F,7KM%$*'(]H8]?$S7:9(6MG. ]4N+$
M7UMT9.Y.FM@_=T/:'UF\%?X5OX6$LK&N\Q7EN0BE0H7!_W"[3GCZ?;1^0_%W
MFM1D2,,2C3F6P.]*'!2XE.CVQ3>SCG70":/S,PX&PX'>(*_YNJ[PL2M?J(A1
M0:9+![<$R/BO[<\H%0%ST"[\],CJN,S/#UQB]YJ$WEL3Y9*4V>+10@'_G 7@
M!'A^%])#TD=^1T?PL!LF!&_Y1F,QFE-8L_SVFTVY(WRHO6ZJJA(>OV1"OK^]
M@G[F+;0/)DZFQ"*NEAK@JDR^K)V<O\XA%3L2D$X<9H?40$*94?YQ3UK."[<"
MPH)[AQ/#E1O(4VA".X-#B/E\KM3:4,AD2J]<@@\E!W;18=Y[ZJGC</S^K0!H
MDO:2=@S72Y!A2D;[FCW<B3$4%HT "H=/HKKWA]*5\^_Y^@S\R6G]36]Q *.@
ME^2NS6Y,M8DWL8GFWM3JS:L4IBP=Z\,7OM%$GM<U/XN?O;;LHKPP1,A^!KL"
MSZO]7%AE*:TK(8P<PVC;D/6FDO+6[<+K" E)=B<_8[?Y%,Y&W[J.TA)"QA*2
M*M#!LEOZ/F[B\8<I$7=. <YC0WG'Y.L68!&J' 59#OY-6L^H'X=TI!QE%["#
MP0CV\0II&5?[=\YB\[8Q=H!]SW]](O^ \:4T ^WX]HV?N/+_Y'D: 9([!43Z
MG0*^C[5;T0);S[C=LS-N9W*&?W C_SIB,](N#9P"A!^>V/^=.J1R)M"T-)G.
MF*'N*>!>+EM1^W]T-X7#-M-/ 2)CX[2FXC^5?KGG<C'2,@73AU7=)I;*;L_'
M5Y_S/L4\BP"I@6- 0N2&+7E-NT$YI;)B84V^TN-[")9Q&I<G_D'I8FS2^\'Q
MU[=E9I2&KR >MU!@9)27+57;-P@@//A$<SRP4@BJ7;L36^957GN<Q,K$^[XO
MU8"5;DU'*,J7Z%L*=1)\;><&1<OH4*-4#J(IJ43D!0KL.RF IK>J WP(ZVIG
M<=1.T92LKT^N^A9?_;"T1S\4UIW"O.#H]*F7?E9NH#]QA!Y#1P9VT5A($CB$
M\YWCK-A@*61=/(D?.:/;C0->R8_ZE;HWK'%>8G@ =91"S,0V86Q)8<:1 MTR
M&+7GO>+)[W>#O[F.(;2)$*6MX,ZBE<&9^V/Z.U,16L6]Z-KEYH;7>NU1KAZ!
M!_07HB6UHWRI3FTC^TP['+-Q,FZOXL,MNZ@O2*_AVEU@4B:$S\7P:2X[]/)J
MJ^XB>HOG%,"^%U(;I\24<,DY(M?=G/&1*>.@$SMIH1M,L1T*^^3X8MRE2<S5
M[;#2FZS?+2<$S1$%7Z:$_W*/#:)OW"M30^B7(D#DL>EN%TVRTR-#R6)ZL4\X
M3<LPTC QA2J&_IG)G3^ ?Z:GIG:-;HRJ1BE9 M-O'&8X:3;MBIJ\6YKZ2A-&
M0,@'Y4OELKT=UB#']UBB3G@=.A?^VO3DDZ9EB6-]"B@#(*LY>;,E):J-*6>X
MVR?D(/&1^:*!]7S$=<HH.;];FYDFJ,3]^)>3*O;ZL%T)2<6"@B/."<G8G0+,
MDFIGW@T:V*\"HT+!O<.\'BCY,$==+!B_4Q,SC?IK3X!UF0C@SVA!!I/];Z4K
MT]'C$/QKK<_TV\B8.Z#KXS(5)K$B;,(")9QD[JU,TJX9V;K;^8O'2A1QB=_$
M&>R#T"3G4WX9NJ,FMUP3 3.]%DXWB$#F>2<$PN0.=UI7WM:?$<:[I 6B8$4Z
MR7M O^4C\H6>ITN@^$=BVZT8P@P8$3ZN;*P;DKZ51=1(!NT'@61);(FU[4F9
M_CHX[6F%64#59PV=H5!T#_#\',6_=YXN3.J6^&Z]TMB#]H#C$<8O<MW&,!HW
M"$VP^75N-->BAE0,?[VD]2N:ZHHLGAWXH_N-<QG)M:,,>W,*X'U!]4$ACI(P
MMR.<DPR'.0<]PC4GPI4IZ[\LO,X1>^YXK3A>_+Z7RW(*B%VHC4F4Q>BY%U"\
MW>-7U^H?#-Y6= HCI^M3>J;@4Y5CT%[LK:3=[E#]'CE>FVF/4JXL@JWP9&X*
M^ZP(\K;S?",;X_"21B7# -$X5*,%ET2ZGFJHFLOV@N+"ULW"2-!ZWX6+C:UR
M7_6&=JV>?,4X$Y ">L5.#H;+M3/@9'5<+O4>)8D(XT3<'I.I#9,J%>9EN&\I
M++7FI+8D$RKH>6Q8;7+QT2%&.O.F\&&K,2#L<0GYN)NF1K:L3R&$E=<,1IRA
MI>)7X5+PW6]MDA,RFDCMK.+J:Z9:&UB$#!$2SD8UKYX4J0G[P'Z7:QT$ZV^-
M-XGG"!]I'AJ*)0T>.2?YB:=>_,%8#@@1[Q8$=P%):#LCTC2>5TYLX,2PTHT4
MTU/)"[=PJB7U)GHW>.Z*K6A5Q6<23-X L6W2"5NA_K,OWGFEP^96F]KQP]BC
MBE:R^M3+FSVNV2X\C4DFU^B&J.8G!6TW*=8]YEAGN%Y:N_<_E27:[LC$/K(]
M=MO=7W100G/VZ+ R?A_&,:]?7)2$),PD9.W]M5O+UU9^R7]\_?<?BG@G[?ID
MY8OE5T%_$]AY9!;.1:@A.2&?=@_:1O%#\7K)N@*7Q\\>(@=?ZE"?'.03G#JO
M^;98T_K&P9;+$O<6NVLII/EE3^IYD3R_ E:-*?T$S;NE%&OB09-7Z9H*WV1%
MYY>52XSQ@#VY:>1!61N9EE7673DXYC!=(G"$4UDZ!20M7($%KJ9T!HMZ[3KL
M;([GM=7()2PGW$]_O)MP;?:-=2E"BU1"VDKJP%1!ME72FIP\Z ?&ERJ[=[@5
M*,B[F)G*&4$<<ZB7(/2W=F0[!T9OR>3R!A<^JC_;W22V++&7\JU"<;$MTI72
M4>X(^CC%)")]OJ*1\;5#&8B?#(S>3^$V*0XA%_SX=?B4.D'71VDX*"#'1 3V
MY;4WN<W<H,M\RP!M(.MW92$3@"Q[I:71[DTA3S(J.:<T[XJ5+F8;Z4YHRBO/
MURFB9=?R16.4?\\S4Y"?]4G%!O5WJN_Z53#=,F<!O/Q 6K$"7H! @*3._+V*
M]_KX&Y*30PCEFHR!SBFS1ZPKB?3HPH#!&;@=P/@3_DKI6)'%>P94:9..-V1.
MXHS'_"_6/DQ'HP7#K+'(_UO],$8;I#YR 3Y8Y5JDQBGR8]RNZ0WAJR_*J[GZ
M?H]N.\KZ[4GV@2S(0@>8K5UOO%\6+CMN;<=A"&@4$"^"SK5QZ"TFB9]!X/S'
M#6G7:A*Y9>5_2 UI>TKE?:)\ZO]SB/WC.2HR4[\IWAH<"NX>TB:F8)NH\@5P
M.V.6[9OLOP;PBLFM$O399+FNG3@PAZ:AKTID1?U:68'$05G[M+8]AH1,P#B'
M$'&[<BY6;L(Y>G<7@?$-[345Y;(QOH2!;-,(_8^Q!JN5"$'2=DGEAI,BF645
MK63J*=_2>S[^@8*ZZ06Y6.!5FBC"=B0PX13 Z+!%&LI7<"C9Z"B'35>03P'5
MYD9;0]IJROT4;N(^[HRF7(!G=281$CX(';GC^V.:E'^WGY/9]E8RTT0]JN]^
MI6%[,9=-CQ),-"C?QICX7WUF!/^ 6[^ V$/S@^3@(QM\T5$A"1J\'T 1?/L[
M%WXWOP;#RXTQ;PM251U>#W/:'[PD):),L,/<ML9N"QZ-'_JKG$)1@)9%&-[N
MUV-* +"KAAO'X+=/L,O<*B?R4)\ZY]@Z88<ZO<SA0X&X4\#E0""7?5]>+U04
MDYNYVX_N;VQGW<!;1V LN6/V8?1]7QY6Q[9-/!-Q5QT"O*PCA1&YJ=+:;(5_
MMB]_46RT]D*P=+^;-_M[ %QQ"BRBM.N0!)/>?[RM=P8!56,B'N@_.L-?@E0S
MD_.46_NU56&C(_I );I=QLX2$)8<UM,@+\]]A3&\M3O,I ,=CT<G4<6)4C--
MP2>OIJU!DT0D((#%NGM>D1P3*UJ#ZN?_G9TJ8J[^*[YKE";EJ7UA;YC= YH[
MZY@U;<\<:Q(*.)1CIMHWDZ,;Q!)%I N$)!N^.6J]:+L);PH%]0SY  &N;;C*
MGL]'CZ;,;VN_O%BI3]$K7M!?JKRF]-;PRGN>2SR!N:P:3R@E$-(/+Z<_[C<-
MEMUX0/LK\C0\OKZ$2!<&$>F9"5IHAN92\D@N-A,%D[(7TU;%@D VYW^A?E!,
M3F((QYRC<E0!UZ8Y6MVG7-9CXLZ66JD]15P7???]IXD=7K,XP2$7")H+=(NB
MV(42IXK@PLKD@MH8#XU?4,U) J";#:1=F[6B:>%L_F>5C_4"@+566;XG>82+
M7GM_9>_[W*RY^4O@,N  R0N/U/(G8/!168)E'VF6?P^+3P%/;2E+#HT3UU&&
M!58K=S5Q<UQ'B'92"5Y;)O7@5]\.6,9#FR>@\C*EV'9\'TQG!!\L2_ 9%;BZ
MH2,HMSE %GY(DHN@VB.O*KDI_,@;5L9V'$/A^:83?%OBJ;51+PL +SU-6*FB
MDS1A"K0K-"?[/$JOR+:MKS9I:9R3L1.Y.7QQK?C>)$("IQCRL49?1ZB0K'M0
MUEA%0>8[K,G=!,]?B4B=Q6GG4<&4&@*0W2._"Y=5ILQ1>8;SGN/NDL/N?86Q
M4KRA)JR*^8__21(^_AB_3M. NWG=10B*MF8U&5A$@9NZ 5"$,5D<+WT*J/7*
M.I$:.)ZG5+[%:!<B3' @<:- PG'DJ\*!Y5, *W3=V.)>NR/C8<:86N\COMT-
M,!>8*MK&O?9IV,^;WP,?$P_8 "DC[I.+L95L:U7EW[G++\[5G@*XI 8PBL<V
MGN$WQL'8G.L?AC8_]!#B6\AAW<T_JLI^'Y5/I?OZ>C0&O<G3#+7^!Y[3#XO-
M 34TCU*5[WS@,66.5+@ >$%A,Z-$SVM/NI(*>I3CC-)"G[7EGV2$2\(SB=P'
M&-#UQEW7*K^D?<ZL8PW*HS72^MMAC]'9DP^O/F3N"/#E'<M1K"U&$8[$#V+Q
M!M?35F)G+S(KZ@#-\;.]@4*4HR?[G&T=/#];] N-_ELFZ[_^_M<K4CYP3?4!
M.>U1_FT8Z#S5]P2L[L,8?D*Y%R"H>;64XX<L9LCH(\ZI)_:Z&.1%L^X@B4CE
M;VMF^NX"_DKQ()>I"-4-9'2HRD<A>U7Z6W\?= P9!9.PNHU9/\)L7 XN2E7"
MK1XPZ]_,,)ARQ9^%K&1M9B4>G&]MQ*\\B5LN%-^\K5LR!;RPEC^7-U!SO)P&
MA% ST6:#_D$UIW=T9^_763[*=1/4=PE4> $$CCF2CQ).[F>0PBUSXJJC>;1N
MI7Y+K9)44Z+K!2-D1N7N/,-+Q*YSZBN+MF,=&7JTBL:80]]QXD*D6E17LV2:
MC0^C +Y5"(F1_,:PJ/JD!C^&T?@TW+=0AP01\[41R1RZGU)?;3H_FXU8Q+_6
M$;!#W!IQ6;2[QW8<6;Y&HQ\+4'LTLD9Z--0[^#I^7;.J)3@T$& :W;N96M-C
MH'4O2&CB$Z2@UCT0OU3G5.#*?-OC'(^_:'-:4,[>;V_AK!O\ODYU8J,-@E_X
MPU2W;..9N39TF%95LAI@UP;>ADP?GGSI&?UX6, >Y84M!Y@VI&XWZ >>J][[
M&^UO^P?._2#]B1'9&;8J<=QFTU$1D31!%P^HO("YW7=<9]-[>.VIF6AE]O5G
MF[?AO"68PKF65HUK=%;$.3[7H+<E0GL94ROB$)4:N:92CGO5+PF/+2^WZ#\$
MQ#/E*:H*O"^83;H^ZW,2I<[_/.K#NZ<-=E8-#]ZJ 6_GT@V[$SSKNDO<K!YH
MAEKV)AK<#C7_$L5SC8X-Q<'QAYH;.E9:/NB<V@8V>XSB;$S,3RSY=)%C_@8?
MLT3NQ3YN0*YWMK&(I,S2#9OO+X>,!*1XGS'.;SRL^K)WC0[X06QP:S6;2='=
MI]M(#W"[>EM@UZ0H!'HV1NC_-//_A[E<X_]Y+O>_ZBKFLMFD;,<'WM%N^=]I
M]\)X1X-6)S!-"&+0G3!7BGSP4ST^P;3QSNT/?5UFB>UC$?+*L'-KZF<\R<-+
M?:[@\*Y=O9UK1K9GG&"MU:S+LHY4YAA-'AYF2^;X78_CK\R**(C?4#8J#>-7
MR=F*2)9O1 $@XUX?,+U1#&HL\6D:_'?>.EQ,+0#^^;_8^^Z@IM]NSP "T@7I
M58J"5$6*U( *"(B TEL$5(BA2 \0BB @7:0I($6Z$#I$6N@@(#74T$/O"36T
ML/SNSLZ^[WO?G;VS=_?>G9W]XYG,?">9Y/OD.>=\/N?[.>>@.,<%%W@B4@1C
M7NK%M!H&E'\I>;!N=## "?:2#7[^"9'>]4&%8YQY_<XVMGCMW-$ZSJ0&2'<0
MR9%?&X.^G=B_P_@>DCM=UBE[#P1W0<KCEC,^CKY-1.I)NJAPW5Y)?B-=:QXI
M9,?:U1\XZL?3EB3O$*U47?5^EU4X@M0.S]+%S*T\K#.:'12X.%OCP?3KOJBG
MP\\-[P%./5+[<Y'<-G<G_Z[K\0H(1[:?\N,?I/Q<<<[YY4'@SRZU1/"UM]&+
M!G$CW5'<OB/U7V0FKI//!@JM>^J9M2UIV'$UO+*]GDDIY@YQ5!BXSY>56D)J
MWM"@S6%ZY_-Y@:2+!=U'I#@X77BT9,O6QB[\B X.<#_V9RI'HI8B,,-W3>OK
M@L .L+OYIA,Y]R=;0_P8C>46FZ)2!-M,CC9?Q(E+,OE&]&+IMID6G#\A7IBM
MZTBD1YCL6% "#IXZ.&[9V/]Y1X)#<$'8%YO-= YFW<>8YP_[6RPN,CHL)3=T
M5)Y/I8QDU$\QR7XD")O@OWT5#7[EX*;"%7;$]3$%6K%G>Z]@P:7CM3F>Y''5
MKWV!RL!R.8O,DB#!&$,Z(O+9M&ZF6=E[XLC00"$+TTXNAZ1.F2KK?5B#X748
MR0^S6>EVHWL4=-@M)J3B[ZF5-Y.ZAM&IKI]URS.IN1ZWH-^6"ZAO#(N59R1J
M130YYJR?PB+$JC:AS9> I'#V(*!6H^2.R+,X*]EKG&I7>PD-UJD>$X.%PQ=K
M5W?J@DV3 N@.S"GX$TQ;J .7'%7D"HL5P3FST% =818R'#F_=%G-SEZEA60B
M^3(C8$9#L[P),>5QS?46:V_!P^(+V58SR\B3L3&<T*$A<>F?E15KAK2.P9&R
M/F>2BV\FQ IO WE-AIG?1 P_'/WUUI $:/;-P6$[VZ9,@SW]%W%N0O(+^A$>
MGZ"'W>%97_=FUDB8=UOJ%,=YG"V59[U3BR2)(48*K,7;K69F&C=<PJYG&M:[
M/V7I,2+G/FR%;F(LFT(.J;3?GSV+K1HDMZ:-M*46(Y]<?!.?1*HA'<?2=L&.
M>B$;-]GZFK#38BYSK%T 7G<A.OFFRJ14LG#=V_\"H#?:H  N6M\SKZY32VP6
MSC3^#O6:CZX)PUP;:>]+\&LVAHN;+!UL/W]#G<.= ! A8^.,**E9>W,;)-CX
M_!._!6U")&4V,Y<.0/F_^8Q_&.Q2]V[%_TY MQ*.YP*J<PG(9 ><5UQQL2L?
MU?T,IWOQ<>X2\$CZ%#/GV<3_SP; 9-(E-/WSQW3&FE>N[MI?Q5=VA'WCJP]<
M&[H$Q/%;7E&VUD#E@3A9'/I[^SM2CM MKYQ7=&: 4&]JMSOR1D;E"QPT[P*4
M,==7G#7T(#9/89TOURT$HPDR>*]FABKYA.(*"4.K*J+Z'_B;ZH/YW@OE"%.>
MIJ2'<+#8/"*Z._JMT\_B!_BK77I\] $['EN"[,O[1AUX";A1<F8^*N9N*7U(
M%4HLE.RR$LC,^@+BNH?.!.[WVG>8!U/6&]U6(\QS&E,L "-30%$>;T*[]_M%
M&FJ_B\VGVS1?3ZCT)Y$B"H/C6;3'2GZDFYL$Y\M-R,'-+>_T=PZJ\$9UK1G0
M6P@&$63M9^_Y/3.KE)RHU=0=KO.3Z$QQ^M7TZW;RP\SK.5CQ9!>8TXM^UN=N
MM3>(W\T6_C"=ZW-&CMW]:.'TAIRII((O\_8([WJ?'+^AT=2Y 5%X(13T?.3'
MGD#UIV:?\VS&JZ-<]SR,5<;'HPYQG'0_8]DLEZ5WKY>N/[!U1L6Y'AW(#Q$Q
M9;,RX1=O<H\;+L"'J0:;5;[^(AT_&?KN8KO=J&;71?:TBDUZ8!U(+_7]'=[4
MK/?; ( =(.K/LWYO2ITF36NQD%+$1DR&1M:^!J%F=:92),L2[OQ!\.6ZH8<(
M+G>]<K9G[E>X+&(X\$Z*@G?H)>".;'*Y\ ,][;R)=RZ?=HH7$O)OR9/TN2@S
MX;NRH#\N 3V5TQ9<U:@V#)6.\0M?;?5+@.9SLT#QR.L>U&*C5?X6BG<T5/6M
M3*>L-(YTRSND*SU$,R/&+.'<G;?27NWK%P/M%I[2>_4!WJ#QQEK#!DHUWYP;
MCNECL7D;LS=1U1TO72 W^/&>$4._:L&!VL8OYO?[Q):W?!R__:I[2!]5GDDI
MKQOJ(/455E"<1468SR%TH+:=N:'N>,5.5H=;5X1SO\_\*!/K%%MP$>.=L_\@
MJ@!37TJ!W]3")?#YR1V'LO4!!+C)A]BQEA<19,D*GX3DQXEP5/-.R8NEK.@-
M9P8-1BT2X0+ >*GH_3SL1R>G!I3CXEZV4/OK07*)A5)B</I-O:0Z&$V5K7]+
MQK(EE=GD=/:]H+L"^IT&#'35II+4K$,)99Q1XTK>BS02:E\[3TQ-Y@?)OH=$
MZ;#Y?N7W(@_UN(:I+#F_F=,-<P[Y>%/!PT@UXLM I[SC5N^[.R#I4W&(OS1]
M"1$F\,%P9S^'&TUUSKUP,C9;%6"B006VY%O._101(;-%.;JRMR4;XW%@=L-E
MW%E9IT7<MD5^ZURX$0]]L9.3V#1SZ*,P*:*A=_X<9>,+'<O%3EUG/32&0^=T
M.?:BPZI@YD74$E.#P6[WTDN:/\]:=/55Z,729"/KS.W;@P//U#4&AS5SS$Z@
M>T.O+P'I6>J[_7E?M?KS@/6ZGO3MBFA V);,$>X\"1<?\WQH8*S<^5PA9^YN
MDH[\3#X78^9*G1IO OUP]IFHOWW\%8:CGI%X6A$S^7(K[M'<M"& <@A1'3.G
MP&]P2AG? WK@K_S.[S]ILK?D(R/)1SO*":>/'D6E)Q -;%BQE(TG7PCJ!GOZ
MGZBF/#V_G3/YZ <:S7H[RB-:Y<ZO)@[_8>Z;6.[B4_]<D?#Q@N>0QU>!CJE*
M-X*!9TMROFM?SB5&B*2D'+0M9"F^K<\%-1+ITW&VI2GM%A#:O%@!C.JR0$.G
M6NM$T8FH#TQURT4L5Q^_6=7$LQZT,YCT,4V/W%0IRO@Z"TDOL U=)H'D6COV
MH@)._@A5[5_6$[XB3XJ:=@N.DMKUW88VAK?5O=<M$('^PN!9J:%#)4W65%\9
MWB9*P,:.E(AJSD7"E(9[>DSFJ!]=2]W;J &EQC2][ELG0;>8@&$P30C&3W;;
MS/MBUJ4/_+2/+T23)<#?GH2WX6Z>A978]-B00J<KE5#^.W:QZ'WOO$Z.#Z@5
M%37[/C>:^AP&CR]Q").:[;;?![LJC%7?R76')W-#>SC>Q@>7 XIXWL3JQKLS
M__;B3"))\3M/S8H>Q.K(G[T(>X9Z79^V'7I[NC/P0;4SG2GDDQGF^E+\4+)4
MC14WZN 7DS7*<7_P<_"YL 0-OOXJ1.T6<TJNLL%7')8UK Z($KE^F$SG3V ,
MC8#*0Q&_T#I%(*I*AI.)LXF52I@:1D&7VG[<N(*;[T474_A\1GB2LB!V?R,K
M/-RDQ)ZDX-?P5NF=.Y"'D;1>B6SYNM9O7&K4@^26(G>8+>(.BB\$.\;8E]L>
M$W7#9>@G"Q5"%U$I@"*7[,G-SXE-%1&/">A@?; RX_"!M\64B2H]_\],N#F8
M.F[']8%.2&SZ)>">R)8]"6T V7I=[NIWMS<4:"@IN?0[/^8_!94ZRO0./@6J
M$<EF.*ZDL/P!/W?/-D O^]X4';J^Q2PIZ^CIF\_([?I/F$ E<9T[73IAO8BR
M4)UIIHF'!5?<@7BMQF&O)L-I^+>KUZW%=3-Y*SBXT*2KP+S,/F]-M:A2RM>K
M_!J=#P#'97?D->RA&Y$TR^O %$LPI=\;AYNMU5DE3?&7(1"LG0<J%/#KU"_]
M#Q^2C.7\"E7X>')"-<!(]'7,91UQW7&;W^/S<JHS'WS:;++AAZFCC5OL851@
MG,EI6$S5C-AY+0<15*[(!_2I:N!&6\6LX:N ,,5!,LNNH .X[0MPABYB,BWL
M*EX6P6G'M'DJVQC46%G1$0"^JIN](=>L@Q9K($DXXZA,K)28F_]D&,>O@TP:
M,;JV&ODG;WY4ALI5'B>J2"'2.8:K*5),'3*_+"#WKW 7L!DICR+P@E=?H'AD
MUJ9TQ^H\0JZ%JHX,DHF'+1314/7?0S\&Q.\ZJ@BK#6T+(,T__7B474 2,>Y.
MFP/4BIBQ^>@0^T&%L9J&=FS=-4Y TBY9#8 RZYSMO!TMQI]H8CU1 +?,ELON
MY7C:118H]Q'+'7XG+QDW:5XI@=WB@F@%T$WHW'*CM@?6,1*9Z9GGUB6J?M :
M+$J+4Z'YJ%Y^XO**E+4Y-T:I]D[20R/1;49"%6"(K]*1+..92:+Y>T[4VG_(
M'"!*/.3O+ISI$7.JYW.FE+JXB=X/I4BI,F >\&%['$4?I\+JL_KQ8)?Q,7UC
M5<2CAO,>&@,$5CPNKZ[;T9'1J9&X@&G$D<@%_55LR-Q3+I/6?[^-_4WKR1YX
M;-_B>#HP9:R\LBH"$&>N=KV3\B>1L6)YDZ=<CHFAZ2?.]"JB#][SWQD(./&E
M<D2/:X"G7%$15V,*:75EN,WZ7@%QU3-AO;R'2O8QC#%*@; J(BL.!:/H'E5V
MJ6":D)]C/CHUL<Z2+91O'W_/]( +1-NN"=F/?KV_(43\O>I>L;_=I*VF#Z=0
MG\VF%7,9&/,K5AN1]-:ADI&M)-M^)OV@BF@QXP;RNBETJB/%*E=I*6G B8SO
M\0>K$,&/6S%!*4\B!*-=CCLA[\P?YGU[;9UDE2B8@'Q[#ALARLA?9TY12E&%
M0#AM6148*?OKL.IA?NX5?78DW6GGOT6RT7+'!=$_F6=B[(D3T[]!\ON6S2?:
MJ*T*,@T^HU6=%8O+!-[@I[/CC=>+/YP.DE)9BL\RQ<.$6F*>+Y-5WL$:1=\^
MGD+V4LI61*Q]>RR.&OXZMC9T\OKJ[M-F>2J^ZWW]_'.OP;!6U#''$)P9HRL*
M*]Z@%6[M_)FE,O^BCN)&X9H]<:3)5'^K'DLO88W3Z&WYO".'F:&$M6,#YRY]
MU-B!YSJG+^ $O)&E3JX%R,I;.S)3^A8Q-BOUS/5G)HF)*PPX+'%H75!=K"E$
MN/&CKEJEMLM'E;+(B20%\.?+[-QRX*2:,.^\9' $0KKAYD_F#P)W!^^M&S%+
M&XF2WTG4N_->B!@Q.?\K]O7G*Q!E1UQ14N5+U7W-..G&R5/7W,]&1RWU7CZO
MC];?9S[LI[4G$=YMJWL+=UX:L*5MOM=T:UU_$@I2'X;[_TGRW$PGF RLFJ>2
M 0[6];7M./MJKZ"(^IQV=9G-D'IYZ**P_.A7L6U'S;V%&(8+K:BW^1!W^U;Z
MYO4K.W/\?=8H1-23I4XJ_T]F;/T?KLC*ATO^-3/;#.#Q#\G/_UWKWY-*^KNR
M +7_I D<FFS6)S5[$)8NM=C@:LLPB#<Y68VVZ!_CX3+"+0K@ M7H$^W:\^ /
M*CPILZR5.(DP?^7'&/+&A'5<=\_2(MPO'H?JTO' ?A<OEB"QF'YB\)-;7<W;
M*G[^[,*KE27Z2-1BU^:Z%2083T\7WN""XP!AD0AG 1^_J&<V=OT4;)G4I1.I
MFCCNX$+HC]47(P+I"N&1PO>5'H!>XB$=268!$7S@5]RON'2\65IF;AJC8*IP
M\TB^I*$_O?5<E98>G9$%[[AEPL6LWW($?-0CI0OGJ<K+F15/UA[>$A><P"OK
M"48T+NXRS(#PE+Z;4W+7(LFV2VA]C$GG,WADVX#19AGG F8P3?M5&TW)X])7
M^#9,P;GQPJ$E'UHN,T79D[9=C_Q/$\4EP-[2MN7HP;LK)!4M<_?]Q$L$W,^E
M *8>WSE'!9<^XXC=.N'RBDN[N6WE"UE@K+[X>@AYC>*3=5@*G9 UIH&;X5-U
M\;+9+6_L>/6:M:O<K58")5]=E(N[-[&:3TRK\<:P>2I^Q$Z/.^. 1[^KXWN#
MM:+"M6AMI><S;C9(+%R\&->-;1N'>!?_SM1E\%L.T.VO0'*?WVX8/'_I+!L9
M/&EB)R:0'2A$LCD0R,/3M/#*#Z&#5 <SDP'EC@JN3)Z7.AV(8_E&2X?FL.:?
MS<5K8^M;Y3US?8N@=H8LJ&Z*"S2WO&'L!QG9R$5'V^U!#N>Y[V&L U)$"SPU
M+.$E5:5H?NW*)$%DN?N+05K54G?\G3JUY>]M$VN@200-Q<7*'\]2OHN\O'B-
MB]RJR-YZ#S\Y?6VMQ5ONI3^0[# M+.(3O,2AJG !4D[1HRZWKL+MC?52O8>(
MO8/\YE3>\"/=Q8K)&2=H,N0!B=21:<7HKZ2Q)J0?[H"HW6=>=&YVGF&<YUCV
M6G:M/.9!G\9Y:&%6-F-5GXP>\"KDZ?H CDH#@5RYN 04U$NO,EZW'O&I/,4Z
MBN"QG$&O#'RG?!,GO:_ANDU:_/%S?B@ =0!D>#>KB,_Z.0.N>S<%WF83D:(*
MA/09/T8I:GI@4@/H9RXB,$H8)J<K?#E]+G:F805[C@_P*EK':O-,$EXB%.-,
M0967@&W^8F@]YO4L1WU9K4$LL/&]BQ4]%H$Q@F/#6DYCXB'Y8GT)7VZN2![U
M^?&<R>#K'XU)7QNEUE,K[+G7\Y.(D>A0=)S'[KJI6_W!3[-VR<9Z;<YZ ^KM
MGU;"N*3XA<0:PG"MN1OPM+$+;H?OZCCRT0UT]G"1OTB7$O0#P%#8V4T]Y$5>
M-=1H/45*G?>!:08+4G&#0(N3'LX=B66J"O.YNR7"/]^956(!LQDY-\\UK5XN
MQI51DVGX+%7KR$@P0F;%4]O%CN3"W=AEW:ZH%(SO(@<.\\9N[)LRK\C6G#SW
MC;.ZCVE"[QN";F@Z0G[,2#UU.PIY64603L2RM*$3FUJ:;JC:DFA%\SO>\DTY
M&""? IZ+'%36#V7)JG#^'HJ>ZPE\6%2*[C7!!9MVY)E,MXY]]%Y67=VTVG^#
MBR<PT(6PG'XA"]V[UNF[TM T'QOBWS,KDGPF+\?:.=%#*Y)>&6]<C>5&,H\F
M>$>'D,3D!4I*@:88]E5&26NR.(M#CDY*A^OGPM&M>'B#1.%C(>(--0>2#<BJ
M,XN]O''X.9TC6Z+UF.*@F32/K-GA)@_U1L8$\F:TK9>V:]H@.1K-5#=A7V/_
M/,"]]OSGOL1W'DXCS] ^[VRT=S!$]!W=LO&ST)MEU!& %!D"CY8?WU[F\.#?
ME6/]@W+>4OH?6A@!_$W_26LB4-S</]'7#Y+W@+!ZNB>"-0&[TFX!6!V>$P;I
MN=,MD9RKH!84T*UT==*\BZ[>'F1_"?@=5W(5]*Q5>.Q^/PE0DCCMN/9",USY
ML38!KL(Y2,Q&_+MP>GP5L6U=JOOCW%MA 3+UC!I=T!] >4%Y/S0.]*LT&&CO
M?0DH#[!?* (]@N<5 .JCX "?L*W]0OO3HPPW%^[/4N&.&$EFCZEZXE_ \*8J
M\4+XNOPH,L/:Q8/FF_U 0DYPQ$$3'3[L$2XL1$(]4A'L*C81$A;T7-XXZIP>
M_]&?>TWY 0(G_IUR5I/_XIO=L^2E*QQU"9@T[MBFC+VQH2_]Y:Y<D!/=IK&R
M,&$PG;=^3/JANZ](H9B%Y$Z()FN'*X$+=6Z(>S2Z(R856EDIJKMC3%Q/1WQN
M5(4E&CU0,FN=V;DFQE[UF\JI)9.BZ377BX?G+)C-U%0;U&_35/[/D)$&%ASQ
M^+,K%PI\W6VDB&EH.@(A1L=;_172M7G$Q+_/TB.B;J(1[O669@,+?;W2W_9E
MT^^K<*I7GNE#TF_A/&:_YX./K0RSF6\S+A(WQBX,;-]W7*0CVZC4H:_*T'U4
M;#&_9&37G$';X> 1V>T^D5N;,E-92^;#CMMF69@M+X0&=/U SRPP*'ZEC_+*
MI$@]FO<3M+KOS6#9RN/\-9\?[A>'O01T#D$76\;,ZKIBJX04_$060(%S9(HW
M+P'7+8Z0PJ-)XZ8/&/B3=SU*RV&"<*CM0D;(EMA+??6:AT\GKD#Y)#2M.CFD
MFN7SSI_7L>_PJVW*PO5#ROQB^+<R:ZO"(AN@2/\'E<.*%%[ E%_IQ$-G.) 0
M[#Y*FH>#HB2S1E+\Z"0PDRX?)H%+F>OX,JM2(VHU*[E<OB:2@DWN-"$(X'T[
MQL1('CFT=<H:A^,U,-L#;0%LFW5^?16%>]]8WN\&&P6\U?0 T:]; 1OJJV0P
M1IZ1)!P%) UXAB,?T0?/QGZ %3OEB%,+8&;!S4CI$0^VKF3&P!"CAQT@/%6^
M99LM,(.\K[&,U3@<]AIK]TG1;Q&NWFS639/S)(Z/6H_T+ .-V7#F-IDR?]#8
M@+*N20?T^>1W#*"S8!(V29Z>L6ZNN. SI*X6-B"HB0+&88?A)6LLBO1MN4/_
M6G%5>MW_'I8V(Q=F@AKNZ\QRK/);^&Q/PM$,JC8J<BQZ+).;9]%R[0^C5.:'
M/C_+1>TV.$RBL>G3%ECT3^^)\0?_82N>[^?T/V@>:,;(J;4RVP^21$4<;0[(
MS,VGM&^>':&"'(^G5'@ROD OG Z4-+3]R,SKC[X%S5T3=%:N/I#86ER$*M[,
MJD(G#H?2\\PHO(H1^83EB99RIL1[Z:,.(;[N#5^,A%_KU\/=T/FM,Y!.%H:-
ME*=?)W_+^N\JN*AP40?4J,V,M^^6\_T6\T<AY.:CQHMA-A<%72&."^F=8]K)
M>RU[BTOQ5AS8U 7=C\[GJDN;=5\F9[ONW)MQ2SEP9H'2TO!@0E,AKYO0\N9"
M,_Q1$8!>K,:V8?'C .;*0K"7ONET37/%79*4(XFH=,6JV-8C]H^>_A:(N-W'
M,=Y,W80A=LMI LEP\8$CL\3,GYPJ_4"?"%"4$3IQ-P1VTT'LWB:[: 1Y-0 V
MN3#'#FUUCD9[=COI?',^M'W8X2>-"\;4%"[PT-X>[A5PG7_C%FQA&3)^S@MD
M.@AW%N6/F182XQ>S@ST?+U&^!3TE<+T@LEOX7ANQ1GU7BLAK(6#;\*)Z(>#&
MY,:'/*^01*\,!^,$*-VB>NW\): F6N197<K,BE@=DX!'B8TN9:3EBQTEBKX^
M)(8M>1C9=!4*[:4"/II][,YM\_.AN/4T,&-9A0O4/!>KN;CYU$'<,5U,5>-/
MZ7&3\%&"R<27E^#CTF@"^\80]#'F<*RV. 1EFRRR=* /LEJO:TS^)#KF>W?,
MP/JS4:"$YO?:E_J=&%#<.-#,H^&M-&^C_?[G9\:!]L1Z,E&T"55_@_K_D[I/
M&1R"V964WX(:6")J#:MO>U8DJ-?/<8H!_.UACW 0$__A?8X+21V;J?S)H*0+
MD4U= +Y4:]"= ZZ.TB)TQOT0O5&"0N7"3OPP#V%T9X8Z!9M&<50PVYOB:CYS
M[;N,@NUPL25L.X0W7%M2Y6&G$$D/@>_<?5Q1?X'GQI,:!,.3W 1.3FX(\B)-
M6= 42CXO#)$/J7DSJY$TS8Y15, 1#W<MQ'[:DMCFM72F+E/IW9<KGM*EQ,>W
MSU6>]J!]IV9.ZI']V22,1*!%NJMOVZSH*FCC&AK>214*Y,K2\04VUZ^)$FY
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M]^TW]K=?0'D6CD+F4Q^0Q0)B^+P'I(>KPL <5*<H6X\8AC/%\K]2X*4P8FS
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M?G5J#$D$P"2]V]!SD=N5^=54))6N+,Q ?_&DPDU@<B(D2^U'HB?U,9"W":)
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M\H$L%_G6Q'[-"YZKG0&<.&[/5/-L1ZVF%OM<T)EIBE#KCF;@FAWBPR8Q(\9
MX>*;<BT'[3MNY:1O.>(\(*Y8$9"Z6#$L@5TYR2G%N#!!G=#DL#7I%OH5.<G
M@93=F<A*1)Z+(2DN8*L<-3Y/X.",I<B&BM;.R74-^;;1 ;.8*'/*ZQD)R$T<
MH0%B;YS]IUL9/Q(EI"PH5"8:B46-P;5UN.['RF.!/H(G$7]TMF"\>.Z'ITYA
M18!?LQKGI735>(QWT WI@(.;-\4A,2@<0!JMYHM-:H4\69[-32$<?6X9 4(+
M$9T=R907AW+NE@7"B73WTLS^7&L"[$/ D,X5_PAN]7,[PUGXXD4&+171+%8N
M.[<+Y>3*^?L$I0833P6E>&O\6)N#T4 "6J5KBB9Y#B+T;U_6LQZML_Y9EM(<
M)$?14QNSZ#Q4%6:U;=AW*>5Q&[W-G[<'LJ/&PY.<;$HA!-5V?UB)-EB?5(Z-
MH[8'/;^-J?RJI?9$,:=RZ4^=^V\O8RXT C=1.Q8U2Q7+2Q_B0&69+S?N-FKV
M7<TRRUCZ_G/?F^7?]E0_;_-Z(Z$7$$I[*-7IT7@\+4-'YUI*R:X^Y>Z+!LJ*
M .() ?JM6B@G44N@[!<!5T2 ?"A!YDM3,;=:4!JYKJ#.]*-=LC'UD?X:?^)L
M!(ND35-</[!\(VJ9'IQ?'I _&QOU_..)XW*A&;P-OO9*&8X@ HBA?'VH@7>2
M[P/=YH2PX6NZ-5@B>[Z-%9FFQ6UD*2D'AJ)L.P(CMRY9T9ZO>=N=\%'\.N70
MDDV\E";S2.WEZ5O!IWW8<4+9V>?8::$<6NQC&*3-M8;LHR-8.1(XM4G<(=!9
M[L>CDX41S&\R'P?9.738H.J!)_7ME^<QFU;RQ&&"HOXNEZ]L@:F3"7--G8+2
M%NO*))S=4VHE-J$W7JV025(*;4T6Y!P'N4F1@KPR9*#,QR-1804WWM\*2']A
M7'G_@(N#R5LEF3'7,%O[,\&1)H/#,F.V5Z;,Q[Y_?G9IZPKZ#AHN5@%=B";$
M+1%P+5(L"4 ?PBV4(H>P=I3G 8VS6C,8EG=O(!0L8@Z9]I#DS"SEO%B"Z"!.
M?=6G<(?!)/Y!M3J60J#G&+79"KIYN8"E:;%;@?N-O].#RP()_.ULK@[TF><)
M%6QXM4PW*\F&Q\-Z1[3//' O^=6?Z3IPIWNZ=9.E+\VN8]F3EECMF#F+]5=;
M1PA[Q(:$JJ_JLN$[H VV/W^G-FOR%8J.J1B RXL%,+*_IQ YB;M2MS*ZC%;#
M)5@ECKJ_#) &(4/B(QR]&/?4%8 O#,,<4WL??TK-JHCX=*^_^,$#\*#!U7=S
M\3MIPR*@U7+M"NC'W24@=2;PO(3O2_:\!J=[R41D3)S#YY$GCY$%%<]1X7$%
M[2=SF"-P3XM"K?JV^G#U1N12Z_Y[]U_G5O]QY&Q#.7^ 9OKYH%.51W#.E>?&
MN?2345U2K:,'[YR6Q-8'1L+X()GQC3P[ZP<-<H:8XK[.B,%OVYQKH];.:;/@
M_1%P5_6\92T1T-^@.4OX@V\/'M&*J#G7XOG#7!))],V>9!_0SHK?>:O@_$L9
MI36Q0H:5X,?;4#:O\[C7! 7X'5@$\P^'^J=A5?/\H X.(:,SA/7D &52E1X+
MSM=68OU[D1FS<G'=XV9UL?;FJ"]&;UZKO#@P)'@B3C0&(B RX)?8;%3O)=#_
MYO7&(VYWNK'#<)X56')O-WS2TN8)_!@'G6PS2U-<;@Q85J?'9OYK5G,Y;']:
M9<>_E^X;?I=Q\^3[0=N%"IOB=%HL_"A.AXB+M \++$(/(IGT$BX6]Q\PO=U6
MC5-.D:S('106+0NN@KO"@?6UHO9S%G-L$')?1RQJ+S]?:5KRQ#"?R+!"5W$.
MHPO%-9D'[R,ZT3.FW/V0N)V6$@@>.NL(WY%E+D\8@&AJAG:*D#ZE-H/1,YF.
MS:B)/930MUD;4(X4M/E/6!@\8F7A_O*]'%#D?M'L%OQR',*53T]'&DL:(<=6
MU^L<-HY/U*TUQ(SX^9#'6N3D9E19 ]QIWS;,S;6&TC!].UM_9>O6-K4+N3&%
MVN>,?U_YB> AQ&PI(1@/"4UV T^BN;>@HSQ3K.D)*+]VQ1]E,/:-?SP6K;:$
MEWG3]9KG/<C?A52ZJ[=,ZRTYWV#6VEH4_Z* 9G\%FWFC'#$=;BQIO8>IX67Z
M(C1+TV-OP'"PQ^QB?N;PAIS&P=G4?7>DI/;9^OQ\+-[O(H(QIP29))+6J)QB
M;J:@P%DG'-[L05W(0JOC/#A$*GV#6A=-W?3(ZH2Q(K=C\]<YE2MZ.I.QWJ9G
MQC^-6K18OWDY9>T7%;%G)HAVT[PC,$!3!(Q?JGTHPW)=@6)HNDJ28*G29P+7
M79 F/O[MI.9%2A",,<W?,<CM&B.'T.XXZ*55ACI4IR""W\08")YV'\*>_9ON
MF# GQ_(?C-#C^8F %$+E<JN"H)"5Y4;)@*5;^BIDOG,>[5[8^-?G Y7J+"<H
M;%'ZD,"-[18!J83W+X2:RVCY;@T,7G/TXK2%LXZA,".N&@E5Z1J=?]!:\R)P
M+CS:^]G\PO%8W<.;X#(R_VU"_IN<Y;OCP3?_CMH,F8F?>" !D<3!(*ZZ=P[B
M3,5W;VP@>SLVCA62YFR+\X 66 IV* ZI+T<-NC%XM,LK2"4V>;QY1/M84\&-
ML3[R;-L&LN#G^7E/F]:1][.O2'0C=],]C%NWV5EG75[]C-0J;S\F4:!YP-#J
M)]9(YU[/I?4=$OQLG*(XW5ZR%F\K=HHO7UREI67$!>'W%;)*3) C^]M=1"B:
M* 3&<8=>A*&,T3K+>,LN#CZE"MLV@$S^/ONV--1??;1?!WG59=[BZ][[!O*+
MF]:"5X@0+SA]G'L&^LX[@,+6G@6=29Q!9DZZ$S!O 5(Z@CRHHRM%^N?ZXZH#
MZ?4V&A6YYFJ!:E<"!?;K.US*#Q&7666-CSF^S:Z-=[ TOQ_<4J7OU8(\ N,]
M?+:! M>+<$*SE68/4DA-8N)Q<L_GO9DYF0@)2YQW+?_4)%,]_L[L1\CGA-<W
MN0#LB:#9(?79W1/KM[C^V]_*V]+3S<:\!,I0'G>;($L<&&GPQNDU7=Z?6"\/
M0KH(:(GL7;B#MYIJ4:(7<S,XMC5L4CK*CM-<A"^U]G8>/S5Q+7B,;U>STFTR
M$=/AY>@M=^)E$3CGJB"8K]9][!TIT&@W2#CRB!X$>WY_==?6#_"!$$ 1,LJ,
MYKL0* QTJ^%4&Y/TH4&X+1],6T?LQ"&A?G:B$LLN!P=G/ERKCZRW3DCXSEQ(
MQ6L&>HY6)D;VH\P[WW2,&K31\D3 UK7!XI;*+?N54@@,FL\'_W/0..\\?IS0
MMM@7L4\AG,9\\N17Z;1YL3QF1L\?'*"E30^QT*H+ 2=Y1S8<(I-+)[YT7_$/
M/=EUB?K("_XCXA9P3O*OGYZ_R7]R2OF\2T_JON96#<D[+A0 [T6@J(JY(9'!
MM07(Z!M%!-R*_R%6'+W3D^;B/H?3SM)\\6U7#HN8V>=/WR#^X*T<*^>Y9S$F
MCSF95&V35"XZ,5[[IOU&Y+0L8+J(H--Z%_3X4;Q#?#\P9Y7*7MC&MX X#9"X
M*_>!(CFP08>@?YJ8.7*8Z+>1.NU9@M0'Z#-A_MX)GYI?-S5WVC;9%8$%*M.C
M^3II9!VVIB!J-=%8DC]N;0E99PAE:8R%C&T<&.67J%L5 <QOFC.83?)=!M3
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M?@]"0DU-34M#RT9'QR9QD^NFQ/_:B)\ !BI ]](B*0DO<(F!A)2!A-@)\
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MWL*<=??^P!8(!$WRAKKPK<[$&YY_=3D/:=Y74BN<HNB-'2OB&ZJQ(P(.I40
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MO0TQ4>,,VP/0L,UQ,3Q@GO3WCY0A<QTK4/H%K;V=5"*P1S$,VUS1QU_Z^ .
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MJ6O;[H$ S"3 V<YR@_>5R>UAGXMW]?$D3 0BH$T$NLP>% GH:@0,-5"_;]3
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MB[+ ^XMYOE_YC0A\ABP2@=.K*GM!SA<"WG:Q0.-NP);VQDS>NI3*M.($-=Z
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M7%74^?A5"'_'W1$^ODUQ M8VT^#6) *6K=\JA+O::*7H6;0FC/@>;="-K_P
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MK6N#96+74TR3;EP/RI(9=<!62;'EE,)2!=V::WL@E-EF";BGJQ5A,%$1F;E
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M[:NV)L23B79[PYJUKRT=(U!74-1N0#\O.>2*K"A[.0I%N/H$<0",Q7:A0M)
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M0?[6&Z$5_JGW&0>8HHC0O_6^(#_F?R%7GH]IKT]6CSZ.,/L@_>*?>A^_N[A
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MP[.<2! +[D$M;D*;ZPUGH5C8^19W11/BQ#*N<"8?D I)N,T=AQ'D<J*N?/0
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M-S$[C+P5NWL)+I*[[;J$$LP >.=0G+@"A4O&%_\/?TCUA'QNBY#>"Z6Z=Q!
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M.I-?7XH3$#+%9]^<?<-X8?'7N _)I!:?>T!SO<\\(8\%"<G4(I*CDY>9'9$
MO?PE'_Q2MK0J#Z3F)!2C0XYC2=<C417(.A^6)YP(K=HI+'?%Q!E&:?C8+'Y\
M)#2R'BA.B!,J?C)=565_K+OV2 WVP*U9M:9HDA?+)B_^OOO9<4WR8JWAT?DL
MTSQY\<E2$?VH<69B,=60C']L]LB1\EQ-^;$*.WYS'VMZ=.P2"5K6%4D6G-<;
MLA4I1(52(\6DZ>1HK2)4+3=M><&W:7Z3DOT->O96\4HD_9TF=Q<*_'5%,Y>(
MZ -=1;6=<0VZBO ?,3_8G_CFQ[ZPW%%4V$'3G;N,;/"8U Z74L\"W$6=2T@D
M\U*$=+_T-PF2EN=(LT!J[>K9H[K,3%G8_.Y"D;I0OG:$$.6I!T^JAO6&&J:J
M5A)&O'NK>R&&"GQ 8*I>:VTD'>@JD$5L@(M22QS3J9C\>XE"['(S!CN)DEBK
M*T(7V(M>GLE77*@EHW86]0K<@;<A'2R@^;QO2=S MP!3'F#'V'38[^A!\'!>
M>@C]8:[("G@K4HOI!*T3]QB;@=/<!?$0N;V&^N-32#"$@N* P0G%C\AS[6>^
M(^!^3*D8BZ+F'4 $)AOTGJK&A3@8N^$5XSF?T&6 [X7PP+VZ@%(9]9KZ3SF!
MPR",:,S9[!.V)]/(N_=Q^B/7DY.D01<P<M)#Z ]C15;:<7C468 +'')BD7^%
M12K#?DO]$2JF6%-K)6=FO.A3['K1%7(\G]]]4BOX):&4?&/WW#YZ9)]$:QBD
M*J/H#V!U;B!P/ZD%=\K.Y?2R-%[('W.B7OJ#5TX]J)(KMJWL[NQLXF%K16+1
M?1'JH3]*8LI!A')6D_8R_C&%?N4E2J!DDK\/^TG^^N.;F^&<5R+5+JM?G_AL
M7I&4DL.X2@?X.!]D>8#UX41M]EN4&LZ<)79C_BZC 9[*LA&>X+NTR6AXBHFW
M;[ [&5:MYE/\\[ZH.1U^1[W*46R[-Z]RS*L<\RJGPZ]R;GDZ@F^\)&/P(/<8
M1]!#4>ZK!I[@E#"EZ>Y[#AD<VSI7319(DP7R+,#3^50T62!-%LBVC!^B")@<
M,W5C^?)#J'I;W(9=HI(,H+F@<23@45/A8(0_WTPH%H&F%^)&ZX:=,=1"GB4V
M_/8<'LFL7!*?41"FT7!R?H^/^WZ/V7S<_\<OX^N!/?VO__SQW<4/?YOU['_>
M#N>_:><&\5$8CA?98]PQG7H/2YE"1V7]5"[,0MI*7 ZB/OJX#J3 VEM_Y=+H
MB%'_# P0$E@<:4C0T$AD# G&D& ,"<:0H(4AP602.>Y<DLLJHJ!HA\DJ8K**
M'"-X_;**,,&5917)-VF]4EUY4I$#\L!=6?&UM7#_$RL7@BX=V,;+F0"7@H9(
ME=U.A9W4*!7EDI= 2G>%HFFPM#QBF@>TW7R#\;WO.7+I!@N:MG[J5%@/1()T
M\$12<(7=/B*8.3A U".PT@ T[<#) Q,/0='L4V8Y)#+";H/P$3O>PL.NJ$"9
MH'G[BH98ND2&:)U4D*:@T/+L: *N5D\+_B2(!(F?+/'E76*??!MY 9X0)IXK
M[PG_"U.R\? )3Y,Z0]U]:%_'*5\GI &FP,VOX<IG^P1:]^0)S[SG"./@> PE
M1VO=VWTLC%7X@I T>?/5ZKHU<^@K3MAA<NAKK>&:'/J2$&J=2#.WW9>]*CIH
MJG6Z?2'1$!JJLV9.V&"84NPF!&?!H7&T)-3[MR@)G[A?^S5<CPG:D>$%PD_Q
M8MHE?8+HF":[2!K<61XC*=>_RW"*>0(M4MKLD?)+4M"I6P"6,@)>4+1!K?I*
ME.C<613KK4'5SJ_]63B.HS!"@>L%#Q468:Y79_$#.&G:AEQN1<FRX,;WOV,G
MFI,I=O$J*3Q;;C(!NW8$E6KL:*I@-_J*HQNXR;$!X54W*2:PE$8D2K_:(VZ2
MV78S:[;L%!FG>%>)GAT!I!(W$"YU$UM"?N%MNN?Q(I]!=1.LR1;^O1<@P4Y7
M880.X529*U#-;A:O&T2_XBBYR_#T!MM=&0 ':MXA),0L0&*OFYE28IG8S^P7
M+\3)9EJZ?4GT[! 8TMR ZFW3GLHB%EYVU3W:LL\AK.H-UB'XCF$01%1)TLJ7
M'"^#S.8R1\]6&.)M$LLMQ3MO.+\_>,/9_\4>W%[;O?%5;V!?V=.I/>C-K?_M
M6;.9G<MGJ?3YYA3S5*).E+RA[I,PL@*7_0W3)WR =U'"6YG>>F2=W*$UH3-)
M<<NIED\G*3&(-H\]JT +YG^4EIIY ]I^$BIY<,RC4/,H] S!T]GS;1Z%FD>A
M+2VQ@XOJF)TFB&>'O"9AV&>7[O6"T&^(NH*#KL(@=T5[2@N0'G&CJ<J=IK[Q
M0S:BI2C:I+C]6>"W9:0KB_(S93.M E1)^W. ZH4139W<!Q1SFV!B@;5\GWQ#
M@2-0#B4ZGP.( %>:.KH/R!]A8368P];G@-F&#0FGM@K[VC!@?\2,V@DE3QZ_
M= L-;#^(#&S#47]\8R?FM<ET_&4X&XY'QL)F+&S&PJ:#OF\L;,;"9BQL703/
M6-B,A<U8V.ZRTMQ7F!&#?'9ES4IV7^* R5F@6I1T[*"6(<.1YM:SC/:M_B$+
MIES_#F):@3&]%V@2D,_XOF9?56.9BKMW$%AYOC0WS>UP4'OARHS2090KLZ>I
MU>[0QKAOTNHO><+ 85!6W[GJ2!T$O1:+$I9 %<!77M#GLW;K+-./:NVV]F*!
M'5YX8DO[E.T[4\ST-\?SO612"BVY/XHLN?;5E=V?#[_8>9ONU)K;O:G='X_Z
MP^NA-3?676/=-=9=36Q-QKIKK+O&NMM%\(QUUUAWC77W3N9":VTLGES)CADE
MZYW&\")L8/ .JC5-<:VI)5F&O6)K#!;<E8X9]4SGB)#=#F\G&]O,4:&'#7_1
MF4ZAJA+0U!)>S&J?W:J\(&:"RP+:A86#Y<<XF[D ,B=A V_/N+8E6:Y>[*=]
M UK.5*99?5AC(#,&,F,@,P8R8R S!K+N@6<,9,9 9@QD=W7>$PL>V!;-)KUU
MBQ)F-+52*8RGZ1[$M5B46*\J(C2ND$>3O':IH>,&(ZXGNN-@BIV8<ME<HM 3
MYK/Z\%84I'%E#:>]+];UK;W)9G5C6[-;GN%J/.*!&K?3Z7#TN7=IS8::9+K:
MDPFW*7KHWO.9X'&1A%B#$0GHCL D--:&OT;E]M$$*R6*;X-?H8U:?)*)MK=9
M-0Y-1[3K+=^7Z^V/OWCL;*;.<GV-G[ O5K9E^RO3O9L'%I@X4@+4[B*ZI3D3
M!5^(X2$C97I?Q6'4*/ 5H0)PKB(H_71[%7CKK/.W-R>TKK>U)7H8/,91F#!^
M459Y2]!)D06AWB(%0"WF2M-]_ RLY*<^J2O;T!7[IXT-W=C0C0W=V-"UM:$K
MWA^'P1,.H]TC_L6^!J\O<3]5AM8VC!P2G$L8WENTO\;W(?XCYL5NGSC14K$\
M'RX.[*RWES/[G[?V:-ZSO[!_9[J%].SQ*6$4A7LH#=W9I:HL1J>PM396QS)0
M]@-P!+RKL06&-,I!QW[;AXW]Z6[*/3" IL ^SWVL+GI&)%E21&H[.IJ\?,$[
MQ(;L38.6+^6%4B/%I+5TT6Y<J%I>EN4%WZ;52$KV-^C96\4KD?1WFK1]#P;F
M+8&IT]2BL[_ML2\46W3 #EKOW&7$:ZI\%-!;IM<+NJ@QQI3)O!0AW8TP38*D
MY3G2+)!:>RCVJ"[S310V5V23*5\Y0H"T-\0,\'TT#'B<&)^EXD.JJ&T7SB>8
M1^V2?NV2.D*KTDT/[J'F8!((6X3*(:OZ'4G-@:/S@70T@*W:_4<DPA.TYJM?
M:.T_:*?H/"F=]:2$9DTWKC/P85<X42J[HQ6G%#3N:...-NYHXX[6UAVM>'_<
M/96OD(/+W@!!/>X4%:FOZ/$2D@^!I'@?[/LH#,>+7[G;-XC&=.H]+"/[F9WO
M7H@GU'/P]L,P^S2\@!&L-5Q'X*W/FX1!7<4;KCYAG8(0NY?(YZ_19DN,(^&+
MK7>B%UO]\6A@CV;VH'=I75NCOMV;_6+;<SW>9IDD(29)2(%AT20)T5AU-$E"
MC$9I-$JC41J-4A>-4O'^.*'$P=@-KY@,AF$8\TOKD(L7^9/XWO><\6*!^1D!
M+S7I(3J8GK :;YHJI!.T3N*QQXM91)RO&SZ2LUX JZ!7%Y$L8T?3!3K'JT="
M$5W;;&.)UI;C4,QE/"=3[++/^,])D#V,I/00'82U&F_@14<KC/G<Q!.VK1!W
M&#!^4(C'=(#3GZ1A%H[2?:3+V9/P0$(FHNSO_)][-AS[R_\'4$L#!!0    (
M .N&+%0510__F$8  "VZ P 5    9VQA<2TR,#(Q,#DS,%]L86(N>&ULY7W[
M<^O&D>[OM^K^#W.=K;UVE>0C^6QV8SO9+8JBCKGA$1E2LC=Q;;D@<B0AA@!Z
M .J1O_[. P !S!-\S+3VIBH^DM#=^ ;SS;NG^X__\?J4H&=,\CA+__3%^==G
M7R"<+K-5G#[\Z8O;Q>E@,1R/OT!Y$:6K*,E2_*<OTNR+__CW__V_$/W?'__/
MZ2FZBG&R^@Y=9LO3<7J??8^NHR?\'?J$4TRB(B/?HQ^C9,/^DEW%"29HF#VM
M$UQ@^D"\^#OT^Z_/SR-T>NI@]T><KC)R.Q_7=A^+8IU_]^'#R\O+UVGV'+UD
MY-?\ZV7VY&9P443%)J^MG;V>E?\3ZG],XO37[]A_[J(<(_J]TOR[USS^TQ?L
MO>5K7SY^G9&'#]^<G9U_^*_/D\7R$3]%IW'*OML2?U%I,2LJO?-OO_WV W]:
MB4J2KW<DJ=[Q\4,%I[9,G\8&^0:2//XNY_ FV3(J>+5;7X.T$NRWTTKLE/WI
M]/R;TX_G7[_FJR^JC\^_(,D2/,?WB!?SN^)M3:F4QXP)7Y1_>R3X7@TF(>0#
MT_^0XH>HP"OVHF_9B\[_E;WH=^6?)]$=3KY 3)+R0UNN;UNV2J4/OL'.,(FS
MU2C=#757.Q!\VG9(L4<!FOK>BW"3%5&R$_BFIG?8UWBW+[[5\_^E:3^/=_O2
M#<VCP"YDR+T_K_J[)NR/$_I3"R)^+>@ AE<52&;"T /S-_"!H;1=6\^6+;L)
MZ\TS(I>=C8S<9HZ77S]DSQ]6.*:VOSG_[5_8CZ?B1UYT^NLOH[2(B[?!:D5P
MGN.\_.&&OF/P&N>5>5ZV/WWAHO"A"YRI#DB%/B)+RR<H)3XL,SJ K8O31'QL
MH7Y/LB<W'.7'RERD?TGNZC>(STM!:(K2$J-&L@U9XEZUVRR/\X<M(3XE5(7-
MU7!Z>KOXXM^%$JJU3JH?$5-$/S/5__[CA^V[/-'J8I/'*84QS-(B6A:?\=,=
M)HI":^1\D<@(L^*.4@@$94S(NDRI9%$IC'X6XH=EQWV4WW'PF_ST(8K6G"(?
M<%+DU5\X4T[/SLM)X^_*/]=E&2Q_V\1YS&:JBA[(*NV#.8Z0&7\LHL%9Y(9/
MRZ6&^('ZFH<D^HU3Y.S;CV><()\F@[_\\BG)[N(FNF%&ULI>Q2[N@R*NH!E'
M;++!2>((L,L2H='B"-.!UO&P_0#\A--B1'$6;VRW(DOIK[FA^['H^.R$G. W
MNR*C0G"N]4$I38:X*-K*'F/^LSO1**ZG+%T4V?)79<]ED/-)*"W,)HDD(3#$
MT2'KDD7((2X(K4NB<WC>7T;)+(I7XW08K>,B2HRLL>CX9) 3_":;C I@F.6"
MLLNRK0YB2J<Q'0.%&C3.S7$1T4G=:A21-$X?<B/9=,(^668&W*276A(,KXSP
MNH2JA%$E?3 >:6;>?.^3]Y*/6;+")!>CK'[N;5'P-OMV E[/OXW2P:GB#+%+
M%ZX#I(=9;.[R>!5'Y&T1)7AZSXMBFF3KY;U.L&VP6Y-KG7!P"KDB[#*(2:'L
MOIHH09I0STC\3%<)LR1:\J6"<<C2"?NDDAEPDT=J23 D,L+K,J@41K4TM*G/
M3Q$AD84^'1F?K%'":Y*E)0"&(RI476J4,M (,9Y-C61H//=)! E6DP3U0S $
MZ"+J5CY]#JWBI\^8#)(D*U@W-5VSE9N1" 9YG\2PPFX212L,AC@VA%TB,?G3
M6@$)C6.OB\I1;8&7&T*7^%B]8#:+>EL+6<#6JR"-7'!F.(#3S3JVXL?I;-S.
MPR?X(4K*$WZU7X4DX>L,7 .M.OWN/ Y.!3VF+@.X%"H])#R<3BYF@^%D,ARD
MJ]LU_T^YTT?_9CNI=%#U?&KI7)C.":95+SB!=@"K.=EDZHC*HBA=H=MU]4]I
MY(0_.NX$)R=%8W)#?^M.;.B??IE3Z"IOKLXS'P13PF$,:CT(3A$5&FE?I(B*
M."_B)>UC/N,HWY!R;7O$'1*GZOX<I_'3YDG9Y2B>^ZIV):RJZEL/052_"E&7
M J4,M$4,V^'#OVW8V?DS_8_&E],J[7N/U0"YN\.J$ U.&C=\4B]22R,N?C2W
MS8/1R;@>UL@&I))^':P4A$HC8S\DD0A8AS3'";\"$I'B[89$:1XMV0H]OWAK
M/C'T47T,^#V"[ENP]K&TJS885O:&+!]?<S'$Y3PNRAP78&$76RX+*R#=E 68
M;<%T;)\%LLF+P7*9;33CE5;*GW>"%N+6)4$2@5'M6ER2\P$31*4DA)7PC&2K
MS;*8D@4FS_%2MRA6B_E:*)E 5NLEE4QP<EB R1NT7)3OFI32L":^5W2 6S[&
M.39.>24IGQ,0#<3F+*,C$IPE9EQ=DM12$+J/.<XKKW3==EI7PMNFFAI:O;76
M?AR<!'I,\H3Q.68Q(Y@+THS$&4'B)GGX?;;%$J<1A3(C%&*VR1,Z!UYGA,YN
MM5MO=A5??'$%7Q'()@^"48X@Y8&H$D>5/+3>9O5W.I/2NKA9I4/T0AK(JAZI
M(PJ"2W9\KCT5NY)=&3CVPN<V76'R0N("$_VZ1R'D;=FC!5BO>B2)X'0PPNJR
MH"$';1NNOE(W3*(\=_"_ULL'N>"H@ZV\W-@5#LXB5X32/34F=F@';$WW,<<K
MC)^BNP3;[BK:Q;UU*0Z@Z\[%(!N<((X Y6&GTD!'N=*HH<IUEO9DBTW#&V'<
MH-><,8O#H(T3QBYSJ!(*Q)[Z*L!M&A<FSTFEG#^W20/,K<^D0@@&*PS(I#50
M?3>#RQY]GNKN(!?>(<[5 0ZTPUL_![<C.[.97:K+2R%VA^JNH&]W:C70KC-U
M6PH&&TS0=([4E3"$O9&;N&!W%\?I*GZ.5YLHT>S':N1\[8<8858[(4JAX#2Q
M(9/.^I@L6Z9LI8^[5EFLLS3/B*&7Z$IXZQ[4T.I^H?TX>$WK,4E^1J40M(T-
MYC,WO1^P[NE!=SICD?6YH6&$V]S,4 H&YXL+.CG83D*U,Q(5\3-&#1T^S6C^
M/BT>,4'%8\2"A365CMJ9#%9/<1KGA7C78K-FQP"#!X+U]\I[Z'GK>/H4H^Z.
M7)2"DZXO4CD.3U,5E;JH5C[VU+;L.JV#5:BQRCQ402*!"I)FH/)VVA*G#PZ=
MA5'<_PF,'K1\%B/+PB"#':#V?(9J'*'Y'RI4H#@;*)=<4S*/'QY-LQJ#O-?0
M@3;8K1"".N'@U')%J#VJJ<):T"Z(ZQQW\C+;W"7QTF'71"GG;]/$ '.[9Z(0
M"LX'&S)IQX2+HA= &R;UJ6/E(Z/9,-'(>7-+,L&L?9%40L%)8D,FS5%*D>/V
M#8VSH!F)E_@")]G+=9SB61:GQ16="_\-DVR&R>(Q(FI'USWL>.M;]BEFW??L
M8B0X[?9%;@R+RXTA;@U]^_7OSYA'$^(VCCVU[I9H<)?1%5_\6F"<[DE=9U/!
MV-NSL%H".]J!R>%^X!UHS VB\W\]#H\/=><@B@E/3'?Q5O_X0XP)K9''MPE^
MQJJ3CK[*7F\H]"I0Z^*"DV9P\NX$5[KF0#5$0D)4Z_"MT>O!C\ NQ51E&Z?K
M39'S@IV;+\B8-()040]=R3]9'![IM!CU3#M!0ND$<35T#F&=\CEZ-0<O:3_W
M%KQ$!:L.7M)\&)P:.D12\!(A VT O,1WQ3C-"[*Q'.2I!'WV)GJ@S4Y$E@I.
M$"NT+E.8(-I*'G?!>IT5>!:],8]$DRNI).31>U0#L.$PVI$(7N5&6+);*(O5
M+ 2/O<R;L-R8AE.Q]G-O=:R"55=O\R&,FE4@DF,A,I&0$3 [Z2UO&+TZA=&+
M!4HJV@*I227*98+SP +,EC84_<RE ?!B$J=X7. GA]2S#=% _)# :CA2RT'D
M21><G2M, W&5$(2YS)9\'L+\CQ2E:S_V10P5J(H,S6<@"*  ),WY2A$>CRY
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M!,4:+3PM;[@&*E5@48>'\[ZD4R?' C?D0Q)(@FWB4"T,ED9=A(Y,$K'8F5Y
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M[CZI0AE@?()::3S0W1M2JE7RP.X;;K$VOM?$<IG0IA2F[9@*H&X-*@V _#;
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M[KZ(K;G5&R:J7Y@1X28*A+JTA=WCG,&*DBNLS<TGBWF=#VA =GK#E@P86FF
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M%J.MJJ*JFG^:T)_HGZL_T?_<13FF?_E_4$L#!!0    ( .N&+%0YMAYP@CX
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MH _=+A\4YJ"GS]GT.9L^9^L/?OJ<33Z*^IQ-1JC_RL_9/L  &WL^N;KIKKW
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MT*_-)^DV_SC /\(%>*DV];\[O7([M.[-P<+XMTS3?C_K.H%_9B=M]%]^JQ)
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M,(!+CW4W@=I!$-#.WF([ U .$Z27,*F\)2,6';PI1P?'T_&"U*JV'VXGX^'
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MI/POY#^/> S\F_\/4$L! A0#%     @ ZX8L5%)0H7=_ P  XP\   H
M         ( !     &5X,C,M,2YH=&U02P$"% ,4    " #KABQ49H O<'(#
M  !5$@  "@              @ &G P  97@R,RTR+FAT;5!+ 0(4 Q0    (
M .N&+%0"QN]5Z2 ' *5D30 +              "  4$'  !F;W)M<RTT+FAT
M;5!+ 0(4 Q0    ( .N&+%3G_,.60FP  ,"$   /              "  5,H
M!P!F;W)M<RTT7S P,2YJ<&=02P$"% ,4    " #KABQ47271)[A(  #R4@
M#P              @ '"E < 9F]R;7,M-%\P,#4N:G!G4$L! A0#%     @
MZX8L5+FP-5V["@  7PL   \              ( !I]T' &9O<FUS+31?,# V
M+FIP9U!+ 0(4 Q0    ( .N&+%0B79%]FG<  .-]   /              "
M 8_H!P!F;W)M<RTT7S P-RYJ<&=02P$"% ,4    " #KABQ4WA,O;,XV  !J
M-P  #P              @ %68 @ 9F]R;7,M-%\P,#@N:G!G4$L! A0#%
M  @ ZX8L5$/\,X;V8P( UCL#  X              ( !49<( &9O<FUS+31?
M,#(N:G!G4$L! A0#%     @ ZX8L5"PA]Z2";P( HD@#  X
M ( !<_L* &9O<FUS+31?,#,N:G!G4$L! A0#%     @ ZX8L5!_, 9=L'@
M!"    X              ( !(6L- &9O<FUS+31?,#0N:G!G4$L! A0#%
M  @ ZX8L5*DB>;C&&   9"    X              ( !N8D- &9O<FUS+31?
M,#4N:G!G4$L! A0#%     @ ZX8L5'0/-*U;#@  -H<  !$
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L &=L87$M,C R,3 Y,S!?<')E+GAM;%!+!08     $0 1 !4$   O@PX    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
